note_id
stringlengths
13
15
subject_id
int64
10M
20M
hadm_id
int64
20M
30M
note_type
stringclasses
1 value
note_seq
int64
2
133
charttime
stringlengths
19
19
storetime
stringlengths
19
19
text
stringlengths
1.56k
52.7k
10377545-DS-9
10,377,545
23,317,873
DS
9
2127-11-14 00:00:00
2127-11-23 16:27:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: seizure Major Surgical or Invasive Procedure: Stereotactic brain biopsy on ___ History of Present Illness: Mr. ___ is a ___ man reportedly without significant past medical history transferred from ___ after presenting with concern for a new-onset seizure. Mr. ___ son reports hearing Mr. ___ waking from sleep around 3:10 AM this morning and "speaking to himself," at which time Mr. ___ reportedly used the restroom without incident. After his soon then used the restroom, he found Mr. ___ face down on the ground, stuttering with a "th" sound and "kicking" his legs against the ground. These movements lasted for roughly 2 minutes, during which time Mr. ___ son activated EMS and opened the front door. Following cessation of the movements, Mr. ___ was noted to be confused and speaking in nonsensical portmanteaus, reportedly combining "technical terms" from his employment as an ___ in response to EMS questions. He was subsequently taken to ___, where he received 1,500 mg of levetiracetam, as well as dexamethasone due to CT imaging findings concerning for potential neoplasm. CT of the C-spine, chest, and A/P were also obtained, and were notable only for a 7 mm non-obstructive UPJ stone. Following transfer to ___, Mr. ___ son has noted improvement in Mr. ___ speech and ability to cooperate with an examination, though feels that he has not yet fully returned to his baseline. Of note, Mr. ___ son notes that Mr. ___ has had increased fatigue over the past six months, prompting him to fall asleep during long conversations or to retire earlier to bed after returning from work. Mr. ___ has also had increasing difficulty following conversations with his son over this time, though has not been noted to have difficulty navigating to unfamiliar places or misplacing objects throughout the home. Mr. ___ also notably continues to work as an ___ ___ at ___ for three days per week. Unable to obtain review of systems due to speech disturbance. Past Medical History: None reported Social History: ___ Family History: Negative for stroke, brain malignancy, or demyelinating disease. Physical Exam: ADMISSION PHYSICAL EXAMINATION Vitals: T: 97.6 P: 69 R: 18 BP: 118/67 SpO2: 100% RA General: Somnolent but rousable to voice, in NAD HEENT: NC/AT, no scleral icterus noted, MMM Neck: Supple, no nuchal rigidity Pulmonary: No tachypnea or increased WOB Cardiac: RRR Abdomen: ND Extremities: mild BLE edema Skin: no rashes noted Neurologic: -Mental Status: Somnolent but rousable to voice, not oriented to time or place (reports ___, but "houseschool" instead of hospital). Perseverative speech with neologisms, reporting that he had a "sleepdown" as his chief complaint. Nevertheless able to repeat short phrases and follow midline and appendicular commands. Naming impaired, with neologisms as above. No dysarthria. -Cranial Nerves: II, III, IV, VI: PERRL 4 to 2 mm ___. EOMI without nystagmus. Left ptosis, reportedly new. V: Unable to assess. VII: Mild R NLFF, reportedly chronic. VIII: Hearing intact to conversation. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii bilaterally. XII: Tongue protrudes in midline. -Motor: Mild right-sided pronation without drift. Delt Bic Tri WrE FFl FE IP Quad Ham TA L 5 ___ ___ 5 5 5 R 5 ___ 5 4+ 5 5 5 5 -Sensory: No deficits to light touch or pinprick. No extinction to DSS. -DTRs: Bi Tri ___ Pat Ach L 2 2 2 2 1 R 2 2 2 2 1 -Coordination: No intention tremor or dysmetria on FNF bilaterally. -Gait: Able to stand on own weight and take one step. =================================================== DISCHARGE PHYSICAL EXAM: 24 HR Data (last updated ___ @ 1238) Temp: 97.6 (Tm 98.3), BP: 125/69 (111-139/63-75), HR: 57 (55-62), RR: 20 (___), O2 sat: 99% (96-99), O2 delivery: Ra General: Awake, alert, in NAD HEENT: small healing lac R eyebrow, no scleral icterus noted, MMM Neck: Supple Pulmonary: No tachypnea or increased WOB Cardiac: extremities warm and well perfused Abdomen: Nondistended Extremities: minimal BLE edema Skin: no rashes noted, skin check of extremities, face, and back revealed no obvious melanotic macules -Mental Status: Awake, alert, oriented to person, says he is in ___ then corrects himself. Able to recognize ___ when given options. Continues to process questions slowly and answers slowly. Perseverates on feeling "magnificent." Importantly, he was able to relay that the results from his brain biopsy have not yet been finalized, and is aware that he is going to rehab with a follow-up in brain tumor clinic. Able to follow certain midline commands however demonstrates intermittent right-sided neglect. Today demonstrates mild apraxia with finger substitution, improved from prior. On afternoon re-examination pt finds difficulty in shaking hands with R hand, frustrated that arm does not go where he wants it to go. -Cranial Nerves: II, III, IV, VI: PERRL 3 to 2 mm ___. EOMI without nystagmus. Visual fields intact bilaterally. Mild left ptosis. V: Sensation intact and equal V1-V3 VII: Mild R NLFF, reportedly chronic, mild droop on activation (son reports this has been there since his car accident in ___ VIII: Hearing intact to conversation with hearing aids. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii bilaterally. XII: Tongue protrudes in midline. -Motor: No drift (improved from prior). Normal bulk and tone in upper and lower extremities. Muscle strength ___ throughout however struggles to hoist self up in bed. No adventitious movements. -Sensory: No deficits to light touch, pain, or temperature. -DTRs: Bi Tri ___ Pat Ach L 2 1 1 2 1 R 2 1 1 2+ 1 -Coordination: No intention tremor or dysmetria on FNF bilaterally. -Gait: Not tested Pertinent Results: ___ 08:24AM BLOOD WBC-14.0* RBC-5.11 Hgb-14.2 Hct-43.3 MCV-85 MCH-27.8 MCHC-32.8 RDW-15.3 RDWSD-47.4* Plt ___ ___ 06:20AM BLOOD WBC-14.4* RBC-4.38* Hgb-12.0* Hct-36.9* MCV-84 MCH-27.4 MCHC-32.5 RDW-15.3 RDWSD-47.1* Plt ___ ___ 07:07AM BLOOD WBC-11.1* RBC-4.77 Hgb-13.3* Hct-40.8 MCV-86 MCH-27.9 MCHC-32.6 RDW-15.6* RDWSD-48.3* Plt ___ ___ 08:24AM BLOOD Neuts-92.7* Lymphs-4.1* Monos-2.0* Eos-0.2* Baso-0.4 Im ___ AbsNeut-12.97* AbsLymp-0.57* AbsMono-0.28 AbsEos-0.03* AbsBaso-0.06 ___ 06:34AM BLOOD ___ PTT-18.8* ___ ___ 08:24AM BLOOD Glucose-112* UreaN-17 Creat-0.9 Na-144 K-4.4 Cl-103 HCO3-24 AnGap-17 ___ 07:07AM BLOOD Glucose-77 UreaN-16 Creat-0.8 Na-145 K-4.3 Cl-104 HCO3-24 AnGap-17 ___ 05:20AM BLOOD LD(___)-159 ___ 08:24AM BLOOD ALT-19 AlkPhos-64 TotBili-0.6 ___ 08:24AM BLOOD Lipase-29 ___ 08:24AM BLOOD cTropnT-<0.01 ___ 07:07AM BLOOD Calcium-8.9 Phos-3.3 Mg-2.0 ___ 05:20AM BLOOD TSH-5.2* ___ 05:20AM BLOOD T4-5.8 ___ 05:20AM BLOOD CRP-4.9 ___ 05:20AM BLOOD CRP-4.9 ___ 05:20AM BLOOD b2micro-2.9* ___ 05:20AM BLOOD HIV Ab-NEG ___ 08:24AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG QUANTIFERON(R)-TB GOLD NEGATIVE SED RATE BY MODIFIED 2 < OR = 20 mm/h WESTERGREN CSF: ___ 04:55PM CEREBROSPINAL FLUID (CSF) TNC-3 RBC-1 Polys-0 ___ ___ 04:55PM CEREBROSPINAL FLUID (CSF) TotProt-45 Glucose-62 LD(LDH)-27 Test Result Reference Range/Units BETA ___ MICROGLOBULIN, CSF 2.18 0.36-2.56 mg/L ===================================== ___ CTA head/neck: 1. Dental amalgam streak artifact limits study. 2. Dominant, 3.5 x 2.5 cm heterogeneous left paramedian parietal lobe mass with surrounding vasogenic edema, mild local mass effect, and partial effacement of the posterior left lateral ventricle. 3. Additional, 1.8 x 1.5 cm heterogeneous mildly hyperdense mass within the right parietal temporal lobe, also demonstrating mild local mass effect and surrounding vasogenic edema. Given the multiple intracranial masses, metastatic disease is favored, with multifocal primary neoplasm felt less likely. 4. No evidence for acute intracranial hemorrhage or vascular territorial infarction. Please note MRI of the brain is more sensitive for the detection of acute infarct. 5. 9 mm hypodensity within the left internal capsule may represent a late subacute to early chronic infarct, with focal mass lesion felt less likely. 6. Multifocal atherosclerotic disease throughout the cervical and intracranial vasculature, as above, without high-grade stenosis, occlusion, or aneurysm greater than 3 mm. ___ CSF Cytology: Rare atypical cells with eccentric nuclei in a background of reactive lymphocytes and monocytes. ___ MRI w/wo: 1. Study is moderately degraded by motion. 2. Multiple irregular, heterogeneously enhancing, mixed solid and cystic parenchymal lesions involving the left parietal lobe, right temporal lobe, and left thalamus, concerning for metastatic disease. 3. Mild associated vasogenic edema with local mass effect, particularly involving the dominant left parietal lesion. 4. No evidence for ventricular obstruction or downward herniation. 5. No vascular territorial infarction and no acute intracranial hemorrhage. 6. Paranasal sinus disease , as described. ___ Second opinion CT torso: 1. No evidence for a primary malignancy in the chest and parenchymal organs of the abdomen and pelvis. 2. An indeterminate 1.7 cm lesion in the lower pole of the right kidney most likely represents a hyperdense cyst. This could be confirmed with ultrasound. 3. Nonobstructing 7 mm stone in the distal left ureter, a 1 cm nonobstructing stone in the distal urethra 4. Multiple liver cysts ___ Renal u/s: Simple bilateral cortical renal cysts. ___ ___: 1. No evidence of intracranial hemorrhage status post biopsy. 2. Lesions in the posterior right temporal lobe, the left thalamus and the left parietal-occipital lobes are overall unchanged with a similar amount of mass effect on the left lateral and third ventricles. Brief Hospital Course: Mr. ___ is a ___ year old man with mild cognitive decline who presented to ___ after first-time seizure and was subsequently transferred to ___ for concerning imaging findings found to have three rim-enhancing, heterogenous lesions in the L parietal lobe, L thalamus, and R temporal lobe; frozen section from brain biopsy on ___ revealing high-grade glioma with final pathology pending. On admission to ___ Neurology he was alert and in no distress, endorsing only a mild headache on full review of systems. His exam was notable for difficulty with orientation, processing, naming, memory, apraxia, and attention. He was initially able to follow midline commands but unable to perform cross-body commands. He had no major deficits in primary motor and sensory function, reflexes, or coordination. He was continued on levetiracetam 750mg BID (at ___ he had received 1500mg levetiracetam +dexamethasone) and did not require lorazepam for seizure rescue during his current hospitalization. He has not had any seizures since admission. A significant workup was initiated for multifocal brain lesions, including infectious and neoplastic etiologies. Infectious workup was unrevealing. CT torso did not reveal a primary malignancy. A brain biopsy on ___ revealed high-grade glioma (Based upon frozen section). He was started on dexamethasone 2mg PO daily once this was established. His exam was relatively stable throughout his hospitalization. Although his cognition remains impaired, apraxia, orientation, and ability to follow cross-body improved mildly after he was started on dexamethasone for cerebral edema. We have discussed the possible implications of these results at length with Mr. ___ and his son, ___, who has been at the hospital every day with his dad. This included prognosis and management options, which will be finalized in the ___ clinic once the full pathology details are available. Medications on Admission: None Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 2. Dexamethasone 2 mg PO DAILY 3. Docusate Sodium 100 mg PO BID 4. Famotidine 20 mg PO BID 5. LevETIRAcetam 1000 mg PO Q12H 6. Nitrofurantoin Monohyd (MacroBID) 100 mg PO Q12H Duration: 14 Doses 7. Senna 17.2 mg PO DAILY:PRN Constipation 8. Tamsulosin 0.4 mg PO QHS Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Multifocal high-grade glioma, likely glioblastoma multiforme with final pathology pending (biopsy done ___ Discharge Condition: Mental Status: alert, oriented to person and sometimes place. Mild cognitive impairment demonstrating difficulty with processing, naming, memory, and attention. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Lacks insight into physical limitations with some impulsivity and near-falls in shower. Assistance required with any ambulation or OOB activity. Discharge Instructions: Mr. ___, You were admitted with an event concerning for seizure. We found that you have three masses in your brain. One of them was biopsied, and the very preliminary report is that it is a type of cancer called a glioma. -Call the ___ clinic at ___ to have sutures removed on approx. ___. Alternately, sutures can be removed at brain tumor clinic follow up on that day. It was a pleasure taking care of you. Sincerely, Your ___ Neurology Team Followup Instructions: ___
10377744-DS-21
10,377,744
27,366,727
DS
21
2143-11-08 00:00:00
2143-11-08 17:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Optiray 350 Attending: ___. Chief Complaint: weakness, hyponatremia Major Surgical or Invasive Procedure: None this hospitalization History of Present Illness: ___ with panhypopituitary, HTN, HL who presented today from the ED with 3 days of nausea, vomiting, weakness and dizziness. This began while she was at work on ___, with multiple episodes of non-bloody emesis as well as dizziness. She reports she may have had some abdominal pain that preceded these symptoms by a couple days. She continued to take all of her home medications including prednisone throughout these symptoms. . In the ED, her initial vitals were 98 70 92/57 18 100%. She was found to have a sodium of 110 and was given 2L of normal saline. Transferred to the FICU for sodium correction. . On arrival to the ICU, she continues to feel dizzy with some abdominal pain, but overall feels improved. Past Medical History: hypertension hyperlipidemia panhypopituitarism due to ___ syndrome gastritis positive PPD (finished INH, ___ Social History: ___ Family History: Mother: hypertension Physical ___: ADMISSION EXAM: . Vitals: 98.2 75 95/50 13 96% General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, mildly tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Pertinent Results: ADMISSION LABS: . ___ 12:30PM BLOOD WBC-6.4 RBC-4.13* Hgb-12.2 Hct-32.9* MCV-80*# MCH-29.5 MCHC-37.0*# RDW-11.8 Plt ___ ___ 12:30PM BLOOD Neuts-78.5* Lymphs-13.1* Monos-4.4 Eos-1.4 Baso-2.7* ___ 12:30PM BLOOD Glucose-81 UreaN-8 Creat-0.6 Na-110* K-4.8 Cl-75* HCO3-21* AnGap-19 ___ 05:04PM BLOOD Calcium-7.3* Phos-3.1 Mg-1.4* ___ 12:30PM BLOOD Osmolal-238* ___ 05:04PM BLOOD TSH-<0.02* ___ 08:59PM BLOOD T4-11.4 T3-95 calcTBG-0.87 TUptake-1.15 ___ Free T4-2.1* ___ 05:04PM BLOOD Cortsol-4.0 ___ 05:00PM BLOOD freeCa-1.06* ___ 01:05AM BLOOD freeCa-1.11* ___ 02:11PM BLOOD Lactate-1.4 . . IMAGING STUDIES: ___ CT HEAD W/O CONTRAST - There is no acute intra-axial or extra-axial hemorrhage, mass, midline shift, or territorial infarct. Ventricles, sulci, and basilar cisterns are unremarkable and stable in configuration compared to prior. Note is made of a lipoma within the quadrigeminal plate cistern on the right. Orbits are symmetric and unremarkable. Paranasal sinuses included on this exam are clear. Skull and extracranial soft tissues are unremarkable. . ___ CHEST (PA & LAT) - Right basilar opacity is probably atelectasis, but could represent early or developing pneumonia in the appropriate clinical setting. . Cardiovascular Report ECG Study Date of ___ 12:38:32 ___ Normal sinus rhythm with Q-T interval prolongation. Compared to the previous tracing of ___ the Q-T interval is significantly longer. Clinical correlation is suggested. . MICROBIOLOGIC DATA: ___ Blood culture - ngtd ___ MRSA screen - no ___ DISCHARGE LABS: ___ 11:30AM BLOOD WBC-5.5# RBC-4.24 Hgb-12.5 Hct-34.8* MCV-82 MCH-29.4 MCHC-35.9* RDW-12.7 Plt ___ ___ 06:15AM BLOOD Glucose-70 UreaN-16 Creat-0.6 Na-144 K-4.6 Cl-108 HCO3-28 AnGap-13 ___ 11:30AM BLOOD Calcium-8.9 Phos-1.5*# Mg-2.2 ___ 08:59PM BLOOD T4-11.4 T3-95 calcTBG-0.87 TUptake-1.15 ___ Free T4-2.1* Studies pending at discharge: None Brief Hospital Course: ___ yo female with PMH significant for panhypopituitarism in the setting of postpartum hemorrhage ___ syndrome), hypertension, hyperlipidemia admitted with viral gastroenteritis and adrenal crisis associated with hyponatremia to 110 and hypotension. #Adrenal crisis/Hyponatremia: Patient presented with hyponatremia and hyponatremia to 110 in the setting of an acute illness. It was felt that the patient was relatively adrenally insufficent given his acute illness and was treated with IVF and stress dose hydrocortisone. Sodium rapidly improved and GI symptoms resolved quickly as well. Endocrine was consulted and recommended D5W in addition to DDAVP 0.1mcg IV x1 to promote free water reabsorption and prevent too rapid of correction of sodium. HOwever, they did note that rapid correction of sodium in the setting of steroid repletion was okay and expected. Patient was transitioned from stress dose steroids to a rapid prednisone taper and was discharged on a rapid taper to return to his previous maintenance prednisone regimen of 5mg po daily as his acute illness had resolved. Patient will follow with endocrine as an outpatient. #HYPOTHYROIDISM - Patient has known diagnosis of postpartum hemorrhage leading to panhypopituitarism. Admission TSH < 0.02 with TFTs demonstrating T4 11.4, T3 95, free T4 2.1. Initially IV Levothyroxine was used for replacement but was switched to PO Levothyroxine dosing when GI issues resolved. Patient will follow with endocrine as an outpatient. . CHRONIC CARE #GASTRITIS - Patient was continued on omeprazole 20 mg PO daily #HYPERLIPIDEMIA - Pastient was continued on Simvastatin 5 mg PO daily . #Contact: ___ (daughter) - ___ #Code: FULL #Disposition: Patient was discharged to follow up with Endocrinology in one week and PCP ___ 3 weeks. She will have labs prior to her Endocrine follow up appointment. Patient was counseled on symptoms of adrenal insufficiency and told to call her doctor if she experiences any neurologic symptoms. Medications on Admission: HCTZ 12.5mg daily Levothyroxine 125 mcg daily Losartan 50mg daily Omeprazole 20mg daily Prednisone 5mg daily Simvastatin 5mg daily Calcium carbonate 500mg / Vitamin D 200 unit BID Discharge Medications: 1. prednisone 5 mg Tablet Sig: as directed Tablet PO as directed: Please take: 4 tablets on ___ 2 tablets on ___ ___ tablet/daily thereafter. Disp:*35 Tablet(s)* Refills:*2* 2. simvastatin 10 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily). 3. calcium carbonate 200 mg calcium (500 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO BID (2 times a day). 4. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 5. levothyroxine 125 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily). 6. hydrochlorothiazide 12.5 mg Tablet Sig: One (1) Tablet PO once a day: Please do not restart until ___. 7. losartan 50 mg Tablet Sig: One (1) Tablet PO once a day: Please do not start until ___. 8. Outpatient Lab Work Please draw 1) CBC 2) Chem 7 and send labs STAT. Thanks Discharge Disposition: Home Discharge Diagnosis: Hyponatremia Adrenal insufficiency Viral gastroenteritis Panhypopituitarism Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted with a viral gastroenteritis and adrenal insufficiency causing very low sodium levels. Your viral gastroenteritis improved and your symptoms improved with appropriate steroid replacement. You are being discharged on a prednisone taper. You should take 20mg of prednisone on ___, 10mg of prednisone on ___ and resume your usual 5mg daily of prednisone on ___. You should also follow up with both your PCP and ___ in the next few weeks as detailed below. You are being given a prescription to have your labs drawn on the morning ___. Please arrive a few hours before your appointment to have your labs drawn in the ___ or ___ Associates laboratory. Please call your doctor if you experience any fevers, chills, low energy, malaise, abdominal pain, feel as if you are going to pass out, or notice any focal weakness, difficulties moving, or changes in sensation. Followup Instructions: ___
10377951-DS-2
10,377,951
27,882,555
DS
2
2120-10-29 00:00:00
2120-10-29 07:16:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: ORTHOPAEDICS Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: leg pain Major Surgical or Invasive Procedure: ___ Microdiscectomy LEFT History of Present Illness: This patient is a ___ year old male who complains of LEFT LEG PAIN. Patient presents with significant left leg pain and numbness. Patient had an MRI which showed a left-sided disc herniation at L3-L4. Patient denies any fevers or chills. The patient denies any bowel or bladder issues. Past Medical History: Deviated septum, status post surgery in ___. Current Medications: Aleve and tramadol. Allergies: No known drug allergies. Social History: ___ Family History: Negative. Brief Hospital Course: Patient was admitted to the ___ Spine Surgery Service and taken to the Operating Room for the above procedure. Refer to the dictated operative note for further details. The surgery was without complication and the patient was transferred to the PACU in a stable condition. TEDs/pnemoboots were used for postoperative DVT prophylaxis. Intravenous antibiotics were continued for 24hrs postop per standard protocol. Initial postop pain was controlled with a PCA. Diet was advanced as tolerated. The patient was transitioned to oral pain medication when tolerating PO diet. Hospital course was otherwise unremarkable. On the day of discharge the patient was afebrile with stable vital signs, comfortable on oral pain control and tolerating a regular diet. Discharge Medications: 1. Acetaminophen 650 mg PO Q6H RX *acetaminophen 650 mg 1 tablet extended release(s) by mouth every six (6) hours Disp #*100 Tablet Refills:*0 2. Diazepam 2.5-5 mg PO Q6H:PRN pain, spasm RX *diazepam 5 mg 0.5 - 1 tab by mouth every six (6) hours Disp #*20 Tablet Refills:*0 3. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*50 Capsule Refills:*0 4. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN Pain RX *oxycodone 5 mg ___ tablet(s) by mouth q4-6h Disp #*50 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Herniated lumbar disc Discharge Condition: Good Discharge Instructions: You have undergone the following operation: Minimally Invasive Microdiscectomy Immediately after the operation: • Activity: You should not lift anything greater than 10 lbs for 2 weeks. You will be more comfortable if you do not sit or stand more than ~45 minutes without moving around. • Rehabilitation/ Physical Therapy: ___ ___ times a day you should go for a walk for ___ minutes as part of your recovery. You can walk as much as you can tolerate. ___ Limit any kind of lifting. • Diet: Eat a normal healthy diet. You may have some constipation after surgery. • Brace: You do not need a brace. • Wound Care: Remove the dressing in 2 days. If the incision is draining cover it with a new sterile dressing. If it is dry then you can leave the incision open to the air. Once the incision is completely dry (usually ___ days after the operation) you may take a shower. Do not soak the incision in a bath or pool. If the incision starts draining at anytime after surgery, do not get the incision wet. Cover it with a sterile dressing. Call the office. • You should resume taking your normal home medications. • You have also been given Additional Medications to control your pain. Please allow 72 hours for refill of narcotic prescriptions, so please plan ahead. You can either have them mailed to your home or pick them up at the clinic located on ___. We are not allowed to call in narcotic prescriptions (oxycontin, oxycodone, percocet) to the pharmacy. In addition, we are only allowed to write for pain medications for 90 days from the date of surgery. • Follow up: ___ Please Call the office and make an appointment for 2 weeks after the day of your operation if this has not been done already. ___ At the 2-week visit we will check your incision, take baseline X-rays and answer any questions. We may at that time start physical therapy. ___ We will then see you at 6 weeks from the day of the operation and at that time release you to full activity. Please call the office if you have a fever>101.5 degrees Fahrenheit and/or drainage from your wound Followup Instructions: ___
10378026-DS-6
10,378,026
24,981,696
DS
6
2129-08-08 00:00:00
2129-08-08 14:35:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: SMA thrombus and renal infarcts Major Surgical or Invasive Procedure: ___: Exploratory laparotomy, SMA embolectomy and ABThera placement ___: Second look laparotomy and closure of open abdomen History of Present Illness: ___ with cognitive delay/?dementia and afib (two weeks off Xarelto) who presented to OSH with nausea. CT showed SMA occlusion and left renal infarct. He was started on heparin drip, received Metoprolol for HR 130s and 3L NS. He was transferred to ___. Past Medical History: Medical History CAD, DM, B-cell lymphoma, s/p rituximab with resolution, atrial fib, HLD Surgical History: denies, no surgical scars Social History: ___ Family History: unknown Physical Exam: ADMISSION PHYSICAL EXAM: ==================================== T 98.2 HR 118 BP 172/89 RR 24 SatO2 100% RA Combative Oriented to person, disoriented to time and place Irregular heart rate CTA bil Abdomen soft, mild tenderness to palpation ___ R lower abdomen Umbilical hernia without skin changes, appears non tender No edema, palpable DP bilaterally DISCHARGE PHYSICAL EXAM: ==================================== VS: 24 HR Data (last updated ___ @ 2224) Temp: 97.8 (Tm 99.2), BP: 137/84 (101-166/58-84), HR: 78 (51-108), RR: 18 (___), O2 sat: 96% (96-99), O2 delivery: Ra GENERAL: Alert, interactive, NAD HEENT: NC/AT, EOMI, sclera anicteric w/o injection, clear OP, MMM CARDIAC: Irregular rhythm, regular rate, II/VI systolic murmur LUNGS: CTAB, no wheezes, unlabored respirations ABDOMEN: soft, non-distended, no ttp, +BS, midline surgical incision c/d/I w/ staples ___ place EXTREMITIES: No lower extremity edema, 2+ radial/DP pulses SKIN: No rash, warm NEUROLOGIC: A/Ox2, moving upper extremities with purpose Pertinent Results: ADMISSION LABS: ====================================== ___ 11:26PM BLOOD WBC-11.0* RBC-4.36* Hgb-13.4* Hct-40.7 MCV-93 MCH-30.7 MCHC-32.9 RDW-14.2 RDWSD-48.1* Plt ___ ___ 11:26PM BLOOD ___ PTT-150* ___ ___ 06:10PM BLOOD Glucose-253* UreaN-19 Creat-1.0 Na-144 K-3.2* Cl-101 HCO3-18* AnGap-25* ___ 11:26PM BLOOD Calcium-7.7* Phos-2.7 Mg-1.7 ___ 11:33PM BLOOD Type-ART pO2-402* pCO2-37 pH-7.39 calTCO2-23 Base XS--1 ___ 06:17PM BLOOD Lactate-7.1* ___ 08:23PM BLOOD Glucose-204* Lactate-4.6* Na-142 K-2.8* Cl-109* ___ 11:33PM BLOOD Glucose-153* Lactate-3.1* K-3.3 MICROBIOLOGY ====================================== __________________________________________________________ ___ 12:11 am STOOL CONSISTENCY: NOT APPLICABLE Source: Stool. **FINAL REPORT ___ C. difficile DNA amplification assay (Final ___: Negative for toxigenic C. difficile by the Cepheid nucleic acid amplification assay.. (Reference Range-Negative). __________________________________________________________ ___ 3:36 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. __________________________________________________________ ___ 3:36 pm BLOOD CULTURE Source: Line-peripheral. **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. ___ 8:13 pm Mini-BAL **FINAL REPORT ___ GRAM STAIN (Final ___: 3+ ___ per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. 1+ (<1 per 1000X FIELD): GRAM POSITIVE COCCI. ___ PAIRS AND SINGLY. 1+ (<1 per 1000X FIELD): GRAM NEGATIVE DIPLOCOCCI. RESPIRATORY CULTURE (Final ___: 10,000-100,000 CFU/mL Commensal Respiratory Flora. KLEBSIELLA OXYTOCA. >100,000 CFU/mL. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. STAPH AUREUS COAG +. 10,000-100,000 CFU/mL. GRAM NEGATIVE ROD #2. ~4000 CFU/mL. FURTHER WORKUP ON REQUEST ONLY. Isolates are considered potential pathogens ___ amounts >=10,000 cfu/ml. HAEMOPHILUS INFLUENZAE, BETA-LACTAMASE NEGATIVE. >100,000 CFU/mL. Beta-lactamse negative: presumptively sensitive to ampicillin. Confirmation should be requested ___ cases of treatment failure ___ life-threatening infections.. KLEBSIELLA OXYTOCA. 10,000-100,000 CFU/mL. Piperacillin/tazobactam sensitivity testing available on request. SENSITIVITIES: MIC expressed ___ MCG/ML _________________________________________________________ KLEBSIELLA OXYTOCA | STAPH AUREUS COAG + | | KLEBSIELLA OXYTOCA | | | AMPICILLIN/SULBACTAM-- 4 S =>32 R CEFAZOLIN------------- <=4 S =>64 R CEFEPIME-------------- <=1 S <=1 S CEFTAZIDIME----------- <=1 S <=1 S CEFTRIAXONE----------- <=1 S 2 I CIPROFLOXACIN---------<=0.25 S <=0.25 S CLINDAMYCIN----------- <=0.25 S ERYTHROMYCIN---------- <=0.25 S GENTAMICIN------------ <=1 S <=0.5 S <=1 S LEVOFLOXACIN---------- =>8 R MEROPENEM-------------<=0.25 S <=0.25 S OXACILLIN------------- 0.5 S PIPERACILLIN/TAZO----- <=4 S TETRACYCLINE---------- <=1 S TOBRAMYCIN------------ <=1 S <=1 S TRIMETHOPRIM/SULFA---- <=1 S =>16 R <=1 S RELEVANT STUDIES ====================================== ___ TTE: The left atrial volume index is moderately increased. No atrial septal defect is seen by 2D or color Doppler. There is mild symmetric left ventricular hypertrophy. The left ventricular cavity size is normal. Due to suboptimal technical quality, a focal wall motion abnormality cannot be fully excluded. Overall left ventricular systolic function is normal (LVEF = 70%). Right ventricular chamber size and free wall motion are normal. The number of aortic valve leaflets cannot be determined. The aortic valve leaflets are moderately thickened. There is mild aortic valve stenosis. Trace aortic regurgitation is seen. The mitral valve appears structurally normal with trivial mitral regurgitation. There is mild pulmonary artery systolic hypertension. There is no pericardial effusion. ___ CT HEAD W/O CONTRAST: 1. No evidence of mass, hemorrhage or recent infarction. 2. Ventricular enlargement raises the possibility of communicating hydrocephalus. 3. Findings indicating chronic small vessel ischemia. ___ CT HEAD W/O CONTRAST: No acute intracranial process. DISCHARGE LABS ====================================== ___ 08:00AM BLOOD WBC-6.3 RBC-3.46* Hgb-10.4* Hct-33.1* MCV-96 MCH-30.1 MCHC-31.4* RDW-15.5 RDWSD-53.6* Plt ___ ___ 08:00AM BLOOD ___ PTT-33.3 ___ ___ 08:00AM BLOOD Glucose-97 UreaN-9 Creat-0.8 Na-145 K-4.4 Cl-109* HCO3-27 AnGap-9* Brief Hospital Course: Mr. ___ is a ___ male with A. fib, cognitive impairment who was admitted with SMA and left renal artery emboli ___ the setting of anti-coagulation noncompliance at home. # SMA EMBOLUS # LEFT RENAL ARTERY EMBOLUS: Patient presented with abdominal pain, nausea, and vomiting with elevated lactate. CT abdomen/pelvis at outside hospital showed thrombus within SMA throughout majority of the SMA. Patient had history of A. Fib and had been off anti-coagulation for two weeks. He had exploratory laparotomy, SMA thrombectomy, and ABThera vac placement over his abdomen. Patient developed hemorrhagic shock from muscular hemorrhage ___ the SICU and had second look laparotomy and abdominal closure. Patient was anti-coagulated with heparin gtt and transitioned to warfarin, remaining hemodynamically stable. He will be discharged on warfarin to a rehab facility. # ATRIAL FIBRILLATION: Patient has A. fib and was non-compliant with Xarelto. He developed A. fib w/ RVR ___ the ICU requiring diltiazem gtt which was transitioned to PO diltiazem. Patient was discharged on Metoprolol Succinate XL 75 mg PO daily, Diltiazem ER 360 mg PO daily, and warfarin for anti-coagulation. # HYPOXEMIA: # ASPIRATION PNEUMONIA: Patient was intubated ___ and was extubated on ___. Patient had suspected aspiration of tube feeds on ___ and subsequently became more unresponsive throughout the day. He was re-intubated for airway protection and successfully extubated ___. Patient had fever, known aspiration event, and leukocytosis and was treated for aspiration pneumonia with Zosyn from ___ and then Cefepime from ___. Sputum culture grew Klebsiella oxytoca sensitive to Cefepime and coag + staph aureus. Patient failed speech and swallow bedside eval on ___ and recommendation was for strict NPO. Tolerating PO intake now and meeting nutritional requirements. Dobhoff removed ___ and patient tolerating PO intake. # DYSPHAGIA: Patient had Dobhoff feeding tube placed while intubated. Feeding tube was kept after patient had aspiration event. Speech and swallow evaluated patient and recommended strict NPO. Patient was re-evaluated four days later and patient tolerated diet advancement. Nutrition evaluated patient and determined patient had adequate PO intake to meet nutritional requirements. Dobhoff feeding tube was removed prior to discharge. #CAD: Continued Atorvastatin 80 mg QHS, not on asa 81 given bleed this admission #HTN: continued amlodipine #Nutrition: continued MVI/minerals and supplements per nutrition recs #Cognitive impairment: not formally diagnosed. Known to have behavioral disturbances and paranoia at home (e.g. calling FBI on meals on wheels). Currently amenable to team's plan including going to rehab. Has HCP signed ___ chart. SW consulted for future guardianship pursual as current HCP does not want to be decision maker permanently. This may be further discussed after discharge. Seroquel was discontinued and patient remained calm and amenable to team plan throughout the week prior to discharge. #DM: newly diagnosed this admission and monitored on SSI TRANSITIONAL ISSUES =============================== [] Vascular Surgery follow-up scheduled for ___ at 10 AM. Patient has CTA abdomen/pelvis ordered for the same day and should have prior to vascular surgery follow-up appointment. CTA is to evaluate for any interval changes ___ the SMA after SMA embolectomy. [] General Surgery follow-up scheduled for ___ at 1 ___. [] initiated on Coumadin this admission given better ability to monitor INR over xarelto and given noncompliance with medication ___ the past [] HCP amenable to assisting with healthcare decisions; however, may consider guardianship pursual ___ the future as there is concern about ability to care for himself [] DNR/DNI [] HCP ___ ___ ___ Medications on Admission: amlodipine 10 mg daily atorvastatin 80mg daily metoprolol succinate 100 mg ER daily Xarelto 20 mg daily (non-compliant) Discharge Medications: 1. Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL TID 2. Diltiazem Extended-Release 360 mg PO DAILY 3. Multivitamins W/minerals 1 TAB PO DAILY 4. Warfarin 2 mg PO ONCE Duration: 1 Dose 5. Metoprolol Succinate XL 75 mg PO DAILY 6. Atorvastatin 80 mg PO QPM Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary diagnosis: SMA Embolus Left renal artery embolus Hemorrhagic shock Aspiration Pneumonia Atrial fibrillation with RVR Secondary diagnosis: Coronary artery disease Diabetes mellitus Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___. Why was I here? - You were having nausea, vomiting, and abdominal pain. You had a CT scan of your abdomen which showed a blood clot ___ one of your abdomen and kidney arteries. What was done for me while I was here? - You had surgery to remove the blood clots from your abdomen and kidney arteries. - You had bleeding after your surgery and had a repeat surgery to stabilize the bleeding. - You had pneumonia and were treated with antibiotics. - You had difficulty swallowing and had a feeding tube placed to give you nutrition. When your swallowing improved, your feeding tube was removed. - You were started on a different blood thinner called Coumadin. You are on a blood thinner because you have a heart arrhythmia called atrial fibrillation. What should I do when I go home? - You should take all of your medications as prescribed. - You should attend all of your follow-up appointments. We wish you the best ___ the future. Sincerely, Your ___ Care Team Followup Instructions: ___
10378079-DS-33
10,378,079
20,155,894
DS
33
2131-06-26 00:00:00
2131-06-27 22:22:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Headache Major Surgical or Invasive Procedure: None History of Present Illness: Patient received Ommmya shunt placement on ___. She tolerated the procedure well. She complains of sudden onset headache that woke her up from her sleep at 2 AM today. She reports there is no change in the severity of the pain since, it is ___, diffuse, non radiating, accompanied with 4 episodes of vomiting. She denies weakness or numbness, bowel or bladder retention or incontinence. She reports she had some subjective fevers before but no chills. No recorded temperatures to confirm fevers. No blood seen in vomitus. No other sx per pt. No gait imbalance, no bowel or bladder habit changes per pt. Past Medical History: -CNS lymphoma (see below) -Depression -HSV infection during MTX treatment in the past -GERD -HTN Oncological History: She initially presented with headaches, dizziness, and diplopia and then had a head MRI of the brain showed a tectal mass and three areas of nodular enhancement on the ventricular surfaces, concerning for brain metastases with ventricular seeding. -___: Stereotactic biopsy confirmed high-grade B-cell lymphoma. -___: CT torso negative. -___: Started 5 cycles of induction high-dose methotrexate. Social History: ___ Family History: She has 6 healthy children and a nephew with a brain tumor. Physical Exam: ADMISSION PHYSICAL EXAM: General: NAD VITAL SIGNS: 98.7 PO 140 / 70 99 16 97% RA HEENT: MMM, no OP lesions, no cervical, supraclavicular, or axillary adenopathy, no thyromegaly. Eyes PERRL bilaterally. CV: RR, NL S1S2 no S3S4 MRG PULM: CTAB ABD: BS+, soft, NTND, no masses or hepatosplenomegaly LIMBS: No edema, clubbing, tremors, or asterixis; SKIN: No rashes or skin breakdown NEURO: Cranial nerves II-XII are within normal limits excluding visual acuity which was not assessed, no nystagmus; strength is ___ of the proximal and distal upper and lower extremities; reflexes are 2+ of the patellar, and Achilles tendons DISCHARGE PHYSICAL EXAM: VS: 98.1 PO 114 / 70 80 18 98 RA GEN: Alert, responsive, NAD HEENT: MMM, no OP lesions, no cervical, supraclavicular, or axillary adenopathy, no thyromegaly. Eyes PERRL bilaterally. CV: RR, NL S1S2 no S3S4 MRG PULM: CTAB ABD: BS+, soft, NTND, no masses or hepatosplenomegaly LIMBS: No edema, clubbing, tremors, or asterixis SKIN: No rashes or skin breakdown NEURO: Cranial nerves II-XII are within normal limits excluding visual acuity which was not assessed, no nystagmus; strength is ___ of the proximal and distal upper and lower extremities; reflexes are 2+ of the patellar, and Achilles tendons Pertinent Results: ADMISSION LABS ___ 02:40PM BLOOD WBC-14.3*# RBC-2.41* Hgb-7.9* Hct-25.3* MCV-105* MCH-32.8* MCHC-31.2* RDW-23.0* RDWSD-84.0* Plt ___ ___ 02:40PM BLOOD Neuts-78* Bands-5 Lymphs-7* Monos-6 Eos-0 Baso-0 ___ Myelos-4* AbsNeut-11.87* AbsLymp-1.00* AbsMono-0.86* AbsEos-0.00* AbsBaso-0.00* ___ 02:40PM BLOOD Glucose-126* UreaN-6 Creat-0.5 Na-136 K-4.0 Cl-102 HCO3-24 AnGap-14 ___ 02:40PM BLOOD Calcium-8.7 Phos-4.2 Mg-1.9 ___ 02:40PM BLOOD ___ Folate-9.9 ___ 02:40PM BLOOD Lactate-1.0 DISCHARGE LABS ___ 04:45AM BLOOD WBC-4.2 RBC-2.30* Hgb-7.7* Hct-24.0* MCV-104* MCH-33.5* MCHC-32.1 RDW-22.2* RDWSD-83.4* Plt ___ ___ 04:45AM BLOOD Glucose-163* UreaN-8 Creat-0.6 Na-139 K-4.4 Cl-103 HCO3-27 AnGap-13 ___ 04:45AM BLOOD Calcium-9.1 Phos-3.7 Mg-2.1 MICROBIOLOGY ___ 2:40 pm BLOOD CULTURE Blood Culture, Routine (Pending): No growth to date. ___ 5:30 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: < 10,000 CFU/mL. IMAGING ___ ___ IMPRESSION 1. Compared to ___, no significant change. No evidence of infarction, hemorrhage, edema or mass. 2. As before, the patient is status post right Ommaya reservoir placement. 3. Sinus disease as above. CXR ___: No acute intrathoracic process. Brief Hospital Course: ___ is a ___ with a history of a tectal primary CNS lymphoma, who now has an aggressive non-Hodgkin's systemic lymphoma being treated with rituximab/EPOCH (Cycle 4 Day 1: ___ Cycle end: ___ with IT chemotherapy prophylaxis, s/p Ommaya placement ___, presenting two days after the procedure with an acute headache and vomiting but without evidence of acute process on CT head. 1. Headache: Differential includes possible post procedural headache vs infectious complication vs new mechanical obstruction from port placement, though CT is reassuring against hemorrhage or ventricular obstruction. The patient was been evaluated by neurosurgery, who feels that acute process is unlikely according to repeat CT and that no intervention is indicated. Patient was afebrile and hemodynamically stable; headache improved throughout admission; patient without new neurological deficit. Blood, urine cultures without growth. Pain was controlled with Tylenol and PO oxycodone. 2. Orbital Swelling: Per neurosurgery, orbital swelling was complication of port placement and not concerning for infection. Patient does not have pain in the eye, vision changes, fever, leukocytosis. 3. Leukocytosis: Patient with WBC of 48.6 on ___ prior to admission, trended down to 4.2 on discharge. Could have been ___ to neupogen administration with ongoing chemotherapy. 4. IT Chemotherapy for Aggressive Systemic Lymphoma: She is at risk for CNS progression or leptomeningeal involvement. She is being treated with multiple cycles of rituximab/EPOCH Per Neuro onc- needs IT chemotherapy. Will receive IT chemotherapy at appointment on ___. 5. CNS Lymphoma: Stable, though patient should have repeat HIV testing as outpatient (last negative in ___. 6. Macrocytic Anemia: Appears near her recent baseline. Likely ___ known lymphoma and chemotherapy. Folate WNL, B12 above normal. -Continue to trend CBC ***TRANSITIONAL ISSUES*** -Patient scheduled for IT methotrexate for CNS prophylaxis on ___ with Dr. ___. Please see appointment above. -Started on dexamethasone 4mg po daily for headache -Code: Full -Contact: Phone: ___ ___ cell, ___ SON'S PHONE ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Acyclovir 400 mg PO Q8H 2. FLUoxetine 40 mg PO DAILY 3. LaMIVudine 100 mg PO DAILY 4. Filgrastim 480 mcg SC Q24H 5. Nystatin Oral Suspension 5 mL PO QID:PRN mouth pain 6. Simvastatin 40 mg PO QPM 7. Sulfatrim (sulfamethoxazole-trimethoprim) 400-80 (10mL) mg oral DAILY 8. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild Discharge Medications: 1. Dexamethasone 4 mg PO DAILY RX *dexamethasone 4 mg 1 tablet(s) by mouth daily Disp #*14 Tablet Refills:*0 2. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 3. Acyclovir 400 mg PO Q8H 4. Filgrastim 480 mcg SC Q24H 5. FLUoxetine 40 mg PO DAILY 6. LaMIVudine 100 mg PO DAILY 7. Nystatin Oral Suspension 5 mL PO QID:PRN mouth pain 8. Simvastatin 40 mg PO QPM 9. Sulfatrim (sulfamethoxazole-trimethoprim) 400-80 (10mL) mg oral DAILY Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis: Headache Secondary Diagnosis: CNS Lymphoma Leukocytosis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted to ___ with worsening headache. In the Emergency Department you had a CT scan which did not show anything concerning. This is likely due to the recent ___ reservoir placement. You were treated with pain medications, and this improved. We also started you on a medication called Dexamethasone, which you should take daily until you follow-up with Dr. ___ as an outpatient. You are scheduled to follow-up with Dr. ___ on ___ for your ongoing therapy. See below for details. It was a pleasure taking care of you, Your ___ Team Followup Instructions: ___
10378079-DS-38
10,378,079
25,618,479
DS
38
2131-10-06 00:00:00
2131-10-06 21:49:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ ___ Complaint: back pain Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ with a history of a tectal primary CNS lymphoma, who now has an aggressive non-Hodgkin's systemic lymphoma being treated with rituximab/EPOCH with IT chemotherapy prophylaxis, s/p Ommaya placement. Patient states that she has had a few weeks of a lower back pain. Symptoms have progressively gotten worse the point where she is unable to walk now due to the pain. No fevers or chills. Endorses a cough and some shortness of breath. This is new over last 3 days. Denies any bowel or bladder incontinence. No numbness or tingling in her lower extremities. Denies any falls or trauma to her back. In the ER, patient had a normal rectal tone per ER report, she had Lower t-spine and l-spine tenderness. amd ___ strength in bilateral lower extremities. she underwent CT of T and L spine which showed Interval progression of T12 and L3 vertebral body compression deformities. No new fractures were noted. She was admitted for pain control. On floor here pt reports that the pain has been present since last 4 weeks. She mentions that the pain has worsened progressively in the last 2 weeks and because of the pain sshe is hardly able to move. She mentions that she has some sx of urge incontinence in the last week. "I lose urine before I reach the toilet" no retention. no lower extremity weakness or sensory changes. Her pain is mostly in lower back, ___ ___nd ___ on movements. She tries not o move because of the pain. REVIEW OF SYSTEMS: GENERAL: No fever, chills, HEENT: No sores in the mouth, painful swallowing, DENIED DYSPHAGIA. CARDS: No chest pain, chest pressure, exertional symptoms, or palpitations. PULM: No cough, shortness of breath, hemoptysis, or wheezing. GI: No nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel habits, hematochezia, or melena. GU: No dysuria or change in bladder habits. MSK: as above. DERM: Denies rashes, itching, or skin breakdown. NEURO: No headache, visual changes, numbness/tingling, paresthesias, or focal neurologic symptoms. Past Medical History: (1) a stereotaxic mid-brain biopsy on ___, (2) received 5 cycles of induction high-dose methotrexate (3) s/p 8 cycles of maintenance high-dose methotrexate until ___, (4) s/p total left hip replacement on ___ for osteonecrosis, (5) bx of right cervical lymph node ___ at ___ that showed aggressive nonHodgkin's lymphoma, unclassified but intermediate between diffuse large cell and Burkitt's lymphoma, (6) admission to ___ Service on ___ for evaluation and management of lymphoma with 39.4 WBC, 10.0 Hb, 29.9 Hct and 109 plt (7) LP ___ with ___ WBC, 473-550 RBC, 44 protein, and received one dose of IT methotrexate, (8) started C1 EPOCH on ___, (9) CSF showed 7 WBC, 473 RBC, 44 protein, and received IT MTX (10) LP ___ 11 WBC ___ RBC 149 prtn 111 LDH rec'd IT MTX (11) head MRI on ___ showed no gross lymphoma in the brain, (12) received rituximab 100 mg on ___, (13) received rituximab 600 mg on ___, (14) C2 EPOCH on ___, (15) received IT methotrexate on ___, (16) received IT liposomal cytarabine on ___, (17) echocardiogram showed normal EF at 60%, (18) C3 EPOCH with rituximab and IT liposomal cytarabine on ___, (19) C4 EPOCH with rituximab and IT liposomal cytarabine on ___, (20) ___ reservoir placement on ___, and admission to OMED (22) C4 IT liposomal cytarabine on ___ (23) C5 IT liposomal cytarabine and rituxan on ___ (24) C5 of EPOCH on ___ PAST MEDICAL HISTORY: - CNS lymphoma/systemic lymphoma as above - Depression - HSV infection during MTX treatment in the past - GERD - HTN - Cold aggluitinin disease (resolved) - HBcAb Positive; VL negative Social History: ___ Family History: she has 6 healthy children and a nephew with a brain tumor. Physical Exam: ADMISSION PHYSICAL EXAM: General: NAD VITAL SIGNS: 98.1 PO 137 / 78 73 16 93 RA HEENT: MMM, no OP lesions, CV: RR, NL S1S2 no S3S4 MRG PULM: CTAB, no wheezes or crackles. Back- lower back tenderness. Pt refuses palpation of back because of pain. Pain present in both midline and bilateral lower back as well. She guargs her back when moving. No tenderness in thoracic or cervical verterbral region. ABD: BS+, soft, NTND, LIMBS: No edema, clubbing, tremors, or asterixis; no inguinal adenopathy SKIN: No rashes or skin breakdown NEURO: B/L ___ ___ strength. Normal sensation on both lower extremities. Tested DTR but absent in both patella. DISCHARGE PHYSICAL EXAM: GEN: lying in bed, NAD Neuro: ___ L ankle dorsiflexion, ___ L eversion. ___ inversion, ___ ankle flexion, ___ throughout otherwise HEENT: mmm; CV: RRR, +S1/S2, no M/R/G PULM: CTAB ABD: non-distended, soft, non-tender LIMBS: No edema, clubbing, warm distal extremities SKIN: No rashes or skin breakdown Pertinent Results: ADMISSION LABS: ___ 10:31PM BLOOD WBC-4.4 RBC-2.90* Hgb-10.0* Hct-31.2* MCV-108* MCH-34.5* MCHC-32.1 RDW-16.3* RDWSD-64.4* Plt ___ ___ 10:31PM BLOOD Neuts-59 Bands-0 ___ Monos-7 Eos-0 Baso-0 ___ Myelos-0 AbsNeut-2.60 AbsLymp-1.50 AbsMono-0.31 AbsEos-0.00* AbsBaso-0.00* ___ 10:31PM BLOOD Glucose-148* UreaN-16 Creat-0.5 Na-136 K-4.4 Cl-98 HCO3-24 AnGap-18 ___ 10:31PM BLOOD Calcium-9.1 Phos-4.0 Mg-2.2 IMAGING: CT T&L spine ___: IMPRESSION: 1. Study is mildly degraded by motion plan streak artifact secondary to patient's left hip prosthesis. 2. Interval progression of T12 and L3 vertebral body compression deformities compared to ___ prior exam, as described. 3. No definite new fractures identified. 4. Multilevel degenerative changes as described, most pronounced at L3-4, where there is mild vertebral canal narrowing. 5. Question right upper lobe nonspecific patchy opacities versus artifact. If findings are not artifactual, differential considerations include infectious, inflammatory, neoplastic etiologies. If clinically indicated, consider dedicated chest imaging. MRI T&L spine ___: IMPRESSION: 1. Pathologic compression fracture of T12 and likely L5 vertebral bodies. 2. Mild compression fractures of L1 and L5 are new from ___. Chronic compression fractures of T12 and L3 vertebral bodies. 3. Mild multilevel degenerative changes within the thoracolumbar spine, as detailed above. ADDENDUM Addendum to impression 1: The compression fractures at T12 may be secondary to osteoporosis or underlying pathologic process. Since this process has been going on for sometime, it is difficult to make a distinction on imaging alone at this stage. However, the compression of the superior endplate of L5 has an appearance of osteoporotic compression. Please note, there is redemonstration of T1 hypointensity at C2 through C4 levels. Dedicated cervical spine MRI is recommended to further assess. The cervical spine MRI will help in further assessing for bony infiltrative process. ___ CT Chest: IMPRESSION: The previously noted FDG avid nodule in the right upper lobe is in fact composed of multiple small peribronchial nodules which have decreased in size and number on today's study compared to previous PET-CT done ___. This favors an improved infective process. Mycobacterium should be considered in the differential diagnosis. No thoracic lymphadenopathy. ___ CT Head w/o contrast: 1. No evidence of acute hemorrhage, edema, or mass effect. 2. Increased aerosolized secretions in the maxillary sinuses bilaterally, suspicious for acute sinusitis. ___ L SPINE W/O CONTRAST IMPRESSION: 1. Status post T12, L5 kyphoplasty. 2. There are T11, L1, L4 compression fractures, which are new since ___, with suggestion of edema on motion degraded STIR images, suggesting component of acute or chronic compression fractures. 3. There is moderate central canal narrowing at T10-T11, T11-T12, T12-L1 levels, similar. 4. Multilevel degenerative changes in the lumbar spine as above. ___ HEAD AND CTA NECK IMPRESSION: 1. Right frontal approach Ommaya reservoir 2. 3. Right pulmonary apex opacities, new since ___ reflect infection. Normal head and neck CTA. ___ L-SPINE W/O CONTRAST Final Report EXAMINATION: CT L-SPINE W/O CONTRAST Q331 CT SPINE. INDICATION: ___ year old woman with h/o CNS lymphoma, hodgkins, h/o compression fractures, s/p T12 and L5 over weekend. New onset weakness // eval for acute pathology. TECHNIQUE: Non-contrast helical multidetector CT was performed. Soft tissue and bone algorithm images were generated. Coronal and sagittal reformations were then constructed. DOSE: Acquisition sequence: 1) Spiral Acquisition 10.9 s, 35.3 cm; CTDIvol = 40.2 mGy (Body) DLP = 1,388.7 mGy-cm. Total DLP (Body) = 1,389 mGy-cm. COMPARISON: CT L-spine without contrast from ___. FINDINGS: Patient status post kyphoplasties of the T12 and L5 vertebral levels. Bones appear diffusely osteopenic. There has been interval vertebral body height loss of the L1 vertebrae compared to the prior exam in ___, compatible with likely subacute compression fracture, no significant retropulsion is seen. Alignment is otherwise maintained. There is multilevel degenerative changes seen in the lumbosacral spine including loss of intervertebral disc height, facet joint arthropathy, and osteophyte formation. Mild multilevel spinal canal narrowing is identified due to posterior osteophyte formation and disc bulge. There is no evidence of neural foraminal stenosis. There is no prevertebral soft tissue swelling.There is no evidence of infection or neoplasm. Limited views of the abdomen are remarkable for atherosclerotic calcifications in the intra-abdominal aorta. IMPRESSION: 1. Patient is status post kyphoplasties of the T12 and L5 vertebral levels. There has been interval vertebral body height loss of the L1 vertebrae and compared to the prior exam in ___, likely subacute compression fracture. 2. Diffuse osteopenia and multilevel degenerative changes are similar to prior exam in ___. ___ FINDINGS: 1. T12 and L5 compression fractures corresponding to the known CT and MRI locations. 2. Successful T12 vertebral body biopsy 3. Successful kyphoplasty at the T12 level with good cement filling of the superior endplate, the area of fracture 4. Successful L5 vertebral body biopsy 5. Successful kyphoplasty at the L5 level with good cement filling of the entire vertebral body including the superior endplate. IMPRESSION: Successful kyphoplasty of T12 and L5 with biopsies of both areas as well. ___: BONE, BIOPSY FOR TUMOR SPECIMEN 1: BONE, LUMBAR VERTEBRAE 5, BIOPSY. DIAGNOSIS: FRAGMENTS OF BONE WITH MATURING TRILINEAGE HEMATOPOIESIS WITH NO EVIDENCE OF MYELOMA, LYMPHOMA OR MYELOID NEOPLASM. SEE NOTE. SPECIMEN 2: BONE, THORACIC VERTEBRAE 12, BIOPSY. DIAGNOSIS: FRAGMENTS OF BONE WITH MATURING TRILINEAGE HEMATOPOIESIS WITH NO EVIDENCE OF MYELOMA, LYMPHOMA OR MYELOID NEOPLASM. SEE NOTE. Note: Sections are of fragments of cancellous bone with bone marrow element showing maturing trilineage hematopoiesis. By immune histochemistry CD3 and CD5 highlight scattered interstitial T cells. By CD4 and CD8 immunostain the majority of T cells are CD4 positive. PAX5 highlights few scattered B cells. CD138 highlights few scattered plasma cells that are polyclonal for kappa and lambda immunostain . The overall morphology and immunophenotypic pattern is consistent with the above diagnosis. Clinical correlation is recommended. ___ HEAD W/O CONTRAST IMPRESSION: 1. No acute intracranial abnormality on noncontrast head CT. 2. Unchanged Ommaya reservoir with normal and unchanged ventricular size. 3. No significant change in aerosolized secretions in the bilateral maxillary sinuses and ethmoidal air cells, again concerning for acute sinusitis. ___: BONE MARROW CYTOGENETIC DIAGNOSIS: 46,XX[20] Normal female karyotype. INTERPRETATION/COMMENT: Every metaphase bone marrow cell examined appeared to be karyotypically normal. No cells were found with the complex abnormal karyotype with rearrangement of the BCL6 gene that was observed in bone marrow collected on ___. In addition, there was no evidence by FISH of interphase cells with rearrangement of BCL6 (see below). FISH: NEGATIVE for BCL6 REARRANGEMENT. No evidence of interphase bone marrow cells with the previously observed 96/___/16) rearrangement of the BCL6 gene. ___: BONE MARROW, BIOPSY, CORE PATHOLOGIC DIAGNOSIS: BONE MARROW ASPIRATE AND CORE BIOPSY DIAGNOSIS: CELLULAR MARROW ASPIRATE WITH MARKED MYELOID HYPOPLASIA AND LEFT-SHIFT, ERYTHROID PREDOMINANCE, WITH MEGALOBLASTIC AND DYSPLASTIC MATURATION (SEE NOTE). ABUNDANT STORAGE IRON WITH DECREASED SIDEROBLASTS SUGGESTIVE OF ANEMIA OF INFLAMMATION. ___: marrow-Immunophenotyping DIAGNOSIS: FLOW CYTOMETRY REPORT FLOW CYTOMETRY IMMUNOPHENOTYPING The following tests (antibodies) were performed: ___, Kappa, Lambda, TCR alpha/beta and TCR gamma/delta, and CD antigens 2,3,4,5,7,8,10,11c,13,14,16,19,20,23,25,33,34,38,45,56,64,117 and 57. RESULTS: 10-color analysis with linear side scatter vs. CD45 gating is used to evaluate for leukemia/lymphoma. 69% of total acquired events are evaluable non-debris events. The viability of the analyzed non-debris events, done by 7-AAD is 87%. CD45-bright, low side-scatter gated lymphocytes comprise 36% of total analyzed events. B cells are scant in number precluding evaluation of clonality and further characterization. T cells comprise 85% of lymphoid gated events and express mature lineage antigens (CD3, CD5, CD2 and CD7). A significant subset (50%) of CD3 positive T cells shows dim variable expression/loss of CD7. T cells have a helper-cytotoxic ratio of 0.4. There is a population of double positive (CD4 positive/CD8 positive) cells comprising 8% of CD3 positive events which is of unclear significance. 60% of CD8 positive T cells co-express CD57 which is consistent with large granular lymphocytes. CD8 positive T cells appear to be TCR alpha beta expressing cells and no significant population of TCR gamma-delta expressing cells is present. T cells are negative for CD25. CD56 positive, CD3 negative natural-killer cells represent 8% of gated lymphocytes. No abnormal events are identified in the "blast" gate. INTERPRETATION Immunophenotypic findings consistent with involvement by a population of T cell large granular lymphocytes (CD3 positive/CD8 positive/CD57 positive) that represent approximately 37% of lymphoid gated events. T cell receptor gamma gene rearrangement PCR performed at NeoGenomics was positive (see OMR for full test details) consistent with the presence of a clonal T-cell population. If persistent, the findings raise the possibility of involvement by a T large granular lymphocytic leukemia which typically manifesting clinically with neutropenia and splenomegaly. Peripheral blood flow cytometry may be contributory. Correlation with clinical, laboratory and morphologic (see separate bone marrow biopsy report ___ is recommended. Flow cytometry may not detect all abnormal cell populations due to topography, sampling or artifacts of sample preparation. DISCHARGE LABS: ___ 06:07AM BLOOD WBC-7.3# RBC-2.58* Hgb-8.4* Hct-27.8* MCV-108* MCH-32.6* MCHC-30.2* RDW-16.2* RDWSD-63.9* Plt ___ ___ 06:07AM BLOOD Glucose-131* UreaN-15 Creat-0.5 Na-137 K-4.6 Cl-102 HCO3-22 AnGap-18 ___ 06:07AM BLOOD ALT-19 AST-15 LD(LDH)-230 AlkPhos-158* ___ 06:07AM BLOOD Calcium-9.1 Phos-4.2 Mg-2.0 Brief Hospital Course: Ms. ___ is a ___ with a history of a tectal primary CNS lymphoma, who now has an aggressive non-Hodgkin's systemic lymphoma being treated with rituximab/EPOCH with IT chemotherapy prophylaxis, s/p Ommaya placement admitted for back pain. # Back pain # Lumbar and thoracic compression fractures, both acute and chronic # Osteoporosis She has been having worsening lower back pain over the last few weeks. Her pain is non-radiating, she had no weakness, numbness or incontinence. She underwent CT and MRI of her thoracic and lumbar spine. Ortho-spine was consulted. Likely due to osteoporotic compression fractures although per neuroradiology cannot definitively rule out metastatic disease. No clinical concerns for cord compression. Discussed with Dr. ___ neuro-oncology who feels this is all osteoporotic fractures and has a low suspicion for metastatic disease given that recent PET-CT was negative and no other signs of active disease. Neuro-radiology also recommending an MRI cervical spine to further evaluate for infiltrative disease but patient does not want to undergo another MRI at this time. Patient trialed on narcotics however was not able to tolerate as inadequate pain control and hallucinations/delirium with high dose narcotics. Underwent kyphoplasty of T12 and L5 vertebrae without complications. Consider ___ acid in one month as patient failed alendronate. # Acute L foot drop: On ___ nursing noted new LLE foot drop. Code Stroke called. Per Neurology not c/w CVA. MRI-L spine limited but no gross abnormalities to explain L foot drop, no cord compression. Given history of metastatic B-cell Lymphoma an primary CNS lymphoma, patient underwent intrathecal chemotherapy with Ara-C while inpatient. # High Grade B-Cell Lymphoma # Neutropenia On DA-EPOCH/R Cycle 6 and intrathecal cytarabine. BMB (___) showed marked myeloid hypoplasia and left-shift, erythroid predominance, w/ megaloblasts and dysplastic maturation along with decreased sideroblasts suggestive of anemia of chronic disease. The cytogenetics are still pending. Viral study panel antigens and cultures negative. Marrow ICH - negative for BCL 6 rearrangement, negative MDS panel. She had worsening neutropenia likely chemotherapy effect as she has not been started on other new medications and no signs of infection. Potential culprit drugs (naproxen, alendronate, Bactrim) were held, and bone marrow biopsy showed diffuse cellular growth arrest, indicating drug vs. viral etiology. Patient had ___ recovery filgrastim. - has follow up appointment with Dr. ___ for ___ - follow up with Dr. ___ as an outpatient at end of ___ - continue folic acid - continue acyclovir 400 mg TID per Dr ___ - ___ acid in one month as failed alendronate - Follow-up with outpatient oncologist - Continue TMP/SMS SS daily and acyclovir ppx. # Cough: reporting new productive cough, afebrile without leukocytosis and CXR clear. CT chest for reeval known pulmonary nodule decreased in size with non-specific findings, rule out TB. Patient ruled out with NAAT negative, AFB concentrated x3, negative Quant Gold in setting of resolved neutropenia. # Hypertension: continue amlodipine 5mg daily. # Depression: Continued home fluoxetine # HLD: Held home simvastatin as she had not been taking it as outpatient. # Chronic HBV: HBsAb/HBcAb positive. HBV VL neg in ___. -Continue lamivudine. FEN: - Regular diet PAIN: as above DVT PROPHYLAXIS: - Heparin 5000 units SC BID ACCESS: Port CODE STATUS: - Full code Presumed CONTACT INFORMATION: - ___- husband ___ ___ Dispo:home with services TRANSITIONAL ISSUES ==================== [ ] Consider outpatient MRI C-Spine to further evaluate for infiltrative process if patient willing [ ] Consider ___ acid in one month as patient failed alendronate. [ ] Taper dexamethasone [ ] has follow up appointment with Dr. ___ for ___ [ ] follow up with Dr. ___ as an outpatient at ___ of ___ [ ] continue acyclovir 400 mg TID per Dr ___ [ ] Continue TMP/SMS SS daily and acyclovir ppx Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Dexamethasone 0.5 mg PO ASDIR Tapered dose - DOWN 2. amLODIPine 5 mg PO DAILY 3. Docusate Sodium 100 mg PO BID:PRN constipation 4. Famotidine 20 mg PO Q12H 5. FLUoxetine 40 mg PO DAILY 6. LaMIVudine 100 mg PO DAILY 7. Senna 8.6 mg PO BID:PRN constipation 8. Sulfatrim (sulfamethoxazole-trimethoprim) 400-80 (10mL) mg oral DAILY 9. Acyclovir 400 mg PO TID 10. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - Severe 11. Vitamin D 1000 UNIT PO DAILY Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H 2. Calcium Carbonate 1000 mg PO DAILY RX *calcium carbonate 400 mg (1,000 mg) 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 3. Lidocaine 5% Patch 1 PTCH TD QAM RX *lidocaine [Lidoderm] 5 % Apply 1 patch to lower back Daily Disp #*30 Patch Refills:*0 4. Morphine SR (MS ___ 30 mg PO Q12H RX *morphine [___] 30 mg 1 capsule(s) by mouth twice a day Disp #*15 Capsule Refills:*0 5. Pantoprazole 40 mg PO Q12H 6. Senna 8.6 mg PO BID:PRN constipation 7. Acyclovir 400 mg PO TID 8. amLODIPine 5 mg PO DAILY 9. Docusate Sodium 100 mg PO BID:PRN constipation 10. Famotidine 20 mg PO Q12H 11. FLUoxetine 40 mg PO DAILY 12. LaMIVudine 100 mg PO DAILY 13. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - Severe RX *oxycodone 10 mg ___ tablet(s) by mouth q4h:prn Disp #*15 Tablet Refills:*0 14. Sulfatrim (sulfamethoxazole-trimethoprim) 400-80 (10mL) mg oral DAILY 15. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Lower back pain due to multiple thoracic and lumbar compression fractures Neutropenia Discharge Condition: Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear ___, You were admitted with worsening back pain. You had an MRI of your spine which showed multiple fractures of your spine most likely due to osteoporosis. You were seen by the spine surgery team, they recommended using a brace as needed for pain. Your white blood cell count was low, but you were given an injection which caused it to recover. Please follow-up with your oncologists for further treatment of your lymphoma. Followup Instructions: ___
10378079-DS-39
10,378,079
22,526,341
DS
39
2131-11-03 00:00:00
2131-11-03 21:49:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Failure to thrive Major Surgical or Invasive Procedure: None History of Present Illness: Mrs. ___ is a ___ year-old lady with unclassified aggressive NHL with brain involvement who is referred from ECF for FTT. Per ECF paperwork, patient has been having increasing generalized weakness, immobility and decreased PO intake. Of note, had WBC 14 on ___ leading to initiation of CTX which was d/c'd on ___ given improvement in WBC. In the ED she complained of left leg pain. ED initial vitals were 97 112 105/62 18 97% RA Prior to transfer vitals were 98.2 109 129/90 16 98% RA ED labs were significant for: -CBC: WBC: 6.3. HGB: 11.0*. Plt Count: 242. Neuts%: 79.2*. -Chemistry: Na: 134. K: 4.7. Cl: 96. CO2: 20*. BUN: 11. Creat: 0.5. Ca: 9.2. Mg: 2.0. PO4: 4.1. Lactate: -Coags: INR: 1.0. PTT: 30.4. -LFTs: ALT: 17. AST: 13. Alk Phos: 184*. Total Bili: 0.2. CT Head w/o contrast: No acute intracranial process. Right frontal approach ventricular catheter is again seen with stable configuration of the ventricles. CXR: Low lung volumes limiting exam. Bibasilar opacities likely atelectasis though infection would be difficult to exclude. L ___: No DVT On arrival to the floor, patient reported pain in her LLE which subsided before she could get pain medication. She denies other sources of pain Patient denies fevers/chills, night sweats, headache, weakness/numbnesss, shortness of breath, cough, chest pain, abdominal pain, nausea/vomiting, diarrhea, dysuria and new rashes. REVIEW OF SYSTEMS: A complete 10-point review of systems was performed and was negative unless otherwise noted in the HPI. Past Medical History: (1) a stereotaxic mid-brain biopsy on ___, (2) received 5 cycles of induction high-dose methotrexate (3) s/p 8 cycles of maintenance high-dose methotrexate until ___, (4) s/p total left hip replacement on ___ for osteonecrosis, (5) bx of right cervical lymph node ___ at ___ that showed aggressive nonHodgkin's lymphoma, unclassified but intermediate between diffuse large cell and Burkitt's lymphoma, (6) admission to ___ Service on ___ for evaluation and management of lymphoma with 39.4 WBC, 10.0 Hb, 29.9 Hct and 109 plt (7) LP ___ with ___ WBC, 473-550 RBC, 44 protein, and received one dose of IT methotrexate, (8) started C1 EPOCH on ___, (9) CSF showed 7 WBC, 473 RBC, 44 protein, and received IT MTX (10) LP ___ 11 WBC ___ RBC 149 prtn 111 LDH rec'd IT MTX (11) head MRI on ___ showed no gross lymphoma in the brain, (12) received rituximab 100 mg on ___, (13) received rituximab 600 mg on ___, (14) C2 EPOCH on ___, (15) received IT methotrexate on ___, (16) received IT liposomal cytarabine on ___, (17) echocardiogram showed normal EF at 60%, (18) C3 EPOCH with rituximab and IT liposomal cytarabine on ___, (19) C4 EPOCH with rituximab and IT liposomal cytarabine on ___, (20) Ommaya reservoir placement on ___, and admission to OMED (22) C4 IT liposomal cytarabine on ___ (23) C5 IT liposomal cytarabine and rituxan on ___ (24) C5 of EPOCH on ___ PAST MEDICAL HISTORY: - CNS lymphoma/systemic lymphoma as above - Depression - HSV infection during MTX treatment in the past - GERD - HTN - Cold aggluitinin disease (resolved) - HBcAb Positive; VL negative Social History: ___ Family History: She has 6 healthy children and a nephew with a brain tumor. Physical Exam: ADMISSION PHYSICAL EXAMINATION: VS: 98.0 PO 128/93 106 18 97 RA GENERAL: Chronically-ill appearing lady, in no distress lying, in bed comfortably. Has Omaya visible. HEENT: Anicteric, PERLL, Mucous membranes moist, OP clear. CARDIAC: Regular rate and rhythm, normal heart sounds, no murmurs, rubs or gallops. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Non-distended, normal bowel sounds, soft, non-tender, no guarding, no palpable masses, no organomegaly. EXT: Warm, well perfused. No lower extremity edema. No erythema or tenderness. Left sided plantar flexor contracture, per patient not new. NEURO: A&Ox1, mildly decreased strength in LLE otherwise preserved. Normal sensation to light touch. CN II-XII intact. SKIN: No significant rashes. DISCHARGE PHYSICAL EXAMINATION: VS: 98.1 ___ ___ RA GENERAL: Chronically-ill appearing lady, in no distress lying, in bed comfortably. Has Omaya visible. HEENT: Anicteric, PERLL, Mucous membranes moist, OP clear. CARDIAC: Regular rate and rhythm, normal heart sounds, no murmurs, rubs or gallops. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Non-distended, normal bowel sounds, soft, non-tender, no guarding, no palpable masses, no organomegaly. EXT: Warm, well perfused. No lower extremity edema. No erythema or tenderness. NEURO: A&Ox1, 5+ strength proximal muscles of LLE. Left and right foot drop. wrist drop present and weak handgrip. . Normal sensation to light touch. CN II-XII intact. SKIN: No significant rashes. Pertinent Results: ADMISSION LABS: ___ 03:30PM BLOOD WBC-6.3 RBC-3.29*# Hgb-11.0*# Hct-34.8# MCV-106* MCH-33.4* MCHC-31.6* RDW-15.8* RDWSD-62.2* Plt ___ ___ 03:30PM BLOOD Neuts-79.2* Lymphs-17.6* Monos-1.9* Eos-0.3* Baso-0.2 Im ___ AbsNeut-5.01# AbsLymp-1.11* AbsMono-0.12* AbsEos-0.02* AbsBaso-0.01 ___ 03:30PM BLOOD ___ PTT-30.4 ___ ___ 03:30PM BLOOD Glucose-158* UreaN-11 Creat-0.5 Na-134 K-4.7 Cl-96 HCO3-20* AnGap-23* ___ 03:30PM BLOOD ALT-17 AST-13 AlkPhos-184* TotBili-0.2 ___ 03:30PM BLOOD Albumin-3.7 Calcium-9.2 Phos-4.1 Mg-2.0 ___ 03:58PM BLOOD Lactate-1.3 DISCHARGE LABS: ___ 02:53AM BLOOD WBC-4.1 RBC-2.90* Hgb-9.7* Hct-30.6* MCV-106* MCH-33.4* MCHC-31.7* RDW-15.6* RDWSD-60.6* Plt ___ ___ 02:53AM BLOOD Glucose-107* UreaN-11 Creat-0.4 Na-138 K-3.7 Cl-102 HCO3-25 AnGap-15 MICROBIOLOGY: BCX ___ NGTD UCX ___ NGTD IMAGING/STUDIES: CXR ___ Low lung volumes limiting exam. Bibasilar opacities likely atelectasis though infection would be difficult to exclude. ___ L ___ No evidence of deep venous thrombosis in the left lower extremity veins. CT HEAD ___ No acute intracranial process. Right frontal approach ventricular catheter is again seen with stable configuration of the ventricles. Discharge Labs ================ ___ 02:53AM BLOOD WBC-4.1 RBC-2.90* Hgb-9.7* Hct-30.6* MCV-106* MCH-33.4* MCHC-31.7* RDW-15.6* RDWSD-60.6* Plt ___ ___ 02:53AM BLOOD Plt ___ ___ 02:53AM BLOOD Glucose-107* UreaN-11 Creat-0.4 Na-138 K-3.7 Cl-102 HCO3-25 AnGap-15 ___ 02:53AM BLOOD Calcium-8.8 Phos-3.9 Mg-1.9 Brief Hospital Course: Ms. ___ is a ___ with PMH of unclassified aggressive NHL (primary CNS), on EPOCH rituximab with IT chemotherapy, also with h/o GERD, HTN, hepatitis, cold agglutinin disease and depression who presents from ECF with FTT and encephalopathy found to have new neurologic findings found to have likely progressive disease. The decision was made, in discussion with family and with neuro/oncology to transition to comfort focused care and the patient was discharged home with hospice. 1. Encephalopathy, Failure to Thrive: On presentation, patient was alert and oriented to self, and sometimes place but not to date. This was thought to be secondary CNS involvement by lymphoma vs. related to increased use of narcotics with possible side effect of constipation. CT head was without acute changes and infectious work-up was unrevealing. Her lymphoma was evaluated as below. Her pain regimen was decreased from MS contin 30mg q8hrs to 30mg q12hrs and she was started on a bowel regimen. 2. Non-Hodgkins Lymphoma/ Goals of Care: The patient was found to have worsened neurologic symptoms, namely, new wrist drip. This, associated with encephalopathy and FTT were suggestive of progression of CNS disease. The patient and family were involved with Goals of care discussion and informed that further treatment would not provide benefit. The patient and her family decided to stop treatment and transition to comfort focused care. She was made DNR/DNI and discharged home with hospice services. She was continued on acyclovir as this was thought to be in keeping with her goals of care, to support her comfort. 3. Chronic pain: In left leg and back due to pathological fracture. Her MS ___ was adjusted as above due to concerns regarding her mental status. She was continued on oxycodone PRN and baclofen for contracture. She was continued on senna and docusate PRN. 4. Depression: continued home fluoxetine 5. Hypertension: discontinued amlodipine and aspirin, in keeping with goals of care. 6. GERD: continued home pantoprazole 7. Hepatitis: continued lamivudine Transitional Issues: - please continue to monitor comfort, titrate pain medications as needed - please monitor for constipation - patient's family expressed interest in transporting patient to ___ in order to see her grandchildren. Discussed that she would likely need air ambulance transportation to accomplish this, if she was found to be stable enough for travel after discharge home. The patient and family can follow-up with air ambulance companies after discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acyclovir 400 mg PO TID 2. amLODIPine 5 mg PO DAILY 3. Docusate Sodium 100 mg PO BID:PRN constipation 4. FLUoxetine 40 mg PO DAILY 5. LaMIVudine 100 mg PO DAILY 6. Senna 8.6 mg PO BID:PRN constipation 7. Acetaminophen 1000 mg PO Q8H 8. Calcium Carbonate 1000 mg PO DAILY 9. Vitamin D 1000 UNIT PO DAILY 10. Morphine SR (MS ___ 30 mg PO Q8H 11. Pantoprazole 40 mg PO Q12H 12. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - Severe 13. Aspirin 81 mg PO DAILY 14. Baclofen 5 mg PO BID 15. Bisacodyl ___AILY:PRN constipation 16. FoLIC Acid 1 mg PO DAILY 17. GuaiFENesin ER 600 mg PO Q12H 18. Heparin 5000 UNIT SC BID 19. Milk of Magnesia 30 mL PO PRN 2d without bm 20. Ondansetron ODT 4 mg PO Q8H:PRN nausea 21. CefTRIAXone 1 gm IV Q24H elevated WBC Discharge Medications: 1. Senna 8.6 mg PO BID:PRN constipation RX *sennosides 8.6 mg 1 tablet by mouth two times per day Disp #*60 Tablet Refills:*0 2. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever RX *acetaminophen 650 mg 1 tablet(s) by mouth every 6 hours Disp #*30 Tablet Refills:*0 3. Morphine SR (MS ___ 30 mg PO Q12H RX *morphine 30 mg 1 capsule(s) by mouth every 12 hours Disp #*60 Capsule Refills:*0 4. Acyclovir 400 mg PO TID RX *acyclovir 400 mg 1 tablet(s) by mouth three times per day Disp #*90 Tablet Refills:*0 5. Baclofen 5 mg PO BID RX *baclofen 10 mg 0.5 (One half) tablet(s) by mouth two times per day Disp #*30 Tablet Refills:*0 6. Docusate Sodium 100 mg PO BID:PRN constipation RX *docusate sodium 100 mg 1 capsule(s) by mouth two times per day Disp #*60 Capsule Refills:*0 7. FLUoxetine 40 mg PO DAILY RX *fluoxetine 40 mg 1 capsule(s) by mouth every day Disp #*30 Capsule Refills:*0 8. GuaiFENesin ER 600 mg PO Q12H RX *guaifenesin 600 mg 1 tablet(s) by mouth every 12 hours Disp #*40 Tablet Refills:*0 9. LaMIVudine 100 mg PO DAILY RX *lamivudine 100 mg 1 tablet(s) by mouth every day Disp #*30 Tablet Refills:*0 10. Ondansetron ODT 4 mg PO Q8H:PRN nausea RX *ondansetron 4 mg 1 tablet(s) by mouth every 8 hours Disp #*30 Tablet Refills:*0 11. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - Severe RX *oxycodone 10 mg ___ tablet(s) by mouth every 4 hours Disp #*60 Tablet Refills:*0 12. Pantoprazole 40 mg PO Q12H RX *pantoprazole 40 mg 1 tablet(s) by mouth two times per day Disp #*60 Tablet Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary Diagnosis ================ 1) Encephalopathy 2) Failure to thrive Secondary Diagnosis =================== 1) Non-Hodgkins Lymphoma Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear ___, It has been a pleasure caring for you during your stay at ___. You were admitted to the hospital for confusion and increased weakness. You were give a lidocaine patch to help treat the pain from your lymphoma. You had new findings on your neurology exam such as weakness in your wrist. This implies your lymphoma has spread, despite the treatment you have been receiving. After dicussion between your doctors and family ___ have chosen to stop medical treatment of the lymphoma and go home to pursue care focused on comfort. We wish you the best. Sincerely, Your ___ Care team Followup Instructions: ___
10378448-DS-14
10,378,448
28,242,168
DS
14
2143-02-05 00:00:00
2143-02-06 09:25:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: NSAIDS (Non-Steroidal Anti-Inflammatory Drug) Attending: ___ Chief Complaint: Transfer from OSH for alcoholic hepatitis Major Surgical or Invasive Procedure: ENDOSCOPY ___ ENDOSCOPIC ULTRASOUND ___ with 2 bands applied History of Present Illness: This is a ___ man with a history of chronic alcohol use disorder (6 beers and 2 shots of vodka each day) who presented to the ___ emergency department after labs at his primary care doctor's office showed hypokalemia 2.5 and hypomagnesemia 1.4. At ___, he was thought to be in acute liver failure. His potassium and mag repleted, and was transferred to ___ for further evaluation. Reports he is here because he was so directed by his physician. Would not have come to the ED otherwise. He reports that he coughs frequently, bringing up white sputum, worsening in the past few weeks. Can't hold down food - either vomits it up right after eating or has diarrhea, tries to pass BMs several times per hour at home. Noticed abdomen getting more distended along with bilateral leg swelling x3 months. Denies ever having withdrawals. 7 lb weight loss last ___ weeks. No f/c, no night sweats, no headaches, chest pain, palps, dyspnea, abdominal pain. Denies feeling foggy or confused. Of note, had a recent admission to ___ because he was vomiting blood. Unclear whether variceal in origin as reportedly diagnosed with gastritis by endoscopy (___). Had a single jet black stool during that hospitalization but no bloody or black stools otherwise. Normally seen at ___. In the ED: - Initial vital signs were notable for: T98.0 ___ BP 135/71 R16 94% RA - Exam notable for: scleral icterus, palatal jaundice. Abdomen soft, distended + distension. 2+ circumferential pitting edema to the knee bilaterally and into dependent thigh bilaterally. +Asterixis. Normal mood and mentation, A/Ox3 - Labs were notable for: ___ 05:00PM BLOOD WBC: 17.8* RBC: 3.04* Hgb: 10.3* Hct: 30.8* MCV: 101* MCH: 33.9* MCHC: 33.4 RDW: 16.8* RDWSD: 62.0* Plt Ct: 279 ___ 05:00PM BLOOD Neuts: 78.6* Lymphs: 12.1* Monos: 7.8 Eos: 0.4* Baso: 0.4 Im ___: 0.7* AbsNeut: 13.98* AbsLymp: 2.16 AbsMono: 1.39* AbsEos: 0.08 AbsBaso: 0.08 ___ 05:00PM BLOOD ___: 20.4* PTT: 24.0* ___: 1.9* ___ 05:00PM BLOOD Glucose: 107* UreaN: 4* Creat: 0.8 Na: 137 K: 4.2 Cl: 90* HCO3: 33* AnGap: 14 ___ 05:00PM BLOOD ALT: 40 AST: 218* AlkPhos: 321* TotBili: 12.2* ___ 05:00PM BLOOD Lipase: 22 ___ 05:00PM BLOOD Albumin: 3.0* Calcium: 8.5 Phos: 2.9 Mg: 1.8 ___ 05:00PM BLOOD HBsAg: NEG HBs Ab: NEG HBc Ab: NEG HAV Ab: POS* ___ 05:08PM BLOOD Lactate: 2.1* K: 4.1 - Studies performed include: Point-of-care ultrasound: Evidence of moderate ascites, but no fluid pocket with 5 cm of bowel clearance in 2 planes. Liver/Gallbladder US 1. Coarsened echogenic nodular liver concerning for cirrhosis with small volume ascites. 2. Patent flow within the main portal vein and central branches though velocities are sluggish. 3. Splenomegaly measuring 15.1 cm. 4. Partially visualized small left pleural effusion. 5. Gallbladder sludge. CXR Low lung volumes are noted. There is a small left pleural effusion and adjacent compressive atelectasis. There is no focal consolidation or pneumothorax. The cardiomediastinal silhouette is within normal limits. No acute osseous abnormalities are identified - Patient was given: IV K and Mg - Consults: GI consulted Vitals on transfer: Upon arrival to the floor, ___ Temp: 99.2 PO BP: 120/70 L Sitting HR: 96 RR: 18 O2 sat: 93% O2 delivery: Ra REVIEW OF SYSTEMS: negative as per above Past Medical History: Alcohol Abuse Bleeding Esophageal Varices Gastroesophageal Reflux Disease Hypomagnesemia Hypokalemia Gout Social History: ___ Family History: Non-contributory Physical Exam: ADMISSION PHYSICAL EXAM: VITALS: ___ Temp: 99.2 PO BP: 120/70 L Sitting HR: 96 RR: 18 O2 sat: 93% O2 delivery: Ra General: Alert and interactive HEENT: PERRLA, EOMA. icteric sclera without injection. MMM, OP clear. CV: ___ early systolic murmur loudest at the apex. Pulm: CTAB, no wheezes or crackles Abd: +BS, distended. tender to palpation RUQ. Liver percussed at 10 cm. No fluid wave. Extremities: 1+ pitting edema bilaterally to the knees. Skin: jaundiced. Warm. Telangectasias noted. Neuro: CN ___ intact. A/ox3, can ___ backwards, no ifs ands or buts, naming, and recalls ___. DISCHARGE PHYSICAL EXAM: VS: 24 HR Data (last updated ___ @ 1504) Temp: 98.6 (Tm 98.6), BP: 121/67 (103-121/57-68), HR: 78 (72-78), RR: 18, O2 sat: 96% (94-97), O2 delivery: RA HEENT: icteric sclera without injection CV: RRR, ___ early systolic murmur loudest at the apex Pulm: CTAB, no wrr Abd: +BS, mildly distended. NT. No rebound/guarding. Skin: jaundiced. warm. telangectasias noted. Neuro: AOx3, no asterixis Pertinent Results: ADMISSION LABS: -------------- ___ 05:00PM BLOOD WBC-17.8* RBC-3.04* Hgb-10.3* Hct-30.8* MCV-101* MCH-33.9* MCHC-33.4 RDW-16.8* RDWSD-62.0* Plt ___ ___ 05:00PM BLOOD Neuts-78.6* Lymphs-12.1* Monos-7.8 Eos-0.4* Baso-0.4 Im ___ AbsNeut-13.98* AbsLymp-2.16 AbsMono-1.39* AbsEos-0.08 AbsBaso-0.08 ___ 05:00PM BLOOD ___ PTT-24.0* ___ ___ 05:00PM BLOOD Glucose-107* UreaN-4* Creat-0.8 Na-137 K-4.2 Cl-90* HCO3-33* AnGap-14 ___ 05:00PM BLOOD ALT-40 AST-218* AlkPhos-321* TotBili-12.2* ___ 05:00PM BLOOD Albumin-3.0* Calcium-8.5 Phos-2.9 Mg-1.8 ___ 05:00PM BLOOD HBsAg-NEG HBsAb-NEG HBcAb-NEG HAV Ab-POS* ___ 04:00PM BLOOD IgM HAV-NEG ___ 05:00PM BLOOD AMA-NEGATIVE Smooth-NEGATIVE ___ 04:39AM BLOOD ___ ___ 05:00PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Tricycl-NEG ___ 05:00PM BLOOD HCV Ab-NEG ___ 05:08PM BLOOD Lactate-2.1* K-4.1 ___ 04:39AM BLOOD CERULOPLASMIN-Test DISCHARGE LABS: -------------- ___ 05:20AM BLOOD WBC-13.9* RBC-2.44* Hgb-8.1* Hct-25.9* MCV-106* MCH-33.2* MCHC-31.3* RDW-20.3* RDWSD-77.5* Plt ___ ___ 05:20AM BLOOD Glucose-90 UreaN-10 Creat-0.8 Na-139 K-4.5 Cl-102 HCO3-27 AnGap-10 ___ 05:20AM BLOOD ALT-44* AST-144* LD(LDH)-329* AlkPhos-176* TotBili-6.5* ___ 05:20AM BLOOD Calcium-8.1* Phos-3.1 Mg-1.5* = = = = = = = = = = = ================================================================ IMAGING RESULTS ___ ABD LIMIT, SINGLE OR Targeted grayscale ultrasound images were obtained of the four quadrants of the abdomen, revealing moderate, anechoic ascites. The largest pocket is in the right lower quadrant. ___ Endoscopic Ultrasound Esophagus: Two cords of the small varices were seen in the lower esophagus. A hiatal hernia is also noted. The area of the previous nodule at the GEJ seen yesterday was able to be located but notably smaller than on prior EGD. EUS evaluation noted flow, consistent with underlying varix. When investigated with washing and gentle manipulation, the are began to bleed consistent with a bleeding GOV varix. 2 bands were applied for hemostasis successfully. One band placed at bleeding varix right above GEJ. Second band placed one centimeter proximal at 33cm. Stomach: Limited evaluation of the stomach was notable for clotted blood and a small hiatal hernia. Findings: - Two cords of the small varices were seen in the lower esophagus. A hiatal hernia is also noted. The area of the previous nodule at the GEJ seen yesterday was able to be located but notably smaller than on prior EGD. EUS evaluation noted flow, consistent with underlying varix. When investigated with washing and gentle manipulation, the are began to bleed consistent with a bleeding GOV varix. - Limited evaluation of the stomach was notable for clotted blood and a small hiatal hernia. ___ EGD Esophagus: - Lumen: A medium sized hiatal hernia was seen. - Mucosa: Grade B esophagitis with no bleeding was seen in the distal esophagus. - Protruding lesions: 2 cords of grade I varices were seen in the distal esophagus. The varices were not bleeding. - Additional esophagus findings: Distal esophagus around the GE junction in the area of the esophagitis and hiatal hernia sac there was a nodule with some exudate on the edge and some increased vascularity. Case discussed with liver attending. No evidence of banding. Unclear if this is a fundic gland polyp. Stomach: - Mucosa: Diffuse congestion, petechial and mosaic mucosal pattern of the mucosa was noted in the stomach fundus and stomach body. These findings are compatible with portal hypertensive gastropathy. Duodenum: -Mucosa: Normal mucosa was noted in the whole examined duodenum. Impressions: - Varices in the distal esophagus. - Esophageal hiatal hernia. - Grade B esophagitis in the distal esophagus. - Congestion, petechiae and mosaic mucosal pattern in the stomach fundus and stomach body compatible with normal portal hypertensive gastropathy. - Normal mucosa in the whole examined duodenum. - Distal esophagus around the GE junction in the area of the esophagitis and hiatal hernia sac there was a nodule with some exudate on the edge and some increased vascularity. Case discussed with liver attending. No evidence of banding. Unclear if this is a fundic gland polyp. ___ EXAMINATION: LIVER OR GALLBLADDER US (SINGLE ORGAN) INDICATION: ___ with cirrhosis, ascites// Evaluate for acute hepatobiliary pathology, including pvt (please obtain with Doppler) TECHNIQUE: Right upper quadrant ultrasound COMPARISON: Outside hospital ultrasound of the right upper quadrant from earlier today. FINDINGS: The liver is coarsened, echogenic with poor penetration concerning for cirrhosis. The contour of the liver appears subtly nodular. A tiny cyst within the left hepatic lobe measures up to 8 mm. Small volume ascites is noted. Gallbladder contains sludge. CBD measures 5 mm in diameter. Sonographic ___ sign is negative. Right kidney measures 11.2 cm and is normal in grayscale appearance. The spleen is enlarged measuring 15.1 cm in length. A small left pleural effusion is partially visualized. The left kidney measures 13.1 cm in length and appears normal. Free fluid tracks into the lower abdomen, small in overall volume. Doppler: Main portal vein, anterior and posterior right and left portal venous branches are patent with hepatopetal flow. However, note is made of sluggish flow within the portal venous branches measuring between 17 and 28 centimeters/second. Left, right and middle hepatic veins are patent. IVC appears patent. The main hepatic artery appears patent with a normal waveform. IMPRESSION: 1. Coarsened echogenic nodular liver concerning for cirrhosis with small volume ascites. 2. Patent flow within the main portal vein and central branches though velocities are sluggish. 3. Splenomegaly measuring 15.1 cm. 4. Partially visualized small left pleural effusion. 5. Gallbladder sludge. ___ EXAMINATION: CR - CHEST PA LATERAL INDICATION: History: ___ with cirrhosis, leukocytosis// pna? TECHNIQUE: Frontal and lateral view radiographs of the chest. COMPARISON: None. IMPRESSION: Low lung volumes are noted. There is a small left pleural effusion and adjacent compressive atelectasis. There is no focal consolidation or pneumothorax. The cardiomediastinal silhouette is within normal limits. No acute osseous abnormalities are identified. Brief Hospital Course: Mr. ___ is a ___ man with a history of chronic alcohol use disorder, transferred here from an OSH for hypoK/ hypoMag and concern for decompensated cirrhosis and acute alcoholic hepatitis. Course was complicated by acute c. difficile infection and variceal bleed s/p banding. # UPPER GI BLEED # VARICEAL BLEED # PORTAL HYPERTENSIVE GASTROPATHY ___ concern for UGIB given dark guiaic(+) stool with hgb drop. He underwent EGD on ___ which showed no active bleeding but demonstrated portal hypertensive gastropathy, as well as nodule with exudate at distal esophagus/GE junction with increased vascularity. Redemonstrated 2 non-bleeding cords of grade I varices in distal esophagus. Unfortunately on ___ he developed hematemesis and bright red blood per rectum requiring 2 units of pRBC. Due to concern for bleeding at nodule seen previously, repeated EGD with EUS was performed on ___ and the nodule was found to be a bleeding varix. S/p banding x2. He was treated with octreotide, IV PPI, sucralafate, and CTX. With plan to continue BID PPI and sucralafate for two weeks and to complete a 7day course of SBP prophylaxis with cipro on ___. He was also started on nadolol for bleeding ppx. Of note, on prior admission to OSH he had a large Hgb drop and EGD at that time had shown only esophagitis and gastritis for which PPI therapy was initiated. Therefore it was continued on discharge. #C. difficile Patient with positive culture and toxin on stool studies. No known antibiotic exposure. He was treated with PO Vancomycin though the course should be restarted from the time of the end of his Cipro course, which is ___. Therefore the end date of his PO vancomycin is ___. # Presumed Alcoholic Cirrhosis c/b Bleeding Esophageal Varices # Acute Alcoholic Hepatitis # Alcohol use disorder The patients exam and lab findings are most likely related to decompensated cirrhosis in the background of chronic alcohol use disorder. Most likely acute alcoholic hepatitis on background of chronic alcoholic liver disease, ___ DF on admission was ___. Hepatitis serologies were negative as were ___, AMA, and anti-smooth. Serum ceruloplasmin was within normal limits. He was treated with lactulose, rifaximin. Small volume ascites not amenable to tap. Was not initiated on diuretics this admission. A vitamin K trial was initiated due to elevated INR and there was some improvement. Patient was counseled on alcohol cessation and recommendation for outpatient support for helping with alcohol cessation but unfortunately patient was pre-contemplative this admission and not ready to stop drinking entirely despite significant counseling and warning. # Hypokalemia # Hypomagnesaemia Patient presented with severe hypokalemia and hypomagnesaemia in the setting of nausea and vomiting with poor PO intake. He has now been repleted and is within normal limits. Etiology is likely related to his vomiting, diarrhea and poor PO intake. These electrolytes were repleted as needed. #GERD Treated with home pantoprazole 40mg BID due to varices TRANSITIONAL ISSUES =================== [] HBV vaccine #1 was ___, finish vaccination outpatient [] Monitor for need for paracentesis [] Patient started on Lasix on day before discharge. Please monitor weight and adjust as needed. Discharge weight is 82.19 kg. [] Check electrolytes on ___ to be reviewed by PCP. [] Encourage alcohol cessation. Patient unfortunately was pre-contemplative this admission. [] Would benefit from ongoing nutritional counseling and support, recommend outpatient nutritionist counseling for alcoholic hepatitis. [] magnesium started due to chronic low mag,would recheck at next appointment and discontinue if able Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. FoLIC Acid 1 mg PO DAILY 2. Fluticasone Propionate 110mcg 2 PUFF IH BID 3. Pantoprazole 40 mg PO Q12H 4. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation Q4H:PRN 5. Sucralfate 1 gm PO QID Discharge Medications: 1. Ciprofloxacin HCl 500 mg PO Q12H RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*3 Tablet Refills:*0 2. Furosemide 20 mg PO DAILY RX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 3. Lactulose 30 mL PO TID RX *lactulose 10 gram/15 mL (15 mL) 30 ml by mouth three times a day Disp #*3000 Milliliter Refills:*0 4. Magnesium Oxide 280 mg PO DAILY Do not take with ciprofloxacin RX *magnesium oxide 250 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 5. Multivitamins 1 TAB PO DAILY RX *multivitamin 1 tablet(s) by mouth once a day Disp #*60 Tablet Refills:*0 6. Nadolol 20 mg PO DAILY RX *nadolol 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 7. Rifaximin 550 mg PO BID RX *rifaximin [Xifaxan] 550 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 8. Spironolactone 50 mg PO DAILY RX *spironolactone 50 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 9. Thiamine 100 mg PO DAILY RX *thiamine HCl (vitamin B1) 100 mg 1 tablet(s) by mouth once a day Disp #*60 Tablet Refills:*0 10. Vancomycin Oral Liquid ___ mg PO QID RX *vancomycin [Vancocin] 125 mg 125 mg by mouth four times a day Disp #*44 Capsule Refills:*0 11. FoLIC Acid 1 mg PO DAILY RX *folic acid 1 mg 1 tablet(s) by mouth once a day Disp #*60 Tablet Refills:*0 12. Pantoprazole 40 mg PO Q12H RX *pantoprazole [Protonix] 40 mg 1 tablet(s) by mouth twice a day Disp #*30 Tablet Refills:*0 13. Sucralfate 1 gm PO QID RX *sucralfate 1 gram/10 mL 1 g by mouth four times a day Disp #*600 Milliliter Refills:*0 14.Outpatient Lab Work Please draw chem 10 panel and fax to Dr. ___, ___. Discharge Disposition: Home Discharge Diagnosis: #ALCOHOLIC HEPATITIS #ALCOHOLIC CIRRHOSIS #C. DIFFICLE INFECTION #ESOPHAGEAL VARICES #UPPER GI TRACT BLEEDING Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to the hospital because you had elevated liver enzymes. WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL? - You had bleeding from your GI tract and you had an EGD with banding of the bleeding vessels. - Other studies were performed which showed you had an infection in your colon called C DIFFICILE - You were given antibiotics for your infection. - You improved and were ready to leave the hospital. WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL? - You must never drink alcohol again or you will die - your liver cannot survive another round of hepatitis. - Please enroll in AA and work with your primary care doctor to determine the best strategy to help you stay sober - Take all of your medications as prescribed (listed below) - You must ensure to follow up with appointments with your doctors - Weigh yourself every morning, before you eat or take your medications. Call your doctor if your weight changes by more than 3 pounds - Please stick to a low salt diet and monitor your fluid intake - If you experience any of the danger signs listed below please call your primary care doctor or come to the emergency department immediately. It was a pleasure participating in your care. We wish you the best! - Your ___ Care Team Followup Instructions: ___
10379173-DS-2
10,379,173
28,583,242
DS
2
2190-03-10 00:00:00
2190-03-10 16:39:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Sulfa (Sulfonamide Antibiotics) Attending: ___. Chief Complaint: Delirium/Urinary Tract Infection Major Surgical or Invasive Procedure: None History of Present Illness: ___ w/ Dementia, Hip fracture s/p intramedullary nail, chronic sacral decubitus ulcer with osteomyelitis, recurrent UTIs, chronic indwelling Foley catheter, Grave's disease, osteoporosis and a movement disorder NOS, admitted recently (___) to OSH ICU for urosepsis and chronic stage IV sacral ulcer presenting with confusion and whole body stiffness x 1 week. Patient has been bed bound for many months after prolonged ICU stay. She has been seeing wound care at ___ for sacral wound. Her recent MRI was concerning for possible osteomyelitis and she is scheduled for outpatient bone biopsy. Due to intermittent confusion over the last week, a U/A was performed and was consistent with UTI. She has completed a 5 day course of Cipro, but symptoms have continued so the son brought her to the ED. Denies fever, chills, abdominal pain, nausea, vomiting. Denies focal weakness, numbness or tingling. Reports bilateral leg stiffness with pain. Urine/blood cultures were positive for proteus and Ecoli during ICU admission. CT abd/pelvis also showed b/l pyelonephritis/hydronephrosis with marked bladder distension. Has hx of MDR UTIs and had growth of proteus and E coli from urine cultures at BI-N with blood cultures growing proteus and alpha hemolytic strep. She was narrowed to ceftriaxone and completed a ___dmitted to ___ on ___ with hospital acquired Stage IV sacral ulcer. Per Patient care Referral form dated ___ - "Son ___ insists on patient being sent to ___ against clinical judgement. Patient reported to be not in distress and exhibits no s/sx UTI/ no burning on urination. Recent u/a showed colonization vs contamination. Patient was about to be straight cath'ed for repeat UA but son refused." The history of this sacral ulcer began when Ms. ___ suffered an right sided hip fracture in ___ complicated by a provoked segmental pulmonary embolism for which she received 6 months of therapeutic anticoagulation. During recovery from this insult Ms. ___ experienced significant deconditioning along with bilateral knee contractures; the combination of which have left her non-ambulatory currently and led to the development of the pressure ulcer. She is able to stand with assistance at physical therapy for about 20 minutes. In the ED, initial VS were 98.4, HR 85, BP 107/68 RR 14 98%RA Exam in the ED: awake and alert to person, able to state is in hospital but unsure which and unsure of date. Pt appears in no acute distress at this time and is not voicing complaints of pain. Pt skin pwd. RR even/unlabored, no distress, pt with no noted ___ deformities Labs showed normal BMP and CBC, no leukocytosis, UA- cloudy, Large leuks, Mod blood, 30 protein, WBC >182, Epi 0 Imaging showed No acute fracture or dislocation. There is extensive amount of heterotopic bone formation at the left hip joint, IVF at 250cc/h with 1 gm Ceftrixone was started Decision was made to admit to medicine for further management. On arrival to the floor, patient reports feeling "fine", reports some R>L pain in lower foot, denies pain with urinating, any fevers. She is unable to follow a conversation and answer questions. She does not know her name, where she is or the year. Her son is concerned for delirium, upset that Foley in place for 10 days without monitoring. He wants urology evaluation, concern for "Proteus" syndrome. He also wants ultrasound for rigidity for legs. He reports confusion ongoing for about 6 months in the setting of "abuse" by rehab center. REVIEW OF SYSTEMS: Denies fever, headache, vision changes, rhinorrheashortness of breath, chest pain, abdominal pain, hematochezia, dysuria, hematuria. Past Medical History: Dementia Hypothyroidism L hip fx s/p ORIF ___ Recurrent UTI while with chronic indwelling foley Stage IV sacral decub ulcer c/b chronic osteomyelitis Cervical stenosis PE/DVT (previously on Coumadin/xarelto) Hiatal hernia - should sit upright for meals Grave's disease Anemia Surgical debridement of decubitus ulcer Social History: ___ Family History: Non Contributory Physical Exam: ADMISSION PHYSICAL EXAM: ======================== VS 98.1 BP 128/64 HR 78 RR 18 100%RA GENERAL: NAD, AOOx0, elderly, pale woman with exopthalmus HEENT: Significant bilateral exophthalmus, EOMI, PERRL, anicteric sclera, MMM, good dentition NECK: nontender supple neck, no LAD, no JVD CARDIAC: RRR, S1/S2, systolic murmur best heard over left para-sternal border, no gallops, or rubs LUNG: symmetric air entry, bibasilar crackles, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, EXTREMITIES: no edema, left foot internally rotated/contracture, contracture of knees bilaterally PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact, minimal rigidity of lower extremities, most prominently in hands. SKIN: warm and well perfused Left Stage IV sacral ulcer, sized about 6x4 cm, with visualized granulation tissue, no noted purulent drainage Stool noted in rectal vault, rectal bag overlying DISCHARGE PHYSICAL EXAM: ========================= VS 97.5 BP 125/67 HR 66 RR16 96 RA GENERAL: NAD, AOOx2-3 HEENT: PERRL, Notable bilateral exophthalmos unchanged, MMM NECK: nontender supple neck, no LAD, CARDIAC: RRR, S1/S2, unchanged systolic murmur best heard over left sternal border LUNG: symmetric air entry, no wheezes, breathing comfortably without accessory muscle use ABDOMEN: nondistended, +BS, nontender in all quadrants EXTREMITIES: no peripheral edema, contracture of knees bilaterally NEURO: Rigidity in upper arms, but with intact full passive ROM, knee movement limited by contractures SKIN: Left Stage IV sacral ulcer, sized about 6x4 cm, minimal erythema around ulcer, no new drainage noted Pertinent Results: ADMISSION LABS: ================= ___ 02:10AM URINE GR HOLD-HOLD ___ 02:10AM URINE BLOOD-MOD NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.5 LEUK-LG ___ 02:10AM URINE RBC-166* WBC->182* BACTERIA-NONE YEAST-NONE EPI-0 ___ 11:35PM GLUCOSE-118* UREA N-30* CREAT-0.9 SODIUM-138 POTASSIUM-4.8 CHLORIDE-101 TOTAL CO2-25 ANION GAP-17 ___ 11:35PM ALT(SGPT)-10 AST(SGOT)-18 ALK PHOS-104 ___ 11:35PM WBC-9.2 RBC-4.03 HGB-12.0 HCT-38.3 MCV-95 MCH-29.8 MCHC-31.3* RDW-14.6 RDWSD-50.7* ___ 11:35PM NEUTS-52.9 ___ MONOS-6.8 EOS-3.3 BASOS-0.7 IM ___ AbsNeut-4.87 AbsLymp-3.31 AbsMono-0.62 AbsEos-0.30 PERTINENT LABS: ================ ___ 11:35PM VIT B12-610 ___ 11:35PM TSH-4.3* DISCHARGE LABS: ================ ___ 06:38AM BLOOD WBC-6.9 RBC-3.53* Hgb-10.4* Hct-33.5* MCV-95 MCH-29.5 MCHC-31.0* RDW-14.4 RDWSD-49.9* Plt ___ ___ 06:38AM BLOOD Glucose-101* UreaN-21* Creat-0.9 Na-140 K-4.4 Cl-107 HCO3-24 AnGap-13 MICRO: ======= URINE CULTURE (Final ___: ESCHERICHIA COLI. >100,000 ORGANISMS/ML.. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. ESCHERICHIA COLI. 10,000-100,000 ORGANISMS/ML.. PRESUMPTIVE IDENTIFICATION. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. ___ MORPHOLOGY. PROTEUS MIRABILIS. QUANTITATION NOT AVAILABLE. PRESUMPTIVE IDENTIFICATION. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | ESCHERICHIA COLI | | PROTEUS MIRABILIS | | | AMIKACIN-------------- <=2 S <=2 S <=2 S AMPICILLIN------------ 8 S 4 S 8 S AMPICILLIN/SULBACTAM-- 4 S 4 S 8 S CEFAZOLIN------------- <=4 S <=4 S CEFEPIME-------------- <=1 S <=1 S <=1 S CEFTAZIDIME----------- <=1 S <=1 S <=1 S CEFTRIAXONE----------- <=1 S <=1 S <=1 S CIPROFLOXACIN--------- =>4 R =>4 R =>4 R GENTAMICIN------------ =>16 R =>16 R =>16 R MEROPENEM-------------<=0.25 S <=0.25 S <=0.25 S NITROFURANTOIN-------- <=16 S <=16 S PIPERACILLIN/TAZO----- <=4 S <=4 S <=4 S TOBRAMYCIN------------ 8 I 8 I 8 I TRIMETHOPRIM/SULFA---- <=1 S <=1 S =>16 R IMAGING and OTHER STUDIES: ========================== ___ Hip X-Ray: The patient is post normal-appearing right hip arthroplasty with long cemented femoral stem. A right sided intramedullary rod extends throughout the length of the femoral diaphysis with proximal fixation nail extending into the femoral head and single distal interlocking screw. There is an extensive heterotopic bone formation centered at left greater trochanter and inferomedial aspect of the left femoral neck (presumed post previous intertrochanteric fracture with no fracture line identified). Vascular calcifications are seen in the left lower extremity. There is joint space narrowing and osteophyte formation in the left hip and left knee (some of which could relate to non/reduced ambulation. There is no acute fracture or dislocation. Moderate stool throughout the colon. Prior Sacral Ulcer MRI indicates a 6.8 x 1.0 x 3.9cm defect at the sacrum with presacral edema and a T1 hypointense signal at S5 and STIR hyperintensity in that same region. Presacral edema and enhancement is noted without visible fluid collection or abscess. Brief Hospital Course: ___ yo F with hx of dementia, Hip fracture s/p intramedullary nail, chronic sacral decubitus ulcer with osteomyelitis, recurrent UTIs given history of chronic indwelling Foley catheter presenting with concerns for acute encephalopathy. #Acute Encephalopathy: Patient initially presented to ___ with concerns for a urinary tract infection given UA showing high WBCs, but patient also has with history of colonization and contamination given prior indwelling Foley. Patient had a history of recent treatment in ___ with Nitrofurantoin, Levofloxacin. No new medication changes, electrolyte changes. History of recent tx in ___ with Nitrofurantoin, Levofloxacin. Notably, she had a recent admission at ___ ___ with fevers, hypotension, with frank pus from indwelling foley, with ICU admission at the time. She was treated with broad spectrum antibiotics, with urine growing alpha hemolytic strep and proteus at the time, along with oxygen requirement, bilateral hydronephrosis due to pyelonephritis, with recommendation to discontinue Foley. She was alert and arousable, oriented to only self on admission, which improved with reorientation. She was initially treated with IV ceftriaxone. Her electrolytes, CBC, TSH, B12 were all normal, with no other infectious etiology. Given collateral information, she appeared to be at baseline as far as mental status, and was alert an oriented to self and year on discharge, and antibiotics were discontinued. Her urine culture grew E.coli and Proteus, which she has known to be colonized with before, so further treatment was deferred. She was evaluated by nutrition who recommended a regular diet with Ensure supplementation. Physical therapy recommended discharge to Rehab to improve her functional status. #Stage IV Sacral Decubitus Ulcer: Patient noted to have a 3 x 7 x 1.5 cm ulcer in left upper buttock with deepest portion located at the 5 o'clock position. Otherwise, the wound is 1 cm in depth elsewhere. The wound bed was relatively clean( 90% red ) with only 10 % yellow slough and a dark purple/black area within the wound bed. There was no visible bone or tendon. Drainage was moderate serous with scant purulence. There was no odor, erythema or other sign of infection. Wound care recommended cleaning ulcer and filling wound with aquacel along with softsorb, recommended securing with medipore with soft cloth tape. We recommend changing the dressing daily. Per recent plastics note in ___, there was no need culture or biopsy at this time given the status as an open/draining wound and with no indication for operative coverage with a flap or skin graft at this time. If patient out of bed, please request roho cushion from ___ and limit sit time to 1 hour at a time. Patient has outpatient follow up with Orthopedics on ___, please reschedule as appropriate. CHRONIC ISSUES: ================ #Chronic Constipation: Continued on home bowel regimen including Senna 17.2 po qhs, Dulcolax 10mg PR daily PRN, Miralax 17gm po daily, enema if needed. #History of provoked DVTs: Completed Lovenox for 6 months, and now per hematology, and per their recommendations,continued on Aspirin 81 daily. #Anemia:Continued home Ferrous 325 mg daily #Graves Disease: Continued home Levothyroxine 50 daily. #Hyperlipidemia: Continued Atorvastatin 20 mg daily TRANSITIONAL ISSES: =================== -Please ensure patient has wound care follow up, she follows with ___, and also has Orthopedics follow up on ___ -Encourage independence with ADLs and functional mobility as pt is at risk for deconditioning -Please AVOID indwelling Foley catheter given patient's history of urosepsis and recurrent UTIs. -Please limit sitting time to 1 hour on ___ overlay as pt unable to reposition independently and has stage IV sacral ulcer. -If out of bed, please request roho cushion from ___ and limit sit time to 1 hour at a time. -Full Code -EMERGENCY CONTACT HCP: ___ ___ (son) Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Levothyroxine Sodium 50 mcg PO DAILY 2. Acetaminophen 650 mg PO Q4H:PRN Pain 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 20 mg PO QPM 5. Vitamin D ___ UNIT PO DAILY 6. Nitrofurantoin Monohyd (MacroBID) 100 mg PO Q12H 7. Lactobacillus acidoph-L.bulgar 1 million cell oral BID 8. Ferrous Sulfate 325 mg PO DAILY 9. cranberry 450 mg oral DAILY 10. Multivitamins W/minerals 1 TAB PO DAILY Discharge Medications: 1. Acetaminophen 650 mg PO Q4H:PRN Pain 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 20 mg PO QPM 4. Ferrous Sulfate 325 mg PO DAILY 5. Levothyroxine Sodium 50 mcg PO DAILY 6. Multivitamins W/minerals 1 TAB PO DAILY 7. Vitamin D ___ UNIT PO DAILY 8. cranberry 450 mg oral DAILY 9. Lactobacillus acidoph-L.bulgar 1 million cell oral BID Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary Diagnosis: -Delirium -Stage 4 Sacral Pressure Ulcer Secondary Diagnosis: -Chronic Constipation -History of provoked DVTs -Graves Disease Discharge Condition: Mental Status: Confused - sometimes Level of Consciousness: Lethargic but arousable. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Ms. ___, You were admitted to ___ on ___ with concerns of a urinary tract infection. Your laboratory tests were all normal, and you did not have an infection in your urine. The wound on your sacrum did not look to be infected. You were seen by nutritionist, wound care specialists, and physical therapists and it is now safe for you to go to rehab to continue your ongoing care. We wish you the best Happy Belated Birthday! Your ___ Care team Followup Instructions: ___
10379173-DS-5
10,379,173
28,196,126
DS
5
2190-06-11 00:00:00
2190-06-12 19:27:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Sulfa (Sulfonamide Antibiotics) Attending: ___. Chief Complaint: Altered mental status, UTI Major Surgical or Invasive Procedure: ___ line placement ___ History of Present Illness: ___ F w/ h/o recurrent drug resistant UTIs, chronic sacral decubitus ulcer c/b osteomyelitis, dementia, p/w altered mental status, concern for PNA. Patient currently lives at a rehab facility and has a small stage 4 sacral decub incurred in ___ after hip surgery in ___. Pt requires 100% assistance with activities of daily living. The patient is confused and unable to corroborate the history. She was brought to BI urgent care with worsening cough for the past 10 days with decreased sleeping and at times alteration in mentation. Chest x-ray obtained at urgent care was felt to have increased opacification (though subsequently read as negative). She was advised to come to the ED. In the ED, initial vitals: 100.3 90 117/59 18 96% RA. Labs notable for WBC 10.4 w/ normal diff, Hgb 12.2, plts 434, BUN/Cr ___, K 5.3, HCO3 24, Lactate 2.5. UA w/ >182 WBCs, 33 RBCs, moderate bacteria, no epis. CXR without acute cardiopulmonary process. Flu swab was negative. The patient was started on Vancomycin 1g and Pip/tazo 4.5g, and received 1L NS. SBP in the ED ranged from 90-130s; her fever resolved without intervention. Vitals prior to transfer were: 98.2 67 131/49 23 99% RA. Currently, the patient is sleepy but arousable and denies any specific complaints. ROS: Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, melena, hematochezia, dysuria, hematuria. Past Medical History: Dementia Hypothyroidism L hip fx s/p ORIF ___ Recurrent UTI while with chronic indwelling foley Stage IV sacral decub ulcer c/b chronic osteomyelitis Cervical stenosis PE/DVT (previously on Coumadin/xarelto) Hiatal hernia - should sit upright for meals Grave's disease Anemia Surgical debridement of decubitus ulcer Social History: ___ Family History: Non Contributory Physical Exam: PHYSICAL EXAM ON ADMISSION ========================== Vitals - 98.7 128/71 84 18 98% RA GENERAL: NAD, sleepy but arousable HEENT: Dry MM. CARDIAC: RRR, S1 S2 LUNGS: CTAB, good air movement biaterally. ABDOMEN: NABS. Soft, NT, ND. EXTREMITIES: No edema BACK: ~4x5 cm stage 4 sacral ulcer with clean base, clean edges, no induration or erythema, mild serous drainage SKIN: No rashes NEURO: A&Ox1. Confused. PHYSICAL EXAM ON DISCHARGE ========================== Vitals 97.6 108/56 75 18 97%RA GENERAL: NAD, lethargic HEENT: Moist MM. CARDIAC: RRR, S1 S2 LUNGS: CTAB, good air movement bilaterally. ABDOMEN: NABS. Soft, NT, ND. EXTREMITIES: No edema BACK: ~4x5 cm stage 4 sacral ulcer dressed. no surrounding induration or erythema, mild serous drainage SKIN: No rashes NEURO: A&Ox2. Alert Pertinent Results: LABS ON ADMISSION ================= ___ 07:00PM BLOOD WBC-10.4* RBC-4.12 Hgb-12.2 Hct-38.5 MCV-93 MCH-29.6 MCHC-31.7* RDW-15.3 RDWSD-52.4* Plt ___ ___ 07:00PM BLOOD Neuts-64.0 ___ Monos-8.1 Eos-1.6 Baso-0.4 Im ___ AbsNeut-6.64* AbsLymp-2.65 AbsMono-0.84* AbsEos-0.17 AbsBaso-0.04 ___ 07:00PM BLOOD Plt ___ ___ 07:00PM BLOOD Glucose-102* UreaN-25* Creat-0.9 Na-137 K-5.3* Cl-99 HCO3-24 AnGap-19 ___ 07:00PM BLOOD Calcium-9.8 Phos-3.7 Mg-2.3 ___ 06:25PM BLOOD Lactate-2.5* LABS ON DISCHARGE ================== ___ 01:56PM BLOOD WBC-10.3* RBC-3.53* Hgb-10.5* Hct-33.1* MCV-94 MCH-29.7 MCHC-31.7* RDW-15.2 RDWSD-51.4* Plt ___ ___ 08:09AM BLOOD Glucose-89 UreaN-19 Creat-0.8 Na-137 K-4.9 Cl-102 HCO3-27 AnGap-13 MICROBIOLOGY ============ Urine Culture ___ URINE CULTURE (Preliminary): ___ MD (___) RESQUESTS FOSFOMYCIN SENSITIVITIES ___. NON-FERMENTER, NOT PSEUDOMONAS AERUGINOSA. 10,000-100,000 ORGANISMS/ML.. Cefepime = (<2 MCG/ML). MEROPENEM = (<1 MCG/ML). sensitivity testing performed by Microscan. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ NON-FERMENTER, NOT PSEUDOMONAS AERUGINOSA | AMIKACIN-------------- 8 S CEFEPIME-------------- S CEFTAZIDIME----------- =>32 R CEFTRIAXONE----------- <=4 S CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ =>16 R IMIPENEM-------------- <=1 S LEVOFLOXACIN---------- =>8 R MEROPENEM------------- S TOBRAMYCIN------------ =>16 R TRIMETHOPRIM/SULFA---- <=2 S IMAGING ======== ECG ___ Sinus rhythm at upper normal rate. Compared to the previous tracing of ___ the rate is now faster. Otherwise, probably unchanged. CXR ___ FINDINGS: AP upright and lateral views of the chest provided. Volumes are low limiting assessment. The imaged portions of both lungs appear clear. Cardiomediastinal silhouette appears unchanged with top-normal heart size again noted. Imaged bony structures are intact with chronic left ribcage deformities re- demonstrated. IMPRESSION: As above. No acute findings. ___ Imaging PICC LINE PLACMENT SCH 1. The accessed vein was patent and compressible. 2. Brachialvein approach single lumen right PICC with tip in the cavoatrial junction. Brief Hospital Course: ___ F w/ h/o recurrent drug resistant UTIs, chronic sacral decubitus ulcer c/b osteomyelitis, dementia, p/w altered mental status, likely due to recurrent UTI # Delirium: Most likely etiology is UTI, given pyuria on UA in ED and AMS consistent with UTI. Osteo also was a possibility but less likely to cause systemic Sx and physical exam revealed clean wound. No focal neurological signs c/f stroke. UTI treated with zosyn empirically and subsequently with cefepime after sensitivities returned. Cefepime day 1: ___. # UTI: History of multi-drug resistant UTIs in setting of non-obstructive chronic stones that were scheduled for lithostropy and stent placement. Zosyn discontinued on ___ (___). Cefepime started based on sensitivities (day 1: ___. Floor team was in discussions with Dr. ___ scheduling ___ procedure either during her abx treatment or soon thereafter. # Productive Cough: CXR without signs of pneumonia. Patient has remained afebrile without leukocytosis and has had productive cough x 2 weeks according to son. No SOB or O2 requirement. Most likely post-viral cough. Patient had saline nebs PRN and symptomatic control. After two days as inpatient, cough dissipated. # Pre-existing chronic sacral ulcer: Wound care was consulted and recs were followed. Continued zinc, vit C # HLD: Continued Atorvastatin 20 mg PO QPM # Hypothyroidism: Continued Levothyroxine Sodium 50 mcg PO DAILY TRANSITIONAL ISSUES []Will need CBC with diff and LFTs on ___, fax to ___ attn. Dr. ___ []Patient taken off aspirin in anticipation of urological procedures. Was started after she was on anticoagulation x 6 months s/p PE that she developed after L hip surgery. No known cardiac disease. []day 1 cefepime ___. Full 10 day course runs upto and including ___. []may benefit from ___ cefepime if procedure is after her abx course has finished. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Ascorbic Acid ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 20 mg PO QPM 4. Docusate Sodium 100 mg PO BID 5. Ferrous Sulfate 325 mg PO DAILY 6. Levothyroxine Sodium 50 mcg PO DAILY 7. Multivitamins 1 TAB PO DAILY 8. Senna 17.2 mg PO QHS 9. Vitamin D ___ UNIT PO DAILY 10. Zinc Sulfate 220 mg PO DAILY 11. Acetaminophen 1000 mg PO BID:PRN 60 min before dressing change 12. Lactobacillus acidophilus 1 billion cell oral BID 13. Fosfomycin Tromethamine 3 g PO 1X/WEEK (___) 14. Vagifem (estradiol) 10 mcg vaginal 2X/WEEK 15. methenamine hippurate 1 gram oral BID Discharge Medications: 1. Acetaminophen ___ mg PO Q6H:PRN pain 2. Ascorbic Acid ___ mg PO DAILY 3. Atorvastatin 20 mg PO QPM 4. Docusate Sodium 100 mg PO BID 5. Levothyroxine Sodium 50 mcg PO DAILY 6. Senna 17.2 mg PO QHS 7. Vitamin D ___ UNIT PO DAILY 8. Zinc Sulfate 220 mg PO DAILY 9. Ferrous Sulfate 325 mg PO DAILY 10. Lactobacillus acidophilus 1 billion cell oral BID 11. methenamine hippurate 1 gram oral BID 12. Multivitamins 1 TAB PO DAILY 13. Vagifem (estradiol) 10 mcg vaginal 2X/WEEK 14. CefePIME 1 g IV Q24H Duration: 8 Days 15. Outpatient Lab Work CBC with diff and LFTs on ___ Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS ================== urinary tract infection altered mental status dementia SECONDARY DIAGNOSIS =================== chronic stage IV decubitus ulcer hyperlipidemia hypothyroidism Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Bedbound. Discharge Instructions: Ms. ___, You were admitted to ___ with a cough and an infection in the urine. You were treated with IV antibiotics and will be discharged on IV antibiotics that you will receive through a ___ line. You will be able to have the line removed once your antibiotics are finished. Dr. ___ urologist is currently trying to schedule your procedure within the week or early next week. If you do not hear from his office within 2 days of discharge, please call them to inquire. It was a pleasure taking part in your care Your ___ Team Followup Instructions: ___
10379185-DS-6
10,379,185
22,831,206
DS
6
2135-07-05 00:00:00
2135-07-06 09:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: fatigue, left ear bleeding Major Surgical or Invasive Procedure: none History of Present Illness: ___ ___ M PMHx R fronto-parietal stroke, HTN, GERD, recent hospital stay 9.20-9.24 for AMS attributed to TIA with incidental finding of saddle PE that stay started on AC, presents for L ear bleeding and increased fatigue. Per hx given to ED by daughter-in-law, since last night he has been more fatigued. He is usually very active. He is otherwise mentating at his baseline. In the ED initial vitals were: 97.6 89 125/68 18 94%. - Labs significant for normal CBC and Chem7 (BUN mildly elevated to 26), INR 1.7. UA with Tr Leuk and 4 Bacteria. Lactate 2.5. - CXR with hazy bibasilar L > R opacities likely atelectasis but infection cannot be excluded. Old calcified granuloma projecting over lateral R lower lung called in Findings, not previously commented per ___ CXR read though is apparent there too. - CT Head w/o acute bleed. Bilateral soft tissue densities were found. - In discussion with ED resident, patient had gauze in L ear that was removed, no fresh bleeding, source of bleed could not be visualized but do not think he is acutely bleeding. - Patient was given CTX 1g and 500mg Azithromycin and admitted for PNA and fatigue. Vitals prior to transfer were: 98 80 110/67 16 95% RA. On the floor, history is taken primarily through daughter who patient nodding along. Patient was lethargic starting last night with labored breathing, this morning did not want to wake up or be active. No fevers, chills, cough. Patient agrees he had shortness of breath and associated sharp CP with this SOB, but this has resolved now on the floor. No abdominal pain, urinary or bowel symptoms, joint or muscle pains. He has had L ear bleeding when bearing down to stool, has not had before, no other bleeding from other orifices. Past Medical History: Pt recent moved from ___ 1.5 months ago, and family is unaware of most of his history. - Stroke- approximately ___ years ago, etiology unknown to patient and family - Likely MCI given his Donepazil - Likely Hypertension Given Losartan - Likely GERD given Ranitidine - Chronic Left Knee pain - s/p choelctystectomy in ___. Social History: ___ Family History: - 1 grandchild with seizures, type unknown. Otherwise no known history of seizure or stroke. Physical Exam: ON ADMISSION: VS - Temp 98 HR 80 BP 110/67 RR 16 O2 95% RA GENERAL: pleasant, cooperative with physical exam when directions translated into ___, NAD HEENT: NCAT, pupils symmetric, anicteric scleara, pink conjunctiva, dried blood in L auditory canal (none on R), MMM, poor dentition NECK: no LAD, no JVD CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: central obesity, soft, NT, ND, +BS EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 extremities with purpose NEURO: CN II-XII intact, ___ strenght ___ SKIN: warm and well perfused, no excoriations or lesions, no rashes AT DISCHARGE: VS - Temp 98 HR 80 BP 110/67 RR 16 O2 95% RA GENERAL: pleasant, cooperative with physical exam when directions translated into ___, NAD HEENT: NCAT, pupils symmetric, anicteric scleara, pink conjunctiva, dried blood in L auditory canal (none on R), MMM, poor dentition NECK: no LAD, no JVD CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: central obesity, soft, NT, ND, +BS EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 extremities with purpose NEURO: CN II-XII intact, ___ strenght ___ SKIN: warm and well perfused, no excoriations or lesions, no rashes Pertinent Results: ___ 03:45PM ___ PTT-41.2* ___ ___ 03:45PM PLT COUNT-176 ___ 03:45PM NEUTS-55.1 ___ MONOS-10.4 EOS-1.7 BASOS-1.0 ___ 03:45PM WBC-5.7 RBC-5.41 HGB-16.2 HCT-49.5 MCV-91 MCH-30.0 MCHC-32.8 RDW-15.7* ___ 03:45PM estGFR-Using this ___ 03:45PM GLUCOSE-132* UREA N-26* CREAT-1.1 SODIUM-138 POTASSIUM-4.2 CHLORIDE-105 TOTAL CO2-26 ANION GAP-11 ___ 04:30PM URINE MUCOUS-RARE ___ 04:30PM URINE RBC-2 WBC-4 BACTERIA-NONE YEAST-NONE EPI-0 ___ 04:30PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-TR ___ 04:30PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 04:30PM URINE UHOLD-HOLD ___ 04:30PM URINE HOURS-RANDOM ___ 04:30PM URINE UHOLD-HOLD ___ 04:30PM URINE HOURS-RANDOM ___ 06:47PM LACTATE-2.5* Brief Hospital Course: ___ ___ M PMHx R fronto-parietal stroke, HTN, GERD, recent hospital stay 9.20-9.24 for AMS attributed to TIA with incidental finding of saddle PE that started on AC, presents for L ear bleeding and increased fatigue. # Increased Fatigue: Patient back to baseline on the floor after being dosed with ABx in the ED. No SOB or pleuritic chest pain. He is recorded as being 93-100% on RA and in sinus rhythm, reducing concern for new PE, and family has been administering Lovenox and Coumadin, able to recount dosages and frequency. No sputum production or cough. No fevers or chills. He also had a normal white count. We had very low suspicion for a pneumonia on the floor. Of note, he had no other obvious source for fatigue - clear UA, intact neurologic exam, no anemia, unremarkable Chem7. - Stopped CTX/Azithro as low suspicion for PNA - Continued systemic AC - Trended H/H-stable # L Ear Bleeding: Patient has undefined soft tissue densities on head CT with no previous hx bleeding, but bleeding with bearing down for stools, likely because he is on AC. Unless actively extravasating, likely needs ENT evaluation as outpatient; for now, will start laxatives to help ease BMs. - Senna/Colace/Miralax to prevent straining - ENT appointment requested via care connections as outpatient # Elevated Lactate: Mildly elevated at 2.5. Unclear as to what the underlying cause may have been, patient did have diminished PO intake. Patient was given gentle bolus overnight, normalized to 1.5 in AM. - 500cc NS overnight - AM lactate improved = 1.5 # Treatment of PE: Continued ASA, enoxaparin to warfarin bridge, trend INR. # s/p Stroke: Continued ASA, systemic anticoagulation as above. # MCI: Continued home donepazil. # GERD: Continued home ranitidine. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Donepezil 5 mg PO HS 3. Enoxaparin Sodium 80 mg SC Q12H 4. Ranitidine 75 mg PO DAILY 5. Warfarin 4 mg PO DAILY16 Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Donepezil 5 mg PO HS 3. Ranitidine 75 mg PO DAILY 4. Warfarin 4 mg PO DAILY16 5. Enoxaparin Sodium 80 mg SC Q12H Start: Today - ___, First Dose: Next Routine Administration Time Discharge Disposition: Home Discharge Diagnosis: fatigue left ear bleeding Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you during your hospital stay at ___. When you came in, you complained of some bleeding from your left ear while straining in the bathroom. Your granddaughter noted that you were having some difficulty breathing with some shortness of breath and some sharp chest pain which resolved. There was some concern for pneumonia and you were started on antibiotics, however, we did not believe you had the clinical signs of pneumonia and your labs and vital signs remained stable. Your symptoms have improved and it is now safe for you to be discharged. Please be sure to take all of your medications as prescribed and keep your followup appointments. We are arranging for you to see an Ear, Nose and Throat specialist, so that you may have your ear formally examined by an expert. We wish you the very best. Sincerely, Your ___ Team Followup Instructions: ___
10379461-DS-13
10,379,461
24,027,497
DS
13
2124-10-26 00:00:00
2124-10-26 12:16:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROSURGERY Allergies: Penicillins Attending: ___. Chief Complaint: MVA Major Surgical or Invasive Procedure: None History of Present Illness: This is a ___ year old female who was transferred from an outside hospital after an MVA. Per report, the patient was the unrestrained passenger in a vehicle that was traveling approximately 15mph, the car did sustain significant front end damage. She was found to be in a crumpled position underneath the dash board. LOC is unknown. She was amnestic to the event. Past Medical History: dementia hypothyroid ds Hyperlipidemia Social History: ___ Family History: NC Physical Exam: On Admssion: O: T:97.7 BP: 130/93 HR: 103 R 21 O2Sats Gen: WD/WN, comfortable, NAD. HEENT: Pupils: R ___, L unable to examine EOMs R intact Neck: collar Lungs: CTA bilaterally. Cardiac: RRR. S1/S2. Abd: Soft, NT, BS+ Extrem: Warm and well-perfused. Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place. Language: Speech fluent with good comprehension and repetition. Naming intact. No dysarthria or paraphasic errors. Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, to mm bilaterally. Visual fields are full to confrontation. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength full power 4+ right UE; BLE limited due to pain. No pronator drift Sensation: Intact to light touch, propioception, pinprick and vibration bilaterally. Reflexes: Normal bilat Toes downgoing bilaterally At discharge: Alert to self and hospital PERRL EOMs intact, R periorbital ecchymosis Face symmetrical No pronator drift MAE with good strength Pertinent Results: ___ CT C-spine No acute cervical spine fractures. Normal alignment. ___ CT head 1. There is an 8-mm extra-axial hemorrhage overlying the right frontoparietal lobe with a biconvex appearance most suggestive of an epidural hematoma. 2. Extensive left frontal subgaleal hematoma with supraorbital and infraorbital components. 3. Tiny hyperdense focus visualized in a sulcus in the right temporal lobe is suggestive of a tiny focus of subarachnoid hemorrhage versus partial volume averaging. L hip X-rays ___ 1. No definite acute fracture or dislocation. If there is continued clinical concern for left hip fracture, consider correlation with hip MRI. 2. Tricompartmental mild-to-moderate osteoarthritic changes of the left knee secondary to chondrocalcinosis. L Femur X-rays ___ 1. No definite acute fracture or dislocation. If there is continued clinical concern for left hip fracture, consider correlation with hip MRI. 2. Tricompartmental mild-to-moderate osteoarthritic changes of the left knee secondary to chondrocalcinosis CT head ___ 1. Stable appearance of right frontoparietal epidural hematoma. 2. No other apparent foci of hemorrhage. 3. Stable large left orbital subgaleal hematoma. Brief Hospital Course: Ms. ___ was admitted to the ___ under the care of Dr. ___ Q1 hr neuro checks for EDH. She remained stable with some disorientation to time that was consistent with her basline status due to dementia. Repeat CT head was stable. Imaging of the left leg was negative for fracture. She was seen by the medicine service and there were no acute issues and they would not take over her care. She was transfered to the floor. Her collar was cleared by the ___ as she had no fracture or pain. ___ and OT were consulted and they felt that she was safe to go home with 24hr supervision. The daughter will be home with her over the weekend and a home ___ will be assisting on ___. Medications on Admission: ASA Discharge Medications: Patient may take tylenol for pain Discharge Disposition: Home Discharge Diagnosis: EDH Discharge Condition: Neurologically stable Discharge Instructions: Instructions for Follow up for Subdural, Epidural or Subarachnoid Hemorrhages Non-Surgical •You may take tylenol for pain. You do not need to take it if you do not have pain. •Exercise should be limited to walking; no lifting, straining, or excessive bending. •Increase your intake of fluids and fiber, as narcotic pain medicine can cause constipation. We generally recommend taking an over the counter stool softener, such as Docusate (Colace) while taking narcotic pain medication. •DO not take any anti-inflammatory medicines such as Motrin, Aspirin, Advil, or Ibuprofen etc. until follow up. •*****If you were on Aspirin prior to your injury, you may safely resume taking this on ___ CALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE FOLLOWING •New onset of tremors or seizures. •Any confusion, lethargy or change in mental status. •Any numbness, tingling, weakness in your extremities. •Pain or headache that is continually increasing, or not relieved by pain medication. •New onset of the loss of function, or decrease of function on one whole side of your body. Followup Instructions: ___
10379484-DS-10
10,379,484
27,781,554
DS
10
2133-03-18 00:00:00
2133-03-20 21:47:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / albuterol / Sulfa (Sulfonamide Antibiotics) Attending: ___. Chief Complaint: dysuria, chills, aches Major Surgical or Invasive Procedure: none History of Present Illness: ___ with atrial fibrillation not on AC, GERD, meningioma who was seen in ED yesterday for dysuria with positive urinalysis, sent home on nitrofurantoin, who presents with "feeling awful" with worsening dysuria, generalized body aches. She was also noted to have Cr elevation to 1.3. Culture is growing unspeciated GNRs. She also complains of cough, although it seems to be more chronic. Denies dyspnea, chest pain, abdominal pain, diarrhea, melena, BRBPR, rash, neck stiffness. In the ED, initial vitals: 99.4 80 150/60 18 96% Nasal Cannula - Exam notable for:CTAB No CVAT - Labs notable for: BUN/Cr ___, K 3.5, UA neg leuks, trace ketones, lactate 1.4, flu neg - Imaging notable for: CXR Mild vascular congestion, unchanged. Chronic middle lobe collapse. No definite focal consolidation to suggest pneumonia. EKG Atrial fibrillation @ 87 bpm, Probable LVH with secondary repol abnrm Inferior infarct, old, Anterior Q waves, possibly due to LVH - Pt given: CTX 1 gm, 1L NS - She developed acute respiratory distress in ED with IVF. CXR showed pulmonary edema. She briefly required BiPAP in the ED. On arrival to the floor, pt reports that she still feels awful. Two days ago developed dry, "musical" cough then chills ("shaking like a leaf"). She also had dysuria, poor appetite, some nausea. No rhinorrhea, sore throat, abdominal pain, fevers/chills, dyspnea, chest pain, or sick contacts. No lightheadedness, but she did trip with her walker and hurt her ankle. She did not fall. ROS: As per HPI; Otherwise negative Past Medical History: PMH: Afib not on anticoagulation GERD and Gastritis on EGD Right frontal convexity meningioma Hypertension Spinal stenosis Arthritis PSH: 2 prior hip operations with additional revisions L partial mastectomy Cataract surgery in ___ Social History: ___ Family History: Parents are deceased- died at old age. Sister ___, brother ___. Brother with arthritis. Her daughter, at age ___, has arthritis. But her sons, ages ___ and ___, are healthy. Physical Exam: ADMISSION EXAM: Vitals: 97.9 PO 148 / 55 R Lying 95 20 92 2L General: Alert, oriented x3, no acute distress HEENT: Sclerae anicteric, dry oral mucosa, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Generally clear throughout with transmitted upper airway sounds CV: Irregularly irregular, MRG Abdomen: soft, NT/ND bowel sounds present, no rebound tenderness or guarding, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema, Left foot with ecchymoses over dorsal aspect. No TTP of lateral/medial malleoli or metatarsals. Full ankle ROM. Neuro: CN2-12 intact, no focal deficits DISCHARGE Vitals: 98.0, 166/88, 94 bpm, 92%RA General: Awake watching walking to nursing station with walker on her own, looks younger than age, does not cough during our entire encounter. HEENT: Moist mucosa, glasses in place Lungs: lungs are clear with good movement, comfortable on room air CV: Mostly regular, PACs few Abdomen: Mild distension (her baseline), soft, NT/ND bowel sounds present GU: no foley Ext: warm, well perfused, mild edema of RLE with overlying xerosis diffuse Neuro: no focal deficits, walking easily with walker, speech clear, face symmetric Pertinent Results: ADMISSION LABS: ___ 11:51PM BLOOD WBC-11.8*# RBC-4.18 Hgb-11.7 Hct-36.7 MCV-88 MCH-28.0 MCHC-31.9* RDW-14.7 RDWSD-46.9* Plt ___ ___ 11:51PM BLOOD Neuts-85.1* Lymphs-4.2* Monos-8.0 Eos-2.1 Baso-0.1 Im ___ AbsNeut-10.03*# AbsLymp-0.50* AbsMono-0.94* AbsEos-0.25 AbsBaso-0.01 ___ 12:17PM BLOOD ___ PTT-27.1 ___ ___ 11:51PM BLOOD Glucose-122* UreaN-30* Creat-1.3* Na-140 K-3.5 Cl-97 HCO3-27 AnGap-20 ___ 12:17PM BLOOD Calcium-8.1* Phos-3.2 Mg-2.0 ___ 03:25AM BLOOD Lactate-1.4 ___ 02:04AM URINE Color-YELLOW Appear-Clear Sp ___ ___ 02:04AM URINE Blood-NEG Nitrite-NEG Protein-TR Glucose-NEG Ketone-TR Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG ___ 02:04AM URINE RBC-<1 WBC-10* Bacteri-FEW Yeast-NONE Epi-1 TransE-<1 MICROBIOLOGY: URINE CULTURE (Final ___: ESCHERICHIA COLI. >100,000 CFU/mL. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMIKACIN-------------- <=2 S AMPICILLIN------------ =>32 R AMPICILLIN/SULBACTAM-- =>32 R CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ =>16 R MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ 8 I TRIMETHOPRIM/SULFA---- =>16 R STUDIES: ___ CXR: Mild vascular congestion, unchanged. Chronic middle lobe collapse. No definite focal consolidation to suggest pneumonia. ___ 06:36AM BLOOD WBC-4.4 RBC-3.73* Hgb-10.9* Hct-33.2* MCV-89 MCH-29.2 MCHC-32.8 RDW-14.3 RDWSD-45.7 Plt ___ ___ 06:44AM BLOOD Glucose-150* UreaN-17 Creat-1.1 Na-138 K-3.8 Cl-98 HCO3-23 AnGap-21* ___ 06:36AM BLOOD proBNP-4060* Brief Hospital Course: ___ with atrial fibrillation not on AC, GERD, meningioma who presents with dysuria, cough/chills most likely consistent with acute viral syndrome/URI and UTI. Had ECOLI >100k, initially on Ceftriaxone switched to cefpodoxime for 7 day course. Given worsening resp sx during admission given nebs/inhalers and Azithromycin for antiinflammatory effect (for 5 day course). UTI sympotoms quickly improved with Respiratory much improved. Cough ongoing and infrequent. Patient has difficulty sleeping and hip pain, per patient chronic and she uses oxycodone at home for this. seen by our ___ and cleared for home TRANSITIONAL -- PCP ___ on ___, discuss insomnia further and her use of Opioids -- Cefpodoxime and Azithromycin on discharge BY PROBLEM: # Hypoxemia - Resolved. On ___ started 2L NC as her RA SaO2 was in the ___. Seems that diuresis did help as her BNP was 4000+ and did have crackles on ___ and was not getting Lasix (at home 40mg PO daily). No evid of chf exacerbation otherwise. Does have ILI / Bronchitis and likely also contributing. On SQH and only in hospital a few days to suggest PE. Volume status seems that she is euvolemic to hypovolemic -- cont ILI treatment as below -- continue PO Lasix 20mg/day (40mg/day at home), monitor GFR closely given her poor po intake -- prn ipratropium # MALAISE # BRONCHITIS, COUGH - Improving overall. c/w ILI vs atypical pneumonia. ___ some suggestion of LLL consolidation on cxr. No h/o aspiration. Possibly atypical bacterial process thus Azithro added. -- Azithromycin started on ___ x 5 days (QTc on ___ pending) -- standing APAP for now given ongoing pain - Symptomatic treatment: Guaifenesin-Dextromethorphan, Ipratropoium # UTI, ECOLI with resistances: Positive urine cx with dysuria. No CVA TTP/fever/n/v to suggest pyelo, symptoms improved now. - Initially on Ceftriaxone, now Cefpodoxime since ___ (though urinary penetration less than ideal, best option given sensitivities at this time) - ___ for 7 days # Hypokalemia - resolved # Hypernatremia - resolved # ___: Resolved. Cr 1.2 on arrival, baseline 1.0. Likely pre-renal, as resolved with IVF. Cr back at baseline now. -- likely combination of poor freewater intake and poor nutritional intake and Lasix use (though has BNP of 4000 and in afib) -- encourage better nutrition and free water intake -- restart Lasix as above # CODE STATUS - discussed in detail with patient on ___, she is clear and understands details of the conversation, adamant to avoid any interventions such as CPR / Intubation. Does want to have DNR / DNI order. -- inform HCP later today. # Constipation - increase Bowel reg on ___, now had several BMs on ___ # Hypertension # Atrial fibrillation: Not on anti-coagulation since GI bleed in ___. Rate-controlled. - home metoprolol 25mg BID - home Amlodipine 5mg/ BID # Spinal stenosis # Insomnia - an issue while she is here. Apparently oxycodone helps both pain and sleep at home -Continue home mirtazapine -Trial Trazodone qHS -- cont home oxycodone ___ q8h prn CHRONIC # GERD/Gastritis: # Thrombocytopenia - Mild and chronic, I wonder about chronic underlying ITP, medication effect (PPI) can consider further outpatient workup - Continue home omeprazole for GERD/gastritis though could be contributing to some low PLT, outpatient follow up #Misc: -Continue home ASA/docusate/MVI/Ferrous sulfate/INH Fluticasone # CODE STATUS: DNR / DNI # CONTACT: Name of health care proxy: ___ Relationship: son Phone number: ___ Cell phone: ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild 2. Docusate Sodium 100 mg PO BID 3. Metoprolol Tartrate 25 mg PO BID 4. Mirtazapine 7.5 mg PO QHS 5. Omeprazole 20 mg PO BID 6. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Moderate 7. Vitamin D 1000 UNIT PO DAILY 8. HydrOXYzine 10 mg PO QHS:PRN itchiness 9. Furosemide 40 mg PO DAILY 10. Aspirin 81 mg PO DAILY 11. amLODIPine 5 mg PO BID 12. Calcium Carbonate 500 mg PO BID Discharge Medications: 1. Azithromycin 250 mg PO Q24H Duration: 5 Days d1 = ___ RX *azithromycin [Zithromax] 250 mg 1 tablet(s) by mouth daily Disp #*2 Tablet Refills:*0 2. Cefpodoxime Proxetil 200 mg PO Q24H Duration: 6 Days d1 = ___, d7 = ___ RX *cefpodoxime 200 mg 1 tablet(s) by mouth daily Disp #*3 Tablet Refills:*0 3. Cepacol (Sore Throat Lozenge) 1 LOZ PO TID RX *benzocaine-menthol [Sore Throat (benzocaine-menth)] 15 mg-2.6 mg three times a day Disp #*18 Lozenge Refills:*0 4. Guaifenesin-Dextromethorphan ___ mL PO TID Duration: 5 Days RX *dextromethorphan-guaifenesin [Antitussive DM] 100 mg-10 mg/5 mL 5 mL by mouth three times a day Refills:*0 5. Polyethylene Glycol 17 g PO DAILY:PRN constip RX *polyethylene glycol 3350 [Miralax] 17 gram/dose 1 powder(s) by mouth twice a day Refills:*0 6. Acetaminophen 650 mg PO Q6H 7. Docusate Sodium 200 mg PO BID 8. Furosemide 30 mg PO DAILY RX *furosemide [Lasix] 20 mg 1.5 tablet(s) by mouth daily Disp #*90 Tablet Refills:*3 9. amLODIPine 5 mg PO BID 10. Aspirin 81 mg PO DAILY 11. Calcium Carbonate 500 mg PO BID 12. Metoprolol Tartrate 25 mg PO BID 13. Mirtazapine 7.5 mg PO QHS 14. Omeprazole 20 mg PO BID 15. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Moderate 16. Vitamin D 1000 UNIT PO DAILY 17. HELD- HydrOXYzine 10 mg PO QHS:PRN itchiness This medication was held. Do not restart HydrOXYzine until you see your pcp ___: Home With Service Facility: ___ Discharge Diagnosis: Urinary tract infection Acute kidney injury Acute viral syndrome Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms ___, Why were you here: -You had a viral infection, as well as a urinary tract infection What was done: -We gave you antibiotics What to do next: -Take all your medications as prescribed and follow-up with the appointments listed below We wish you all the best, Your ___ team Followup Instructions: ___
10379484-DS-7
10,379,484
20,973,084
DS
7
2131-05-23 00:00:00
2131-05-23 15:37:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Penicillins / sulfur drugs / albuterol Attending: ___ ___ Complaint: post mastectomy discomfort and swelling Major Surgical or Invasive Procedure: s/p Left breast partial mastectomy for invasive ductal carcinoma on ___ History of Present Illness: Mrs ___ is a ___ yo woman with history of atrial fibrillation (on warfarin) s/p L breast partial mastectomy for invasive ductal carcinoma re-admitted POD 4 with L breast hematoma. She presented electively to the ___ on ___ ___. She underwent left partial mastectomy on the day of presentation and was discharged the following day without any immediate complication. On ___ she developed nausea and vomiting earlier in the evening and presented to ___ ER for evaluation. On clinical exam she was found to have a left breast hematoma and eccymosis extending down her lateral torso. Of note, her operative incision was intact with no distension of the hematoma. Labs, CT of the torso and left breast ultrasound were performed and most remarkable for HCT drop from 34 to 27.Ms. ___ was admitted for hydration, observation and possible evacuation of hematoma. Past Medical History: PMH:Right frontal convexity meningioma,Hypertension, Arthritis,GERD,Spinal stenosis, Afib PSH:L partial mastectomy,Cataract surgery in ___ prior hip operations with additional revisions Social History: She lives with her sister who is ___. No tobacco. Lifelong non-smoker. No EtoH. Widowed x ___ years. She lives in an apartment in ___. She has a housekeeper. Her sister drives. Her sister does the accounting for the house. She does her own personal accounts. She is independent of bathing but has been taking sponge baths recently due to fear of falls. Her son is her HCP: ___ - 1 ___ ___ ___ ADLS: Indep of dressing ambulating hygiene eating toileting IADLS:Indep shopping accounting telephone use food preparation Lives with: family Walks with a walker and a cane. Fall last year + gait + Visual aides - Dentures Family History: Parents are deceased- died at old age. Sister ___, brother ___. Brother with arthritis. Her daughter, at age ___, has arthritis. But her sons, ages ___ and ___, are healthy. Physical Exam: VS:98.6 75 125/70 18 97%RA General - Awake and alert. NAD. Oriented x 3. Pleasantly conversant. Left Breast - L breast soft, with marked ecchymosis extends down flank, hematoma is stable and resolving. CV - RRR Pulmonary-clear ABD-soft, nontender,nondistended Ext - WWP. No edema. Pertinent Results: ___ 07:00AM BLOOD WBC-4.3 RBC-3.49* Hgb-10.3* Hct-30.4* MCV-87 MCH-29.6 MCHC-34.0 RDW-15.7* Plt ___ ___ 07:08AM BLOOD Hct-24.7* ___ 07:55AM BLOOD WBC-5.8 RBC-3.32* Hgb-10.0* Hct-28.3* MCV-85 MCH-30.2 MCHC-35.4* RDW-15.4 Plt ___ ___ 03:45PM BLOOD WBC-6.0 RBC-3.13* Hgb-8.9*# Hct-27.3* MCV-87 MCH-28.5 MCHC-32.6 RDW-15.7* Plt ___ ___ 11:30AM BLOOD ___ Brief Hospital Course: Ms. ___ ___ h/o atrial fibrillation (on warfarin) s/p left breast partial mastectomy for invasive ductal carcinoma re-admitted POD 4 for symptoms of nausea and vomiting of unclear etiology and was found to have a left breast hematoma. Ms. ___ was admitted for hydration, observation and possible evacuation of hematoma .Ultimately,decision was made not to take her to OR for evacuation as her left breast hematoma was stable and resolving. Hospital course by systems: Neuro:pleasantly alert,conversant, notable for short term memory loss. Mildly anxious, no agitation. Cardiac: patient with Rate controlled Afib,HR 70's,mildly hypotensive, SBP 90-100. orthostatic VS were negative. Her cardiac medications were titrated,her Valsartan and Lasix was discontinued. She continued on Metoprolol, Amlodipine and remained normotensive (SBP 120's). Cardiology were consulted regarding Coumadin therapy and risk/benefit indication given her age and rate controlled afib. Per cardiology fellow, who spoke with her cardiologist ___, who recommended continuing holding Coumadin until her breast hematoma resolves and until she is seen in outpatient cardiac clinic in approximately ___ week. Pulmonary: Patient remained stable from pulmonary standpoint. GI/GU/FEN: Patient received IV fluids overnight and she was heplocked on HD 2.She was started on a diet. Patient with intermittent nausea/gas pain, She was started on simethicone and PPI for GERD. HD 4,Patient with low urine output overnight, voided 50 cc over 9 hours. Bladder scanned for 160 cc; thereafter voided without any intervention. Wound: Patient with resolving left breast hematoma. ID: Patient remained afebrile and had no signs or symptoms of wound infection. HEME: Patient found to have acute anemia due to blood loss from surgery. On, HD 3, she was transfused with 1 unit RBC for HCT 24.7, post transfusion HCT 30.4. stool guaiac negative. Prophylaxis:Patient ambulated with cane and assistance by nursing staff. On HD 4, Ms. ___ was deemed stable for discharge to extended care facility. Medications on Admission: 1. Acetaminophen 1000 mg PO Q6H Never exceed 4000 mg in 24 hours 2. Amlodipine 5 mg PO BID 3. Diazepam 5 mg PO QHS:PRN anxiety 4. Escitalopram Oxalate 10 mg PO DAILY 5. Fluticasone Propionate 110mcg 2 PUFF IH BID 6. Metoprolol Tartrate 25 mg PO BID 7. Mirtazapine 7.5 mg PO QHS 8. TraMADOL (Ultram) 25 mg PO Q6H:PRN pain RX *tramadol 50 mg 0.5 (One half) tablet(s) by mouth every six (6) hours Disp #*15 Tablet Refills:*0 9. TraZODone 25 mg PO QHS:PRN insomnia 10. Valsartan 80 mg PO DAILY 11. Warfarin 3 mg PO DAILY16 Discharge Medications: 1. Amlodipine 5 mg PO DAILY 2. Escitalopram Oxalate 10 mg PO DAILY 3. Fluticasone Propionate 110mcg 2 PUFF IH BID 4. Metoprolol Tartrate 25 mg PO BID 5. Mirtazapine 7.5 mg PO QHS 6. Omeprazole 20 mg PO DAILY 7. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN pain 8. Simethicone 80 mg PO TID 9. Acetaminophen 650 mg PO Q6H:PRN pain 10. TraMADOL (Ultram) 25 mg PO Q6H:PRN pain 11. TraZODone 25 mg PO QHS:PRN insomnia 12. Diazepam 5 mg PO QHS:PRN anxiety 13. Docusate Sodium 100 mg PO DAILY 14. Ferrous Sulfate 325 mg PO DAILY 15. Multivitamins 1 TAB PO DAILY 16. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: 1. Left breast hematoma secondary to anti-coagulation for atrial fibrillation 2. Left Breast Cancer 3. Atrial Fibrillation 4. Spinal Stenosis with Gait unseteadiness 5. Hypertension Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Discharge Instructions: PERSONAL CARE: 1. Please wear surgical bra for support,keep your incision covered with a clean, sterile gauze that you change daily. 2. You may shower daily with assistance as needed and pat your incision dry. ACTIVITY: 1. You may resume your regular diet. 2. Walk several times a day. 3. DO NOT lift anything heavier than 5 pounds or engage in strenuous activity for 6 weeks following surgery. MEDICATIONS: 1. Resume your regular medications and take any new medications as ordered. 2. You may take your normal pain medication (Percocet) that you regularly take at home. You may switch to Tylenol or Extra Strength Tylenol for mild pain as directed on the packaging. Please note that Percocet have Tylenol as an active ingredient, so do not take these meds with additional Tylenol. 3. Take Colace, 100 mg by mouth 2 times per day, while taking the prescription pain medication. You may use a different over-the-counter stool softener if you wish. 4. Do not drive or operate heavy machinery while taking any narcotic pain medication. You may have constipation when taking narcotic pain medications (oxycodone, percocet, vicodin, hydrocodone, dilaudid, etc.); you should continue drinking fluids, you may take stool softeners, and should eat foods that are high in fiber. ANTICOAGULATION: 1. Your warfarin is on hold until you follow-up with your outpatient cardiologist. Call the office IMMEDIATELY if you have any of the following: 1. Signs of infection: fever with chills, increased redness, swelling, warmth or tenderness at the surgical site, or unusual drainage from the incision(s). 2. A large amount of bleeding from the incision(s) or drain(s). 3. Fever greater than 101.5 oF 4. Severe pain NOT relieved by your medication. Return to the ER if: * If you are vomiting and cannot keep in fluids or your medications. * If you have shaking chills, fever greater than 101.5 (F) degrees or 38 (C) degrees, increased redness,swelling or discharge from incision, chest pain, shortness of breath, or anything else that is troubling you. * Any serious change in your symptoms, or any new symptoms that concern you. Followup Instructions: ___
10379484-DS-8
10,379,484
20,944,057
DS
8
2132-07-07 00:00:00
2132-07-07 15:22:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / albuterol / Sulfa (Sulfonamide Antibiotics) Attending: ___. Chief Complaint: Bilateral hip pain Major Surgical or Invasive Procedure: None History of Present Illness: This is a ___ year old female with a history of bilateral hip replacement, hypertension and atrial fibrillation who presents with bilateral hip pain after running out of her oxycodone, also found to have possible RLL opacity concerning for pneumonia. Per OMR, patient requested early oxycodone refill for ongoing hip pain and was denied. She denies any recent trauma or falls and ambulates with a walker. In the ED, initial vital signs were: 98.5 89 146/64 18 97% RA. Labs were notable for Lactate of 1.3, Cr of 1.2, H/H of ___ and WBC of 8.9. CXR showed a new medial right base opacity, which may reflect pneumonia in the correct clinical setting. The patient was given: Zofran 4mg X 1, CTX 1gm and Azithromycin 500mg, Oxycodone 5mg and Acetaminophen 1000mg X 1. Vitals prior to transfer were: 99.8 93 117/64 16 92% RA. Upon arrival to the floor, she reports the history above. She also reports a cough but denies fevers, chest pain, shortness of breath, abdominal pain, N/V/D. REVIEW OF SYSTEMS: Reports bilateral hip pain and cough. Denies fever, chills, CP, SOB, N/V/D. Past Medical History: PMH:Right frontal convexity meningioma,Hypertension, Arthritis,GERD,Spinal stenosis, Afib PSH:L partial mastectomy,Cataract surgery in ___ prior hip operations with additional revisions Social History: She lives with her sister who is ___. No tobacco. Lifelong non-smoker. No EtoH. Widowed x ___ years. She lives in an apartment in ___. She has a housekeeper. Her sister drives. Her sister does the accounting for the ___. She does her own personal accounts. She is independent of bathing but has been taking sponge baths recently due to fear of falls. Her son is her HCP: ___ - ___ ___ ___ ___ ADLS: Indep of dressing ambulating hygiene eating toileting IADLS:Indep shopping accounting telephone use food preparation Lives with: family Walks with a walker and a cane. Fall last year + gait + Visual aides - Dentures Family History: Parents are deceased- died at old age. Sister ___, brother ___. Brother with arthritis. Her daughter, at age ___, has arthritis. But her sons, ages ___ and ___, are healthy. Physical Exam: ADMISSION PHYSICAL: GENERAL: NAD, lying in bed HEENT: NC/AT, no scleral icterus, PERRLA, EOMI NECK: supple, no LAD CARDIAC: RRR, normal S1/S2, no murmurs PULMONARY: clear to auscultation without wheezing ABDOMEN: soft, non-tender, non-distended EXTREMITIES: warm, well-perfused, no edema NEUROLOGIC: A&Ox3, CN II-XII grossly normal DISCHARGE PHYSICAL: VITALS: Tm98 BP110s/50s HR50s-70s 94RA GENERAL: NAD, appears much younger than stated age HEENT: NC/AT, no scleral icterus, PERRLA, EOMI CARDIAC: RRR, II/VI systolic murmur at LSB, no rubs or gallops PULMONARY: decreased right lower breath sounds but otherwise CTAB ABDOMEN: soft, non-tender, non-distended EXTREMITIES: warm, well-perfused, no edema. Patient in hip brace NEUROLOGIC: A&Ox3, grossly intact Pertinent Results: ADMISSION LABS: ___ 03:30AM ___ PTT-27.2 ___ ___ 03:30AM PLT COUNT-184 ___ 03:30AM NEUTS-87.2* LYMPHS-5.0* MONOS-6.8 EOS-0.1* BASOS-0.1 IM ___ AbsNeut-7.78* AbsLymp-0.45* AbsMono-0.61 AbsEos-0.01* AbsBaso-0.01 ___ 03:30AM WBC-8.9 RBC-3.87* HGB-11.0* HCT-33.5* MCV-87 MCH-28.4 MCHC-32.8 RDW-14.8 RDWSD-46.9* ___ 03:30AM OTHER BODY FLUID FluAPCR-NEGATIVE FluBPCR-NEGATIVE ___ 03:30AM estGFR-Using this ___ 03:30AM GLUCOSE-103* UREA N-31* CREAT-1.2* SODIUM-136 POTASSIUM-3.4 CHLORIDE-98 TOTAL CO2-25 ANION GAP-16 ___ 03:41AM LACTATE-1.6 ___ 03:41AM ___ COMMENTS-GREEN TOP ___ 06:30AM URINE MUCOUS-RARE ___ 06:30AM URINE RBC-2 WBC-110* BACTERIA-MOD YEAST-NONE EPI-<1 ___ 06:30AM URINE BLOOD-TR NITRITE-POS PROTEIN-30 GLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-0.2 PH-6.0 LEUK-MOD ___ 06:30AM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 06:30AM URINE UHOLD-HOLD ___ 06:30AM URINE HOURS-RANDOM MICRO: FLU A & B PCR - NEGATIVE BLOOD CULTURE X 2 ON ___ NGTD **FINAL REPORT ___ URINE CULTURE (Final ___: ESCHERICHIA COLI. 10,000-100,000 ORGANISMS/ML.. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMIKACIN-------------- <=2 S AMPICILLIN------------ =>32 R AMPICILLIN/SULBACTAM-- 8 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ =>16 R MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ 8 I TRIMETHOPRIM/SULFA---- =>16 R IMAGING: CXR ON ___ IMPRESSION: New medial right base opacity, which may reflect pneumonia in the correct clinical setting. HIP FILMS ___ There are bilateral extended total hip arthroplasty is in-situ. There is abundant callus formation around the proximal right femur with cerclage wires seen at this site. There is bony buttressing along the distal aspect of the femoral prosthesis. No acute fracture seen. Moderate vascular calcification. There is heterotopic ossification around the left hip joint. No periprosthetic loosening or periprosthetic fracture seen. Severe degenerative changes in the lumbar spine. DISCHARGE LABS: ___ 06:07AM BLOOD WBC-6.7 RBC-4.12 Hgb-11.7 Hct-36.6 MCV-89 MCH-28.4 MCHC-32.0 RDW-15.1 RDWSD-48.8* Plt ___ ___ 06:07AM BLOOD Glucose-83 UreaN-14 Creat-1.1 Na-143 K-4.1 Cl-103 HCO3-28 AnGap-16 ___ 06:07AM BLOOD Calcium-9.2 Phos-2.8 Mg-2.3 Brief Hospital Course: Ms. ___ is a ___ year old woman with a history of bilateral hip replacement who presents with bilateral hip pain after running out of her oxycodone. Hospital course included treatment for CAP and E. coli UTI. #HIP PAIN: The patient has chronic bilateral hip pain and shares she had run out of her oxycodone and presented to the ED for pain control as her PCP did not refill it. Per her PCP, the patient has been on this regimen of oxycodone for an extended period of time, and it is unusual for her to run out and that is why he did not refill it. She had an X-ray done of her pelvis that showed no acute pathology as a cause for worsening pain, and her pain was controlled was started back on the oxycodone. Team spoke with the PCP, who will continue to follow her pain management. She was also continued on home tramadol and a lidocaine patch to the right hip was added to her pain regimen. #CAP and UTI: Patient had also reported chills upon admission. She had a CXR with a right medial base opacity, and urine cultures were growing E coli. She was HDS with intact respiratory status. She was initially started on ceftriaxone/azithromycin for CAP, as ceftriaxone would also cover UTI. Ceftriaxone was transitioned to levofloxacin. Once urine cultures sensitivities returned, showing cipro resistance, and she was given a third dose of ceftriaxone to complete a total 3 day course for an uncomplicated UTI. Total CAP course ___ for five day course. #Indigestion: the patient reports feelings of being "sick to her stomach" but is unable to clarify further. EKG with no evidence of ischemia. She denied any nausea/vomiting or pain and says this is her baseline indigestion and her PCP confirmed this. She was given maalox 30 ml QID prn and zofran 4 mg po q 8 h prn with mild relief. #Vaginal/rectal bleeding: Patient reports chronic vaginal and rectal bleeding but declines any further workup. Further discussion regarding evaluation of these sources of bleeding can be held with her PCP as an outpatient. #HYPERTENSION: Continued home amlodipine and metoprolol. #ATRIAL FIBRILLATION: Not on anticoagulation after discussion with family and PCP, may be secondary to age vs other comorbidities. Continued home Metoprolol tartrate 25 mg BID. #GERD: Continued home Omeprazole. #Depression: Continued home escitalopram and mirtazapine. #Asthma: Continued home flovent. #Iron deficiency anemia: as above, patient has declined further workup. Continued ferrous sulfate. TRANSITIONAL ISSUES: - Pain management with oxycodone for bilateral hip pain - Last day of antibiotics levofloxacin/azithromycin for CAP: ___ - Patient had reported chronic vaginal bleeding, but said she does not desire further workup. Continue to follow. - Discuss whether or not patient would benefit from anticoagulation for afib Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Amlodipine 5 mg PO DAILY 2. Escitalopram Oxalate 10 mg PO DAILY 3. Fluticasone Propionate 110mcg 2 PUFF IH BID 4. Metoprolol Tartrate 25 mg PO BID 5. Mirtazapine 7.5 mg PO QHS 6. Omeprazole 20 mg PO DAILY 7. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN pain 8. Simethicone 80 mg PO TID 9. Acetaminophen 650 mg PO Q6H:PRN pain 10. TraMADol 25 mg PO Q6H:PRN pain 11. TraZODone 25 mg PO QHS:PRN insomnia 12. Diazepam 5 mg PO QHS:PRN anxiety 13. Docusate Sodium 100 mg PO DAILY 14. Ferrous Sulfate 325 mg PO DAILY 15. Multivitamins 1 TAB PO DAILY 16. Vitamin D 1000 UNIT PO DAILY Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN pain 2. Amlodipine 5 mg PO DAILY 3. Docusate Sodium 100 mg PO DAILY 4. Escitalopram Oxalate 10 mg PO DAILY 5. Ferrous Sulfate 325 mg PO DAILY 6. Fluticasone Propionate 110mcg 2 PUFF IH BID 7. Metoprolol Tartrate 25 mg PO BID 8. Mirtazapine 7.5 mg PO QHS 9. Multivitamins 1 TAB PO DAILY 10. Omeprazole 20 mg PO DAILY 11. Simethicone 80 mg PO TID 12. TraMADol 25 mg PO Q6H:PRN pain 13. Vitamin D 1000 UNIT PO DAILY 14. Aluminum-Magnesium Hydrox.-Simethicone ___ mL PO QID:PRN belching/dyspepsia 15. Azithromycin 250 mg PO Q24H Duration: 4 Doses 16. Levofloxacin 750 mg PO Q48H 17. Lidocaine 5% Patch 1 PTCH TD DAILY 18. Polyethylene Glycol 17 g PO DAILY 19. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN pain RX *oxycodone-acetaminophen 5 mg-325 mg 1 tablet(s) by mouth q6h prn Disp #*20 Tablet Refills:*0 20. TraZODone 25 mg PO QHS:PRN insomnia 21. Diazepam 5 mg PO QHS:PRN anxiety RX *diazepam 5 mg 1 tablet by mouth qhs prn Disp #*5 Tablet Refills:*0 Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSES Chronic bilateral hip pain Community acquired pneumonia Urinary tract infection SECONDARY DIAGNOSES Nausea Hypertension Atrial fibrillation Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you during your hospitalization at the ___. You were admitted for management of your hip pain. Your pain was managed well with oxycodone. You will continue to follow up with your primary care physician for pain control. In addition, you had signs and symptoms concerning for both a pneumonia (lung infection) and for a urinary tract infection. You were treated with antibiotics and felt better. We wish you the best of luck in your health. Sincerely, Your ___ Care Team Followup Instructions: ___
10379635-DS-9
10,379,635
28,777,948
DS
9
2154-07-16 00:00:00
2154-07-16 11:54:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: lisinopril / hydrochlorothiazide Attending: ___. Chief Complaint: Cough, myalgias Major Surgical or Invasive Procedure: None History of Present Illness: ___ year old male with medical history notable for severe COPD, colonic adenoma, CAD, CHF (LVEF 30% to 35% s/p ICD), HTN, HLD who presents with two days of flu-like symptoms as well as one day of substernal burning that worse with activity. Symptoms began two days ago and include cough, congestion, body aches, fever, shortness of breath, and rhinorrhea. He also reports new onset substernal burning that is worse with activity. Burning is not similar to prior MI and is not associated with food. He reports some orthopnea, no lower extremity swelling. In the ED, initial vital signs were 100.2 96 168/80 18 94% RA. Exam showed bilateral rhonchi, bibasilar crackles. JVP was not elevated. There is no was no edema. Labs showed K 5.4, Cr 1.1, BNP 592, bicarbonate 20, anion gap 18. Testing was positive for influenza A. Patient was provided albuterol nebulizers, ipratropium and tiotropium, oseltamivir 75 mg x 1, carvedilol 3.125 mg x 1, aspirin 81 mg x 1, acetaminophen 1000 mg x 1, and fluticasone-salmeterol diskus. CXR showed now edema and hyperinflated lungs. Currently, the patient feels better. He is not short of breath, with no chest pain, no myalgias, no fever. There are no reported sick contacts. He received his flu shot this year. Review of systems: 10 pt ROS negative other than noted. PAST MEDICAL HISTORY: -CAD: Cath ___ with severe RCA and LCx disease not amenable to PCI and moderate LAD disease. -CARDIOMYOPATHY: LVEF 35%, s/p ICD. -ALCOHOL ABUSE - started at age ___ -- increased to 1 case beer/day; stopped drinking at age ___ after inpt detox, AA. Abstinent since. -COLONIC POLYPS ___ colonoscopy-->single adenoma. ___ study normal. ___ study with 1 adenomatous, 1 hyperplastic polyp. Repeat ___ due ___ w/ Dr. ___. -ERECTILE DYSFUNCTION -HYPERTENSION -HYPERCHOLESTEROLEMIA -IRITIS -LUNG NODULE - 3mm, seen on chest CT ___, stable on ___ repeat, new 1mm RUL nodule, recommended repeat CT in ___ year, All nodules stable on ___ CT, likely granuloma, no need for further surveillance -SMOKING - quit ___ -CHRONIC OBSTRUCTIVE PULMONARY DISEASE - Severe -DIVERTICULOSIS MEDICATIONS AT HOME: The Preadmission Medication list is accurate and complete 1. Aspirin 81 mg PO DAILY 2. Atorvastatin 80 mg PO QPM 3. Carvedilol 3.125 mg PO BID 4. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 5. Tiotropium Bromide 1 CAP IH DAILY 6. albuterol sulfate 90 mcg/actuation INHALATION Q6H:PRN SOB, wheezing 7. Cetirizine 10 mg PO DAILY:PRN allergies 8. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain 9. Losartan Potassium 12.5 mg PO DAILY 10. budesonide-formoterol 80-4.5 mcg/actuation inhalation BID 11. Ibuprofen 800 mg PO DAILY:PRN Pain - Mild ALLERGIES: hydrochlorothiazide lisinopril (dizziness) SOCIAL HISTORY: ___ FAMILY HISTORY: Mother died of possible heart disease. Sister died of ovarian cancer (age ___. PHYSICAL EXAM: Vitals: T: BP: P: R: O2: GEN: Alert, oriented to name, place and situation. Fatigued appearing but comfortable, no acute signs of distress. HEENT: NCAT, Pupils equal and reactive, sclerae anicteric, OP clear, MMM. Neck: Supple, JVP not elevated Lymph nodes: No cervical, supraclavicular LAD. CV: S1S2, reg rate and rhythm, no murmurs, rubs or gallops. RESP: Good air movement bilaterally, bibasilar crackles, scattered wheezes ABD: Soft, non-tender, non-distended, + bowel sounds. EXTR: No lower leg edema, no clubbing or cyanosis DERM: No active rash. Neuro: Cranial nerves ___ grossly intact, muscle strength ___ in all major muscle groups, sensation to light touch intact, non-focal. PSYCH: Appropriate and calm. LABS: See below STUDIES: CXR on admission: No acute cardiopulmonary process. Hyperinflated lungs. Past Medical History: HYPERTENSION CHRONIC OBSTRUCTIVE PULMONARY DISEASE CONGESTIVE HEART FAILURE (EF 35% in ___ DIVERTICULOSIS CORONARY ARTERY DISEASE HYPERLIPIDEMIA HYPERCHOLESTEROLEMIA Social History: ___ Family History: Mother died of possible heart disease. Sister died of ovarian cancer (age ___. Physical Exam: Admission exam 100.3 132 / 71 85 20 94 RA GEN: Alert, oriented to name, place and situation. Fatigued appearing but comfortable, no acute signs of distress. HEENT: NCAT, Pupils equal and reactive, sclerae anicteric, OP clear, MMM. Neck: Supple, JVP not elevated Lymph nodes: No cervical, supraclavicular LAD. CV: S1S2, reg rate and rhythm, no murmurs, rubs or gallops. RESP: Good air movement bilaterally, bibasilar crackles, scattered wheezes ABD: Soft, non-tender, non-distended, + bowel sounds. EXTR: No lower leg edema, no clubbing or cyanosis DERM: No active rash. Neuro: Cranial nerves ___ grossly intact, muscle strength ___ in all major muscle groups, sensation to light touch intact, non-focal. PSYCH: Appropriate and calm. Discharge exam 97.9 135 / 84 71 18 95 Ra gen: Thin male, well appearing, NAD Lung: Diffuse end expiratory wheezes, no rhonchi, fair air entry throughout. Exam otherwise unchanged from admission Pertinent Results: ___ 06:21AM BLOOD WBC-8.2 RBC-4.88 Hgb-14.4 Hct-43.9 MCV-90 MCH-29.5 MCHC-32.8 RDW-15.4 RDWSD-50.5* Plt ___ ___ 06:10AM BLOOD WBC-5.2 RBC-4.84 Hgb-14.3 Hct-43.9 MCV-91 MCH-29.5 MCHC-32.6 RDW-15.6* RDWSD-51.7* Plt ___ ___ 06:10AM BLOOD ___ PTT-31.9 ___ ___ 06:21AM BLOOD Glucose-105* UreaN-22* Creat-1.1 Na-137 K-5.4* Cl-99 HCO3-20* AnGap-18 ___ 06:10AM BLOOD Glucose-91 UreaN-12 Creat-0.9 Na-140 K-4.5 Cl-104 HCO3-25 AnGap-11 ___ 06:21AM BLOOD cTropnT-<0.01 proBNP-592* ___ 06:10AM BLOOD ALT-29 AST-30 LD(LDH)-208 AlkPhos-75 TotBili-0.3 ___ 06:10AM BLOOD Calcium-8.4 Phos-3.2 Mg-2.1 ___ 06:45AM OTHER BODY FLUID FluAPCR-POSITIVE* FluBPCR-NEGATIVE CXR Single right ventricular lead is contiguous with a left chest wall generator. Flattening of bilateral hemidiaphragms suggest lung hyperinflation.The lungs are clear without focal consolidation. No pleural effusion or pneumothorax is seen. The cardiac and mediastinal silhouettes are unremarkable. IMPRESSION: No acute cardiopulmonary process. Hyperinflated lungs. Brief Hospital Course: ASSESSMENT AND PLAN: ___ year old male with medical history notable for severe COPD, colonic adenoma, CAD, CHF (LVEF 30% to 35% s/p ICD), HTN, HLD who presents with two days of flu-like symptoms. # Influenza # COPD: patient is high-risk flu case given chronic medical conditions (CHF, COPD). BNP was in 500s and CXR without edema, so unlikely to have volume overload component. He improved rapidly with Tamiflu, and dyspnea resolved as did myalgias. He was given standing bronchodilators but was not given steroids for his COPD. He did remain somewhat symptomatic from cough, so he will continue tessalon perles at home. His hypoxia resolved. He was seen by ___ and was also cleared for discharge home. He has five doses of Tamiflu treatment remaining. He was also advised to use standing albuterol MDI for five days and then to use prn dyspnea # Chronic systolic heart failure # CAD # Hypertension: His carvedilol was continued, but losartan and imdur held in the face of normotension during infection. His pressures did start to rise as he was approaching discharge so he was told to f/u with PCP before resuming imdur. # Anion gap acidosis: lactate normal - AG acidosis resolved greater than ___ hour spent on care on day of discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Atorvastatin 80 mg PO QPM 3. Carvedilol 3.125 mg PO BID 4. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 5. Tiotropium Bromide 1 CAP IH DAILY 6. albuterol sulfate 90 mcg/actuation INHALATION Q6H:PRN SOB, wheezing 7. Cetirizine 10 mg PO DAILY:PRN allergies 8. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain 9. Losartan Potassium 12.5 mg PO DAILY 10. budesonide-formoterol 80-4.5 mcg/actuation inhalation BID 11. Ibuprofen 800 mg PO DAILY:PRN Pain - Mild Discharge Medications: 1. OSELTAMivir 75 mg PO BID 2. Tessalon Perles (benzonatate) 100 mg oral Q12H:PRN 3. Albuterol Inhaler 2 PUFF IH Q8H Use your albuterol inhaler 3 times a day for the next five days, and then as needed. 4. Aspirin 81 mg PO DAILY 5. Atorvastatin 80 mg PO QPM 6. budesonide-formoterol 80-4.5 mcg/actuation inhalation BID 7. Carvedilol 3.125 mg PO BID 8. Cetirizine 10 mg PO DAILY:PRN allergies 9. Ibuprofen 800 mg PO DAILY:PRN Pain - Mild Use this sparingly as it can affect your kidney function 10. Losartan Potassium 12.5 mg PO DAILY 11. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain 12. Tiotropium Bromide 1 CAP IH DAILY 13. HELD- Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY This medication was held. Do not restart Isosorbide Mononitrate (Extended Release) until you see your PCP; right now your blood pressure is not high and you do not need the medication Discharge Disposition: Home Discharge Diagnosis: 1. Influenza 2. COPD 3. Hypertension Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted due to the flu and increased cough and difficulty breathing. You have improved dramatically, and are stable for discharge home. You need to take five additional doses of Tamiflu to complete your course. I have faxed a prescription to ___ on ___ in ___. Please hold your blood pressure medicine isosorbide (imdur); your blood pressures are not very elevated now due to infection, and I want your PCP to check your blood pressure before you resume taking the medication. Followup Instructions: ___
10379765-DS-11
10,379,765
26,882,615
DS
11
2132-06-19 00:00:00
2132-06-19 11:44:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Allergies/ADRs on File Attending: ___. Chief Complaint: groin pain Major Surgical or Invasive Procedure: none History of Present Illness: PCP: unknown CHIEF COMPLAINT: groin pain HISTORY OF PRESENT ILLNESS: ___ male h/o R groin abscess s/p I&D on ___ complicated by 2 surgeries after that presents with R groin pain. He was initially admitted to ___ in ___ and was on vancomycin and augmentin and underwent I&D. He then went to ___ ___ and had explroatory surgery and wide excision by Dr ___ urology given rapid progression of the infection. There was necrotic gracillis muscle. There is question on if the cultures grew MRSA or not (a note says it did however there is not culture data in his OSH records). Subsequent notes state wound grew MSSA pansensitive. He was discharged on linezolid and dilaudid however per pt his insurance didnt cover linezolid so it was switched to bactrim. Pt was readmitted ___ ___ for recurrent cellulitis and she underwent I&D for necrotizing fascitis and required a wound vac and he was d/cd on augmentin. In the ED, initial vitals: 99.2 ___ 18 99% RA - Labs notable for: WBC 11 - Imaging notable for: CT scan: Skin thickening and subcutaneous soft tissue thickening along the right scrotum and right inguinal region at the site of prior surgery, best seen on series 3, image 39. This is likely due to a combination of postsurgical changes with likely superimposed cellulitis. No subcutaneous gas or fluid collection. Correlate clinically with signs of infection. - Pt given: vanc and zosyn - Vitals prior to transfer: Past Medical History: R groin abscess ___ - multiple surgeries from urology chronic pain Social History: ___ Family History: HTN, CAD, CVA in mother and grandparents Physical Exam: admission 99.2 ___ 18 99% RA General: NAD, obese HEENT: EOMI Lungs: clear to auscultation bl no crackles wheeze CV: normal S1 S2 RRR no GCMR Abdomen: nontender pos BS GU: R scrotum with scar tissue, tenderness Ext: warm Neuro: ambulates, moves all extremities d/c vitals wnl and exam unchanged, groin area not tender Pertinent Results: ___ 09:05AM BLOOD WBC-11.4* RBC-5.11 Hgb-14.8 Hct-42.7 MCV-84 MCH-29.1 MCHC-34.8 RDW-14.2 Plt ___ ___ 09:05AM BLOOD Neuts-63.5 ___ Monos-4.7 Eos-1.8 Baso-0.5 ___ 09:05AM BLOOD Glucose-99 UreaN-11 Creat-1.2 Na-140 K-3.9 Cl-101 HCO3-28 AnGap-15 ___ 09:05AM BLOOD Plt ___ ___ 09:05AM BLOOD Glucose-99 UreaN-11 Creat-1.2 Na-140 K-3.9 Cl-101 HCO3-28 AnGap-15 ___ 09:21AM BLOOD Lactate-1.7 ___ CT abd and pelvis Skin thickening and subcutaneous soft tissue thickening along the right scrotum and right inguinal region at the site of the prior surgery, probably due to a combination of postsurgical changes with likely superimposed cellulitis. No subcutaneous gas or focal fluid collections. ___ scrotum u/s diffuse edematous changes within the R hemiscrotum and soft tissues no drainable fluid collection ___ MRI pelvis with and without gad diffuse extensive edema involving subcutaneous and superficial soft tissue of the right inguinoscrotal region extending to the scrotum. No loculated fluid collection is seen. On MRI examination it is difficult to exclude presence of soft tissue gas. The deeper soft tissues in teh right hip, right thigh, and pelvis are not involved. b/l testes are unremarkable. These findings are consistent with cellulitis and soft tissue osteomyelitis possiblility is Fourier's gangrene is not excluded ___ MRI diffuse extensive soft tissue swelling and subcutaneous edema invlving the right inguinal region which is less severe than prior study compatiblie with patient's history of drainage. However interval extension to the medial gluteal region and perianal region on the right not seen on prior study. Interval development of fluid collection in the right groin measuring 2 x 3 x 4.5cm with peripheral rim enhancement. This may be related to abscess versus seroma. Again foutnier's ganagrene cannot be excluded. clinical correlation is recommended. Brief Hospital Course: ___ male h/o R groin abscess s/p I&D on ___ complicated by persistent infection requiring wide excisional surgery and wound vac in ___ presents with R groin pain concerning for cellulitis. #R groin Cellulitis: CT abd and pelvis showed superimposed cellulitis without subcutaneous gas or focal fluid collections. Given concern that prior wound grew MRSA he was treated with vancomycin/Unasyn. He will be discharged on Bactrim/Augmentin for a total of ___nd will find a new PCP at ___. He is not interested in seeing his prior urologist from ___ ___ and after establishing care at ___ he can then find a new urologist if needed. He was also discharged on miconazole powder to help keep the area dry and treat any fungal element that may be present. #Chronic pain: He was continued on Ultram. He was instructed pt to stop naproxen which he has taken daily for months given the potential side effects including stomach ulcers and kidney damage. #OSA: pt reports OSA for years and he usually takes Flonase and cetirizine which he says helps. I explained to him that he needs CPAP transitional issues: #he needs CPAP mask for OSA #f/u on groin cellulitis #outside records re his scrotal cellulitis and surgeries will be scanned into OMR Medications on Admission: The Preadmission Medication list is accurate and complete. 1. TraMADOL (Ultram) 50 mg PO Q4H:PRN pain 2. Gabapentin 400 mg PO BID 3. Naproxen 500 mg PO Q8H:PRN pain Discharge Medications: 1. Sulfameth/Trimethoprim DS 1 TAB PO BID Duration: 13 Days RX *sulfamethoxazole-trimethoprim 800 mg-160 mg 1 tablet(s) by mouth twice a day Disp #*26 Tablet Refills:*0 2. Amoxicillin-Clavulanic Acid ___ mg PO Q8H Duration: 13 Days RX *amoxicillin-pot clavulanate 250 mg-125 mg 1 tab by mouth every eight (8) hours Disp #*39 Tablet Refills:*0 3. Gabapentin 400 mg PO BID 4. TraMADOL (Ultram) 50 mg PO Q4H:PRN pain 5. Miconazole Powder 2% 1 Appl TP BID:PRN yeast in groin RX *miconazole nitrate [Zeasorb (miconazole)] 2 % apply powder to groin twice a day Refills:*0 Discharge Disposition: Home Discharge Diagnosis: priamry: cellulitis secondary: OSA Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, It was a pleasure caring for you here at ___. You came in because you had cellulitis in your groin. You were treated with IV antibiotics and you started to feel better. We want you to go home on oral antibiotics and to followup with a primary care doctor. We hope you feel better, ___ team Followup Instructions: ___
10380149-DS-5
10,380,149
27,748,450
DS
5
2121-05-07 00:00:00
2121-05-07 16:48:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ ___ Complaint: Dyspnea on exertion / ___ edema Major Surgical or Invasive Procedure: ___: Cardiac catherization History of Present Illness: Mr. ___ is a ___ yo male with severe aortic stenosis ___ of 0.681 cm2) who was transferred from ___ with worsening dyspnea on exertion and ___ edema. Per patient he has developed worsening DOE over the last few months where he can only walk 25 feet now, from a baseline of playing tennis three times per week. Last evening he devloped orthopnea that caused him to present to see his NP at ___, who recommended that he present to the emergency department. He also describes one week of productive cough, as well as fevers and chills last evening. At ___ he had a CXR that showed pulm edema w/ a possible R bilobar PNA for which he received ceftriaxone, azithro. No lasix was given as his pressures were soft (SBP of 103). HR's also noted to be in the 40's (in afib). Labs notable for a BNP of 15,236, troponin of 0.045, INR of 1.4. Pt was transferred to ___ for aortic valve replacement and pacer evaluation. Per report his cardiologist in ___ not comfortable performing procedure. In the ED, initial vitals were 97.8 44 120/56 24 97%. On the floor patient is very conversant and comfortable. On review of systems, he denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, hemoptysis, black stools or red stools. He denies exertional buttock or calf pain. All of the other review of systems were negative. Past Medical History: - Severe aortic stenosis - atrial fibrillation on coumadin - HTN - Glaucoma Social History: ___ Family History: His mother died of TB when he was age ___. His father had bladder cancer. He has no brothers or sisters. He was accompanied on today's visit by his son. Physical Exam: Physical Exam: VS: T= 97.6 BP= 117/50 HR= 52 RR= 22 O2 sat= 97% RA General: nad, lying comfortably HEENT: no oral erythema Neck: JVP elevated to halfway to the ankle of the mandible CV: Bradycardic, ___ crecendo descrecendo best heard at the LUSB Lungs: Crackles bilaterally at the bases Abdomen: soft, nontender, nondistended Ext: 1+ pitting edema to the shin Pertinent Results: Labs on admission: ___ 08:55PM BLOOD WBC-6.7 RBC-4.31* Hgb-12.5* Hct-39.8* MCV-93 MCH-29.1 MCHC-31.5 RDW-14.0 Plt ___ ___ 08:55PM BLOOD ___ PTT-36.3 ___ ___ 08:55PM BLOOD Glucose-193* UreaN-32* Creat-1.7* Na-136 K-3.8 Cl-98 HCO3-28 AnGap-14 ___ 08:55PM BLOOD ALT-48* AST-31 AlkPhos-92 TotBili-0.3 ___ 08:55PM BLOOD Calcium-8.3* Phos-3.3 Mg-2.0 ___ 03:38PM BLOOD Lactate-1.6 Labs on discharge: ___ 06:10AM BLOOD WBC-6.3 RBC-3.88* Hgb-12.0* Hct-35.7* MCV-92 MCH-30.8 MCHC-33.5 RDW-14.0 Plt ___ ___ 06:10AM BLOOD ___ PTT-33.5 ___ ___ 06:10AM BLOOD Glucose-102* UreaN-19 Creat-1.3* Na-140 K-3.9 Cl-103 HCO3-28 AnGap-13 ___ 06:10AM BLOOD Albumin-PND Calcium-8.9 Phos-3.7 Mg-2.1 Cardiac catherization ___: 1. Mild coronary artery disease 2. Patent distal abdominal aorta, iliac and CF arteries bilaterally ECHO ___: The left atrium is elongated. There is mild symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function (LVEF>55%). Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets are severely thickened/deformed. There is critical aortic valve stenosis (valve area <0.8cm2). Trace aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Mild (1+) mitral regurgitation is seen. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. IMPRESSION: Critical aortic valve stenosis. Symmetric LVH with normal global and regional biventricular systolic function. Mild mitral regurgitation. Brief Hospital Course: Mr. ___ is a ___ yo male with severe aortic stenosis ___ of 0.681 cm2) who was transferred from ___ with worsening congestive heart failure symptoms as well as pneumonia. # Severe Aortic stenosis: ECHO on ___ confirmed critical AS with valve area of 0.7 cm2. Given that he was symptomatic with DOE and ___ edema he underwent evaluation for valve repair by cardiac surgery and TAVR team. Cardiac cath and CT scan were performed. Afterwards cardiac surgery decided that he was not a candidate for surgical repair. He will therefore undergo a TAVR with Dr. ___ in the near future. Pt was discharged with prn lasix as needed for weight gain. # Pneumonia - Pt described one week of increasing sputum production, as well as fevers and chills. Given clinical symptoms and concern for consolidation on CXR he was treated with ceftriaxone and azithromycin x 7 days. # Atrial fibrillation - Pt with slow a fib with rates in the 40's on admission. His beta-blocker was held and HR's increased to 50's and 60's. He was discharged on coumadin. # HTN: continued amlodpine, held metoprolol as above Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Amlodipine 10 mg PO DAILY please hold for sbp<100 2. Metoprolol Succinate XL 100 mg PO DAILY 3. Timolol Maleate 0.25% 1 DROP BOTH EYES BID 4. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS 5. Multivitamins 1 TAB PO DAILY 6. Warfarin 4 mg PO DAILY16 7. Furosemide 20 mg PO DAILY 8. Ferrous Sulfate 325 mg PO TID Discharge Medications: 1. Amlodipine 10 mg PO DAILY 2. Ferrous Sulfate 325 mg PO TID 3. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS 4. Multivitamins 1 TAB PO DAILY 5. Timolol Maleate 0.25% 1 DROP BOTH EYES BID 6. Warfarin 4 mg PO DAILY16 7. Azithromycin 250 mg PO Q24H Duration: 3 Days RX *azithromycin 250 mg 1 tablet(s) by mouth daily Disp #*3 Tablet Refills:*0 8. Furosemide 20 mg PO PRN weight gain greater than 3 pounds 9. Cefpodoxime Proxetil 400 mg PO Q12H Duration: 3 Days RX *cefpodoxime 200 mg 2 tablet(s) by mouth twice a day Disp #*12 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary: Critical Aortic stenosis Secondary: Atrial Fibrillation Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you during your hospitalization at ___. You were admitted with shortness of breath and leg swelling that resulted from your aortic stenosis, as well as pneumonia. You had an evaluation for a valve replacement and this will be performed by Dr. ___ in the next few weeks. You were also treated for pneumonia, for which you will need to take another three days of antibiotics. It was pleasure taking care of you and good luck with the upcoming valve replacement! Followup Instructions: ___
10380149-DS-8
10,380,149
24,423,561
DS
8
2123-08-16 00:00:00
2123-08-16 12:53:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Status post fall on coumadin with left buttock hematoma, left ninth rib fracture, stable small hemothorax. Major Surgical or Invasive Procedure: None History of Present Illness: HPI: Mr. ___ is a ___ yo male with a history of afib and aortic stenosis s/p TAVR on warfarin presenting after a mechanical fall earlier today. At 1450 today, he was walking down stairs at his swimming facility when the bag he was carrying began to slip off his shoulder. As he was trying to catch the bag, he tripped and fell down ___ stairs, landing on his back and left side. He was on the ground very briefly before staff assisted him and called EMS which transported him to ___. At the time, he only noted pain in his back and left arm. He remembers the event fully and denies any loss of consciousness. He denies striking his head, headache, vision changes, or dizziness. He did not experience any shortness of breath or chest pain. He does endorse easy bruising secondary to warfarin anticoagulation. At ___, he underwent CT head, c-spine, and torso which revealed left ___ and 10th rib fractures. He also had a right arm laceration repaired and a left thigh hematoma with possible active extravasation on imaging. His pain was well controlled with morphine. Transferred to ___ for trauma evaluation. At time of consultation, pt AFVSS without respiratory distress, soft left thigh hematoma without distal neurovascular changes, stable pelvis and hematocrit of 32 from 38 in the setting of aggressive resuscitation. Past Medical History: 1. CARDIAC RISK FACTORS: (-)Diabetes, (-)Dyslipidemia, (-)Hypertension 2. CARDIAC HISTORY: -CABG: none -PERCUTANEOUS CORONARY INTERVENTIONS: none -PACING/ICD: none 3. OTHER PAST MEDICAL HISTORY: Severe aortic stenosis Atrial fibrillation (on coumadin) Hypertension Glaucoma Hernia Hx of pressure ulcers on coccyx Social History: ___ Family History: His mother died of TB when he was age ___. His father had bladder cancer. He has no brothers or sisters. No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise non-contributory. Physical Exam: VITAL SIGNS: Temp Tm 98.5 Tc 97.9 HR 70 BP 109/46 RR 18 O2100RA General: NAD, alert and oriented x3 HEENT: No scleral icterus. Moist mucous membranes. NECK: No JVD. Carotids 2+, brisk, and without bruits. CARDIAC: Regular rate and rhythm. Normal S1 and S2. ___ systolic murmur heard at the apex. ABDOMEN: Soft, nontender, nondistended. Normoactive bowel sounds. EXTREMITIES: 2+ bilateral pitting edema in UE and ___. Pertinent Results: ___ 11:07PM PLT COUNT-205 ___ 11:07PM ___ PTT-38.0* ___ ___ 11:07PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 11:07PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-10 BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG ___ 01:35PM HCT-27.8* ___ 10:00AM GLUCOSE-138* UREA N-34* CREAT-1.4* SODIUM-139 POTASSIUM-4.1 CHLORIDE-100 TOTAL CO2-23 ANION GAP-20 ___ 10:00AM CALCIUM-8.4 PHOSPHATE-5.3* MAGNESIUM-2.1 ___ 10:00AM WBC-13.7* RBC-3.08* HGB-9.3* HCT-28.8* MCV-94 MCH-30.2 MCHC-32.3 RDW-15.2 RDWSD-51.3* ___ 10:00AM PLT COUNT-181 ___ 10:00AM ___ PTT-34.1 ___ ___ 05:36AM HCT-30.3* ___ 02:11AM HCT-31.2* ___ 11:07PM GLUCOSE-125* UREA N-31* CREAT-1.3* SODIUM-136 POTASSIUM-5.7* CHLORIDE-98 TOTAL CO2-22 ANION GAP-22* Brief Hospital Course: This is a ___ coumadin (AVR) s/p mechanical fall, ___ hsp CThead/cspine/torso notable for L9/10nd rib fx, L thigh hematoma with extravasation. The patient has the following comorbidities: PMH: HTN, atrial fibrillation, aortic stenosis s/p TAVR. The patient had significantly blood loss with drop in hematocrit from 30 to 24 and has coagulopathy given use coumadin prior to admission. The patient has CKD with creat near 2.0 and is at risk for ongoing blood loss, potential hypotension and worsened renal failure and elevated risk of stroke with any need for interruoption of anticoagulation. THe plan of care includes: monitoring blood counts and clinical exam and transfusing RBCs if indicated and obtaining ___ consult. On ___ patient was discharged to rehab hospital in stable condition given the level of care he agreed to accept. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Amlodipine 5 mg PO DAILY 2. Furosemide 20 mg PO EVERY OTHER DAY 3. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 4. Timolol Maleate 0.5% 1 DROP BOTH EYES BID 5. Warfarin 8 mg PO 3X/WEEK (___) 6. Warfarin 7 mg PO 4X/WEEK (___) 7. Aspirin 81 mg PO DAILY 8. Ferrous Sulfate 325 mg PO DAILY 9. potassium gluconate 550 mg (90 mg) oral DAILY 10. Multivitamins 1 TAB PO DAILY 11. Garlic-X (garlic) 400 mg oral DAILY Discharge Medications: The Preadmission Medication list is accurate and complete. 1. Amlodipine 5 mg PO DAILY 2. Furosemide 20 mg PO EVERY OTHER DAY 3. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 4. Timolol Maleate 0.5% 1 DROP BOTH EYES BID 5. Warfarin 8 mg PO 3X/WEEK (___) 6. Warfarin 7 mg PO 4X/WEEK (___) 7. Aspirin 81 mg PO DAILY 8. Ferrous Sulfate 325 mg PO DAILY 9. potassium gluconate 550 mg (90 mg) oral DAILY 10. Multivitamins 1 TAB PO DAILY 11. Garlic-X (garlic) 400 mg oral DAILY Discharge Disposition: Extended Care Facility: ___ ___ Diagnosis: Status post fall with injury Discharge Condition: Stable Discharge Instructions: * Your injury caused slightly displaced fracture of the left 9th rib fractures which can cause severe pain and subsequently cause you to take shallow breaths because of the pain. * You should take your pain medication as directed to stay ahead of the pain otherwise you won't be able to take deep breaths. If the pain medication is too sedating take half the dose and notify your physician. * Pneumonia is a complication of rib fractures. In order to decrease your risk you must use your incentive spirometer 4 times every hour while awake. This will help expand the small airways in your lungs and assist in coughing up secretions that pool in the lungs. * You will be more comfortable if you use a cough pillow to hold against your chest and guard your rib cage while coughing and deep breathing. * Symptomatic relief with ice packs or heating pads for short periods may ease the pain. * Narcotic pain medication can cause constipation therefore you should take a stool softener twice daily and increase your fluid and fiber intake if possible. * Do NOT smoke * If your doctor allows, non steroidal antiinflammatory drugs are very effective in controlling pain ( ie, Ibuprofen, Motrin, Advil, Aleve, Naprosyn) but they have their own set of side effects so make sure your doctor approves. * Return to the Emergency Room right away for any acute shortness of breath, increased pain or crackling sensation around your ribs ( crepitus ). Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Followup Instructions: ___
10380647-DS-11
10,380,647
25,877,663
DS
11
2169-05-20 00:00:00
2169-05-20 18:49:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: withdrawal Major Surgical or Invasive Procedure: NONE History of Present Illness: Mr. ___ is a ___ yo M w/ HIV on HAART, HCV cirrhosis s/p 2 cycles of treatment, and polysubstance abuse who was referred by PCP for concern for withdrawal as well as new onset word finding difficulty. Patient endorses hx of methadone, IV fentanyl, cocaine and benzodiazapine use that were discontinued approximately 12 days prior to presentation. Patient states he had previously been participating in a ___ clinic where he had a contact that providing him with recreational drugs. He states he had been using methadone for many years, however, had only started IV fentanyl and cocaine fairly recently. Patient left clinic approximately 12 days ago and has not used any of the above substances since. Since ceasing use of recreational drugs, patient has been having intermittent nausea and vomiting, associated with constipation (last bowel movement five days prior) as well as insomnia. Endorses significant dyspnea with minimal exertion. No seizures, visual changes, loss of consciousness. Patient presented to ___ for scheduled appointment earlier today and was noted to have new word finding difficulty as well as auditory hallucinations, with exam notable for hypertension with systolic>190. Given concerns for possible endocarditis with septic emboli given neuro deficits, he was transferred to ED. - Initial vital signs were notable for T 99.0, HR 65, BP 192/92, RR 18, SpO2 100% RA - Exam notable for: tremulous, non focal neuro exam - Labs were notable for: WBC: 18.0 -> 16.5 Hgb: 10.9 -> 9.7 Chem: K 3.1, Cl 111, HCO3 21, BUN 25, Cr 1.3, Mg 1.3, P 2.6 Lactate: 1.2 - Studies performed include: CXR: No acute intrathoracic process. CTH: No acute infarction observed Blood culture, HBV/HCV, HIV studies pending - Patient was given 2L NS, 40 mEq KCl, and 400mg Magnesium Oxide Upon arrival to the floor, patient denies symptoms and endorses the above history. States he is having word finding difficulty for last 2 weeks and has never experienced this before, but otherwise feels "sharp" Past Medical History: -Polysubstance use disorder -HIV:HIV viral load that is detectable less than 20 and a CD4 count of 735 -HCV s/p treatment x2:chronic hepatitis C genotype 1A, on Vosevi of week ___. He is on Vosevi from ___ through ___ with an SVR date of ___. -Hypertension -CKD: Baseline 1.4 -Anxiety -Hypothyroidism -Seasonal allergies Social History: ___ Family History: Father: ___ at ___ ___ to MI, hx of lung cancer Physical Exam: ADMISSION PHYSICAL EXAM: PHYSICAL EXAM: VS-98.3; BP: 163/80; HR: 75; RR: 16; GEN- tremulous, alert but having difficulty with word finding HEENT- PERRLA, EOMI with bilateral nystagmusTongue fasiculations CV- RRR, normal S1S2, no murmurs appreciated Lungs: CTAB Abdomen: Nontender nondistended Neuro: CN II-XII intact. Slight left sided eyelid droop, otherwise no abnormalities observed. Strength ___ upper and lower extremities, intention tremor on finger to nose. ___ stroke scale testing. DISCHARGE PHYSICAL EXAM: 24 HR Data (last updated ___ @ 721) Temp: 98.4 (Tm 98.8), BP: 179/63 (131-180/63-100), HR: 80 (80-103), RR: 20 (___), O2 sat: 98% (95-99), O2 delivery: Ra GEN- tremulous, alert, no appreciable word finding difficulty on exam but patient endorsing presence of it HEENT- PERRLA, EOMI CV- RRR, normal S1S2, no murmurs appreciated Lungs: CTAB Abdomen: Nontender nondistended Neuro: CN II-XII intact. Slight left sided eyelid droop, otherwise no abnormalities observed. Strength ___ upper and lower extremities. ___ stroke scale testing. Pertinent Results: ADMISSION LABS: ___ 11:35AM BLOOD WBC-18.0* RBC-3.63* Hgb-10.9* Hct-34.0* MCV-94 MCH-30.0 MCHC-32.1 RDW-15.6* RDWSD-52.6* Plt ___ ___ 11:35AM BLOOD Neuts-77.8* Lymphs-16.1* Monos-5.1 Eos-0.3* Baso-0.2 Im ___ AbsNeut-14.00* AbsLymp-2.89 AbsMono-0.92* AbsEos-0.06 AbsBaso-0.03 ___ 11:35AM BLOOD Glucose-110* UreaN-25* Creat-1.3* Na-147 K-3.1* Cl-111* HCO3-21* AnGap-15 ___ 11:35AM BLOOD ALT-15 AST-19 AlkPhos-83 TotBili-0.5 ___ 11:35AM BLOOD Albumin-3.6 Calcium-8.1* Phos-2.6* Mg-1.3* PERTINENT LABS: ___ 02:30AM BLOOD CK(CPK)-37* ___ 11:35AM BLOOD Lipase-61* ___ 02:30AM BLOOD HAV Ab-POS* ___ 02:30AM BLOOD HIV1 VL-Detected < ___ 04:20PM BLOOD Lactate-1.2 DISCHARGE LABS: ___ 07:20AM BLOOD WBC-10.6* RBC-3.52* Hgb-10.5* Hct-32.8* MCV-93 MCH-29.8 MCHC-32.0 RDW-15.9* RDWSD-54.2* Plt ___ ___ 07:20AM BLOOD Glucose-93 UreaN-21* Creat-1.2 Na-148* K-3.7 Cl-112* HCO3-22 AnGap-14 ___ 07:20AM BLOOD Calcium-8.9 Phos-3.3 Mg-2.0 MICRO: ___ 12:20 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. ========================================================== ___ 3:30 pm BLOOD CULTURE Blood Culture, Routine (Pending): No growth to date. ========================================================== ___ 11:35 am BLOOD CULTURE Blood Culture, Routine (Pending): No growth to date. ========================================================== ___ 4:10 pm BLOOD CULTURE Blood Culture, Routine (Pending): No growth to date. ========================================================== IMAGING/RESULTS: CXR ___: No acute intrathoracic process. NCHCT ___: No acute intracranial process. MRI HEAD W/ AND W/O CONTRAST ___: 1. No evidence of acute infarction, hemorrhage or intracranial mass. 2. Nonspecific patchy white matter changes in the cerebral hemispheres bilaterally, likely sequela of chronic small vessel ischemic changes. TTE ___: The left atrial volume index is normal. There is normal left ventricular wall thickness with a normal cavity size. There is normal regional and global left ventricular systolic function. The visually estimated left ventricular ejection fraction is 60%. There is no resting left ventricular outflow tract gradient. Normal right ventricular cavity size with normal free wall motion. The aortic sinus diameter is normal for gender. The aortic arch diameter is normal. The aortic valve leaflets (3) are mildly thickened. No masses or vegetations are seen on the aortic valve. There is no aortic valve stenosis. There is trace aortic regurgitation. The mitral valve leaflets are mildly thickened with no mitral valve prolapse. No masses or vegetations are seen on the mitral valve. There is trivial mitral regurgitation. The tricuspid valve leaflets appear structurally normal. No mass/vegetation are seen on the tricuspid valve. There is physiologic tricuspid regurgitation. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. IMPRESSION: No 2D echocardiographic evidence for endocarditis. Normal biventricular cavity sizes and regional/global biventricular systolic function. Normal estimated pulmonary artery systolic pressure. Compared with the prior TTE (images not available for review) of ___, the findings are similar. Brief Hospital Course: Mr. ___ is a ___ yo M with a history of HIV, hepatitis C with recurrence secondary to IVDU s/p ___ treatment with Vosevi referred to ___ by PCP for concern for possible opioid and benzodiazepine withdrawal and work up notable for leukocytosis. ACUTE PROBLEMS: ========================= #Leukocytosis Patient found to have a WBC count of 18.0 in the ED. Infectious work up with CXR, UA, and blood cultures were unrevealing. TTE was performed for evaluation of endocarditis which showed no evidence of vegetations. Patient was initially started on broad spectrum abx with ceftriaxone/vancomycin. These were discontinued after 48 hours as cultures remained negative. WBC downtrended during hospitalization with discharge WBC count of 10.6. #Word Finding Difficulty Patient describes having word finding difficulty which was appreciated by his PCP during his office visit. Given his history of IV substance use, there was concerns for possible infectious etiology. Patient had NCHCT and MRI without evidence of strokes or infectious etiology to explain his word finding difficulty. Word finding difficulty appeared to improve on its own during hospitalization and was not appreciated at time of discharge. #Polysubstance use disorder #Concerns for withdrawal Patient with history of polysubstance use disorder (opioids and cocaine). Patient discontinued use of substances a few weeks prior to presentation. During his admission, he was initially monitored on CIWA and ___ but these were discontinued as it was felt he was outside of the acute withdrawal window. Addiction psychiatry was consulted during hospitalization and started on Suboxone during the hospitalization. He plans to follow up with addiction psychiatry as an outpatient. #Hypertension SBPs in 160-180s throughout his hospitalization. He was started on amlodipine 5mg with plans to continue as an outpatient. CHRONIC PROBLEMS: ========================== # HIV HIV VL undetectable at last check. CD4 > 700 at last check. Remained on home Triumeq. HIV VL checked during hospitalization and was pending at time of discharge. # History of hypothyroidism- euthyroid clinically and by report off medications. TRANSITIONAL ISSUES: ========================== [] follow up HIV VL [] patient started on Suboxone during the hospitalization - has outpatient follow with OBOT on ___ [] started amlodipine during hospitalization - consider uptitration pending BP as outpatient [] recheck Na at follow up as mildly hypernatremic at time of discharge Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Gabapentin 300 mg PO Q6H:PRN pain 2. ClonazePAM 1 mg PO TID 3. Methadone 70 mg PO ONCE 4. Triumeq (abacavir-dolutegravir-lamivud) 600-50-300 mg oral DAILY Discharge Medications: 1. amLODIPine 5 mg PO DAILY RX *amlodipine 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 2. Buprenorphine-Naloxone Film (8mg-2mg) 1 FILM SL BID 3. FoLIC Acid 1 mg PO DAILY RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 4. Multivitamins W/minerals 1 TAB PO DAILY RX *multivitamin,tx-minerals 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 5. Thiamine 100 mg PO DAILY RX *thiamine HCl (vitamin B1) 100 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 6. Triumeq (abacavir-dolutegravir-lamivud) 600-50-300 mg oral DAILY Discharge Disposition: Home Discharge Diagnosis: Leukocytosis Word finding difficulty Polysubstance use disorder Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you during your hospitalization! WHY WERE YOU ADMITTED? - You were having word finding difficulties. - There was concern that you might have an infection. WHAT HAPPENED DURING YOUR HOSPITALIZATION? - You were started on antibiotics given concern for infection. These were stopped after two days as we could not find any source of infection. - You had imaging of your head (CT and MRI) which did not show any reason for your word finding difficulty. - You were started on Suboxone during your hospitalization. WHAT SHOULD YOU DO ONCE YOU GET HOME? - Continue taking all of your medications as prescribed. - Follow up with your doctors as ___ below. Again, it was a pleasure. All the best, Your ___ Team Followup Instructions: ___
10380837-DS-11
10,380,837
25,027,752
DS
11
2178-02-25 00:00:00
2178-02-25 10:21:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Bactrim / lisinopril / lorazepam Attending: ___. Chief Complaint: Pain, fevers Major Surgical or Invasive Procedure: Placement of percutaneous nephrostomy tube History of Present Illness: Patient is a ___ y/o male with dementia, bedbound (s/p left sided BKA for PVD), BPH (has suprapubic tube), atrial fibrillation (not anticoagulated) who has a history of recurrent UTIs. He had developed UTIs at his ___ (___ and had received courses of antibiotics. However, he started to complain of left sided pain, and CT scan showed left sided kidney stone. His ___ providers were working on getting him here for lithotripsy or PCN, when he became acutely ill with T of 101 on ___. He was taken to ___ where BP "99/83" and rectal temp was 103.3. He was given IV antibiotics and transferred to ___ where he was seen by urology. CT scan showed obstructing left sided renal stone at Left UPJ with evidence of pyelonephritis. Thick urine, ? "purulent" vs viscous drained from suprapubic catheter. He is a poor historian given his dementia, but with his daughter at the bedside, he denies nausea, vomiting or pain at the present time. No abdominal pain or diarrhea. Past Medical History: 1. BPH with suprapubic tube 2. Dementia 3. s/p L BKA for PVD 4. Atrial fibrillation 5. CHF 6. Cirrhosis 7. H/o gastric ulcer 8. H/o ischemic stroke Social History: ___ Family History: Non contributory. Physical Exam: 98.8 128/93 ___ Gen: Elderly male, pleasant, lying in bed comfortably Lung: CTA B CV: RRR, no m/r/g Abd: mild distension, soft, nabs Ext: left BKA, right leg warm, 2+ DP pulses neuro: AOX1, not aware of location, year. Pertinent Results: ___ 10:45PM BLOOD WBC-13.1* RBC-2.78* Hgb-8.8* Hct-29.0* MCV-104* MCH-31.7 MCHC-30.3* RDW-13.5 RDWSD-52.1* Plt ___ ___ 03:05AM BLOOD ___ PTT-32.6 ___ ___ 10:45PM BLOOD ALT-27 AST-57* AlkPhos-122 TotBili-0.5 ___ 10:45PM BLOOD Albumin-2.1* Calcium-7.1* Mg-1.8 ___ 08:50AM BLOOD WBC-8.0 RBC-2.94* Hgb-9.2* Hct-30.4* MCV-103* MCH-31.3 MCHC-30.3* RDW-14.5 RDWSD-55.0* Plt ___ ___ 08:50AM BLOOD Glucose-105* UreaN-7 Creat-0.9 Na-139 K-4.1 Cl-108 HCO3-27 AnGap-8 ___ ___ Blood culture: E Coli, resistant to cephalosporins, sensitive to zosyn Coag negative staph ___ blood culture: NGTD Urine cx FLUID CULTURE (Final ___: ESCHERICHIA COLI. >10,000 CFU/ML. Cefepime sensitivity testing confirmed by ___. PROTEUS MIRABILIS. > 10,000 CFU/ML. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | PROTEUS MIRABILIS | | AMPICILLIN------------ =>32 R =>32 R AMPICILLIN/SULBACTAM-- 4 S 8 S CEFAZOLIN------------- =>64 R CEFEPIME-------------- 2 S <=1 S CEFTAZIDIME----------- 4 S <=1 S CEFTRIAXONE----------- =>64 R <=1 S CIPROFLOXACIN--------- =>4 R =>4 R GENTAMICIN------------ <=1 S <=1 S MEROPENEM-------------<=0.25 S <=0.25 S NITROFURANTOIN-------- 32 S PIPERACILLIN/TAZO----- <=4 S <=4 S TOBRAMYCIN------------ <=1 S <=1 S TRIMETHOPRIM/SULFA---- =>16 R <=1 Ct scan report LOWER CHEST: The imaged lung bases demonstrate mild bibasilar atelectasis, but no consolidation or large pleural effusion. The heart is moderately enlarged with extensive coronary artery calcification but no pericardial effusion. ABDOMEN: HEPATOBILIARY: The liver is nodular in contour which suggests cirrhosis. Attenuation of the liver slightly heterogeneous. The portal vein is patent. The gallbladder is contracted containing hyperdensities within the lumen reflective of stones. There is no evidence cholecystitis. PANCREAS: The pancreas has normal attenuation throughout, without evidence of focal lesions or pancreatic ductal dilatation. There is no peripancreatic stranding. Scattered pancreatic calcifications are seen, indicative of chronic pancreatitis. SPLEEN: The spleen measures 12 cm in greatest dimension, with no focal lesions. ADRENALS: The right and left adrenal glands are normal in size and shape. URINARY: The right kidney is normal in size with no hydronephrosis or renal stones. Scattered vascular calcifications are noted about the right kidney. The left kidney contains multiple hyperdensities reflective of renal stones with the largest in the renal pelvis measuring up to 2.8 cm. There is moderate hydronephrosis and moderate perinephric stranding. No evidence of forniceal rupture. The left kidney demonstrates a mildly delayed nephrogram. GASTROINTESTINAL: The stomach and small bowel are normal in caliber without obstruction the large bowel contains oral contrast from a prior cross-sectional study, without evidence of colitis. Enlarged left perinephric lymph nodes are likely reactive. VASCULAR: There is no abdominal aortic aneurysm. There is heavy calcium burden in the abdominal aorta and great abdominal arteries, most severe at the SMA. Isolated gastric varices are noted. PELVIS: The urinary bladder is decompressed via a suprapubic catheter. The prostate is moderately enlarged. No pelvic lymphadenopathy or free fluid. BONES AND SOFT TISSUES: There is extensive degenerative change at L5-S1 with partial fusion of the vertebral bodies. Extensive facet arthropathy is noted bilaterally from L3 through S1. Endplate deformity at the superior aspect of the L1 vertebral body is likely secondary to a Schmorl's node. No concerning osseous lesions. IMPRESSION: 1. Multiple left-sided renal stones including an obstructive stone at the UPJ measuring up to 2.8 cm resulting in moderate hydronephrosis, perinephric stranding, and a delayed nephrogram. Moderate left periureteral stranding is also seen. Findings are compatible with pyelonephritis. 2. Nodular heterogeneous liver compatible with cirrhosis, with mild perigastric varices. 3. Pancreatic parenchymal calcifications compatible with chronic pancreatitis. 4. Extensive atherosclerotic disease of the aorta and main branches, particularly the SMA. Brief Hospital Course: ___ y/o male with dementia, bedbound s/p left-sided AKA, h/o of suprapubic tube admitted with obstructing left sided renal stone, pyelonephritis and sepsis. # Sepsis # Pyelonephritis # Nephrolithiasis, left sided partially obstructing renal stone # Bacteremia - E.coli and CNS at ___ Pt initiated on broad antibiotics (zosyn) and is now s/p percutanous nephrostomy tube (pus expressed at placement) and is now draining appropriately. He received ~___ntibiotic course, initially intended as a ___ut his hospitalization was complicated by pt pulling at lines, pulling PICC and peripheral IV. His last full antibiotic day was ___ when he took Augmentin (instead of zosyn) due to lost IV access. He was followed this admission by urology and they felt that given his clinical stability, underlying dementia, and the challenges administering medical care (refusal intermittently of VS, IVs, lab draws), the best plan for now would be to finish his antibiotics (now done) and f/u as an outpt with urology. He will have nephrostomy tube changes with ___ q3-4 months, and the first one has been scheduled for ___ here at ___. He should also have regular changes of his suprapubic catheter (BPH) and this should be done with his outpatient urologist in ___ (appt scheduled) Percutaneous nephrostomy tube should put out at least 100 cc of urine a day; if it does not, please ask RN to flush it with ___ cc of sterile saline. If it still does not put out urine, it may need to be repositioned by ___ contact for BI ___ is ___ ___ and ___ can be reached at ___. Should he develop any complications such as recurrent infection or recurrent clogged nephrostomy tube, then urology may consider a more definitive procedure for stone removal such as percutaneous nephrolithotomy or even nephrectomy. (He will have regular f/u with his urologist at ___, but may be referred to ___ for any of the above complications) # Dementia with delirium: this has improved, appears now at baseline # Diarrhea: stool test for C. diff negative on ___. Probably a side-effect of zosyn (common adverse effect). Diarrhea has resolved over several days. # Anorexia, malnutrition - reportedly not eating much prior to hospitalization. Likely multifactorial including acute illness/infection, delirium, underlying dementia. Discussed with son, who is aware that pt's nutrition remains an issue. We discussed that the best approach to pts in this situation is often gentle encouragement to take whatever po they can. No plans for feeding tube (and is not clinically recommended in advanced dementia) # Hypophosphatemia, Hypomagnesemia, Hypocalcemia, Hypokalemia - most likely due to very poor PO intake. Repleted prn. # Stage II pressure ulcer on coccyx - wound care per RN # Atrial fibrillation: Rate controlled, not anticoagulated. Continued on metoprolol. Appears he was taking metoprolol XL prior to admission -- can consider switching back, but at this time pt is intermittently refusing VS and po meds # Goals of Care: **Remains FULL CODE*** Discussed with son. He reports that pt has been DNR/DNI in the past and there were several hospitalizations in which he appeared (or family was told at least) that he was likely not going to survive. However, each time he survived and bounced back. Son has concluded after these incidents that for now he should remain full code. He states he does understand that DNR/DNI is not the same as "do not treat." Patient intermittently refusing medications here, but has been stable for many days and appears comfortable. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Simvastatin 40 mg PO QPM 2. Aspirin 81 mg PO DAILY 3. Metoprolol Succinate XL 50 mg PO DAILY 4. Omeprazole 20 mg PO DAILY 5. Calcium Carbonate 500 mg PO QPM 6. TraZODone 100 mg PO QHS Discharge Medications: 1. Metoprolol Succinate XL 50 mg PO DAILY 2. Calcium Carbonate 500 mg PO QPM 3. Omeprazole 20 mg PO DAILY 4. Simvastatin 40 mg PO QPM 5. TraZODone 100 mg PO QHS 6. Acetaminophen 1000 mg PO Q8H pain/fever 7. Docusate Sodium 100 mg PO BID 8. Multivitamins W/minerals 1 TAB PO DAILY 9. Senna 17.2 mg PO QHS 10. Sodium Chloride 0.9% Flush ___ mL IV DAILY and PRN, line flush 11. Aspirin 81 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Urinary tract infection Nephrolithiasis with urinary tract obstruction Hydronephrosis Sepsis Delirium Dementia Hypertension Discharge Condition: Mental Status: AOx2, confused (chronic due to dementia). Level of Consciousness: Alert and interactive. Activity Status: Bedbound. Discharge Instructions: You were admitted with pain and fevers due to a kidney stone that was blocking the passage of urine from your left kidney. You developed a urinary tract infection that led to a blood stream infection (sepsis) for which you were treated with antibiotics. You received a nephrostomy tube to help drain the blocked urine. You should continue to followup regularly with your urologist; you are scheduled to return in ___ to have the drain changed. If you have any problems with the nephrostomy tube (like it not draining urine) please call ___ ___ or ___ at ___ at ___ Followup Instructions: ___
10381182-DS-12
10,381,182
26,081,413
DS
12
2122-10-16 00:00:00
2122-10-16 20:02:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Non-fluent aphasia Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ year old man with history of type 1 diabetes mellitus on insulin, otherwise no significant past medical history who presents after waking up this morning with expressive aphasia. History provided by patient and parents via collateral. Mr. ___ was in his usual state of health until this morning. Prior to that, he went out last night with a few friends to play darts. He said he had two beers, otherwise denies any drug use, denies marijuana, denies the possibility of an accidental ingestion. His girlfriend was not with him at the time, but reports that there was no mention of unusual behavior by his friends. He returned home at 11:30PM and went to sleep in his usual state of health. The patient woke up this morning at 0530, and recalls checking his glucose which was 76. He recalls reporting a generalized, holocephalic headache. He then has minimal recollection of the events that followed. His mother woke up when he did at ___, and notes that this was earlier than he usually wakes up. He walked into the kitchen and started eating a donut, which was unusual for him as he does not like donuts. She was concerned that he was hypoglycemic and gave him two glasses of orange juice to drink. She checked his glucose after and it was 176. She tried to talk to him and noted that he was minimally verbal. He answered "I ___ go back" to all questions asked. He seemed to attend to her but was either nonverbal or saying "I ___ go back" in response to questions. Concerned, EMS was called and patient presented to ___ for further evaluation. Parents note that he has never exhibited this behavior before. His sugars generally run in the 100 to 200 range, as far as they are aware. When he does run high or low, he complains of fatigue and does not have issues with language or speech. At ___, NIHSS was 5, scoring predominantly for expressive aphasia (minimal verbal output, followed simple commands only). He was out of the window for tPA given he woke up with symptoms. He was then transferred to ___ urgently, before more thorough evaluation could be completed, for consideration of thrombectomy. At ___ was 2, scoring for moderate aphasia only. He underwent STAT CTA Head/Neck and CT perfusion which did not reveal any large vessel occlusion, and CT perfusion also did not reveal evidence of infarct. His symptoms have overall gradually improved since this morning. He is now able to string together several words at a time, which he could not do before, and relate some history. Prior to this morning, parents report the patient has been stressed over the last week. He works allocating money for a ___, and it is the end of the fiscal year, where he has had increased pressure and demands at work. In addition, his diabetes was recently found to be poorly controlled at his routine endocrinology checkup this summer (A1c 9.7). Otherwise, family denies any recent changes to his health. Denies recent illness including no recent fevers or chills. No medication changes. They report he has never done drugs to their knowledge, and his alcohol use is minimal. Past Medical History: Type 1 Diabetes Mellitus, on insulin, poorly controlled (A1c 9.7) History of lyme disease remotely Social History: ___ Family History: Denies family history of early stroke or premature CAD. No history of seizures in family. Physical Exam: Admission Physical Examination: Vitals: Tm 98.9F/ Tc 98.6F, HR 110s-130s (sinus tachycardia), BP 120s-140s/70s-80s, RR 14, O2 99% RA General: Awake, alert, in no acute distress HEENT: NCAT, no oropharyngeal lesions, neck supple ___: warm, well perfused; regular on telemetry Pulmonary: breathing non labored on room air Abdomen: Soft, NT, ND, no guarding Extremities: Warm, no edema Neurologic Examination: - Mental status: Awake, alert. Expressive aphasia; When answering questions, strings together up to ___ words in a sentence. Often says "I think it was a lot of nervous...this morning" and perseverates on this phrase throughout the interview. When asked orientation questions, says "This morning, this morning." Attentive to examiner, unable to complete attention tasks. Can repeat very simple, brief phrases only (i.e. "Today is a sunny day") but cannot repeat longer ("The cat always hid under the couch") or more grammatically complex ("No ifs ands or buts") phrases. Naming intact to all objects on stroke card except "hammock". No paraphasias. No dysarthria. Normal prosody. No apraxia; can pantomime brushing teeth, combing hair and using a nail and hammer. He can read sentences on stroke card. He struggles with writing. When asked to write "Today is a sunny day", writes 'Today" and then is unable to proceed further. No evidence of hemineglect. No left-right confusion. He is able to follow one step midline and appendicular commands, but not more complex commands. When asked about recent events in news, perseverates on "this morning." - Cranial Nerves: Mydriasis; pupils 6>4mm and briskly reactive. VF full to finger wiggling. EOMI, no nystagmus. Funduscopic exam reveals crisp disc margins bilaterally. V1-V3 without deficits to light touch bilaterally. No facial movement asymmetry. Hearing intact to finger rub bilaterally. Palate elevation symmetric. SCM/Trapezius strength ___ bilaterally. Tongue midline. - Motor: Normal bulk and tone. No drift. No tremor or asterixis. [___] L 5 5 5 5 ___ 5 5 5 5 5 R 5 5 5 5 ___ 5 5 5 5 5 - Reflexes: [Bic] [Tri] [___] [Quad] [Gastroc] L 2+ 2+ 2+ 2+ 1 R 2+ 2+ 2+ 2+ 1 Plantar response flexor bilaterally - Sensory: No deficits to light touch, pin, or proprioception bilaterally. No extinction to DSS. - Coordination: No dysmetria with finger to nose testing bilaterally. Good speed and intact cadence with rapid alternating movements. - Gait: Normal initiation. Narrow base. Normal stride length and arm swing. Stable without sway. Negative Romberg. Discharge Physical Examination: Vitals: T 98.5F, HR 101, BP 116/73, RR 20, O2 97% RA General: Awake, alert, in no acute distress HEENT: NCAT, no oropharyngeal lesions, neck supple ___: warm, well perfused; regular on telemetry Pulmonary: breathing non labored on room air Abdomen: Soft, NT, ND, no guarding Extremities: Warm, no edema Neurologic Examination: - Mental status: Alert and oriented to person, place, and date. Attentive and able to name ___ backwards and correctly spell "world" backwards. Registered ___ words and able to retrieve ___ after 5 min. Speech was fluent, but perhaps a little slower than usual with mild word finding difficulty that manifested in patient having to contemplate the occasional word choice. Patient was able to talk in full, grammatically correct sentences. Normal prosody and no paraphasic errors. Intact repetition of "no ifs and or buts" and "Today is a sunny day in ___. Intact comprehension. He was able to name all objects on the stroke card, but took a few seconds to find the word for "hammock". In general, patient was able to relate the events of the day, but seemed to have limited insight into what might have caused it. He kept emphasizing that he was nervous this morning and that he thought his state may have been due to his diabetes. He remembered being unable to communicate clearly this AM and endorsed feeling frustrated. Able to copy a rectangle but not to draw a cube from memory (loss of 3D features). Able to put the numbers on a clock face and draw the hands at ten past eleven. When asked how a "ruler" and a "watch" are similar, he said "they both have the same numbers"; asked to clarify, he said "they both have numbers like 4, 6, and 12". When asked how a train and a bicycle are similar, he said "they both go in the same direction". - Cranial Nerves: Mydriasis; pupils 6>4mm and briskly reactive. VF full to finger wiggling. EOMI, no nystagmus. Funduscopic exam reveals crisp disc margins bilaterally. V1-V3 without deficits to light touch bilaterally. No facial movement asymmetry. Hearing intact to finger rub bilaterally. Palate elevation symmetric. SCM/Trapezius strength ___ bilaterally. Tongue midline. - Motor: Normal bulk and tone. No drift. No tremor or asterixis. [___] L 5 5 5 5 ___ 5 5 5 5 5 R 5 5 5 5 ___ 5 5 5 5 5 - Reflexes: [Bic] [Tri] [___] [Quad] [Gastroc] L 2+ 2+ 2+ 2+ 1 R 2+ 2+ 2+ 2+ 1 Plantar response flexor bilaterally - Sensory: No deficits to light touch, pin, or proprioception bilaterally. No extinction to DSS. - Coordination: No dysmetria with finger to nose testing bilaterally. Good speed and intact cadence with rapid alternating movements. - Gait: Normal initiation. Narrow base. Normal stride length and arm swing. Stable without sway. Negative Romberg. Pertinent Results: ___ 07:20AM BLOOD WBC-7.4 RBC-5.20 Hgb-14.8 Hct-45.8 MCV-88 MCH-28.5 MCHC-32.3 RDW-13.7 RDWSD-43.8 Plt ___ ___ 10:24AM BLOOD WBC-12.0* RBC-5.18 Hgb-14.5 Hct-44.7 MCV-86 MCH-28.0 MCHC-32.4 RDW-13.4 RDWSD-42.3 Plt ___ ___ 10:24AM BLOOD Neuts-85.4* Lymphs-9.3* Monos-4.5* Eos-0.1* Baso-0.4 Im ___ AbsNeut-10.10* AbsLymp-1.10* AbsMono-0.53 AbsEos-0.01* AbsBaso-0.05 ___ 07:20AM BLOOD Plt ___ ___ 10:24AM BLOOD Plt ___ ___ 10:24AM BLOOD ___ PTT-30.0 ___ ___ 07:20AM BLOOD Glucose-67* UreaN-13 Creat-0.8 Na-141 K-4.8 Cl-102 HCO3-23 AnGap-16 ___ 10:24AM BLOOD Creat-0.8 ___ 10:24AM BLOOD Glucose-266* UreaN-10 Creat-1.0 Na-137 K-4.9 Cl-96 HCO3-22 AnGap-19* ___ 10:24AM BLOOD ALT-14 AST-22 AlkPhos-59 TotBili-0.3 ___ 10:24AM BLOOD Lipase-15 ___ 07:20AM BLOOD Calcium-9.5 Phos-4.3 Mg-2.1 ___ 10:24AM BLOOD Albumin-4.5 Calcium-10.2 Phos-3.4 Mg-1.9 ___ 10:24AM BLOOD TSH-2.5 ___ 10:24AM BLOOD Free T4-1.1 ___ 10:29AM BLOOD Glucose-258* Na-135 K-4.5 Cl-97 calHCO3-25 IMAGES: MRI Brain w/wo contrast ___: IMPRESSION: 1. No intracranial abnormality. 2. Mild paranasal sinus disease, as above. XR Chest ___: IMPRESSION: No acute cardiopulmonary process. No focal consolidation to suggest pneumonia. CTA Head and Neck ___: FINDINGS: CT HEAD WITHOUT CONTRAST: There is no evidence of no evidence of infarction, hemorrhage, edema, or mass. The ventricles and sulci are normal in size and configuration. There is a mucous retention cyst and mild mucosal thickening in the left maxillary sinus. The visualized portion of the remaining paranasal sinuses, mastoid air cells, and middle ear cavities are clear. The visualized portion of the orbits are unremarkable. CTA HEAD: The vessels of the circle of ___ and their principal intracranial branches appear normal without stenosis, occlusion, or aneurysm formation. The left PCA is diminutive in comparison to the right, likely congenital. The left A1 segment is also diminutive compared to the right, likely congenital. The dural venous sinuses are patent. CTA NECK: The carotid and vertebral arteries and their major branches appear normal with no evidence of stenosis or occlusion. There is no evidence of internal carotid stenosis by NASCET criteria. OTHER: The visualized portion of the lungs are clear. The visualized portion of the thyroid gland is within normal limits. There is no lymphadenopathy by CT size criteria. IMPRESSION: 1. No acute intracranial abnormalities identified. 2. Patent Circle of ___ without evidence of aneurysm or stenosis. 3. No evidence of internal carotid artery stenosis by NASCET criteria. 4. No asymmetric perfusion abnormalities identified. Brief Hospital Course: Mr. ___ is a ___ year old man with history of type 1 DM insulin dependent who presents after waking up this morning with expressive aphasia. Initial NIHSS at OSH 5, scoring predominantly for expressive aphasia. Patient transferred here for possible endovascular intervention. On imaging, NCHCT is unremarkable, no vessel occlusion on CTA H/N. Not tPA candidate given out of window. Not endovascular candidate given no vessel occlusion noted. Admission exam notable for expressive aphasia (but improved from OSH), able to string only ___ words together, quite perseverative, can read but not write; can follow only simple commands. General exam notable for pupillary dilation and tachycardia. On discharge exam, his expressive aphasia has resolved, his speech fluent with comprehension, repetition, and naming intact. # Expressive (non-fluent) aphasia Presented with expressive aphasia and was evaluated for stroke. ___ stroke scale at admission was 2 (down from 5 at ___). tPA was not administered because out of window (last well 11:30 ___ on ___. Overall low suspicion for stroke given improving deficits, minimal stroke risk factors apart from diabetes. His TSH, free T4 were WNL. Head MRI with and without contrast showed no intracranial abnormality. CTA of head and neck with and without contrast showed no acute intracranial abnormalities, a patent Circle of ___ without evidence of aneurysm or stenosis, no evidence of internal carotid artery stenosis by NASCET criteria, and no asymmetric perfusion abnormalities. Urine toxicology negative. Preliminary EEG report showed left-sided slowing. Final EEG report pending. # Type 1 diabetes Mr. ___ T1DM is poorly controlled (A1c 9.7). Blood glucose on admission was elevated at 266. We administered fixed dose insulin (Humalog ___ 40 units BID at breakfast and at dinner) and sliding scale insulin. He should follow up with his diabetes care provider to discuss diet, exercise, and insulin regimen. # Initial concern for pneumonia Chest X-ray was done because of clinical concern for pneumonia. CXR however shows no acute cardiopulmonary process and no focal consolidation to suggest pneumonia. Patient was not tachypneic, afebrile, therefore not treated. # Transitional issues Counseled to abstain from driving for 6 months because of abnormal sensorium as per EEG. Patient instructed to follow up with neurology to monitor seizure activity. Medications on Admission: insulin regular human 100 unit/mL injection ___ID insulin lispro 100 unit/mL subcutaneous PRN Discharge Medications: 1. Humalog ___ 55 Units Breakfast Humalog ___ 50 Units Dinner Insulin SC Sliding Scale using HUM Insulin 2. HumaLOG Mix ___ (insulin lispro protamin-lispro) 50 subcutaneous BID Discharge Disposition: Home Discharge Diagnosis: Transient aphasia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were transferred from an outside hospital to ___ and admitted into the hospital for further evaluation of abnormal speech and confusion which you experienced on the morning of ___. The work-up included neuroimaging (CT scan of the head, CT scan of the head vessels, as well as MRI of the brain) - all scans were within normal limits, specifically negative for stroke and/or brain lesions. Electroencephalography was completed and per preliminary report showed slowing on the left side of the brain. This finding can be seen after a seizure, but it can also be seen in the setting of hypoglycemia alone. Blood work was unrevealing. Given the neurologic changes and question of possible seizure, the ___ law prohibits you from driving for 6 months following the incident. Additionally you should avoid swimming alone and climbing high places. Your insulin home regimen (Humalog 75/25) for type 1 diabetes mellitus was started, glucose ranged from 67-220's. Transitional issues: - Emphasized importance of good glycemic control, which includes insulin use per primary Endocrinologists recommendation, as well as regular meals. Discussed risks of hypoglycemia with alcohol use. - Please schedule a follow-up appointment with your primary care doctor within ___ weeks of discharge. - Please follow-up with your Endocrinologist as previously scheduled. - Please schedule follow-up appointment with General Neurology at ___ within 6 months or sooner if needed Followup Instructions: ___
10381436-DS-4
10,381,436
20,855,287
DS
4
2162-12-18 00:00:00
2162-12-18 09:32:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: ORTHOPAEDICS Allergies: Sulfa (Sulfonamide Antibiotics) Attending: ___. Chief Complaint: left intertrochanteric femur fracture Major Surgical or Invasive Procedure: Trochanteric femoral nail on ___ History of Present Illness: ___ male with a history of MS ___ fall with left hip pain. Pt states that he fell yesterday on the street. He was walking with walker and lost his balance falling on to his left hand. He was able to get up afterwards and continue on with minimal pain in his left hand; however since then has had worsening weakness in his left hand and fell last night because of it. He states he got up to go to the bathroom, lost his balance again but unable to use left hand to catch himself (he is right hand dominant). He fell onto left hip, no head strike but unable to get up afterwards due to pain. His wife helped him to bed and because of continued pain came to the Emergency Room. He denies numbness or tingling distally. He has never injured this leg in the past. Past Medical History: Multiple Sclerosis Osteoporosis Social History: ___ Family History: NC Physical Exam: Upon Admission: General: Well-appearing male in no acute distress. Pelvis is stable Left lower extremity: - Skin intact - Left leg is held in external rotation and shortened compared to right lower extremity. He has tenderness to palpation over the anterior proximal hip. no overlying erythema. - unable to range the hip due to pain. Full ROM at the ankle and distally. - Fires ___ - SILT S/S/SP/DP/T distributions - 1+ ___ pulses, WWP Upon discharge: Vitals: Temp: 99.4 AdultAxillary BP: 117/71 R Lying HR: 82 RR: 18 O2 sat: 99% O2 delivery: Cpap General: Well-appearing, breathing comfortably MSK:Left lower extremity: - Skin intact - Dressing is c/d/I, no surrounding erythema - Fires ___ - SILT S/S/SP/DP/T distributions - 1+ ___ pulses, WWP Pertinent Results: ___ 11:42AM BLOOD WBC-7.0 RBC-3.71* Hgb-12.0* Hct-35.7* MCV-96 MCH-32.3* MCHC-33.6 RDW-12.3 RDWSD-43.1 Plt ___ ___ 11:42AM BLOOD Neuts-82.6* Lymphs-7.5* Monos-9.1 Eos-0.1* Baso-0.4 Im ___ AbsNeut-5.75 AbsLymp-0.52* AbsMono-0.63 AbsEos-0.01* AbsBaso-0.03 ___ 11:42AM BLOOD ___ PTT-26.9 ___ ___ 11:42AM BLOOD Plt ___ ___ 11:42AM BLOOD Glucose-125* UreaN-18 Creat-0.7 Na-138 K-5.1 Cl-100 HCO3-24 AnGap-14 ___ 06:00AM BLOOD WBC-5.3 RBC-2.42* Hgb-7.8* Hct-23.5* MCV-97 MCH-32.2* MCHC-33.2 RDW-12.4 RDWSD-43.6 Plt ___ ___ 07:10AM BLOOD Hct-23.3* ___ 06:00AM BLOOD Glucose-113* UreaN-25* Creat-0.7 Na-141 K-4.6 Cl-104 HCO3-29 AnGap-8* Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have left intertrochanteric femur fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for placement of trochanteric femoral nail for fixation of left hip fracture, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications. The patient was given ___ antibiotics and anticoagulation per routine. His post-operative HCT down trended to 23.4, though the patient was asymptomatic therefore blood transfusion was deemed to be unnecessary at the time. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to rehab was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is weight bearing as tolerated to the left lower extremity, and will be discharged on lovenox 4omg daily x4weeks for DVT prophylaxis. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: Aubagio 14mg Daily Forteo 20mcg/dose daily Discharge Medications: 1. Acetaminophen 1000 mg PO TID RX *acetaminophen 500 mg 2 tablet(s) by mouth three times daily Disp #*68 Tablet Refills:*0 2. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 tablet(s) by mouth twice daily Disp #*50 Tablet Refills:*0 3. Enoxaparin Sodium 40 mg SC QPM RX *enoxaparin 40 mg/0.4 mL 40 mg SC daily Disp #*28 Syringe Refills:*0 4. OxyCODONE (Immediate Release) 2.5 mg PO Q4H:PRN pain RX *oxycodone 5 mg 1 to 2 tablet(s) by mouth every four (4) hours Disp #*28 Tablet Refills:*0 5. Senna 8.6 mg PO BID:PRN Constipation - First Line RX *sennosides 8.6 mg 1 tab by mouth twice daily Disp #*50 Tablet Refills:*0 6. Aubagio (teriflunomide) 14 mg oral DAILY MS 7. Forteo (teriparatide) 20 mcg/dose - 600 mcg/2.4 mL subcutaneous daily Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Left intertrochanteric femur fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: -Weightbearing as tolerated to left lower extremity Resident covering MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take Lovenox 40 mg daily for 4 weeks WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - Please remain in your dressing and do not change unless it is visibly soaked or falling off. - Splint must be left on until follow up appointment unless otherwise instructed - Do NOT get splint wet DANGER SIGNS: Please call your PCP or surgeon's office and/or return to the emergency department if you experience any of the following: - Increasing pain that is not controlled with pain medications - Increasing redness, swelling, drainage, or other concerning changes in your incision - Persistent or increasing numbness, tingling, or loss of sensation - Fever > 101.4 - Shaking chills - Chest pain - Shortness of breath - Nausea or vomiting with an inability to keep food, liquid, medications down - Any other medical concerns THIS PATIENT IS EXPECTED TO REQUIRE <30 DAYS OF REHAB Physical Therapy: Weightbearing as tolerated to left lower extremity Treatments Frequency: Any staples or superficial sutures you have are to remain in place for at least 2 weeks postoperatively. Incision may be left open to air unless actively draining. If draining, you may apply a gauze dressing secured with paper tape. You may shower and allow water to run over the wound, but please refrain from bathing for at least 4 weeks postoperatively. Please remain in the splint until follow-up appointment. Please keep your splint dry. If you have concerns regarding your splint, please call the clinic at the number provided. Call your surgeon's office with any questions. Followup Instructions: ___
10381484-DS-15
10,381,484
27,486,461
DS
15
2172-08-03 00:00:00
2172-08-05 13:58:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Abdominal Pain Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ man with stage IV (pT3 pN2a pM1b) colon cancer s/p laparoscopic low anterior resection with removal of a rectosigmoid mass and two drop mets, also s/p 7 cycles of XELOX adjuvant therapy (stopped ___ side effects), now presenting twice today to the ED with abdominal pain, admitted for refractory abdominal pain. Patient was seen in the ED this morning and had a CT abdomen without acute process. Was felt to have functional abdominal pain. His abdominal pain improved after initial ED visit this morning and so he was discharged to his oncology f/u clinic visit. THere, hisabd pain returned and was ___. Dr. ___ for po Dilaudid, but when nursing was trying to dispense the PO med he was out of his chair, bending over chair c/o increased pain and then vomited. Pt assisted back to chair, VS 139/80 98.2-50-16, Sat 99%. Episode lasted 5 min and he was unable to take po pain med. At that point MD made decision to transfer pt back to ER for further workup. He was worried about going home and having to go back to ER during the night. As such he received IV Dilaudid 0.5mg prior to transfer to ambulance stretcher for ___ abdominal pain. In the ED, initial VS were: 13:35 7 98.8 50 144/88 18 100% RA Labs were notable for: lactate 2.1. Imaging included: CT a/p with contrast on first visit, see below Treatments received: 1L NS, simethicone 80mg, morphin 5mg Despite IV morphine had persistent writhing pain in the ED and was admitted for pain control. On arrival to the floor, patient reports pain started a few days after CT scan last ___ (had chest CT). This type of pain started only after getting surgery ___, a total of 3 times, each time he was admitted and it was felt to be ___ bowel reg noncompliance or constipation and pain resolved with BMs. The pain is intermittent (comes and goes), but over the last few days each time it comes back it gets worse. Morphine helps, food makes it worse, and movement. Bowel movements also make it better. Pain is "strong," ___, across anterior upper abdomen. Denies constipation, reports 1BM daily, before surgery had constipation but now reports regular BMs. Describes pain as "gas" and "severe bloating." Denies ETOH use and NSAID use, does have history of GERD but doesnt take anything for it. Past Medical History: PAST ONCOLOGIC HISTORY: - endoscopy for rectal bleeding performed on ___. It showed a fungating, circumferential mass of malignant appearance in the sigmoid colon at 18cm. The mass caused a complete obstruction. Biopsy of this mass revealed fragments of adenoma with high-grade dysplasia and focal adenocarcinoma, with intact expression of MLH-1, PMS-2, MSH-2, and MSH-6. - CT torso on ___ showed no evidence of distant metastases - referred to Dr. ___ palpated a nodule in the rectum. - MRI of the pelvis was performed on ___ which showed an ill-defined sigmoid mass, approximately 15 cm above the anal verge, with extension across the muscularis propria, suspicious for T3 disease. It also revealed a 1.6 x 1.5 cm mass abutting the anterior aspect of the rectum and posterior aspect of the seminal vesicles, 7 cm above the anal verge, that was suspicious for a drop metastasis. - laparoscopic low anterior resection on ___. Path revealed colonic adenocarcinoma in the resected rectosigmoid colon. Tumor size was 3.6cm, low grade, staged pT3. Margins were negative. Of the 15 nodes examined, 6 were positive, thus staged pN2a. Finally, a separate nodule of adenocarcinoma was identified 9 cm distal to the primary tumor involving pericolonic adipose tissue, serosa, and muscularis propria, consistent with metastasis of the primary tumor. Furthermore, the resected peritoneal nodule showed metastatic adenocarcinoma with perineural invasion. Thus, this was staged pM1b. Of note, KRAS mutation was detected. - ___ port placement - ___ admitted for abdominal pain, OSH CT was reviewed here and felt to be not concerning for any acute intra-abdominal process including leak or abcess however there was a high stool burden and gas. Pt discharged on bowel regimen. - ___ ED visit for abdominal pain, KUB reassuring, discharged after bowel regimen - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ admission for abdominal pain, no clear obstruction but improved with NG tube for decompression - ___ admission for constipation due to bowel med noncompliance PAST MEDICAL HISTORY: Rectal cancer as above Lipoma Social History: ___ Family History: Negative for colon cancer, inflammatory bowel disease, uterine cancer. He does have history of lipomas in his family. Physical Exam: ON ADMISSION: VS: 98.2 118/74 45 18 97RA GENERAL: very uncomfortable gentleman leaning over sitting on the side of bed, friend at bedside ___: NC/AT, EOMI, MMM, sclera anicteric CARDIAC: RRR, normal S1 & S2, without murmurs, S3 or S4 LUNG: poor effort, but clear to auscultation, no wheezes or rhonchi ABD: bowel sounds present, TTP in bilateral upper quadrants, negative murphys sign, minimal TTP RLQ, no rebound, +voluntary guarding, no CVA tenderness but discomfort anteriorly with CVA tenderness EXT: No lower extremity pitting edema NEURO: face symmetric, MAE, gait WNL, orientedx3 SKIN: Warm and dry, without rashes ON DISCHARGE: VS: Tmax 98.9 Tc 97.6 HR ___ BP ___ RR 18 SpO2 96-98% RA, I/O 24h ___, 8h 30/NR GENERAL: Patient in moderate pain, but improved from yesterday ___: NC/AT, EOMI, MMM, sclera anicteric CARDIAC: RRR, normal S1 & S2, without murmurs, S3 or S4 LUNG: poor effort, but clear to auscultation, no wheezes or rhonchi ABD: bowel sounds present, resolved tenderness, negative murphys sign, minimal TTP RLQ, no rebound, +voluntary guarding, no CVA tenderness EXT: No lower extremity pitting edema NEURO: face symmetric, MAE, gait WNL, orientedx3 SKIN: Warm and dry, without rashes Pertinent Results: ADMISSION LABS: ___ 02:20AM BLOOD WBC-9.6# RBC-5.22 Hgb-15.6 Hct-46.1 MCV-88 MCH-29.8 MCHC-33.8 RDW-12.5 Plt ___ ___ 02:20AM BLOOD Plt ___ ___ 02:20AM BLOOD Glucose-123* UreaN-15 Creat-1.2 Na-140 K-3.7 Cl-101 HCO3-25 AnGap-18 ___ 02:20AM BLOOD Albumin-4.5 Calcium-9.9 Phos-2.4* Mg-2.0 ___ 02:20AM BLOOD Lactate-2.1* IMAGING: CT ABD & PELVIS WITH CO ___: IMPRESSION: 1. Normal appendix. 2. Small amount of nonspecific free fluid in the right lower quadrant and pelvis, which is new over the interval. MICROBIOLOGY: NONE DISCHARGE LABS: ___ 05:54AM BLOOD WBC-7.8 RBC-4.89 Hgb-14.6 Hct-43.0 MCV-88 MCH-29.9 MCHC-33.9 RDW-12.0 Plt ___ ___ 05:54AM BLOOD Plt ___ ___ 05:54AM BLOOD Glucose-87 UreaN-12 Creat-1.1 Na-138 K-3.7 Cl-99 HCO3-30 AnGap-13 ___ 05:54AM BLOOD Calcium-9.4 Phos-4.1 Mg-2.0 Brief Hospital Course: Mr. ___ is a ___ man with stage IV (pT3 pN2a pM1b) colon cancer s/p laparoscopic low anterior resection with removal of a rectosigmoid mass and two drop mets, also s/p 7 cycles of XELOX adjuvant therapy (stopped ___ side effects), now presenting twice today to the ED with abdominal pain, admitted for refractory abdominal pain. # ABDOMINAL PAIN: Patient was admitted with refractory abdominal pain. Exam was unremarkable for peritoneal signs, but notable for diffuse abdominal tenderness. LFTs and lipase were unremarkable. Abdominal CT demonstrated normal appendix and now evidence of obstructive processes. The patient was made NPO and managed with PCA dilaudid, IV reglan, simethicone, and increased bowel regimen. An EGD was originally planned but not pursued since the patient's abdominal pain markedly improved. The patient's pain was likely from dysmotility in the setting of his previous colon surgeries and constipation as his symptoms improved with moving his bowels. He was eating a regular diet and was discharged with a bowel regimen. # Stage IV (pT3 pN2a pM1b) colon cancer. In terms of his colon cancer he is disease free, with no signs or symptoms concerning for recurrence. CEA low, with recent outpatient ___ showing only lymphoid aggregates on path, and plan for f/u imaging q3 months. No chemotherapy was administered during this hospitalization. # GERD: Pt denies that acid is much of the problem. -Continued home Pantoprazole TRANSITIONAL ISSUES: []CODE STATUS: Full []Discharge bowel regimen: Colace and senna with PRN Miralax and Bisacodyl if no BM for greater than 2 days. Reglan PRN nausea []Consider elective removal of port cath if patient will not have further chemo treatments []Consider followup outpatient EGD if patient develops worsening abdominal pain []Patient will have Med Onc followup Medications on Admission: The Preadmission Medication list is accurate and complete. 1. This patient is not taking any preadmission medications Discharge Medications: 1. Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 2. Senna 8.6 mg PO BID constipation RX *sennosides [___] 8.6 mg 1 tablet by mouth twice a day Disp #*60 Tablet Refills:*0 3. Simethicone 40-80 mg PO QID:PRN gas pains RX *simethicone [Bicarsim] 80 mg 1 tablet by mouth every six (6) hours Disp #*60 Tablet Refills:*0 4. Metoclopramide 10 mg PO Q8H:PRN Nausea RX *metoclopramide HCl [Reglan] 10 mg 1 tablet(s) by mouth every eight (8) hours Disp #*30 Tablet Refills:*0 5. Polyethylene Glycol 17 g PO DAILY:PRN constipation Please take if no bowel movements for more than 2 days 6. Bisacodyl 10 mg PO DAILY:PRN constipation Please take if no bowel movements for more than 2 days RX *bisacodyl [Alophen] 5 mg 2 tablet(s) by mouth once a day Disp #*15 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary: Abdominal Pain Colon Cancer Secondary: Gastroesophageal Reflux Disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you during your hospitalization at the ___. As you know, you were admitted with abdominal pain. We did imaging of your abdomen which did not show any blockages. We treated your pain with IV medictions and your pain improved. We felt your abdominal pain was likely related to your bowel not moving well and constipation. Since your symptoms improved, we did not do a test to look at your gastrointestinal tract. Please continue to take your medications to move your bowels. If you do not have a bowel movement for more than 2 days with colace and senna, you may take medications called Miralax or Bisacodyl as instructed. Please followup with your cancer doctor as below. Sincerely, Your ___ Care Team Followup Instructions: ___
10381484-DS-17
10,381,484
25,659,319
DS
17
2175-10-27 00:00:00
2175-10-27 18:47:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: pollen Attending: ___. Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: None History of Present Illness: HISTORY OF PRESENT ILLNESS: Patient is a ___ year old M with history of stage IV metastatic sigmoid adenocarcinoma s/p LAR ___, 7 cycles of XELOX, with subsequent metastasis to spenic bed s/p lap splenectomy, gastric wedge resection (___), with metastatic disease to the liver, found on recent CT A/P to have worsening hepatic metastatic disease with increasing soft tissue density with necrotic nodes in jejunal wall with plan for palliative FOLFOX, who presents with worsening abdominal pain. Patient states that he has had 1 month history of worsening diffuse abdominal pain that has acutely worsened over last several days. Started having nausea yesterday evening without emesis. Also experiencing early satiety, has had minimal PO intake, able to tolerate some small bites and liquids. Still passing gas, last bowel movement was yesterday evening, however it was small and constipated. Denies any urinary symptoms no burning or pain on urination, no recent fevers or chills. On arrival to the ED, Initial VS: T 98.6 HR 77 BP 151/86 RR 18 O2 100%RA Exam: GA: Comfortable Neuro: Cranial nerves II -XII intact, 5 out of 5 strength bilaterally upper and lower extremities, full sensation bilaterally HEENT: No scleral icterus Cardiovascular: Normal S1, S2, regular rate and rhythm, no murmurs/rubs/gallops, 2+ peripheral pulses bilaterally Pulmonary: Clear to auscultation bilaterally Abdominal: Soft, tender to palpation left upper and lower quadrants, nondistended, no masses, no CVA tenderness Extremities: No lower leg edema Integumentary: No rashes noted Labs notable for: - WBC 12.4 with 74% neutrophils, Hb 13.1, K 4.2, BUN 16, Cr 1.0, LFTs within normal limits, lipase 20 Administered: ___ 02:14 IV Morphine Sulfate 4 mg ___ 02:14 IV Ondansetron 4 mg ___ 02:41 IVF NS ___ 04:14 IVF NS 1000 mL ___ 04:15 IV Morphine Sulfate 4 mg ___ 05:52 IV Morphine Sulfate 4 mg ___ 08:53 IV Morphine Sulfate 4 mg ___ 12:48 IVF NS 125cc/hr Imaging: CT A/P WC: 1. Closed loop small-bowel obstruction of the jejunum measuring up to 2.8 cm. 2. Stable, metastatic disease as described above. Colorectal surgery consulted for potential surgical intervention. SUBJECTIVE: Patient confirms the above history. Currently complaining of mild diffuse abdominal pain, no nausea, no vomiting. Past Medical History: PAST ONCOLOGIC HISTORY: PAST ONCOLOGIC HISTORY: Reconciled in OMR. Colon cancer stage IIIC (T3N2M0) of the sigmoid colon with progressive metastatic disease - ___ Colonscopy for weight loss of 26 lbs in a year revealed a fungating, circumferential mass of malignant appearancae was found in the sigmoid colon at 18cm. Biopsy consistent with adenocarcinoma. CT torso revealed 3.7 cm segment of the mid sigmoid colon demonstrating circumferential wall thickening in keeping with tumor. There is no associated bowel obstruction at present time. Adjacent mesenteric lymph nodes measuring up to 6 mm in short axis dimension are noted. No evidence of metastatic disease within the chest, abdomen, or pelvis. - ___ MR pelvis revealed Ill-defined sigmoid mass, approximately 15 cm above the anal verge, as seen on the CT examination from ___, with extension across the muscularis propria. This is suspicious for T3 disease. 1.6 x 1.5 cm mass abutting the anterior aspect of the rectum and posterior aspect of the seminal vesicles, 7 cm above the anal verge, is suspicious for a drop metastasis as it is not convincingly arising from rectal wall. This likely corresponds to the palpable finding on physical exam. Intrapelvic lymphadenopathy adjacent to the sigmoid mass, some with morphology suspicious for tumor involvement. - ___ Undderwent LAR. Path revealed colonic adenocarcinoma in the resected rectosigmoid colon. Tumor size was 3.6cm, low grade, staged pT3. Margins were negative. Of the 15 nodes examined, 6 were positive, thus staged pN2a. Finally, a separate nodule of adenocarcinoma was identified 9 cm distal to the primary tumor involving pericolonic adipose tissue, serosa, and muscularis propria, consistent with metastasis of the primary tumor. Furthermore, the resected peritoneal nodule showed metastatic adenocarcinoma with perineural invasion. Thus, this was staged pM1b. Of note, KRAS mutation was detected. - ___ to ___ admitted for abdominal pain, OSH CT was reviewed here and felt to be not concerning for any acute intra-abdominal process including leak or abcess however there was a high stool burden and gas. Pt discharged on bowel regimen. - ___ ED visit for abdominal pain, KUB reassuring, discharged after bowel regimen - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ to ___ Admission for n/v and abd pain. CT showed mildly dilated stomach and proximal small bowel, but no evidence of obstruction. He underwent NGT decompression with good bilious output and improvement in symptoms and was slowly advanced to regular diet. - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ to ___ admission for abd pain and constipation. CT showed multiple mildly distended loops of ileum with fecalized contents and a narrow caliber of the terminal ileum. Stool and air seen in the colon. Symptoms improved with aggressive bowel regimen. - ___ C3D1 XELOX (Xeloda 1500mg BID) - ___ C4D1 XELOX (Xeloda 1500mg BID) - ___ C5D1 XELOX (Xeloda 2000mg BID) - ___ C6D1 XELOX (Xeloda 2000mg BID) - ___ C7D1 XELOX (Xeloda 2000mg BID) - ___ CT torso with no evidence of recurrence or metastases - ___ colonoscopy showed multiple tiny 2 mm polypoid lesions which showed to be lymphoid aggregates on path - ___ CT torso with no evidence of recurrence or metastases - ___ CT abdomen in the ED for abdominal pain showed ___ - ___ CT abdomen in the ED for abdominal pain showed ___ but indeterminate liver lesion - ___ CT torso ___ with stable liver lesion - ___ Colonoscopy revealed a single polyp, pathology consistent with adenoma. - ___ CT torso showed a new lesion in the splenic hilum concerning for recurrence - ___ PET CT showed avid lesion in the spleen, no other sites of disease - ___ Splenectomy revealed metastatic colon cancer - ___ CT torso showed ___ - ___ CT torso extensive recurrence in the spenic bed and nodes, CEA rising - ___ Biopsy of the splenic bed confirmed metastatic adenocarcinoma - ___ CT torso showed increase in metastatic disease - ___ CT torso showed increase in metastatic and concerning new areas in the liver PAST MEDICAL HISTORY: Colon Ca as above Lipoma DVT Social History: ___ Family History: Negative for colon cancer, inflammatory bowel disease, uterine cancer. He does have history of lipomas in his family. Physical Exam: Admission Physical Exam ========================= PHYSICAL EXAM: VS: T 97.7 BP 122/74 HR 44 RR 16, O2 99%RA GENERAL: Comfortable, in NAD HEENT: AT/NC, anicteric sclera, MMM NECK: supple, no LAD CV: Bradycardic, S1/S2, no murmurs, gallops, or rubs PULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABD: Soft, minimal TTP in lower abdomen, no rebound or guarding, no peritoneal signs EXT: 2+ peripheral pulses no c/c/e SKIN: Warm and well perfused, no excoriations or lesions, no rashes NEURO: CN II-XII intact no focal neurological deficits Discharge Physical Exam ========================= GENERAL: Comfortable, in NAD, lying in bed HEENT: AT/NC, anicteric sclera, MMM NECK: supple, no LAD CV: Bradycardic, S1/S2, no MRG PULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably ABD: Soft, minimal TTP in epigastrium, no rebound or guarding, no peritoneal signs, non distended, non-tympanitic EXT: 2+ peripheral pulses no c/c/e SKIN: Warm and well perfused, no excoriations or lesions, no rashes NEURO: CN II-XII intact no focal neurological deficits Pertinent Results: Admit Labs ========== ___ 01:50AM BLOOD WBC-12.4* RBC-4.41* Hgb-13.1* Hct-40.3 MCV-91 MCH-29.7 MCHC-32.5 RDW-13.2 RDWSD-44.1 Plt ___ ___ 01:50AM BLOOD Neuts-74.0* Lymphs-15.8* Monos-7.0 Eos-2.6 Baso-0.4 Im ___ AbsNeut-9.15* AbsLymp-1.95 AbsMono-0.87* AbsEos-0.32 AbsBaso-0.05 ___ 01:50AM BLOOD Plt ___ ___ 01:50AM BLOOD Glucose-110* UreaN-16 Creat-1.0 Na-141 K-4.2 Cl-102 HCO3-26 AnGap-13 ___ 01:50AM BLOOD Albumin-4.3 Pertinent Labs ============== ___ 01:50AM BLOOD Glucose-110* UreaN-16 Creat-1.0 Na-141 K-4.2 Cl-102 HCO3-26 AnGap-13 ___ 06:23AM BLOOD Glucose-123* UreaN-9 Creat-0.8 Na-143 K-3.7 Cl-104 HCO3-27 AnGap-12 ___ 06:01AM BLOOD Glucose-122* UreaN-11 Creat-0.9 Na-140 K-4.4 Cl-101 HCO3-25 AnGap-14 ___ 06:18AM BLOOD Glucose-113* UreaN-16 Creat-1.0 Na-139 K-4.0 Cl-101 HCO3-25 AnGap-13 ___ 05:30AM BLOOD Glucose-89 UreaN-14 Creat-0.9 Na-139 K-3.8 Cl-101 HCO3-26 AnGap-12 ___ 01:50AM BLOOD Neuts-74.0* Lymphs-15.8* Monos-7.0 Eos-2.6 Baso-0.4 Im ___ AbsNeut-9.15* AbsLymp-1.95 AbsMono-0.87* AbsEos-0.32 AbsBaso-0.05 Imaging ========= ___ 9:___BD & PELVIS WITH CONTRAST FINDINGS: LOWER CHEST: Imaged lung bases are clear aside from mild dependent atelectasis. The imaged portion of the heart is unremarkable. ABDOMEN: HEPATOBILIARY: A capsular implant is again noted along the hepatic dome measuring approximately 1.8 x 1.8 x 3.0 cm, slightly increased in size from prior. The lesion involving segment 3 is noted on series 2, image 22 measuring approximately 2.5 x 2.3 cm. Main portal vein and central branches are patent. No biliary ductal dilation is seen. The gallbladder appears normal. PANCREAS: The pancreas enhances normally. A lesions are seen. SPLEEN: The spleen is surgically absent. Within the left upper quadrant, there is an ill-defined mass containing several areas of calcification with relative central hypodensity. This lesion abuts the greater curvature of the stomach and measures approximately 8.3 x 6.5, not significantly changed in overall size when compared to the most recent prior exam. This finding remain concerning for malignancy. ADRENALS: Adrenals are normal. URINARY: Mild right hydroureteronephrosis is noted with slight delay in excretion of contrast. Given tumor implant in the region of the right distal ureter best seen on series 2, image 68, findings likely reflect partial tethering of the right distal ureter with resultant partial obstruction. Left kidney enhances normally with prompt excretion of contrast. GASTROINTESTINAL: Suture material noted along the proximal stomach. Stomach is fluid distended and abuts a mass in the left upper abdomen in the splenectomy bed which is grossly unchanged in size. The duodenum is unremarkable. There is a small bowel obstruction which can be traced to the level of a jejunal mass best seen on series 2, image 44. This tumor causes significant obstruction at this level though the lumen is not completely occluded. Additional points of relative caliber transition for example in the right lower abdomen on series 601 image 21 likely reflect partial destruction due to serosal implants. A bilobed mass is noted in the small-bowel mesentery of the right lower abdomen on series 2, image 58 not significantly changed in overall size. Distal small bowel is decompressed. The appendix is normal. The colon contains a moderate fecal load. Fiducials are seen adjacent to the rectum. PELVIS: The urinary bladder and distal ureters are unremarkable. Small volume ascites is noted. REPRODUCTIVE ORGANS: Multiple fiducial markers are noted within the prostate which appears heterogenous. LYMPH NODES: A bilobed soft tissue lesion is again noted just anterior to the right common iliac bifurcation, unchanged from recent prior. No retroperitoneal lymphadenopathy. No pelvic sidewall or inguinal adenopathy. Several mesenteric nodules for example in the left mid abdomen on series 2, image 42 measuring 11 mm in short axis appears similar to prior. VASCULAR: There is no abdominal aortic aneurysm. No atherosclerotic disease is noted. BONES: No worrisome bony lesion is seen. SOFT TISSUES: The abdominal and pelvic wall is within normal limits. IMPRESSION: 1. Partial small-bowel obstruction the level of a jejunal mass. Additional sites of subtle stricture in the small bowel could reflect the presence of additional small-bowel metastatic lesions. Small volume ascites. 2. Metastatic disease in the abdomen and pelvis appears grossly stable though a hepatic capsular implant appears slightly increased in size. 3. New mild right hydroureteronephrosis likely due to partial obstruction of the right distal ureter due to an adjacent metastatic lesion. NOTIFICATION: D/w Dr. ___ (Surgery) BY ELECTRONICALLY SIGNING THIS REPORT, I THE ATTENDING PHYSICIAN ATTEST THAT ___ HAVE REVIEWED THE ABOVE IMAGES FOR THE ABOVE EXAMINATION(S) AND AGREE WITH THE FINDINGS AS DOCUMENTED ABOVE. ___, MD ___, MD electronically signed on WED ___ 11:49 ___ Discharge Labs ================ ___ 05:30AM BLOOD WBC-11.1* RBC-4.01* Hgb-11.8* Hct-35.6* MCV-89 MCH-29.4 MCHC-33.1 RDW-12.9 RDWSD-42.1 Plt ___ ___ 05:30AM BLOOD Plt ___ ___ 05:30AM BLOOD Glucose-89 UreaN-14 Creat-0.9 Na-139 K-3.8 Cl-101 HCO3-26 AnGap-12 ___ 06:01AM BLOOD ALT-13 AST-15 LD(LDH)-166 AlkPhos-63 TotBili-0.4 ___ 05:30AM BLOOD Calcium-8.8 Phos-3.7 Mg-1.9 Brief Hospital Course: Mr. ___ is a ___ year old male with stage IV metastatic sigmoid adenocarcinoma s/p lower abdominal resection, mets to splenic bed s/p splenectomy, gastric wedge re-section, with metastatic disease to liver, found on recent CT A/P to have worsening hepatic metastatic disease with increasing soft tissue density with necrotic nodes in jejunal wall, presenting with abdominal pain. Was found to have malignant partial SBO on CT A/P. Was evaluated by colorectal surgery however surgical intervention was deferred and patient was instead started on palliaitve FOLFOX C1D1 ___. Patient tolerated 48 hours of FOLFOX well, was also tolerating a regular diet and having bowel movements prior to discharge. Of note, with history of R gastroc DVT, was non-adherent to Eliquis prior to admission, was briefly on a heparin drip and transitioned to lovenox, however decision was made to continue with Eliquis BID to promote adherence on discharge. #Stage IV metastatic sigmoid adenocarcinoma #Malignant SBO - History of stage IV metastatic sigmoid adenocarcinoma s/p lower abdominal resection, mets to splenic bed s/p splenectomy, gastric wedge re-section, with metastatic disease to liver, found on recent CT A/P to have worsening hepatic metastatic disease with increasing soft tissue density with necrotic nodes in jejunal wall, presenting with abdominal pain. Was found on CT A/P to have partial malignant SBO at the level of a jejunal mass. Also with additional sites of subtle stricture possibly reflecting presence of additional small bowel metastatic lesions. Imaging showing hepatic capsular implant appearing slightly increased in size, also with new mild right hydroureternephrosis likely due to partial malignant obstruction. Was evaluated by colorectal surgery, surgical intervention was deferred. Patient was instead started on palliaitve FOLFOX C1D1 ___. Was also tolerating a regular diet and having bowel movements prior to discharge. Received dexamethasone during hospitalization to help relieve SBO, was discharged with planned dexamethasone taper 2mg ___, followed by 1mg on ___ without plan for ongoing maintenance dosing, however future steroid plan to be determined by primary oncologist. Arranged for follow-up on ___. Plan per primary oncologist for additional IVF on ___ and ___ given at risk for dehydration. #Deep Venous Thrombosis - History of DVT R gastroc (___), for which he was previously prescribed eliquis 5 BID. The patient had been non-adherent for months to current admission. Given initially considering surgical intervention, he was briefly placed on a heparin drip, however after surgical intervention was deferred he was transitioned to lovenox. Given ongoing issues with adherence and tolerating POs, decision was made to re-start eliquis 5mg BID in order to better promote adherence. #Mild Right Hydroureteronephrosis - Mild right hydroureteronephrosis noted on ___ CT A/P which was not seen in previous CT A/P ___, secondary to metastatic partial obstruction. Renal function was normal during hospitalization, as without CVA tenderness. #Bradycardia - EKG showing stable sinus bradycardia ___, which is chronic with no higher grade block on repeat EKG. #Dental Infection - Recent dental infection per OMR review, was referred to ___. Per patient had a root canal performed, no evidence of current infection on exam or tooth pain. TRANSITIONAL ISSUES ======================= [ ] NEW/CHANGED MEDICATIONS - Started dexamethasone taper 2mg ___, followed by 1mg ___ with no maintenance dosing. Future steroids ASDIR per primary oncologist for ___ - Re-started eliquis 5mg BID for right gastroc DVT - Discharged with Zofran, bisacodyl, senna, Colace PRN [ ] Palliative FOLFOX C1D1 ___ with day 15 ___ [ ] Consider additional dexamethasone PRN ASDIR by primary oncologist for ___ [ ] IVF on ___ and ___ given at risk for dehydration at primary oncology follow-up [ ] With new mild Right Hydroureteronephrosis secondary to partial malignant obstruction [ ] Continue to assess medication adherence to eliquis #CODE STATUS: Full Code Medications on Admission: none Discharge Medications: 1. Apixaban 5 mg PO BID RX *apixaban [Eliquis] 5 mg 1 tablet(s) by mouth twice a day Disp #*30 Tablet Refills:*0 2. Bisacodyl 10 mg PO DAILY:PRN Constipation - First Line Reason for PRN duplicate override: Alternating agents for similar severity RX *bisacodyl [Laxative (bisacodyl)] 5 mg 2 tablet(s) by mouth Daily:PRN Disp #*30 Tablet Refills:*0 3. Dexamethasone 1 mg PO DAILY Take 2mg ___ and 1 mg ___ and then stop taking Tapered dose - DOWN RX *dexamethasone 1 mg 1 tablet(s) by mouth ASDIR Disp #*30 Tablet Refills:*0 4. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line RX *docusate sodium 100 mg 1 tablet(s) by mouth BID:PRN Disp #*30 Tablet Refills:*0 5. Ondansetron 4 mg PO Q8H:PRN nausea RX *ondansetron 4 mg 1 tablet(s) by mouth Q8H:PRN Disp #*15 Tablet Refills:*0 6. Senna 8.6 mg PO BID:PRN Constipation - First Line Reason for PRN duplicate override: Alternating agents for similar severity RX *sennosides [senna] 8.6 mg 1 by mouth BID:PRN Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary Diagnoses ================== #Malignant Small Bowel Obstruction #Mild Right Hydroureteronephrosis Chronic Diagnoses ================== #Adenocarcinoma of the sigmoid colon #Deep Venous Thrombosis #Bradycardia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at ___ ___. WHY WAS I IN THE HOSPITAL? - You came into the hospital because of worsening abdominal pain WHAT HAPPENED TO ME IN THE HOSPITAL? - You were found on your CT of the abdomen to have an obstruction or constriction of the bowel because of your cancer - We started you on chemotherapy to help relieve the obstruction in your bowel - We helped control your pain - You were also given a blood thinner for the blood clot in your leg WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medications as prescribed and keep your follow-up appointments as listed below We wish you the best! Sincerely, Your ___ Care Team Followup Instructions: ___
10381484-DS-18
10,381,484
24,324,627
DS
18
2175-11-21 00:00:00
2175-11-23 13:13:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: pollen Attending: ___. Chief Complaint: R arm pain subjective fevers Major Surgical or Invasive Procedure: None History of Present Illness: ___ is a ___ yo ___ speaking man with stage IV sigmoid adenocarcinoma s/p LAR (___), progression of disease to spleen s/p splenectomy/distal pancreatectomy/wedge gastrectomy (___), on palliative FOLFOX, ___ DVT ___ on Xarelto, who presented with right arm pain and subjective fevers/chills x 3 days. Mr. ___ was hospitalized ___ for malignant partial SBO in s/o progression of his metastatic colon cancer. During that admission, Mr. ___ reported poor compliance to apixaban, which was stated on ___ for RLE DVT. He was briefly on heparin gtt before being discharged back on apixaban. He was then seen in follow up with ___ on ___ for C1D15 FOLFOX. He reported apixaban made him feel unwell with poor appetite. He switched to rivaroxaban, in the hope that daily dosing would improve compliance, and advised that symptoms were likely ___ malignancy rather than anticoagulation. On interview, Mr. ___ reports that the pharmacy did not receive the script for rivaroxaban, so he has not been on AC for at least 2 weeks. He did not continue taking apixaban, believing it to be contributing to his abdominal discomfort and poor appetite. Subjectively, Mr. ___ reports he noted right arm/axilla pain ___ days ___ to presentation. The pain is ___ ___ut feels as if someone is cutting him from inside with any movement. Around this time, he also noted that the underside of his right upper arm was "hot" and swollen. He had subjective fevers on and off for a week which caused sweats and chills. He reports he noted some right shoulder pain when taking in a deep breath 1 week ago, but did not have any pleuritic pain since then. Pertinent negatives: No chest pain, no shortness of breath, cough/hemoptysis. No nausea, diarrhea, dysuria, cold symptoms. no sick contacts. no tooth pain. In the ED: Tmax 100.7 F | 76 | 122/78 | 100% RA. A CT Chest demonstrated "dilated right axillary vein, with adjacent fat stranding, possibly reflecting a deep venous thrombosis. Recommend upper extremity ultrasound for further evaluation". There was no evidence of acute disease within the chest. A RUE U/S was performed and has not yet been interpreted. He received IV dilaudid, vanc/zosyn, and heparin gtt ___ to admission All other review of systems are negative unless stated otherwise Past Medical History: PAST ONCOLOGIC HISTORY: PAST ONCOLOGIC HISTORY: Reconciled in OMR. Colon cancer stage IIIC (T3N2M0) of the sigmoid colon with progressive metastatic disease - ___ Colonscopy for weight loss of 26 lbs in a year revealed a fungating, circumferential mass of malignant appearancae was found in the sigmoid colon at 18cm. Biopsy consistent with adenocarcinoma. CT torso revealed 3.7 cm segment of the mid sigmoid colon demonstrating circumferential wall thickening in keeping with tumor. There is no associated bowel obstruction at present time. Adjacent mesenteric lymph nodes measuring up to 6 mm in short axis dimension are noted. No evidence of metastatic disease within the chest, abdomen, or pelvis. - ___ MR pelvis revealed Ill-defined sigmoid mass, approximately 15 cm above the anal verge, as seen on the CT examination from ___, with extension across the muscularis propria. This is suspicious for T3 disease. 1.6 x 1.5 cm mass abutting the anterior aspect of the rectum and posterior aspect of the seminal vesicles, 7 cm above the anal verge, is suspicious for a drop metastasis as it is not convincingly arising from rectal wall. This likely corresponds to the palpable finding on physical exam. Intrapelvic lymphadenopathy adjacent to the sigmoid mass, some with morphology suspicious for tumor involvement. - ___ Undderwent LAR. Path revealed colonic adenocarcinoma in the resected rectosigmoid colon. Tumor size was 3.6cm, low grade, staged pT3. Margins were negative. Of the 15 nodes examined, 6 were positive, thus staged pN2a. Finally, a separate nodule of adenocarcinoma was identified 9 cm distal to the primary tumor involving pericolonic adipose tissue, serosa, and muscularis propria, consistent with metastasis of the primary tumor. Furthermore, the resected peritoneal nodule showed metastatic adenocarcinoma with perineural invasion. Thus, this was staged pM1b. Of note, KRAS mutation was detected. - ___ to ___ admitted for abdominal pain, OSH CT was reviewed here and felt to be not concerning for any acute intra-abdominal process including leak or abcess however there was a high stool burden and gas. Pt discharged on bowel regimen. - ___ ED visit for abdominal pain, KUB reassuring, discharged after bowel regimen - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ to ___ Admission for n/v and abd pain. CT showed mildly dilated stomach and proximal small bowel, but no evidence of obstruction. He underwent NGT decompression with good bilious output and improvement in symptoms and was slowly advanced to regular diet. - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ to ___ admission for abd pain and constipation. CT showed multiple mildly distended loops of ileum with fecalized contents and a narrow caliber of the terminal ileum. Stool and air seen in the colon. Symptoms improved with aggressive bowel regimen. - ___ C3D1 XELOX (Xeloda 1500mg BID) - ___ C4D1 XELOX (Xeloda 1500mg BID) - ___ C5D1 XELOX (Xeloda 2000mg BID) - ___ C6D1 XELOX (Xeloda 2000mg BID) - ___ C7D1 XELOX (Xeloda 2000mg BID) - ___ CT torso with no evidence of recurrence or metastases - ___ colonoscopy showed multiple tiny 2 mm polypoid lesions which showed to be lymphoid aggregates on path - ___ CT torso with no evidence of recurrence or metastases - ___ CT abdomen in the ED for abdominal pain showed ___ - ___ CT abdomen in the ED for abdominal pain showed ___ but indeterminate liver lesion - ___ CT torso ___ with stable liver lesion - ___ Colonoscopy revealed a single polyp, pathology consistent with adenoma. - ___ CT torso showed a new lesion in the splenic hilum concerning for recurrence - ___ PET CT showed avid lesion in the spleen, no other sites of disease - ___ Splenectomy revealed metastatic colon cancer - ___ CT torso showed ___ - ___ CT torso extensive recurrence in the spenic bed and nodes, CEA rising - ___ Biopsy of the splenic bed confirmed metastatic adenocarcinoma - ___ CT torso showed increase in metastatic disease - ___ CT torso showed increase in metastatic and concerning new areas in the liver PAST MEDICAL HISTORY: Colon Ca as above Lipoma DVT Social History: ___ Family History: Negative for colon cancer, inflammatory bowel disease, uterine cancer. He does have history of lipomas in his family. Physical Exam: ADMISSION PHYSICAL EXAM: ================================ VITALS: T 99.2, 112/66, 65, 98% RA General: Well appearing young Hispanic man, resting in bed comfortably Neuro: Cranial nerves: PERRL, EOMI, palate elevates symmetrically, facial sensation intact bilaterally Alert and oriented, provides clear and cogent history HEENT: Oropharynx clear, moist mucus membranes, no sinus tenderness, no swelling/erythema in gingiva Cardiovascular: RRR no murmurs Chest/Pulmonary: Clear to auscultation bilaterally Abdomen: Well healed surgical scars. Mildly tender to palpation in the LLQ, chronic per patient. No rebound or guarding Extr/MSK: Underside of right upper arm is pink and slightly swollen. Mildly tender to palpation. Erythema outlined with pen; about 15 cm extending from axilla down the arm No swelling of LUE No ___ edema, calf tenderness Skin: + Tattoos over legs. Erythema of RUE as above. No rashes seen elsewhere Access: R POC, nontender to palpation, c/d/I DISCHARGE PHYSICAL EXAM: ========================= vitals T 97.9 PO BP 108 / 65 HR 60 RR 15 98 RA General: Well appearing young Hispanic man, resting in bed comfortably HEENT: Oropharynx clear, moist mucus membranes, no lymphadenopathy Cardiovascular: RRR no murmurs Chest/Pulmonary: Clear to auscultation bilaterally Abdomen: Well healed surgical scars. Mildly tender to palpation in the LLQ, chronic per patient. No rebound or guarding Extr/MSK: Underside of right upper arm less erythematous than yesterday, with no appreciable swelling. Mildly tender to deep palpation. No swelling of LUE No ___ edema, calf tenderness Skin: + Tattoos over legs. Erythema of RUE as above. No rashes seen elsewhere Neuro: CN ___ grossly intact; no focal neuro deficits; AAOx4 Pertinent Results: ADMISSION LABS: =================== ___ 02:19AM BLOOD WBC-10.6* RBC-4.14* Hgb-12.4* Hct-37.2* MCV-90 MCH-30.0 MCHC-33.3 RDW-12.8 RDWSD-41.6 Plt ___ ___ 02:19AM BLOOD Neuts-58.5 ___ Monos-15.4* Eos-1.9 Baso-0.5 NRBC-0.3* Im ___ AbsNeut-6.18* AbsLymp-2.46 AbsMono-1.62* AbsEos-0.20 AbsBaso-0.05 ___ 02:19AM BLOOD Glucose-123* UreaN-14 Creat-1.0 Na-136 K-4.3 Cl-96 HCO3-28 AnGap-12 ___ 02:19AM BLOOD Calcium-8.9 Phos-3.4 Mg-2.3 RUE ULTRASOUND: ================= IMPRESSION: Occlusive thrombosis of the axillary vein and proximal portion of one of the paired brachial veins in the right upper extremity. Non-occlusive thrombus around the catheter in the right subclavian vein. CT CHEST ============== IMPRESSION: 1. Dilated right axillary vein, with adjacent fat stranding, possibly reflecting a deep venous thrombosis. Recommend upper extremity ultrasound for further evaluation. 2. Otherwise, no acute intrathoracic abnormality. 3. Stable prominent anterior paracardiac nodes. 4. Redemonstration of an ill-defined mass within the left upper quadrant and a hepatic dome lesion, slightly increased in size, both concerning for malignancy. DISCHARGE LABS: ================= ___ 05:10AM BLOOD WBC-7.2 RBC-3.97* Hgb-11.7* Hct-35.9* MCV-90 MCH-29.5 MCHC-32.6 RDW-13.1 RDWSD-43.2 Plt ___ ___ 05:10AM BLOOD Plt ___ ___ 04:06AM BLOOD Neuts-40.5 ___ Monos-16.5* Eos-3.8 Baso-0.6 NRBC-0.4* Im ___ AbsNeut-3.27 AbsLymp-3.10 AbsMono-1.33* AbsEos-0.31 AbsBaso-0.05 ___ 05:10AM BLOOD Glucose-108* UreaN-12 Creat-0.9 Na-141 K-4.5 Cl-102 HC___ AnGap-12 Brief Hospital Course: TRANSITIONAL ISSUES: ========================= [ ] started on rivaroxiban for AC - will take 15 BID for 20 days and then decrease to 20mg daily. [ ] There is a ___ authorization pending for the rivaroxaban starter pack that will likely be approved early ___. His ___ clinic will ensure the PA is approved and contact the family. SUMMARY: ================ ___ yo ___ speaking man with stage IV sigmoid adenocarcinoma on palliative FOLFOX, DVT ___ not adherent to AC due to issues with filling prescription, who presented with right arm pain and subjective fevers/chills x 3 days and was found to have likely RUE DVT. ACUTE ISSUES: =========================== # RUE DVT, new encounter # RLE DVT, ___. Difficulty with apixaban adherence previously and recently switched to rivaroxaban, but did not receive medication yet so has been off AC for at least 2 weeks ___ to admission. CT Chest w/ contrast showing likely RUE DVT. Has R POC, so likely in s/o catheter and malignancy w/ noncompliance of AC. He had some right shoulder pain associated w/ deep breathing 1 week ago, raising question of PE. Reviewed images with radiology overnight; there was no evidence of central PE and likely no segmental PE. Subsegments not very well visualized ___ motion artifact and fact that this was not CTA. RUE ultrasound ___ positive for occlusive thrombus involving R axillary vein and brachial vein. Treated with heparin gtt and then restarted on Rivaroxaban ___. Because rivaroxaban had not been approved by his insurance at the time of discharge, he was given 1.5mg/kg of lovenox on ___ in the evening to bridge him for 24 hours. His primary oncologist's office planned to follow-up on the ___ authorization and contact the family once it was approved tomorrow. If not approved, the plan would be to come to ___ clinic for lovenox again. The sister of the patient ensured she would be able to fill the scrip tomorrow and we carefully reviewed the importance of not missing a dose. # Leukocytosis, Resolving(At baseline. Without neutrophilic predominance or left shift) # 3 days fever/chills # Right arm swelling/erythema Received vanc/zosyn in ED. Has erythema, swelling, tenderness of RUE; Otherwise ROS unrevealing for other source of infxn. Has mild leukocytosis at baseline and white count has normalized today, with patient afebrile and asymptomatic. LFTs within normal limits. Antibiotics were discontinued and he remained afebrile. #Stage IV sigmoid adenocarcinoma on palliative FOLFOX ___. next due for C2D1 on ___ oxali ___ ___: s/p LAR ___, 7 cycles of XELOX, with subsequent metastasis to spenic bed s/p lap splenectomy, and gastric wedge resection (___), with metastatic disease to the liver, recent admit ___ for malignant partial SBO improved with conservative mgmt. and initiation of palliative FOLFOX. #Cancer-associated pain - Continued hydromorphone 2 mg ___ tabs q4 PRN - BM regimen PRN ordered (not requiring at home) - T/b with oncologist regarding continuing FOLFOX C2D1 #Insomnia Started mirtazapine ___ continue Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Ondansetron 8 mg PO Q8H:PRN nausea 2. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate 3. Mirtazapine 15 mg PO QHS 4. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 5. Rivaroxaban 20 mg PO DAILY Discharge Medications: 1. Rivaroxaban 15 mg PO BID with food RX *rivaroxaban [___] 15 mg (42)- 20 mg (9) 1 tablets(s) by mouth see below Disp #*1 Dose Pack Refills:*0 2. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate 3. Mirtazapine 15 mg PO QHS 4. Ondansetron 8 mg PO Q8H:PRN nausea 5. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line Discharge Disposition: Home Discharge Diagnosis: Primary: ------------- Deep Venous Thrombosis of the RUE Leukocytosis Stage IV sigmoid adenocarcinoma on palliative FOLFOX Secondary: -------------- Insomnia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at ___ ___. WHY WAS I IN THE HOSPITAL? - You had pain in your right arm and it was discovered you had a blood clot. - You had fevers and chills. WHAT HAPPENED TO ME IN THE HOSPITAL? - You were given medications to prevent further blood clotting. - Your fever and chills were determined to be due to your blood clot and cancer, and not due to an infection. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. - It is very important that you take your medication called Rivaroxaban, as it will prevent you from getting more blood clots in the future. We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
10381484-DS-19
10,381,484
20,384,105
DS
19
2175-12-23 00:00:00
2175-12-23 15:28:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: pollen Attending: ___. Chief Complaint: abdominal pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ is a ___ yo ___ speaking man with stage IV sigmoid adenocarcinoma s/p LAR (___), progression of disease to spleen s/p splenectomy/distal pancreatectomy/wedge ___, on palliative FOLFOX (last chemo on ___, prior DVT ___ on ___ who presented with gradual onset of abdominal pain and emesis with imaging concerning for a partial bowel obstruction. In the ED, he reported 3 episodes of food filled emesis and subjective fevers and chills. He has not had bowel movements since the pain. Exam was notable for periumbilical and epigastric tenderness with guarding and positive rebound. CRS was consulted who felt this was not an acute surgical issue. Pain improved with 0.5 of IV Dilaudid x 2. On arrival to the floor, he is able to say that he feels great. His friend helps to translate for him. He denies any abdominal pain or nausea. He states that he had a bowel movement earlier in the night after he received the pain medication. He states that he would like to go home. I encouraged him to trial clears and then try eating in the morning. He agreed with this plan. REVIEW OF SYSTEMS: A complete 10-point review of systems was performed and was negative unless otherwise noted in the HPI. Past Medical History: Colon cancer stage IIIC (T3N2M0) of the sigmoid colon with progressive metastatic disease - ___ Colonscopy for weight loss of 26 lbs in a year revealed a fungating, circumferential mass of malignant appearance was found in the sigmoid colon at 18cm. Biopsy consistent with adenocarcinoma. CT torso revealed 3.7 cm segment of the mid sigmoid colon demonstrating circumferential wall thickening in keeping with tumor. There is no associated bowel obstruction at present time. Adjacent mesenteric lymph nodes measuring up to 6 mm in short axis dimension are noted. No evidence of metastatic disease within the chest, abdomen, or pelvis. - ___ MR pelvis revealed Ill-defined sigmoid mass, approximately 15 cm above the anal verge, as seen on the CT examination from ___, with extension across the muscularis propria. This is suspicious for T3 disease. 1.6 x 1.5 cm mass abutting the anterior aspect of the rectum and posterior aspect of the seminal vesicles, 7 cm above the anal verge, is suspicious for a drop metastasis as it is not convincingly arising from rectal wall. This likely corresponds to the palpable finding on physical exam. Intrapelvic lymphadenopathy adjacent to the sigmoid mass, some with morphology suspicious for tumor involvement. - ___ Undderwent LAR. Path revealed colonic adenocarcinoma in the resected rectosigmoid colon. Tumor size was 3.6cm, low grade, staged pT3. Margins were negative. Of the 15 nodes examined, 6 were positive, thus staged pN2a. Finally, a separate nodule of adenocarcinoma was identified 9 cm distal to the primary tumor involving pericolonic adipose tissue, serosa, and muscularis propria, consistent with metastasis of the primary tumor. Furthermore, the resected peritoneal nodule showed metastatic adenocarcinoma with perineural invasion. Thus, this was staged pM1b. Of note, KRAS mutation was detected. - ___ to ___ admitted for abdominal pain, OSH CT was reviewed here and felt to be not concerning for any acute intra-abdominal process including leak or abcess however there was a high stool burden and gas. Pt discharged on bowel regimen. - ___ ED visit for abdominal pain, KUB reassuring, discharged after bowel regimen - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ to ___ Admission for n/v and abd pain. CT showed mildly dilated stomach and proximal small bowel, but no evidence of obstruction. He underwent NGT decompression with good bilious output and improvement in symptoms and was slowly advanced to regular diet. - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ to ___ admission for abd pain and constipation. CT showed multiple mildly distended loops of ileum with fecalized contents and a narrow caliber of the terminal ileum. Stool and air seen in the colon. Symptoms improved with aggressive bowel regimen. - ___ C3D1 XELOX (Xeloda 1500mg BID) - ___ C4D1 XELOX (Xeloda 1500mg BID) - ___ C5D1 XELOX (Xeloda 2000mg BID) - ___ C6D1 XELOX (Xeloda 2000mg BID) - ___ C7D1 XELOX (Xeloda 2000mg BID) - ___ CT torso with no evidence of recurrence or metastases - ___ colonoscopy showed multiple tiny 2 mm polypoid lesions which showed to be lymphoid aggregates on path - ___ CT torso with no evidence of recurrence or metastases - ___ CT abdomen in the ED for abdominal pain showed ___ - ___ CT abdomen in the ED for abdominal pain showed ___ but indeterminate liver lesion - ___ CT torso ___ with stable liver lesion - ___ Colonoscopy revealed a single polyp, pathology consistent with adenoma. - ___ CT torso showed a new lesion in the splenic hilum concerning for recurrence - ___ PET CT showed avid lesion in the spleen, no other sites of disease - ___ Splenectomy revealed metastatic colon cancer - ___ CT torso showed ___ - ___ CT torso extensive recurrence in the spenic bed and nodes, CEA rising - ___ Biopsy of the splenic bed confirmed metastatic adenocarcinoma - ___ CT torso showed increase in metastatic disease - ___ CT torso showed increase in metastatic and concerning new areas in the liver - ___ Admitted with malignant SBO - ___ C1D1 FOLFOX6 - ___ ___ FOLFOX (oxaliplatin at 65 ___ neuropathy) - ___ C2D1 FOLFOX (oxaliplatin at 65 ___ neuropathy PAST MEDICAL HISTORY: Colon Ca as above Lipoma DVT Social History: ___ Family History: Negative for colon cancer, inflammatory bowel disease, uterine cancer. He does have history of lipomas in his family. Physical Exam: ADMISSION PHYSICAL EXAM: ============================= Vitals: T: 98.4 PO BP:119/66 L Lying HR: 94 RR: 18 Sp02: 96 RA GENERAL: Lying in bed appearing comfortable. LUNGS: On RA, no increased work of breathing, no wheezes, rales or ronchi. HEART: RRR no m/r/g ABD: Soft, non-tender, non-distended, + BS (but minimal) EXT: No edema. DISCHARGE PHYSICAL EXAM: ============================= VITALS: ___ 0852 Temp: 98.7 PO BP: 124/69 HR: 60 RR: 16 O2 sat: 100% O2 delivery: RA Dyspnea: 0 RASS: 0 Pain Score: ___ GENERAL: Alert and in no apparent distress EYES: Anicteric, no conjunctival injection, pupils equally round CV: Heart regular, no murmur, no S3, no S4. RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: Abdomen soft, non-tender in all quadrants, non-distended. No rebound or guarding. EXT: Warm and well perfused. No ___ edema. NEURO: Alert, oriented, face symmetric, gaze conjugate with EOM, speech fluent, moves all limbs PSYCH: pleasant, appropriate mood and affect Pertinent Results: ADMISSION LABS: ======================== ___ 09:20AM BLOOD WBC-9.5 RBC-3.75* Hgb-11.2* Hct-34.7* MCV-93 MCH-29.9 MCHC-32.3 RDW-16.7* RDWSD-54.6* Plt ___ ___ 09:20AM BLOOD Neuts-86.1* Lymphs-8.0* Monos-4.8* Eos-0.4* Baso-0.4 NRBC-0.8* Im ___ AbsNeut-8.16* AbsLymp-0.76* AbsMono-0.46 AbsEos-0.04 AbsBaso-0.04 ___ 09:20AM BLOOD Glucose-142* UreaN-11 Creat-0.7 Na-141 K-4.2 Cl-102 HCO3-25 AnGap-14 ___ 10:30AM BLOOD ALT-13 AST-15 AlkPhos-65 TotBili-0.2 ___ 10:30AM BLOOD Lipase-24 ___ 10:30AM BLOOD Albumin-4.0 ___ 10:37AM BLOOD Lactate-1.1 DISCHARGE LABS: ======================== ___ 05:52AM BLOOD WBC-6.8 RBC-3.73* Hgb-11.1* Hct-34.1* MCV-91 MCH-29.8 MCHC-32.6 RDW-16.5* RDWSD-54.6* Plt ___ ___ 05:52AM BLOOD Neuts-45.6 ___ Monos-14.8* Eos-2.8 Baso-0.6 NRBC-1.0* Im ___ AbsNeut-3.11 AbsLymp-2.44 AbsMono-1.01* AbsEos-0.19 AbsBaso-0.04 ___ 05:52AM BLOOD ___ PTT-30.6 ___ ___ 05:52AM BLOOD Glucose-106* UreaN-9 Creat-0.9 Na-142 K-3.9 Cl-103 HCO3-28 AnGap-11 ___ 05:52AM BLOOD ALT-11 AST-13 LD(LDH)-206 AlkPhos-60 TotBili-0.4 ___ 05:52AM BLOOD Albumin-3.8 Calcium-9.2 Phos-4.3 Mg-2.1 PERTINENT STUDIES: ======================== CT ABD/PELVIS W/ CONTRAST ___ IMPRESSION: 1. Dilated loops of small bowel in the mid abdomen, likely jejunal loops, with transition point at the unchanged 3.6 x 2.4 x 2.5 cm soft tissue mass, which appears contiguous with the wall of the jejunum, consistent with partial/early small-bowel obstruction. 2. Unchanged moderate right hydronephrosis due to patient's 3 focal peritoneal soft tissue lesions in the right lower quadrant, which are unchanged compared to prior. 3. Trace perihepatic ascites. 4. Additional, unchanged, chronic findings, as above. Brief Hospital Course: ___ is a ___ yo ___ speaking man with stage IV sigmoid adenocarcinoma s/p LAR (___), progression of disease to spleen s/p splenectomy/distal pancreatectomy/wedge ___, on palliative FOLFOX (last chemo on ___, prior DVT ___ on ___ who presented with gradual onset of abdominal pain and emesis with imaging concerning for a partial bowel obstruction, his symptoms subsequently resolved and he was able to tolerate food well. Active Issues: #Partial SBO: He had abdominal pain and vomiting with imaging concerning for partial SBO. His symptoms completely resolved and he had a bowel movement in the emergency room before coming to the floor. He continued to have flatus on the floor without a second bowel movement. His diet was advanced from clears to regular diet and he was able to tolerate food without any issues. Colorectal surgery evaluated him and signed off prior to his discharge. I expressed the preference to monitor him until he had another bowel movement but he preferred to be discharged home. He was counseled on the risk of recurrent obstruction and warning signs that should prompt return to the hospital. This was done with the assistance of a ___ interpreter. The patient stated he had someone who could translate discharge instructions written in ___. Chronic Issues: #Stage IV sigmoid adenocarcinoma on palliative FOLFOX Prior: s/p LAR ___, 7 cycles of XELOX, with subsequent metastasis to spenic bed s/p lap splenectomy, and gastric wedge resection (___), with metastatic disease to the liver, recent admit ___ for malignant partial SBO improved with conservative mgmt and initiation of palliative FOLFOX. He has a f/u with oncology on ___. #Cancer-associated pain: Continued hydromorphone 2 mg ___ tabs q4 PRN with bowel regimen. #Insomnia: Continue home mirtazapine. Transitional Issues: [ ] Will need to ensure he takes senna when he takes his Dilaudid. This patient was prescribed, or continued on, an opioid pain medication at the time of discharge (please see the attached medication list for details). As part of our safe opioid prescribing process, all patients are provided with an opioid risks and treatment resource education sheet and encouraged to discuss this therapy with their outpatient providers to determine if opioid pain medication is still indicated. The patient was seen and examined today. Greater than 30 minutes were spent on discharge planning and coordination. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate 2. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 3. Ondansetron 8 mg PO Q8H:PRN nausea 4. Mirtazapine 15 mg PO QHS 5. Rivaroxaban 20 mg PO DAILY Discharge Medications: 1. Senna 8.6 mg PO BID:PRN Constipation - First Line RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp #*60 Tablet Refills:*0 2. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate 3. Mirtazapine 15 mg PO QHS 4. Ondansetron 8 mg PO Q8H:PRN nausea 5. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 6. Rivaroxaban 20 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Partial Small Bowel Obstruction Abdominal Pain Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were brought to the hospital because you had significant abdominal pain and we found that you had a partial bowel obstruction. While you were here, your symptoms resolved and you started to feel much better. We gave you some food which you were able to eat without issue. You had a bowel movement and passed some gas. We preferred to continue to observe you until you had another bowel movement but you expressed a strong desire to return home. If you have any worsening abdominal pain, swelling, or other symptoms you should return to the hospital. We encourage you to make sure that take Senna whenever you take your pain pills to make sure you don't get constipated. It was a pleasure taking care of you, -Your ___ Team Followup Instructions: ___
10381484-DS-21
10,381,484
25,100,289
DS
21
2176-02-17 00:00:00
2176-02-17 23:58:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: pollen Attending: ___. Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: none History of Present Illness: Mr. ___ is a pleasant ___ with stage IV sigmoid adenocarcinoma s/p LAR (___) with subsequent POD involving spleen now s/p splenectomy/distal pancreatectomy/wedge gastrectomy (___) currently on palliative C1D25 Irinotecan and DVT on rivaroxaban who p/w diffuse abdominal pain, concern for malignant bowel obstruction. Sx started yesterday w/ diffuse abd pain, + nausea, no vomiting, + diarrhea at 2 am. Of note, recently admitted ___ for abdominal pain thought to be related to neoplasm but no acute pathology otherwise seen on CT. Discharged on dilaudid and apap. He subsequently represented to the ED with abdominal pain ___ and CT showed persistent R hydronephrosis iso malignant obstruction, 3 pelvic soft tissue masses (mild interval increase in size), and large mass in the splenectomy bed (no interval change). No SBO on this CAT scan. He presents this time to ED with diffuse abdominal pain, diarrhea, and nausea. Patient was afebrile and mildly hypertensive upon arrival. Labs were all largely unremarkable. Repeat CT A/P shows concern for SBO ___ omental implant in the L mid abdomen, additionally thickening of the bowel wall in the L mid abdomen concern for an additional submucosal metastatic lesion. Patient was administered dilaudid and IVF. He refused placement of an NGT in the ED. Colorectal was consulted, no acute indication for surgical intervention. Of note, patient last took xeralto at 12AM ___. Patient was admitted for IVF, bowel rest, serial abdominal exams. On arrival to the oncology service, pt noted he had zero abd pain and zero nausea. Admits to passing gas, no stool yet, and feeling "very hungry." Past Medical History: PAST ONCOLOGIC HISTORY (per OMR): As per last ___ clinic note by Dr ___: "Colon cancer stage IIIC (T3N2M0) of the sigmoid colon with progressive metastatic disease, KRAS mutated, MSI intact - ___ Colonscopy for weight loss of 26 lbs in a year revealed a fungating, circumferential mass of malignant appearance was found in the sigmoid colon at 18cm. Biopsy consistent with adenocarcinoma. CT torso revealed 3.7 cm segment of the mid sigmoid colon demonstrating circumferential wall thickening in keeping with tumor. There is no associated bowel obstruction at present time. Adjacent mesenteric lymph nodes measuring up to 6 mm in short axis dimension are noted. No evidence of metastatic disease within the chest, abdomen, or pelvis. - ___ MR pelvis revealed Ill-defined sigmoid mass, approximately 15 cm above the anal verge, as seen on the CT examination from ___, with extension across the muscularis propria. This is suspicious for T3 disease. 1.6 x 1.5 cm mass abutting the anterior aspect of the rectum and posterior aspect of the seminal vesicles, 7 cm above the anal verge, is suspicious for a drop metastasis as it is not convincingly arising from rectal wall. This likely corresponds to the palpable finding on physical exam. Intrapelvic lymphadenopathy adjacent to the sigmoid mass, some with morphology suspicious for tumor involvement. - ___ Undderwent LAR. Path revealed colonic adenocarcinoma in the resected rectosigmoid colon. Tumor size was 3.6cm, low grade, staged pT3. Margins were negative. Of the 15 nodes examined, 6 were positive, thus staged pN2a. Finally, a separate nodule of adenocarcinoma was identified 9 cm distal to the primary tumor involving pericolonic adipose tissue, serosa, and muscularis propria, consistent with metastasis of the primary tumor. Furthermore, the resected peritoneal nodule showed metastatic adenocarcinoma with perineural invasion. Thus, this was staged pM1b. Of note, KRAS mutation was detected. - ___ to ___ admitted for abdominal pain, OSH CT was reviewed here and felt to be not concerning for any acute intra-abdominal process including leak or abcess however there was a high stool burden and gas. Pt discharged on bowel regimen. - ___ ED visit for abdominal pain, KUB reassuring, discharged after bowel regimen - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ to ___ Admission for n/v and abd pain. CT showed mildly dilated stomach and proximal small bowel, but no evidence of obstruction. He underwent NGT decompression with good bilious output and improvement in symptoms and was slowly advanced to regular diet. - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ to ___ admission for abd pain and constipation. CT showed multiple mildly distended loops of ileum with fecalized contents and a narrow caliber of the terminal ileum. Stool and air seen in the colon. Symptoms improved with aggressive bowel regimen. - ___ C3D1 XELOX (Xeloda 1500mg BID) - ___ C4D1 XELOX (Xeloda 1500mg BID) - ___ C5D1 XELOX (Xeloda 2000mg BID) - ___ C6D1 XELOX (Xeloda 2000mg BID) - ___ C7D1 XELOX (Xeloda 2000mg BID) - ___ CT torso with no evidence of recurrence or metastases - ___ colonoscopy showed multiple tiny 2 mm polypoid lesions which showed to be lymphoid aggregates on path - ___ CT torso with no evidence of recurrence or metastases - ___ CT abdomen in the ED for abdominal pain showed ___ - ___ CT abdomen in the ED for abdominal pain showed ___ but indeterminate liver lesion - ___ CT torso ___ with stable liver lesion - ___ Colonoscopy revealed a single polyp, pathology consistent with adenoma. - ___ CT torso showed a new lesion in the splenic hilum concerning for recurrence - ___ PET CT showed avid lesion in the spleen, no other sites of disease - ___ Splenectomy revealed metastatic colon cancer - ___ CT torso showed ___ - ___ CT torso extensive recurrence in the spenic bed and nodes, CEA rising - ___ Biopsy of the splenic bed confirmed metastatic adenocarcinoma - ___ CT torso showed increase in metastatic disease - ___ CT torso showed increase in metastatic and concerning new areas in the liver - ___ Admitted with malignant SBO - ___ C1D1 FOLFOX6 - ___ C1D15 FOLFOX (oxaliplatin at 65 ___ neuropathy) - ___ C2D1 FOLFOX (oxaliplatin at 65 ___ neuropathy - ___ CT torso shows stable disease - ___ Treatment delayed per patient preference - ___ C3D1 FOLFOX (oxaliplatin at 65 ___ neuropathy) - ___ Patient requested to defer dose, CEA rising - ___ C1D1 ___ PAST MEDICAL HISTORY (per OMR): as above Social History: ___ Family History: Negative for colon cancer, inflammatory bowel disease, uterine cancer. He does have history of lipomas in his family. Physical Exam: ADMISSION PHYSICAL EXAM: ========================= VITAL SIGNS: 97.7 PO 134 / 81 54 18 99 RA General: NAD, Resting in bed comfortably HEENT: MMM, no OP lesions CV: RR, NL S1S2 no S3S4 No MRG PULM: CTAB, No C/W/R, No respiratory distress ABD: BS+, soft, NTND, no peritoneal signs LIMBS: WWP, no ___, no tremors SKIN: No notable rashes on trunk nor extremities NEURO: CN III-XII intact, strength b/l ___ intact PSYCH: Thought process logical, linear, future oriented ACCESS: R Chest port site intact w/o overlying erythema, accessed and dressing C/D/I DISCHARGE PHYSICAL EXAM: ========================== VITAL SIGNS: 24 HR Data (last updated ___ @ 850) Temp: 98.8 (Tm 98.8), BP: 132/81 (132-149/80-83), HR: 53 (53-55), RR: 18, O2 sat: 99% General: NAD, Resting in bed comfortably HEENT: MMM, no OP lesions CV: RR, NL S1S2 no S3S4 No MRG PULM: CTAB, No C/W/R, No respiratory distress ABD: BS+, soft, non distended, mildly tender to palpation in LLQ, no peritoneal signs LIMBS: WWP, no ___, no tremors SKIN: No notable rashes on trunk nor extremities NEURO: CN III-XII intact, strength b/l ___ intact PSYCH: Thought process logical, linear, future oriented ACCESS: R Chest port site intact w/o overlying erythema, accessed and dressing C/D/I Pertinent Results: ADMISSION LABS: =============== ___ 04:00AM BLOOD WBC-8.0 RBC-3.62* Hgb-10.9* Hct-33.2* MCV-92 MCH-30.1 MCHC-32.8 RDW-14.5 RDWSD-48.7* Plt ___ ___ 04:00AM BLOOD Neuts-54.1 ___ Monos-13.3* Eos-10.9* Baso-0.5 Im ___ AbsNeut-4.33 AbsLymp-1.65 AbsMono-1.06* AbsEos-0.87* AbsBaso-0.04 ___ 04:00AM BLOOD Plt ___ ___ 09:25PM BLOOD PTT-45.9* ___ 04:00AM BLOOD Glucose-108* UreaN-12 Creat-1.1 Na-140 K-3.8 Cl-103 HCO3-25 AnGap-12 ___ 04:00AM BLOOD ALT-18 AST-16 AlkPhos-67 TotBili-<0.2 ___ 04:00AM BLOOD Albumin-4.0 Calcium-9.2 Phos-3.6 DISCHARGE LABS: ================ ___ 05:30AM BLOOD WBC-6.4 RBC-3.49* Hgb-10.5* Hct-32.2* MCV-92 MCH-30.1 MCHC-32.6 RDW-14.5 RDWSD-48.6* Plt ___ ___ 05:30AM BLOOD Plt ___ ___ 11:30AM BLOOD PTT-115.4* ___ 05:30AM BLOOD Glucose-104* UreaN-6 Creat-1.0 Na-141 K-3.6 Cl-102 HCO3-29 AnGap-10 ___ 05:30AM BLOOD Calcium-8.5 Phos-4.4 Mg-1.8 IMAGING: ========= ___BD & PELVIS WITH CO IMPRESSION: 1. Findings concerning for small bowel obstruction secondary to a 3.2 cm omental implant in the left mid abdomen. No signs to suggest bowel ischemia. 2. Relatively hyperdense, asymmetric thickening of the bowel wall in the left mid abdomen (601:75, 2:48) likely represents an additional submucosal metastatic lesion. 3. Persistent moderate to severe right-sided hydroureteronephrosis with a delayed right nephrogram secondary to malignant obstruction of the right distal ureter, similar to prior. 4. Re-demonstration of the 3 previously noted omental implants in the abdomen/pelvis measuring up to 3.6 cm, similar to prior. 5. Re-demonstration of a large 7.1 cm mass in the splenectomy bed as well as a 2.2 cm omental implant fat in the liver dome. Brief Hospital Course: HOSPITAL COURSE: ===================== ___ with stage IV sigmoid adenocarcinoma s/p LAR (___) with subsequent POD involving spleen now s/p splenectomy/distal pancreatectomy/wedge gastrectomy (___) currently on palliative C1D25 Irinotecan and DVT on rivaroxaban who p/w diffuse abdominal pain, concerning for malignant small bowel obstruction. # Stage IV Sigmoid Adenocarcinoma s/p LAR ___ # S/p splenectomy/distal pancreatectomy/wedge gastrectomy (___) # Malignant SBO A CT scan performed on the day of admission showed a small bowel obstruction secondary to a 3.2 cm omental implant in the left mid abdomen and with no signs to suggest bowel ischemia. Pt noted his symptoms are continuing to improve since arriving to the ED. Upon discharge and during his hospital course, he did not have nausea or vomiting, and is passing gas. He did not pass any stool from the time of admission for discharge. His exam was not concerning for acute abdomen and was only notable for LLQ tenderness on palpation which started to resolve during his hospital course. After speaking to his oncologist (Dr. ___, it was determined that since he could tolerate clear liquids as well as yogurt, he could be discharged with close follow up. He will follow up with his appointment with Dr. ___ on ___. If he could not tolerate any PO intake, the plan was to start inpatient chemotherapy. Colorectal surgery was also consulted and agreed that surgery was not needed now if chemotherapy is an option. Please note that there have been some issues with compliance with chemotherapy in the past, there might be some process of denial. # hx DVT Due to his potential for surgical intervention, his rivaroxaban was held and he was started on a heparin gtt. After confirming that there was no need for surgery, he was restarted on his rivaroxaban. Greater than 30 min were spent in discharge coordination and care TRANSITIONAL ISSUES: ====================== [ ] Please ensure that Mr. ___ follows up with his outpatient oncologist on ___. [ ] Please ensure that Mr. ___ has a bowel movement. He has not had one during his stay in the hospital. He has been passing gas and his abdominal exam was unremarkable upon discharge. This was discussed with Dr. ___ agreed that if the patient could tolerate even soup, then it was reasonable to discharge and follow up with him next week. [ ] Please ensure that Mr. ___ can continue tolerating PO intake. ACCESS: PORT CODE STATUS: Full code, presumed #HCP/Contact: friend ___ ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate 2. Ondansetron 8 mg PO Q8H:PRN nausea 3. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 4. Rivaroxaban 20 mg PO DAILY 5. Senna 8.6 mg PO BID:PRN Constipation - First Line 6. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Second Line 7. Acetaminophen 650 mg PO Q8H 8. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line Discharge Medications: 1. Acetaminophen 650 mg PO Q8H 2. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 3. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate 4. Ondansetron 8 mg PO Q8H:PRN nausea 5. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Second Line 6. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 7. Rivaroxaban 20 mg PO DAILY 8. Senna 8.6 mg PO BID:PRN Constipation - First Line Discharge Disposition: Home Discharge Diagnosis: PRIMARY: ========= Malignant small bowel obstruction SECONDARY: =========== Stage IV adenocarcinoma History of DVTs Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a privilege caring for you at ___ ___. WHY WAS I IN THE HOSPITAL? - You came to the hospital because of abdominal pain. WHAT HAPPENED TO ME IN THE HOSPITAL? - We performed imaging that showed that intestines were being compressed from your cancer, causing obstruction. - We gave you pain medication, and allow your intestines to rest. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. - Please ensure that you follow-up with the outpatient oncologist next ___. This is absolutely essential. We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
10381484-DS-22
10,381,484
22,964,619
DS
22
2176-03-04 00:00:00
2176-03-05 13:54:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: pollen Attending: ___. Chief Complaint: diarrhea, abdominal pain Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ year-old man with a history of stage IV sigmoid adenocarcinoma s/p LAR (___) with subsequent disease progression involving the spleen now s/p splenectomy/distal pancreatectomy/wedge gastrectomy (___), currently on palliative Irinotecan, as well as history of DVT on rivaroxaban, who presents with diarrhea and abdominal pain for 3 days. The patient states that he has had diarrhea and abdominal pain for the past 3 days. He also notes feeling weak. Does not report melena or hematochezia. No nausea or vomiting. No fever or chills. He has been able to eat and drink at home. The diarrhea has been occurring ___ and the patient feels like he is constantly on the toilet. On arrival to the ED: Initial vitals- T 98.7, HR 70, BP 132/95, RR 16, O2 sat 100% RA Physical exam- Tender left lower quadrant to palpation. Otherwise normal physical exam. Labs notable for- Hgb 11.6, WBC 6.4, chem-7 and LFTs wnl, lactate 1.0 Imaging notable for- CT A/P: 1. Stable malignant obstruction of the right kidney resulting in moderate to severe hydroureteronephrosis, unchanged compared to prior exam. 2. Redemonstration of a large 6.9 cm mass in the splenectomy bed with multiple omental, peritoneal, and pelvic implants consistent with metastatic foci. These are not substantially changed in size compared to recent CT abdomen pelvis dated ___. 3. Stable asymmetric wall thickening of left mid abdominal wall bowel loop, likely representing a additional focus of submucosal metastatic disease. 4. No imaging evidence to suggest colitis, diverticulitis, or bowel obstruction. In the ED, the patient received 1 dose of morphine 4mg and 1L of NS. Vital signs on floor transfer- T 97.8, HR 61, BP 133/84, RR 16, O2 sat 100% RA On arrival to the floor, the patient confirmed the above history. He is quite bothered by the frequency of his diarrhea. Also describes left sided abdominal pain. Does not report fevers, chills, chest pain, shortness of breath, nausea, and vomiting. Past Medical History: PAST ONCOLOGIC HISTORY (per OMR): As per last ___ clinic note by Dr ___: "Colon cancer stage IIIC (T3N2M0) of the sigmoid colon with progressive metastatic disease, KRAS mutated, MSI intact - ___ Colonscopy for weight loss of 26 lbs in a year revealed a fungating, circumferential mass of malignant appearance was found in the sigmoid colon at 18cm. Biopsy consistent with adenocarcinoma. CT torso revealed 3.7 cm segment of the mid sigmoid colon demonstrating circumferential wall thickening in keeping with tumor. There is no associated bowel obstruction at present time. Adjacent mesenteric lymph nodes measuring up to 6 mm in short axis dimension are noted. No evidence of metastatic disease within the chest, abdomen, or pelvis. - ___ MR pelvis revealed Ill-defined sigmoid mass, approximately 15 cm above the anal verge, as seen on the CT examination from ___, with extension across the muscularis propria. This is suspicious for T3 disease. 1.6 x 1.5 cm mass abutting the anterior aspect of the rectum and posterior aspect of the seminal vesicles, 7 cm above the anal verge, is suspicious for a drop metastasis as it is not convincingly arising from rectal wall. This likely corresponds to the palpable finding on physical exam. Intrapelvic lymphadenopathy adjacent to the sigmoid mass, some with morphology suspicious for tumor involvement. - ___ Undderwent LAR. Path revealed colonic adenocarcinoma in the resected rectosigmoid colon. Tumor size was 3.6cm, low grade, staged pT3. Margins were negative. Of the 15 nodes examined, 6 were positive, thus staged pN2a. Finally, a separate nodule of adenocarcinoma was identified 9 cm distal to the primary tumor involving pericolonic adipose tissue, serosa, and muscularis propria, consistent with metastasis of the primary tumor. Furthermore, the resected peritoneal nodule showed metastatic adenocarcinoma with perineural invasion. Thus, this was staged pM1b. Of note, KRAS mutation was detected. - ___ to ___ admitted for abdominal pain, OSH CT was reviewed here and felt to be not concerning for any acute intra-abdominal process including leak or abcess however there was a high stool burden and gas. Pt discharged on bowel regimen. - ___ ED visit for abdominal pain, KUB reassuring, discharged after bowel regimen - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ to ___ Admission for n/v and abd pain. CT showed mildly dilated stomach and proximal small bowel, but no evidence of obstruction. He underwent NGT decompression with good bilious output and improvement in symptoms and was slowly advanced to regular diet. - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ to ___ admission for abd pain and constipation. CT showed multiple mildly distended loops of ileum with fecalized contents and a narrow caliber of the terminal ileum. Stool and air seen in the colon. Symptoms improved with aggressive bowel regimen. - ___ C3D1 XELOX (Xeloda 1500mg BID) - ___ C4D1 XELOX (Xeloda 1500mg BID) - ___ C5D1 XELOX (Xeloda 2000mg BID) - ___ C6D1 XELOX (Xeloda 2000mg BID) - ___ C7D1 XELOX (Xeloda 2000mg BID) - ___ CT torso with no evidence of recurrence or metastases - ___ colonoscopy showed multiple tiny 2 mm polypoid lesions which showed to be lymphoid aggregates on path - ___ CT torso with no evidence of recurrence or metastases - ___ CT abdomen in the ED for abdominal pain showed ___ - ___ CT abdomen in the ED for abdominal pain showed ___ but indeterminate liver lesion - ___ CT torso ___ with stable liver lesion - ___ Colonoscopy revealed a single polyp, pathology consistent with adenoma. - ___ CT torso showed a new lesion in the splenic hilum concerning for recurrence - ___ PET CT showed avid lesion in the spleen, no other sites of disease - ___ Splenectomy revealed metastatic colon cancer - ___ CT torso showed ___ - ___ CT torso extensive recurrence in the spenic bed and nodes, CEA rising - ___ Biopsy of the splenic bed confirmed metastatic adenocarcinoma - ___ CT torso showed increase in metastatic disease - ___ CT torso showed increase in metastatic and concerning new areas in the liver - ___ Admitted with malignant SBO - ___ C1D1 FOLFOX6 - ___ C1D15 FOLFOX (oxaliplatin at 65 ___ neuropathy) - ___ C2D1 FOLFOX (oxaliplatin at 65 ___ neuropathy - ___ CT torso shows stable disease - ___ Treatment delayed per patient preference - ___ C3D1 FOLFOX (oxaliplatin at 65 ___ neuropathy) - ___ Patient requested to defer dose, CEA rising - ___ C1D1 ___ PAST MEDICAL HISTORY: Sigmoid adenocarcinoma DVT Social History: ___ Family History: Negative for colon cancer, inflammatory bowel disease, uterine cancer. He does have history of lipomas in his family. Physical Exam: ADMISSION PHYSICAL EXAM: ======================== Vitals: T98.1 PO, BP 115 / 75, HR 59, RR 18, O2 sat 100% on RA GENERAL: thin, middle-aged man, lying down in bed, appears comfortable and in no acute distress HEENT: oropharynx clear, without erythema or exudate, MMM NECK: supple LUNGS: clear to auscultation bilaterally, no wheezes, rales, or rhonchi HEART: regular rate and rhythm, nl s1/s2, no murmurs, rubs, or gallops ABD: soft, non-distended, tenderness to palpation in the LLQ, normal bowel sounds EXT: warm and well-perfused, no lower extremity edema SKIN: no rashes NEURO: A&Ox3, moving all 4 extremities with purpose ACCESS: Port DISCHARGE PHYSICAL EXAM: ======================== Vitals: ___ 0350 Temp: 98.5 PO BP: 135/88 HR: 65 RR: 18 O2 sat: 99% O2 delivery: RA GENERAL: thin, middle-aged man, sitting up in bed, appears comfortable and in no acute distress HEENT: oropharynx clear, without erythema or exudate, MMM NECK: supple LUNGS: clear to auscultation bilaterally, no wheezes, rales, or rhonchi HEART: regular rate and rhythm, nl s1/s2, no murmurs, rubs, or gallops ABD: soft, non-distended, tenderness to palpation in the LLQ, normal bowel sounds EXT: warm and well-perfused, no lower extremity edema SKIN: no rashes NEURO: A&Ox3, moving all 4 extremities with purpose ACCESS: Port Pertinent Results: ADMISSION LABS: =============== ___ 04:30AM BLOOD WBC-6.4 RBC-3.88* Hgb-11.6* Hct-35.9* MCV-93 MCH-29.9 MCHC-32.3 RDW-13.9 RDWSD-46.4* Plt ___ ___ 04:30AM BLOOD Neuts-47.6 ___ Monos-13.5* Eos-9.5* Baso-0.6 Im ___ AbsNeut-3.07 AbsLymp-1.82 AbsMono-0.87* AbsEos-0.61* AbsBaso-0.04 ___ 04:30AM BLOOD Glucose-105* UreaN-15 Creat-1.1 Na-140 K-4.4 Cl-104 HCO3-25 AnGap-11 ___ 04:30AM BLOOD ALT-18 AST-18 AlkPhos-69 TotBili-<0.2 ___ 04:30AM BLOOD Albumin-4.2 ___ 04:47AM BLOOD Lactate-1.0 DISCHARGE LABS: =============== ___ 08:00AM BLOOD WBC-6.6 RBC-3.57* Hgb-10.8* Hct-33.3* MCV-93 MCH-30.3 MCHC-32.4 RDW-13.8 RDWSD-46.5* Plt ___ ___ 08:00AM BLOOD Plt ___ ___ 08:00AM BLOOD Glucose-90 UreaN-16 Creat-1.0 Na-142 K-4.0 Cl-103 HCO3-25 AnGap-14 ___ 08:00AM BLOOD ALT-14 AST-13 AlkPhos-59 TotBili-<0.2 ___ 08:00AM BLOOD Calcium-9.0 Phos-4.6* Mg-2.0 MICRO: ====== ___ 4:15 am BLOOD CULTURE #1. Blood Culture, Routine (Pending): No growth to date. ___ 4:30 am BLOOD CULTURE #2. Blood Culture, Routine (Pending): No growth to date. IMAGING: ======== ___ CT ABD/PELVIS 1. Stable malignant obstruction of the right kidney resulting in moderate to severe hydroureteronephrosis, unchanged compared to prior exam. 2. Redemonstration of a large 6.9 cm mass in the splenectomy bed with multiple omental, peritoneal, and pelvic implants consistent with metastatic foci. These are not substantially changed in size compared to recent CT abdomen pelvis dated ___. 3. Stable asymmetric wall thickening of left mid abdominal wall bowel loop, likely representing a additional focus of submucosal metastatic disease. 4. No imaging evidence to suggest colitis, diverticulitis, or bowel obstruction. Brief Hospital Course: Mr. ___ is a ___ year-old man with a history of stage IV sigmoid adenocarcinoma s/p LAR (___) with subsequent disease progression involving the spleen now s/p splenectomy/distal pancreatectomy/wedge gastrectomy (___), currently on palliative Irinotecan, as well as history of DVT on rivaroxaban, who presented with diarrhea and abdominal pain for 3 days likely secondary to irinotecan. ACUTE ISSUES #Abdominal pain #Diarrhea: The patient's current presentation is most likely secondary to a known side effect of his chemotherapy, as irinotecan is quite diarrheogenic. While infection is also possible, this would seem less likely given the patient's lack of recent travel or eating unusual foods. CT abdomen and pelvis in the ED showed no evidence of infection or colitis. Normal WBC count on labs. The patient was given Lomotil with improvement in his symptoms and pain. #Metastatic sigmoid adenocarcinoma: Currently on palliative irinotecan with no evidence of disease progression on CT scan. Plan for next cycle on ___. CHRONIC ISSUES #DVT: Continued home rivaroxaban. TRANSITIONAL ISSUES [] patient has had problems with medication non-compliance in the past; should continue to encourage taking medications as prescribed [] has high healthcare utilization (inpatient); encourage patient to call ___ clinic with problems prior to coming in to the ED [] plan for cycle 2 of irinotecan on ___ [] should have ___ conversation regarding code status with patient; indicated during hospitalization that he is at least considering DNR/DNI and no prior documentation of formal conversation with outpatient provider #HCP/CONTACT: Name of health care proxy: ___ Relationship: Friend Phone number: ___ #CODE STATUS: FULL CODE (presumed) This patient was prescribed, or continued on, an opioid pain medication at the time of discharge (please see the attached medication list for details). As part of our safe opioid prescribing process, all patients are provided with an opioid risks and treatment resource education sheet and encouraged to discuss this therapy with their outpatient providers to determine if opioid pain medication is still indicated. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Rivaroxaban 20 mg PO DAILY 2. Acetaminophen 650 mg PO Q8H 3. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 4. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate 5. Ondansetron 8 mg PO Q8H:PRN nausea 6. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Second Line 7. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 8. Senna 8.6 mg PO BID:PRN Constipation - First Line Discharge Medications: 1. Diphenoxylate-Atropine 1 TAB PO Q6H:PRN diarrhea RX *diphenoxylate-atropine 2.5 mg-0.025 mg 1 tablet(s) by mouth every 6 hours Disp #*30 Tablet Refills:*0 2. Acetaminophen 650 mg PO Q8H 3. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 4. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate 5. Ondansetron 8 mg PO Q8H:PRN nausea 6. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Second Line 7. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 8. Rivaroxaban 20 mg PO DAILY 9. Senna 8.6 mg PO BID:PRN Constipation - First Line Discharge Disposition: Home Discharge Diagnosis: Primary: diarrhea ___ irinotecan Secondary: metastatic sigmoid adenocarcinoma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___ ___. Why was I admitted to the hospital? - You were having diarrhea and abdominal pain What was done while I was in the hospital? - You had a CT scan that showed your cancer was stable; there was no sign of an infection - You received a medication to slow down your bowels and felt better; we think your diarrhea was a side effect of your chemotherapy What should I do when I get home from the hospital? - Be sure to take all of your medications as prescribed, especially your rivaroxaban - If you are having symptoms, please call the ___ clinic first to talk with one of the providers there; their number is ___. - If you have fevers, chills, worsening abdominal pain, nausea, vomiting, worsening diarrhea, or generally feel unwell, please call your doctor or go to the emergency room Sincerely, Your ___ Treatment Team Followup Instructions: ___
10381484-DS-24
10,381,484
23,579,949
DS
24
2176-04-23 00:00:00
2176-04-23 17:55:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: pollen Attending: ___. Chief Complaint: abdominal pain Major Surgical or Invasive Procedure: none History of Present Illness: Mr. ___ is a ___ year old male history of stage IV sigmoid adenocarcinoma disease s/p LAR (___) with progressive metastatic disease involving spleen s/p splenectomy/distal pancreatectomy/wedge gastrectomy (___), on palliative irinotecan, course complicated by DVT on rivaroxaban, malignant bowel obstruction, and abdominal pain due to presumed Meckel's diverticulitis who is admitted from the ED with acute on chronic abdominal pain with imaging concerning for acute obstruction and persistent ? Meckel's diverticulitis. Patient recently hospitalized from ___ - ___ with similar abdominal pain. Course was notable for possible inflamed appendix vs Meckel's diverticulum. After extensive consultation with surgery, no intervention was planned and he was started on ciprofloxacin/flagyl. It was ultimately felt that chemotherapy would provide best hope for palliation. Pain was controlled with MS ___, hydromorphone, and phenazopyridine. He was discharged on ___ with plan to resume chemotherapy on ___. Patient reports his pain was persistent, but somewhat controlled on discharge. However over the last few days his pain has worsened. It seems to be the same pain as before, primarily a constant mid abdominal pain that gets up to ___. Yesterday, he felt like he was hungry and ate more than usual; the pain then became so severe he could not stand up. He also had assocated nausea without emesis and felt like the food 'sat there'. His last BM was last night. He denies flatus today. He reports no FC. No CP, SOB or cough. He notes mild dysuria. No leg pain or swelling. In the ED, initial VS were pain 10, T 100.0, HR 67, BP 143/90, RR 18, O2 100%RA. Labs notable for Na 139, K 3.9, HCO3 25, Cr 1.1, Ca 9.1, Mg 2.1, P 3.0, ALT 8, AST 16, ALP 56, LDH 202, Lipase 19, TBili <0.2, WBC 11.9, HCT 35.0, PLT 295. Lactate 0.9. UA 1 RBC and 1 WBC. CXR showed no acute process. CT a/p showed worsening malignant obstruction of small bowel due to mass in mid-jejunum along with stable appearance of 12 mm dilated fluid filled blind tubular structure felt either obstructed appendix or cystic implant and stable right hydroureteronephrosis and metastatic disease burden. Surgery was consulted, final recs pending but deferred emergent surgical intervention. Patient spent an extended period of time in the ED and received multiple doses of IV dilaudid along with LR and IV CTX. VS prior to transfer were pain 7, T 98.2, HR 56, BP 134/94, RR 14, O2 97%RA. Past Medical History: Colon cancer stage IIIC (T3N2M0) of the sigmoid colon with progressive metastatic disease, KRAS mutated, MSI intact - ___ Colonscopy for weight loss of 26 lbs in a year revealed a fungating, circumferential mass of malignant appearance was found in the sigmoid colon at 18cm. Biopsy consistent with adenocarcinoma. CT torso revealed 3.7 cm segment of the mid sigmoid colon demonstrating circumferential wall thickening in keeping with tumor. There is no associated bowel obstruction at present time. Adjacent mesenteric lymph nodes measuring up to 6 mm in short axis dimension are noted. No evidence of metastatic disease within the chest, abdomen, or pelvis. - ___ MR pelvis revealed Ill-defined sigmoid mass, approximately 15 cm above the anal verge, as seen on the CT examination from ___, with extension across the muscularis propria. This is suspicious for T3 disease. 1.6 x 1.5 cm mass abutting the anterior aspect of the rectum and posterior aspect of the seminal vesicles, 7 cm above the anal verge, is suspicious for a drop metastasis as it is not convincingly arising from rectal wall. This likely corresponds to the palpable finding on physical exam. Intrapelvic lymphadenopathy adjacent to the sigmoid mass, some with morphology suspicious for tumor involvement. - ___ Undderwent LAR. Path revealed colonic adenocarcinoma in the resected rectosigmoid colon. Tumor size was 3.6cm, low grade, staged pT3. Margins were negative. Of the 15 nodes examined, 6 were positive, thus staged pN2a. Finally, a separate nodule of adenocarcinoma was identified 9 cm distal to the primary tumor involving pericolonic adipose tissue, serosa, and muscularis propria, consistent with metastasis of the primary tumor. Furthermore, the resected peritoneal nodule showed metastatic adenocarcinoma with perineural invasion. Thus, this was staged pM1b. Of note, KRAS mutation was detected. - ___ to ___ admitted for abdominal pain, OSH CT was reviewed here and felt to be not concerning for any acute intra-abdominal process including leak or abcess however there was a high stool burden and gas. Pt discharged on bowel regimen. - ___ ED visit for abdominal pain, KUB reassuring, discharged after bowel regimen - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ to ___ Admission for n/v and abd pain. CT showed mildly dilated stomach and proximal small bowel, but no evidence of obstruction. He underwent NGT decompression with good bilious output and improvement in symptoms and was slowly advanced to regular diet. - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ to ___ admission for abd pain and constipation. CT showed multiple mildly distended loops of ileum with fecalized contents and a narrow caliber of the terminal ileum. Stool and air seen in the colon. Symptoms improved with aggressive bowel regimen. - ___ C3D1 XELOX (Xeloda 1500mg BID) - ___ C4D1 XELOX (Xeloda 1500mg BID) - ___ C5D1 XELOX (Xeloda 2000mg BID) - ___ C6D1 XELOX (Xeloda 2000mg BID) - ___ C7D1 XELOX (Xeloda 2000mg BID) - ___ CT torso with no evidence of recurrence or metastases - ___ colonoscopy showed multiple tiny 2 mm polypoid lesions which showed to be lymphoid aggregates on path - ___ CT torso with no evidence of recurrence or metastases - ___ CT abdomen in the ED for abdominal pain showed ___ - ___ CT abdomen in the ED for abdominal pain showed ___ but indeterminate liver lesion - ___ CT torso ___ with stable liver lesion - ___ Colonoscopy revealed a single polyp, pathology consistent with adenoma. - ___ CT torso showed a new lesion in the splenic hilum concerning for recurrence - ___ PET CT showed avid lesion in the spleen, no other sites of disease - ___ Splenectomy revealed metastatic colon cancer - ___ CT torso showed ___ - ___ CT torso extensive recurrence in the spenic bed and nodes, CEA rising - ___ Biopsy of the splenic bed confirmed metastatic adenocarcinoma - ___ CT torso showed increase in metastatic disease - ___ CT torso showed increase in metastatic and concerning new areas in the liver - ___ Admitted with malignant SBO - ___ C1D1 FOLFOX6 - ___ C1D15 FOLFOX (oxaliplatin at 65 ___ neuropathy) - ___ C2D1 FOLFOX (oxaliplatin at 65 ___ neuropathy - ___ CT torso shows stable disease - ___ Treatment delayed per patient preference - ___ C3D1 FOLFOX (oxaliplatin at 65 ___ neuropathy) - ___ Patient requested to defer dose, CEA rising - ___ C1D1 Irinotecan - ___ Admitted with recurrent malignant SBO - ___ C2D1 ___ - ___ Admitted for inflamed ? Meckel's diverticulum cause by extrinsic compression by malignancy PAST MEDICAL HISTORY: Sigmoid adenocarcinoma DVT Social History: ___ Family History: Negative for colon cancer, inflammatory bowel disease, uterine cancer. He does have history of lipomas in his family. Physical Exam: 24 HR Data (last updated ___ @ 1116) Temp: 98 (Tm 98.7), BP: 120/77 (109-120/65-77), HR: 55 (55-66), RR: 18 (___), O2 sat: 99% (97-99), O2 delivery: RA GENERAL: Sitting in bed, NAD, uncomfortable, fatigued HEENT: dry MM, EOMI LUNGS: CTAB HEART: RRR no R/M/G ABD: soft, non-distended, mildly TTP periumbilically. No rebound tenderness noted. EXT: no peripheral edema SKIN: warm and dry NEURO: no focal neuro deficits ACCESS: POC c/d/i Pertinent Results: CT A/P ___ FINDINGS: LOWER CHEST: Visualized lung fields are within normal limits. There is no evidence of pleural or pericardial effusion. ABDOMEN: HEPATOBILIARY: 1.8 cm right hepatic dome hypodensity is unchanged (6:7). There are few scattered subcentimeter hepatic hypodensities which are too small to characterize but likely represents hepatic cyst or biliary hamartomas, unchanged from prior. The remainder of the liver demonstrates homogenous attenuation throughout. There is no evidence of intrahepatic or extrahepatic biliary dilatation. The gallbladder is within normal limits. PANCREAS: The pancreas has normal attenuation throughout, without evidence of focal lesions or pancreatic ductal dilatation. There is no peripancreatic stranding. SPLEEN: Surgically absent spleen. Redemonstrated in the splenectomy surgical bed is 6.9 x 4.4 x 7.7 cm metastatic soft tissue mass inseparable from the gastric fundus/cardia (06:19, 08:28). ADRENALS: The right and left adrenal glands are normal in size and shape. URINARY: Left kidney is normal in size and nephrogram. Right kidney demonstrates a delayed nephrogram and moderate to severe hydronephrosis with hydroureter which extends distally, terminating at instructing 3.7 x 2.0 cm soft tissue mass just to the right of the mid pelvis (6:62). GASTROINTESTINAL: Patient is status post partial gastrectomy and partial colectomy for metastatic sigmoid adenocarcinoma. There is no bowel obstruction. 2.4 x 3.2 x 3.4 cm eccentric mural thickening with luminal narrowing of the left abdominal jejunal loop (without obstruction) which likely represents a metastatic focus (6:49, 8:16), unchanged from most recent prior. The previously described 13 mm dilated fluid-filled blind-ending tubular structure within the right mid pelvis which appears obstructed by the same right pelvic soft tissue deposit obstructing the distal right ureter, thought to represent either an obstructed appendix or cystic implant, is re-demonstrated and unchanged from ___ CT abdomen and pelvis. Scattered omental and peritoneal implants are unchanged. There is no free air or evidence of perforation. The remainder of the small bowel loops are normal in caliber. The colon and rectum are within normal limits. PELVIS: Re-demonstrated in the lower pelvis just to the right of midline, posterior to the urinary bladder, is a 2.4 x 2.5 x 2.7 cm centrally hypoattenuating soft tissue deposit which is likely also metastatic, unchanged from most recent prior CT. The urinary bladder is unremarkable. There is no free fluid in the pelvis. A fiducial markers are demonstrated in situ. REPRODUCTIVE ORGANS: The visualized reproductive organs are unremarkable. LYMPH NODES: There is no retroperitoneal or mesenteric lymphadenopathy. There is no pelvic or inguinal lymphadenopathy. VASCULAR: There is no abdominal aortic aneurysm. No atherosclerotic disease is noted. BONES: There is no evidence of worrisome osseous lesions or acute fracture. SOFT TISSUES: The abdominal and pelvic wall is within normal limits. IMPRESSION: 1. No interval change in appearance of the 13 mm dilated fluid-filled blind-ending tubular structure within the mid pelvis obstructed by a metastatic mesenteric soft tissue deposit thought to represent an obstructed appendix or cystic implant. No evidence of perforation. 2. No interval change in delayed nephrogram and degree of moderate to severe right hydronephrosis/ hydroureter secondary to distal obstruction by metastatic mesenteric soft tissue deposit. 3. Scattered metastatic soft tissue deposits detailed in body of report are unchanged. CT AP ___ FINDINGS: LOWER CHEST: Visualized lung fields are within normal limits. There is no evidence of pleural or pericardial effusion. ABDOMEN: HEPATOBILIARY: The liver demonstrates homogenous attenuation throughout. A 1.9 cm right hepatic dome hypodensity is unchanged (2:7). Additional scattered hepatic hypodensities including a 9 mm lesion in the right hepatic lobe (02:21) are also unchanged and are too small to characterize. There is no evidence of intrahepatic or extrahepatic biliary dilatation. The gallbladder is within normal limits. PANCREAS: The pancreas has normal attenuation throughout, without evidence of focal lesions or pancreatic ductal dilatation. There is no peripancreatic stranding. SPLEEN: The spleen is surgically absent. Re-demonstrated is an ill-defined metastatic soft tissue mass in the splenectomy bed measuring 6.6 x 5.2 x 4.1 cm, similar to prior (2:16, 601:26). As before, the mass is indistinguishable from the gastric fundus/cardia. ADRENALS: The right and left adrenal glands are normal in size and shape. URINARY: The left kidney again demonstrates normal size with normal nephrogram. The right kidney demonstrates a delayed nephrogram with persistent severe hydroureteronephrosis secondary to a 2.8 x 2.1 x 2.8 cm soft tissue mass in the right mid pelvis (02:58). There is no perinephric abnormality. GASTROINTESTINAL: As before, the patient is status post partial gastrectomy and partial colectomy for metastatic sigmoid adenocarcinoma. Evaluation of the bowel loops is mildly limited due to lack of oral contrast and a paucity of intra-abdominal fat. Within these limitations, there is persistent distension of the small bowel loops in the left hemiabdomen, although this appears progressed compared to the ___ study. As before, there is eccentric mural thickening and luminal narrowing of a left abdominal jejunal loop (02:51), with resultant upstream dilatation of the bowel loops. There is new trace adjacent ascites with mild peritoneal thickening (02:51). A blind ending 1.2 cm tubular structure in the mid pelvis appears unchanged and again appears obstructed by the same right pelvic soft tissue deposit causing right ureteral obstruction. As before, this is thought to represent either an obstructed appendix or a cystic implant (02:54). There is no evidence of free air. The remaining colon and rectum are within normal limits. PELVIS: The urinary bladder and distal ureters are unremarkable. Re-demonstrated is a 2.8 x 2.7 cm centrally hypoattenuating soft tissue deposit in the lower pelvis, which appears unchanged. Fiducial markers are again seen in the lower pelvis. REPRODUCTIVE ORGANS: The visualized reproductive organs are unremarkable. LYMPH NODES: There is no retroperitoneal or mesenteric lymphadenopathy. There is no pelvic or inguinal lymphadenopathy. VASCULAR: There is no abdominal aortic aneurysm. No atherosclerotic disease is noted. BONES: There is no evidence of worrisome osseous lesions or acute fracture. Small foci of sclerosis in the right femoral neck and right iliac bone are unchanged and likely represent bone islands. SOFT TISSUES: The abdominal and pelvic wall is within normal limits. IMPRESSION: 1. Mildly limited exam due to the lack of oral contrast and paucity of intra-abdominal fat. Within these limitations, there is worsening malignant obstruction of the small bowel due to a mass in the mid jejunum in the left hemiabdomen. New trace ascites adjacent to the affected bowel loops. 2. No significant interval change in appearance of a 12 mm dilated, fluid-filled, blind-ending tubular structure in the mid pelvis, which is likely obstructed by a mesenteric soft tissue deposit. As before, this likely represents an obstructed appendix or cystic implant. 3. Unchanged severe right-sided hydroureteronephrosis secondary to obstruction from a metastatic soft tissue deposit. 4. Unchanged metastatic soft tissue deposit in the splenectomy bed, which is indistinguishable from the gastric fundus/cardia. 5. Unchanged metastatic soft tissue deposit in the lower midline pelvis adjacent to the bladder. CT AP ___ FINDINGS: LOWER CHEST: Visualized lungs are within normal limits. There is no evidence of pleural or pericardial effusion. ABDOMEN: Study is slightly limited due to paucity of intra-abdominal fat and crowding of structures. HEPATOBILIARY: Geographic hyperattenuation of large areas of segments VII and nearly the entire left hepatic lobe is likely perfusional. A 1.8 cm hypodensity near the hepatic dome in segment VII (04:10) and a 1.1 cm hypodensity in the periphery of segments VII/VIII (04:20) are stable compared to prior but new since the study of ___ and are consistent with metastasis. There is no evidence of intrahepatic or extrahepatic biliary dilatation. The gallbladder is within normal limits. PANCREAS: The pancreas has normal attenuation throughout, without evidence of focal lesions or pancreatic ductal dilatation. There is no peripancreatic stranding. SPLEEN: The spleen is surgically absent. Metastatic soft tissue mass in the splenectomy bed is stable from prior, measuring 7.9 x 5.3 x 4.3 cm (4:22, 6:24), previously 7.8 x 5.2 x 4.1 cm. However, it has markedly increased in size since ___. ADRENALS: The right and left adrenal glands are normal in size and shape. URINARY: The left kidney is normal in size and nephrogram. As with prior, the right kidney demonstrates a delayed nephrogram with persistent severe hydronephrosis secondary to a 3.2 x 3.0 x 2.6 cm soft tissue mass in the right mid pelvis (4:73, 6:29) which appears similar to slightly increased in size, previously measuring 2.8 x 2.1 x 2.8 cm. GASTROINTESTINAL: The patient is status post partial gastrectomy and partial colectomy for metastatic sigmoid adenocarcinoma. There is persistent distention of small-bowel loops in the left hemiabdomen. An implant in the left lower quadrant measuring approximately 3.4 x 3.5 x 4.3 cm (4:57, 6:18) involves loops of small bowel with resultant upstream wall thickening and edema which has progressed since the previous study, likely due to partial small bowel obstruction. A blind-ending 1.2 cm tubular structure in the mid lower abdomen adjacent to a soft tissue implant (4:64) appears unchanged (4:60), possibly an obstructed appendix, Meckel's diverticulum, or cystic implant. The aforementioned soft tissue implant has slightly increased in size, currently measuring 3.2 x 2.9 x 2.8 cm (4:64, 6:23), previously 2.8 x 2.1 x 2.8 cm. No free air. The large bowel is mildly distended throughout and filled with stool. Adjacent to extensive pelvic implants, there is decreased bowel diameter and stool burden (4:70, 06:24) with stool and air seen distally within the rectum, possibly suggesting partial large bowel obstruction. PELVIS: As described above, a 3.2 x 3.0 x 2.6 cm soft tissue mass in the right mid pelvis appears similar to slightly increased in size, previously measuring 2.8 x 2.1 x 2.8 cm. The urinary bladder is unremarkable. No definite free fluid. REPRODUCTIVE ORGANS: The prostate and seminal vesicles are grossly unremarkable. LYMPH NODES: There is no definite retroperitoneal or mesenteric lymphadenopathy. There is no pelvic or inguinal lymphadenopathy. VASCULAR: There is no abdominal aortic aneurysm. No atherosclerotic disease is noted. BONES: There is no evidence of worrisome osseous lesions or acute fracture. Small foci of sclerosis in the right femoral neck and right iliac bone are unchanged and likely represent bone islands. SOFT TISSUES: The abdominal and pelvic wall is within normal limits. IMPRESSION: 1. Interval increase in size of left lower quadrant implant with persistent upstream small bowel dilation and worsening of upstream wall thickening and edema likely due to partial small bowel obstruction, although superimposed gastroenteritis cannot be excluded. 2. Interval increase in size of metastatic soft tissue implants in the lower abdomen and pelvis with resultant narrowing of the distal large bowel within the pelvis which may suggest possible partial large bowel obstruction. 3. Metastatic splenectomy bed and hepatic lesions are stable compared to prior but increased since early ___. 4. No significant change in appearance of fluid-filled blind ending tubular structure in the mid lower abdomen possibly representing an obstructed appendix, Meckel's diverticulum, or cystic implant. 5. Severe persistent right hydroureteronephrosis secondary to obstruction from metastatic soft tissue deposit. 6. Geographic hyperenhancement involving large areas of both hepatic lobes are likely perfusional. Brief Hospital Course: Mr. ___ is a ___ year old male history of stage IV sigmoid adenocarcinoma disease s/p LAR (___) with progressive metastatic disease involving spleen s/p splenectomy/distal pancreatectomy/wedge gastrectomy (___), on palliative irinotecan, course complicated by DVT on rivaroxaban, malignant bowel obstruction, and abdominal pain due to presumed Meckel's diverticulitis who was admitted from the ED with acute on chronic abdominal pain with imaging concerning for acute obstruction and persistent ? ___'s diverticulitis. His obstruction resolved with conservative measures and he received chemotherapy with irinotecan while in house. His pain regimen was optimized with the help of Palliative care. At time of discharge he was having bowel movements and taking in p.o. without nausea or vomiting. # Peritoneal metstatic disease # Small bowel obstruction # Meckel's diverticulitis # Constipation Patient has extensive peritoneal metastatic disease leading to recurrent small bowel obstruction along with the presumed obstruction and inflammation of Meckel's diverticulum. His more global bowel obstruction seems intermittent and was treated conservatively with NPO and miVF. He did not required NG tube placement. Colorectal surgery saw the patient while in house with no indication for surgery. He was kept on cipro/flagyl for coverage of ?Meckel's diverticulum inflammation. Ultimately his SBO resolved and he was able to take in POs. His course was complicated by severe constipation, which resolved with scheduled senna BID, docusate, mag citrate, and suppository. His acute on chronic abdominal pain from this was managed as below. His antibiotics were discontinued on the day of discharge. # Acute on chronic abdominal pain Initially presented with acute exacerbation of his chronic abdominal pain in the setting of his small bowel obstruction. He was managed with IV Dilaudid initially and then was transition back to his home dose of MS ___ 30mg twice daily. Throughout the course his as needed Dilaudid was increased to 4 mg every 3 hours as needed pain. His long-acting MS ___ was up titrated based on this requirement to 60 mg twice daily at discharge. Palliative care recommended that he may continue the hydromorphone ___ he has at home and that when he runs out, his outpatient oncology team may consider switching this to short-acting morphine 15 mg q4h PRN. #Dysuria Pt having some dysuria, no other s/sx of infection. UA was bland no signs of infection. # Fever/Low grade temperature # Leukocytosis (resolved) T 100.0 in ED; presumably has widespread inflammation from bowel obstruction +/- diverticulitis. His WBC normalized and remained normal throughout the remainder of his hospital stay. He had no further fevers. # Metastatic sigmoid adenocarcinoma Started on ir___ ___. Tolerated chemotherapy. Seen by Dr. ___ patient, who felt it is important to have patient undergo his next dose of chemotherapy on time. He is scheduled to undergo chemotherapy after discharge this ___, ___. # Hx of DVT On rivaroxaban as outpatient, was transitioned to lovenox while NPO and having poor PO intake. Upon discharge, patient transitioned back to rivaroxaban, to be initiated at his home dose the evening of discharge. # Anemia in malignancy The patient's H/H remained stable throughout his admission. TRANSITIONAL ISSUES: ====================== [] Palliative care recommended that he may continue the hydromorphone ___ he has at home and that when he runs out, his outpatient oncology/palliative care team may consider switching this to short-acting morphine 15 mg q4h PRN. [] Would continue to optimize his bowel regimen PRN [] Cipro/flagyl was stopped on ___, as patient had completed chemotherapy and had reached his nadir [] Patient has known hydronephrosis, may need a perc neph tube if renal function declines [] Should take next dose of xarelto at 1800 on ___ [] Xarelto required a prior authorization, so the patient was given a free supply with the use of a coupon on ___. This PA will need to be continued to be follow-up on. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Ciprofloxacin HCl 500 mg PO Q12H 2. MetroNIDAZOLE 500 mg PO Q8H 3. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate 4. Acetaminophen 650 mg PO Q8H:PRN Pain - Mild/Fever 5. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 6. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Second Line 7. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 8. Rivaroxaban 20 mg PO DAILY 9. Senna 8.6 mg PO BID:PRN Constipation - First Line 10. Phenazopyridine 100 mg PO TID 11. Ondansetron 8 mg PO Q8H:PRN nausea 12. Morphine SR (MS ___ 30 mg PO Q12H Discharge Medications: 1. Bisacodyl ___AILY:PRN Constipation - Second Line Only take after discussing with Oncologist RX *bisacodyl 10 mg 1 suppository(s) rectally daily Disp #*12 Suppository Refills:*0 2. Metoclopramide 5 mg PO TID RX *metoclopramide HCl 5 mg 1 tab by mouth three times a day Disp #*90 Tablet Refills:*0 3. Morphine SR (MS ___ 60 mg PO Q12H RX *morphine [MS ___ 30 mg 2 tablet(s) by mouth in the AM and ___, take 1 tablet in the afternoon Disp #*35 Tablet Refills:*0 RX *morphine 60 mg 1 tablet(s) by mouth twice a day Disp #*28 Tablet Refills:*0 4. Polyethylene Glycol 17 g PO DAILY RX *polyethylene glycol 3350 [Miralax] 17 gram 1 powder(s) by mouth daily Disp #*30 Packet Refills:*0 5. Senna 17.2 mg PO BID RX *sennosides [senna] 8.6 mg 2 tab by mouth twice a day Disp #*30 Tablet Refills:*0 6. Acetaminophen 650 mg PO Q8H:PRN Pain - Mild/Fever 7. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 8. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate 9. Ondansetron 8 mg PO Q8H:PRN nausea RX *ondansetron 8 mg 1 tablet(s) by mouth Every 8 hours Disp #*30 Tablet Refills:*0 10. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 11. Rivaroxaban 20 mg PO DAILY RX *rivaroxaban [Xarelto] 20 mg 1 tablet(s) by mouth qpm Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary ============ Small bowel obstruction Secondary ============ Metastatic sigmoid adenocarcinoma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___! He came to the hospital because you are having abdominal pain. While you are here, you were found to have a blockage in your bowels. Over time this got better. You were given antibiotics to help prevent infection. You were seen by the palliative care doctors who helped to increase your pain medicines to better control your pain. You also had some constipation so you were given medications to help with this. You were seen by your outpatient Oncologist while in the hospital, who would like you to have your next chemotherapy session as scheduled this ___, ___. Details of your appointment are below. When you leave it is important you take your medications as prescribed. It is also important you attend your follow-up appointments as listed below. If you have any nausea, vomiting, fevers, chills, severe constipation, or diarrhea, call your oncologist and let them know or come to the ER immediately. We wish you the best, Your ___ Care team Followup Instructions: ___
10381484-DS-29
10,381,484
25,362,840
DS
29
2176-08-14 00:00:00
2176-08-14 10:57:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: pollen Attending: ___. Chief Complaint: Abdominal pain, concern for dislodged G tube Major Surgical or Invasive Procedure: Vented G tube replacement by ___ on ___ History of Present Illness: ___ is a ___ year old ___ man with metastatic sigmoid adenocarcinoma, progressive through multiple lines of therapy, c/b recurrent malignant SBO s/p venting G (___) on home hospice, who presents with concern for dislodged G tube and abdominal pain. - 5 days ago, noticed decreased output from G tube and had sensation that air seemed to be going in - No acute changes, but finally decided to present to ED tonight - While waiting for CT scan, tube fully dislodged (fell out; ED resident clarified pt did not pull it out). Then started developing abd pain and distension - No nausea/vomiting. Prior to this, was passing gas, having BM In the ED: T 98.9 F | 76 | 117/83 | 100% RA. He was noted on exam to have dry mucus membranes, abdominal distension, and diffuse tenderness to palpation. While awaiting his CT scan, patient's G tube spontaneously dislodged. CT A/P demonstrated persistent malignant SBO. Colorectal surgery was consulted and recommended against surgical intervention and recommended ___ replacement of G tube. He was given 4 mg SC morphine and 1 mg + 4mg + 1mg IV dilaudid. NGT placement was discussed but declined by patient, given prior experiences of significant discomfort. On arrival to the floor, he shares that he is having ___ pain in his abdomen, which worsened after the G tube fell out in the ED. He also feels dehydrated. He shares that he did not like inpatient hospice and has been living at home with a friend on home hospice. Had been taking 4mg dilaudid PO for pain at home. All other review of systems are negative unless stated otherwise Past Medical History: === PAST MEDICAL HISTORY === DVT on lovenox ONCOLOGIC HISTORY -Colon cancer stage IIIC (T3N2M0) of the sigmoid colon with progressive metastatic disease, KRAS mutated, MSI intact - ___ Colonscopy for weight loss of 26 lbs in a year revealed a fungating, circumferential mass of malignant appearance was found in the sigmoid colon at 18cm. Biopsy consistent with adenocarcinoma. CT torso revealed 3.7 cm segment of the mid sigmoid colon demonstrating circumferential wall thickening in keeping with tumor. There is no associated bowel obstruction at present time. Adjacent mesenteric lymph nodes measuring up to 6 mm in short axis dimension are noted. No evidence of metastatic disease within the chest, abdomen, or pelvis. - ___ MR pelvis revealed Ill-defined sigmoid mass, approximately 15 cm above the anal verge, as seen on the CT examination from ___, with extension across the muscularis propria. This is suspicious for T3 disease. 1.6 x 1.5 cm mass abutting the anterior aspect of the rectum and posterior aspect of the seminal vesicles, 7 cm above the anal verge, is suspicious for a drop metastasis as it is not convincingly arising from rectal wall. This likely corresponds to the palpable finding on physical exam. Intrapelvic lymphadenopathy adjacent to the sigmoid mass, some with morphology suspicious for tumor involvement. - ___ Undderwent LAR. Path revealed colonic adenocarcinoma in the resected rectosigmoid colon. Tumor size was 3.6cm, low grade, staged pT3. Margins were negative. Of the 15 nodes examined, 6 were positive, thus staged pN2a. Finally, a separate nodule of adenocarcinoma was identified 9 cm distal to the primary tumor involving pericolonic adipose tissue, serosa, and muscularis propria, consistent with metastasis of the primary tumor. Furthermore, the resected peritoneal nodule showed metastatic adenocarcinoma with perineural invasion. Thus, this was staged pM1b. Of note, KRAS mutation was detected. - ___ to ___ admitted for abdominal pain, OSH CT was reviewed here and felt to be not concerning for any acute intra-abdominal process including leak or abcess however there was a high stool burden and gas. Pt discharged on bowel regimen. - ___ ED visit for abdominal pain, KUB reassuring, discharged after bowel regimen - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ to ___ Admission for n/v and abd pain. CT showed mildly dilated stomach and proximal small bowel, but no evidence of obstruction. He underwent NGT decompression with good bilious output and improvement in symptoms and was slowly advanced to regular diet. - ___ C1D1 XELOX (Xeloda 1000mg BID) - ___ to ___ admission for abd pain and constipation. CT showed multiple mildly distended loops of ileum with fecalized contents and a narrow caliber of the terminal ileum. Stool and air seen in the colon. Symptoms improved with aggressive bowel regimen. - ___ C3D1 XELOX (Xeloda 1500mg BID) - ___ C4D1 XELOX (Xeloda 1500mg BID) - ___ C5D1 XELOX (Xeloda 2000mg BID) - ___ C6D1 XELOX (Xeloda 2000mg BID) - ___ C7D1 XELOX (Xeloda 2000mg BID) - ___ CT torso with no evidence of recurrence or metastases - ___ colonoscopy showed multiple tiny 2 mm polypoid lesions which showed to be lymphoid aggregates on path - ___ CT torso with no evidence of recurrence or metastases - ___ CT abdomen in the ED for abdominal pain showed ___ - ___ CT abdomen in the ED for abdominal pain showed ___ but indeterminate liver lesion - ___ CT torso ___ with stable liver lesion - ___ Colonoscopy revealed a single polyp, pathology consistent with adenoma. - ___ CT torso showed a new lesion in the splenic hilum concerning for recurrence - ___ PET CT showed avid lesion in the spleen, no other sites of disease - ___ Splenectomy revealed metastatic colon cancer - ___ CT torso showed ___ - ___ CT torso extensive recurrence in the spenic bed and nodes, CEA rising - ___ Biopsy of the splenic bed confirmed metastatic adenocarcinoma - ___ CT torso showed increase in metastatic disease - ___ CT torso showed increase in metastatic and concerning new areas in the liver - ___ Admitted with malignant SBO - ___ C1D1 FOLFOX6 - ___ C1D15 FOLFOX (oxaliplatin at 65 ___ neuropathy) - ___ C2D1 FOLFOX (oxaliplatin at 65 ___ neuropathy - ___ CT torso shows stable disease - ___ Treatment delayed per patient preference - ___ C3D1 FOLFOX (oxaliplatin at 65 ___ neuropathy) - ___ Patient requested to defer dose, CEA rising - ___ C1D1 Irinotecan - ___ Admitted with recurrent malignant SBO - ___ C2D1 Irinotecan - ___ Admit for recurrent SBO, concern for ___ diverticulitis - ___ Readmitted for recurrent SBO - ___ C3D1 Irinotecan (150 ___ diarrhea) - ___ C4D1 Irinotecan (150 ___ diarrhea) - ___ Treatment held ___ fatigue - ___ C1D1 Weekly irinotecan 100 mg/m2 1, 8, 15 and 22 of a 42-day cycle - ___ Prolonged hospitalization for SBO - ___: recurrent malignant SBO. S/p G tube placement ___. After discussion with oncology team, decision made to focus on quality of life and transition to home hospice - ___: Malignant SBO, improved with venting G tube. Discharged back to home hospice Social History: ___ Family History: Negative for colon cancer, inflammatory bowel disease, uterine cancer. He does have history of lipomas in his family. Physical Exam: ADMISSION PHYSICAL EXAM ========================== VITALS: ___ 0849 Temp: 97.5 PO BP: 127/86 L HR: 73 RR: 18 O2 sat: 100% O2 delivery: RA General: Cachectic, chronically ill-appearing man lying still in bed with eyes closed. HEENT: dry mucous membranes, OP clear CV: RR, no m/r/g PULM: Unlabored breathing ABD: Soft BS, mildly distended, soft, diffusely tender to palpation without rebound. + gastrostomy tube site without surrounding erythema or drainage LIMBS: WWP, 2+ bilateral ___ edema SKIN: No notable rashes on trunk nor extremities NEURO: Alert and oriented. Moves all extremities equally. PSYCH: Depressed affect. Thought process is linear. ACCESS: Chest port site intact w/o overlying erythema, accessed and dressing C/D/I DISCHARGE PHYSICAL EXAM ========================== VS: ___ ___ Temp: 98.6 PO BP: 115/80 L Sitting HR: 74 RR: 16 O2 sat: 96% O2 delivery: RA General: Cachectic, chronically ill-appearing man sitting in chair in NAD HEENT: moist mucous membranes, OP clear CV: RR, no m/r/g PULM: Unlabored breathing ABD: Soft BS, mildly distended, soft, mildly tender to palpation without rebound. G tube site c/d/i LIMBS: WWP, 2+ bilateral ___ edema SKIN: No notable rashes on trunk nor extremities NEURO: Alert and oriented. Moves all extremities equally. PSYCH: Depressed affect. Thought process is linear. ACCESS: Chest port site intact w/o overlying erythema Pertinent Results: ADMISSION LABS ==================== ___ 02:15AM BLOOD WBC-6.1 RBC-3.09* Hgb-7.8* Hct-25.7* MCV-83 MCH-25.2* MCHC-30.4* RDW-16.8* RDWSD-50.1* Plt ___ ___ 02:15AM BLOOD Neuts-69.9 Lymphs-15.1* Monos-13.4* Eos-1.0 Baso-0.3 Im ___ AbsNeut-4.26 AbsLymp-0.92* AbsMono-0.82* AbsEos-0.06 AbsBaso-0.02 ___ 02:15AM BLOOD ___ PTT-27.2 ___ ___ 02:15AM BLOOD Glucose-121* UreaN-29* Creat-1.0 Na-135 K-4.5 Cl-97 HCO3-27 AnGap-11 ___ 02:15AM BLOOD Albumin-3.2* Calcium-8.5 Phos-4.0 Mg-2.2 ___ 02:15AM BLOOD ALT-12 AST-18 AlkPhos-61 TotBili-0.2 ___ 02:15AM BLOOD Lipase-13 ___ 02:15AM BLOOD proBNP-68 ___ 03:50AM BLOOD Lactate-0.9 DISCHARGE LABS ==================== ___ 05:50AM BLOOD WBC-4.9 RBC-3.02* Hgb-7.6* Hct-24.3* MCV-81* MCH-25.2* MCHC-31.3* RDW-17.2* RDWSD-49.6* Plt ___ ___ 05:50AM BLOOD Glucose-134* UreaN-20 Creat-0.8 Na-135 K-4.3 Cl-97 HCO3-28 AnGap-10 ___ 05:50AM BLOOD Calcium-8.3* Phos-3.8 Mg-2.0 MICROBIOLOGY ==================== ___ 3:40 am URINE **FINAL REPORT ___ URINE CULTURE (Final ___: < 10,000 CFU/mL. IMAGING ==================== ___ CXR IMPRESSION: Comparison to ___. In the interval, the feeding tube was removed. The right pectoral Port-A-Cath remains in stable correct position. The partially imaged upper abdomen shows mild intestinal distension but no evidence of free intra-abdominal air. Normal size of the heart. Normal hilar and mediastinal contours. No pulmonary edema. No pneumonia. No pneumothorax. ___ KUB IMPRESSION: Findings concerning for small bowel obstruction. No free intraperitoneal air. ___ CT ABD/PELVIS 1. Dilated loops of small bowel, similar in configuration to the ___ CT examinations. There is a persistent obstructing 2.7 cm mid-left mass at the transition point. No perforation or pneumatosis. 2. Unchanged metastatic deposits adjacent to the gastrectomy site and along the right pelvis. 3. Severe right hydroureteronephrosis from one of the metastatic lesions, unchanged from prior examinations. 4. Unchanged hepatic metastases. 5. Unchanged ___ opacities at the right lung base, likely inflammatory from recent aspiration. ___ ULTRASOUND GUIDED G TUBE REPLACEMENT BY ___ FINDINGS: 1. Successful placement of a 18 ___ MIC gastrostomy tube through a pre-existing tract. IMPRESSION: Successful placement of a 18 ___ MIC gastrostomy tube. The tube is ready for immediate use. Brief Hospital Course: ___ ___ with metastatic sigmoid adenocarcinoma, progressive through multiple lines of therapy, c/b recurrent malignant SBO s/p venting G (___) on home hospice, who presents with dislodged G tube x 5 days w/ severe abdominal pain and distention, improved after G tube replacement and initiation of dilaudid PCA. # Displaced G tube # Abdominal pain Presented with 5 days of G tube discomfort/dysfunction. Spontaneously dislodged in ED, with subsequent onset of severe abdominal pain and bloating, c/w worsening of his chronic SBO in absence of venting G. He was discharged to inpatient hospice with dilaudid PCA on ___. Most recently had been on PO dilaudid 4mg (unknown frequency) at home prior to this admission. S/p replacement of vented G tube on ___ by ___. Palliative Care was consulted for pain control and clarification of GOC. Required frequent IV dilaudid boluses for pain control, transitioned to dilaudid PCA with pain well controlled on 1mg IVPCA basal per hour with 1mg bolus q10 minutes prn. # Insomnia Pt c/o insomnia and "all-over body pain". Improved on lorazepam and trazodone QHS. # Metastatic sigmoid adenocarcinoma, on home hospice Metastatic colon cancer complicated by recurrent malignant obstructions. CT abd/pelvis this admission without significant change in tumor burden from prior CT exams in ___, including unchanged hepatic metastases and metastatic deposits adjacent to gastrectomy site and along right pelvis. Discussed with pt that his cancer has progressed through multiple lines of therapy and unfortunately there are no additional treatments available. # Bilateral lower extremity edema Likely anasarca in setting of malignancy and malnutrition. Also would consider DVT given history as below, but lower suspicion given bilateral and home apixaban. Pt declined TEDS and ACE bandage wraps. Encouraged lower extremity elevation and ambulation. # Hx of DVT (diagnosed ___ Home apixaban held in setting of ___ procedure, restarted at discharge. TRANSITIONAL ISSUES: [] manage pain as bale with PCA and uptitrate as needed [] patient may vent G-tube per his preference for any worsening abdominal pain or nausea [] patient may eat my mouth as able for his comfort This patient was prescribed, or continued on, an opioid pain medication at the time of discharge (please see the attached medication list for details). As part of our safe opioid prescribing process, all patients are provided with an opioid risks and treatment resource education sheet and encouraged to discuss this therapy with their outpatient providers to determine if opioid pain medication is still indicated. Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Dexamethasone 4 mg PO DAILY 2. HYDROmorphone (Dilaudid) 2 mg IV Q3H:PRN Pain - Severe 3. HYDROmorphone (Dilaudid) 1 mg IVPCA Lockout Interval: 10 minutes Basal Rate: 1.5 mg(s)/hour 1-hr Max Limit: 5 mg(s) 4. amLODIPine 5 mg PO DAILY 5. Apixaban 5 mg PO BID 6. Docusate Sodium 100 mg PO BID 7. Ondansetron 8 mg PO Q8H:PRN nausea 8. Polyethylene Glycol 17 g PO DAILY 9. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - Second Line Discharge Medications: 1. Heparin Flush (10 units/ml) 5 mL IV DAILY and PRN, line flush 2. Heparin Flush (100 units/ml) 5 mL IV PRN DE-ACCESSING port 3. LORazepam 0.5 mg IV QHS 4. Sodium Chloride 0.9% Flush 10 mL IV DAILY and PRN, line flush 5. TraZODone 50 mg PO QHS:PRN insomnia 6. Apixaban 5 mg PO BID 7. Docusate Sodium 100 mg PO BID 8. HYDROmorphone (Dilaudid) 1 mg IVPCA Lockout Interval: 10 minutes Basal Rate: 1.5 mg(s)/hour 1-hr Max Limit: 5 mg(s) RX *hydromorphone 60 mg/30 mL (2 mg/mL) 1 mg IV hourly Disp #*1 Vial Refills:*0 9. HYDROmorphone (Dilaudid) 2 mg IV Q3H:PRN Pain - Severe 10. Ondansetron 8 mg PO Q8H:PRN nausea 11. Polyethylene Glycol 17 g PO DAILY 12. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - Second Line Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: # Encounter for palliative care # Malignant small bowel obstruction # Metastatic colon cancer # Displaced G tube # Insomnia # Lower extremity edema Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___ ___. You were admitted with concern that your G tube was dislodge and abdominal pain due to your bowel obstruction. Your G tube fell out in the ED and was replaced by the Interventional Radiology team. We started you on IV pain medications and you felt better. After discussion with you and your hospice team, the decision was made to discharge you home with hospice, which will monitor your symptoms closely and help with symptom control and support. Sincerely, Your ___ Care Team Followup Instructions: ___
10381538-DS-4
10,381,538
23,716,656
DS
4
2151-12-15 00:00:00
2151-12-16 17:26:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROSURGERY Allergies: ACE Inhibitors / diltiazem / haloperidol / Losartan / opiate agonists Attending: ___ Chief Complaint: Left Subdural Hematoma Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ year old male with history of advanced ___ body dementia presented to OSH ED with new inability to ambulate. His wife reports that the patient had an unwitnessed fall 5 days ago and has had ongoing behavioral changes over the last month with increased outbursts and decreased communication (minimally verbal baseline). The OSH ___ revealed a left SDH 33mm with 1cm MLS acute on chronic blood products, therefore he was transferred to ___ ED for further evaluation and management. He is on 81 mg ASA daily. Past Medical History: ___ Body Dementia HTN Hypercholesterol Social History: ___ Family History: Non-contributory Physical Exam: PHYSICAL EXAM ON ADMISSION: Gen: WD/WN, comfortable, NAD. HEENT: Pupils: PERRL ___ EOMs: will not follow Extrem: Warm and well-perfused. Neuro: Mental status: intermittently awake, not cooperative with exam/unable to follow commands Orientation: will not answer orientation questions Language: minimally verbal at baseline Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, 4 to 3mm bilaterally. III, IV, VI: Extraocular movements unable to be assessed V, VII: Facial strength and sensation unable to be assessed . VIII: Hearing intact to voice. XII: Tongue unable to be assessed . Motor: Will not follow commands for motor exam, however is moving all four extremities spontaneously and anti-gravity. Pronator drift unable to be assessed. __________________________________ PHYSICAL EXAM ON DISCHARGE: Spontaneously opening eyes, non-verbal, not following commands. Pertinent Results: CT HEAD - ___: Interval increase in left subdural hematoma in last 8 hours (measuring up to 36 mm in maximum dimension from 32 mm). Associated rightward shift has also slightly increased (12 mm, previously 11 mm). ___ 11:25PM BLOOD WBC-9.0 RBC-3.83* Hgb-11.7* Hct-35.6* MCV-93 MCH-30.5 MCHC-32.9 RDW-13.9 RDWSD-47.3* Plt ___ ___ 11:25PM BLOOD Neuts-63.1 ___ Monos-8.5 Eos-3.8 Baso-0.2 Im ___ AbsNeut-5.64 AbsLymp-2.17 AbsMono-0.76 AbsEos-0.34 AbsBaso-0.02 ___ 11:25PM BLOOD ___ PTT-27.0 ___ ___ 11:25PM BLOOD Glucose-96 UreaN-14 Creat-1.0 Na-141 K-3.9 Cl-104 HCO3-25 AnGap-16 Brief Hospital Course: Mr. ___ was admitted to the ICU at ___ on ___ for close neurological monitoring in the setting of large acute-on-chronic subdural hematoma. His Aspirin was held on admission and Keppra was started for seizure prophylaxis. Operative planning was initiated. Extensive discussion was had with the patient's family, as well as his outpatient PCP & Neurologist. The family decided that given his advanced dementia they would defer surgical intervention and pursue Hospice care. The patient was transferred to the inpatient floor, where he remained hemodynamically stable. Palliative Care, Case Management, and Social Work assisted in establishing home hospice care. The patient was discharged in stable condition on ___. The ___ Hospice agency was extremely helpful in facilitation this discharge. Through their agency, a general prescription was provided for a "hospice bag" with the necessary medications to keep the patient comfortable at home. Medications on Admission: Mirtazapine 7.5mg QHS Atorvastatin 10 mg, daily Verapamil ER (SR) 120mg BID Sertraline 150 mg QHS Valsartan 160mg-Hydrochlorothiazide 12.5 mg daily Aspirin 81 mg daily Vitamin D3 1,000 unit daily Discharge Medications: 1. Atorvastatin 10 mg PO QPM 2. Hydrochlorothiazide 12.5 mg PO DAILY 3. Mirtazapine 7.5 mg PO QHS 4. Valsartan 160 mg PO DAILY 5. Vitamin D 1000 UNIT PO DAILY 6. Acetaminophen 325-650 mg PO Q6H:PRN fever/pain 7. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation 8. LeVETiracetam 500 mg PO BID RX *levetiracetam 500 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 9. Lorazepam 0.5 mg PO Q4H:PRN agitation 10. Senna 8.6 mg PO BID:PRN Constipation 11. OLANZapine (Disintegrating Tablet) 5 mg PO Q4H:PRN delirium/restlessness 12. Sertraline 150 mg PO QHS 13. Verapamil 40 mg PO Q8H RX *verapamil 40 mg 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills:*0 14. Docusate Sodium (Liquid) 100 mg PO BID Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Left Subdural Hematoma Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Lethargic but arousable. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: You were admitted to ___ after you were found to have a large left subdural hematoma. After discussion with Dr. ___ your family, you were not taken for surgery. You are now being sent home with hospice services. Below are your other discharge instructions: Activity: As Tolerated Medications: - We recommend avoiding blood thinning medication (Aspirin, Ibuprofen, Plavix, Coumadin) - You have been discharged on Keppra (Levetiracetam). This medication helps to prevent seizures. Please continue this medication as indicated on your discharge instruction. - You may use Acetaminophen (Tylenol) for minor discomfort if you are not otherwise restricted from taking this medication. What You ___ Experience: - Emotional and/or behavioral difficulties are common, particularly in the setting of underlying dementia. - Feeling more tired, restlessness, irritability, and mood swings are also common. - Constipation is common. Be sure to drink plenty of fluids and eat a high-fiber diet. If you are taking narcotics (prescription pain medications), try an over-the-counter stool softener. Headaches: - Headache is one of the most common symptom after a brain bleed. - Most headaches are not dangerous but you should call your doctor if the headache gets worse, develop arm or leg weakness, increased sleepiness, and/or have nausea or vomiting with a headache. - Mild pain medications may be helpful with these headaches but avoid taking pain medications on a daily basis unless prescribed by your doctor. - There are other things that can be done to help with your headaches: avoid caffeine, get enough sleep, daily exercise, relaxation/ meditation, massage, acupuncture, heat or ice packs. When to Call Your Doctor at ___ for: - Severe pain, swelling, redness or drainage from the incision site. - Fever greater than 101.5 degrees Fahrenheit - Nausea and/or vomiting - Extreme sleepiness and not being able to stay awake - Severe headaches not relieved by pain relievers - Seizures - Any new problems with your vision or ability to speak - Weakness or changes in sensation in your face, arms, or leg Call ___ and go to the nearest Emergency Room if you experience any of the following: - Sudden numbness or weakness in the face, arm, or leg - Sudden confusion or trouble speaking or understanding - Sudden trouble walking, dizziness, or loss of balance or coordination - Sudden severe headaches with no known reason Followup Instructions: ___
10381607-DS-13
10,381,607
21,718,540
DS
13
2150-10-10 00:00:00
2150-10-13 00:57:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: ___ Attending: ___ Chief Complaint: left face/arm weakness and left arm numbness Major Surgical or Invasive Procedure: None History of Present Illness: The patient is a ___ year-old right-handed man with a history of HTN, HLD and asthma who presented to the ED after acute onset of left face/arm weakness and left arm numbness at 830am this morning. Neurology was consulted as part of a code stroke protocol. Mr. ___ awoke at 3am the day of presentation with difficulty sleeping and took Unisom at that time. He was not weak and there was no numbness/tingling. He briefly aroused from sleep at 730am when there was a noise in his house and he is unsure if he had any tingling or weakness at that time. At ___, he awoke with left face and entire arm tingling and numbness. He could not raise his arm from the bed easily. He had more difficulty with hand movements than shoulder movements. There was no numbness or weakness elsewhere. No other neurological symptoms. No palpitations he recalls. EMS was activated and he was taken to ___ where vitals were T97.9 HR95 RR22 BP 205/99 -> 188/87 (without anti-hypertensives) and POX 99RA. There his NIHSS was 8 for left arm weakness, left facial droop, mild dysarthria, and numbness. Basic labs were normal. ___ without signs of early ischemia. No IV tpa given, but the patient was given ASA 324 and was urgently transported via medflight to ___. No antihypertensives given en route. At ___, code stroke was called at approximately 1115am. At that time, NIHSS 2 (left facial palsy) and the patient was reporting improvement in symptoms, particularly numbness and tingling was now distal to mid forearm and weakness was only of the left wrist and hand. No IV tpa given. CTA head and neck in the ED showed vascular dilatation of the distal R MCA inferior division vasculature and on CT perfusion there was an area suggestive of hyperemia (dec MTT, inc CBF, inc CBV). He was given 2 IVF boluses of 500cc NS and started on maintenance IVF and HOB <30 to maximize cerebral perfusion. Later at 2pm, the patient had new onset of left perioral numbness that but no other symptoms and exam otherwise unchanged. Repeat IVF bolus was given and he was kept flat in bed. Of note, the patient notes that over the past couple of months, he has had symptoms of a chest cold, but was actually starting to feel better the past ___ days. Also, he was not particularly dehydrated the day prior to his symptom onset. ROS: positive as above. Negative for HA, lightheadedness, or confusion. Denies difficulty with producing or comprehending speech. Denies loss of vision, blurred vision, diplopia, vertigo, tinnitus, hearing difficulty, dysarthria, or dysphagia. Denies bowel or bladder incontinence or retention. Denies difficulty with gait. On general review of systems, the patient denies fevers, rigors, night sweats, or noticeable weight loss. Denies chest pain, palpitations. Denies nausea, vomiting, diarrhea, constipation, or abdominal pain. No recent change in bowel or bladder habits. Denies dysuria or hematuria. Denies myalgias, arthralgias, or rash. Past Medical History: - HTN - on 2 antihypertensives - HLD - never required a statin - asthma Social History: ___ Family History: Father's family history unknown as father was adopted. In mother's side, there are no strokes or seizures or neurological conditions. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals at 1115am: BP 176/96 HR 86 RR 14 POX 100 RA General: NAD HEENT: NCAT, no oropharyngeal lesions, neck supple ___: RRR, no M/R/G, no carotid bruits Pulmonary: CTAB, no crackles or wheezes Abdomen: Soft, NT, ND, +BS, no guarding Extremities: Warm, no edema Neurologic Examination: - Mental Status - Awake, alert, oriented x 3. Attention to examiner easily maintained. Recalls a coherent history. Able to recite months of year backwards. Speech is fluent with full sentences, intact repetition, and intact verbal comprehension. Naming intact to stroke card, thumb and knuckles. No paraphasias. Normal prosody. No dysarthria. No apraxia. No evidence of hemineglect. No left-right confusion. No finger agnosia. - Cranial Nerves - PERRL 4->2 brisk. VF full to number counting. EOMI, no nystagmus. V1-V3 without deficits to light touch bilaterally. At rest there is slight LNFF. With activation there is a moderate-severe lower facial palsy on the left. No involvement of eye closure or brow furrowing on the left. Hearing intact to finger rub bilaterally. Palate elevation symmetric. SCM/Trapezius strength ___ bilaterally. Tongue midline. - Motor - Normal bulk and tone. No drift bilaterally. No tremor or asterixis. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L 5 ___ 0 0 5 5 5 5 5 5 5 R 5 ___ ___ 5 5 5 5 5 5 - Sensory - No deficits to light touch, pin bilaterally despite subjective feeling of numbness and tingling distal to mid forearm. No extinction to DSS. -DTRs: Bi Tri ___ Pat Ach L 2 2 2 2 1 R 2 2 2 2 1 Plantar response flexor bilaterally. - Coordination - No dysmetria with finger to nose testing bilaterally. Good speed and intact cadence with rapid alternating movements on the right - Gait - deferred to maintain cerebral perfusion. =========================================================== DISCHARGE PHYSICAL EXAM: Pertinent Results: ADMISSION LABS: ___ 11:20AM BLOOD WBC-9.7 RBC-4.57* Hgb-14.8 Hct-42.4 MCV-93 MCH-32.4* MCHC-34.9 RDW-11.5 RDWSD-38.6 Plt ___ ___ 11:20AM BLOOD ___ PTT-29.8 ___ ___ 06:15AM BLOOD Glucose-83 UreaN-14 Creat-0.9 Na-137 K-4.1 Cl-100 HCO3-26 AnGap-15 ___ 11:20AM BLOOD ALT-32 AST-34 AlkPhos-111 TotBili-0.6 ___ 11:20AM BLOOD cTropnT-<0.01 ___ 09:42PM BLOOD CK-MB-2 cTropnT-<0.01 ___ 11:20AM BLOOD Albumin-4.4 Calcium-9.7 Phos-2.3* Mg-1.9 ___ 02:22PM BLOOD %HbA1c-5.3 eAG-105 ___ 06:15AM BLOOD Triglyc-77 HDL-43 CHOL/HD-4.3 LDLcalc-126 ___ 11:20AM BLOOD ASA-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG IMAGING: CTA HEAD AND NECK ___: 1. No stenosis by NASCET criteria in bilateral carotid arteries. 2. Small irregularities and a tiny ulcer are present at the left internal carotid artery origin. There are bilateral mild calcified plaques at the internal carotid artery origins. Atheromas are visualized on the aortic arch. CXR ___: No acute cardiopulmonary abnormality. MRI BRAIN ___: 1. Acute infarction in the cortex of the right precentral and postcentral gyri. 2. Normal MRA of the head. TTE ___: The left atrial volume index is normal. No atrial septal defect or patent foramen ovale is seen by 2D, color Doppler or saline contrast with maneuvers. The estimated right atrial pressure is ___ mmHg. Normal left ventricular wall thickness, cavity size, and regional/global systolic function (biplane LVEF = 61 %). The estimated cardiac index is normal (>=2.5L/min/m2). Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. The mitral valve leaflets are structurally normal. There is no mitral valve prolapse. Mild (1+) mitral regurgitation is seen. The estimated pulmonary artery systolic pressure is high normal. There is no pericardial effusion. IMPRESSION: Mild mitral regurgitation with normal valve morphology. Normal biventricular cavity sizes with preserved regional and global biventricular systolic function. No definite structural cardiac source of embolism identified. DISCHARGE LABS: NONE Brief Hospital Course: Mr. ___ is a ___ year-old right-handed man with a history of HTN, HLD and asthma who presented to the ED after acute onset of left face/arm weakness and left arm numbness with MRI showing acute ischemic infarct in the primary motor and sensory cortecies. # Acute ischemic infarct: On admission, the patient's neurological exam revealed left lower face, hand and wrist weakness, without objective sensory findings. MRI showed an acute ischemic infarct in the right MCA distribution. He was monitored on tele which showed sinus bradycardia. TTE was without PFO or thrombus. CTA did not show any evidence of stenosis. A1c 5.3. He was scheduled for a TEE but elected to have this done as an outpatient. Etiology of stroke was thought secondary to embolic cause. He was discharged with ___ of ___ monitor to monitor for atrial fibrillation. He will follow-up with stroke neurology. # HTN: His home amlodipine and HCTZ were initially held to allow for perfusion and restarted on discharge. # HLD: Patient is not on home treatment. His cholesteral panel was HDL 43, LDL 126 triglycerides 77. Statin therapy should be discussed an outpatient. Transitional issus: - f/u ___ data - will need TEE as an outpatient, will be contacted by the cardiology department with a time for procedure - consider treatment for cholesterol - no HCP chosen - family contact: daughter ___: ___ - code: presumed FULL Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Hydrochlorothiazide 25 mg PO DAILY 2. Amlodipine 2.5 mg PO DAILY 3. Famotidine 10 mg PO DAILY 4. Albuterol Inhaler ___ PUFF IH Q4H:PRN sob 5. Centrum Silver (multivit-min-FA-lycopen-lutein;<br>mv-min-folic acid-lutein) 0.4-300-250 mg-mcg-mcg oral DAILY Discharge Medications: 1. Albuterol Inhaler ___ PUFF IH Q4H:PRN sob 2. Famotidine 10 mg PO DAILY 3. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*3 4. Amlodipine 2.5 mg PO DAILY 5. Centrum Silver (multivit-min-FA-lycopen-lutein;<br>mv-min-folic acid-lutein) 0.4-300-250 mg-mcg-mcg oral DAILY 6. Hydrochlorothiazide 25 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Primary diagnosis: Acute ischemic infaract, right frontal lobe Secondary diagnosis: Hypertension Hyperlipidemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, You were admitted to ___ with left facial droop, slurred speech, left sided arm weakness and parasthesias. You had a CT and MRI of your brain and found to have a stroke. You were started on aspirin. You were also monitored on telemetry which did not show any evidence of atrial fibrillation. Additionally, you had an ultrasound of your heart which did not show any evidence of clot. You will need a trans-esophageal echocardiogram to further evaluate from clot in your heart. This will be done as an outpatient. You will be contacted by someone from the cardiology department to have this done at BID- ___. If you do not get a call within 2 weeks, you should call ___ and ask to speak to the cardiology department for scheduling trans-esophageal echocardiograms. You will be leaving with a long-term monitor to check your heart rhythm after you leave the hospital. You will follow-up with stroke neurology as an outpatient. It was a pleasure taking care of you, Your ___ Neurologists Followup Instructions: ___
10381829-DS-12
10,381,829
21,090,381
DS
12
2137-03-25 00:00:00
2137-03-25 11:59:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: sudden onset of R sided hemiparesis Major Surgical or Invasive Procedure: none History of Present Illness: ___ presents for right-sided hemiparesis. He is post-op day 6 from a left temporal craniotomy for tumor resection with Dr. ___ on ___. He reports he was doing quite well until around 1630 on ___ when he had an acute onset of right-sided hemiparesis. He denies headache, vision changes, numbness, tingling, difficulty with speech. He initially presented to ___ where he underwent a non-contrast head CT that only revealed post-surgical changes. He was then transferred to ___ for further evaluation and management. He now reports that his symptoms are somewhat improving but he still has significant weakness. Past Medical History: Past Medical History: He has a thyroid mass which is benign on biopsy. He does not have diabetes, hypertension, hypercholesterolemia, or COPD. Past Surgical History: He had an appendectomy for ruptured appendicitis. He also had a cholecystectomy. Social History: ___ Family History: Family History: His mother has multiple sclerosis. His father is healthy. He has a younger sister and she is healthy. He does not have children. Physical Exam: PHYSICAL EXAM: Temp: 98.3 HR: 86 BP: 151/90 RR: 18 O2Sat: 98% RA Gen: WD/WN, comfortable, NAD. HEENT: Pupils: PERRL ___, brisk EOMs: Intact Extrem: Warm and well-perfused. Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Language: Speech fluent with good comprehension and repetition. Naming intact. No dysarthria or paraphasic errors. Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, 5 to 3mm bilaterally. III, IV, VI: Extraocular movements intact bilaterally without nystagmus, though requires head tilt to the right in order to see without diplopia V, VII: right-sided facial droop present. VIII: Hearing intact to voice. XII: Tongue deviated to right Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. + right-sided pronator drift D B T Grip IP Q H AT ___ G Sensation: Intact to light touch Pertinent Results: ___ 06:45AM BLOOD WBC-13.2* RBC-4.63 Hgb-13.5* Hct-38.2* MCV-83 MCH-29.2 MCHC-35.3 RDW-12.2 RDWSD-36.1 Plt ___ ___ 06:45AM BLOOD Glucose-115* UreaN-11 Creat-0.7 Na-137 K-4.1 Cl-100 HCO3-24 AnGap-17 ___ 06:35PM BLOOD ALT-29 AST-14 LD(LDH)-166 CK(CPK)-40* AlkPhos-77 TotBili-0.5 ___ 06:35PM BLOOD TotProt-6.3* Albumin-3.8 Globuln-2.5 Cholest-156 ___ 06:35PM BLOOD %HbA1c-5.0 eAG-97 ___ 06:35PM BLOOD Triglyc-147 HDL-37 CHOL/HD-4.2 LDLcalc-90 ___ 06:35PM BLOOD TSH-0.20* ___ 12:45PM BLOOD T4-8.8 T3-97 ___ 06:35PM BLOOD CRP-2.6 Brief Hospital Course: Mr. ___ was admitted to the neurology stroke service. MRI Brain revealed a subacute infarct in the left caudate. EEG showed no epileptiform discharges. He was increased on Keppra to 1500 BID and steroid taper was increased from 2 mg BID to 4 mg Q8h. During his admission, he was noted to have asymptomatic tachycardia. TSH was 0.20 but T3 and T4 were wnl. Given the tachycardia (140s) he was started on low dose propranolol 10 mg TID with improvement in the HR (70s-100s). Because of the new hemiplegia, he was planned to transition to fluoxetine 20 mg daily from citalopram 10 mg daily, per ___ trial. Cross-taper is described in discharge instructions. He also noted that he had diplopia which is improved with head tilt to the right which should be further discussed with Dr. ___ at next neurosurgery visit; if not improving neuro-ophthalmology can be considered. He will be discharged to rehab with follow up with neurosurgery (post-op), neurooncology (path follow-up), and endocrinology (low TSH and tachycardia). ----------- Studies: CTA H&N ___ 1. Dental amalgam streak artifact limits study. 2. Status post resection of a left temporal and insular mass with postsurgical changes, as described above with stable 6 mm rightward midline shift, and approximately 8 mm extracranial fluid collection overlying surgical bed. 3. Left lenticulostriate corresponding CT perfusion images demonstrate a match defect. 4. Matched perfusion defect within the left temporal lobe and insula correspond to surgical resection cavity. 5. Attenuated left superior division M2 segment of the middle cerebral artery. Otherwise, patent circle of ___. 6. No internal carotid artery stenosis by NASCET criteria. 7. Re-demonstration of patient's known left thyroid gland lesion. MRI Brain ___ 1. Subacute infarction in the left caudate body, posterior limb of the left internal capsule, and left putamen in the lenticulostriate distribution. 2. Edema and postoperative inflammatory changes in the resection cavity in the left temporal lobe with mass effect and rightward midline shift of 6 mm, unchanged from CT head ___. EEG ___ IMPRESSION: This is an abnormal routine EEG in the awake and asleep states due to the presence of continuous slowing over the left hemisphere. This finding indicates focal cerebral dysfunction on the left side, as from a structural lesion. No epileptiform features were seen. Note is made of a regular tachycardia. AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic Attack 1. Dysphagia screening before any PO intake? (x) Yes, confirmed done - () Not confirmed () No 2. DVT Prophylaxis administered? (x) Yes - () No 3. Antithrombotic therapy administered by end of hospital day 2? (x) Yes - () No 4. LDL documented? (x) Yes (LDL = 90) - () No 5. Intensive statin therapy administered? (simvastatin 80mg, simvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg, rosuvastatin 20mg or 40mg, for LDL > 70) () Yes - (x) No [if LDL >70, reason not given: [ ] Statin medication allergy [x ] Other reasons documented by physician/advanced practice nurse/physician ___ (physician/APN/PA) or pharmacist #1 we expect a 30% reduction of LDL with this dose #2 given recent surgery there is a 5% risk of bleed with high dose atorvastatin [ ] LDL-c less than 70 mg/dL ] 6. Smoking cessation counseling given? () Yes - (x) No [reason (x) non-smoker - () unable to participate] 7. Stroke education (personal modifiable risk factors, how to activate EMS for stroke, stroke warning signs and symptoms, prescribed medications, need for followup) given (verbally or written)? (x) Yes - () No 8. Assessment for rehabilitation or rehab services considered? (x) Yes - () No 9. Discharged on statin therapy? (x) Yes - () No [if LDL >70, reason not given: [ ] Statin medication allergy [ ] Other reasons documented by physician/advanced practice nurse/physician ___ (physician/APN/PA) or pharmacist [ ] LDL-c less than 70 mg/dL 10. Discharged on antithrombotic therapy? (x) Yes [Type: (x) Antiplatelet - () Anticoagulation] - () No 11. Discharged on oral anticoagulation for patients with atrial fibrillation/flutter? () Yes - () No - (x) N/A Medications on Admission: The Preadmission Medication list is accurate and complete. 1. LevETIRAcetam 1250 mg PO BID 2. Citalopram 10 mg PO DAILY 3. Dexamethasone 2 mg PO Q12H Discharge Medications: 1. Artificial Tears ___ DROP RIGHT EYE PRN dry/itchy eyes 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 10 mg PO QPM 4. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation 5. Citalopram 3.5 mg PO DAILY Duration: 3 Days ___ 6. Docusate Sodium 100 mg PO BID 7. Famotidine 20 mg PO BID 8. FLUoxetine 10 mg PO DAILY Duration: 2 Weeks ___ 9. FLUoxetine 20 mg PO DAILY starting ___ 10. HydrOXYzine 25 mg PO QHS:PRN Insomnia 11. Milk of Magnesia 30 mL PO Q6H:PRN Constipation 12. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Moderate 13. Propranolol 10 mg PO/NG TID 14. Citalopram 5 mg PO DAILY Duration: 4 Days ___ 15. Dexamethasone 4 mg PO Q8H 16. LevETIRAcetam 1500 mg PO BID Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: left basal ganglia and posterior limb of internal capsule ischemic stroke Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, You were hospitalized due to symptoms of left sided weakness resulting from an ACUTE ISCHEMIC STROKE, a condition where a blood vessel providing oxygen and nutrients to the brain is blocked by a clot. The brain is the part of your body that controls and directs all the other parts of your body, so damage to the brain from being deprived of its blood supply can result in a variety of symptoms. Stroke can have many different causes, so we assessed you for medical conditions that might raise your risk of having stroke. In order to prevent future strokes, we plan to modify those risk factors. Your risk factors are: cholesterol 90 We are changing your medications as follows: atorvastatin 10 mg nightly Please take your other medications as prescribed. Please followup with Neurolosurgery, neuro oncology, and endocrinology. If you experience any of the symptoms below, please seek emergency medical attention by calling Emergency Medical Services (dialing 911). In particular, since stroke can recur, please pay attention to the sudden onset and persistence of these symptoms: - Sudden partial or complete loss of vision - Sudden loss of the ability to speak words from your mouth - Sudden loss of the ability to understand others speaking to you - Sudden weakness of one side of the body - Sudden drooping of one side of the face - Sudden loss of sensation of one side of the body Sincerely, Your ___ Neurology Team Followup Instructions: ___
10381881-DS-14
10,381,881
21,161,617
DS
14
2182-12-15 00:00:00
2182-12-15 18:31:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: diverticulitis pelvic abscess Major Surgical or Invasive Procedure: ___ ___ drainage ___ sigmoid colectomy (open), diverting loop ileostomy History of Present Illness: ___ PMH HTN recently admitted for sigmoid diverticulitis w/ intramural abscess now w/ enlarged abscess causing left hydronephrosis and colouterine fistula. Patient was recently admitted to ___ ___ with acute sigmoid diverticulitis with a 4x2x4 cm intramural abscess. She was treated with bowel rest and levaquin/flagyl. She remained afebrile and hemodynamically stable through the hospital stay and WBC was 9.2 on discharge. She was discharged with prescription for 12 more days of levaquin/flagyl. Plan was to follow-up with PCP ___ 2 weeks for repeat exam/imaging. She reports that her pain never really improved after admission and was ___ at time of discharge and has slowly worsened. She reports persistent anorexia and frequent loose bowel movements. She has noted she is urinating more than usual, but attributes this to drinking much more water in an effort to stay hydrated. She was also instructed to follow-up with her PCP within the week which she did on ___. Her PCP was concerned that she was not improving as expected and referred her to ___ earlier today for CT scan which showed interval increase in the size of pelvic abscess as well as interval development of mild left hydroureter and air within the uterus concerning for colouterine fistula. She was transferred to ___ for further intervention. Past Medical History: -HTN -sigmoid diverticulitis with lateral sigmoid -gout Social History: ___ Family History: -Mother with ___ procedure and reversal for perforated diverticulitis in her ___ or ___, CABG in her later years -Brother with colon cancer in his ___ as well as EtOH cirrhosis (deceased in his ___ -Father deceased from CVA in his ___ Physical Exam: Vitals Temp:98.4 BP:109/69 HR:90 RR:18 O2sat:98 Ra GEN: NAD, siting in chair comfortably HEENT: PERRLA, EOMI, no scleral icterus CV: RRR PULM: clear to auscultation bilaterally, non-labored breathing ABD: soft, non distended, non tender, with ostomy bag that has stool output. wound looks clean, dry and intact EXT: warm and well perfused, no edema NEURO: A&Ox3 Pertinent Results: ___ 04:09PM URINE HOURS-RANDOM ___ 04:09PM URINE UHOLD-HOLD ___ 04:09PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 04:09PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR* GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-LG* ___ 04:09PM URINE RBC-2 WBC-40* BACTERIA-FEW* YEAST-NONE EPI-0 ___ 03:20PM GLUCOSE-108* UREA N-10 CREAT-1.0 SODIUM-137 POTASSIUM-3.9 CHLORIDE-102 TOTAL CO2-19* ANION GAP-16 ___ 03:20PM estGFR-Using this ___ 03:20PM ___ PTT-27.6 ___ ___ 02:44PM COMMENTS-GREEN TOP ___ 02:44PM LACTATE-2.8* ___ 02:30PM WBC-16.3* RBC-3.92 HGB-12.3 HCT-38.9 MCV-99* MCH-31.4 MCHC-31.6* RDW-13.0 RDWSD-47.4* ___ 02:30PM NEUTS-82.6* LYMPHS-7.5* MONOS-8.1 EOS-0.1* BASOS-0.7 IM ___ AbsNeut-13.44* AbsLymp-1.22 AbsMono-1.32* AbsEos-0.02* AbsBaso-0.11* ___ 02:30PM PLT COUNT-298 Brief Hospital Course: ___ were admitted to ___ and underwent sigmoid resection and loop ileostomy. ___ initially came with diverticulitis recurrence and ___ were found to have an increased pelvic abscess and a colovesical fistula. It was decided to place a drain for bowel rest and to plan for sigmoid resection and ileostomy. During your hospital stay it was noted that ___ were not progressing appropriately. On ___ your drain cultures came back with pseudomona aeruginosa and ___ were started on cefepime and flagyl. ___ began to progress appropriately. During the hospital stay ___ were also found to have a positive stool culture for c. diff and ___ were started on PO vancomycin. After your pain was well controlled, your vital signs were stable and your labs were within normal limits, it was decided to proceed with the sigmoid resection and loop ileostomy. After an uncomplicated procedure ___ were taken to the floor. ___ were started on a clear liquid diet on POD 1 and once ___ tolerated ___ were given a regular diet. ___ had a JP drain placed in the OR that has had minimal serosanguinous output through out the hospital stay. The JP was removed on the day of discharge. ___ have been progressing appropriately, tolerating a regular diet, walking, with pain well controlled, and vital signs within normal limits. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 20 mg PO DAILY 2. Allopurinol Dose is Unknown PO DAILY Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H RX *acetaminophen [8 Hour Pain Reliever] 650 mg 1 tablet(s) by mouth Q8 Disp #*40 Tablet Refills:*0 2. Omeprazole 20 mg PO DAILY RX *omeprazole 20 mg 1 capsule(s) by mouth daily Disp #*20 Capsule Refills:*0 3. Ondansetron 4 mg PO Q8H:PRN Nausea/Vomiting - First Line Duration: 5 Days RX *ondansetron 4 mg 1 tablet(s) by mouth Q8 Disp #*10 Tablet Refills:*0 4. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Moderate RX *oxycodone [Oxaydo] 5 mg 1 tablet(s) by mouth Q4 Disp #*4 Tablet Refills:*0 5. Vancomycin Oral Liquid ___ mg PO QID RX *vancomycin [Firvanq] 25 mg/mL 5 ml by mouth four times a day Refills:*0 6. Allopurinol ___ mg PO DAILY 7. Lisinopril 20 mg PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: sigmoid diverticulitis pelvic abscess colovesical fistula Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Please get an abdomen and pelvis CT scan with rectal contrast and bring the live images plus the interpretation to your appointment in ___ in ___. Dear ___, ___ were admitted to ___ and underwent sigmoid resection and loop ileostomy. ___ initially came with diverticulitis recurrence and ___ were found to have an increased pelvic abscess and a colovesical fistula. It was decided to place a drain for bowel rest and to plan for sigmoid resection and ileostomy. During your hospital stay it was noted that ___ were not progressing appropriately. On ___ your drain cultures came back with pseudomona aeruginosa and ___ were started on cefepime and flagyl. ___ began to progress appropriately. During the hospital stay ___ were also found to have a positive stool culture for c. diff and ___ were started on PO vancomycin. After your pain was well controlled, your vital signs were stable and your labs were within normal limits, it was decided to proceed with the sigmoid resection and loop ileostomy. After an uncomplicated procedure ___ were taken to the floor. ___ were started on a clear liquid diet on POD 1 and once ___ tolerated ___ were given a regular diet. ___ had a JP drain placed in the OR that has had minimal serosanguinous output through out the hospital stay. The JP was removed on the day of discharge. ___ have been progressing appropriately, tolerating a regular diet, walking, with pain well controlled, and vital signs within normal limits. ___ are recovering well and are now ready for discharge. Please follow the instructions below to continue your recovery: Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: ___ experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If ___ are vomiting and cannot keep down fluids or your medications. ___ are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. ___ see blood or dark/black material when ___ vomit or have a bowel movement. ___ experience burning when ___ urinate, have blood in your urine, or experience a discharge. *Your pain is not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. ___ have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern ___. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until ___ follow-up with your surgeon. Avoid driving or operating heavy machinery while taking pain medications. Incision Care: *Please call your doctor or nurse practitioner if ___ have increased pain, swelling, redness, or drainage from the incision site. *Avoid swimming and baths until your follow-up appointment. ___ may shower, and wash surgical incisions with a mild soap and warm water. Gently pat the area dry. Monitoring Ostomy output/ Prevention of Dehydration: *Keep well hydrated. *Replace fluid loss from ostomy daily. *Avoid only drinking plain water. Include Gatorade and/or other vitamin drinks to replace fluid. *Try to maintain ostomy output between 1000mL to 1500mL per day. *If Ostomy output >1 liter, take 4mg of Imodium, repeat 2mg with each episode of loose stool. Do not exceed 16mg/24 hours. OSTOMY DISCHARGE INSTRUCTIONS: ___ have a new ileostomy. The most common complication from a new ileostomy placement is dehydration. The output from the stoma is stool from the small intestine and the water content is very high. The stool is no longer passing through the large intestine which is where the water from the stool is reabsorbed into the body and the stool becomes formed. ___ must measure your ileostomy output for the next few weeks. The output from the stoma should not be more than 1200cc or less than 500cc. If ___ find that your output has become too much or too little, please call the office for advice. The office nurse or nurse practitioner can recommend medications to increase or slow the ileostomy output. Keep yourself well hydrated, if ___ notice your ileostomy output increasing, take in more electrolyte drink such as Gatorade. Please monitor yourself for signs and symptoms of dehydration including: dizziness (especially upon standing), weakness, dry mouth, headache, or fatigue. If ___ notice these symptoms please call the office or return to the emergency room for evaluation if these symptoms are severe. ___ may eat a regular diet with your new ileostomy. However it is a good idea to avoid fatty or spicy foods and follow diet suggestions made to ___ by the ostomy nurses. Please monitor the appearance of the ostomy and stoma and care for it as instructed by the wound/ostomy nurses. ___ stoma (intestine that protrudes outside of your abdomen) should be beefy red or pink, it may ooze small amounts of blood at times when touched and this should subside with time. The skin around the ostomy site should be kept clean and intact. Monitor the skin around the stoma for bulging or signs of infection listed above. Please care for the ostomy as ___ have been instructed by the wound/ostomy nurses. ___ will be able to make an appointment with the ostomy nurse in the clinic 7 days after surgery. ___ will have a visiting nurse at home for the next few weeks helping to monitor your ostomy until ___ are comfortable caring for it on your own. Followup Instructions: ___
10381914-DS-17
10,381,914
21,523,240
DS
17
2185-07-26 00:00:00
2185-07-26 13:29:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: Penicillins Attending: ___ Chief Complaint: RUQ pain Major Surgical or Invasive Procedure: ___: laparoscopic cholecystectomy History of Present Illness: Mr. ___ is a ___ male with an episode of RUQ pain he attributes to gallstones eight months ago who now presents with pain since ___ afternoon. He was seen the in ___ ED on ___ night and observed overnight with improvement in his pain by morning. He was discharged to home but his pain persisted and he also reports a low grade fever to 100.1 and now represents to ___ ED for evaluation. He denies nausea and emesis, chest pain and SOB. Past Medical History: none Social History: ___ Family History: NC Physical Exam: Admission PE ___ Vitals: 99.0 83 126/72 16 98% RA NAD, AAOx3 RRR CTA b/l soft, nondistended, tender to palpation in RUQ, no rebound, no guarding, positive Murphys no peripheral edema or cyanosis Discharge PE: ___: Vitals: 99.8, 75, 135/82, 18, 99% on RA Gen: NAD, comfortable appearring man Lungs: CTAB CV: S1, S2, RRR Abd: soft, appropriately tender at port sites, X 4 lap ports sites with primary dressing, no staining Ext.: Warm, well perfused, +PP Neuro: Alert and oriented X3, MAE to command Pertinent Results: ___ 01:30AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG ___ 01:30AM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 10:00PM LACTATE-1.1 ___ 10:00PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-2* PH-7.0 LEUK-NEG ___ 07:55PM GLUCOSE-94 UREA N-14 CREAT-0.8 SODIUM-141 POTASSIUM-4.5 CHLORIDE-102 TOTAL CO2-29 ANION GAP-15 ___ 07:55PM ALT(SGPT)-35 AST(SGOT)-24 ALK PHOS-62 TOT BILI-0.8 ___ 07:55PM LIPASE-38 ___ 07:55PM ALBUMIN-4.6 ___ 07:55PM WBC-7.6 RBC-4.35* HGB-13.8* HCT-40.7 MCV-94 MCH-31.7 MCHC-33.8 RDW-13.1 ___ 07:55PM NEUTS-66.5 ___ MONOS-7.1 EOS-2.0 BASOS-0.5 ___ 07:00AM BLOOD WBC-7.6 RBC-4.38* Hgb-13.4* Hct-40.2 MCV-92 MCH-30.5 MCHC-33.3 RDW-12.6 Plt ___ ___ 07:00AM BLOOD Glucose-94 UreaN-10 Creat-0.9 Na-139 K-4.4 Cl-100 HCO3-31 AnGap-12 ___ 07:00AM BLOOD Calcium-9.0 Phos-3.5 Mg-2.2 Brief Hospital Course: Mr. ___ is a ___ year old who was admitted on ___ under the acute care surgery service for management of acute cholecystitis. He was taken to the operating room and underwent a laparoscopic cholecystectomy by Dr. ___. Please see operative report for details of this procedure. He tolerated the procedure well and was extubated upon completion. He was subsequently taken to the PACU for recovery. He was transferred to the surgical floor hemodynamically stable. His vital signs were routinely monitored and he remained afebrile and hemodynamically stable. He was initially given IV fluids postoperatively, which were discontinued when he was tolerating PO's. His diet was advanced on the evening of ___ to regular, which he tolerated without abdominal pain, nausea, or vomiting. He was voiding adequate amounts of urine without difficulty. He was encouraged to mobilize out of bed and ambulate as tolerated, which he was able to do independently. His pain level was routinely assessed and well controlled at discharge with an oral regimen as needed. On ___, he was discharged home with scheduled follow up in ___ clinic on ___. Medications on Admission: none Discharge Medications: 1. Acetaminophen ___ mg PO Q6H:PRN pain 2. Docusate Sodium 100 mg PO BID constipation RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 3. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN pain Do not drive or drink alcohol while on this medication. RX *hydromorphone [Dilaudid] 2 mg ___ tablet(s) by mouth every four (4) hours Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: cholecystitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mr. ___, You were admitted to the hospital with acute cholecystitis. You were taken to the operating room and had your gallbladder removed laparoscopically. You tolerated the procedure well and are now being discharged home to continue your recovery with the following instructions. Please follow up in the Acute Care Surgery clinic at the appointment listed below. ACTIVITY: o Do not drive until you have stopped taking pain medicine and feel you could respond in an emergency. o You may climb stairs. o You may go outside, but avoid traveling long distances until you see your surgeon at your next visit. o Don't lift more than ___ lbs for 4 weeks. (This is about the weight of a briefcase or a bag of groceries.) This applies to lifting children, but they may sit on your lap. o You may start some light exercise when you feel comfortable. o You will need to stay out of bathtubs or swimming pools for a time while your incision is healing. Ask your doctor when you can resume tub baths or swimming. HOW YOU MAY FEEL: o You may feel weak or "washed out" for a couple of weeks. You might want to nap often. Simple tasks may exhaust you. o You may have a sore throat because of a tube that was in your throat during surgery. o You might have trouble concentrating or difficulty sleeping. You might feel somewhat depressed. o You could have a poor appetite for a while. Food may seem unappealing. o All of these feelings and reactions are normal and should go away in a short time. If they do not, tell your surgeon. YOUR INCISION: o Tomorrow you may shower and remove the gauzes over your incisions. Under these dressing you have small plastic bandages called steri-strips. Do not remove steri-strips for 2 weeks. (These are the thin paper strips that might be on your incision.) But if they fall off before that that's okay). o Your incisions may be slightly red around the stitches. This is normal. o You may gently wash away dried material around your incision. o Avoid direct sun exposure to the incision area. o Do not use any ointments on the incision unless you were told otherwise. o You may see a small amount of clear or light red fluid staining your dressing or clothes. If the staining is severe, please call your surgeon. o You may shower. As noted above, ask your doctor when you may resume tub baths or swimming. YOUR BOWELS: o Constipation is a common side effect of narcotic pain medications. If needed, you may take a stool softener (such as Colace, one capsule) or gentle laxative (such as milk of magnesia, 1 tbs) twice a day. You can get both of these medicines without a prescription. o If you go 48 hours without a bowel movement, or have pain moving the bowels, call your surgeon. PAIN MANAGEMENT: o It is normal to feel some discomfort/pain following abdominal surgery. This pain is often described as "soreness". o Your pain should get better day by day. If you find the pain is getting worse instead of better, please contact your surgeon. o You will receive a prescription for pain medicine to take by mouth. It is important to take this medicine as directed. o Do not take it more frequently than prescribed. Do not take more medicine at one time than prescribed. o Your pain medicine will work better if you take it before your pain gets too severe. o Talk with your surgeon about how long you will need to take prescription pain medicine. Please don't take any other pain medicine, including non-prescription pain medicine, unless your surgeon has said its okay. o If you are experiencing no pain, it is okay to skip a dose of pain medicine. o Remember to use your "cough pillow" for splinting when you cough or when you are doing your deep breathing exercises. If you experience any of the following, please contact your surgeon: - sharp pain or any severe pain that lasts several hours - pain that is getting worse over time - pain accompanied by fever of more than 101 - a drastic change in nature or quality of your pain MEDICATIONS: Take all the medicines you were on before the operation just as you did before, unless you have been told differently. If you have any questions about what medicine to take or not to take, please call your surgeon. Followup Instructions: ___
10382041-DS-2
10,382,041
29,030,020
DS
2
2188-08-31 00:00:00
2188-08-31 15:34:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Major Surgical or Invasive Procedure: ERCP X 2 attach Pertinent Results: Admission Labs: =============== ___ 07:05PM BLOOD WBC-8.4 RBC-4.02* Hgb-11.6* Hct-37.4* MCV-93 MCH-28.9 MCHC-31.0* RDW-15.1 RDWSD-50.4* Plt ___ ___ 07:05PM BLOOD Neuts-70.5 ___ Monos-8.3 Eos-0.4* Baso-0.2 Im ___ AbsNeut-5.94 AbsLymp-1.68 AbsMono-0.70 AbsEos-0.03* AbsBaso-0.02 ___ 07:05PM BLOOD ___ PTT-27.8 ___ ___ 07:05PM BLOOD Glucose-99 UreaN-10 Creat-0.7 Na-141 K-4.1 Cl-101 HCO3-25 AnGap-15 ___ 07:05PM BLOOD ALT-117* AST-108* AlkPhos-1636* TotBili-1.9* ___ 07:00AM BLOOD Calcium-8.6 Phos-2.8 Mg-1.6 ___ 07:05PM BLOOD Albumin-3.8 ___ 07:11PM BLOOD Lactate-1.5 Imaging: ======== CT Chest w/ Contrast: No evidence of infection. CT Abd/Pelvis w/ Contrast: 1. Deep venous thrombosis of the right common iliac vein and right IVC. 2. Possible stone noted in the distal CBD, at the level of the ampulla. Recommend further evaluation with MRCP. This could also better assess the mild unexplained pancreatic duct dilation. 3. Hyperemia of the common bile duct, an expected finding in the setting of recent ERCP. Discharge Labs: =============== ___ 06:15AM BLOOD WBC-5.4 RBC-3.12* Hgb-8.9* Hct-28.3* MCV-91 MCH-28.5 MCHC-31.4* RDW-14.6 RDWSD-47.9* Plt ___ ___ 06:15AM BLOOD ___ PTT-66.7* ___ ___ 06:15AM BLOOD Glucose-98 UreaN-7 Creat-0.6 Na-146 K-3.5 Cl-106 HCO3-27 AnGap-13 ___ 06:15AM BLOOD ALT-51* AST-55* AlkPhos-875* TotBili-0.8 ___ 06:15AM BLOOD Calcium-8.1* Phos-3.4 Mg-1.8 Brief Hospital Course: Mr. ___ is a ___ male with a PMHX of GERD, HLD, and recurrent cholangitis with bacteremia, who again presented with bacteremia in the setting of cholangitis. # Transaminitis # Biliary Obstruction s/p stent # Cholangitis: # Bacteremia: Multiple recent episodes of biliary obstruction complicated by cholangitis and bacteremia. He was scheduled for ERCP with Dr. ___ on ___ but then developed fever and was admitted on ___. Given rising bilirubin to 2.4 on admission, it was suspected that his fevers were secondary to cholangitis/intra-abdominal process. Blood cultures from ___ and ___ were positive for Klebsiella, also grown from previous positive cultures in ___ and ___. He underwent ERCP with removal of stones and sludge. Given recurrent/persistent bacteremia (three episodes in seven weeks), there was some concern for additional source of infection or lack of source control. CT torso was obtained and was negative for abscess, though did note a common iliac DVT extending into the IVC. There was also concern for ampullary stone on CT. He underwent repeat ERCP and no stones were found. He was initially treated with ceftriaxone/flagyl and narrowed to cipro based on culture data. He was also seen by ID who recommended an extended four week course of ciprofloxacin (last day ___ due to the possibility that clot was seeded in the setting of bacteremia or the source of his recurrent bacteremia (unlikely but unable to rule out). He will need a repeat ERCP in ___ weeks with spyglass cholangiography to further evaluate previously noted hepatic duct abnormality seen at ___. # Iliac vein DVT, IVC thrombus: Incidentally found to have right common iliac vein DVT extending to IVC. Would consider provoked due to immobility and inflammatory state. He was started on a heparin drip and transitioned to apixaban at discharge and will need at least a three month course. There was some concern that clot could be seeded/infected in the setting of recurrent/persistent bacteremia, though no clear phlebitis seen on CT. Therefore ID recommended four week antibiotic course as above. # Fever # Cough # Pneumonia CXR suggestive of pneumonia. He had fever (likely due to bacteremia). He endorsed cough but no shortness of breath. He was treated with a five day course of ceftriaxone/azithromycin. # Severe Malnutrition Has lost significant amount of weight over past couple months likely secondary to intraabdoinal infection/complication. Seen by nutrition who recommended ensure supplements # GERD: continued home omeprazole 20mg BID # HLD: held statin given transaminitis. Also held on discharge due to potential interaction with ciprofloxacin (increased risk of rhabdomyolysis). Can resume after ciprofloxacin course completed > 30 minutes spent on discharge coordination and planning Transitional Issues: ==================== - discharged on ciprofloxacin for four week course (last day ___ - found to have iliac vein and IVC thrombus. Will need three month course of anticoagulation for provoked DVT - he will need a repeat ERCP in ___ weeks with spyglass cholangiography to further evaluate previously noted hepatic duct abnormality seen at ___. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Omeprazole 20 mg PO BID 2. Simvastatin 40 mg PO QPM Discharge Medications: 1. Apixaban 10 mg PO BID for 7 days, then decrease to 5mg twice a day RX *apixaban [Eliquis] 5 mg (74 tabs) 10 mg by mouth twice a day Disp #*1 Dose Pack Refills:*0 2. Ciprofloxacin HCl 500 mg PO BID RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day Disp #*54 Tablet Refills:*0 3. Omeprazole 20 mg PO BID 4. HELD- Simvastatin 40 mg PO QPM This medication was held. Do not restart Simvastatin until you finish taking ciprofloxacin (simvastatin and ciprofloxacin can interact) Discharge Disposition: Home Discharge Diagnosis: Primary: Bacteremia Cholangitis Acute DVT Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You came in with fevers. We found that you had another infection in your bile ducts that spread to your blood. We treated you initially with IV antibiotics, and then switched to oral antibiotics once we identified the organism in your blood (Klebsiella, the same bacteria that grew in the blood before). Given your multiple recent infections, you had a CT scan to look for any other sources of infection. This scan showed a blood clot in the veins in your abdomen (right common iliac vein and IVC). We started you on a blood thinner. You will need to continue taking an oral blood thinner at home for the next three months. Blood thinners increase the risk of bleeding. Please avoid any contact sports, and if you fall and hit your head you should come to the emergency room immediately (blood thinners significantly increase your risk of bleeding into the head). You were seen by the infectious disease team. They feel that it is possible that the blood clot became infected. Because of this they recommended a longer course of antibiotics. You should take ciprofloxacin for one month (last day ___. You will also need to follow up with the ERCP doctors for ___ repeat ERCP. Someone should call you with an appointment, but if you do not hear from anyone please call ___ to schedule an appointment. It was a pleasure taking care of you, and we are happy that you're feeling better! Followup Instructions: ___
10382464-DS-21
10,382,464
21,171,914
DS
21
2114-10-06 00:00:00
2114-10-08 09:50:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: ACE Inhibitors / amlodipine / clonidine Attending: ___ Chief Complaint: presyncope Major Surgical or Invasive Procedure: None History of Present Illness: ___ hx of SSS now on coumadin after dual-chamber pacemaker placement ___, presents after 2 episodes of prescynope. Two days ago, pt lost her balance as her was bent over and fell onto a bureau, hitting her left back. That evening at ___ dinner, she experienced her first episode of presyncope: she was at the table when she suddenly became hot, sweaty, and lightheaded, but returned to baseline within one minute. On the morning of admission, she was placing a heating pad to her sore left-back and had a similar, but less severe sensation of heat, diaphoresis and lightheadedness, that resolved within one minute. Her daughter was concerned and brought her to the ED. She denies any palpitations, chest pain, shortness of breath, orthopnea, PND. Pt states she never had symptoms like this before, with her prior admissions for atrial fibrillation. She denies any medication changes since her pacemaker was placed one month ago. She was in her usual state of health until 2 days ago. She denies F/C, N/V/D. She c/o left low back pain but otherwise denied CP, SOB, lightheadedness, or other complaints. In the ED, initial vitals were 97.9 60 142/56 18 97% RA. Orthostatics were negative. She had TTP on the left lower back with concern for possible rib fracture from fall on exam. Labs notable for INR of 3.8. Guaiac negative. Troponin x1 negative. Per review of OMR notes, she was first diagnosed with atrial fibrillation in ___ when she presented to ___ with rapid palpitations, lightheadedness, and nausea. She underwent successful cardioversion to restore sinus rhythm. Coumadin was initiated. LVEF was noted to be at 35% at the time. She had recurrent symptoms one month later and was successfully cardioverted to sinus with initiation of Amiodarone. She presented again in ___ to ___ with presyncope and racing palpitations. She was found to be in atrial flutter and underwent ablation. She felt significantly better in sinus rhythm. In ___, she represented to ___ with recurrent rapid atrial fibrillation with heart rates 120-130's. As she had failed Amiodarone it was discontinued and Metoprolol was aggressively titrated up, currently 150mg bid. During that admission she had CHF. In addition she had acute cholecystitis requiring cholecystectomy. When she was evaluated in ___, she was found to be in sinus bradycardia with a heart rate in the 40-50 range. Due to this bradycardia, LBBB, and depressed LV function, she was referred for BiV pacemaker but was unsuccessful in implanting an LV lead. She had a dual-chamber pacer placed ___ and started on amiodarone and warfarin. On review of systems, she denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism. Cardiac review of systems is notable for absence of chest pain, dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, or palpitations. Past Medical History: 1. CARDIAC RISK FACTORS: - Diabetes, + Dyslipidemia, + Hypertension 2. CARDIAC HISTORY: Atrial fibrillation/flutter s/p ablation at ___ in ___ Congestive heart failure, LVEF 35% LBBB - CABG: none - PERCUTANEOUS CORONARY INTERVENTIONS: none - PACING/ICD: dual-chamber pacemaker, DDD mode 3. OTHER PAST MEDICAL HISTORY: Colon cancer, s/p right hemicolectomy in ___ Reflux esophagitis, hx of chronic gastritis s/p right knee replacement glucose intolerance Osteoporosis per ___ (patient denies) Hypothyroidism Cholecystitis s/p cholecystectomy ___ oophorectomy, hysterectomy (___) Glaucoma per ___ Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise non-contributory. Physical Exam: ADMISSION VS: Wt=91.9kg T=98.3 BP=161/65 HR=60 RR=20 O2 sat=98%RA General: slightly overweight woman in NAD HEENT: MMM, OP clear Neck: no JVD CV: RRR, nl s1/s2, ___ sysolic murmur heard in aortic and pulmonic areas Lungs: CTAB Abdomen: obese, soft, NT, normoactive BS GU: no foley Ext: warm, no edema Neuro: AAOx3 Skin: no lesions or rashes noted PULSES: 2+ radial pulse DISCHARGE General: slightly overweight woman in NAD HEENT: MMM, OP clear Neck: no JVD CV: RRR, nl s1/s2, ___ sysolic murmur heard in aortic and pulmonic areas Lungs: CTAB Abdomen: obese, soft, NT, normoactive BS Ext: warm, no edema Neuro: AAOx3 Pertinent Results: ADMISSION LABS ___ 01:11PM BLOOD WBC-10.3 RBC-4.82 Hgb-12.5 Hct-40.2 MCV-83 MCH-26.0* MCHC-31.2 RDW-16.4* Plt ___ ___ 01:11PM BLOOD Neuts-68.9 ___ Monos-6.8 Eos-0.8 Baso-0.5 ___ 01:11PM BLOOD Glucose-112* UreaN-18 Creat-0.9 Na-140 K-4.1 Cl-99 HCO3-31 AnGap-14 ___ 01:11PM BLOOD ___ PTT-41.9* ___ ___ 01:11PM BLOOD cTropnT-<0.01 ___ 09:30PM BLOOD CK-MB-2 cTropnT-<0.01 ECG ___: Atrial pacing. Intraventricular conduction delay. Left ventricular hypertrophy. Inferolateral ST segment changes may be due to left ventricular hypertrophy. Compared to the previous tracing of ___ there is now atrial pacing. The QRS morphology appears similar. CT HEAD ___ There is no evidence of intracranial hemorrhage, acute major vascular territorial infarction, shift of the normally midline structures, mass effect or edema. The ventricles and sulci are mildly prominent, compatible with age-related global atrophy. Periventricular and subcortical white matter hypodensities likely reflect the sequelae of chronic small vessel ischemic disease. The basal cisterns appear patent. The gray-white matter differentiation is preserved. No fractures are identified. The cranial and facial soft tissues are unremarkable. The visualized paranasal sinuses, mastoid air cells and middle ear cavities are clear. IMPRESSION: No acute intracranial process. Chronic small vessel ischemic disease. CT C-SPINE ___ FINDINGS: The cervical lordosis is preserved. There is no evidence of fracture or acute malalignment in the cervical spine. The prevertebral soft tissues are unremarkable. There is no lymphadenopathy. The visualized lung apices are grossly clear. The thyroid gland is unremarkable. Multilevel mild degenerative changes are present in the cervical spine including anterior and posterior osteophyte formation, multilevel facet arthropathy, and subchondral cystic change. IMPRESSION: No fracture or acute malalignment in the cervical spine. Mild degenerative changes. CT L-SPINE ___ FINDINGS: There is a compression deformity of the L3 vertebral body with approximately 50% loss of height, and no evidence of retropulsion of fracture fragments (420:29), likely chronic. Multilevel disc space narrowing, facet arthropathy and anterior and posterior osteophyte formation is noted, most prominent at the T12-L1 level. There is no malalignment within the lumbar spine. The prevertebral soft tissues are unremarkable. A small left dependent pleural effusion is noted, better characterized on the concurrent CT of the chest, along with subtle cortical disruption of the left posterior 11th rib at the costovertebral margin (2:7). Sigmoid diverticulosis is noted, with no evidence of diverticulitis. Dense atherosclerotic calcifications are noted in the abdominal aorta and common iliac vessels. IMPRESSION: 1. Compression deformity of the L3 vertebral body is likely chronic; with no evidence of retropulsion of fracture fragments or critical spinal canal narrowing. 2. Multilevel degenerative changes as described above, most prominent at T12-L1. 3. Left posterior 11th rib fracture, appears acute. CT CHEST WITHOUT IV CONTRAST ___ The intrathoracic aorta and pulmonary arteries are of normal caliber. Dense atherosclerotic calcifications are present in the aortic arch and descending thoracic aorta, as well as within the coronary arteries and aortic valve. A dual lead pacemaker device is in place, with leads terminating in the right atrium and right ventricle. The heart is mildly enlarged, with no pericardial effusion. The esophagus is unremarkable. There is no pathologic enlargement of the supraclavicular, axillary, mediastinal or hilar lymph nodes by imaging size criteria, with the exception of a 13 mm right lower paratracheal lymph node (2:19), likely reactive. A small left pleural effusion is noted, with linear atelectasis or scarring in the left lung base. Fluid is seen tracking along the fissure (4:87). Mild air trapping is present in the lung bases, along with mild emphysema. A punctate calcified granuloma is present in the right upper lobe (4:52). No concerning nodules or masses are identified. The airways are patent to the subsegmental level. Although the study is not designed for evaluation of subdiaphragmatic structures, the imaged upper abdomen is unremarkable. Cholecystectomy clips are noted. Mild nonspecific fat stranding noted at the mesenteric root. OSSEOUS STRUCTURES: Subtle cortical irregularity of the posterior left 11th rib (301:88), and possibly the posterior left 10th rib (301:77) near the costovertebral junction are consistent with non-displaced fractures. No lytic or blastic lesions suspicious for malignancy is present. IMPRESSION: 1. Subtle non-displaced fractures of the posterior left ___, and possibly 10th ribs, near the costovertebral junction. 2. Small left pleural effusion. 3. Mild cardiomegaly. DISCHARGE LABS ___ 06:32AM BLOOD ___ Brief Hospital Course: ___ with afib/flutter s/p ablation in ___ and DDD dual chamber pacemaker ___, on coumadin, presents after 2 short-lived episodes of presyncope associated with diaphoresis, likely vasovagal. # presyncope: lasted minutes and were associated with diaphoresis but no chest pain, palpitations or dypsnea. Pt was observed to be atrially paced while on telemetry, and experienced no further episodes of presyncope. Pacemaker was interrogated and revealed no malfunction. No medication changes since pacemaker placement. ACS ruled out with trop neg x 2 and no ischemic changes on EKG. Presyncope was thought to be vasovagal. Pt was instructed to follow up with electrophysiologist Dr. ___ placed her pacemaker. # Afib / Sick sinus syndrome s/p pacemaker on coumadin: INR supratherapeutic at 3.8. Warfarin was held during admission. Pt was instructed to check INR daily at home and call ___ clinic when INR <3.0 for warfarin dosing instructions. Pt was maintained on metoprolol succinate XL 100 mg PO BID, and was discharged on scheduled reduction in amiodarone dose to 200mg daily. # Non-displaced rib fracture: Pt found with subtle nondisplaced fracture of posterior left 11th rib, after direct impact trauma to the area during a mechanical fall on ___. Pt discharged on acetaminophen 1000mg q6h x 7 days for pain control. # CHF (EF 35%): Pt appeared euvolemic during admission and was maintained on furosemide 40 mg daily and irbesartan 150 mg daily. TRANSITIONAL ISSUE - Electrophysiologist to consider possible changes in pacemaker settings by reducing PR interval via RV pacing to optimize ventricular synchronization, vs. maintaining atrial pacing with current prolonged PR interval. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Atorvastatin 10 mg PO DAILY 2. Citalopram 10 mg PO DAILY 3. Furosemide 40 mg PO DAILY 4. Levothyroxine Sodium 50 mcg PO DAILY 5. Multivitamins 1 TAB PO DAILY 6. Omeprazole 20 mg PO BID 7. Warfarin 7.5 mg PO DAILY 8. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit oral bid 9. Amiodarone 200 mg PO BID 10. Avapro (irbesartan) 150 mg oral daily 11. Metoprolol Succinate XL 100 mg PO BID Discharge Medications: 1. Atorvastatin 10 mg PO DAILY 2. Avapro (irbesartan) 150 mg oral daily 3. Citalopram 10 mg PO DAILY 4. Furosemide 40 mg PO DAILY 5. Levothyroxine Sodium 50 mcg PO DAILY 6. Metoprolol Succinate XL 100 mg PO BID 7. Multivitamins 1 TAB PO DAILY 8. Omeprazole 20 mg PO BID 9. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit oral bid 10. Amiodarone 200 mg PO DAILY RX *amiodarone 200 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 11. Acetaminophen 1000 mg PO Q6H RX *acetaminophen 500 mg 2 tablet(s) by mouth every 6 hours Disp #*56 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary Vasovagal syncope Secondary Atrial fibrillation and flutter s/p ablation and pacemaker systolic congestive heart failure, compensated Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: It was a pleasure to take care of you at ___. You came in with 2 episodes of lightheadedness. Your description of what happened is very consistent with what we call "vasovagal syncope" - the same thing that happens to people when they faint. We monitored your heart rhythm and saw that the pacemaker was functioning properly. We had the electrophysiologists tweak the pacemaker so that it does the best job to help the way your heart pumps, given your heart failure. You should decrease your amiodarone to 1 pill daily. Your INR was too high. The goal is 2.0-3.0 Don't take your warfarin until your INR is less than 3.0. When your INR is less than 3.0, call ___ clinic, tell them the last time you took warfarin was ___ night, and ask them how much you should take. For your rib pain, you can take 1000mg tylenol every 6 hours. Followup Instructions: ___
10382464-DS-22
10,382,464
29,596,890
DS
22
2115-07-18 00:00:00
2115-07-18 21:48:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: ACE Inhibitors / amlodipine / clonidine / codeine Attending: ___. Chief Complaint: Dyspnea Major Surgical or Invasive Procedure: Cardioversion History of Present Illness: ___ year old woman w/PMH of HTN, HLD, CHF (EF 30%), Afib s/p ablation and PPM, who presents with complaint of dyspnea. Reports intermittent dyspnea and had a ___ lbs weight gain over the last several days, with mild nausea. Has worsening orthopnea and slept in a chair for several days. She called her cardiologist and had her amiodarone and lasix doses increased. Also with increased HR up to 110+ in past week. No chest pain. No increase in leg swelling. She denies urinary symptoms. In the ED, initial VS: 99.1 84 120/72 18 95% RA. Labs notable for H/H 10.6/33.3, INR 4.8, Trop/CKMB neg, proBNP 3328. UA with large leuk, few bacteria. EKG showing ... CXR showing small R side pleural effusion. Patient was given Furosemide 40mg IV x1. She was evaluated by Dr. ___ recommended admission for IV diuresis and cardioversion. Past Medical History: 1. CARDIAC RISK FACTORS: - Diabetes, + Dyslipidemia, + Hypertension 2. CARDIAC HISTORY: Atrial fibrillation/flutter s/p ablation at ___ in ___ Congestive heart failure, LVEF 35% LBBB - CABG: none - PERCUTANEOUS CORONARY INTERVENTIONS: none - PACING/ICD: dual-chamber pacemaker, DDD mode 3. OTHER PAST MEDICAL HISTORY: Colon cancer, s/p right hemicolectomy in ___ Reflux esophagitis, hx of chronic gastritis s/p right knee replacement glucose intolerance Osteoporosis per ___ (patient denies) Hypothyroidism Cholecystitis s/p cholecystectomy ___ oophorectomy, hysterectomy (___) Glaucoma per ___ Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise non-contributory. Physical Exam: ADMISSION PHYSICAL EXAM: VS: 97.4, BP 134/73, HR 83, RR 16, 94% on RA, Wt: General: NAD, comfortable, pleasant, alert and oriented x3 HEENT: NCAT, PERRL, EOMI Neck: supple, no JVD CV: irregular rate and rhythm, normal S1, physiologic splitting of S2, no murmurs, clicks, rubs, gallops Lungs: CTAB, no wheezing, rhonchi, rales, crackles Abdomen: soft, NT/ND, BS+ Ext: WWP, no clubbing or cyanosis, 1+ pitting edema halfway up bilateral lower legs Pulses: 1+ DP pulses bilaterally Neuro: moving all extremities grossly DISCHARGE PHYSICAL EXAM: VS: T= 98.0, BP= 119-136/65-71, HR= 57-60, RR= ___, O2 sat= 92-98% on RA Wt: 99.1kg <- 98.7kg, I/O: 220/300 since MN, 1100/670 over past 24h General: NAD, comfortable, pleasant, alert and oriented x3 HEENT: NCAT, PERRL, EOMI Neck: supple, no JVD CV: regular rate and rhythm, normal S1, S2, no murmurs, clicks, rubs, gallops Lungs: CTAB, no wheezing, rhonchi, rales, crackles Abdomen: soft, NT/ND, BS+ Ext: WWP, no clubbing or cyanosis, 1+ pitting edema halfway up bilateral lower legs Pulses: 1+ DP pulses bilaterally Neuro: moving all extremities grossly Pertinent Results: ADMISSION LABS: ___ 09:00AM BLOOD WBC-9.6 RBC-3.95* Hgb-10.6* Hct-33.3* MCV-84 MCH-26.8* MCHC-31.8 RDW-18.3* Plt ___ ___ 09:00AM BLOOD Neuts-70.0 ___ Monos-6.7 Eos-1.6 Baso-0.5 ___ 09:00AM BLOOD ___ PTT-40.4* ___ ___ 09:00AM BLOOD Plt ___ ___ 09:00AM BLOOD Glucose-173* UreaN-36* Creat-1.1 Na-140 K-4.2 Cl-102 HCO3-26 AnGap-16 ___ 09:00AM BLOOD CK(CPK)-45 ___ 09:00AM BLOOD CK-MB-2 proBNP-3328* ___ 09:00AM BLOOD cTropnT-<0.01 PERTINENT RESULTS: CBC TREND: ___ 09:00AM BLOOD WBC-9.6 RBC-3.95* Hgb-10.6* Hct-33.3* MCV-84 MCH-26.8* MCHC-31.8 RDW-18.3* Plt ___ ___ 06:14AM BLOOD WBC-7.6 RBC-4.00* Hgb-10.3* Hct-33.7* MCV-84 MCH-25.7* MCHC-30.5* RDW-18.4* Plt ___ ___ 05:06AM BLOOD WBC-10.8 RBC-3.97* Hgb-10.6* Hct-33.0* MCV-83 MCH-26.8* MCHC-32.3 RDW-18.5* Plt ___ ___ 05:20AM BLOOD WBC-12.4* RBC-4.08* Hgb-10.8* Hct-34.6* MCV-85 MCH-26.4* MCHC-31.2 RDW-18.8* Plt ___ ___ 05:05AM BLOOD WBC-11.6* RBC-3.81* Hgb-10.2* Hct-32.2* MCV-85 MCH-26.7* MCHC-31.6 RDW-18.5* Plt ___ ___ 05:00AM BLOOD WBC-9.3 RBC-3.59* Hgb-9.7* Hct-30.5* MCV-85 MCH-27.0 MCHC-31.8 RDW-19.2* Plt ___ CHEM 7: ___ 09:00AM BLOOD Glucose-173* UreaN-36* Creat-1.1 Na-140 K-4.2 Cl-102 HCO3-26 AnGap-16 ___ 06:14AM BLOOD Glucose-102* UreaN-35* Creat-1.2* Na-140 K-4.6 Cl-102 HCO3-30 AnGap-13 ___ 05:06AM BLOOD Glucose-112* UreaN-32* Creat-1.2* Na-140 K-4.6 Cl-102 HCO3-31 AnGap-12 ___ 05:20AM BLOOD Glucose-126* UreaN-44* Creat-1.4* Na-140 K-4.8 Cl-100 HCO3-28 AnGap-17 ___ 05:05AM BLOOD Glucose-118* UreaN-49* Creat-1.4* Na-139 K-4.8 Cl-100 HCO3-28 AnGap-16 ___ 03:35PM BLOOD Glucose-122* UreaN-48* Creat-1.3* Na-138 K-4.5 Cl-100 HCO3-29 AnGap-14 ___ 05:00AM BLOOD Glucose-115* UreaN-51* Creat-1.3* Na-139 K-4.4 Cl-99 HCO3-31 AnGap-13 COAGULATION PROFILE: ___ 09:00AM BLOOD ___ PTT-40.4* ___ ___ 06:14AM BLOOD ___ PTT-42.0* ___ ___ 05:06AM BLOOD ___ PTT-41.5* ___ ___ 05:20AM BLOOD ___ PTT-39.3* ___ ___ 05:05AM BLOOD ___ ___ 05:00AM BLOOD ___ IMAGING AND PROCEDURES: The left atrium is elongated. No atrial septal defect is seen by 2D or color Doppler. The estimated right atrial pressure is at least 15 mmHg. Left ventricular wall thicknesses and cavity size are normal. Overall left ventricular systolic function is moderately depressed ( LVEF = 30%) secondary to.akinesis to dyskinesis of the septum, and akinesis of the apex and anterior wall The right ventricular cavity is mildly dilated with normal free wall contractility. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. The mitral valve leaflets do not fully coapt. The effective regurgitant orifice is >=0.40cm2 Severe (4+) mitral regurgitation is seen. Moderate to severe [3+] tricuspid regurgitation is seen. There is severe pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Moderate-severe regional and global left ventricular systolic dysfunction c/w CAD. Severe functional mitral regurgitation. Mildly dilated right ventricular cavity with normal systolic function, moderate-severe tricuspid regurgitation and severe pulmonary artery systolic hypertension. Brief Hospital Course: # Dyspnea: likely ___ to decompensation of her sCHF ___ to her afib and poor rate control. Pt recently had amiodarone increased to 300mg daily from 200mg daily but was still having HR up to the 110s and having symptoms of dyspnea and presyncope. She was admitted and had successful direct current cardioversion with resultant HR in the ___ paced. She did not have any recurrence of her tachycardia and did not have further episodes of tachycardia or presyncope. Pt still had symptoms of dyspnea due to her decompensated sCHF. She was diuresed with IV lasix and had resolution of her symptoms. She is being discharged home with an increase in her lasix dosing of 60 PO daily to 60 PO BID. She will follow up with Dr. ___ on ___ for further management of her atrial fibrillation. # Leukocytosis: pt had initial UA positive for leukocytes, leukocyte esterase, and few bacteria, but did not have any urinary symptoms. UA showed bacteria and leukocytes. She was initiated on a 3-day course of IV rocephin to treat her uncomplicated UTI. She finished the course of antibiotics and her leuckocytosis resolved. She did not have any persistent urinary symptoms during admission. # Atrial fibrillation: atrial fibrillation/flutter s/p ablation at ___ in ___. She received DC cardioversion which successfully controlled her rate back to the ___. She remained asymptomatic and her HR remained in the 60-70s throughout admission on her paced rhythm. Her Metoprolol Succinate was increased from 100mg BID to ___ BID and she will be discharged on 200mg amiodarone daily. During admission her INR was initially therapeutic but was 1.5 on discharge. She was placed on a lovenox bridge and instructed to check her INR at ___ ___ clinic on ___ to follow up. She was restarted on her home warfarin dose the day of the cardioversion. She will need to follow up in ___ clinic on further management of her warfarin dosing. # GERD: patient has been having increased heartburn over past few days alleviated by maalox each time. She was discharged on her home 20mg BID of omeprazole. Transitions in care: # Follow up with Dr. ___ # Amiodarone decreased from 300mg daily back to 200mg daily # Increased lasix dose to 60mg BID from 60 mg daily # Metoprolol increased to 150gm BID instead of 100mg BID # Emergency contact: ___ (daughter) ___ # Code status: DNR/DNI Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Amiodarone 300 mg PO DAILY 2. Metoprolol Succinate XL 100 mg PO BID 3. Atorvastatin 40 mg PO DAILY 4. Furosemide 60 mg PO DAILY 5. Omeprazole 20 mg PO BID 6. Levothyroxine Sodium 50 mcg PO DAILY 7. irbesartan 150 mg oral DAILY 8. Calcium Carbonate 500 mg PO BID 9. Warfarin 5 mg PO 4X/WEEK (___) 10. Warfarin 1.5 mg PO 3X/WEEK (___) Discharge Medications: 1. Amiodarone 200 mg PO DAILY RX *amiodarone 200 mg 1 tablet(s) by mouth DAILY Disp #*30 Tablet Refills:*0 2. Atorvastatin 40 mg PO DAILY 3. Calcium Carbonate 500 mg PO BID 4. irbesartan 150 mg oral DAILY 5. Levothyroxine Sodium 50 mcg PO DAILY 6. Metoprolol Succinate XL 150 mg PO BID RX *metoprolol succinate 100 mg 1.5 tablet(s) by mouth TWICE DAILY Disp #*90 Tablet Refills:*0 7. Omeprazole 20 mg PO BID 8. Warfarin 5 mg PO 4X/WEEK (___) 9. Warfarin 7.5 mg PO 3X/WEEK (___) 10. Furosemide 60 mg PO BID RX *furosemide 40 mg 1.5 tablet(s) by mouth TWICE DAILY Disp #*90 Tablet Refills:*0 11. Enoxaparin Sodium 100 mg SC BID Start: Today - ___, First Dose: Next Routine Administration Time Please give yourself the injections twice daily. RX *enoxaparin 100 mg/mL 1 Injection SC TWICE DAILY Disp #*14 Syringe Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary diagnosis: atrial fibrillation with rapid ventricular response Secondary diagnosis: decompensated systolic congestive heart failure, hypertension, urinary tract infection Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, ___ were seen at the ___ because of shortness of breath and palpitations. It was found that your heart rate was elevated causing your symptoms. We did a cardioversion procedure to slow your heart rate back down. As of now, your heart rate is well controlled and we are discharging ___ home. Please follow up with Dr. ___ in the future for your heart condition. It was a pleasure taking care of ___. Sincerely, Your ___ Team Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Followup Instructions: ___
10382575-DS-12
10,382,575
22,808,403
DS
12
2113-01-01 00:00:00
2113-01-01 19:17:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: codeine Attending: ___. Chief Complaint: fatigue, abnormal labs Major Surgical or Invasive Procedure: liver biopsy ___ EGD ___ History of Present Illness: Ms. ___ is a ___ lady with a PMH signficant for aplastic anemia and cryptogenic cirrhosis who presents to the ED after outpatient labs showed new bilirubin elevation to 20. The patient does not seem to know very well her history of liver disease. When asked about liver problems, she reports that she never knew she had liver disease until a few months ago when she noticed increased abdominal swelling. For the past few weeks, she started having lower extremity edema, and she was started on furosemide and spironolactone, which improved the swelling. Today, she went for routine follow up with her hematologist and mentioned worsening fatigue. Incidentally, she was found to have bilirubin of 20. Her hematologist, Dr. ___, discussed with her gastroenterologist, Dr. ___, and wanted the patient admitted. After discussion with her husband, they preferred to come direct to the ___ rather than go to ___ ___ first. Looking through her outpatient records, she was seen in the ___ on ___ for new cirrhosis. Per that note, she was hospitalized at ___ in ___ for fatigue. At that time, she was found to have anemia requiring transfusions as well as new cirrhosis by labs and imaging. She had a work up that included HAV, HBsAg, HBsAb, HBcAb, HCV Ab, ___, AMA, ferritin, iron studies, ceruloplasmin, and alpha 1 anti-trypsin, which were all negative. Abdominal ultrasound with Doppler was normal as well. She subsequently switched provider and started seeing Dr. ___ ___ gastroenterology. She had a screening EGD on ___ at ___, but the report was not available. In the ED, initial vitals were: T 98.3 HR 105 BP 108/67 RR 18 SAT 99% RA. Exam notable for no asterixis, spider angiomas over the chest, ___ systolic murmur, distended but nontender abdomen, jaundice, and lower extremity pitting edema. Labs notable for INR 2.4, ___ 26.8, WBC 13.5, H/H 7.9/23.1, PLT 142, Retic 7.8%, Na 128, BUN/Cr ___, ALT 53, AST 106, LDH 380, TBili 17.2, albumin 3.0, trop-T <0.01. Diagnostic paracentesis performed with 24 WBC and 138 RBC. Preliminary liver ultrasound read showed: 1. The anterior right portal vein is patent, but with reversed flow. Otherwise, imaged hepatic vasculature is patent with flow in the appropriate direction. 2. Avascular cystic lesion in the right lobe measuring up to 2.3 cm may represent a hemorrhagic cyst. Per the patient's report, she has previously been imaged at ___ ___. Comparison to prior imaging is recommended. If not available, short interval follow-up ultrasound is recommended. 3. Cirrhotic liver, recanalized umbilical vein, splenomegaly, and large ascites. On transfer, vitals were: T 98.9 HR 94 BP 105/54 RR 18 SAT 97% RA. On the floor, the patient reports feeling a bit tired, but otherwise at her baseline level of health. Review of systems: (+) Per HPI. In addition, she has had a history of frequent epistaxis and gum bleeding, for which she has aminocaproic acid mouthwash as needed. Has also had significant weight loss in the setting of starting diuretics. She reports a dry cough for the past several weeks. (-) Denies fever, chills, night sweats. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies shortness of breath. Denies chest pain or tightness, palpitations. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No melena or hematemesis. No dysuria. Denies arthralgias or myalgias. Past Medical History: - Aplastic anemia ___ yrs, maintained on regular iron and red blood cell transfusions) - Hypertension (no longer on medication) - History of epistaxis - Alcoholic cirrhosis c/b ascites - Acute alcoholic hepatitis Social History: ___ Family History: Mother had ___ lymphoma and possibly pancreatic vs. stomach cancer. Father had ___ disease. There is mention in her outpatient records of autoimmune disorder in her brother, possibly myasthenia ___. Physical Exam: ADMISSION: Vital Signs: T 99.2 BP 101/60 HR 99 RR 20 SAT 96% on RA General: Alert, oriented, no acute distress HEENT: Sclera icteric, MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, ___ systolic murmur loudest at the upper sternal borders Chest: Diffuse spider angioma Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, significantly distended, bowel sounds present, hepatomegaly difficult to appreciate with distension, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ peripheral pulses, 2+ lower extremity pitting edema Neuro: Grossly no deficits, no asterixis DISCHARGE: Vital Signs: 98.4 ___ 18 100%RA. General: Alert, oriented, no acute distress. Jaundiced. Somewhat anxious HEENT: Sclera icteric, NCAT CV: Regular rate and rhythm, normal S1 + S2, ___ systolic murmur loudest at the upper sternal borders Chest: Diffuse spider angioma Lungs: CTAB Abdomen: Soft, non-tender, minimally distended, no rebound or guarding GU: No foley Ext: Warm, well perfused, trace lower extremity pitting edema Neuro: A&Ox3. Grossly no deficits, no asterixis Pertinent Results: ADMISSION/IMPORTANT LABS: ======================= ___ 06:40PM BLOOD WBC-13.5* RBC-2.07* Hgb-7.9* Hct-23.1* MCV-112* MCH-38.2* MCHC-34.2 RDW-14.9 RDWSD-60.2* Plt ___ ___ 06:40PM BLOOD Neuts-78.5* Lymphs-9.4* Monos-9.7 Eos-1.6 Baso-0.3 Im ___ AbsNeut-10.58* AbsLymp-1.27 AbsMono-1.31* AbsEos-0.22 AbsBaso-0.04 ___ 06:40PM BLOOD ___ PTT-40.1* ___ ___ 06:40PM BLOOD Ret Aut-7.8* Abs Ret-0.16* ___ 06:40PM BLOOD Glucose-120* UreaN-15 Creat-0.8 Na-128* K-3.9 Cl-93* HCO3-25 AnGap-14 ___ 06:40PM BLOOD ALT-53* AST-106* LD(LDH)-380* AlkPhos-53 TotBili-17.2* ___ 06:40PM BLOOD Albumin-3.0* Calcium-8.5 Phos-2.6* Mg-1.7 Iron-145 ___ 06:40PM BLOOD calTIBC-156* Hapto-<10* Ferritn-964* TRF-120* ___ 05:40AM BLOOD HBcAb-Negative HAV Ab-BORDERLINE ___ 06:10AM BLOOD IgM HAV-Negative ___ 12:26PM BLOOD AMA-NEGATIVE Smooth-NEGATIVE ___ 05:40AM BLOOD AFP-10.8* ___ 12:26PM BLOOD ___ ___ 05:40AM BLOOD HCV Ab-Negative ___ 03:55PM BLOOD ALPHA-1-ANTITRYPSIN-Test LABS AT DISCHARGE: ================ ___ 06:20AM BLOOD WBC-15.9* RBC-2.24* Hgb-8.6* Hct-24.4* MCV-109* MCH-38.4* MCHC-35.2 RDW-17.7* RDWSD-72.0* Plt ___ ___ 06:20AM BLOOD ___ PTT-34.4 ___ ___ 06:20AM BLOOD Glucose-99 UreaN-22* Creat-0.6 Na-127* K-4.0 Cl-96 HCO3-21* AnGap-14 ___ 06:20AM BLOOD ALT-61* AST-76* AlkPhos-55 TotBili-11.1* ___ 06:20AM BLOOD Calcium-9.0 Phos-3.8 Mg-1.7 IMAGING/STUDIES: ============== ___ Liver biopsy results: Liver, needle core biopsy: 1. Established cirrhosis with prominent sinusoidal pattern of fibrosis, confirmed by trichrome stain (Stage 4). 2. Mild macrovesicular steatosis with associated scattered foci of ballooning degeneration, intracytoplasmic hyalin and lobular neutrophils. 3. Patchy canalicular cholestasis. 4. Iron stain demonstrates focal mild iron deposition within Kupffer cells and rare hepatocytes. Note: The findings are consistent with a chronic active toxic/metabolic pattern of injury with prominent lobular neutrophils and hyalin, most likely due to a toxin induced cause. Clinical correlation is needed. CLINICAL ___ Transjugular Bx: IMPRESSION: 1. Portal hypertension with measured portosystemic gradient of 34 mm Hg. 2. Four 18 Gauge core biopsies of the liver sent for analysis. ___ EGD: 4 cords of grade I varices were seen in the esophagus. The varices were not bleeding. Mosaic appearance in the whole stomach compatible with portal hypertensive gastropathy. Normal mucosa in the duodenum Otherwise normal EGD to third part of the duodenum ___ RUQ: IMPRESSION: 1. Coarsened, nodular liver consistent with provided history of cirrhosis. 2. Sequelae of portal hypertension including large-volume ascites and persistent splenomegaly. Patent portal vein. 3. 2.3-cm right hepatic dome simple cyst, unchanged. No new or concerning focal hepatic masses. 4. Cholelithiasis and biliary sludge. ___ CXR: IMPRESSION: There is minimal blunting of left costophrenic angle and patchy opacity at the left base which may reflect a combination of atelectasis and or scarring in the setting of a small effusion or chronic pleural thickening. An early infectious process should also be considered. Clinical correlation is recommended. No pulmonary edema or pneumothorax. Overall cardiac and mediastinal contours are within normal limits. ___ 6:48 ___ LIVER US IMPRESSION: 1. The anterior right portal vein is patent, but with reversed flow. Otherwise, imaged hepatic vasculature is patent with flow in the appropriate direction. 2. Avascular cystic lesion in the right lobe measuring up to 2.3 cm may represent a hemorrhagic cyst. Per the patient's report, she has previously been imaged at ___. Comparison to prior imaging is recommended. If not available, short interval follow-up ultrasound is recommended. 3. Cirrhotic liver, recanalized umbilical vein, splenomegaly, and large ascites. Brief Hospital Course: Ms. ___ is a ___ lady with a PMH signficant for aplastic anemia and cryptogenic cirrhosis who presents with new bilirubin elevation to 20 and evidence of decompensating cirrhosis found to have alcoholic cirrhosis. # EtOH hepatitis on cirrhosis: Complicated by ascites and grade I varices (EGD ___. Per outpatient records, patient has had an extensive work up for cirrhosis with no clear etiology, which included consideration of viral hepatitis, NAFLD, autoimmune hepatitis, PBC, ___ disease, hemochromatosis, alpha-1 antitrypsin deficiency (negative), portal vein thrombosis, or Budd-Chiari syndrome. There is thought that she may have short telomere syndrome, which would explain concurrent bone marrow failure. Discussion with patient reveals some EtOH use, collateral suggestive of significant use. Hep B and C negative. AFP at 10.8 is mildly elevated. Clinically, she is stable with no evidence of encephalopathy. Diagnostic paracentesis showed no evidence of SBP. S/p therapeutic 5L paracentesis ___ for which she was given 37.5 g albumin. She underwent repeat LVP on ___ with 6.6L removed and albumin was given. Autoimmune antibodies were negative, Hep A borderline positive but IgM negative. Liver Bx consistent with EtOH hepatitis, so she was started on 40 prednisone ___. Maddreys Discriminant Function was 64.4 ___. Hyponatremia worsened with diuretics, therefore this was discontinued. # Aplastic Anemia Managed with frequent iron and red cell transfusions. Baseline hemoglobin appears to be 9 in outside labs. Labs here show Hgb of 7.2 with low haptoglobin, suggesting possible hemolysis though can be falsely low in cirrhosis. Difficult to interpret causes of hemolysis with chronically low platelets and abnormal coagulopathy with liver disease. Smear showed occasional fragments, low concern for true hemolysis. B12 was elevated, fibrinogen was > 100 (low concern for DIC). Received 1U PRBC ___. # Hyponatremia: Pt had acute drop after paracentesis. Also endorsing "drinking a lot of water". Mental status at baseline. Managed with 2L fluid restriction. Managed with albumin and 2L fluid restriction. Lasix/spironolactone discontinued due to hyponatremia. # Hyperglycemia: i/s/o steroids. Started on NPH insulin to take once daily. Patient taught regarding insulin use and close monitoring of blood sugars. # Liver cyst: Noted to have Avascular cystic lesion on ___. RUQ ___ unchanged. Consider repeat RUQ for close monitoring # Dispo: Patient will need close substance-abuse follow-up to be eligible for transplant eval. Will need at least 6 months of documented sobriety. Patient has been counseled extensively on importance of not drinking. Plan to establish hepatology care with Dr. ___. TRANSITIONAL ISSUES: =================== - Has follow up appointment on ___ with Dr. ___ to establish care and for follow up. - Check CBC, LFTs, Chem 7, and Albumin on ___ - F/u Lille score at follow up, plan for 1 mo steroids then taper if responsive. One month of steroids to end ___. - HgbA1c pending at time of discharge - Noted to have Avascular cystic lesion on ___ unchanged on RUQ ___, consider repeat imaging. - Hyperglycemic initially upon starting steroids. Discharged on 10U NPH daily - 2L fluid restriction for hyponatremia - Consider checking HFE as outpatient, as well as possible workup for short telomere syndrome. - Consider further work-up of elevated AFP if persistently elevated in outpatient setting. Can be mildly elevated in acute inflammation. # CODE: FULL # CONTACT: ___ (husband, cell: ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. ALPRAZolam 1 mg PO PRN Flying 2. Amicar (aminocaproic acid) 1.25 gm oral Q6H:PRN bleeding 3. Vitamin D Dose is Unknown PO DAILY 4. Furosemide 20 mg PO DAILY 5. Spironolactone 50 mg PO DAILY 6. Multivitamins 1 TAB PO DAILY 7. triamcinolone acetonide 0.5 % topical TID Discharge Medications: 1. BD Ultra-Fine Nano Pen Needles (pen needle, diabetic) 32 gauge x ___ miscellaneous DAILY 2. PredniSONE 40 mg PO DAILY RX *prednisone 20 mg 2 tablet(s) by mouth daily Disp #*50 Tablet Refills:*0 3. Multivitamins 1 TAB PO DAILY 4. triamcinolone acetonide 0.5 % topical TID 5. Vitamin D 1000 UNIT PO DAILY 6. NPH 10 Units Breakfast RX *insulin NPH human recomb [Humulin N KwikPen] 100 unit/mL (3 mL) AS DIR 10 Units before BKFT; Disp #*30 Syringe Refills:*0 7. Amicar (aminocaproic acid) 1.25 gm oral Q6H:PRN bleeding Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Alcoholic hepatitis Cirrhosis steroid induced hyperglycemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were seen at ___ because your bilirubin was elevated. You were found to have acute alcoholic hepatitis. You were started on a medication called prednisone, which in some people can help their alcoholic hepatitis. You will need lab tests on ___ to determine if you should stay on this medication. You also had your abdomen tapped (paracentesis) to remove fluid and relieve discomfort. You may need this done as an outpatient as well. We strongly recommend that you stop drinking all alcohol. To be considered for transplant, you will need to be followed by psychiatry or an abstinence program that can document your sobriety. During you hospitalization, you were found to have elevated blood sugars. This was likely due to the prednisone. You were started on NPH insulin in the hospital. Please monitor your blood sugars closely and follow up with your PCP regarding this. We have scheduled a follow up appointment for you with Dr. ___ ___ you. Please see below. We wish you the best in your care. -Your ___ team Followup Instructions: ___
10382575-DS-13
10,382,575
23,878,644
DS
13
2113-02-12 00:00:00
2113-02-12 17:59:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: codeine Attending: ___ Chief Complaint: fever, shortness of breath Major Surgical or Invasive Procedure: ___ guided paracentesis ___ exploratory laparotomy ___ ___ guided thoracentesis ___ ___ guided paracentesis ___ Diagnostic paracentesis ___ History of Present Illness: Ms. ___ is a ___ lady with a PMH signficant for aplastic anemia and cryptogenic and alcoholic cirrhosis who presents with abdominal pain and cough Patient has had increasing abdominal distension and shortness of breath. The patient was recently discharged after an admission for large volume paracentesis. Since discharge about 2 weeks ago she has had gradually increasing abdominal distention and shortness of breath. She has a known history of hepatic hydrothorax. She reports an associated nonproductive cough. No shortness of breath is worse when lying down. He denies any hemoptysis. She denies any abdominal pain, nausea, vomiting, blood in the stool, melena. No change in mental status. The patient does not feel that she is more jaundiced. No fevers. No urinary symptoms. Patient with recent admission from ___ to ___ - for acute decompensation of her cirrhosis with elevated bilirubin to 20 found to have ETOH cirrhosis and alcoholic hepatitis. She was started on prednisone 40 mg in the hospital on ___ and was stopped on ___ as it was not shown to be effective as given bilirubin still 12. Patient need to have paracentesiswhich was scheduled as an outpatient day prior to admission however patient was not notified of appointment and could not get it done. She has been admitted for these procedures. In ED Initial vitals notable for: 99.9 119 152/89 20 97% RA Exam notable for: Labs notable for: Normal Chem 7. 9.5 13.5>--< 113 27.7 N:76.2 L:13.0 M:7.9 E:2.2 Bas:0.1 ___: 0.6 ___: 23.3 PTT: 31.3 INR: 2.1 Lactate:2.5 ALT: 59 AP: 53 Tbili: 14.0 Alb: 3.4 AST: 54 Lip: 138 Patient underwent diagnostic para that showed 92 WBC with 65% poly, 22% lymph. Protein 0.6 Imaging notable for: Large right pleural effusion with compressive atelectasis in the right middle lower lung. Patient was given: no medications. Hepatology consulted and recommended: admission to ET. Vitals prior to transfer: 98.4 109 146/77 20 96% RA On the floor, patient has dry cough, SOB and abdominal distension. Past Medical History: - Aplastic anemia ___ yrs, maintained on regular iron and red blood cell transfusions) - Hypertension (no longer on medication) - History of epistaxis - Alcoholic cirrhosis c/b ascites - Acute alcoholic hepatitis Social History: ___ Family History: Mother had ___ lymphoma and possibly pancreatic vs. stomach cancer. Father had ___ disease. There is mention in her outpatient records of autoimmune disorder in her brother, possibly myasthenia ___. Physical Exam: ADMISSION EXAM ============== Vital Signs: 99.1 147 / 82 117 20 95 ra General: Alert, oriented, no acute distress. Jaundiced. HEENT: Sclera icteric, NCAT CV: Regular rate and rhythm, normal S1 + S2, ___ systolic murmur loudest at the upper sternal borders Lungs: decreased breath sounds half way up right lung base, CTA on right. Abdomen: Soft, non-tender, distended with ascites, no rebound or guarding GU: No foley Ext: Warm, well perfused,2 plus extremity pitting edema up to knee Neuro: A&Ox3. Grossly no deficits, no asterixis DISCHARGE EXAM ============== VS - patient refused Full physical exam deferred for pt comfort. General: NAD, lying comfortably in bed, breathing comfortably Abdomen: non tender Pertinent Results: ADMISSION LABS ============= ___ 08:30PM ASCITES WBC-92* RBC-487* POLYS-65* LYMPHS-22* MONOS-1* MESOTHELI-2* MACROPHAG-10* ___ 08:30PM ASCITES TOT PROT-0.6 GLUCOSE-153 ___ 08:45PM ___ PTT-31.3 ___ ___ 08:45PM PLT COUNT-113* ___ 08:45PM NEUTS-76.2* LYMPHS-13.0* MONOS-7.9 EOS-2.2 BASOS-0.1 IM ___ AbsNeut-10.28* AbsLymp-1.75 AbsMono-1.06* AbsEos-0.30 AbsBaso-0.02 ___ 08:45PM WBC-13.5* RBC-2.46* HGB-9.5* HCT-27.7* MCV-113* MCH-38.6* MCHC-34.3 RDW-16.2* RDWSD-67.4* ___ 08:45PM LACTATE-2.5* ___ 08:45PM ALBUMIN-3.4* ___ 08:45PM LIPASE-138* ___ 08:45PM ALT(SGPT)-59* AST(SGOT)-54* ALK PHOS-53 TOT BILI-14.0* ___ 08:45PM GLUCOSE-131* UREA N-19 CREAT-0.6 SODIUM-134 POTASSIUM-3.5 CHLORIDE-100 TOTAL CO2-22 ANION GAP-16 PERTINENT LABS ============== ___ 07:00PM URINE Blood-NEG Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-MOD Urobiln->12 pH-6.5 Leuks-MOD ___ 07:00PM URINE RBC-1 WBC-13* Bacteri-FEW Yeast-NONE Epi-3 TransE-<1 ___ 07:00PM URINE Color-AMBER Appear-Hazy Sp ___ ___ 01:44PM ASCITES WBC-67* RBC-90* Polys-42* Lymphs-1* Monos-21* Mesothe-9* Macroph-24* Other-3* ___ 01:44PM ASCITES TotPro-0.6 Glucose-148 Creat-0.4 LD(LDH)-45 Amylase-24 Albumin-LESS THAN DISCHARGE LABS ============= No labs on discharge Most recent labs: ___ 01:42PM BLOOD WBC-40.6* RBC-2.76* Hgb-9.5* Hct-29.7* MCV-108* MCH-34.4* MCHC-32.0 RDW-22.6* RDWSD-88.3* Plt Ct-62* ___ 01:42PM BLOOD Neuts-92.7* Lymphs-1.7* Monos-3.8* Eos-0.1* Baso-0.2 Im ___ AbsNeut-37.58* AbsLymp-0.69* AbsMono-1.55* AbsEos-0.03* AbsBaso-0.09* ___ 01:42PM BLOOD Glucose-129* UreaN-63* Creat-0.9 Na-150* K-3.8 Cl-115* HCO3-22 AnGap-17 ___ 07:30PM BLOOD ALT-63* AST-117* AlkPhos-73 TotBili-10.1* MICRO ===== ___ BCx Pending ___ BCx NGTD ___ Peritoneal FlCx enterococcus. No organisms on gram stain. ___ Peritoneal cx w/ enterococcus ___ C.Diff Neg ___ UrineCx neg ___ BCx x2 Gram + cocci in chains; resistant->amp/vanc ___ Peritoneal Cx 4+ PMNs 2+ gram positive cocci in pairs ___ OR Cx 2+ GPC, 1+ GPR, 1+ yeast; 4+ PMN, WBC 3K; enterococus ___ BCx No growth ___ BCx no growth ___ Peritoneal Cx No growth, WBC 12K ___ Pleural cx No growth ___ BCx no growth ___ Urine Cx <10,000 organisms/ml ___ 7:00 pm URINE Source: ___. URINE CULTURE (Final ___: YEAST. 10,000-100,000 ORGANISMS/ML.. IMAGING ======= ___ CT A/P 1. Cirrhotic liver with evidence of chronic splenic vein thrombosis. 2. Similar large volume ascites with enhancement of the peritoneum, which could be related to peritonitis. 3. Distended gallbladder containing gallstones and sludge within it. ___ CT Chest 1. Diffuse bilateral ground-glass opacities throughout both lungs with areas of focal consolidation in the upper lobes that could represent pulmonary edema, however infection cannot be completely excluded. Please correlate clinically. 2. Moderate to large bilateral pleural effusions with passive atelectasis in both lower lobes ___ CT A/P 1. Expected evolution of hyperdense material within the pelvis which may represent enteric contents from focal bowel perforation or prior hemorrhage with blood products. No evidence of acute hemorrhage or contrast extravasation. 2. Cirrhosis with large volume ascites, patent umbilical vein and esophageal varices. 3. Stable moderate right and small left non hemorrhagic pleural effusions with bibasilar atelectasis. 4. Cholelithiasis with persistent mild gallbladder wall edema secondary to cirrhosis and ascites. 5. Significant decrease in non dependent free intraperitoneal air with locules of gas within the mesentery adjacent to the sigmoid colon. 6. Findings worrisome for peritonitis with mild diffuse peritoneal thickening, unchanged since prior examination. 7. Foley catheter likely within the urethra. ___ ABD US Large ascites in the abdomen. ___ CXR Slight improvement in pulmonary edema ___ CT A/P IMPRESSION: 1. Large volume intraperitoneal free air layering over a large volume ascites. There is new hyperdense layering material within the posterior cul-de-sac, when compared to the recent CT dated ___. These findings are concerning for bowel perforation with possible leak of orally ingested contrast presenting as hyperdense material in the pelvis. Bowel perforation may be secondary to a perforated diverticulum given the presence of extensive sigmoid diverticulosis and locules of free air tracking into the adjacent mesentery. The hyperdense material in the pelvis is less likely contrast opacified blood given that the patient is hemodynamically otherwise stable. 2. Uniform mild enhancement of the peritoneal lining may reflect presence of underlying peritonitis. 3. Cirrhotic morphology of the liver with unchanged simple hepatic cyst at the dome measuring 2.4 cm in diameter. This scan is not optimized to look for HCC. 4. Patent portal vein, SMV and splenic vein with a few varices at the gastric fundus and in the perisplenic region along with re- cannalization of the umbilical vein. 5. Large right pleural effusion with underlying relaxation atelectasis is partially visualized. 6. Diffuse small bowel wall thickening and anasarca are likely related to ascites and hyperproteinemia. ___ CT abdomen/pelvis: IMPRESSION: 1. Extensive wall thickening oft the colon with relative sparing of the cecum and sigmoid colon. This is nonspecific, and can reflect infectious or inflammatory etiology. Portal colopathy is less likely given relative sparing of the cecum. 2. Cirrhotic liver with a small amount residual ascites after recent paracentesis. Trace intraperitoneal free air is likely related to recent paracentesis. 3. Bilateral lower lobe consolidations and a moderate right pleural effusion. ___: CT Chest w/contrast: IMPRESSION: 1. Multifocal airspace opacities involving the left lung to a much greater degree than the right, with rapid progression between ___ and ___. In the setting of fever, a rapidly progressive multifocal pneumonia should be considered. An asymmetrical pattern of pulmonary edema is considered less likely. Alternative diagnoses such as pulmonary hemorrhage and widespread aspiration are also possible in the appropriate clinical setting. 2. Decreased right pleural effusion following recent thoracentesis with residual moderate sized pleural effusion remaining it and associated adjacent atelectasis. 3. Please see separately dictated CT of the abdomen and pelvis for complete description of subdiaphragmatic findings. ___ CXR: IMPRESSION: Large right pleural effusion appears to be even more pronounced than on the prior study. Mild vascular congestion is present. Cardiomediastinal silhouette is unchanged. No definitive focal consolidation to suggest infectious process demonstrated. ___ CXR:IMPRESSION: Compared to chest radiographs ___ and ___. Large right pleural effusion which increased from ___ to ___ is now displayed with the patient supine. I suspect it is smaller, but I can't be sure. There is no appreciable pneumothorax. Pulmonary vasculature is more engorged, even though the heart is normal size. ___ Chest x-ray: PA and lateral views of the chest provided. There is a large right pleural effusion, new from prior exam with associated compressive atelectasis in the right middle lower lung. The left lung is clear aside from mild left lower lung atelectasis. Heart size difficult to assess given effacement of the right heart border. Bony structures are intact. IMPRESSION: Large right pleural effusion with compressive atelectasis in the right middle lower lung. Brief Hospital Course: ___ with aplastic anemia and decompensated ETOH cirrhosis (MELD NA 27) found to have alcoholic hepatitis s/p failed treatment with prednisone, initially admitted with cough and abdominal distension consistent with hepatic hydrothorax and abdominal ascites. Hospital course was complicated by SBP with VRE and candidiasis, worsening encephalopathy, worsening WBC and LFTs, and finally, concern for cholecystitis at which point the patient and her family decided to focus on symptom management and quality of her remaining life, and rather than undergo further invasive surgeries the decision was made to go to hospice. ICU Course: Patient brought to the ICU for afib with RVR and hypotension. Was controlled with beta blockade and patient converted to sinus rhythm while in the ICU. Antibiotics changed from zosyn to meropenem given the concern that patient developed SBP while on zosyn. She was transferred to the medicine floor on ___. SICU Course: Patient was transferred to the SICU after 1 night on the medicine floor concern for secondary bacterial peritonitis in the setting of worsening free air seen on CT. ___: Ex lap, no resection, no clear source of SBP, copious fibropurulent exudate. Yeast in addition to GPC, GPR in peritoneal fluid, added fluc to ___. ___: 2u pRBC in early AM, Post transfusion Hct 29.9. 250cc albumin 5% x5 + 50cc 25% albumin x1. Promote + fiber TF started @10cc/hr. Neo@1. ___: 2u pRBC in early AM. Post transfusion Hct 30.2. RSBI 12, passed SBT. Weaned off pressors. ___: Started lactulose q2h, pt began stooling with improvement in mental status. Restarted TFs. Ascitic fluid cx showed VRE, continued daptomycin and meropenem. BS consistently >200, so IV hydrocortisone decreased to 25. ___: In early AM, pt began having runs of SVT to 180s w/ frequent ectopy, spontaneously broke to baseline rhythm of sinus tach in 110s. Given 5 IV metoprolol with resolution. Put out 1.2L stool so lactulose was stopped; K+ 3.0, repleted. To get therapeutic paracentesis today by primary team. Medical Floor Course: The patient was transferred to the medical floor after initial improvement in hemodynamics and mental status. However, the patient's WBC rose to 24.7 and she had ___ to 1.2 (baseline Cr 0.7). Her mental status declined. She received a third diagnostic paracentesis on ___ and was subsequently transferred back to ___ for suspected ongoing peritonitis. #Fever: Patient developed persistent intermittent on ___. Patient was placed on empiric Vanc/Zosyn on ___. Infectious work-up was negative (CXR negative, Ascitic fluid w/o SBP on ___, BCx pending, UCx pending). Differential also included PE given tachycardia, though patient was satting well and was without chest pain and Well's score only of 1.5. LENIs without evidence of DVT. Only localizing sign was patient's cough, though CXR was without evidence of PNA. Patient was without an obvious source, but given risk for SBP, Vanc/zosyn was narrowed to CTX and patient was given albumin for empiric treatment of SBP on ___. Patient developed recurrent fevers and was transitioned back to vanc/Zosyn on ___. LVP on ___ showed >11,000 WBCs with elevated LDH and protein, felt to be secondary peritonitis. Her thoracentesis that day also showed ___ WBCs. After ex-lap for secondary peritonitis, the patient was started on meropenem, daptomycin, and fluconazole. # Tachycardia: Patient was tachycardic on admission and continued to be so during hospitalization. Differential included decompensated cirrhosis or infection given concurrent fever. Multiple EKGs with poor baseline, but possibly with multi-focal atrial tachycardia. In the setting of fevers, pt developed worsening tachycardia. On ___, pt was triggered for tachycardia to the 180's, during which time she was found to be in Afib with RVR. #Cough/SOB, resolving: Patient presented with worsening SOB and cough. No evidence of PNA on CXR, no fevers, chills, mild leukocytosis which could be from recent steroids. Patient with large right sided hepatic hydrothorax, likely causing her cough and SOB. Patient underwent thoracentesis with 1.5L of fluid removed on ___ and patient's SOB improved, though she continued to have some cough. Pt developed worsening SOB shortly after her paracentesis, and CXR was c/w re-expanding hepatic hydrothorax. Pt underwent diagnostic/therapeutic throacentesis on ___, during which time 1.7L fluid were removed, and she was found to have ___ WBCs in the thoracentesis fluid (see above) # Ascites: As above, patient had a LV paracentesis on ___ with removal of 5.5L fluid. Her ascites rapidly reaccumulated after that. Repeat paracentesis on ___ removed 3L, but also showed secondary peritonitis. Third paracentesis was performed on ___ for evaluation for continued peritonitis. #Hepatic hydrothorax: Pt received a thoracentesis on ___ in the setting of dyspnea and persistent cough. Her symptoms improved immediately afterwards, but her fluid reaccumulated shortly thereafter. Repeat ___ on ___ removed 1.7L fluid, but also showed ___ WBCs. # Epistaxis, resolved: Patient with nosebleed on ___, which has stopped spontaneously. Patient has a history of nosebleeds in the past, requiring cauterization. Patient remained hemodynamically stable throughout admission. # Aplastic Anemia: Managed with frequent iron and red cell transfusions. Baseline hemoglobin appears to be 9. Work up on last hospitalization was less concerning for hemolysis, patient had low haptoglobin but likely decreased in setting of cirrhosis. Patient received 4 U RBC while in the SICU. #Alcoholic hepatitis and cirrhosis: MELD-Na 27 on admission. Complicated by ascites and grade I varices (EGD ___. Liver bx recently confirmed ETOH cirrhosis, other work up negative. Patient stopped steroids ___ for alcoholic hepatitis. Patient not transplant candidate yet given need to enroll in program for sobriety. Patient had social work and nutrition consults to optimize her. Patient was started on lactulose during admission with improvement in asterixis and encephalopathy. # Hyponatremia: Patient with worsening hyponatremia during hospitalization, felt to be due to her liver disease. Patient was placed on 1.5L fluid restriction and ***. #Hx of Hyperglycemia: likely in setting of steroids, discontinued on ___. Patient with mildly elevated blood sugars, though has not required any insulin off sliding scale, so discontinued. #COAGULOPATHY: likely related to liver disease, remained stable throughout admission. SICU course 2: ___: Transferred to ___ for worsening abdominal pain, worsening mental status/increasing confusion. Paracentesis completed prior to transfer featured removal of 2L of ascitic fluid which by gram stain met criteria for persistent SBP (3K WBC w/ 95% Nx). CT AP was also completed prior to transfer which demonstrated interval decrease in intraperitoneal free air though was noted to feature persistent loculations of air within mesentery and for these reasons tube feeds were held and the patient was permitted ice chips by mouth. She was started on tramadol and her lactulose was resumed. ___: WBC 24. 23, glucose values increasing, RISS increased, Abx changed as per ID recommendations, GPC in blood culture. Concern for infection. ___: Bedside paracentesis w/ US by ___, removed 7L for source control. Got FFP x2 units prior to procedure. Tolerated, no issues. ___ had decreased mental status, repeat labs normal, blood cx sent per primary team. Na still 150, free H2O flushes increased to 350 q6h. ___: Continued high residuals from tube feeds, restarted at 40; started D5W gtt, 25 g albumin, Na continued elevated, kept central line ___ difficult peripheral access ___: Abdominal binder. WBC 32.9. 5 staples at midportion of incision removed, no dehiscence appreciated, packed with dry gauze. CT C/AP: GB w/layering and mild distension, moderate B/L pulm effusions, no acute intrabdominal cxn. Patient's CT scan was discussed w/family, and family requested social work consult which was placed. Incontinent and UOP marginal, given 1000cc 5% albumin, foley replaced. Zosyn DCD, started meropenem and IV flagyl per ID recs. Medical Floor Course 2: Patient was transferred to the medical floor on ___ for management of symptoms and goals of care discussion. # Goals of care Patient expresses wishes to maximize comfort and symptom management without further escalation of care or further procedures. Patient wishes to discontinue vitals, labs, and further ICU transfers. She named her husband as her HCP: ___ ___ (cell: ___. She confirmed her code status as DNR/DNI and wishes to be transferred to hospice care. # Hepatic encephalopathy We continued lactulose and rifaximin, with goal ___ BMs daily # SBP We continued ___ and fluconazole, transitioned to PO linezolid and fluconazole on discharge # Bilateral pleural effusions Contributing to occasional tachypnea. She was breathing comfortably on room air. # Persistent sinus tachycardia She was given 12.5mg metop x1 for symptomatic relief. # Pain She was continued on dilaudid and pain was well controlled. TRANSITIONAL ============ - plan for antibiotics is to continue because they are likely helping to maintain pt's clear mental status. Her infection will likely worsen over the next ___ days, and if she is no longer lucid then there is no indication for antibiotic coverage - plan to continue lactulose/rifaxamin while the pt is agreeable in order for her to be able to interact with her family: she may refuse these at any time - pt discharged with foley and flexiseal in place for comfort Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Multivitamins 1 TAB PO DAILY 2. triamcinolone acetonide 0.5 % topical TID 3. Vitamin D 1000 UNIT PO DAILY 4. Amicar (aminocaproic acid) 1.25 gm oral Q6H:PRN bleeding Discharge Medications: 1. Fluconazole 400 mg PO Q24H Duration: 5 Days RX *fluconazole 200 mg 2 tablet(s) by mouth once a day Disp #*5 Tablet Refills:*0 2. HYDROmorphone (Dilaudid) 0.25-0.5 mg IV Q3H:PRN BREAKTHROUGH PAIN 3. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN moderate to severe pain 4. Lactulose 30 mL PO Q2H 5. Linezolid ___ mg PO Q12H Duration: 5 Days RX *linezolid ___ mg 1 tablet(s) by mouth twice a day Disp #*5 Tablet Refills:*0 6. Rifaximin 550 mg PO BID 7. Amicar (aminocaproic acid) 1.25 gm oral Q6H:PRN bleeding 8. Multivitamins 1 TAB PO DAILY 9. triamcinolone acetonide 0.5 % topical TID 10. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary Diagnosis: hepatic hydrothorax asicites spontaneous bacterial peritonitis septic shock bacteremia fungemia decompensated alcoholic cirrhosis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure caring for you during your recent admission. You initially came to the ___ with cough and shortness of breath as a result of fluid in your lungs and abdomen because of your liver disease. We removed the fluid, but unfortunately your liver disease worsened and you developed some very serious infections. While we did everything we could to treat these, you continued to become more sick. You and your family decided that given how sick you are and how much suffering you've been through during this long hospitalization, it made sense to focus on controlling your symptoms rather than aggressively doing more invasive procedures. You were discharged to hospice so that you could spend more time with your loved ones. We wish you the best, Your ___ Care Team Followup Instructions: ___
10382912-DS-15
10,382,912
21,344,480
DS
15
2184-08-25 00:00:00
2184-08-25 13:34:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: falls Major Surgical or Invasive Procedure: none History of Present Illness: History of Present Illness: patient unable to answer most questions, but per report, the patient was exiting the bathroom when he fell to the floor. His wife tried to help him but but he kept going down to the floor. Per wife: Heard patient fall, got him up and then he fell again, never passed out. Patient was in the bathroom right before, exited and then fell. Patient fully responsive but only mumbling. Wife finally got him into bed and called ___. No lose of bowel or bladder. Patient was shaking when on the bed. Hx of syncope in the past thought to be due to "heat". In USOH prior to this incident no fevers of chills. Notes patient has had decrease appetite and has not been taking much fluids. Has been drinking more wine than usual at night ___ (usually just one). No hx of alcohol abuse. CT scan wet read shows no abnormalities. . Denies feeling lighteaded, denies dizzyness, denies chest pain discomfort or pressure, denies SOB, denies nausea, denies abd pain. Past Medical History: 1. Hypertension 2. Diabetes mellitus type 2 3. Hyperlipidemia. 4. SVT 5. History of prostate cancer in ___ 6. Dementia . Social History: ___ Family History: Parents lived to mid ___ and he is not sure about the etiology of death. No history of premature CAD. Physical Exam: ON Admission Vitals: 100.1 74 N 144/70 16 100%RA General: alert but not oriented to day. HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNs2-12 intact, motor function grossly normal . On Discharge: Physical Exam: Vitals: (current and maX), 160/75, 60, 22, 94%RA General: alert but not oriented to date. HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNs2-12 intact, motor function grossly normal Pertinent Results: On admission ___ 01:00PM BLOOD WBC-8.3# RBC-4.08* Hgb-12.6* Hct-39.3* MCV-96 MCH-30.9 MCHC-32.1 RDW-12.8 Plt ___ ___ 01:00PM BLOOD Neuts-83.8* Lymphs-10.9* Monos-3.8 Eos-1.3 Baso-0.2 ___ 01:00PM BLOOD Glucose-102* UreaN-13 Creat-1.5* Na-139 K-3.4 Cl-98 HCO3-26 AnGap-18 ___ 09:30PM BLOOD CK(CPK)-196 ___ 01:00PM BLOOD Calcium-9.6 Phos-3.6 Mg-1.8 . Imaging Head CT ___ No acute intracranial abnormality. . CXR ___ IMPRESSION: Subtle opacity in the left mid-to-lower lung may represent overlapping osseous structures, although possibility of pneumonia impossible to exclude. Recommend oblique views to clarify. . Discharge labs ___ 08:05AM BLOOD WBC-6.9 RBC-3.54* Hgb-10.6* Hct-33.4* MCV-94 MCH-30.0 MCHC-31.8 RDW-12.8 Plt ___ ___ 08:05AM BLOOD Glucose-122* UreaN-11 Creat-1.1 Na-138 K-3.2* Cl-100 HCO3-27 AnGap-14 ___ 08:05AM BLOOD Albumin-3.8 Calcium-9.2 Phos-2.2* Mg-1.8 Brief Hospital Course: Patient came in with baseline dementia per his wife. She stated that he had fallen at home. While in the ED, he had a CT scan which showed no acute process. His chest xray was unremarkable. THe patient's UA came back indicating infection. He was started on cefpodoxime 200mg PO BID. Unfortunately, the patient continued to spike fevers. His urine culture came back negative. A repeat CXR was ordered that showed LLL pneumonia. The patient was started on levofloxacin and remained afebrile. The patient was discharged in stable condition and will be followed up as an outpatient. Medications on Admission: AMLODIPINE - 10 mg Tablet - 1 Tablet(s) by mouth once a day ATENOLOL - 50 mg Tablet - 1 Tablet(s) by mouth once a day ATORVASTATIN [LIPITOR] - 40 mg Tablet - 1 Tablet(s) by mouth daily at bedtime GLIMEPIRIDE - 2 mg Tablet - 1 Tablet(s) by mouth once a day HYDROCHLOROTHIAZIDE - 12.5 mg Tablet - 1 Tablet(s) by mouth once a day LISINOPRIL - 40 mg Tablet - 1 Tablet(s) by mouth once a day MEMANTINE [NAMENDA] - 10 mg Tablet - one Tablet(s) by mouth twice a day after completing starter pack PIOGLITAZONE [ACTOS] - 45 mg Tablet - 1 Tablet(s) by mouth once a day Medications - OTC ASPIRIN - 81 mg Tablet, Delayed Release (E.C.) - 1 Tablet(s) by mouth once a day Discharge Medications: 1. amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 2. atenolol 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. atorvastatin 40 mg Tablet Sig: One (1) Tablet PO HS (at bedtime). 4. pioglitazone 45 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 6. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6 hours) as needed for pain/fever. 7. glimepiride 2 mg Tablet Sig: One (1) Tablet PO once a day. 8. hydrochlorothiazide 12.5 mg Tablet Sig: One (1) Tablet PO once a day. 9. lisinopril 40 mg Tablet Sig: One (1) Tablet PO once a day. 10. memantine 10 mg Tablet Sig: One (1) Tablet PO twice a day. 11. levofloxacin 750 mg Tablet Sig: One (1) Tablet PO once a day for 5 days. Disp:*10 Tablet(s)* Refills:*0* Discharge Disposition: Home Discharge Diagnosis: 1) UTI 2) dementia Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mr. ___, you came in with fevers, chills, and were determined to have a UTI. We evaluated you for other problems but UTI was the only problem we came across. We started you on appropriate antibiotics. You were sent home in stable condition. The following changes were made to your antibiotics. Please start cefpodoxime by mouth 200mg twice a day Followup Instructions: ___
10382912-DS-16
10,382,912
21,404,037
DS
16
2186-12-23 00:00:00
2186-12-24 19:27:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: syncope Major Surgical or Invasive Procedure: None History of Present Illness: ___ with PMH dementia, DMII brought in by EMS after being found down by wife on the floor. Per report, wife ___ heard a crash from the kitchen and found Mr. ___ down with mouth open and eyes closed, unresponsive for 2min. Wife denies any shaking movements, came to and was at mental baseline. When EMS arrived, was hypotensive at 90/40 then 70/40, FSBG 417, IVF started. In the ED intial vitals were: 0 97.2 60 122/70 99%RA. UA with 1000 glucose, serum glucose >300. He was given 2L IVF for suspected orthostatic hypotension, lactate 4.4, recheck was 1.8. CT head and Cspine done, abnormality noted (hygroma vs chronic subdural hematoma) and patient seen and examined by neurosurgery, found to be a neurological baseline, no role to neurosurgical intervention. Haldol IV given for agitation. Vitals prior to transfer were: 0 75 132/74 19 99% RA On the floor, patient is wandering around the halls and wants to go home. He is able to understand that he fell, but has no recollection of events, has no acute complaints. Per phone discussion with wife, she denies any prodromal symptoms in the days leading to this event, but states she is no longer comfortable taking care of him at home. Wife states he eats sweets at home all the time, has an occasional beer, does not drink enough fluids. Past Medical History: DEMENTIA vascular dementia. DIABETES TYPE II HYPERLIPIDEMIA HYPERTENSION PROSTATE CANCER H/o. in ___. Last PSA undetectable in ___. SUPRAVENTRICULAR TACHYCARDIA OSTEOARTHRITIS Lumbar Back pain ___ radiculopathy; BLADDER CANCER ___ BACK PAIN Social History: ___ Family History: Parents lived to mid ___ and he is not sure about the etiology of death. No history of premature CAD. Physical Exam: ADMISSION EXAM: ================ GENERAL: NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, patent nares, MMM, adentulous, nontender supple neck, no LAD, no JVD CARDIAC: RRR, nl S1, S2, no murmurs, gallops, or rubs LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: moving all extremities well, no cyanosis, clubbing or edema PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact, gait narrow based and steady SKIN: unable to examine DISCHARGE EXAM: ================= GENERAL: NAD, AAOx1 (thought in ___, ___, didn't know year). Bump near R temple, non-tender. CARDIAC: RRR, nl S1, S2, no murmurs, gallops, or rubs LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: strength ___ in all extremities, no cyanosis, clubbing or edema Pertinent Results: ADMISSION LABS: ================ ___ 05:15PM BLOOD WBC-5.4 RBC-3.74* Hgb-11.4* Hct-34.3* MCV-92 MCH-30.5 MCHC-33.2 RDW-12.5 Plt ___ ___ 05:15PM BLOOD Glucose-338* UreaN-8 Creat-1.0 Na-136 K-3.8 Cl-99 HCO3-24 AnGap-17 ___ 05:15PM BLOOD Calcium-9.4 Phos-2.8 Mg-1.7 ___ 05:27PM BLOOD Lactate-4.4* ___ 09:04PM BLOOD Lactate-1.8 DISCHARGE LABS: ================= ___ 08:10AM BLOOD WBC-5.8 RBC-3.68* Hgb-11.0* Hct-33.0* MCV-90 MCH-29.7 MCHC-33.2 RDW-12.4 Plt ___ ___ 08:10AM BLOOD Glucose-207* UreaN-5* Creat-0.9 Na-141 K-3.7 Cl-102 HCO3-31 AnGap-12 ___ 08:10AM BLOOD Calcium-9.6 Phos-2.8 Mg-1.6 STUDIES: ================= ___ CT Head w/o contrast: IMPRESSION: Prominent extra-axial CSF density bilaterally suggesting low-density subdural fluid collections, potentially chronic subdural hematomas, effusions or hygromas, new since ___. No definite acute intracranial process. ___ CT C-spine w/o contrast: IMPRESSION: Degenerative changes without acute cervical spine fracture identified. Brief Hospital Course: ___ with DM, vascular dementia presenting s/p syncopal episode likely due to dehydration secondary to hypoglycemia. # Syncope: Though unable to assess prodromal symptoms due to patient's dementia and lack of witness, wife's history of patient's diet and lack of fluid intake along with known progressing vascular dementia, glucosuria and elevated serum glucose, elevated lactate argues for episode of global hypoperfusion precipitating syncope. Seizure is unlikely given immediately return to baseline, lack of seizure history, lack of witnessed tonic-clonic movements. Cardiogenic source is possible though arrhythmia would not explain elevated lactate. No events on telemetry. No signs of ischemia on EKG. Orthostatics were negative (after IVF resuscitation). Presentation was consistent with hypovolemia possibly related to poor po fluid intake from dementia and osmotic diuresis from hyperglycemia. # Dementia: Wife states she cannot care for him at home any longer and would like assistance with placement. Patient is ambulatory and wanders into the park, gets lost. The patient was deemed fit for discharge to home with 24 hour supervision by family. Case management provided a list of phone numbers for adult care facilities. # DMII: FSBG normalized after IVF. Suspect dietary nonadherence as culprit. Last A1c 7.5% ___. Continued MetFORMIN (Glucophage) 1000 mg PO BID. # HTN: continue home meds, Cr at baseline. Transitional issues: -case management/social work for caregiver support and adult housing/placement -recheck A1c and uptitrate oral diabetes regimen as needed # Code: DNR/DNI Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 40 mg PO DAILY 2. QUEtiapine Fumarate 25 mg PO DAILY:PRN agitation 3. Atenolol 25 mg PO DAILY 4. MetFORMIN (Glucophage) 1000 mg PO BID 5. Memantine 10 mg PO BID 6. Amlodipine 10 mg PO DAILY 7. Donepezil 5 mg PO QAM 8. Atorvastatin 40 mg PO DAILY 9. Aspirin 81 mg PO DAILY 10. Hydrochlorothiazide 12.5 mg PO DAILY Discharge Medications: 1. Amlodipine 10 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atenolol 25 mg PO DAILY 4. Atorvastatin 40 mg PO DAILY 5. Donepezil 5 mg PO QAM 6. Hydrochlorothiazide 12.5 mg PO DAILY 7. Lisinopril 40 mg PO DAILY 8. Memantine 10 mg PO BID 9. MetFORMIN (Glucophage) 1000 mg PO BID 10. QUEtiapine Fumarate 25 mg PO DAILY:PRN agitation Discharge Disposition: Home Discharge Diagnosis: Primary diagnosis: Syncope Secondary diagnosis: Dementia Diabetes Mellitus Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to the hospital for a passing out spell at home. We found you to be dehydrated with a high blood sugar. We gave you IV fluids and you improved. We did not find any other causes of loss of consciousness, and we now feel you are safe to leave the hospital. When you go home, please remember to drink plenty of fluid throughout the day and avoid high sugar, high carbohydrate foods. The case manager has given you a list of places you can call to arrange full time adult care. Please attend your appointment with Dr. ___ on ___. It was a pleasure taking care of you at ___! Sincerely, Your medical team Followup Instructions: ___
10383045-DS-15
10,383,045
29,899,941
DS
15
2118-04-23 00:00:00
2118-04-23 16:05:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: latex Attending: ___ Chief Complaint: Recurrent headaches Major Surgical or Invasive Procedure: ___ - PICC Placed ___ - PICC Removed History of Present Illness: Ms. ___ is a ___ yr F with PMH of DM c/b gastroparesis and neuropathy, HTN, HLD, migraines, and genital herpes on Valtrex who is transferred from OSH with recurrent headaches since this past ___, with an incidental ICA aneurysm. The patient reports development of headache last ___, "stabbing" and well-localized over L orbit. Her headache developed gradually, becoming worse day by day and requiring her to stay home from work by ___ and ___. She began waking up at night with headache starting ___, although states she would take Fioricet with relief and be able to go back to bed before headache returned in afternoon. No association with positional changes. In the following days she also began to notice L sided ptosis as well as binocular horizontal diplopia, unclear if worst with near sight or distance. At OSH, a CTA showed 2-3mm R ICA aneurysm, so she was transferred to ___ for a neurosurgery evaluation. Neurosurgery evaluated her in the ED, and determined that the aneurysm was an incidental finding, not associated with her symptoms. They did not recommend an intervention, but rather outpatient follow-up in two weeks with Dr. ___. On evaluation in the ED by neurology, the patient stated that her headache has mostly resolved with medications given in ED. On physical exam in the ED, patient had a L CN III palsy, pupil-sparing, and L ptosis. Otherwise, her exam was non-focal. CT/CTA do not explain pt's neurologic findings. Per neurology, her clinical presentation was consistent with diabetic changes. In the ED, initial VS were 98.4 79 129/67 94% RA. Exam notable for ptosis, and pupil sparing. Labs showed WBC 11.9, Hb 13, Platelets 422, CRP 5.3. CTA head from OSH significant for 2-3mm R ICA aneurysm. Received IV morphine x2, IVF, IV Zofran, IV nicardipine drip, IV metoclopramide x2, IV diphenhydramine, IV procholorperazine x2. She continued vomiting in the ED, and her oral intake was poor. The decision was made to admit to medicine for further management of her headaches. On arrival to the floor, patient verifies the above information. She reports that her headache is improved from when she presented to the ED, but it still comes and goes. She still reports that it is throbbing. She has no history of blood clots. She does report that she lives in a wooded area, and has a dog. Has not seen a tick on her. Nor does she report any rashes. Past Medical History: - T1DM complicated by diabetic gastroparesis, neuropathy - HTN - HLD - Migraines (headache w/ n/v a few times a year) - Genital herpes Social History: ___ Family History: Father-ALS Physical ___: ADMISSION PHYSICAL EXAM ====================== VS: 98.1 PO 153 / 73 78 18 94 Ra GENERAL: NAD, patient purposely closing L eye HEENT: Pupils PEARRL, L eye does not move past the midline. L eyelid droop. Oropharynx clear, moist mucous membranes. NECK: nontender supple neck, no LAD, no JVD HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 extremities with purpose PULSES: 2+ DP pulses bilaterally NEURO: ___ strength in upper and lower extremities. sensation grossly intact SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE PHYSICAL EXAM ======================== VS: 98.3 PO 174 / 81 77 18 96 RA GENERAL: NAD, patient purposely closing L eye HEENT: Pupils PEARRL, L eye adducts slightly medially past the midline. L eyelid droop, improving. Oropharynx clear, moist mucous membranes. NECK: nontender supple neck, no LAD, no JVD HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 extremities with purpose PULSES: 2+ DP pulses bilaterally NEURO: ___ strength in upper and lower extremities. sensation grossly intact SKIN: warm and well perfused, no excoriations or lesions, no rashes Pertinent Results: ADMISSION LAB RESULTS ==================== ___ 06:39PM BLOOD WBC-11.9* RBC-4.03 Hgb-13.0 Hct-36.0 MCV-89 MCH-32.3* MCHC-36.1 RDW-11.2 RDWSD-36.3 Plt ___ ___ 06:39PM BLOOD Neuts-64.4 ___ Monos-6.5 Eos-2.5 Baso-0.5 NRBC-0.2* Im ___ AbsNeut-7.64* AbsLymp-3.02 AbsMono-0.77 AbsEos-0.30 AbsBaso-0.06 ___ 06:39PM BLOOD Glucose-100 UreaN-16 Creat-0.8 Na-137 K-4.1 Cl-98 HCO3-26 AnGap-17 ___ 01:38PM BLOOD Calcium-9.2 Phos-2.8 Mg-1.8 ___ 06:39PM BLOOD CRP-5.3* ___ 01:37PM BLOOD %HbA1c-9.6* eAG-229* DISCHARGE LAB RESULTS ==================== ___ 05:26AM BLOOD WBC-7.7 RBC-3.13* Hgb-10.0* Hct-28.9* MCV-92 MCH-31.9 MCHC-34.6 RDW-11.8 RDWSD-39.3 Plt ___ ___ 05:26AM BLOOD Glucose-127* UreaN-13 Creat-0.6 Na-140 K-4.3 Cl-103 HCO3-28 AnGap-13 ___ 05:45AM BLOOD Calcium-8.4 Phos-2.7 Mg-1.9 ___ 01:37PM BLOOD %HbA1c-9.6* eAG-229* MICROBIOLOGY ============ ___ Lyme Serology: preliminary positive ___ Blood Culture: pending ___ Urine Culture: negative IMAGING ======= ___ MR HEAD: 1. There is no evidence of acute intracranial process or hemorrhage. 2. No evidence of cavernous sinus thrombosis or dural venous sinus thrombosis. 3. No enhancing mass or abnormal enhancement. 4. Slightly prominent sulci for the patient's age suggesting mild cortical volume loss, however, this finding is nonspecific. Brief Hospital Course: Ms. ___ is a ___ yr F with PMH of DM c/b gastroparesis and neuropathy, HTN, HLD, migraines, and genital herpes on Valtrex who was transferred to ___ from ___ after she presented with recurrent headaches and ptosis. A CT scan of the head revealed an incidental R ICA aneurysm. Neurosurgery evaluated the patient and determined that the aneurysm was not the cause of her ptosis and headaches. An MRI was without mass or hemorrhage. Neurology and Neuro-ophtalmology evaluated the patient and determined that the cause of the patient's symptoms was diabetic third nerve palsy. Her headache slowly improved, and her blood sugars improved as well. Lyme serologies came back preliminarily positive on day of discharge, and she was started on doxycycline. She was discharged home with close follow-up. #DKA #Type 1 Diabetes Mellitus Patient has a history of poorly controlled T1DM complicated by diabetic neuropathy and gastroparesis. Her HbA1c this admission is 9.6%. She did not receive Lantus in ED on ___, and she refused Lantus once she was admitted since she was nauseous and not eating. Her VBG on ___ was without evidence of academia, but a VBG on ___ showed a pH of 7.24 with a bicarb of 14. The patient was admitted to the MICU on ___ for management of diabetic ketoacidosis. Per protocol, an insulin drip was started and her acidosis resolved. On ___, she was transitioned back to her home dose of Lantus and a low dose novolog insulin sliding scale. She continued to feel nauseous without a substantial appetite so she was maintained on ___ normal saline IV fluids. She was transferred back to the floor on ___. ___ diabetes helped to manage the patient's blood sugars while in house. She should follow closely with her endocrinologist. Her discharge insulin regimen is *** #Diabetic Third Nerve Palsy #Ptosis #Eye pain The patient's ptosis was deemed secondary to diabetic third nerve palsy per neuro-ophthalmology and neurology. Physical exam consistent with partial CN III palsy. MRI of the brain was without masses or optic nerve inflammation. She was told to patch her eye as symptoms can take weeks to months to resolve. She should follow-up outpatient with neuro-ophthalmology. #Lyme Disease On day of discharge, the preliminary Lyme test came back positive. It was sent to an outside lab for confirmatory testing. The patient was started on doxycycline. She should continue a ___ay 1 = ___. Day 14 = ___. #Nausea/Vomiting Likely secondary to headache and diplopia. There may also have been a component of diabetic gastroparesis. Her symptoms were controlled with IV Zofran. Her symptoms improved as her blood sugar was controlled. #R ICA aneurysm Patient with an incidental 2-3mm ICA aneurysm seen on OSH CTA. Per neurosurgery, this is not attributable to the patient's symptoms, and patient should have outpatient follow-up in two weeks with Dr. ___. #HTN She was continued on her home HCTZ and lisinopril. TRANSITIONAL ISSUES ================= - CTA showed incidental 2-3mm right ICA. The patient can follow up in the ___ clinic with Dr ___ in ___ weeks. - Patient should follow-up with neuro-ophthalmology. - The patient should follow-up with her endocrinologist for further management of her type 1 diabetes. - She should complete 14 days of doxycycline for Lyme Disease. Day 1 = ___. Day 14 = ___. #CODE: Full (presumed) #CONTACT: ___ (daughter), ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 10 mg PO DAILY 2. Atorvastatin 10 mg PO QPM 3. Acetaminophen-Caff-Butalbital ___ TAB PO Q8H:PRN Headache 4. ValACYclovir 500 mg PO Q24H 5. Humalog 26 Units Breakfast Humalog 4 Units Bedtime Insulin SC Sliding Scale using HUM Insulin 6. Hydrochlorothiazide 25 mg PO DAILY Discharge Medications: 1. Doxycycline Hyclate 100 mg PO Q12H RX *doxycycline hyclate 100 mg 1 capsule(s) by mouth twice a day Disp #*28 Capsule Refills:*0 2. Gabapentin 100 mg PO TID RX *gabapentin 100 mg 1 capsule(s) by mouth three times a day Disp #*30 Capsule Refills:*0 3. Glargine 26 Units Breakfast Insulin SC Sliding Scale using Novolog Insulin 4. Acetaminophen-Caff-Butalbital ___ TAB PO Q8H:PRN Headache 5. Atorvastatin 10 mg PO QPM 6. Hydrochlorothiazide 25 mg PO DAILY 7. Lisinopril 10 mg PO DAILY 8. ValACYclovir 500 mg PO Q24H Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis: - Diabetic Third Nerve Palsy Secondary Diagnosis: - Type 1 DM complicated by DKA - Headache - Nausea/Vomiting - Right ICA aneurysm Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were hospitalized at ___. Why did you come to the hospital? ================================= - You were transferred here from another hospital because you developed an eyelid droop and blurry vision. You were also found to have an aneurysm. What did we do for you? ======================= - While you were here, you developed diabetic ketoacidosis, and you were transferred to the ICU for IV insulin. - Your blood work gradually improved, and you were transferred out of the ICU. - The neurosurgery team evaluated you and determined that there was no surgical intervention needed for your aneurysm. - An MRI of your head did not show any bleeds or masses. - The neurology team and the neuro-ophthalmology team evaluated you. - We think that the cause of your symptoms is from diabetic third nerve palsy. This is something that we expect to take several weeks to several months to improve. - Your Lyme Disease test was also preliminarily positive, so we started you on an antibiotic to treat it (doxycycline). What do you need to do? ======================= - Please wear an eye patch to help with the blurry vision. - It is VERY important that you follow-up with your endocrinologist within three days of discharge. If you would like to be seen by ___ Endocrinologist, please call to schedule an appointment: ___. - It is important that you follow up with Dr. ___ Neuro-opthalmology for further evaluation of your eyelid droop. (Appointment information below.) - It is important that you follow up with Dr. ___ ___ ___ for further evaluation of your aneurysm. - Please monitor your blood sugars closely. Call your doctor or come back to the hospital if your blood sugars remain below 70 or greater than 300. You should take 26 units of lantus in the morning at 4 units of humalog with meals and also use a sliding scale. It was a pleasure caring for you. We wish you the best! Sincerely, Your ___ Medicine Team Followup Instructions: ___
10383358-DS-17
10,383,358
25,076,192
DS
17
2149-11-03 00:00:00
2149-11-12 03:48:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Abdominal Pain Major Surgical or Invasive Procedure: none History of Present Illness: ___ presenting with 2 days of worsening LLQ pain with chills and rigors at home. No associated vomiting and continues to mover her bowels and pass flatus. The pain has been focused in the LLQ only and she denies any vaginal discharge or dysuria. This is her first episode of diverticulitis. Past Medical History: Past Medical History: borderline HTN attempting to control with diet Past Surgical History: Knee surgery, C-section Social History: ___ Family History: Per records- mother and maternal GM with T2DM Physical Exam: ADMISSION EXAM ------------------- Vitals: 100.7 HR 95 BP 126/73 RR 16 94% RA GEN: A&O, NAD HEENT: No scleral icterus, mucus membranes moist CV: RRR, No M/G/R PULM: Clear to auscultation b/l ABD: Soft, nondistended, TTP in LLQ ad suprapubic area, no rebound or guarding, no palpable masses Ext: No ___ edema, ___ warm and well perfused DC EXAM ---------- Vitals: 98.8 PO BP: 110 / 75 HR 50 RR18 O2: 98RA GEN: AOx3, NAD HEENT: moist mucous membranes CV: RRR, no murmurs PULM: CTAB ABD: Soft, non-distended, mild TTP at LLQ, no rebound/guarding, no masses appreciated EXT: no ___ ___ Results: Blood Hematology COMPLETE BLOOD COUNTWBCRBCHgbHctMCVMCHMCHCRDWRDWSDPlt Ct ___ 06:00 ___ ___ 05:40 ___ ___ 06:29 ___ ___ 06:05 ___ ___ 23:00 ___ DIFFERENTIALNeutsBandsLymphsMonosEosBasoAtypsMetasIm GranAbsNeutAbsLympAbsMonoAbsEosAbsBaso ___ 23:00 69.8 19.89.40.5*0.2 0.316.71*1.900.90*0.050.02 INCLUDES METAS, MYELOS AND PROS. BASIC COAGULATION ___, PTT, PLT, INR)PTPTTPlt ___ ___ 06:00 200 ___ 05:40 175 ___ 06:29 203 ___ 06:05 185 ___ 06:05 14.0*28.1 1.3* ___ 23:00 185 Chemistry RENAL & GLUCOSEGlucoseUreaNCreatNaKClHCO3AnGap ___ 06:00 ___ ___ 05:40 ___ ___ 06:29 ___ ___ 06:05 ___ ___ 23:00 ___ CHEMISTRYTotProtAlbuminGlobulnCalciumPhosMgUricAcdIron ___ 06:00 8.93.62.1 ___ 05:40 8.3*3.82.2 ___ 06:29 8.73.52.3 ___ 06:05 8.73.52.1 Urine Hematology GENERAL URINE ___ ___ ___ YellowClear1.026 DIPSTICK U R I N A L Y S ISBloodNitriteProteinGlucoseKetoneBilirubUrobilnpHLeuks ___ 22:50 NEGNEGTRNEG10NEGNEG6.0NEG MICROSCOPIC URINE EXAMINATIONRBCWBCBacteriYeastEpiTransERenalEp ___ 22:50 1<1NONENONE<1 OTHER URINE FINDINGSMucous ___ 22:50 RARE Chemistry URINE CHEMISTRYHours ___ 22:50 RANDOM OTHER URINE CHEMISTRYUCG ___ 22:50 NEGATIVE1 NEGATIVE FOR QUANTITATION OF POSITIVES, SEND SERUM FOR HCG MICRO ------- ___ 6:05 pm URINE SPECIMEN RECEIVED >12 HRS AFTER COLLECTION. Chlamydia trachomatis, Nucleic Acid Probe, with Amplification (Pending): NEISSERIA GONORRHOEAE (GC), NUCLEIC ACID PROBE, WITH AMPLIFICATION (Pending): __________________________________________________________ ___ 2:50 am BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. IMAGING --------- ___ 12:42 AM# ___ CT ABD & PELVIS WITH CO 1. Diverticulitis of the distal descending colon without focal fluid collection. 2. Non-occlusive left ovarian vein thrombosis in the region of inflammation. 3. There is complex free fluid in the pelvis. Brief Hospital Course: Ms. ___ is a ___ who presented with her first episode of complicated diverticulitis. #Diverticulitis: Presented with LLQ tenderness, WBC of 9.6 that peaked to 10.4, and imaging notable for diverticulitis in the distal descending colon. Was initially kept NPO and was started on IV antibiotics (ciprofloxacin and flagyl) on ___. On HD2, was advanced to CLD which she tolerated well. Pain was controlled with IV then PO pain medications. Patient was placed on a bowel regimen and at time of discharge, pain was controlled and patient was counseled on foods to eat and avoid at home. Patient was discharged on PO Ciprolfoxacin and PO Flagyl for a total 10 day course of antibiotics (last day ___. Discharge WBC was 4.1 #Non-occlusive left ovarian vein thrombus: was noted on admission CT, adjacent to area of diverticulitis. CT also notable for complex free fluid in pelvis; likely in setting of the inflammatory processes in the abdomen. These findings did not require any further follow-up. Patient was notified of findings and recommended to discuss at next PCP ___. Transitional Issues ------------------- [] Patient being discharged on Ciprofloxacin PO and Metronidazole PO for a total course between ___ [] CT findings showed Non-occlusive left ovarian vein thrombus with complex free fluid in pelvis; all likely in setting of acute inflammatory process adjacent to the diverticulitis. No further evaluation was done in the hospital, however patient was advised to follow-up with PCP. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 2. Excedrin Migraine (aspirin-acetaminophen-caffeine) 250-250-65 mg oral DAILY PRN headache Discharge Medications: 1. Ciprofloxacin HCl 500 mg PO Q12H RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*13 Tablet Refills:*0 2. Docusate Sodium 100 mg PO BID Hold for loose stools RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*2 3. MetroNIDAZOLE 500 mg PO Q8H RX *metronidazole 500 mg 1 tablet(s) by mouth every eight (8) hours Disp #*21 Tablet Refills:*0 4. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Severe DO NOT DRIVE WHILE TAKING THIS MEDICATION. CAN CAUSE SEDATION RX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours Disp #*10 Tablet Refills:*0 5. Polyethylene Glycol 17 g PO DAILY:PRN constipation RX *polyethylene glycol 3350 17 gram/dose 1 powder(s) by mouth Daily Refills:*2 6. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild RX *acetaminophen 325 mg 1 tablet(s) by mouth every six (6) hours Disp #*60 Tablet Refills:*0 7. Excedrin Migraine (aspirin-acetaminophen-caffeine) 250-250-65 mg oral DAILY PRN headache Discharge Disposition: Home Discharge Diagnosis: Diverticulitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted to the hospital with abdominal pain. You were found to have diverticulitis (inflammation/infection of an "out-pouching" of your bowels) on imaging. Your imaging also showed some fluid in your pelvis and a non-occlusive clot near your left ovarian vein, all which are near to where you had the abdominal inflammation. These findings did not require further follow up, but please discuss these findings with your primary care doctor to determine if any future re-imaging is needed. In the hospital, you received bowel rest and slowly tolerated a diet. Your pain was controlled and you received antibiotics. When you go home - Eat foods that are easy for you to digest and slowly get back to your normal diet. Diet recommendations are included for you below. - Continue taking antibiotics till ___ - Follow up with your doctors. It was a pleasure taking care of you, --Your ___ Care Team Followup Instructions: ___
10383860-DS-18
10,383,860
21,630,078
DS
18
2143-10-14 00:00:00
2143-10-16 10:28:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: oxycodone / aspirin Attending: ___ Chief Complaint: abdominal pain, nausea, fever Major Surgical or Invasive Procedure: None History of Present Illness: Patient is a ___ female with a history of autoimmune hepatitis related cirrhosis (c/b HE, ascites, and EVs), s/p gastric bypass, and prior history of gallstone pancreatitis who p/w N/V, elevated lipase, concerning for pancreatitis. Three days ago, patient developed epigastric pain. Acute worsening over the last 24 hours. Presented to OSH, where lipase was greater than 1200. Patient received 500 cc of fluid at outside hospital as well as 8 mg of Zofran and pain control. She was transferred to ___ for further management. Patient states that she has also had several days of nausea and nonbilious nonbloody vomiting. Bedside ultrasound revealed enlarged gallbladder with normal wall, no pericholecystic fluid. Common bile duct less than 4 mm. No ascites. Patient's blood pressure in ED with systolics in the ___. Per patient, this is normal for her. Blood pressure at last liver transplant outpatient visit had patient's blood pressure at 91/57. The patient states that her urine turned dark yesterday, and that was also when the fevers started. Patient denies any fevers, chills, chest pain, shortness of breath, urinary or bowel symptoms. Patient denies any melena or bloody stools. She has diarrhea, but she reports it is at her baseline since she takes lactulose and rifaximin. Past Medical History: Autoimmune hepatitis with portal hypertension Esophageal varices Hypothyroidism Asthma Anemia Gastric bypass surgery C-section Social History: ___ Family History: Mother ___ CIRRHOSIS Father ___ END STAGE RENAL DISEASE Physical Exam: ADMISSION PHYSICAL EXAM: ======================== VS: 98.6PO 102 / 58 95 18 92 RA GENERAL: NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM NECK: supple, no LAD, no JVD HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB ABDOMEN: mildly distended, TTP in epigastric area and RUQ EXTREMITIES: no cyanosis, clubbing, or edema, no asterixis PULSES: 2+ DP pulses bilaterally NEURO: A&Ox3, moving all 4 extremities with purpose SKIN: mildly jaundiced, no rashes DISCHARGE PHYSICAL EXAM: ======================== Vitals: T 97.9 HR 69 BP 95/59 RR 18 O2 96% RA GENERAL: lying in bed, NAD HEENT: anicteric sclera, MMM HEART: RRR, nl S1/S2, no murmurs, gallops, or rubs LUNGS: expiratory wheezing heard throughout all lung fields, no crackles or rhonchi, good air movement overall ABDOMEN: mildly distended, mildly TTP in RUQ without rebound tenderness or guarding, nontender in epigastrium. Normoactive BS. EXTREMITIES: no cyanosis, clubbing, or edema, no asterixis NEURO: A&Ox3, moving all 4 extremities with purpose SKIN: mildly jaundiced, no rashes Pertinent Results: ADMISSION LABS: =============== ___ 07:39PM BLOOD WBC-5.2 RBC-3.59* Hgb-11.8 Hct-33.4* MCV-93 MCH-32.9* MCHC-35.3 RDW-14.7 RDWSD-49.7* Plt Ct-25* ___ 07:39PM BLOOD Neuts-81.4* Lymphs-9.0* Monos-8.8 Eos-0.2* Baso-0.4 Im ___ AbsNeut-4.26# AbsLymp-0.47* AbsMono-0.46 AbsEos-0.01* AbsBaso-0.02 ___ 07:39PM BLOOD ___ PTT-36.5 ___ ___ 07:39PM BLOOD ___ 07:39PM BLOOD Glucose-78 UreaN-15 Creat-0.6 Na-138 K-3.7 Cl-106 HCO3-20* AnGap-12 ___ 07:39PM BLOOD ALT-42* AST-69* LD(LDH)-206 AlkPhos-129* TotBili-9.4* DirBili-7.0* IndBili-2.4 ___ 07:39PM BLOOD Lipase-1117* ___ 05:50AM BLOOD Calcium-7.5* Phos-4.5 Mg-1.3* Cholest-100 ___ 05:50AM BLOOD Triglyc-79 HDL-19* CHOL/HD-5.3 LDLcalc-65 ___ 06:50AM BLOOD HBsAg-NEG HBsAb-POS HBcAb-NEG ___ 07:49PM BLOOD Lactate-2.1* DISCHARGE LABS: =============== ___ 06:50AM BLOOD WBC-3.7* RBC-3.29* Hgb-10.8* Hct-31.5* MCV-96 MCH-32.8* MCHC-34.3 RDW-15.6* RDWSD-53.4* Plt Ct-55* ___ 06:50AM BLOOD ___ PTT-35.8 ___ ___ 06:50AM BLOOD Glucose-76 UreaN-9 Creat-0.4 Na-138 K-4.0 Cl-104 HCO3-22 AnGap-12 ___ 06:50AM BLOOD ALT-26 AST-61* LD(LDH)-219 AlkPhos-125* TotBili-5.2* ___ 06:50AM BLOOD Calcium-7.7* Phos-2.7 Mg-1.5* Brief Hospital Course: ___ female with a history of autoimmune hepatitis related cirrhosis (c/b HE, ascites, and EVs)(Childs C, MELD-Na 24), s/p gastric bypass, and prior history of gallstone pancreatitis who p/w N/V, elevated lipase, LFTs, and E. coli bacteremia concerning for pancreatitis and cholangitis. ACUTE ISSUES: ============= #Pancreatitis The patient presented with RUQ/epigastric abdominal pain, nausea and vomiting and was found to have a lipase over 1200. RUQ ultrasound revealed cholelithiasis but no cholecystitis. Etiology most likely a passed gallstone. She was made NPO and started on IV fluids and pain medications. Her abdominal pain and nausea improved over the following days. Her diet was slowly advanced as tolerated and IV fluids were stopped after she was taking in enough fluids by mouth. Pain medications were changed from IV to oral and this was tolerated well. #Cholangitis The patient presented with fever, jaundice, RUQ pain, and elevated bilirubin consistent with cholangitis. She was started on Zosyn initially and this was changed to ceftriaxone and metronidazole. MRCP showed cholelithiasis but no choledocolithiasis, so she did not receive ERCP as the culprit stone likely passed. Antibiotics were switched to oral ciprofloxacin and metronidazole prior to discharge to be continued for a ___. coli bacteremia The patient had positive blood cultures for pan-sensitive E. coli in the setting of her cholangitis, likely from translocation. She was treated with Zosyn, ceftriaxone/metronidazole, and sent home on oral ciprofloxacin/metronidazole to complete a 2 week course on ___. CHRONIC ISSUES: =============== #Cirrhosis Thought to be most likely secondary to autoimmune hepatitis vs. ___. Complicated by ascites, hepatic encephalopathy and esophageal varicies. Patient being worked up for liver transplant prior to cholecystectomy. She had daily MELD labs. Her hold spironolactone was held while she was given IV fluids. Her rifaximin and lactulose were continued. She continued her home nadolol to prevent variceal bleeding. #Coagulopathy The patient has an elevated INR and thrombocytopenia related to her liver disease. She had an active type and screen while in the hospital and daily coagulation labs were drawn. #Hypotension The patient has consistent SBPs in the ___ at home. She was continued on midodrine and prednisone. #Hypothyroidism She was continued on her home levothyroxine TRANSITIONAL ISSUES: =================== [ ] The patient will need to complete a 2 week course of antibiotics for cholangitis and E. coli bacteremia with ciprofloxacin and metronidazole. End date ___. [ ] The patient would benefit from a cholecystectomy after liver transplant workup to prevent future episodes of gallstone pancreatitis and cholangitis. This is complicated by her cirrhosis making such an operation risky. [ ] Patient discharged with diarrhea and C. diff pending. Please follow-up and initiate treatment with oral vancomycin for 14 days after ___ if positive. Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. PredniSONE 3.75 mg PO DAILY 2. Midodrine 2.5 mg PO BID 3. Nadolol 20 mg PO DAILY 4. Spironolactone 50 mg PO DAILY 5. Calcium Carbonate 500 mg PO DAILY 6. Rifaximin 550 mg PO BID 7. Levothyroxine Sodium 75 mcg PO DAILY 8. Cyanocobalamin 1000 mcg PO DAILY 9. Vitamin D ___ UNIT PO DAILY 10. Vitamin E 800 UNIT PO DAILY 11. Lactulose 30 mL PO TID 12. Famotidine 40 mg PO QHS 13. Albuterol Inhaler 2 PUFF IH Q4H:PRN SOB 14. Furosemide 20 mg PO DAILY Discharge Medications: 1. Ciprofloxacin HCl 500 mg PO Q12H RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day Disp #*20 Tablet Refills:*0 2. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate RX *hydromorphone 2 mg 1 tablet(s) by mouth every six (6) hours Disp #*6 Tablet Refills:*0 3. MetroNIDAZOLE 500 mg PO Q8H RX *metronidazole 500 mg 1 tablet(s) by mouth every eight (8) hours Disp #*30 Tablet Refills:*0 4. Midodrine 5 mg PO TID RX *midodrine 5 mg 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills:*1 5. Ondansetron ODT 4 mg PO Q8H:PRN nausea RX *ondansetron 4 mg 1 tablet(s) by mouth every eight (8) hours Disp #*12 Tablet Refills:*0 6. Albuterol Inhaler 2 PUFF IH Q4H:PRN SOB 7. Calcium Carbonate 500 mg PO DAILY 8. Cyanocobalamin 1000 mcg PO DAILY 9. Famotidine 40 mg PO QHS 10. Furosemide 20 mg IV DAILY 11. Furosemide 20 mg PO DAILY RX *furosemide 20 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*1 12. Lactulose 30 mL PO TID 13. Levothyroxine Sodium 75 mcg PO DAILY 14. PredniSONE 3.75 mg PO DAILY 15. Rifaximin 550 mg PO BID 16. Spironolactone 50 mg PO DAILY 17. Vitamin D ___ UNIT PO DAILY 18. Vitamin E 800 UNIT PO DAILY Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSES ================== Pancreatitis Cholangitis SECONDARY DIAGNOSES ===================== Cirrhosis Autoimmune hepatitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure being involved in your care. Why you were admitted to the hospital: ============================== You were admitted to the hospital because you had a fever, nausea, and abdominal pain and were found to have lab abnormalities consistent with inflammation of your pancreas and cholangitis, which is an infection of the bile ducts. Bacteria were also found in your blood, likely as a result of the infection in your bile ducts. What happened in the hospital: ======================== - To treat your pancreatitis, you were given IV fluids, pain medications, and your diet was slowly advanced until you could comfortably eat normally again. - To treat your cholangitis and bacteria in your blood, you were given IV antibiotics. These were switched to oral antibiotics prior to discharge. - You had an MRI to look at your liver, bile ducts, gallbladder, and pancreas that showed gallstones but no stones in your bile ducts. This suggests that your infection was caused by a stone that passed. What to do when you leave the hospital: =============================== - Please take your antibiotics until they finish treating your infection on ___. - Please attend all of your follow-up appointments, including those related to your liver transplant and future removal of your gallbladder. We wish you the best! Your ___ Team Followup Instructions: ___
10384049-DS-12
10,384,049
29,851,042
DS
12
2177-07-18 00:00:00
2177-07-17 16:54:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROSURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: ___ Major Surgical or Invasive Procedure: None History of Present Illness: ___ yr old male pt intoxicated, who presented with small bifrontal SDH s/p fall, no LOC, no seizures. Past Medical History: None Social History: ___ Family History: NC Physical Exam: On Admission: AVSS awake, confused, oriented x ___ follows commands throughout PERRL, EOMI, FSTM No drift MAE ___ sensation intact to light touch Neck: Supple. Lungs: CTA bilaterally. Cardiac: RRR. S1/S2. Abd: Soft, NT, BS+ Extrem: Warm and well-perfused. On Discharge: A&Ox3 L pupil surgical, R ___ EOMs intact Face symmetrical tongue midline No pronator drift Motor: ___ throughout Pertinent Results: head CT: small bifrontal and falcine SDH, no mass effect or midline shift Head CT ___: Thin 2 mm subdural hemorrhage along the right frontoparietal convexity and thin parafalcine subdural hemorrhage without evidence of mass effect Brief Hospital Course: ___ y/o M who was intoxicated, presents with with bifrontal SDH s/p fall. He was admitted to neurosurgery for monitoring overnight. He was started on MVI, thalamine and folic acid. On ___, patient remained stable on exam, social work was consulted and ___. His repeat head CT showed no increase in SDHs. On ___, he was cleared to be discharged home by both ___ and SW. His pain was under control and he was discharged in stable condition. Medications on Admission: None Discharge Medications: 1. Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 2. LeVETiracetam 500 mg PO BID RX *levetiracetam [Keppra] 500 mg 1 tablet(s) by mouth twice a day Disp #*12 Tablet Refills:*0 3. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO Q4H:PRN pain RX *oxycodone-acetaminophen [Percocet] 5 mg-325 mg ___ tablet(s) by mouth every four (4) hours Disp #*60 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Bifrontal SDH Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: •Take your pain medicine as prescribed. •Exercise should be limited to walking; no lifting, straining, or excessive bending. •Increase your intake of fluids and fiber, as narcotic pain medicine can cause constipation. We generally recommend taking an over the counter stool softener, such as Docusate (Colace) while taking narcotic pain medication. •Unless directed by your doctor, do not take any anti-inflammatory medicines such as Motrin, Aspirin, Advil, or Ibuprofen etc. •**You have been discharged on Keppra (Levetiracetam)for 6 more days, you will not require blood work monitoring. CALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE FOLLOWING •New onset of tremors or seizures. •Any confusion, lethargy or change in mental status. •Any numbness, tingling, weakness in your extremities. •Pain or headache that is continually increasing, or not relieved by pain medication. •New onset of the loss of function, or decrease of function on one whole side of your body. Followup Instructions: ___
10384457-DS-12
10,384,457
24,737,154
DS
12
2138-02-02 00:00:00
2138-02-02 20:13:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Diffuse lower abdominal pain that migrated to the right lower quadrant. Major Surgical or Invasive Procedure: ___ laparoscopic appendectomy History of Present Illness: Mrs. ___ is a ___ year old female who presents with 18 hours of abdominal pain that was originally diffuse lower abdominal pain that migrated to the RLQ. The pain was associated with chills, nausea, and emesis prior to admission. No diarrhea or dysuria. No prior episodes of pain. Past Medical History: Asthma, allergies. Social History: ___ Family History: Non-contributory. Physical Exam: On admission: PE: 98.7 65 113/71, 18, 100% on room air Gen: no distress, alert and oriented x 3 HEENT: PERLA, EOMI, anicteric Chest: RRR, lungs clear bilaterally Abd: soft, nondistended, tender to palpation in RLQ, no rebound or guarding, (+) Rosving's sign Rectal: Ext: no edema, warm On discharge: VS: Temp 98.6, HR 60, BP 100/50, RR 18, sat 99% on room air. Neuro: AAO x 3. NAD. General abdominal tenderness, more superficial near trocar sites. Soft, non-distended. Pertinent Results: ___ 12:24PM BLOOD WBC-13.6* RBC-4.19* Hgb-12.5 Hct-36.8 MCV-88 MCH-29.7 MCHC-33.8 RDW-13.3 Plt ___ ___ 12:24PM BLOOD Neuts-89.1* Lymphs-7.4* Monos-3.1 Eos-0.2 Baso-0.2 ___ 12:24PM BLOOD Glucose-111* UreaN-10 Creat-0.6 Na-138 K-4.0 Cl-101 HCO3-25 AnGap-16 ___ 12:47PM BLOOD Lactate-1.5 ___ CT abdomen and pelvis with contrast Distended fluid-filled appendix measuring 10 mm with mucosal hyperemia and surrounding periappendiceal stranding and trace free fluid, concerning for uncomplicated acute appendicitis. Brief Hospital Course: Mrs. ___ was admitted on ___ under the acute care surgery service for management of her acute appendicitis. She was taken to the operating room and underwent a laparoscopic appendectomy. Please see operative report for details of this procedure. She tolerated the procedure well and was extubated upon completion. She was subsequently taken to the PACU for recovery. She was transferred to the surgical floor hemodynamically stable. Her vital signs were routinely monitored and she remained afebrile and hemodynamically stable. She was initially given IV fluids postoperatively, which were discontinued when she was tolerating oral intake. Her diet was advanced on the morning of ___ to regular, which she tolerated without abdominal pain, nausea, or vomiting. She was voiding adequate amounts of urine without difficulty. She was encouraged to mobilize out of bed and ambulate as tolerated, which she was able to do independently. Her pain level was routinely assessed and well controlled at discharge with an oral regimen as needed. On the evening of ___, Mrs. ___ was discharged home in the care of her parents. A follow-up appointment has been scheduled with with the ACS service. She was hemodynamically stable and afebrile. Discharge instructions were provided by myself and the bedside RN. Medications on Admission: Allegra, singulair, zyrtec, veramyst, QVAR inhaler Discharge Medications: 1. Montelukast Sodium 10 mg PO DAILY 2. Docusate Sodium 100 mg PO BID 3. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*30 Tablet Refills:*0 4. Acetaminophen 325-650 mg PO Q6H:PRN pain 5. Qvar *NF* (beclomethasone dipropionate) 80 mcg/actuation Inhalation 3 puffs daily 6. Fexofenadine 180 mg PO DAILY 7. Veramyst *NF* (fluticasone furoate) 27.5 mcg/actuation NU each nostril daily 8. Patanol *NF* (olopatadine) 0.1 % ___ 1 - 2 drops to each eye twice daily Discharge Disposition: Home Discharge Diagnosis: Acute appendicitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital with acute appendicitis. You were taken to the operating room and had your appendix removed laparoscopically. You tolerated the procedure well and are now being discharged home with the following instructions: Please follow up at the appointment in clinic listed below. We also generally recommend that patients follow up with their primary care provider after having surgery. We have scheduled an appointment for you listed below. ACTIVITY: o Do not drive until you have stopped taking pain medicine and feel you could respond in an emergency. o You may climb stairs. o You may go outside, but avoid traveling long distances until you see your surgeon at your next visit. o Don't lift more than ___ lbs for ___ weeks. (This is about the weight of a briefcase or a bag of groceries.) This applies to lifting children, but they may sit on your lap. o You may start some light exercise when you feel comfortable. o You will need to stay out of bathtubs or swimming pools for a time while your incision is healing. Ask your doctor when you can resume tub baths or swimming. HOW YOU MAY FEEL: o You may feel weak or "washed out" a couple weeks. You might want to nap often. Simple tasks may exhaust you. o You may have a sore throat because of a tube that was in your throat during surgery. o You could have a poor appetite for a couple days. Food may seem unappealing. o All of these feelings and reactions are normal and should go away in a short time. If they do not, tell your surgeon. YOUR INCISION: o Tomorrow you may shower and remove the gauzes over your incisions. Under these dressings you have small plastic bandages called steri-strips. Do not remove steri-strips for 2 weeks. (These are the thin paper strips that might be on your incision.) But if they fall off before that that's okay. o Your incisions may be slightly red around the stitches. This is normal. o You may gently wash away dried material around your incision. o Avoid direct sun exposure to the incision area. o Do not use any ointments on the incision unless you were told otherwise. o You may see a small amount of clear or light red fluid staining your dressing or clothes. If the staining is severe, please call your surgeon. o You may shower. As noted above, ask your doctor when you may resume tub baths or swimming. YOUR BOWELS: o Constipation is a common side effect of narcotic pain medications. If needed, you may take a stool softener (such as Colace, one capsule) or gentle laxative (such as milk of magnesia, 1 tbs) twice a day. You can get both of these medicines without a prescription. o If you go 48 hours without a bowel movement, or have pain moving the bowels, call your surgeon. PAIN MANAGEMENT: o It is normal to feel some discomfort/pain following abdominal surgery. This pain is often described as "soreness". o Your pain should get better day by day. If you find the pain is getting worse instead of better, please contact your surgeon. o You will receive a prescription for pain medicine to take by mouth. It is important to take this medicine as directed. Do not take it more frequently than prescribed. Do not take more medicine at one time than prescribed. Do not drink alcohol or drive while taking narcotic pain medication. o Your pain medicine will work better if you take it before your pain gets too severe. o Talk with your surgeon about how long you will need to take prescription pain medicine. Please don't take any other pain medicine, including non-prescription pain medicine, unless your surgeon has said its okay. o If you are experiencing no pain, it is okay to skip a dose of pain medicine. o Remember to use your "cough pillow" for splinting when you cough or when you are doing your deep breathing exercises. o If you experience any of the following, please contact your surgeon: - sharp pain or any severe pain that lasts several hours - pain that is getting worse over time - pain accompanied by fever of more than 101 - a drastic change in nature or quality of your pain MEDICATIONS: Take all the medicines you were on before the operation just as you did before, unless you have been told differently. If you have any questions about what medicine to take or not to take, please call your surgeon. Followup Instructions: ___
10384955-DS-4
10,384,955
26,681,962
DS
4
2167-04-24 00:00:00
2167-04-30 16:28:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: fluticasone Attending: ___. Chief Complaint: speech difficulty Major Surgical or Invasive Procedure: none History of Present Illness: Mr. ___ is a ___ yo M with a history of HTN, HLD, and recently diagnosed HepC who presented to the ED with complaints of chest pain, dyspnea on exertion, and lower extremity edema. Given his cardiac risk factors, the patient was to be evaluated with cardiac stress test. However, on further questioning by ED physicians, there was concern for neurologic deficits on history. The patient reports that he was trying to talk and was mumbling instead and couldn't get the words out properly. He felt that his words were slurred. When he spoke his family thought he was trying to be funny but this was not his intension. This first occurred a few weeks ago but these symptoms occurred again on ___. Both times the symptoms were transient and would fully resolve within that day. The morning of presentation the patient reports a headache on the L side that feels like "marbles inside of the head" and sharp/stabbing. The headache lasted for 1 hour; this wakes him up from sleep ___ x per week and then gradually resolves. The patient does not have associated nausea. It is unknown whether he has photophobia. This has been going on for a few months. The patient has had headaches in the past but were persistent and dull, due to HTN. They resolved once the patient started antihypertensives. The patient also reports L mouth tremulousness and numbness, also present for a few months. This occurs occasionally but the patient cannot remember how often. It is most prominent in the morning when he wakes up. These are not temporally associated with the headaches. On neuro ROS, the pt reports chronic tinnitus, frequent lightheadedness when standing. He denies headache, loss of vision, blurred vision, diplopia, dysarthria, dysphagia, lightheadedness, vertigo, tinnitus or hearing difficulty. Denies difficulties producing or comprehending speech. Denies focal weakness, numbness, parasthesiae. No bowel or bladder incontinence or retention. Denies difficulty with gait. On general review of systems, the pt reports feet/leg swelling, SOB, chest pain, occassional palpitations. He denies recent fever or chills. No night sweats or recent weight loss or gain. Denies cough. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Denies rash. Past Medical History: Hepatitis C - recently diagnosed, possibly could undergo treatment, no history of cirrhosis HTN HLD Asthma Social History: ___ Family History: Brother with epilepsy, deceased of brain tumor age ___ (unknown etiology of epilepsy, diagnosed age ___ Physical Exam: Physical Exam on Admission: Vitals: T= 97.7F, BP= 144/80, HR= 52, RR= 18, SaO2= 98% General: Awake, cooperative, NAD. HEENT: NC/AT Neck: Supple, no carotid bruits appreciated. No nuchal rigidity Pulmonary: CTABL Cardiac: RRR, no murmurs Abdomen: soft, nontender, nondistended Extremities: no edema, pulses palpated Skin: no rashes or lesions noted. Neurologic: -Mental Status: Alert, oriented x 3. Able to relate history without difficulty. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Pt. was able to name both high and low frequency objects. Speech was not dysarthric. Able to follow both midline and appendicular commands. Attentive, able to name ___ backward without difficulty. Pt. was able to register 3 objects and recall ___ at 5 minutes, ___ with category cueing. The pt. had good knowledge of current events. There was no evidence of apraxia or neglect. -Cranial Nerves: I: Olfaction not tested. II: PERRL 3 to 2mm, both directly and consentually; brisk bilaterally. VFF to confrontation. Funduscopic exam was attempted but unable to fully visual discs so papilledema was not able to be assessed. III, IV, VI: EOMI without nystagmus. Normal saccades. + exophoria V: Facial sensation intact to light touch, pinprick in all distributions, and ___ strength noted bilateral in masseter VII: No facial droop, facial musculature symmetric and ___ strength in upper and lower distributions, bilaterally VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline, and is equal ___ strength bilaterally as evidenced by tongue-in-cheek testing. -Motor: Normal bulk, tone throughout. No pronator drift bilaterally. No adventitious movements, such as tremor, noted. No asterixis noted. Delt Bic ___ WrE FFl FE IO IP Quad Ham TA ___ L ___ 5 5 R ___ 5 5 -DTRs: ___ Pat Ach L 0 0 0 0 0 R 0 0 0 0 0 - Plantar response was flexor bilaterally. - Pectoralis Jerk was absent, and Crossed Adductors are absent. -Sensory: No deficits to light touch, pinprick, cold sensation, vibratory sense, proprioception throughout. No extinction to DSS. -Coordination: No intention tremor, no dysdiadochokinesia noted. No dysmetria on FNF or HKS bilaterally. -Gait: Good initiation. Narrow-based, normal stride and arm swing. Labs/Studies: Physical Exam on Discharge: Unchanged Pertinent Results: Labs ___ 10:24PM WBC-5.0 RBC-5.30 HGB-15.8 HCT-43.9 MCV-83 MCH-29.9 MCHC-36.1* RDW-14.7 ___ 10:24PM cTropnT-<0.01 ___ 10:24PM GLUCOSE-148* UREA N-14 CREAT-1.2 SODIUM-142 POTASSIUM-3.2* CHLORIDE-105 TOTAL CO2-26 ANION GAP-14 ___ 04:50AM ALBUMIN-3.9 ___ 04:50AM cTropnT-<0.01 ___ 04:50AM ALT(SGPT)-43* AST(SGOT)-47* ALK PHOS-61 TOT BILI-0.7 ___ 10:15AM TSH-2.5 ___ 10:15AM TRIGLYCER-208* HDL CHOL-33 CHOL/HDL-5.1 LDL(CALC)-93 ___ 10:15AM %HbA1c-5.1 eAG-100 ___ 10:15AM ALT(SGPT)-47* AST(SGOT)-54* CK(CPK)-51 ALK PHOS-65 TOT BILI-0.9 ___ 10:15AM GLUCOSE-94 UREA N-12 CREAT-1.1 SODIUM-140 POTASSIUM-3.5 CHLORIDE-103 TOTAL CO2-27 ANION GAP-14 Imaging CTA head/neck No significant abnormalities on CT of the head without contrast. No significant abnormalities on CT angiography of the head. No evidence for sinus thrombosis. MRI brain w/ and w/o contrast No significant abnormalities are seen on MRI of the brain with and without gadolinium. Brief Hospital Course: Mr. ___ is a ___ yo M with a history of HTN, HLD, and recently diagnosed HepC who presented to the ED with complaints of chest pain, dyspnea on exertion, and lower extremity edema concerning for cardiac chest pain with initial plan to work up with cardiac stress testing. He also reported several episodes of intermittent word finding difficulty/dysarthria. Presented with chest pain to ED. 2 sets of cardiac enzymes and ECG not concerning for acute coronary syndrome. Reported transient word finding difficulty/dysarthria and headaches with symptoms suggestive of increased intracranial pressure (eg. awoken from sleep by his headaches). CT brain did not show any evidence of hemorrhage. CTA head/neck showed patent vasculature, no venous sinus thrombosis, or AVM, or aneurysm. MRI brain w/ and w/o contrast ruled out stroke and mass lesion. Upon obtaining additional history from him once he was admitted to the Neurology service, he reported that his episodes of dysarthria were only lasting for a word or two. There was low suspicion for TIA as his episodes of speech difficulty were quite brief. Transthoracic echocardiogram was deferred due to low suspicion for TIA and given that he already had a TTE (non bubble study) in ___ that showed a normal EF of 65% without evidence of intracardiac thrombus or PFO/ASD. Headache may be due to temporomandibular joint dysfunction or tension headaches. The patient was started on aspirin 81mg qd. Will have cardiac stress test as outpatient, communicated this to PCP, ___. Medications on Admission: Atenolol 75 mg PO BID Amlodipine 2.5 mg PO QAM Amlodipine 5 mg PO HS Hydrochlorothiazide 25 mg PO DAILY Moexipril 15 mg PO BID Discharge Medications: 1. Aspirin 81 mg PO DAILY RX *aspirin [Adult Low Dose Aspirin] 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*6 2. Atenolol 75 mg PO BID 3. Amlodipine 2.5 mg PO QAM 4. Amlodipine 5 mg PO HS 5. Hydrochlorothiazide 25 mg PO DAILY 6. Moexipril 15 mg PO BID Discharge Disposition: Home Discharge Diagnosis: possible TIA (low suspicion) headache Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You came to the emergency room with chest pain. An EKG and blood tests of your heart were normal. You will need a CARDIAC STRESS TEST as an outpatient. We have let Dr. ___ about this. In the emergency room, you reported several episodes of slurred speech and trouble finding words as well as headaches that wake you up in the middle of the night. So, we admitted you to neurology to rule out a stroke, blood clot, mass in your brain with an MRI. The MRI of your brain was NORMAL, which is great! We think your headache might be from grinding your teeth. We did start you on a baby aspirin for stroke prevention. We have made the following changes to your medications: START aspirin 81mg daily On discharge: Please call to schedule an appointment with Dr. ___ in neurology: ___ You will need to schedule a cardiac stress test. Please talk to Dr. ___ to help facilitate this. It was a pleasure taking care of you, we wish you all the best Followup Instructions: ___
10384987-DS-19
10,384,987
27,055,047
DS
19
2172-06-30 00:00:00
2172-07-06 09:48:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: bee stings Attending: ___. Chief Complaint: Polytrauma s/p MCC Major Surgical or Invasive Procedure: ___: Open reduction internal fixation right lateral condyle proximal tibia fracture with depression and use of calcium phosphate filler. History of Present Illness: This patient is a ___ year old male who complains of MCC. Patient status post motor vehicle collision sustaining right pneumothorax was multiple rib fractures. Chest tube was placed with some clinical improvement. Patient was tachycardic with increased work of breathing. Patient is given pain medication and the chest tube was repositioned with significant improvement in symptoms. In discussion, patient is admitted to the ICU for continued pulmonary monitoring. Past Medical History: PMH: Lyme, OSA PSH: Appendectomy, tonsillectomy Social History: ___ Family History: Father had MI @ ___, and Mother @ ___ yrs, both deceased, 2 brothers are healthy Physical Exam: PHYSICAL EXAMINATION ON ADMISSION Constitutional: Agitated HEENT: Normocephalic, atraumatic Oropharynx within normal limits Chest: Crackles right Cardiovascular: Tachycardic Abdominal: Soft, Nontender GU/Flank: No costovertebral angle tenderness Extr/Back: No cyanosis, clubbing or edema Skin: No rash, Warm and dry Neuro: Speech fluent Pertinent Results: ___ 04:45AM BLOOD WBC-9.0 RBC-3.48* Hgb-11.0* Hct-33.2* MCV-95 MCH-31.6 MCHC-33.2 RDW-13.3 Plt ___ ___ 05:45AM BLOOD WBC-8.8# RBC-3.14* Hgb-10.3* Hct-29.4* MCV-94 MCH-32.7* MCHC-34.9 RDW-13.2 Plt ___ ___ 12:51PM BLOOD WBC-5.4 RBC-2.83* Hgb-9.5* Hct-26.6* MCV-94 MCH-33.5* MCHC-35.6* RDW-13.0 Plt ___ ___ 04:46AM BLOOD WBC-7.7 RBC-3.40* Hgb-10.9* Hct-31.7* MCV-93 MCH-32.0 MCHC-34.3 RDW-13.5 Plt ___ ___ 12:38AM BLOOD WBC-8.4 RBC-3.55* Hgb-11.5*# Hct-33.5* MCV-94 MCH-32.5* MCHC-34.5 RDW-13.6 Plt ___ ___ 10:13PM BLOOD WBC-14.2* RBC-4.52* Hgb-14.7 Hct-42.8 MCV-95 MCH-32.6* MCHC-34.4 RDW-13.5 Plt ___ ___ 07:05PM BLOOD WBC-17.1* RBC-4.73 Hgb-15.5 Hct-44.3 MCV-94 MCH-32.7* MCHC-34.9 RDW-13.3 Plt ___ ___ 04:45AM BLOOD Glucose-106* UreaN-20 Creat-0.7 Na-135 K-4.0 Cl-100 HCO3-23 AnGap-16 ___ 05:00AM BLOOD Glucose-116* UreaN-20 Creat-0.7 Na-139 K-3.9 Cl-102 HCO3-27 AnGap-14 ___ 05:45AM BLOOD Glucose-288* UreaN-14 Creat-0.8 Na-134 K-3.4 Cl-100 HCO3-24 AnGap-13 ___ 04:46AM BLOOD Glucose-120* UreaN-15 Creat-0.8 Na-137 K-3.7 Cl-103 HCO3-27 AnGap-11 ___ 12:38AM BLOOD Glucose-138* UreaN-23* Creat-1.1 Na-139 K-3.8 Cl-104 HCO___ AnGap-10 ___ 05:45AM BLOOD TSH-0.74 Radiology: X-ray Tib/Fib: There has been interval placement of a lateral longitudinal plate and perpendicularly oriented screws stabilizing a tibial plateau fracture. Alignment appears improved from the initial injury. CT Chest: IMPRESSION: 1. Small right hemopneumothorax. Moderate pneumomediastinum. No evidence of intra-abdominal injury. 2. Multiple right-sided rib fractures as described above. No fractures in the thoracolumbar spine identified. The right subclavian vein is not well seen in the area of trauma, this may represent vessel injury or spasm however there is no adjacent hemorrhage of any substantial size. Right subclavian artery appears intact. 3. 2.8 cm right common iliac aneurysm with peripheral thrombus. Celiac aneurysm measures 1.7 cm. Recommend follow up with vascular surgery when clinically appropriate. 4. Fatty liver. XRay Chest: IMPRESSION: Markedly displaced right second through fourth rib fractures. Right-sided chest tube in place with no substantial pneumothorax. XRay Shoulder: IMPRESSION: Findings consistent with shoulder separation involving the acromioclavicular joint. No definite fracture involving the right shoulder although the possibility of a nondisplaced distal acromial fracture is not entirely excluded. ___ ECHO a-fib, no abnormalities Brief Hospital Course: The patient is a ___ gentleman transferred from OSH status post motorcycle collision resulting in multiple injuries including right ___ rib fractures, right acromioclavicular dissociation, right pneumothorax requiring a chest tube (at OSH), and a right proximal tibia fracture. The patient experienced LOC but GCS was 15 upon arrival to ___, and the patient was complaining of chest pain. The patient became hemodynamically unstable with notable flail chest and tachycardia, so he was transferred to the ___ for close monitoring. Acute Pain Service was consulted and an epidural was placed. He then became hypotensive requiring fluid resuscitation and neo drip for a short while. The epidural was then split and the patient stabilized. Orthopedics were consulted to address the patient's right proximal tibia fracture and acromioclavicular dissociation. The AC separation did not require surgery and was placed in a sling. The patient was taken to the operating room on HD#3 for ORIF right tibia. The patient tolerated the procedure well and was successfully extubated postoperatively. He was transferred out of the unit to the floor in hemodynamnicallt stable condition. Initial work-up CT showed an incidental finding of a 1.7cm celiac aneurym & 2.8 cm right common iliac aneurym. Vascular was consulted for this, who felt there was no urgent operative indication. The patient will follow-up with Dr ___ in 6 months for repeat CTA. On HD#4 Cardiology was consulted for new onset Atrial fibrillation with RVR; the patient was found to have RBBB at baseline. Patient did not have any CP, palpitation, SOB, or lightheadedness but c/o pain all over his body aggravated with movements. The cardiologists felt the new AF was likely precipitated by the acute chest trauma and blood loss. He was started on metoprolol with good effect. On HD#6 the chest tube was d/c'd. Post pull CXR did not show any recurrent pneumothorax and the patient's respiratory status was improved. He was seen by Physical therapy and Occupational therapy, who felt the patient met the criteria for a rehab at the time of discharge, based on his injuries and functioning below baseline. Pain was well controlled. Diet was progressively advanced as tolerated to a regular diet with good tolerability. The patient voided without problem. During this hospitalization, the patient was out of bed with assist, was adherent with respiratory toilet and incentive spirometry, and actively participated in the plan of care. The patient received subcutaneous lovenox and venodyne boots were used during this stay. . At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, out of bed with assist, voiding without assistance, and pain was well controlled. The patient was discharged to rehab. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Medications on Admission: none Discharge Medications: 1. Acetaminophen 650 mg PO Q6H pain 2. Baclofen 10 mg PO TID 3. Diazepam 5 mg PO Q6H:PRN spasm 4. Docusate Sodium 100 mg PO BID 5. Enoxaparin Sodium 40 mg SC DAILY Start: Today - ___, First Dose: Next Routine Administration Time 6. Famotidine 20 mg PO BID 7. HYDROmorphone (Dilaudid) ___ mg PO Q3H:PRN pain 8. Lidocaine 5% Patch 2 PTCH TD QAM 9. Metoprolol Tartrate 25 mg PO BID 10. Senna 8.6 mg PO BID Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Polytrauma: Right proximal tibia fracture Right ___ rib fracture Right hemothorax Right shoulder AC separation Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Mr ___, You were admitted to ___ after a motorcycle collision. You sustained multiple injuries, including 8 right sided rib fractures, a right lung injury, right shoulder separation, and right tibia fracture. You were taken to the operating room with the Orthopedic team for repair of the tibia fracture. * Your injury caused 8 rib fractures which can cause severe pain and subsequently cause you to take shallow breaths because of the pain. * You should take your pain medication as directed to stay ahead of the pain otherwise you won't be able to take deep breaths. If the pain medication is too sedating take half the dose and notify your physician. * Pneumonia is a complication of rib fractures. In order to decrease your risk you must use your incentive spirometer 4 times every hour while awake. This will help expand the small airways in your lungs and assist in coughing up secretions that pool in the lungs. * You will be more comfortable if you use a cough pillow to hold against your chest and guard your rib cage while coughing and deep breathing. * Symptomatic relief with ice packs or heating pads for short periods may ease the pain. * Do NOT smoke * If your doctor allows, non-steroidal ___ drugs are very effective in controlling pain ( ie, Ibuprofen, Motrin, Advil, Aleve, Naprosyn) but they have their own set of side effects so make sure your doctor approves. * Return to the Emergency Room right away for any acute shortness of breath, increased pain or crackling sensation around your ribs (crepitus). Discharge Instructions: MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take lovenox 40mg daily for 2 weeks WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - No dressing is needed if wound continues to be non-draining. - Splint must be left on until follow up appointment unless otherwise instructed - Do NOT get splint wet ACTIVITY AND WEIGHT BEARING: -Right lower extremity TDWB in ___ -Right upper extremity NWB, sling for comfort Followup Instructions: ___
10385319-DS-6
10,385,319
22,825,754
DS
6
2174-08-14 00:00:00
2174-08-14 20:05:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: s/p assault Major Surgical or Invasive Procedure: none History of Present Illness: ___ s/p assault who presented to ___ on the evening of ___. Per report he reportedly lost consciousness in the field and then again at ___. He had facial swelling and reportedly could not protect his airway. Four attempts at endotracheal intubation were attempted. He was then transferred to the OR for a tracheostomy, but anesthesia was able to successfully intubate the patient on their ___ attempt. He then underwent a CT scan of his face and c-spine and was transferred to ___ for further management. Upon arrival to ___ he was hemodynamically stable with normal oxygen saturations. Other than his facial edema he had no other injuries identified on secondary survey. He then underwent CT scans of his head, face, c-spine, and torso which revealed a left orbial wall fracture, left maxillary sinus fracture, left zygomatic arch fracture, and 2 small foci of SAH. He was admitted to the trauma SICU for observation and treatment. Past Medical History: ? bipolar disorder, chronic bronchitis Social History: ___ Family History: N/C Physical Exam: Gen: Intubated and sedated, able to follow commands, unable to communicate HEENT: ___, L periorbital ecchymoses and edema, left subconjuctival hemorrhage, blood in nares, blood in right ear canal from small laceration, no Battle sign, no septal hematoma, no nasal deviation, trachea midline Chest: RRR, lungs clear, no chest wall tenderness Abd: soft, nontender, nondistended Rectal: minimal tone, no gross blood Ext: no long bone deformities, palpable pulses Spine: no stepoffs Pertinent Results: ___ 03:47PM GLUCOSE-110* UREA N-11 CREAT-0.8 SODIUM-139 POTASSIUM-4.0 CHLORIDE-102 TOTAL CO2-29 ANION GAP-12 ___ 03:47PM ALT(SGPT)-39 AST(SGOT)-51* LD(LDH)-268* ALK PHOS-58 TOT BILI-0.6 ___ 03:47PM ALBUMIN-4.1 CALCIUM-8.8 PHOSPHATE-3.3 MAGNESIUM-2.3 ___ 03:47PM WBC-9.7 RBC-4.02* HGB-13.5* HCT-39.5* MCV-98 MCH-33.6* MCHC-34.2 RDW-12.9 ___ 03:47PM PLT COUNT-189 ___ 09:30AM LACTATE-1.7 ___ 02:25AM ASA-NEG ___ ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG Brief Hospital Course: See the HPI for presenting details. Upon weaning down his sedation he was following commands and he extubated successfully. His pain was initially controlled with IV medications and this was transitioned to PO meds. He remained normotensive with a normal HR throughout his stay. His oxygen saturations remained normal on room air after extubation. Plastic surgery was consulted and they recommened sinus precautions, antibiotics, and an opthamology consult. They plan on having him follow up in their clinic to discuss potential operative repair. A detailed physical examination of his left eye revealed no abnormalities so an Ophthamology consult was deferred. We did not start antibiotics as there is no indication for them in closed facial fractures. On ___ he was started on a regular diet which he tolerated with no nausea or emesis. His pain was well controlled on oral medications. He was discharged with appropriate follow up with the plastic surgeon. Medications on Admission: None Discharge Medications: 1. Acetaminophen 325-650 mg PO Q6H:PRN pain 2. Levofloxacin 500 mg PO Q24H Duration: 3 Days RX *levofloxacin 500 mg 1 tablet(s) by mouth once a day Disp #*2 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: 1) Subarachnoid hemorrhage 2) left orbital floor fracture 3) Left maxillary sinus fracture 4) left maxillary bone fracture involving the zygomatic process 5) right maxillary sinus fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Stable. Discharge Instructions: Please resume all regular home medications, unless specifically advised not to take a particular medication. Please take any new medications as prescribed. Specifically, please take your 2 day course of Levofloxacin, an antibiotic to treat your aspiration pneumonia. You may also take acetaminophen for pain (Tylenol) as directed, but do not exceed 4000 mg in one day. Please get plenty of rest, continue to walk several times per day, and drink adequate amounts of fluids. Avoid strenuous physical activity and refrain from heavy lifting greater than 20 lbs., until you follow-up with your surgeon, who will instruct you further regarding activity restrictions. Please also follow-up with your primary care physician. It is very important that you follow up with your plastic surgeon, Dr. ___, regarding your facial fractures. We also recommend that you follow up with a psychiatrist as an outpatient. At home, you must obey strict "sinus precautions" due to your facial fractures until further instructed by your plastic surgeon, which include: AVOID ___ blowing your nose It is best to wipe away nasal secretions carefully. After 2 weeks, if you must blow your nose, blow gently through both sides at the same time. Do not pinch your nose; do not blow just one side at a time. ___ sneezing If you must sneeze, keep your mouth open and do not pinch your nose closed. ___ sucking Do not drink through a straw. Do not smoke. ___ blowing Do not play a wind instrument. Do not blow up balloons. ___ pushing or lifting Do not lift or push objects weighing more than 20 pounds. ___ bending over Keep your head above the level of your heart. Sleep with your head slightly raised. Followup Instructions: ___
10385370-DS-6
10,385,370
20,094,739
DS
6
2204-10-15 00:00:00
2204-10-16 16:39:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Atrial Fibrillation Major Surgical or Invasive Procedure: TEE Cardioversion ___ History of Present Illness: ___ PMH CAD, HTN, carotid artery stenosis, TIA who presents with new onset AF found on outpatient EKG done for preop visit for TCAR (transcarotid artery revascularization). He has no known prior history of AF and given AF w/RVR he was referred in to the ED. Prior to the AF being found on EKG at his pre-op eval he says he was having no new symptoms. He denies palpitations, CP, SOB, cough, pain with inspiration, abdominal pain, nausea, vomiting, lower extremity edema, lightheadedness, dizziness, fatigue. On arrival to the ED his initial VS were 97.0 106 177/89 17 97% RA. Basic labs, CXR and EKG were all obtained. For his AF w/RVR he was first given Diltiazem 15mg IV with improvement in rates so was then followed with Diltiazem 30mg PO. He was also started on a hep gtt and given Mg and K repletion. He was admitted to cardiology for further workup and management of his new AF. Upon arrival to the floor, he says that he is feeling fine but is tired from waiting in the ED for so long. Past Medical History: CAD HTN Left carotid artery stenosis Allergic rhinitis BPH Psoriasis Epistaxis TIA Folliculitis Social History: ___ Family History: He says that his father had cardiac disease but he is not sure the specifics of it. Physical Exam: ADMISSION ========= VITALS: 97.4PO 165 / 89R Sitting 120 18 97 RA GENERAL: Alert, NAD, sitting up on edge of bed HEENT: atraumatic, normocephalic, EOMI, PERRL CARDIAC: Irregularly irregular, no m/r/g LUNGS: CTAB, no wheezes, ronchi or crackles ABDOMEN: soft, NT, ND EXTREMITIES: wwp, 1+ edema to bilateral shins NEUROLOGIC: AAOx3, CN II-XII intact, strength ___ bilateral upper and lower extremities, speech fluent DISCHARGE ========= VITALS: Reviewed in OMR GENERAL: Alert and oriented, no acute distress ENT: NT/AC, MMM, EOMI CV: Irregularly irregular, no murmurs, rubs, or gallops. +L sided carotid bruit. RESP: CTAB, normal work of breathing GI: NT/ND, BS+ EXT: Warm and well perfused, non-edematous NEURO: CNII-XII grossly intact, no focal neurologic deficits Pertinent Results: ADMISSION ========= ___ 11:10AM WBC-5.5 RBC-4.90 HGB-14.7 HCT-44.4 MCV-91 MCH-30.0 MCHC-33.1 RDW-12.9 RDWSD-42.0 ___ 11:10AM ___ PTT-35.4 ___ ___ 11:10AM UREA N-26* CREAT-1.1 SODIUM-141 POTASSIUM-3.2* CHLORIDE-98 TOTAL CO2-32 ANION GAP-11 ___ 04:45PM cTropnT-<0.01 ___ 04:45PM TSH-1.3 DISCHARGE ========= None Brief Hospital Course: SUMMARY ======= Mr ___ is a ___ year old male with a PMH of CAD, HTN, carotid artery stenosis, TIA who presents with new onset AF. ACUTE ISSUES ============ # New AF w/RVR: His last TTE was from a stress test back in ___ where he showed excellent exercise capacity and EF >55%. There are multiple possible etiologies for his new AF. Given his significant CAD ___ cath showed 3v disease s/p DES to OM) he could have developed ischemic cardiomyopathy and should have TTE to eval his cardiac function, however no anginal symptoms and trop negative x1 with no ischemic EKG changes. Valvular disease also a possibility given his history of long-standing HTN and CAD. Also possibly iso age-related changes with new onset stable atrial arrhythmia. He had good response to diltizem in the ED, and was given a larger AM dose of his home metoprolol, and then he was successfully cardioverted during TEE and started on apixaban for anticoagulation (CHADs2VASC 6) with cardiology follow up as outpatient. Did have some runs of atrial flutter on telemetry prior to cardioversion, so might need amiodarone or other antiarrhythmic as an outpatient. CHRONIC ISSUES ============== # Carotid stenosis: Most recent ultrasound showed 80-99% L carotid stenosis. He has been seen by vascular surgery as an outpatient. His options for management were explained to him and he elected to pursue workup for TCAR as part of the ___ II study. He presented for pre-op planning for TCAR and that is when he was found to be in AF w/RVR, which is an exclusion criteria for the study. Per vascular surgery notes, even if he was a candidate he would have wanted to wait until ___ to have any procedures done, so if he changes his mind can reach out to vascular while inpatient about options or if patient prefers can defer to outpatient setting. # CAD: (Last cath ___, 3v CAD with culprit OM s/p DES) Continued home ___ 81mg, and Atorvastatin # BPH: Continued home Tamsulosin # HTN: Continued home losartan, chlorthalidone, and carvedilol TRANSITIONAL ISSUES =================== Discharge INR: 1.2 Discharge plt: 122 A1c: 5.8% TSH: 1.3 [ ] Started on apixaban this admission, now on triple therapy (___) due to Carotid stenosis. Defer to outpatient cardiologist regarding anticoagulation/antiplatelet going forward. Continue to monitor for signs of bleeding on triple therapy. ___ need to drop aspirin [ ] Please have patient see Vascular Surgery again as an outpatient to revist surgical options for his carotid artery stenosis [ ] Continue to monitor for atrial fibrillation (patient was completely asymptomatic this time) and consider amiodarone versus uptitration of carvedilol for rate control if needed. ___ need anti-arrhythmic agent given afib/flutter combination seen on telemetry this admission although maintained sinus rhythm post cardioversion [ ] Consider ziopatch as outpatient to monitor afib/flutter burden [ ] Consider formal TTE to look closely at valves and chambers [ ] Follow up full read of TEE #CODE: Full confirmed #CONTACT: ___ (wife) ___ Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Acetaminophen ___ mg PO Q8H:PRN Pain - Mild/Fever 2. Losartan Potassium 50 mg PO BID 3. metroNIDAZOLE 1 % topical DAILY 4. Ketoconazole Shampoo 1 Appl TP ASDIR 5. CARVedilol 12.5 mg PO BID 6. Clobetasol Propionate 0.05% Cream 1 Appl TP BID 7. Desonide 0.05% Cream 1 Appl TP ASDIR 8. Fluocinonide 0.05% Cream 1 Appl TP ASDIR 9. Triamcinolone Acetonide 0.1% Ointment 1 Appl TP ASDIR 10. Atorvastatin 80 mg PO QPM 11. sulfacetamide sodium (acne) 10 % topical BID 12. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN Chest pain 13. sildenafil 50-100 mg oral ASDIR 14. Clopidogrel 75 mg PO DAILY 15. Aspirin 81 mg PO DAILY 16. Tamsulosin 0.4 mg PO QHS 17. Chlorthalidone 25 mg PO DAILY Discharge Medications: 1. Apixaban 5 mg PO BID RX *apixaban [Eliquis] 5 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 2. Acetaminophen ___ mg PO Q8H:PRN Pain - Mild/Fever 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 80 mg PO QPM 5. CARVedilol 12.5 mg PO BID 6. Chlorthalidone 25 mg PO DAILY 7. Clobetasol Propionate 0.05% Cream 1 Appl TP BID 8. Clopidogrel 75 mg PO DAILY 9. Desonide 0.05% Cream 1 Appl TP ASDIR 10. Fluocinonide 0.05% Cream 1 Appl TP ASDIR 11. Ketoconazole Shampoo 1 Appl TP ASDIR 12. Losartan Potassium 50 mg PO BID 13. metroNIDAZOLE 1 % topical DAILY 14. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN Chest pain 15. Sildenafil 50-100 mg oral ASDIR 16. sulfacetamide sodium (acne) 10 % topical BID 17. Tamsulosin 0.4 mg PO QHS 18. Triamcinolone Acetonide 0.1% Ointment 1 Appl TP ASDIR Discharge Disposition: Home Discharge Diagnosis: Primary ======= Atrial Fibrillation Secondary ========= Coronary Artery Disease Hypertension Hyperlipidemia Carotid Artery Stenosis Benign Prostatic Hypertrophy Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: ====================== DISCHARGE INSTRUCTIONS ====================== Dear Mr. ___, It was a privilege caring for you at ___. WHY WAS I IN THE HOSPITAL? - You were found to be in an abnormal heart rhythm called atrial fibrillation. WHAT HAPPENED TO ME IN THE HOSPITAL? - You were put under anesthesia and shocked to restore your heart back to your normal heart rhythm. - You were started on a blood thinner (Eliquis / Apixaban) to reduce your risk of stroke associated with atrial fibrillation. You should continue to follow up with your cardiologist about this (below). - You were continued on your home dose of carvedilol for rate control WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
10385501-DS-10
10,385,501
23,794,052
DS
10
2167-05-09 00:00:00
2167-05-10 11:03:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: shellfish derived Attending: ___. Chief Complaint: Dyspnea Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ with alcoholic cirrhosis/NASH, colon cancer, and refractory ascites s/p TIPS ___ who was presenting with confusion and headache. Family reports that the patient hasn't taken his lactulose for ___ days, but has had 1 bowel movement daily nonetheless. Endorses one episodes of non-bloody vomiting. Denies fevers/chills, CP, SOB, abd pain. Denies any falls. Of note, patient was recently admitted from ___ to ___ for increased dypsnea and worsening pleurel effusions. As an outpatinet, the patient has been undergoing paracentesis weekly and had a TIPS place for recurrent ascites. He was initially managed with diuretics and albumin and had a therapeutic para on ___. He also had a thoracentesis on ___. He was discharged on torsemide and spironolactone. He was scheduled to have paracenteses every other week. His discharge weight was 111.5 kg. The family reports that they felt the patient was slightly confused at the time of discharge as well. Of note, it appears that lactulose was started at end of ___ after TIPS procedure at 15ml BID. This was not mentioned in the previous discharge summary and it was not on his discharge medication list. - Initial VS in the ED: 97.8 69 114/73 16 97% RA. - Labs were notable for INR 1.4 (baseline), Cr 2.0 (slighly above baseline 1.8), Hgb 9.2/27.2 (baseline), Plt 58 (slightly below baseline), TB 1.8 (baseline 1.4). Negative UA. - Imaging: Liver Us with doppler with cirrhosis, small ascites and R plueral effusion. Patent TIPS with decreased distal flow since most recent study. CXR with stable bilateral pleural effusions. CT Scan was ordered given ongoing headache and was unremarkable for bleed. FYI, some pituitary prominence, so they recommended outpatient pituitary MRI. - Patient was given lactulose 30mL and had blood and uring cultures drawn. - Consulted hepatology who recommended admission to ET. - Vitals on transfer: 98.6 65 127/80 18 100% RA On arrival to the floor, patiet was examined sitting upright in bed eating a sandwich. Per nurse ___ took care of him on previous admission), patient seems slower and more confused. Mr. ___ was able to recounts some details of the past 3 days since his discharge, but the details were unclear. He does endorse a headache and currently denies any chest pain, nausea, vomiting, diarrhea, constipation, or change in the size of his abdomen or lower extremities. He does say that he usually has ___ bowel movements. Past Medical History: - Colon cancer. - Cirrhosis (?EtOH/NASH) complicated by portal hypertension, esophageal varices, coagulopathy - Hypertension. - Obesity - MGUS - History of solitary left kidney (R nephrectomy in the ___) due to ruptured benign cyst - History of gout. Social History: ___ Family History: No known family history of liver disease, liver cancer or colon cancer. Physical Exam: >> Admission Physical Exam: Vitals - 97.5 117/69 67 20 100% on RA Wt: 103.4kg (prior discharge weight 111.5 kg) GENERAL: Well-appearing gentleman in NAD, AOx3 HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, dry mucous membranes NECK: nontender supple neck, no LAD, no JVD CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG: CTAB, no wheezes or rhonchi ABDOMEN: moderately protuberant abdomen, +BS, nontender in all quadrants, no rebound/guarding, no hepatomegaly, spleen palpably 3cm below right costal border EXTREMITIES: no cyanosis, clubbing, trace edema, moving all 4 extremities with purpose PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact. Mild resting tremor, + asterixis. Able to slowly do days of week backward and forward with ___ mistakes. SKIN: warm and well perfused, no excoriations or lesions, no rashes . >> Discharge Physical Exam: VITALS: 98.2 74 106/55 18 99/RA I/O: 1110/500+ 2BM Discharge Weight: 106.5kg GENERAL: Well-appearing gentleman in NAD, lying in bed HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM. NECK: nontender supple neck, no LAD, no JVD appreciated. CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG: dimished breath sounds in R base, no wheezes or rhonchi heard at bases. ABDOMEN: moderately protuberant abdomen, +BS, nontender in all quadrants, no rebound/guarding, no hepatomegaly, spleen palpably 3cm below right costal border EXTREMITIES: no cyanosis, clubbing, trace edema, moving all 4 extremities with purpose PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact. No asterixis. AAO to ___ and month SKIN: warm and well perfused Pertinent Results: >> Admission Labs: ___ 03:45PM BLOOD WBC-4.0 RBC-2.64* Hgb-9.2* Hct-27.2* MCV-103* MCH-35.0* MCHC-34.0 RDW-17.1* Plt Ct-58* ___ 03:45PM BLOOD Glucose-154* UreaN-56* Creat-2.0* Na-143 K-3.6 Cl-104 HCO3-30 AnGap-13 ___ 03:45PM BLOOD ALT-38 AST-49* AlkPhos-141* TotBili-1.8* . >> Pertinent Reports: # CT Head non-con (___): 1. No acute intracranial process. 2. Mild prominence of the pituitary gland. Recommend further evaluation with non-emergent pituitary MRI. 3. Mild mucosal thickening of the left maxillary sinus. 4. Opacification of the left mastoid air cells may be due to chronic inflammation. # Liver U/S with Doppler (___): 1. Cirrhosis with a small amount of ascites and a right pleural effusion. 2. Patent TIPS. 3. Left portal vein not visualized. 4. Distended gallbladder containing sludge. TIPS VELOCITIES: 86, 119 and 76 cm/second in the proximal, mid and distal portions, respectively, previously 120, 186 than 136 cm/second. # CXR (___): Small bilateral pleural effusions, not changed in the interval, with streaky left basilar atelectasis. . ___ Imaging CHEST (PA & LAT) IMPRESSION: In comparison with the study of ___, there is again increased opacification at the right base above an elevated hemidiaphragm, consistent with atelectasis and possible small effusion. Continued enlargement of the cardiac silhouette with tortuosity of the aorta, but no evidence of vascular congestion. >> Discharge Labs: ___ 07:15AM BLOOD WBC-3.5* RBC-2.49* Hgb-9.1* Hct-25.5* MCV-102* MCH-36.4* MCHC-35.6* RDW-17.7* Plt ___ ___ 05:20AM BLOOD ___ PTT-40.8* ___ ___ 07:15AM BLOOD Glucose-168* UreaN-48* Creat-1.6* Na-141 K-4.2 Cl-104 HCO3-31 AnGap-10 ___ 05:20AM BLOOD ALT-33 AST-43* AlkPhos-149* TotBili-0.9 ___ 07:15AM BLOOD Calcium-8.9 Phos-4.7* Mg-1.7 >> MICRO: ___ 6:48 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: MICROCOCCUS/STOMATOCOCCUS SPECIES. PRESUMPTIVE IDENTIFICATION. IDENTIFICATION PERFORMED ON CULTURE # ___ ___. VIRIDANS STREPTOCOCCI. FINAL SENSITIVITIES. Sensitivity testing performed by Sensititre. CEFTRIAXONE REQUESTED PER ___ ___. CEFTRIAXONE SENSITIVITIY TESTING PERFORMED BY ___.. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ VIRIDANS STREPTOCOCCI | CEFTRIAXONE----------- 0.25 S CLINDAMYCIN----------- 0.5 I ERYTHROMYCIN---------- 4 R PENICILLIN G---------- 0.5 I VANCOMYCIN------------ <=1 S Aerobic Bottle Gram Stain (Final ___: GRAM POSITIVE COCCI IN PAIRS, CHAINS, AND CLUSTERS. Reported to and read back by ___ ___ ___ 1215PM. Anaerobic Bottle Gram Stain (Final ___: GRAM POSITIVE COCCI IN PAIRS, CHAINS, AND CLUSTERS. Brief Hospital Course: Mr. ___ is a ___ with a history of NASH/EtOH cirrhosis and refractory ascites s/p TIPS ___, recent hospital stay for volume overload, now presenting with increasing confusion. . >> ACTIVE ISSUES: # Bacteremia: Micrococcus/stomatococcus and Strep Viridans. Found incidentally on ED blood cultures as part of encephalopathy workup. Possible contamination versus GI translocation. Given high grade (cultures positive in less than 12 hours) opted to treat with short 2 week course of ceftriaxone (narrowed from vancomycin after sensitivities returned). ID followed during this admission. TTE negative for vegetations. Last day of 14 day course = ___. # Hepatic Encechalopathy / Confusion: Patient was not given lactulose during past hospital stay due to adequate BMs then. Here, confusion improved with lactulose, rifaxmin, and treatment of bacteremia. Infectious workup otherwise unremarkable. TIPS patent and perhaps contributing. If confusion in the future despite lactulose/rifaxmin, consider TIPS evaluation with venogram and potential downsizing. # Pituitary Enhancement: CT-head on admission showedf mild prominence of the pituitary gland. Recommend further evaluation with non-emergent pituitary MRI to assess for an underlying lesion. # Headache: Non-specific, likely tension headache. Improved with holding diuretics. # ___ on CKD Stage IIIa: Creatinine above baseline after TIPS, trended down to likely new baseline of 1.5 after holding diuretics. Diuretics restarted at lower doses prior to discharge. # Portal HTN c/b ascites and hepatic hydrothorax: S/p TIPS for refractory ascites on ___, and recent hospital stay for aggressive diuresis. TIPS patent per RUQ doppler, although slow flow in distal asepct. CXR without stable small b/l pleural effusion with minimal ascites on ultrasound. Last para inpatient ___, last thoracentesis ___. His diuretics were initially held then restarted at lower dose for goal "dry" weight 103 kg. # Cirrhosis ___ NASH and ETOH: Chils Class B, MELD 19, has prior h/o decompensation with PTH (as above), esophageal varices (Grade I x 2 cords ___, encephalopathy as above. Not transplant candidate. Generally stable this admission. # Hypertension: (clonidine discontinued during last hospital stay) Continued home carvedilol. # GOUT: Continue home allopurinol # Tachycardia - Patient had run of tachycardia overnight on ___, possibly SVT, in setting of his beta blockers being held for ___. Stable after a few doses of metoprolol then transition back to home carvedilol. TRANSITIONAL ISSUES: # Bacteremia: Ceftriaxone x 14 days (last day ___ # Please check CBC, Chem-10, Hepatic panel on ___ and ___ with results faxed to the ___ at fax ___. # Ascites: If reaccumulates, may need to resume outpatient paracentesis schedule. # Goal "dry" weight 103 kg. # Recommend further evaluation with non-emergent pituitary MRI to assess for an underlying pituitary lesion. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Carvedilol 12.5 mg PO BID 4. Spironolactone 100 mg PO DAILY 5. Torsemide 100 mg PO DAILY 6. Vitamin D 1000 UNIT PO BID 7. Lactulose 15 mL PO BID Discharge Medications: 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Carvedilol 12.5 mg PO BID 4. Lactulose 30 mL PO QID Titrate to ___ bowel movements daily 5. Lactulose 30 mL PO PRN RASS<0 6. Spironolactone 50 mg PO DAILY 7. Torsemide 40 mg PO DAILY 8. Vitamin D 1000 UNIT PO BID 9. Acetaminophen 650 mg PO Q8H:PRN pain 10. Bisacodyl 10 mg PR QHS:PRN constipation 11. CeftriaXONE 2 gm IV Q24H 12. Rifaximin 550 mg PO BID Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSES: 1. Bacteremia SECONDARY DIAGNOSES: 1. Cirrhosis s/p TIPS procedure Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you during your hospital stay at ___. You were admitted to the hospital after not feeling well at home, and you were found to have an infection in your blood stream. For this, you were treated with intravenous antibiotics to continue for a total of 2 weeks ending ___. Please see changes to your home medications below. Please follow up with your primary care physician and your liver specialists upon discharge from the rehab. Take Care, Your ___ Team. Followup Instructions: ___
10385964-DS-16
10,385,964
25,330,346
DS
16
2183-06-11 00:00:00
2183-06-11 17:24:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Sulfa (Sulfonamide Antibiotics) Attending: ___. Chief Complaint: Falls, weakness, subjective cognitive decline Major Surgical or Invasive Procedure: None History of Present Illness: ___ with history of discoid lupus, depression and anxiety, dizziness, osteoporosis who presents with recurrent falls and whole body weakness and subjective cognitive decline. She reports that over the last few weeks she has felt progressively weaker. She has had several falls, at least ___ due to weakness where she lots her balance and had a hard time standing up. On some of these she actually hit her head. She is certain that she has not lost consciousness during the falls. The most recent fall was the day prior to presentation. She was reaching over, lost her balance and was unable to stop herself from falling slowly. She was unable to get up and was able to call from her phone. She denies lightheadedness or dizziness on standing routinely. She denies chest pain, palpitations, shortness of breath, abdominal pain, nausea, vomiting or diarrhea. She has had ongoing constipation issues for her whole life and this may be slightly worse. She does note for the last day a constant sensation of having to urinate, without dysuria specifically. She denies fevers, chills, or flank pain. She denies focal numbness or weakness. She has a longstanding history of depression which has been followed by a psychiatrist. She has no present SI or HI, but does feel that the last few weeks were stressful because of family visits and due to trying to arrange for the new medication fetzima. She has been on multiple medications and has had several medication changes over the years. She currently takes lorazepam 1mg four times daily. She started a new medication called Fetzima a few days ago after a long battle with insurance. Unfortunately when she presented to the ED she was found to have a nonpruritic urticarial type rash over the chest and abdomen. She denies any other new medications, over the counter agents, or new soaps or lotions. Of note, she was seen several times over the last few months for dizziness which was thought to be related to BPPV and was having physical therapy for this. She was having persistent symptoms and so a neurologist visit and MRI had been planned but she had not yet completed. In the ED, initial vitals 98.3 105 153/86 18 97% RA. Exam notable for nonpruritic urticarial rash over her back with no other abnormalities. Labs notable for Na 130, Cr 0.6, UA equivocal for UTI with mod ___, neg nitrites, 11 WBC, few bacteria and no epis. Troponin was negative. EKG was abnormal with anterolateral STD, R bundle morphology, TWI V2-V5, but upon comparison with priors in the ___ record this is unchanged. CBC, LFTs and electrolytes were otherwise wnl. Toxicology screen negative. Head CT showed no acute process and CXR was without consolidation. She was given 1L of LR and 1g ceftriaxone. Neurology was consulted for gait instability and felt likely toxic metabolic in etiology. Of note, the patient had an Na of 130 on ___ at ___, and 131 in ___, so her hyponatremia appears to be chronic. On the floor, she endorses the history above. She is very uncomfortable with sensation of needing to urinate and interrupts the conversation to use the bedpan several times. Past Medical History: Hypercholesterolemia Anticardiolipin antibody positive Osteoporosis Colon adenoma Sleep apnea, obstructive bh Lumbar scoliosis Discoid lupus Impaired glucose tolerance Connective tissue disease, undifferentiated RBBB (right bundle branch block) Dizziness Social History: ___ Family History: Father CAD/PVD - Early Maternal Aunt Cancer - Lung Maternal Uncle ___ pancreatic cancer [OTHER] Mother ___ Other Cancer - Breast Sister No Significant Medical History Pertinent Negatives Neg HX Cancer - Colon Physical Exam: Admission Physical Exam: General: Alert, oriented, no acute distress, able to provide coherent history and detailed medication list with ease HEENT: Sclerae anicteric, dry MM, oropharynx clear, EOMI, PERRL, neck supple CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no rebound or guarding GU: No foley Ext: Warm, well perfused, trace edema bilaterally, 2+ DPs Skin: Warm, dry, no rashes or notable lesions. Neuro: CNII-XII intact, ___ strength upper/lower extremities, normal sensation, appropriate affect Discharge Physical Exam: General: Anxious appearing, pleasant, comfortable HEENT: Sclerae anicteric, oropharynx clear, EOMI, PERRL, neck supple CV: Tachycardic, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no rebound or guarding GU: No foley Ext: Warm, well perfused, trace edema bilaterally, 2+ DPs Skin: Resolved raised red papules on torso and legs Neuro: AAOx3, ___ strength upper/lower extremities, normal sensation, appropriate affect Pertinent Results: IMAGING: TTE ___: IMPRESSION: Normal study CTA Chest ___ IMPRESSION: 1. No pulmonary embolus or acute intrathoracic abnormality. 2. 6 mm left upper lobe pulmonary nodular focus. Please see recommendations below. RECOMMENDATION(S): For incidentally detected single solid pulmonary nodule measuring 6 to 8 mm, a CT follow-up in 6 to 12 months is recommended in a low-risk patient, optionally followed by a CT in ___ months. In a high-risk patient, a CT follow-up in 6 to 12 months, and a CT in ___ months is recommended. EEG ___ IMPRESSION: This is a normal routine EEG in the waking and asleep. No epileptiform features are seen. MR HEAD W & W/O CONTRAST; MRA BRAIN W/O CONTRAST; MRA NECK W&W/O CONTRAST ___ IMPRESSION: 1. Study is moderately degraded by motion, especially on postcontrast imaging. 2. No acute intracranial abnormality. 3. Extensive paranasal sinus disease with findings concerning for acute sinusitis, and nonspecific left mastoid fluid, as described. 4. Numerous probable calvarial hemangiomas as described. If concern for osseous metastatic disease, consider bone scan for further evaluation. 5. Findings suggestive of pontine capillary telangiectasia, as described. 6. 2 mm left internal carotid artery supraclinoid probable infundibulum, with differential consideration of small aneurysm. 7. Otherwise, grossly patent circle of ___ without definite evidence of stenosis or occlusion. 8. Minimal probable atherosclerotic narrowing of bilateral internal carotid artery origin without definite moderate or high-grade stenosis by NASCET criteria. 9. Otherwise, grossly patent bilateral cervical carotid and vertebral arteries without definite evidence of stenosis, occlusion, or dissection, by NASCET criteria. CT Head W/O Contrast ___ IMPRESSION: 1. No acute intracranial process. 2. Paranasal sinus disease, as above. 3. Tiny focal fluid in left mastoid air cell, nonspecific. Labs: ___ 03:54PM BLOOD Glucose-117* UreaN-8 Creat-0.6 Na-130* K-4.6 Cl-94* HCO3-24 AnGap-12 ___ 03:00PM BLOOD Glucose-116* UreaN-6 Creat-0.5 Na-124* K-4.0 Cl-88* HCO3-22 AnGap-14 ___ 01:10PM BLOOD Glucose-128* UreaN-8 Creat-0.6 Na-127* K-4.0 Cl-86* HCO3-25 AnGap-16 ___ 05:55AM BLOOD Glucose-117* UreaN-5* Creat-0.6 Na-131* K-4.2 Cl-92* HCO3-26 AnGap-13 ___ 05:47AM BLOOD Glucose-109* UreaN-13 Creat-0.7 Na-138 K-4.4 Cl-99 HCO3-27 AnGap-12 Brief Hospital Course: Transitional Issues: [ ] Incidental findings: 6 mm left upper lobe pulmonary nodular focus. RECOMMENDATION(S): For incidentally detected single solid pulmonary nodule measuring 6 to 8 mm, a CT follow-up in 6 to 12 months is recommended in a low-risk patient, optionally followed by a CT in ___ months. In a high-risk patient, a CT follow-up in 6 to 12 months, and a CT in ___ months is recommended. [ ] Continue to wean lorazepam if tolerated [ ] Outpatient cognitive neurology follow up, with possible neuropsychiatric testing [ ] Patient interested in ___ partial program after discharge from rehab [ ] Patient interested in having BI PCP and ___, though this should be discussed further with patient's current providers [ ] Consider further workup for patient's sinus tachycardia, rates ___ at discharge [ ] Patient with report of significant sedation on olanzapine 5 mg, switched to 2.5 QHS for insomnia but may be able to uptitrate as an outpatient [ ] Please recheck BMP in 1 week and ensure stability of sodium. If worsening hyponatremia consider fluid restriction +/- salt tabs. ___ with history of discoid lupus, depression and anxiety, dizziness, and osteoporosis who presents with recurrent falls and whole body weakness w/ subjective cognitive decline. ACUTE/ACTIVE PROBLEMS: # Recurrent falls # Memory/Cognitive deficits # Weakness Patient with several falls and diffuse weakness over the last few weeks. UTI may be contributing to weakness, though it does seem that the falls preceded UTI symptoms and daughters note at least 2 weeks of cognitive decline where pt is no longer eating much, slowed speech, depressed mood (unable to do tasks like answer emails and perform basic math). Hypoactive delirium in the setting of lorazepam use, hyponatremia, and UTI felt to be the most likely cause of her symptoms. Hyponatremia of 130 dates back to ___ but worse on admission to 124. Of note, she has had ongoing issues with vertigo as an outpatient and although she does not describe any dizziness presently there may be some central disequilibrium contributing to her symptoms. A TTE was performed that was unremarkable and did not show any etiologies to explain her falls or weakness. Patient has a significant amount of anticipatory anxiety and it is unclear how much psychiatric comorbidities are contributing at this time. Patient stated that when she slid off the bed during her last fall, she was so nervous that she could not get up, but also states that weakness was a part of it. MRI brain, MRA neck ___ performed and unremarkable. ___ eval demonstrating significant difficulties with balance below baseline. Per neurology, her mental status exam highlights marked deficits in executive function, functional pattern of dementia. Her effort appeared good. However, instability does not appear to be from a structural lesion based on sensory and strength testing. An EEG did not show any epileptiform features. Her balance improved with decreasing her lorazepam dose, improving hyponatremia, and treatment of her UTI. However, her balance remained below baseline and it was felt that she would benefit from ___ rehab. She should follow up with her PCP and psychiatrist once she leaves the rehab center. It might also be worthwhile to pursue cognitive neurology follow up. # Anxiety and depression: Patient on multiple medications. Most recently was started on Fetzima by her psychiatrist. She developed a rash a few days after starting Fetzima, and this was felt to be a drug rash, so Fetzima was stopped and a few days later the rash resolved. The patient is at significant risk of polypharmacy given multiple medications and multiple medication changes. Her current presentation could be hypoactive delirium in the setting of benzo use, hyponatremia, and UTI. Spoke w/ psychiatrist from ___ (Dr. ___- talked about her difficult to control anxiety and depression, requiring increases of wellbutrin to 450mg and remeron to 60mg, although her symptoms ultimately returned and these doses were decreased and other medications were tried. He strongly agreed that she is off her baseline and agrees with further workup beyond attributing symptoms to anxiety/depression. Her TSH and B12 were within normal limits. RPR was negative. She was started on olanzapine 2.5mg nightly to help with sleep given that her trazodone was stopped due to concern for SIADH from trazodone. She may also benefit from 2.5mg olanzapine as needed for anxiety during the day. Her lorazepam dose was decreased from 1mg QID PRN to 0.5mg TID. Her bupropion was continued. She was started on ___ to help with sleep. She tolerated this medication regimen well. #Tachycardia: Patient was frequently tachycardic to low 100s throughout hospitalization. Telemetry showed sinus tachycardia. Patient endorsing significant anxiety, which is the most likely etiology. She had positive orthostatic vital signs on ___, but unlikely the cause of her tachycardia, as this was the only day she had positive orthostatics. Although a PE was felt to be unlikely, given no shortness of breath or oxygen desaturations, a d-dimer was obtained that was elevated at 983. Therefore a CT PE was obtained that did not show any signs of PE, but did show a pulmonary nodule (6 mm left upper lobe) that should be followed up with a repeat CT scan in ___ months. # Hyponatremia: Chronic, though worse on admission. Serum osm 259, urine Na 124, urine osm 529 c/w SIADH vs renal salt wasting. On multiple psych meds which could be the etiology, although trazadone and lorazepam are less likely than other psych meds such as SSRIs to cause hyponatremia. She received salt tabs for a few days while in the hospital and was fluid restricted to 2L. Her sodium was 132 on ___. # UTI: Symptoms of urinary frequency and bladder spasms. UA with leukocyte esterase and WBCs. Treated with CTX 1g daily for intended 3 day course (___) Also received 2 days of phenazopyridine. Symptoms resolved by ___. Urine culture ultimately showed mixed bacterial flora consistent with fecal contamination. # Rash (resolved) Torso rash and leg rash- not pruritic, slightly raised macular rash, in some places appearing urticardial though in others not. Likely drug reaction to Fetzima (levomilnacipran). Normal eosinophils, no e/o mucosal involvement and no end organ damage appreciable c/f DRESS. - Hold Fetzima Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Alendronate Sodium 70 mg PO QSUN 2. Simvastatin 40 mg PO QPM 3. LORazepam 1 mg PO QID:PRN anxiety 4. BuPROPion (Sustained Release) 200 mg PO BID 5. TraZODone 50 mg PO QHS:PRN insomnia 6. Fetzima (levomilnacipran) 40 mg oral DAILY 7. Aspirin 81 mg PO DAILY 8. Docusate Sodium 100 mg PO BID 9. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Third Line 10. One Daily For Women (multivit-iron-min-folic acid) ___ mg oral DAILY 11. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 1200-1000 units oral DAILY Discharge Medications: 1. OLANZapine 2.5 mg PO QHS 2. Ramelteon 8 mg PO QHS:PRN insomnia 3. LORazepam 0.5 mg PO TID anxiety RX *lorazepam 0.5 mg 1 tablet by mouth three times a day Disp #*30 Tablet Refills:*0 4. Alendronate Sodium 70 mg PO QSUN 5. Aspirin 81 mg PO DAILY 6. BuPROPion (Sustained Release) 200 mg PO BID 7. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 1200-1000 units oral DAILY 8. Docusate Sodium 100 mg PO BID 9. One Daily For Women (multivit-iron-min-folic acid) ___ mg oral DAILY 10. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Third Line 11. Simvastatin 40 mg PO QPM Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary Diagnoses: - Polypharmacy (over-medication) - Hyponatremia (low sodium) - UTI - Anxiety/Depression - Drug rash Secondary Diagnoses: - Osteoporosis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear ___, ___ was a pleasure to care for you at the ___ ___. Why did you come to the hospital? - You came to the hospital because you had noticed several changes over the past few weeks, including falls, full body weakness, and difficulty with memory and completing tasks that you normally could do. You also had a recent increase in urination and discomfort with urination. You also had a rash on your torso and legs that was new. What did you receive in the hospital? - We were concerned about your recent falls and we did an MRI of your brain and neck, which did not show any signs of strokes or brain changes that would explain your falls or weakness. We also did an ultrasound of your heart, which did not show any problems with your heart that might explain your symptoms. Lab tests showed that you had a urinary tract infection and low sodium levels, both of which could be contributing to your symptoms. Ultimately, we felt that a lot of your symptoms could be due to over-medication. We tried decreasing the dose of several of your medications and completely stopping other medications. We believe that your rash was a reaction to one of these medications (Fetzima), which we stopped. After adjusting your medications, you performed better on cognitive/memory tests and showed improvement with physical therapy. What should you do once you leave the hospital? - You should take your medications as prescribed - You should follow up with your current PCP and current psychiatrist until you make any changes to your providers - ___ small lung nodule was seen on a CT scan you had- you should have a repeat CT scan in ___ months to re-evaluate the nodule We wish you the best! Your ___ Team Followup Instructions: ___
10386093-DS-4
10,386,093
28,621,266
DS
4
2135-06-09 00:00:00
2135-06-09 10:44:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROSURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Bilateral Subdural hematomas Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a vibrant ___ year-old male who underwent a non-contrast head CT today, ___, for staging of questionable skin cancer on his face. The images revealed bilateral subacute subdural hematomas. The patient was transferred to ___ for further Neurosurgical evaluation. Mr. ___ acknowledges that he has fallen approximately 1 - 2 months ago. He takes aspirin 325mg daily due to a history of vascular disease. He had no neurologic deficits, loss of consciousness or further issues after that fall. Past Medical History: Throat polyps, hepatitis, right femoral bypass, stenting of left leg vessel (pt unsure what vessel), right hip fracture s/p repair Social History: ___ Family History: NC Physical Exam: On Admission: O: T: 98.2 HR 85 BP 121/73, RR 14, O2 Sat 93% on room air Gen: WD/WN, comfortable, NAD. HEENT: PERRL, EOMs intact. Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Language: Speech fluent with good comprehension and repetition. Naming intact. No dysarthria or paraphasic errors. Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, to mm bilaterally. Visual fields are full to confrontation. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength full power ___ throughout. No pronator drift Sensation: Intact to light touch. Toes downgoing bilaterally On Discharge: Intact Pertinent Results: CT Head ___: Stbale bialteral subdural hematomas, formal read pending at time of discharge Brief Hospital Course: Patient presented to ___ for evaluation of bilateral subdural hematomas found on work up for skin cancer. He was admitted to the floor for observation and remained stable overnight into ___. He was NPO in case surgical intervention was required however repeat CT head showed stable bilateral subdural hematomas and decision was made that he was safe to discharge to home with followup. He agreed with this plan and was given prescriptions for required medications, instructions for follow-up, and all questions were answered prior to discharge. We recommended that he hold his aspirin for the time being and discuss it with his cardiologist/PCP regarding the utility of continuing in setting of intracranial bleed. Medications on Admission: Aspirin 325', simvastatin (unknown dose) daily, iron daily, Zantac daily Discharge Medications: 1. Acetaminophen 650 mg PO Q8H:PRN pain 2. Ranitidine 75 mg PO BID 3. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*30 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Bilateral Subdural Hematomas Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: •Take your pain medicine as prescribed. •Exercise should be limited to walking; no lifting, straining, or excessive bending. •Increase your intake of fluids and fiber, as pain medicine can cause constipation. We generally recommend taking an over the counter stool softener, such as Docusate (Colace) while taking pain medication. •Unless directed by your doctor, do not take any anti-inflammatory medicines such as Motrin, Aspirin, Advil, or Ibuprofen etc. •DO NOT TAKE ASPIRIN. We recommend that you stop taking this given the bleeding in your head. Please discuss this with your cardiologist/primary care doctor CALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE FOLLOWING •New onset of tremors or seizures. •Any confusion, lethargy or change in mental status. •Any numbness, tingling, weakness in your extremities. •Pain or headache that is continually increasing, or not relieved by pain medication. •New onset of the loss of function, or decrease of function on one whole side of your body. Followup Instructions: ___
10386389-DS-10
10,386,389
21,422,154
DS
10
2203-12-23 00:00:00
2203-12-23 08:20:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Keflex Attending: ___. Chief Complaint: Left post-mastectomy incision area cellulitis Major Surgical or Invasive Procedure: Stage 3 breast cancer s/p left mastectomy (___) complicated with cellulitis History of Present Illness: Ms. ___ is a ___ woman with newly diagnosed stage IIIB left breast cancer, found on routine imaging and thus received left simple mastectomy with left sentinel node procedure on ___. She presented to the ED on ___ with complaint of increasing erythema and tenderness over the surgical site. Her story is as follows: She had been doing fine post discharge and had her JP drains removed on ___ (output < 30cc), however, began to experience increasing area of tenderness over the area along with erythema. She presented to the clinic ___ and the area was inspected, aspirated, sent for culture, and she was then discharged with levafloxacin and cephalexin. She re-presented to the clinic with expanding erythema along with lightheadedness and was then referred to ___ ED. At the time of interview, she complained of the same symptoms (tenderness over the area, increased erythema, now fatigue). She was afebrile and denied other constitutional symptoms. In the ED she was put on vancomycin. Past Medical History: senile angiomas, benign Basal cell cancer CLS 4 cm cecal adenoma ___, CLS ___ Colon polyps Diverticulosis DM (diabetes mellitus), type 2 Esophageal reflux Hyperlipidemia Hypertension, essential Hypothyroidism Iron deficiency anemia Osteopenia Rosacea Syncope Urge incontinence Social History: ___ Family History: no breast or ovarian history, not ___ Physical Exam: At the time of discharge, her physical exam was as follows: VITAL SIGNS: 97.4 69 106/50 16 97% RA GENERAL: AAOx3 NAD HEENT: NCAT, EOMI, PERRLA, No scleral icterus, mucosa moist, no LAD CARDIOVASCULAR: R/R/R, S1/S2, NO M/R/G PULMONARY: CTA ___, No crackles or rhonchi GASTROINTESTINAL: S/NT/ND. No guarding, rebound, or peritoneal signs. +BSx4 INCISION/WOUNDS: No obvious induration or fluctuance under the incision. If there were fluid collections, it's not easily appreciated. She is tender over the area and there is a 5cm radius of erythema around incision. EXT/MS/SKIN: No C/C/E; Feet warm. Good perfusion. NEUROLOGICAL: Reflexes, strength, and sensation grossly intact CNII-XII: WNL Pertinent Results: ___ 06:26AM BLOOD WBC-6.7 RBC-4.46 Hgb-11.4 Hct-37.1 MCV-83 MCH-25.6* MCHC-30.7* RDW-13.3 RDWSD-39.8 Plt ___ ___ 06:25AM BLOOD WBC-6.4 RBC-4.46 Hgb-11.5 Hct-37.2 MCV-83 MCH-25.8* MCHC-30.9* RDW-13.3 RDWSD-40.3 Plt ___ ___ 06:15AM BLOOD WBC-7.2 RBC-4.49 Hgb-11.4 Hct-36.9 MCV-82 MCH-25.4* MCHC-30.9* RDW-13.4 RDWSD-39.9 Plt ___ ___ 06:53PM BLOOD WBC-7.2 RBC-4.33 Hgb-11.2 Hct-36.2 MCV-84 MCH-25.9* MCHC-30.9* RDW-13.4 RDWSD-40.5 Plt ___ ___ 06:26AM BLOOD Neuts-68.0 Lymphs-18.1* Monos-8.7 Eos-4.0 Baso-0.6 Im ___ AbsNeut-4.55 AbsLymp-1.21 AbsMono-0.58 AbsEos-0.27 AbsBaso-0.04 ___ 06:53PM BLOOD Neuts-62.9 ___ Monos-9.3 Eos-3.6 Baso-0.6 Im ___ AbsNeut-4.55 AbsLymp-1.68 AbsMono-0.67 AbsEos-0.26 AbsBaso-0.04 ___ 06:26AM BLOOD Plt ___ ___ 06:25AM BLOOD Plt ___ ___ 06:26AM BLOOD Glucose-181* UreaN-15 Creat-0.7 Na-136 K-4.2 Cl-100 HCO3-24 AnGap-16 ___ 06:25AM BLOOD Glucose-115* UreaN-11 Creat-0.6 Na-141 K-4.9 Cl-102 HCO3-31 AnGap-13 ___ 06:15AM BLOOD Glucose-125* UreaN-11 Creat-0.6 Na-136 K-4.4 Cl-100 HCO3-26 AnGap-14 ___ 06:26AM BLOOD Calcium-9.5 Phos-3.9 Mg-1.8 ___ 06:25AM BLOOD Calcium-9.9 Phos-3.9 Mg-1.9 Brief Hospital Course: Ms. ___ was admitted to our service on ___ after her course of outpatient PO antibiotic course did not show improvement of her symptoms. She was put on vancomycin from (___). Throughout the entire course, she was afebrile & her WBC count normal. She tolerated the vancomycin course well, was eating and ambulating as normal, and her area of erythema slowly improved. She was put on PO Bactrim on ___ and will be discharged home today with ___ with a 10 day course of continued PO Bactrim. She will be seen by Dr. ___ on ___ in clinic. Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. amLODIPine 2.5 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Cyanocobalamin 1000 mcg PO DAILY 4. Carbidopa-Levodopa (___) 1 TAB PO BID 5. Donepezil 5 mg PO QHS 6. Gabapentin 600 mg PO QHS 7. GlipiZIDE 10 mg PO DAILY 8. Levothyroxine Sodium 75 mcg PO DAILY 9. Lisinopril 30 mg PO DAILY 10. Omeprazole 20 mg PO DAILY 11. Ranitidine 150 mg PO BID 12. Simvastatin 20 mg PO QPM 13. Tolterodine 4 mg PO DAILY Discharge Medications: 1. Sulfameth/Trimethoprim DS 1 TAB PO BID Duration: 10 Days RX *sulfamethoxazole-trimethoprim 400 mg-80 mg 1 tablet(s) by mouth twice a day Disp #*20 Tablet Refills:*0 2. amLODIPine 2.5 mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Carbidopa-Levodopa (___) 1 TAB PO BID 5. Cyanocobalamin 1000 mcg PO DAILY 6. Donepezil 5 mg PO QHS 7. Gabapentin 600 mg PO QHS 8. GlipiZIDE 10 mg PO DAILY 9. Levothyroxine Sodium 75 mcg PO DAILY 10. Lisinopril 30 mg PO DAILY 11. Omeprazole 20 mg PO DAILY 12. Ranitidine 150 mg PO BID 13. Simvastatin 20 mg PO QPM 14. Tolterodine 4 mg PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Cellulitis of left mastectomy incision area Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Ms. ___, It was a pleasure to have you on our service at the ___ ___. Please read below for your discharge instructions: Personal Care: 1. You may keep your incisions open to air or covered with a clean, sterile gauze that you change daily. 2. You may wear a surgical bra or soft, loose camisole for comfort. 3. You may shower daily with assistance as needed. 4. The Dermabond skin glue will begin to flake off in about ___ days. Activity: 1. You may resume your regular diet. 2. Walk several times a day. 3. DO NOT lift anything heavier than 5 pounds or engage in strenuous activity for 6 weeks following surgery. Medications: 1. Resume your regular medications unless instructed otherwise and take any new meds as ordered . 2. You may take your prescribed pain medication for moderate to severe pain. You may switch to Tylenol or Extra Strength Tylenol for mild pain as directed on the packaging. Please note that Percocet and Vicodin have Tylenol as an active ingredient so do not take these meds with additional Tylenol. 3. Take prescription pain medications for pain not relieved by Tylenol. 4. Take Colace, 100 mg by mouth 2 times per day, while taking the prescription pain medication. You may use a different over-the-counter stool softener if you wish. 5. Do not drive or operate heavy machinery while taking any narcotic pain medication. You may have constipation when taking narcotic pain medications (oxycodone, percocet, vicodin, hydrocodone, dilaudid, etc.); you should continue drinking fluids, you may take stool softeners, and should eat foods that are high in fiber. 6. Please take your oral antibiotic as instructed. Please call the office if you do not see improvement of your left incision redness. (See below for more detail) Call the office IMMEDIATELY if you have any of the following: 1. Signs of infection: fever with chills, increased redness, swelling, warmth or tenderness at the surgical site, or unusual drainage from the incision(s). 2. A large amount of bleeding from the incision(s) or drain(s). 3. Fever greater than 101.5 oF 4. Severe pain NOT relieved by your medication. Return to the ER if: * If you are vomiting and cannot keep in fluids or your medications. * If you have shaking chills, fever greater than 101.5 (F) degrees or 38 (C) degrees, increased redness, swelling or discharge from incision, chest pain, shortness of breath, or anything else that is troubling you. * Any serious change in your symptoms, or any new symptoms that concern you. Followup Instructions: ___
10386441-DS-8
10,386,441
26,725,151
DS
8
2112-09-01 00:00:00
2112-09-09 16:01:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Vicodin Attending: ___ Chief Complaint: fevers, fatigue Major Surgical or Invasive Procedure: None History of Present Illness: ___ year old female with history of asthma who presents with fevers (Tm ~ 100.6) and fatigue/myalgias for 2 weeks with anterior non-radiating chest pain and dyspnea on exertion. She was seen by her PCP ___ ___ with 5 days of intermittent fevers, with Tm ~100.7. She denied nausea, vomiting, sore throat, rhinorrhea, diarrhea, urinary symptoms, rash. Labs at that appointment including CBC, chem7, UA, Strep, EBV, and lyme serologies were negative. Due to persistent fevers, additional labs were checked on ___ which included LDH 167, CK 100, D-dimer 2260, and blood cultures. Due to elevated D-dimer, she was referred to the ED. In the ED, initial vitals were: 99.0 90 123/73 22 100%. Labs were notable for WBC 11.2, INR 1.0, D-dimer 554. EKG showed SR, normal axis, and isolated TWI in III. Rt ___ was negative for DVT and CTA chest was negative for pulmonary embolism. On the floor, she is comfortable and asymptomatic. Past Medical History: Asthma Dysthymic disorder Patellar tendonitis Social History: ___ Family History: Parents without significant medical problems. Aunt with ovarian cancer. Maternal great uncle had MI at ___. MGF had MI in mid ___. MGM had arrhythmia. Physical Exam: Admission Physical Exam: VS: 97.5 95 113/54 99%RA Gen: NAD HEENT: No LAD, No JVD CV: RRR, S1 and S2, no m/r/g Pulm: CTAB Abd: BS+, soft, ND, mildly tender, no HSM Ext: Pain to palp bilat SI joints, pain on shoulder when reaching across body, reproducible pain on sternum Skin: No erythema or concerning lesions Neuro: Grossly intact Psych: Appropriate Discharge Physical Exam: VS: 98.2 136/74 93 20 97%ra Gen: NAD, lying comfortably in bed HEENT: MMM, no erythema Cardiac: normal S1,S2, no m,r,g. Resp: Lungs clear to ausculatation bilaterally Abd: Soft, NT, ND, no HSM Ext: WWP, no edema, cyanosis MSK: Reproducible pain along lower sternum and right sternal border. TTP in sacroiliac joint region bilaterally. TTP on plantar surface of right heel. No TTP or deformities noted in the MCP, PIP, DIP (both UE and ___, wrist, shoulders, knees, ankles. Normal tone in UE and ___ bilaterally Neuro: Grossly intact Pertinent Results: ==ADMISSION LABS== ___ 03:30AM BLOOD WBC-11.2* RBC-4.96 Hgb-13.0 Hct-38.4 MCV-77* MCH-26.2 MCHC-33.9 RDW-13.5 RDWSD-37.4 Plt ___ ___ 03:30AM BLOOD Neuts-69.8 ___ Monos-4.1* Eos-1.1 Baso-0.3 Im ___ AbsNeut-7.79* AbsLymp-2.71 AbsMono-0.46 AbsEos-0.12 AbsBaso-0.03 ___ 03:30AM BLOOD ___ PTT-29.2 ___ ___ 03:30AM BLOOD Glucose-108* UreaN-8 Creat-0.7 Na-138 K-3.8 Cl-103 HCO3-22 AnGap-17 ___ 03:30AM BLOOD ALT-13 AST-21 AlkPhos-64 TotBili-0.3 ___ 03:30AM BLOOD cTropnT-<0.01 ___ 03:30AM BLOOD Calcium-9.4 Phos-3.0 Mg-1.8 ___ 03:30AM BLOOD D-Dimer-554* ___ 01:45AM URINE Color-Straw Appear-Clear Sp ___ ___ 01:45AM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-10 Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG ___ 01:45AM URINE UCG-NEG ==DISCHARGE LABS== ___ 08:00AM BLOOD WBC-8.9 RBC-5.36* Hgb-13.8 Hct-43.8 MCV-82 MCH-25.7* MCHC-31.5* RDW-13.9 RDWSD-40.2 Plt ___ ___ 08:00AM BLOOD Glucose-84 UreaN-8 Creat-0.7 Na-137 K-3.8 Cl-102 HCO3-18* AnGap-21* ___ 08:00AM BLOOD ALT-18 AST-24 LD(LDH)-211 AlkPhos-65 TotBili-0.4 ___ 08:00AM BLOOD Calcium-9.4 Phos-3.4 Mg-2.0 ___ 08:00AM BLOOD TSH-4.1 ___ 08:00AM BLOOD CRP-30.3* ___ 08:00AM BLOOD HIV Ab-Negative ==OTHER RESULTS== ___ LOWER EXT US No evidence of deep venous thrombosis in the right lower extremity veins. ___ CT CHEST ANGIO No evidence of pulmonary embolism or aortic abnormality. ___ PELVIC XRAY Normal pelvis x-ray ==RESULTS RETURNING AFTER DISCHARGE== ___ 08:00AM BLOOD HIV Ab-Negative ___ 08:00AM BLOOD SED RATE 11 Brief Hospital Course: Ms. ___ presented with fevers, fatigue, and chest pain for two weeks. She had an elevated DDimer but her CT angiogram was negative and her ECG was normal. Her fevers and symptoms were most suspicious for rheumatologic disease and she had an elevated ESR/CRP. She had a pelvic xray to assess for ankylosis spondylitis that was normal. She requires follow up with her primary care physician within two weeks for further evaluation. # FEVER: Patient presented with 2 weeks of intermittent fevers and fatigue x 2 weeks. Outpatient w/u included negative negative EBV abd lyme serologies. The symptoms were most likely c/w a rheumatologic or CTD given the fatigue, SI tenderness, and shoulder pain but could also be due to a viral illness. Given normal ECG and readily reproducible chest pain, acute cardiac process was unlikely. Infectious etiologies were also considered. She had an elevated ESR and CRP. She had a pelvic xray that was normal. She also had an HIV test sent that was pending at the time of discharge and later returned negative. She should see her primary care physician within two weeks to consider further evaluation. She remained afebrile and hemodynamically stable throughout her hospitalization. # MUSCULOSKELETAL PAIN/Costochondritis: Given normal ECG and negative CTA, PE is unlikely. DDimer is sensitive but not specific so elevated DDimer in setting of normal CTA is reassuring. The normal ECG and negative trops argue against ACS. The reproducible nature of the CP is also reassuring that this is not ACS and suggests that this is MSK in nature. She also had sacroilitus on physical examination. She had a pelvic xray that was normal. Transitional Issues: - Pt requires follow up with primary care physician ___ 2 weeks - Consider sending HLA-B27 as an outpatient - HIV test and ESR pending at time of discharge. HIV-Ab returned as NEGATIVE after discharge and ESR back at 11 after discharge. - Code: Full - Contact: ___ (Mother) ___ (cell) Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Apri (desogestrel-ethinyl estradiol) 0.15-0.03 mg oral DAILY 2. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob 2. Apri (desogestrel-ethinyl estradiol) 0.15-0.03 mg oral DAILY 3. Acetaminophen 325-650 mg PO Q6H:PRN pain 4. Naproxen 500 mg PO Q8H:PRN pain RX *naproxen 500 mg 1 tablet(s) by mouth EVERY 8 HOURS AS NEEDED Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis: Fever of Unknown Etiology Secondary Diagnoses: Anxiety Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a plesaure caring for you at ___. You were admitted to the hospital with fevers, fatigue, and chest pain for two weeks. Your D-Dimer was high, but a CT scan showed that you did not have an pulmonary embolism. You had other blood tests that showed that there is inflammation in your body, but did not identify the cause of your symptoms. You can take naproxen for pain, but take this with food. You had a pelvic xray that was normal. You should see your primary care physician within two weeks. Thank you for allowing us to participate in your care. Sincerely, Your ___ Team Dear Ms. ___, It was a plesaure caring for you at ___. You were admitted to the hospital with fevers, fatigue, and chest pain for two weeks. Your D-Dimer was high, but a CT scan showed that you did not have an pulmonary embolism. You had other blood tests that showed that there is inflammation in your body, but did not identify the cause of your symptoms. You can take naproxen for pain, but take this with food. You had a pelvic xray that was normal. You should see your primary care physician within two weeks. Thank you for allowing us to participate in your care. Sincerely, Your ___ Team Followup Instructions: ___
10386562-DS-12
10,386,562
21,391,032
DS
12
2169-05-27 00:00:00
2169-05-30 14:53:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins / Shellfish Derived Attending: ___. Chief Complaint: Hallucinations Major Surgical or Invasive Procedure: 1) ___ guided aspiration of right elbow and right hip. 2) PICC Line Placement 3) Transesophageal Echo History of Present Illness: ___ with a history of CML, high cholesterol, hypertension, presents to the ER with hallucinations. History is obtained from the patient and his wife. They state that this problem began about one month ago. Since that time, he received treatment for a UTI, and had his pain medications discontinued. Despite these changes, he has not had significant changes in his symptoms. He describes these hallucinations as several individuals, sometimes a total of 8. They did speak with him, no commands, he often says that they will touch his skin. There was no history is hallucinations prior to month ago when he started on Gleevec for his leukemia. His dose was discontinued 5 days prior to presentation along with his Allopurinol; he had one day where he was hallucinations free, but has otherwise had these hallucinations approximately every night around 2 AM. He has no other medication changes, herbals, drug use. . ROS: He is maintaining his ADLs, I ADLs despite having some persistent pain from his right hip. There is been no fevers, chills, sweats. No abdominal pain. He been having normal regular solid formed bowel movements. His only complaint at this time otherwise his increased upper respiratory congestion and mucus production. He has not been having any cough or shortness of breath. All other ROS negative. . Vitals in the ER: 99.2 °F (37.3 °C), Pulse: 87, RR: 15, BP: 124/60, O2Sat: 98% , O2Flow: ra. He received Levofloxacin 750mg IV, Tylenol, and NS 250cc. . Past Medical History: HEMATOLOGIC HISTORY: - ___: the patient is found to have leukocytosis with immature myeloid forms, including myelocytes, metamyelocytes, and promyelocytes. RT-PCR for BCR-ABL was sent, and returned positive for the ___ translocation with a BCR ABL1/ABL1 ratio of 69.659%. - ___ start Imatinib 100 mg daily - ___ increase Imatininb to 200 mg daily - ___ increase Imatininb to 300 mg daily - ___ increase Imatininb to 400 mg daily - ___ Since the last visit, the patient developed a constellation of problems that are most likely related to this treatment including the worsening anemia and kidney function, the thrombocytopenia and the lower extremity edema. He also received 1 unit PRBCs ___ in ___ clinic. PMH: -Hypertension -Diabetes: controlled with pioglitazone, HbA1c:6.2% (___) -Hyperlipidemia -Spinal stenosis -Trigeminal Neuralgia: last symptomatic over ___ years ago, carbamazepine discontinued -Pseudogout, manifesting as fevers of unknown origin until a knee effusion was tapped revealing crystals -Polyarticular arthritis -CKD: baseline creatinine of 1.7 -BPH with elevated PSA; prior prostate biopsy reportedly negative for malignancy -S/P polypectomy of several adenomatous polyps -Bilateral THAs in ___ and ___ . Social History: ___ Family History: Negative for coronary artery disease, diabetes, or cancer. Physical Exam: ADMISSION VS: T 98.2 bp 123/66 HR 84 RR 18 SaO2 100 2L NC GEN: NAD, awake, alert HEENT: EOMI, sclera anicteric, conjunctivae clear, OP moist and without lesion NECK: Supple CV: Reg rate, normal S1, S2. No m/r/g. CHEST: Resp unlabored, no accessory muscle use. CTAB, no crackles, wheezes or rhonchi. ABD: Soft, obese, NT, ND, bowel sounds present MSK: normal muscle tone and bulk GU: rectal: prostate not tender or boggy, brown stool EXT: No c/c, normal perfusion SKIN: No rash, warm skin NEURO: oriented x 3, normal attention, no focal deficits, intact sensation to light touch PSYCH: has insight into condition, calm, coperative . DISCHARGE Vitals 97.8 152/78 p80 r20 95%RA GENERAL: NAD HEENT: AT/NC, EOMI, PERRLA CARDIAC: RRR, S1/S2, no mrg LUNG: CTAB, no w/r/r ABDOMEN: nondistended, +BS, nontender in all quadrants PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact, strength ___ in all ___+ edema to B/L UE and ___. Wwelling of R elbow with dressing in place over aspiration site.ROM ~135 degrees. sore to palpation Pertinent Results: ADMISSION LABS ___ 07:30PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 07:30PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-LG ___ 07:30PM URINE RBC-1 WBC-32* BACTERIA-NONE YEAST-NONE EPI-0 ___ 04:51PM LACTATE-1.0 ___ 04:35PM GLUCOSE-106* UREA N-37* CREAT-1.8* SODIUM-141 POTASSIUM-4.2 CHLORIDE-109* TOTAL CO2-25 ANION GAP-11 ___ 04:35PM ALT(SGPT)-18 AST(SGOT)-30 ALK PHOS-64 TOT BILI-0.4 ___ 04:35PM LIPASE-35 ___ 04:35PM ALBUMIN-3.6 CALCIUM-8.5 PHOSPHATE-2.7# MAGNESIUM-1.9 ___ 04:35PM WBC-3.7* RBC-2.39* HGB-7.9* HCT-25.1* MCV-105* MCH-33.2* MCHC-31.6 RDW-18.9* ___ 04:35PM NEUTS-80.8* LYMPHS-10.4* MONOS-6.7 EOS-2.1 BASOS-0.1 ___ 04:35PM PLT COUNT-105* RELEVANT LABS ___ 4:50 pm BLOOD CULTURE #2. **FINAL REPORT ___ Blood Culture, Routine (Final ___: STAPH AUREUS COAG +. Consultations with ID are recommended for all blood cultures positive for Staphylococcus aureus, yeast or other fungi. FINAL SENSITIVITIES. This isolate is presumed to be resistant to clindamycin based on the detection of inducible resistance . Staphylococcus species may develop resistance during prolonged therapy with quinolones. Therefore, isolates that are initially susceptible may become resistant within three to four days after initiation of therapy. Testing of repeat isolates may be warranted. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ STAPH AUREUS COAG + | CLINDAMYCIN----------- R ERYTHROMYCIN---------- R GENTAMICIN------------ <=0.5 S LEVOFLOXACIN----------<=0.12 S OXACILLIN------------- 0.5 S TRIMETHOPRIM/SULFA---- <=0.5 S Anaerobic Bottle Gram Stain (Final ___: GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS. Reported to and read back by ___. ___ ___ 10:00AM. . ___ 5:00 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. . ___ 06:30AM BLOOD TSH-4.1 ___ 04:35PM BLOOD ALT-18 AST-30 AlkPhos-64 TotBili-0.4 URINE STUDIES ___ 07:30PM URINE Blood-NEG Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-LG ___ 07:30PM URINE RBC-1 WBC-32* Bacteri-NONE Yeast-NONE Epi-0 ___ 07:30PM URINE CastHy-2* ___ 07:30PM URINE Color-Yellow Appear-Clear Sp ___ ___ 12:23PM URINE Blood-MOD Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG ___ 12:23PM URINE RBC-59* WBC-0 Bacteri-NONE Yeast-NONE Epi-0 ___ 12:23PM URINE Color-Straw Appear-Clear Sp ___ ___ 06:15AM URINE Blood-NEG Nitrite-NEG Protein-TR Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG ___ 06:15AM URINE RBC-<1 WBC-1 Bacteri-FEW Yeast-NONE Epi-<1 ___ 06:15AM URINE Color-Straw Appear-Clear Sp ___ ___ 3:29 pm URINE Source: ___. **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. JOINT FLUID STUDIES ___ 02:00PM JOINT FLUID ___ Polys-100* ___ ___ 02:00PM JOINT FLUID Crystal-FEW Shape-RHOMBOID Locatio-INTRAC Birefri-POS Comment-c/w calciu ___ 01:30PM JOINT FLUID WBC-3450* ___ Polys-79* ___ Monos-16 NRBC-1* Macro-3 ___ 01:30PM JOINT FLUID Crystal-NONE DISCHARGE LABS: ___ 06:00AM BLOOD WBC-5.0 RBC-2.97* Hgb-9.6* Hct-29.2* MCV-98 MCH-32.4* MCHC-33.0 RDW-17.9* Plt ___ ___ 07:25AM BLOOD ___ PTT-29.1 ___ ___ 06:00AM BLOOD Glucose-103* UreaN-34* Creat-1.4* Na-143 K-3.9 Cl-104 HCO3-31 AnGap-12 ___ 06:00AM BLOOD Calcium-8.5 Phos-3.9 Mg-1.7 | | IMAGING ___ Head CT - no acute intracranial process ___ CXR IMPRESSION: Low lung volumes. Left basilar opacity may reflect atelectasis or infection in the correct clinical setting. Bilateral calcified pleural plaques compatible with prior asbestos exposure. IMPRESSION: Chondrocalcinosis. Conclusions The left atrium is elongated. The estimated right atrial pressure is ___ mmHg. There is mild symmetric left ventricular hypertrophy with normal cavity size and global systolic function. The estimated cardiac index is normal (>=2.5L/min/m2). Tissue Doppler imaging suggests a normal left ventricular filling pressure (PCWP<12mmHg). The right ventricular cavity is dilated with mild global free wall hypokinesis. The aortic root is mildly dilated at the sinus level. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No masses or vegetations are seen on the aortic valve. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. No mass or vegetation is seen on the mitral valve. The left ventricular inflow pattern suggests impaired relaxation. There is borderline pulmonary artery systolic hypertension. No masses or vegetations are seen on the pulmonic valve, but cannot be fully excluded due to suboptimal image quality. There is a trivial/physiologic pericardial effusion. IMPRESSION: No echocardiographic evidence of endocarditis or pathologic valvular flow.Mild symmetric left ventricular hypertrophy with preserved global systolic function. Mildly dilated right ventricle with mild global hypokinesis. Borderline pulmonary hypertension. Mildly dilated aortic root. Compared with the prior study (images reviewed) of ___, the right ventricle appears slightly larger and with mildly depressed free wall systolic function. Pulmonary arterial pressures are likely underestimated in the current study. Conclusions The left atrium is dilated. No spontaneous echo contrast or thrombus is seen in the body of the left atrium or left atrial appendage or the body of the right atrium/right atrial appendage. No atrial septal defect is seen by 2D or color Doppler. Overall left ventricular systolic function is normal (LVEF>55%). There are simple atheroma in the aortic arch. There are complex (>4mm, non-mobile) atheroma in the descending thoracic aorta. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No masses or vegetations are seen on the aortic valve. Very mild (1+) aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. No mass or vegetation is seen on the mitral valve. Mild to moderate (___) mitral regurgitation is seen. No vegetation/mass is seen on the pulmonic valve. IMPRESSION: Mild-moderate mitral regurgitation with mildly thickened leaflets but no discrete vegetaqtion. Very mild aortic regurgitatation. No discrete vegetations identified. Complex, non-mobile atheroma in the descending thoracic aorta. FINDINGS: Low lung volumes are unchanged. Calcified bilateral pleural plaques are redemonstrated. Moderate cardiomegaly is slightly larger compared to next most recent examination. There is no evidence of pneumothorax or large pleural effusion. The remainder of the chest is not appreciably changed. IMPRESSION: New left PICC line terminates in the mid SVC. Brief Hospital Course: ___ with CML who was admitted for visual hallucinations, believed to be related to Imatinib (Gleevec) therapy for CML, but uncertain. Other workup for his hallucinations incidentally found a positive blood culture with MSSA, for which he was treated with vancomycin. He also developed an acute flare of pseudogout of his right elbow, and had pain and his right hip. Both joints were tapped and grew negative cultures, although this was in the setting of antibiotics already on board. Patient was also treated for a 20lb volume overload secondary to IV fluids and his CKD. # MSSA bacteremia: Unclear source, though most obvious and concerning is his recently painful/sore hip joint. Infectious diseases and orthopedics consulted. Both right elbow (acutely inflamed, see below) and right hip joint (which had been sore for several weeks and evalauted by orthopedics at outpatient recently) were aspirated by ___. Synovial fluid analysis grw negative cultures, although this was after also receiving vancomycin. TTE and TEE this admission negative for evidence of vegetations/endocarditis. ID feels there is still a chance his hip hardware could have been the source of the MSSA. Will require IV vancomycin for at least 4 weeks total through a PICC line and OPAT followup with Infectious Diseases. Patient also has Ortho followup regarding hip, as negative cultures were in setting of antibiotics already on board. # R elbow Pseudogout: On ___ patient developed acute painful, hot, erythematous swelling of his right elbow initially concerning for infection (esp. given the positive MSSA). After joint aspiration, synovial fluid cultures returned negative (though with vancomycin on board). Fluid analysis consistent with pseudogout crystals and formal evaluation by orthopedic surgery consistent with pseudogout and not infectious join. Patient treated with prednisone taper to be completed as an outpatient. Pain controled with tylenol and lidocaine patches. # Visual hallucinations: Resolved.Unclear etiology, but patient had ___ blood culture bottles positive for MSSA. The time course of the hallucinations is over at least a month, so if attributed to MSSA, this indicates he has been seeding for some time. His hallucinations may also have been an idiosyncratic reaction to Imatinib (not improved with dose-reduction as an outpatient). Dr. ___ he was planning on restarting Imatinib in the near future, so can monitor for recurrence of symptoms then. Not likely leptomeningeal disease given his CML response. RPR negative and TSH normal. Not likely primary psychiatric disorder presenting at this age. # Volume overload with edema - Secondary to multiple nights of maintanence fluids while NPO in case of OR washout of elbow (which he did not require) as well as CKD and fluid retention. Responded very well to multiple doses 40mg IV lasix and his discharge weight was 170lbs. His goal weight is 160-165 lbs. We instructed him to weigh himself daily and call his PCP if he gains 3 pounds (especially since he will get IV vancomycin daily for 19 more days). CHRONIC ISSUES # Chronic Mylogenous Leukemia - Imatinib treatment held given hallucinations. Patient has outpatient followup appointment with Heme/Onc. # CKD IV with baseline creatinine of 1.6; stable # BPH: Doxazosin held given concern that in elderly with CKD can cause cognitive changes. # HTN - Stable. Continued home Losartan # DM2 - Held Home Actos and instead used HISS while inpatient. # Chronic macrocytic Anemia secondary to malignancy and inflammation - Continued vitamin B complex supplements. TRANSITIONAL ISSUES: 1) Heme/Onc followup to possibly restart Imatinib. 2) Orthopedic follow-up with consideration for infected hip joint 3) Steroid taper and pesudogout response 4) Infectious Disease followup to determine exact course of treatment (currently planned for 4 weeks total IV vancomycin) 5) Goal weight 160-165 lbs. Outpatient PCP was emailed in advance of discharge in case patient calls with weight gain/fluid retention. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Atorvastatin 10 mg PO DAILY 2. Doxazosin 8 mg PO HS 3. Lidocaine 5% Patch 1 PTCH TD DAILY 4. Losartan Potassium 25 mg PO DAILY 5. Metoprolol Tartrate 12.5 mg PO BID 6. Aspirin 81 mg PO DAILY 7. Vitamin B Complex 1 CAP PO DAILY 8. ferrous fumarate *NF* 324 mg (106 mg iron) Oral BID 9. Pyridoxine 25 mg PO DAILY Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H pain 2. Atorvastatin 10 mg PO DAILY 3. Lidocaine 5% Patch 1 PTCH TD DAILY RX *lidocaine 5 % (700 mg/patch) Apply 1 patch to elbow and 1 patch to hip daily Disp #*28 Transdermal Patch Refills:*2 4. Losartan Potassium 25 mg PO DAILY 5. Metoprolol Tartrate 12.5 mg PO BID 6. Pyridoxine 25 mg PO DAILY 7. Vitamin B Complex 1 CAP PO DAILY 8. Docusate Sodium 200 mg PO BID RX *docusate sodium 100 mg 2 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*2 9. Senna 2 TAB PO BID RX *sennosides [senna] 8.6 mg ___ tablets by mouth for constipation Disp #*60 Tablet Refills:*2 10. Aspirin 81 mg PO DAILY 11. ferrous fumarate *NF* 324 mg (106 mg iron) Oral BID 12. Pioglitazone 45 mg PO DAILY 13. PredniSONE 10 mg PO DAILY Duration: 2 Days Take on ___ Tapered dose - DOWN RX *prednisone 10 mg 1 tablet(s) by mouth daily Disp #*2 Tablet Refills:*0 14. PredniSONE 5 mg PO DAILY Duration: 5 Days Take on ___, and ___ then STOP. Tapered dose - DOWN RX *prednisone 5 mg 1 tablet(s) by mouth daily Disp #*5 Tablet Refills:*0 15. OxycoDONE (Immediate Release) 2.5 mg PO Q4H:PRN pain RX *oxycodone 5 mg one-half tablet by mouth every four (4) hours Disp #*15 Tablet Refills:*0 16. Vancomycin 1000 mg IV Q 24H RX *vancomycin 1 gram Administer 1000mg IV Solution Q24H Disp #*20 Gram Refills:*0 17. Multivitamins 1 TAB PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary: Visual Hallucinations, Staphylococcus Aureus bacteremia, Pseudogout, Volume overload Secondary: Chronic Myelogenous Leukemia, Chronic Kidney Disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at ___ ___. You were admitted because you were having hallucinations (which may have been due to your Gleevec, or an infection). In attempting to find the reason for hallucincations we found bacteria in your blood, which can be serious. We tried to look for a source of this bacteria, but found nothing obvious. It may well be from your hip-joint, although we did not grow any cultures. You will need treatment with IV antibiotics for at least a total of 4 weeks, with routine blood monitoring. You were also affected by a flare of pseudogout, for which we treated you with pain control and steroids (prednisone), which you will slowly taper off. You also retained fluid, so we gave you medications to make you urinate more. Please weigh yourself every day. Your goal weight is between 160 to 165 pounds. Your weight at discharge was 170 pounds. If your weight increases by 3 pounds, call your doctor ___ ___, MD ___ for instructions. Please review your medication list carefully for the changes. I will highlight here: You should STOP ___ until you follow up with Dr. ___. Your appointments are listed below. Followup Instructions: ___
10386562-DS-14
10,386,562
22,701,838
DS
14
2169-06-16 00:00:00
2169-06-17 17:00:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins / Shellfish Derived / vancomycin Attending: ___ Chief Complaint: Fever, joint pain. Major Surgical or Invasive Procedure: None. History of Present Illness: ___ with hx of CML now w/ L shoulder pain, neck pain and dyspnea. Patient currently taking daptomycin for MSSA with R sided PICC line. He initially had PICC in his left arm that was removed on ___ due to pain and concern for infectin causing MSSA bacteremia. The patient reportedly has diffuse aches in his joints but the shoulder is reported to be the worst. Question of some mildly decreased mental status per family as well. Patient endorses pain ___ in the left shoulder currently. No dyspnea, fever, chills. Pt was originally admitted to the floor and continued on antibiotics Dapto and cipro for prior infections. His shoulder was tapped in the ED that revealed calcium pyrophosphate crystals. While on the floor he suddenly developed hypoxia to the ___ on 2L NC, he correspondingly also had an elevated BP to 170s/100s and HR in the 130s with a RR of 40. An ekg obtained was consistent w/ a.fib with rvr. He was then given 40mg of IV lasix, IV morphine and a CXR was obtained. He was transfered to the MICU for acute hypoxia and tachypnea. On arrival to the MICU, His work of breathing had improved. His initial VS 100.2, HR 125, BP 110/62,19 99% NRB. He was only able to speak in one word sentences. Past Medical History: PAST ONCOLOGIC HISTORY: - ___: the patient is found to have leukocytosis with immature myeloid forms, including myelocytes, metamyelocytes, and promyelocytes. RT-PCR for BCR-ABL was sent, and returned positive for the ___ translocation with a BCR ABL1/ABL1 ratio of 69.659%. - ___ start Imatinib 100 mg daily - ___ increase Imatininb to 200 mg daily - ___ increase Imatininb to 300 mg daily - ___ increase Imatininb to 400 mg daily - ___ Presented to ___ clinic with worsening anemia and kidney function, thrombocytopenia and the lower extremity edema. Worsening right hip pain as well. He had hallucinations as well. He received 1 unit PRBCs in ___ clinic, and was admitted and treated with antibiotics for MSSA bacteremia, discharged on a course of Vancomycin IV via ___ -___ patient discharged off of imatinib to be restarted as an outpatient -___- re-presents to the ED with pain at ___ site and question ___ line infection PAST MEDICAL HISTORY: -Hypertension -Diabetes: controlled with pioglitazone, HbA1c:6.2% (___) -Hyperlipidemia -Spinal stenosis -Trigeminal Neuralgia: last symptomatic over ___ years ago, carbamazepine discontinued -Pseudogout, manifesting as fevers of unknown origin until a knee effusion was tapped revealing crystals. Repeat flare ___ of right elbow, synovial fluid confirmed. -Polyarticular arthritis -CKD: baseline creatinine of 1.7 -BPH with elevated PSA; prior prostate biopsy reportedly negative for malignancy -S/P polypectomy of several adenomatous polyps -Bilateral THAs in ___ and ___ -MSSA Bacteremia ___ with 4 planned weeks OPAT Social History: ___ Family History: No known history of hematologic or oncologic dyscrasia. 1 of 2 brothers is deceased; 1 sister is deceased. Physical Exam: Physical exam at admission: Vitals: T: 100.2 BP:177/100 P:133 R:40 O2:100% NRB General: pt sitting upright with increased work of breathing, only able to respond with one word answers HEENT: Sclera anicteric, oropharynx clear, EOMI, PERRL Neck: supple, JVP elevated, no LAD CV: tachycardic rate, S1 + S2, no murmurs, rubs, gallops Lungs: diminished breath sounds bilaterally, no wheezes, rales, ronchi Abdomen: soft, non-tender, non-distended, bowel sounds present, no organomegaly GU: foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis, 2+ pitting edema to knees b/l Neuro: grossly intact, no focal deficits noted . DISCHARGE PHYSICAL EXAM: Vitals: 98.5 - 126/72 - 100 - 18 - 99RA GENERAL: NAD, pleasant elderly gentleman, lying in bed SKIN: warm and well perfused, no excoriations, no rashes, multiple bruises, dry skin HEENT: EOMI, anicteric sclera, pink conjunctiva, patent nares NECK: nontender supple neck w/ excess skin folds, no LAD, no JVD CARDIAC: irregular rate but not tachycardic, S1/S2, no mrg LUNG: clear to auscultation bilaterally, no crackles or wheezes ABDOMEN: soft, obese, nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly PULSES: 2+ radial pulses bilaterally NEURO: CN II-XII intact, strength exam tested in BUEs: ___ in upper arms (limited on left side ___ pain), hand grip ___ alert, oriented to person, not year, attempted to read calendar (but calendar is wrong), oriented to place EXT: 1+ pedal edema, no left arm edema GU: no foley. holding urinal. urine is yellow. Pertinent Results: ADMISSION LABS: ___ 04:00PM JOINT FLUID ___ RBC-40* POLYS-92* ___ ___ 04:00PM JOINT FLUID NUMBER-FEW SHAPE-RHOMBOID LOCATION-INTRAC BIREFRI-POS COMMENT-c/w calciu ___ 12:33PM ___ COMMENTS-GREEN TOP ___ 12:33PM LACTATE-1.2 ___ 12:00PM GLUCOSE-159* UREA N-28* CREAT-1.8* SODIUM-138 POTASSIUM-3.9 CHLORIDE-100 TOTAL CO2-25 ANION GAP-17 ___ 12:00PM estGFR-Using this ___ 12:00PM CALCIUM-8.6 PHOSPHATE-3.5 MAGNESIUM-1.9 ___ 12:00PM CRP-212.4* ___ 12:00PM WBC-26.9* RBC-3.09* HGB-9.9* HCT-30.7* MCV-99* MCH-32.0 MCHC-32.2 RDW-17.7* ___ 12:00PM NEUTS-67 BANDS-5 LYMPHS-2* MONOS-9 EOS-0 BASOS-0 ___ METAS-15* MYELOS-2* ___ 12:00PM HYPOCHROM-1+ ANISOCYT-1+ POIKILOCY-OCCASIONAL MACROCYT-NORMAL MICROCYT-NORMAL POLYCHROM-OCCASIONAL BITE-OCCASIONAL ___ 12:00PM PLT SMR-NORMAL PLT COUNT-221 ___ 12:00PM ___ PTT-35.0 ___ ___ 12:00PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 12:00PM URINE BLOOD-TR NITRITE-NEG PROTEIN-100 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-NEG ___ 12:00PM URINE RBC-2 WBC-2 BACTERIA-NONE YEAST-NONE EPI-0 ___ 12:00PM URINE HYALINE-3* ___ 12:00PM URINE MUCOUS-RARE . OTHER PERTINENT LABS ___ 02:42AM BLOOD ALT-20 AST-39 CK(CPK)-40* AlkPhos-75 TotBili-0.6 ___ 01:28AM BLOOD ALT-19 AST-43* LD(LDH)-472* AlkPhos-84 TotBili-0.4 ___ 02:42AM BLOOD CK-MB-2 cTropnT-0.18* ___ ___ 11:02AM BLOOD CK-MB-2 cTropnT-0.14* ___ 02:42AM BLOOD TSH-2.3 ___ 12:00PM BLOOD CRP-212.4* ___ 03:13AM BLOOD IgG-634* IgA-89 IgM-42 ___ 06:13AM BLOOD Type-ART Temp-40.1 PEEP-5 FiO2-40 pO2-144* pCO2-63* pH-7.25* calTCO2-29 Base XS-0 Intubat-NOT INTUBA ___ 01:54AM BLOOD K-4.8 calHCO3-28 ___ 03:20AM BLOOD Lactate-0.9 ___ 12:33PM BLOOD Lactate-1.2 . DISCHARGE LABS ___ 07:40AM BLOOD WBC-28.0* RBC-2.74* Hgb-8.5* Hct-26.9* MCV-98 MCH-30.9 MCHC-31.5 RDW-17.6* Plt ___ ___ 05:30AM BLOOD WBC-34.7*# RBC-2.69* Hgb-8.4* Hct-26.6* MCV-99* MCH-31.4 MCHC-31.8 RDW-17.4* Plt ___ ___ 05:30AM BLOOD Neuts-79* Bands-5 Lymphs-1* Monos-3 Eos-0 Baso-0 ___ Metas-3* Myelos-9* ___ 05:30AM BLOOD Hypochr-1+ Anisocy-1+ Poiklo-NORMAL Macrocy-3+ Microcy-NORMAL Polychr-NORMAL Pappenh-OCCASIONAL ___ 07:40AM BLOOD Glucose-101* UreaN-67* Creat-1.8* Na-140 K-3.4 Cl-104 HCO3-28 AnGap-11 ___ 05:30AM BLOOD Albumin-3.1* Calcium-8.1* Phos-3.0# Mg-2.1 . URINE STUDIES ___ 12:00PM URINE Color-Yellow Appear-Clear Sp ___ ___ 12:00PM URINE Blood-TR Nitrite-NEG Protein-100 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG ___ 12:00PM URINE RBC-2 WBC-2 Bacteri-NONE Yeast-NONE Epi-0 ___ 12:00PM URINE CastHy-3* ___ 12:00PM URINE Mucous-RARE ___ 12:00PM URINE Mucous-RARE ___ 10:34AM URINE Color-DkAmb Appear-Cloudy Sp ___ ___ 10:34AM URINE Blood-LG Nitrite-NEG Protein-100 Glucose-NEG Ketone-TR Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-MOD ___ 05:21PM URINE Color-Red Appear-Cloudy Sp ___ ___ 05:21PM URINE Blood-LG Nitrite-NEG Protein->300 Glucose-NEG Ketone-15 Bilirub-MOD Urobiln-1 pH-5.0 Leuks-TR ___ 05:21PM URINE RBC->182* WBC->182* Bacteri-FEW Yeast-NONE Epi-0 . URINE LYTES ___ 10:36PM URINE Eos-NEGATIVE ___ 06:04AM URINE Osmolal-347 ___ 05:21PM URINE Osmolal-366 ___ 06:04AM URINE Hours-RANDOM UreaN-256 Creat-60 Na-83 K-39 Cl-91 ___ 05:21PM URINE Hours-RANDOM UreaN-339 Creat-153 Na-54 K-23 Cl-24 . JOINT FUILD ANALYSIS ___ 04:00PM JOINT FLUID ___ RBC-40* Polys-92* ___ ___ 04:00PM JOINT FLUID Crystal-FEW Shape-RHOMBOID Locatio-INTRAC Birefri-POS Comment-c/w calciu . MICROBIOLOGY ___ URINE CULTURE-FINAL - NO GROWTH ___ MRSA SCREEN-FINAL - NO GROWTH ___ BLOOD CULTURE -PENDING ___ JOINT FLUID GRAM STAIN-FINAL; FLUID CULTURE-FINAL NO GROWTH ___ BLOOD CULTURE -FINAL - NO GROWTH ___ BLOOD CULTURE - FINAL - NO GROWTH ___ URINE CULTURE-FINAL - NO GROWTH . IMAGING/OTHER REPORTS ___ GLENO-HUMERAL SHOULDER X-RAY IMPRESSION: No evidence of acute fracture or dislocation. High-riding left humeral head again seen, which can be seen in rotator cuff disease. . ___ CHEST PA/LAT IMPRESSION: Opacities projecting over the bilateral lung fields, in part relating to calcified pleural plaques, although increased perihilar opacities compared to the prior study, left greater than right, raise concern for pulmonary edema with possible underlying infection, as above. . ___ CHEST-PORTABLE Perihilar opacities seen on the prior chest x-ray have diminished . Calcified pleural plaques are again noted. No failure is present. The costophrenic angles show mild blunting of the left, but none on the right. . ___ CT C-SPINE WIHTOUT CONTRAST IMPRESSION: No acute fracture. Multilevel degenerative changes. Mild anterolisthesis of C3 and C4, potentially due to associated facet joint hypertrophic changes at this level. Degenerative changes, more significantly at C5-C6 and C6-C7 as above. . ___ CT CHEST WITHOUT CONTRAST IMPRESSION: 1. Non-aneurysmal moderately calcified thoracic aorta and coronary arteries 2. Numerous calcified pleural plaques, unchanged from prior and suggestive of prior asbestos. 3. Bibasilar atelectasis. No consolidation or pleural effusion. 4. 2.3 cm right thyroid nodule. Non-emergent thyroid ultrasound could be performed for further assessment. 5. New subcentimeter hyperdense right renal lesion. Ultrasound could be performed for further assessment. . ___ EKG Probable atrial flutter with 2:1 A-V conduction. Right bundle-branch block. Compared to the previous tracing atrial flutter is new. The other findings are similar. Rate PR QRS QT/QTc P QRS T 153 0 ___ 0 0 -7 . ___ EKG Sinus rhythm. Right ventricular conduction delay. Slowing of the rate as compared to the previous tracing of ___ and appearance of sinus rhythm. Otherwise, no diagnostic interim change. Rate PR QRS QT/QTc P QRS T 98 ___ 50 45 -10 . ___ EKG Sinus rhythm with further slowing of the rate as compared to the previous tracing of ___. There is continued right ventricular conduction delay and ST-T wave changes as previously recorded without diagnostic interim change. Rate PR QRS QT/QTc P QRS T 80 ___ 63 22 -14 . ___ ULTRASOUND BLES No lower extremity DVT. Right 1.8 ___ cyst. . ___ ULTRASOUND BUES No evidence of deep venous thrombosis in bilateral upper extremities . ___ CT HEAD WITHOUT CONTRAST There is no evidence of infarction, edema, hemorrhage, mass effect or shift of normally midline structures. The sulci and ventricles are prominent, likely age-related involutional changes. Minimal confluent hypodensities in periventricular and subcortical white matter distribution likely reflect sequela of vessel ischemic disease. Basal cisterns are patent. There is no hydrocephalus. Mild mucosal thickening of maxillary sinuses and ethmoid air cells is noted. Otherwise, imaged paranasal sinuses and mastoid air cells are well aerated. Vascular calcifications are noted. Right lens prosthesis is in place. IMPRESSION: 1. No evidence of hemorrhage or infarction. MRI is more sensitive for detection of acute ischemia. 2. Prominent sulci and ventricles, likely age-related involutional changes. 3. Small vessel ischemic disease. . ___ CARDIAC ECHO Results Measurements Normal Range Left Atrium - Long Axis Dimension: *4.5 cm <= 4.0 cm Left Atrium - Four Chamber Length: *7.3 cm <= 5.2 cm Right Atrium - Four Chamber Length: *5.4 cm <= 5.0 cm Left Ventricle - Septal Wall Thickness: *1.2 cm 0.6 - 1.1 cm Left Ventricle - Inferolateral Thickness: *1.2 cm 0.6 - 1.1 cm Left Ventricle - Diastolic Dimension: 4.2 cm <= 5.6 cm Left Ventricle - Ejection Fraction: >= 70% >= 55% Left Ventricle - Stroke Volume: 66 ml/beat Left Ventricle - Cardiac Output: 5.01 L/min Left Ventricle - Cardiac Index: 2.85 >= 2.0 L/min/M2 Left Ventricle - Lateral Peak E': 0.09 m/s > 0.08 m/s Left Ventricle - Septal Peak E': *0.06 m/s > 0.08 m/s Left Ventricle - Ratio E/E': 9 < 15 Aorta - Sinus Level: *3.7 cm <= 3.6 cm Aorta - Ascending: *4.0 cm <= 3.4 cm Aortic Valve - Peak Velocity: 1.5 m/sec <= 2.0 m/sec Aortic Valve - LVOT VTI: 21 Aortic Valve - LVOT diam: 2.0 cm Mitral Valve - E Wave: 0.7 m/sec Mitral Valve - A Wave: 1.0 m/sec Mitral Valve - E/A ratio: 0.70 Mitral Valve - E Wave deceleration time: *256 ms 140-250 ms TR Gradient (+ RA = PASP): *31 mm Hg <= 25 mm Hg Findings This study was compared to the prior study of ___. LEFT ATRIUM: Mild ___. RIGHT ATRIUM/INTERATRIAL SEPTUM: Mildly dilated RA. LEFT VENTRICLE: Mild symmetric LVH with normal cavity size and regional/global systolic function (LVEF>55%). No resting LVOT gradient. RIGHT VENTRICLE: Mildly dilated RV cavity. Mild global RV free wall hypokinesis. AORTA: Mildy dilated aortic root. Focal calcifications in aortic root. Mildly dilated ascending aorta. AORTIC VALVE: Mildly thickened aortic valve leaflets (3). No AS. No masses or vegetations on aortic valve, but cannot be fully excluded due to suboptimal image quality. No AR. MITRAL VALVE: Mildly thickened mitral valve leaflets. No masses or vegetations on mitral valve, but cannot be fully excluded due to suboptimal image quality. Trivial MR. ___ inflow pattern c/w impaired relaxation. TRICUSPID VALVE: Mildly thickened tricuspid valve leaflets. Mild [1+] TR. Mild PA systolic hypertension. PULMONIC VALVE/PULMONARY ARTERY: Pulmonic valve not visualized. No PS. Physiologic PR. PERICARDIUM: No pericardial effusion. Conclusions The left atrium is mildly dilated. There is mild symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function (LVEF>55%). The right ventricular cavity is mildly dilated with mild global free wall hypokinesis. The aortic root is mildly dilated at the sinus level. The ascending aorta is mildly dilated. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No masses or vegetations are seen on the aortic valve, but cannot be fully excluded due to suboptimal image quality. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. No masses or vegetations are seen on the mitral valve, but cannot be fully excluded due to suboptimal image quality. Trivial mitral regurgitation is seen. The left ventricular inflow pattern suggests impaired relaxation. The tricuspid valve leaflets are mildly thickened. There is mild pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Mild symmetric left ventricular hypertrophy with preserved global and regional left ventricular systolic function. Dilated and hypokinetic right ventricle. No significant valvular regurgitation. No echocardiographic evidence of endocarditis. Dilated ascending aorta and aortic sinus. If clinically indicated, a transesophageal echocardiogram may better assess for valvular vegetations. . ___ LUNG SCAN V/Q IMPRESSION: Low likelihood for acute pulmonary embolism. . ___ RENAL U/S The right kidney measures 10.3 cm. The left kidney measures 9.77 cm. Bilateral kidneys demonstrate cortical thinning, unchanged. There is no hydronephrosis, nephrolithiasis, or renal masses. A Foley catheter is present and the bladder is decompressed. IMPRESSION: No hydronephrosis. Brief Hospital Course: >> BRIEF HOSPITAL COURSE ___ with CML with recent admission for MSSA bacteremia from likely PICC line infection, left sided PICC line removed, right sided put in and receving Daptomycin admitted for left sided shoulder pain (found to be pseudogout), chest pain and fever. On the floor, the patient had an acute episode of respiratory distress with hypoxia to ___, associated with afib with RVR, and hypertension requiring BiPap and ICU transfer. He improved on Bipap, stabilized, and was transferred to the Oncology floor. There, he was restarted on his imatinib, which he tolerated well. Foley and PICC line were removed. He was discharged to a rehabilitation facility for continued physical therapy. . >> ACTIVE ISSUES #) Hypoxemia: The patient became acutely tachypnic and hypoxemic on the floor associated with afib with RVR and hypertension. A CXR was performed that was a poor study but did not show a consolidation or flash edema. The patient had a CT chest done the day previous that was clear as well. The patient was given 40mg IV lasix, with little UOP and morphine for resp distress. The differential for his respiratory distress was initially pulmonary edema vs PE. He was empirically started on a heparin drip, which was discontinued when he negative upper and lower extremity dopplers and a low probability V/Q scan. His respiratory status remained stable thereafter. Suspect this episode was related to some increased pulmonary edema in the setting of new afib and dCHF. # Leukocytosis and CML: The patient's WBC was elevated at admission -- it was unclear if this was infection vs his known CML. Infectious work up was negative at this time and his primary oncologist believed the WBC was likely due to his CML. His primary oncologist recommended restarting Gleevac, while he was an inpatient. His WBC was improving at discharge. #) Acute altered mental status: On ___ patient became altered more so from baseline. CT head was negative. He had been receiving narcotics for pain relief including IV morphine -- once his pain regimen was switched to tylenol with occassional breakthrough dilaudid his mental status returned to his baseline. #) Acute renal failure: His creatinine was elevated to a peak of 3.5 -- the etiologu of his renal failure is unclear. His potassium rose to 6.2 without ECG changes in setting of ARF. He was given Lasix and Kayexalate and his potassium came down. Initially it was thought that his daptomycin was contributing as daptomycin can cause renal failure in 2-3% -- however urine eosinophils were negative. Renal was consulted as initially they believed this was instrinsic renal pathology. His Cr was down to 1.8 on discharge. Baseline is ~1.4-1.6. #) UTI: U/A collected on ___ was concerning for infection. Started on IV cipro on ___. Transitioned to PO cipro and will complete a 10-day course. #) Clots in foley: There were blood clots seen in the foley, which was thought to be due to a traumatic foley placement. The patient was started on CBI without improvement. Urology was contacted and they recommended replacing his 3 way foley with a large 2 way foley and stopping CBI. This was done and the patient's hematuria improved. He was scheduled for follow-up with urology and nephrology for further evaluation of hematuria and renal failure (eg cystoscopy). # Recent MSSA Infection: Being followed by ___ clinic for ongoing daptomycin treatment. ID saw him as an inpatient and recommended stopping his dapto a few days early as it was thought that perhapts the daptomycin was contributing to his acute renal failure. TTE was negative for vegetation. # Shoulder Pain: Patient presented with pain in the ED. CPPD crystals seen on aspiration consisten with pseudogout on aspiration. No organisms grew from joint aspiration cultures. Initially pain controlled with tylenol and dilaudid. After sspeaking with Rheumatology patient was started on short prednison taper. Per Rheum, the patient should continue on prednisone 5mg daily until he follows up in ___ clinic - which is scheduled. # DM2 - Held home Actos. ISS while inpatient. His actos was NOT restarted on discharge as it may not be the best choice given patient's heart failure and hematuria. Consider alternative agents as an outpatient. He had increased insulin requirements on prednisone here and should remain on insulin while on prednisone. CHRONIC/INACTIVE ISSUES # Chronic macrocytic Anemia secondary to malignancy and inflammation - Continued vitamin B complex supplements. # CAD: Continue aspirin, statin. TRANSITIONAL ISSUE: - Code status: DNR/DNI - Emergency contact: HCP & wife ___ ___, nephew ___ ___ cell. - Studies pending on discharge: Blood culture from ___ is still pending. - Given history of paroxysmal atrial fibrillation on this hospitalization (still appears to be in atrial fibrillation), consider anti-coagulation. Anti-coagulation not started on this admission ___ recent hematuria, but once this resolves as an outpatient, please consider. - As his creatinine improves and his blood sugars normalize, insulin regimen should be adjusted accordingly. Pioglitazone likely should not be re-started given his heart failure status and risk for lactic acidosis, and metformin is contra-indicated with his baseline kidney dysfunction. Please explore alternative oral medications for outpatient use. - QTc on ___ was 412. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Daptomycin 420 mg IV Q24H 2. Acetaminophen 1000 mg PO Q8H:PRN pain 3. Aspirin 81 mg PO DAILY Start: In am 4. Atorvastatin 10 mg PO DAILY Start: In am 5. Docusate Sodium (Liquid) 100 mg PO BID 6. Losartan Potassium 25 mg PO DAILY Start: In am 7. Metoprolol Tartrate 12.5 mg PO BID Start: In am 8. Multivitamins 1 TAB PO DAILY Start: In am 9. Senna 2 TAB PO BID 10. Vitamin B Complex w/C 1 TAB PO DAILY Start: In am 11. Imatinib Mesylate 100 mg PO DAILY Start: In am 12. Ferrous Sulfate 325 mg PO DAILY 13. Pioglitazone 45 mg PO DAILY 14. Lidocaine 5% Patch 1 PTCH TD DAILY Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H:PRN pain 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 10 mg PO DAILY 4. Docusate Sodium (Liquid) 100 mg PO BID 5. Multivitamins 1 TAB PO DAILY 6. Senna 2 TAB PO BID 7. Vitamin B Complex w/C 1 TAB PO DAILY 8. Heparin 5000 UNIT SC TID 9. OxycoDONE (Immediate Release) ___ mg PO Q6H:PRN pain please hold for RR<12, sedation 10. PredniSONE 5 mg PO DAILY should continue until follow up with rheumatology. 11. Imatinib Mesylate 100 mg PO DAILY 12. Ferrous Sulfate 325 mg PO DAILY 13. Lidocaine 5% Patch 1 PTCH TD DAILY 14. Losartan Potassium 25 mg PO DAILY 15. Metoprolol Tartrate 25 mg PO TID 16. Ciprofloxacin HCl 250 mg PO Q12H until ___. 17. Glargine 10 Units Bedtime Insulin SC Sliding Scale using REG Insulin 18. Pyridoxine 25 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary: Multiple myeloma Pseudogout Respiratory failure Atrial fibrillation with rapid ventricular response Hematuria Acute on chronic kidney injury Altered mental status Secondary: Type 2 diabetes Hypertension BPH Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, You were admitted to ___ because of shoulder pain, which turned out to be pseudogout. While you were admitted, you had difficulty breathing, for which you were sent to the ICU. You were also found to have a fast, irregular heart rate at that time (atrial fibrillation). You improved in the ICU and were able to breathe well on room air. Unfortunately you were less reponsive than normal, but you improved after being treated for a UTI. You also had blood in your urine, which improved by itself. Finally, you had kidney dysfunction, which also improved. You should follow up with Rheumatology, Urology, your primary care doctor after discharge from the rehabilitation facility, and your Oncologist, Dr. ___. While you were here, some changes were made to your medications. Please see your medication sheet for the changes. Followup Instructions: ___
10386562-DS-15
10,386,562
24,266,920
DS
15
2169-07-06 00:00:00
2169-07-09 12:28:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins / Shellfish Derived / vancomycin Attending: ___ Chief Complaint: Shortness of breath Major Surgical or Invasive Procedure: ___: Intra-articular steroid injection of Left shoulder. History of Present Illness: ___ with h/o CML, HTN, DMII, h/o Afib with RVR, CKD (Cr 1.4-1.6) presents with worsening SOB since the morning from rehab. Per pt and his wife, last ___ approx 5d ago the pt developed chest congestion and had a fever to approx 101. No recurrent fevers but persistent chest congestion. No significant coughing or nasal congestion. Pt reports SOB mostly DOE over the past few days. No CP, palpitations. No abd pain, diarrhea, dysuria. Pt with ___ edema that is worse and just started over the past several weeks. Pt recently admitted ___ with fever, shoulder pain. During admission, pt had issues with hypoxemia and respiratory distress in the setting of afib with RVR and HTN. Pt had neg UE and ___ dopplers and low prob V/Q scan. Diuresis trial without significant UOP. Pt required ICU transfer for BiPAP. He improved on BiPAP and stabilized. Pt also admitted ___ for MSSA bacteremia thought ___ PICC line infection. At rehad today prior to transfer, the patient was given albuterol nebs x2 & mucinex this AM, and then 40mg PO lasix at 2pm. At rehab, pt ambulates with walker. Pt noted to have wheezing ___ and was getting albuterol nebs. Per rehab note, pt with worsening wheezing and cough this AM and family requested transfer to hospital. In the ED, initial vitals were: 97.0 107 151/97 24 100% 3L. The patient was briefly placed on BIPAP ___ with FiO2 50%. He was transitioned to CPAP, given 40mg IV lasix. Pt had fever to 101.2, given tylenol ___ PR. Pt given an Ipratropium nebulizer treatment, dilt ___ IV x1 for afib with RVR followed by 45mg PO dilt. Pt given levoflox 750 IV x1. Transitioned to NRB prior to transfer. On arrival to the ICU, pt reports breathing comfortable. No SOB, cough, CP. Feels chest congested still. Past Medical History: -CML on gleevec and prednisone -Hypertension -Diabetes: controlled with pioglitazone, HbA1c:6.2% (___) -Hyperlipidemia -Spinal stenosis -Trigeminal Neuralgia: last symptomatic over ___ years ago, carbamazepine discontinued -Pseudogout, manifesting as fevers of unknown origin until a knee effusion was tapped revealing crystals. Repeat flare ___ of right elbow, synovial fluid confirmed. -Polyarticular arthritis -CKD: baseline creatinine of 1.7 -BPH with elevated PSA; prior prostate biopsy reportedly negative for malignancy -S/P polypectomy of several adenomatous polyps -Bilateral THAs in ___ and ___ -MSSA Bacteremia ___ with 4 planned weeks OPAT with dapto Social History: ___ Family History: No known history of hematologic or oncologic dyscrasia. 1 of 2 brothers is deceased; 1 sister is deceased. Physical Exam: Admission PE: VS: 124/66, 113, 17, 99% on facetent and NC GENERAL: A&Ox3, hard of hearing, pleasant, looks comfortable, speaking in full sentences HEENT: NCAT. MMM. NECK: Supple, JVD. CARDIAC: irregular, rate in 100s, no murmurs LUNGS: breathing comfortably, not tachypeic, coarse bibasilar rales with diffuse rhonchorous breath sounds, good bilateral air movement ABDOMEN: Soft, NT,ND. +BS. EXTREMITIES: 2+ ___ edema up to knees, warm and well perfused with 1+ DP pulses SKIN: candidal rash in inguinal folds, small 0.5 flesh colored and slight white papules on posterior scrotum . DISCHARGE PHYSICAL EXAM: VS: 97.9 111/64 101 20 95% RA GENERAL: NAD, pleasant elderly gentleman who looks comfortable, smiling CARDIAC: irregular rate, tachycardic, S1/S2, no mrg LUNG: Good air entry b/l. Improved crackles at bilateral bases. ABDOMEN: soft, obese, nondistended, +BS, no rebound/guarding, no hepatosplenomegaly GU: no foley EXT: full flex/ext/rotation of bilateral arms Pertinent Results: Admission Labs: ___ 03:37PM LACTATE-1.9 ___ 03:30PM GLUCOSE-172* UREA N-28* CREAT-1.5* SODIUM-143 POTASSIUM-4.8 CHLORIDE-104 TOTAL CO2-30 ANION GAP-14 ___ 03:30PM ALT(SGPT)-27 AST(SGOT)-28 CK(CPK)-39* ALK PHOS-103 TOT BILI-0.3 ___ 03:30PM cTropnT-0.07* ___ 03:30PM CK-MB-4 ___ ___ 03:30PM ALBUMIN-3.5 ___ 03:30PM WBC-14.6* RBC-2.69* HGB-8.6* HCT-27.8* MCV-103* MCH-32.0 MCHC-31.0 RDW-18.2* ___ 03:30PM NEUTS-80* BANDS-2 LYMPHS-8* MONOS-6 EOS-0 BASOS-0 ___ METAS-2* MYELOS-2* ___ 03:30PM HYPOCHROM-2+ ANISOCYT-2+ POIKILOCY-1+ MACROCYT-2+ MICROCYT-OCCASIONAL POLYCHROM-OCCASIONAL OVALOCYT-OCCASIONAL TARGET-OCCASIONAL STIPPLED-OCCASIONAL TEARDROP-OCCASIONAL ACANTHOCY-OCCASIONAL ___ 03:30PM PLT SMR-NORMAL PLT COUNT-368 ___ 03:30PM ___ PTT-32.4 ___ DISCHARGE PHYSICAL EXAM ___ 07:35AM BLOOD WBC-16.2* RBC-2.86* Hgb-9.0* Hct-29.2* MCV-102* MCH-31.5 MCHC-30.8* RDW-18.1* Plt ___ ___ 07:10AM BLOOD Glucose-68* UreaN-68* Creat-2.7* Na-138 K-3.9 Cl-95* HCO3-32 AnGap-15 ___ 07:35AM BLOOD Calcium-8.5 Phos-4.9* Mg-1.8 >> STUDIES: - CXR ___: Calcified pleural plaques compatible with prior asbestos exposure. No new focal consolidation to suggest pneumonia. . CXR ___ Asbestos-related pleural plaque heavily calcified, is longstanding. The patient was in pulmonary edema on ___, subsequently improved. Small region of consolidation developed in the right lower lung on ___, has improved. This could be atelectasis, particularly due to aspiration. Borderline interstitial edema present yesterday has improved, but there still marked chronic mediastinal venous and pulmonary vascular engorgement. Pleural effusions are small if any. MICRO ___ JOINT FLUID GRAM STAIN-FINAL; FLUID CULTURE-FINAL ___ URINE CULTURE-FINAL ___ Rapid Respiratory Viral Screen & Culture Respiratory Viral Culture-FINAL; Respiratory Viral Antigen Screen-FINAL ___ MRSA SCREEN-FINAL ___ URINE CULTURE-FINAL ___ BLOOD CULTURE-FINAL ___ BLOOD CULTURE -FINAL Brief Hospital Course: BRIEF HOSPITAL COURSE =============== ___ year old gentleman with CML on gleevec, history of a-fib w/ RVR, CKD, recent admission to Omed for pseudogout complicated by respiratory failure (bipap), UTI, AMS, ___, a-fib with RVR, who presented with hypoxia and SOB. He was started on CPAP in ED, got diltiazem for a-fib with RVR, and transferred to the ICU. Given CXR with concern for ?aspiration pneumonia and recent hospital admissions and well as residence at rehab he was also covered for ha-Pneumonia and CA-pneumonia briefly, but more likely cause for hypoxia appeared to be pulmonary edema. Initially treated with antibiotics which were stopped, aggressively diuresed in concordance with Cardiology team. Diuresis was complicated by acute kidney injury, which complicated discharge somewhat. Also found to have recurrence of pseudogout in left shoulder; this improved after intra-articular steroid injection. He was discharged to a rehab facility for continued work with physical therapy. Weight on discharge was 145 pounds. ACTIVE ISSUES ========= # Hypoxia attributed to pulmonary edema: He reported chest congestion and fevers which suggests possible infectious etiology. Respiratory viral cultures/screens were negative. He was started on ___ and community acquired pneumonia coverage with linezolid and cefepime (due to allergies to PCN and vancomycin), but these were discontinued given the more likely etiology of pulmonary congestion causing hypoxia. He was initially on a NRB mask in the ICU, but oxygen was weaned and he tolerated room air well on the Oncology floor. Wells score was 2.5, he had no evidence of DVT, so pulmonary embolism was thought to be much less likely. Cardiac enzymes were flat. On exam his lungs were quite rhonchorous, with coarse rales at bases (though no clear pulmonary process on CXR). Cardiology was consulted for management of pulmonary congestion and diuresis, and he diuresed well. - Weight on discharge as above. He should continue on torsemide. Furosemide was discontinued. # Acute kidney injury: Creatinine elevated in the setting of aggressive diuresis. Peak creatinine was 3.1 and diuresis was briefly held. Creatinine was improving by the time of discharge (2.7) He was discharged on torsemide. # Atrial fibrillation with RVR: IN the emergency department, he received a bolus of diltiazem and oral diltiazem. His metoprolol was up-titrated on the Oncology floor for better rate control. He was continued on home aspiring 81mg. - Anticoagulation should be re-addressed as an outpatient. . # HTN: Normotensive during this admission. Losartan held for acute kidney injury, and metoprolol was up-titrated (for rate control of a fib). In addition, diuretic regimen was changed per the Cardiology team; torsemide was started and furosemide was stopped. # CML: His imatinib was briefly held in the ICU, but restarted on the Oncology floor. INACTIVE ISSUES ========== # DM: Continued home lantus and managed with humalog ISS in house. # CKD: Please see above discussion of kidney function. TRANSITIONAL ISSUES ============== PLEASE CHANGE HIS METOPROLOL TARTRATE 25mg TID TO METOPROLOL SUCCINATE 200mg daily. We were unable to change this prior to his discharge. - Code status: DNR, ok to intubate. - Emergency contact: HCP & wife ___ ___, nephew ___ ___ cell. - Studies pending on discharge: None. - Please re-address code status. - No need for allopurinol. - Given history of atrial fibrillation on this hospitalization, consider anti-coagulation. - As his creatinine improves and his blood sugars normalize, insulin regimen should be adjusted accordingly. Pioglitazone likely should not be re-started given his heart failure status and risk for lactic acidosis, and metformin is contra-indicated with his baseline kidney dysfunction. Please explore alternative oral medications for outpatient use. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 1000 mg PO Q8H:PRN pain 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 10 mg PO DAILY 4. Docusate Sodium (Liquid) 100 mg PO BID 5. Multivitamins 1 TAB PO DAILY 6. Senna 2 TAB PO BID 7. Vitamin B Complex w/C 1 TAB PO DAILY 8. OxycoDONE (Immediate Release) ___ mg PO Q6H:PRN pain please hold for RR<12, sedation 9. PredniSONE 5 mg PO DAILY should continue until follow up with rheumatology. 10. Imatinib Mesylate 100 mg PO DAILY 11. Ferrous Sulfate 325 mg PO DAILY 12. Lidocaine 5% Patch 1 PTCH TD DAILY 13. Losartan Potassium 25 mg PO DAILY 14. Metoprolol Tartrate 25 mg PO TID 15. Glargine 6 Units Bedtime Insulin SC Sliding Scale using REG Insulin 16. Pyridoxine 25 mg PO DAILY 17. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheezing 18. Azithromycin 500 mg PO ONCE Duration: 1 Doses ___ 19. Furosemide 40 mg PO DAILY start ___. Loperamide 2 mg PO BID:PRN loose stool 21. Milk of Magnesia 15 mL PO QHS: PRN constipation 22. Guaifenesin ER 600 mg PO Q12H 23. Calcium Carbonate 500 mg PO BID:PRN GI distress Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H:PRN pain 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 10 mg PO DAILY 4. Docusate Sodium (Liquid) 100 mg PO BID 5. Ferrous Sulfate 325 mg PO DAILY 6. Lidocaine 5% Patch 1 PTCH TD DAILY 7. PredniSONE 5 mg PO DAILY should continue until follow up with rheumatology. 8. Senna 2 TAB PO BID 9. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheezing 10. Calcium Carbonate 500 mg PO BID:PRN GI distress 11. Imatinib Mesylate 100 mg PO DAILY 12. Loperamide 2 mg PO BID:PRN loose stool 13. Milk of Magnesia 15 mL PO QHS: PRN constipation 14. OxycoDONE (Immediate Release) ___ mg PO Q6H:PRN pain please hold for RR<12, sedation 15. Multivitamins 1 TAB PO DAILY 16. Pyridoxine 25 mg PO DAILY 17. Vitamin B Complex w/C 1 TAB PO DAILY 18. Guaifenesin ER 600 mg PO Q12H 19. Torsemide 10 mg PO DAILY please hold for SBP<100 20. Glargine 6 Units Bedtime Insulin SC Sliding Scale using REG Insulin 21. Metoprolol Succinate XL 200 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary: Pulmonary edema Pseudogout of left shoulder Atrial fibrillation Chronic myelogenous leukemia Secondary: Hypertension Type 2 diabetes Acute on chronic kidney injury Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, You were admitted to ___ because of difficulty breathing. You were originally admitted to the ICU and improved there, and were transferred to the Oncology floor. While here, you were stable and did well after we gave you some medications that helped remove fluid from your lungs. You also had some left shoulder pain while here, and were found to have a recurrence of pseudogout in your left shoulder. This pain improved a great deal after you got a steroid injection from the Rheumatology team. While you were here, some medications were changed. Please START torsemide. Please STOP furosemide. Please STOP azithromycin. Please INCREASE your metoprolol. STOP losartan. Please follow up with Dr. ___, Dr. ___, and Urology as below. Followup Instructions: ___
10386562-DS-16
10,386,562
27,324,245
DS
16
2169-08-19 00:00:00
2169-08-19 21:02:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins / Shellfish Derived / vancomycin / Amoxicillin Attending: ___. Chief Complaint: fall, confusion Major Surgical or Invasive Procedure: left trochanteric bursa steroid injection (Solumedrol) History of Present Illness: ___ with a medical history of CML on gleevac, Pseudogout, CKD (baseline creatinine 2.0-2.7) with left knee pain for several days, increasing confusion, and now mechanical fall resulting in ED visit. He was in his normal state of health until ___ this past week when he started to develop vague left lower extremity pain that appears to localize to the knee. The pain is worse w/ movement. He has taken tylenol but unclear if helping. The patient attributes these symptoms to pseudogout. It became progressively worse over the week to the extent that he could not ambulate (typically ambulates w/ walker) and was "crawling around like a dog." When walking back from the bathroom on ___ he slipped and fell. He was unable to get up by himself. After the fall he reports left elbow pain, left hip pain, and right hand pain. Denies speech changes, sensation changes. . Regarding his mental status, his wife feels that over the past several days he is more confused than normal. He denies fever, chills, cough. He endorses stable dyspnea on exertion that is chronic. He has not taken oxycodone for his leg pain. Recent medication changes include starting on allopurinol for gout (ordered in OMR to start ___ but pt wife reports started ___, starting ciprofloxacin for possible UTI (___) and starting no finasteride for BPH (___). . Of note, he has a diagnosis of pseudogout, established in ___ when he presented with polyarticular arthritis. Joint aspiration of his knee revealed CPPD crystals. Plain films of his knee revealed chondrocalcinosis. He has had increasing flares recently, this month he was seen by rheumatology who administered an injection of steroids to his shoulder and was started on a 12 day prednisone taper with significant symptomatic improvement. . In the ED, initial vitals T:98.3 BP:119/64 HR:90 RR:18 O2:100%RA. Currently AAOx2, confused on date but pts. wife states that is not that abnormal. Labs notable for WBC 12.8 (baseline CML), HCT 31.5, creatinine 2.3 (baseline 2.0 - 2.7). UA w/ 1WBC, no bacteria, neg leuk/nitrite. Ct head w/ no acute process,left ___ negative for DVT, CXR obtained, left knee/tib/fib imaging obtained. Past Medical History: -CML on gleevec and prednisone -Hypertension -Diabetes: controlled with pioglitazone, HbA1c:6.2% (___) -Hyperlipidemia -Spinal stenosis -Trigeminal Neuralgia: last symptomatic over ___ years ago, carbamazepine discontinued -Pseudogout, manifesting as fevers of unknown origin until a knee effusion was tapped revealing crystals. Repeat flare ___ of right elbow, synovial fluid confirmed. -Polyarticular arthritis -CKD: baseline creatinine of 1.7 -BPH with elevated PSA; prior prostate biopsy reportedly negative for malignancy -S/P polypectomy of several adenomatous polyps -Bilateral THAs in ___ and ___ -MSSA Bacteremia ___ with 4 planned weeks OPAT with dapto Social History: ___ Family History: No known history of hematologic or oncologic dyscrasia. Physical Exam: VS - Afebrile BP:113/58 HR:93 RR:18 O2: 100%RA GENERAL - well-appearing elderly man, comfortable, hard of hearing HEENT - NC/AT, anicteric, OP clear NECK - JVP not visualized LUNGS - CTA bilat, good air movement, resp unlabored HEART - PMI non-displaced, irregular rhythm, nl S1-S2 ABDOMEN - NABS, soft/NT/ND, no rebound/guarding EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs) SKIN - ecchymosis on upper extremities NEURO - awake, oriented to self, hospital, can ___ forward in <10 seconds, speech fluent, tongue midline, face symmetric, PERRL, move upper extremity antigravity, right lower extremity dorsiflex/plantar flex/extension ___, left lower extremity plantar/dorsiflexion ___ but leg extension limited by knee pain, gait not assessed MSK: pain with flexion and extension of left elbow, left knee appears slightly larger than right, no overlying erythema or warmth, pain with flexion and extension Discharge exam: afebrile, normal vital signs. very hard of hearing Left ___ with pain on lateral aspect no knee or hip instability on exam CV- occasionally irregular, no murmurs Lungs- clear Abdomen- soft Neuro- no ___ weakness or numbness (able to flex left hip with some difficulty, more flexion when pain is better controlled) Pertinent Results: ___ 11:55AM BLOOD WBC-12.8* RBC-2.96* Hgb-9.9* Hct-31.5* MCV-106* MCH-33.4* MCHC-31.4 RDW-18.5* Plt ___ ___ 11:55AM BLOOD Neuts-84.5* Lymphs-9.4* Monos-5.0 Eos-0.7 Baso-0.4 ___ 11:55AM BLOOD Glucose-193* UreaN-51* Creat-2.3* Na-140 K-4.1 Cl-102 HCO3-28 AnGap- . #CXR: pleural plaque, decreased lung volume, no opacity or effusion #L. KNEE FILM: Chondrocalcinosis, no effusion, + vascular calcifications. ___: Negative for DVT. #CT head: no acute process Discharge labs: ___ RBC Hgb Hct MCV MCH MCHC RDW Plt Ct 8.2 2.92 9.4 29.7 102 32.2 31.5 18.3 344 UreaN Creat Na K Cl HCO3 AnGap 54 2.1 143 4.6 106 33 9 CXR: IMPRESSION: Extensive pleural plaque limits evaluation. Allowing for this, no obvious signs of infection. Two views of the left elbow were reviewed: There is no overt fracture, but fluid in the elbow cannot be excluded. If clinically warranted, correlation with cross-sectional imaging might be considered. CT pelvis: IMPRESSION: 1. Limited study due to streak artifact from bilateral total hip prosthesis. No fracture identified. 2. Sigmoid diverticulosis with a focus of mild sigmoid wall thickening and surrounding fat stranding in the left lower quadrant, new from ___. In the proper clinical setting, these findings may represent mild acute diverticulitis. Otherwise, in the absence of clinical symptoms, these findings may be due to a prior episode of diverticulitis but new from ___. 3. Enlarged prostate. Ultrasound left hip: IMPRESSION: Small left greater trochanteric bursitis. MR hip: IMPRESSION: 1. Bilateral total hip arthroplasties limits evaluation of the immediate neighboring structures. However, no acute fracture is detected in the visualized bones. 2. Mild left greater trochanteric bursitis. 3. Right hamstring tendon attachment partial tear. Brief Hospital Course: #KNEE PAIN/PSEUDOGOUT: Patient with a history of crystal proven pseudogout with increasing flares recently with progressively worsening left knee pain over the past several days. X-ray showing chondrocalcinosis. While OMR indicates allopurinol was ordered on ___, around the same time that patient's symptoms started, wife reports did not start taking until yesterday. His presentations seems most c/w pseudogout. ___ negative for DVT. No symptoms concerning for systemic infection at this time. Neuro exam does not seem consistent w/ focal UMN abnormality. Patient evaluated by both orthopedic surgery and rheumatology. Extensive imaging did not reveal any fracture or obvious malalignment of left hip prosthesis. Patient underwent left trochanteric bursa injection, with some improvement in pain. Additional exam revealed likely IT band syndrome on left thigh. Patient's pain and stability with ambulation improved following ___ for IT band syndrome (massage left lateral thigh TID, ice, lidocaine patches). . #MECHANICAL FALL: Patient w/ mechanical fall in the setting of left knee pain. Management as above. Ambulatory with walker with close supervision. Patient has no pain at rest, only with ambulation. . #AMS: mental status normalized after pain controlled. Patient is A and O x 3, very pleasant, very hard of hearing. . #CML: Continued Gleevac . #CKD: Creatinine at baseline. Renally dosed medication. Avoided nephrotoxins . #DM2: held actos, continued on regular insulin SS. Restarting Actos upon discharge, patient will likely not need regular insulin SS (keeping on med list for now) . #Atrial fibrillation: continued beta blocker and aspirin 325 mg . #HL: continued statin DNR Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen ___ mg PO Q8H pain 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 10 mg PO DAILY 4. PredniSONE 5 mg PO DAILY 5. Imatinib Mesylate 100 mg ORAL DAILY 6. Multivitamins 1 TAB PO DAILY 7. Vitamin B Complex 1 CAP PO DAILY 8. Torsemide 10 mg PO DAILY 9. Metoprolol Succinate XL 300 mg PO DAILY 10. Finasteride 5 mg PO DAILY 11. Ciprofloxacin HCl 250 mg PO Q12H 12. Allopurinol ___ mg PO EVERY OTHER DAY 13. Pioglitazone 45 mg PO DAILY Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 10 mg PO DAILY 4. Finasteride 5 mg PO DAILY 5. Multivitamins 1 TAB PO DAILY 6. Torsemide 10 mg PO DAILY 7. Vitamin B Complex 1 CAP PO DAILY 8. Bisacodyl 10 mg PO DAILY:PRN constipation 9. Insulin SC Sliding Scale Fingerstick QACHS Insulin SC Sliding Scale using REG Insulin 10. Lidocaine 5% Patch 1 PTCH TD DAILY 11. Senna 1 TAB PO DAILY 12. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain 13. Allopurinol ___ mg PO EVERY OTHER DAY 14. Imatinib Mesylate 100 mg ORAL DAILY 15. Metoprolol Succinate XL 300 mg PO DAILY 16. Pioglitazone 45 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ ___ Diagnosis: Primary diagnoses: left IT band syndrome left trochanter bursitis Secondary diagnoses: CML CKD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane) and very close supervision. Discharge Instructions: You were admitted to the hospital with left leg pain. You underwent extensive testing and were seen by both rheumatology and orthopedic surgery. Multiple imaging studies revealed a small area of inflammation near the left hip- this was injected with a steroid. Imaging tests did not reveal any significant problems with the left hip replacement. Your pain is likely from a strained tendon on the outside of your left leg- you should continue to receive physical therapy and massage this three times daily. Please see below for your follow up appointments and medications. Followup Instructions: ___
10386562-DS-17
10,386,562
26,699,119
DS
17
2169-09-25 00:00:00
2169-09-27 20:24:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins / Shellfish Derived / vancomycin / Amoxicillin Attending: ___. Chief Complaint: Hallucinations Major Surgical or Invasive Procedure: None History of Present Illness: ___ with history of CML on Gleevec, HTN, HL, DM, spinal stenosis, pseudogout, CKD, BPH, and several recent falls, presenting now with hallucinations. Per his wife, he was sitting at the edge of his bed on ___ night (4 days PTA), about to get up, when the bed rolled back and he slipped and fell on the floor. No LOC or head strike. His wife then fell trying to get him up, and had to call EMS for assistance. No intervention taken at time, as patient did not want to go to ED. Since then, his wife reports he has been having hallucinations, such as seeing animals or people in the home. However, on review of his chart, he was actually having hallucinations before this fall, as reported in an Oncology note from ___. Has had hallucinations in the past, in the context of infection. Was also some concern in past that hallucinations could be related to taking Gleevec, and dose was decreased from 400 mg daily to 100 mg daily. Also has a history of confusion in setting of pain. Saw his PCP today, who was concerned about his hallucinations and referred him to ED for further evaluation. On arrival to the ED, initial vitals were 97.4 66 136/84 20 93%. On exam, a trauma survey was negative for any injuries, and he had a stable pelvis with no reported hip pain. Labs notable for Cr 2.3 (baseline 1.5 in ___, more recently ___, WBC 17.7 (recently has ranged ___. LFTs and lactate WNL. UA not suggestive of UTI. CXR not suggestive of PNA. CT head negative for any acute intracranial process, and CT c-spine negative for fracture or vertebral malalignment. ED did not feel safe discharging patient without a longer period of observation to rule out infection; therefore he is being admitted to Medicine. Vitals prior to transfer 97.4 91 135/92 18 99%. On arrival to floor, patient complains of mild headache, neck pain, and bilateral shoulder pain, which were present prior to his fall. States he is hungry but has no other complaints. Denies recent sick contacts. Of note, patient has had several recent falls. Was admitted last month after a mechanical fall in the setting of left knee pain from pseuogout. He was also felt to have left IT band syndrome. Initially had confusion, which resolved with improvement in pain control. Did not have signs/symptoms of infection at the time. ROS: Positive as per HPI. Has chronic chills and recent loose stools. No fever, sweats, weight change, vision changes, sore throat, chest pain, dyspnea, cough, abdominal pain, nausea, vomiting, constipation, bloody stools, dysuria, knee pain. Has lower extremity edema that is improving. Past Medical History: -CML on Gleevec -Hypertension -Diabetes mellitus -Hyperlipidemia -Spinal stenosis -Trigeminal Neuralgia -Pseudogout -Polyarticular arthritis -CKD, baseline creatinine recently ___ -BPH with elevated PSA; prior prostate biopsy reportedly negative for malignancy -s/p polypectomy of several adenomatous polyps -Bilateral THAs in ___ and ___ -MSSA Bacteremia ___ -Atrial fibrillation -Lower extremity edema (preserved EF on echo ___ Social History: ___ Family History: No known history of hematologic or oncologic dyscrasia. Physical Exam: ADMISSION EXAM: VS - Temp 98.6 F, BP 156/78, HR 88, RR 18, SpO2 97% RA, weight 63 kg GENERAL - elderly male, resting comfortably in NAD, hard of hearing HEENT - NC/AT, PERRL, EOMI, sclerae anicteric, dry MM, OP clear NECK - supple, no JVD, no cervical LAD HEART - irregularly irregular, no r/m/g LUNGS - CTAB, no wheezes/rales/rhonchi, good air movement ABDOMEN - normoactive bowel sounds, soft, non-distended, non-tender, + splenomegaly, no guarding or rebound tenderness EXTREMITIES - trace-1+ edema bilaterally, DP/PTs 1+ bilaterally SKIN - no jaundice, scattered ecchymoses on lower extremities, no lesions on feet NEURO - awake, AAOx3, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout, gait assessment deferred MSK: diffuse tenderness to palpation of bilateral shoulders not localized to the joints or tendons, no effusion; L knee slightly larger than R but without clear effusion/warmth/erythema, no TTP along knee joint line bilaterally DISCHARGE EXAM: T ___ BP 100-120/60-70 HR 80 RR 18 O2 Sat 100% RA GENERAL: resting comfortably, NAD, hard of hearing HEENT: sclerae anicteric, MMM NECK: supple HEART: irregularly irregular, no r/m/g LUNGS: CTAB, no wheezes/rales/rhonchi, good air movement ABDOMEN: normoactive bowel sounds, soft, slightly distended, non-tender EXTREMITIES: trace edema bilaterally, DP/PTs 1+ bilaterally SKIN: no jaundice, scattered ecchymoses on lower extremities NEURO: Vision is intact bilaterally at 4 feet. CN II-XII grossly intact. Non focal. Pertinent Results: ADMISSION LABS: ___ 01:02PM BLOOD WBC-17.7* RBC-3.22* Hgb-10.4* Hct-32.6* MCV-101* MCH-32.1* MCHC-31.8 RDW-17.5* Plt ___ ___ 01:02PM BLOOD Neuts-79* Bands-0 Lymphs-3* Monos-5 Eos-0 Baso-2 ___ Metas-3* Myelos-8* ___ 01:02PM BLOOD Hypochr-2+ Anisocy-1+ Poiklo-NORMAL Macrocy-2+ Microcy-NORMAL Polychr-1+ Target-OCCASIONAL ___ 01:02PM BLOOD ___ PTT-35.4 ___ ___ 01:02PM BLOOD Glucose-141* UreaN-62* Creat-2.3* Na-140 K-4.2 Cl-100 HCO3-25 AnGap-19 ___ 01:02PM BLOOD ALT-12 AST-23 AlkPhos-59 TotBili-0.3 ___ 01:02PM BLOOD Albumin-3.8 Calcium-9.3 Phos-4.7* Mg-2.2 ___ 01:12PM BLOOD Lactate-1.5 ___ 01:02PM URINE Color-Yellow Appear-Clear Sp ___ ___ 01:02PM URINE Blood-NEG Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-TR ___ 01:02PM URINE RBC-0 WBC-1 Bacteri-FEW Yeast-NONE Epi-1 OTHER PERTINENT LABS: ___ 02:40PM BLOOD CRP-170.8* ___ 06:30AM BLOOD CRP-136.5* ___ 02:40PM BLOOD ESR-60* ___ 06:30AM BLOOD ESR-52* DISCHARGE LABS: ___ 06:30AM BLOOD WBC-15.1* RBC-3.11* Hgb-9.7* Hct-31.6* MCV-102* MCH-31.1 MCHC-30.6* RDW-17.3* Plt ___ ___ 06:30AM BLOOD Glucose-99 UreaN-66* Creat-2.1* Na-136 K-4.3 Cl-103 HCO3-23 AnGap-14 ___ 06:30AM BLOOD Calcium-8.1* Phos-4.2 Mg-2.0 MICROBIOLOGY: Urine culture ___: mixed bacterial flora c/w contamination Blood culture ___: pending, no growth at time of discharge IMAGING: CXR ___: Mild bibasilar atelectasis or scarring. Low lung volumes. Calcified bilateral pleural plaques. No definite new areas of focal consolidation is identified. CT Head w/o contrast ___: No acute intracranial process. CT C-spine w/o contrast ___: 1. No acute fracture or change in vertebral alignment. 2. Stable multilevel degenerative changes with mild spinal canal narrowing and mild multilevel neural foraminal narrowing. 3. Calcified pleural plaques consistent with prior asbestos exposure. 4. Stable hypodense nodule in the right thyroid lobe. Brief Hospital Course: ___ with history of CML on Gleevec, HTN, HL, DM, spinal stenosis, pseudogout, CKD, BPH, and several recent falls, presenting now with hallucinations. # Hallucinations: In past, hallucinations have occurred in setting of infection, pain, and possibly related to his Gleevec. During this admission, patient was afebrile without evidence of an acute infectious process. Given concern about Gleevec possibly contributing, this was initially held after contacting his outpatient oncologist. The Geriatrics team was consulted, and felt that patient has underlying cognitive impairment with abnormal mini-cog and a history of functional decline over the last few years, placing him at high risk for delirium. They felt he his hallucinations were likely in setting of delirium, secondary to pain from headache and possibly the Gleevec. They also felt that he may have ___ body dementia, given cognitive impairment, falls and fluctuating course. Did not recommend treating the hallucinations, as he is not distressed by them. He did not have further hallucinations in the hospital. # Headache: CT head on admission negative for any acute intracranial process. ___ have been tension-type headache, but given tenderness to palpation over temporal areas bilaterally and elevated ESR/CRP, was some concern for GCA. Rheumatology consulted, and recommended Vascular surgery consult for temporal artery biopsy. Did not feel patient needed to start on steroids prior to biopsy, given overall lower suspicion for GCA. Patient's headache then resolved over next ___ days without intervention, and it was felt GCA was unlikely. Temporal artery biopsy therefore not pursued. Pain was controlled with acetaminophen as needed. # Anion gap metabolic acidosis: No significant hyperglycemia or ketones in urine to suggest DKA. Lactate WNL. Resolved with PO hydration. # Recent falls: Per report, seem to all have been mechanical in nature. CT head and C-spine in ED unremarkable for acute process. As above, some concern for ___ Body Dementia. Patient seen by ___, and cleared for discharge home with ___. # CML: Held Gleevec per outpatient oncologist as above on presentation, but this was restarted on discharge. Per oncology, unlikely to be cause of hallucinations. # Elevated inflammatory markers: ESR/CRP significantly elevated this admission, without clear etiology. Infectious work-up, including UA, CXR, and blood cultures negative (though final blood culture results still pending at time of discharge). Was some concern for GCA given headache, but headache was somewhat atypical and resolved without intervention, making this seem less likely as above. Rheumatology followed the patient. He did not have any evidence of a recurrent flare of his pseudogout. Of note, his PSA is elevated, and an underlying malignancy would be on differential. ESR/CRP were trending down at time of discharge. CHRONIC ISSUES: # CKD: Recent baseline Cr ___. Cr was generally within this range during admission. # Hypertension: Continued home metoprolol, torsemide. # Diabetes mellitus: Held home pioglitazone while in house; resumed on discharge. HISS. # Hyperlipidemia: Continued home statin. # Atrial fibrillation: Continued home metoprolol, aspirin. # Lower extremity edema: Continued home torsemide. # Pseudogout: No active flare. Continued home allopurinol. Was seen by Rheumatology. # Polyarticular arthritis: Acetaminophen prn pain. # BPH: Continued finasteride. TRANSITIONAL ISSUES: -During admission, Geriatrics consult team felt patient may have underlying ___ Body Dementia. He may benefit from further work-up in the outpatient setting. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Ferrous Sulfate 325 mg PO BID 3. Metoprolol Tartrate 100 mg PO TID 4. Atorvastatin 10 mg PO DAILY 5. Pioglitazone 45 mg PO DAILY 6. Imatinib Mesylate 100 mg PO DAILY CML 7. Torsemide 10 mg PO DAILY 8. Allopurinol ___ mg PO MWF 9. Finasteride 5 mg PO DAILY Discharge Medications: 1. Allopurinol ___ mg PO MWF 2. Atorvastatin 10 mg PO DAILY 3. Finasteride 5 mg PO DAILY 4. Ferrous Sulfate 325 mg PO DAILY 5. Metoprolol Tartrate 100 mg PO TID 6. Torsemide 10 mg PO DAILY 7. Acetaminophen 1000 mg PO TID 8. Pioglitazone 45 mg PO DAILY 9. Aspirin 81 mg PO DAILY 10. Imatinib Mesylate 100 mg PO DAILY CML Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary: Acute toxic-metabolic encephalopathy, Headache Secondary: CML, anion gap metabolic acidosis, chronic kidney disease Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr ___, It was a pleasure taking care of you during your stay at ___. You were admitted to the hospital after having hallucinations at home. We were initially concerned about a possible infection, but you did not have any signs of an infection while you were here. You were seen by our Geriatrics consult service, who felt that you had delirium. It is also possible you are developing a type of dementia called ___ Body Dementia, and you should discuss this with your primary care doctor. While you were here, you reported a headache. The rheumatologists felt your headache was not dangerous and did not recommended any steroids or biopsy. Your headache improved with Tylenol. It is possible, though less likely, that your Gleevec is contributing to your hallucinations. We held this medication for you while you were here. You should resume taking this once you leave the hospital. Please weigh yourself every morning, and call your doctor if your weight goes up more than 3 pounds. Followup Instructions: ___
10386699-DS-17
10,386,699
29,955,927
DS
17
2152-06-09 00:00:00
2152-06-10 14:14:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: morphine Attending: ___. Chief Complaint: Subdural Hematoma Major Surgical or Invasive Procedure: None History of Present Illness: ___ y/o M with significant cardiac history on Coumadin and plavix presents with elevated INR of 3.___t OSH that shows small parafalcine SDH. He was transferred to ___ for further management. Once at ___, he was given Profilnine. Patient reports that he was walking from the bed to the bathroom and felt like he was falling forward. He usually ambulates with a cane and states that he fell forward on the floor at around 8pm with loss of consciousness. The patient was uncertain of how long he was unconscious. He awoke and felt asymptomatic so stayed at home. Today, he presented to his PCP for ___ routine INR check when the nurse noted ___ ecchymotic R eye. His INR was found to be 3.9 and he was sent to OSH for a workup. Patient reports an unintentional weight loss of 12 pounds in 1 month with constant achy LLQ abdominal pain with nausea. He denies any headaches, changes in vision, dizziness, or dysarthria. Past Medical History: CAD, MI, ischemic cardiomyopathy, single chamber ICD, depression, DM2, HTN, dyslipidemia, COPD, stents x 4, constipation, pancreatitis, PAF, ___ and 9th rib fx, s/p cholecystectomy, bowel blockage with surgical exploration ___ yrs ago. Social History: ___ Family History: Non-contributory Physical Exam: ADMISSION PHYSICAL EXAM: ========================= O: T:98.4 BP:106/74 HR: 65 R: 16 O2Sats: 96% Gen: WD/WN, comfortable, NAD. HEENT: R periorbital ecchymosis Pupils: 3-2mm bilaterally EOMs: intact Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Recall: ___ objects at 5 minutes. Language: Speech fluent with good comprehension and repetition. Naming intact. No dysarthria or paraphasic errors. Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, 3 to 2 mm bilaterally. Visual fields are full to confrontation. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength full power ___ throughout. No pronator drift Sensation: Intact to light touch DISCHARGE PHYSICAL EXAM: ========================== VS - 97.7 102/63 57 18 99/RA General: Thin gentlemen HEENT: Bruise over R eye, NC, no other e/o trauma Neck: Supple CV: RRR, no m/r/g Lungs: CBAT Abdomen: Soft, ND, mild tenderness on deep palpation of umbilicus but distractable exam, no hepatosplenomegaly, +BS GU: No foley Ext: No c/c/e Neuro: CN II-XII intact Skin: No rashes Pertinent Results: LABS: ====== ___ 04:40AM BLOOD WBC-7.8 RBC-4.26* Hgb-12.9* Hct-41.0 MCV-96 MCH-30.3 MCHC-31.5 RDW-13.1 Plt ___ ___ 05:35AM BLOOD WBC-6.0 RBC-3.89* Hgb-11.8* Hct-37.6* MCV-97 MCH-30.3 MCHC-31.4 RDW-12.9 Plt ___ ___ 05:00PM BLOOD ___ ___ 05:35AM BLOOD ___ PTT-37.1* ___ ___ 05:40PM BLOOD ___ PTT-35.4 ___ ___ 04:40AM BLOOD ___ PTT-32.8 ___ ___ 05:35AM BLOOD Glucose-135* UreaN-11 Creat-0.7 Na-142 K-3.9 Cl-101 HCO3-34* AnGap-11 ___ 04:40AM BLOOD Glucose-75 UreaN-13 Creat-0.8 Na-141 K-4.3 Cl-104 HCO3-33* AnGap-8 ___ 05:35AM BLOOD ALT-16 AST-20 AlkPhos-43 Amylase-57 TotBili-0.9 ___ 05:35AM BLOOD Albumin-3.6 Calcium-8.4 Phos-2.9 Mg-1.8 ___ 04:40AM BLOOD Calcium-8.8 Phos-3.0 Mg-1.9 IMAGING: ======== CXR (___): IMPRESSION: No definite acute cardiopulmonary process. Please note that CT is more sensitive in detecting pulmonary nodules. CT Scan Head (___): IMPRESSION: Stable left anterior parafalcine subdural hemorrhage. Brief Hospital Course: ___ y/o M with PMH DM2, HTN, HLD, CAD s/p ___, ischemic cardiomyopathy with ICD, depression, and chronic abdominal pain transferred from ___ for ___ management after syncopal episode. ACTIVE ISSUES: =============== # Subdural Hematoma Diagnosed after fall in setting of supratherapeutic INR. Referred to ___ for further management. While here neurosurgery evaluated and followed patient with no e/o progression of SDH with INR reversed. Plavix/ASA resumed after 48 hours given recent ___. Coumadin instructed could be resumed 10 days (___) after being in the hospital, per neurosurgery with PCP to resume as appropriate for his paroxsmal afib. While here no e/o neurological symptoms or complaints. # Syncope Longstanding history without clear etiology. On history of presentation, appears to most likely be orthostatic hypotension with report of syncope after standing up. Thought to be most consistent with orthostasis due to lack of PO intake with improvement noted after resuming diet and IVF hydration. Prior episodes reported with admission during ___ for similar presentation. No events on tele. Consulted EP who interrogated ICD with no evidence of firing or events during reported events. No clear evidence of acute etiology for his syncope. # Abdominal Pain Chronic, had been evaluated in the past including at ___ with recommendation for GI follow-up. Unclear etiology. KUB negative. CT abd at ___ without acute process or clear cause. Prior reports improved after bowel regiment for constipation including while here on standin bowel regiment. Does have concerning features of weight loss but no GI bleed or melena. History was not as c/w for gastroparesis. Negative amylase/lipase for pancreatitis. LFTs unremarkable. Contributing is also recent opiod use that may be causing gut slowdown with recommendation to avoid using for abdominal pain. Continue follow-up closely with GI as scheduled recommended. CHRONIC ISSUES: ================ # CAD w/ ___ Reportedly had stents in ___. Had held Plavix/ASA for ___ given ___ per neurosurgery but resumed before dispo. # Paroxsmal Afib Was on ongoing coumadin therapy. Held given ___. Told by neurosurgery could resume ___ with PCP resuming and monitoring. TRANSITIONAL ISSUES: ===================== - F/u with GI for work-up of abdominal pain, nausea, and weight loss - Resume coumadin after ___ with close monitoring required - Ensure f/u with cardiology - Continue syncope evaluation - Ensure routine cancer screening by PCP given weight loss - Discuss with social work/case management to have service consideration for patient - Continued f/u with neurosurgery in 4 weeks with letter sent to pt as a reminder Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Carvedilol 3.125 mg PO BID 2. Lisinopril 2.5 mg PO HS 3. Simvastatin 20 mg PO QPM 4. Albuterol Inhaler 2 PUFF IH Q4H:PRN SOB, wheezing 5. MetFORMIN (Glucophage) 500 mg PO BID 6. ClonazePAM 1 mg PO TID 7. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID 8. Clopidogrel 75 mg PO DAILY 9. Nitroglycerin SL 0.3 mg SL PRN Chest Pain 10. Duloxetine 30 mg PO DAILY 11. TraZODone 25 mg PO HS:PRN Insomnia 12. Warfarin 5 mg PO DAILY16 13. Psyllium 1 PKT PO TID:PRN Constipation 14. Multivitamins 1 TAB PO DAILY 15. Ranexa (ranolazine) 500 mg oral BID 16. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN Pain 17. Aspirin 81 mg PO DAILY Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q4H:PRN SOB, wheezing 2. Carvedilol 3.125 mg PO BID 3. ClonazePAM 1 mg PO TID 4. Clopidogrel 75 mg PO DAILY 5. Duloxetine 30 mg PO DAILY 6. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID 7. Lisinopril 2.5 mg PO HS 8. Multivitamins 1 TAB PO DAILY 9. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN Pain 10. Simvastatin 20 mg PO QPM 11. TraZODone 25 mg PO HS:PRN Insomnia 12. Aspirin 81 mg PO DAILY 13. MetFORMIN (Glucophage) 500 mg PO BID 14. Nitroglycerin SL 0.3 mg SL PRN Chest Pain 15. Psyllium 1 PKT PO TID:PRN Constipation 16. Ranexa (ranolazine) 500 mg ORAL BID 17. Bisacodyl 10 mg PR HS:PRN Constipation RX *bisacodyl 10 mg 1 suppository(s) rectally Daily Disp #*30 Suppository Refills:*0 18. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth Twice a day Disp #*30 Capsule Refills:*0 19. Senna 8.6 mg PO BID RX *sennosides [senna] 8.6 mg 1 tablet by mouth Twice a day Disp #*30 Capsule Refills:*0 20. Simethicone 40-80 mg PO QID:PRN Bloating, abdominal pain RX *simethicone 80 mg 1 tablet by mouth Four times a day Disp #*30 Tablet Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Subdural Hematoma Constipation Weight loss Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to the hospital as you had evidence a small, but stable brain bleed known as a subdural hematoma. Our neurosurgeons followed you here and no further treatment was needed. Your blood thinning medications were stopped while you were here but the aspirin and plavix were restarted before you left since you have stents in your heart. Your coumadin (warfarin) was held but, per our neurosurgeons, can restart treatment on ___ after stopping for 10 days. You will need to follow-up with your primary care physician to help restart your warfarin and ensure proper monitoring. Your lightheadness with falls is likely due to not eating or drinking sufficiently. Your symptoms improved after giving you fluids. Cardiology assessed your pacemaker and no evidence of an abnormality in your heart rhythm. However, they continued to recommend that you follow-up with your cardiologist shortly after leaving the hospital. Given your weight loss related to loss of appetite, you will need to follow-up with gastroenterology (GI) who will be able to perform further testing as needed and help treat your symptoms. Please continue to take medications to help with your constipation. Please avoid using too many pain medications for your abdominal pain because it can slow your stomach down. Please continue to take your normal medications as prescribed. Take care. - Your ___ Team Followup Instructions: ___
10386699-DS-18
10,386,699
27,478,074
DS
18
2156-02-15 00:00:00
2156-02-16 11:44:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: worsening abdominal pain and nausea x1 week with known AAA Major Surgical or Invasive Procedure: ___ - EVAR History of Present Illness: ___ h/o known AAA, MI x3, a-fib, and T2DM p/w periumbilical pain radiating to back x10 days. He underwent abdominal CTA and carotid ultrasound 1 week ago at ___ due to periumbilical pain intermittently radiating to back with known 4.9cm AAA. These symptoms have persisted and he now reports nausea, dizziness, and diaphoresis with worsening pain. He arrived to ___ ED via EMS. Past Medical History: CAD, MI, ischemic cardiomyopathy, single chamber ICD, depression, DM2, HTN, dyslipidemia, COPD, stents x 4, constipation, pancreatitis, PAF, ___ and 9th rib fx, s/p cholecystectomy, bowel blockage with surgical exploration ___ yrs ago. Social History: ___ Family History: Non-contributory Physical Exam: Vitals: T98.0 58 146/88 16 99% Gen: uncomfortable HEENT: NCAT, MMM Cardio: RRR Pulm: CTAB ABD: soft, diffuse tenderness on light palpation, most TTP at periumbilical region, nondistended. No palpable masses noted. Back: mild L CVA tenderness Extremities: No ___ edema, WWP Pertinent Results: Pertinent Admission Labs: ___ 03:25PM BLOOD WBC-8.9 RBC-4.07* Hgb-11.9* Hct-37.1* MCV-91 MCH-29.2 MCHC-32.1 RDW-13.8 RDWSD-46.4* Plt ___ ___ 03:25PM BLOOD Neuts-56.2 ___ Monos-8.5 Eos-5.4 Baso-0.9 Im ___ AbsNeut-5.03 AbsLymp-2.54 AbsMono-0.76 AbsEos-0.48 AbsBaso-0.08 ___ 03:25PM BLOOD ___ PTT-38.2* ___ ___ 03:25PM BLOOD Glucose-87 UreaN-23* Creat-1.2 Na-141 K-4.4 Cl-99 HCO3-29 AnGap-13 ___ 05:20PM BLOOD CK-MB-1 cTropnT-0.03* proBNP-5617* ___ 03:25PM BLOOD Calcium-9.1 Phos-2.9 Mg-1.6 ___ 03:38PM BLOOD Lactate-1.9 Pertinent Discharge Labs: ___ 05:12AM BLOOD WBC-8.9 RBC-3.39* Hgb-9.9* Hct-30.6* MCV-90 MCH-29.2 MCHC-32.4 RDW-13.8 RDWSD-45.2 Plt ___ ___ 05:12AM BLOOD Plt ___ ___ 05:12AM BLOOD Glucose-108* UreaN-25* Creat-1.1 Na-138 K-4.9 Cl-98 HCO3-30 AnGap-10 ___ 09:21AM BLOOD CK(CPK)-39* ___ 05:12AM BLOOD Calcium-9.1 Phos-3.3 Mg-1.7 Imaging: CTA abdomen ___. Infrarenal abdominal aortic aneurysm measuring 4.9 cm maximally with irregular outpouchings posteriorly which may represent penetrating ulcers or ulcerated atherosclerotic plaque. No evidence of active rupture. 2. Linear hypodensity within the aneurysm makes a small focal dissection difficult to exclude of uncertain chronicity (series 2, image 52 through 54). 3. No priors currently available for direct comparison, which would be helpful. CXR ___ No acute cardiopulmonary abnormality. Brief Hospital Course: P: ___ w/ symptomatic AAA now s/p EVAR A: Underwent urgent uncomplicated EVAR ___ C: Metformin and Coumadin held for 48 hour ___ T: Patient to restart Coumadin and Metformin ___ in pm Discharge Medications: 1. Docusate Sodium 100 mg PO DAILY:PRN constipation RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth once a day Disp #*10 Capsule Refills:*0 2. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Moderate RX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours Disp #*18 Tablet Refills:*0 3. Senna 8.6 mg PO BID:PRN constipation RX *sennosides [senna] 8.6 mg 1 tab by mouth twice a day Disp #*10 Tablet Refills:*0 4. Albuterol Inhaler 2 PUFF IH Q6H:PRN shortness of breath 5. Aspirin 81 mg PO DAILY 6. Carvedilol 6.25 mg PO BID 7. Diazepam 5 mg PO Q12H:PRN anxiety 8. Digoxin 0.125 mg PO 3X/WEEK (___) 9. Escitalopram Oxalate 20 mg PO DAILY 10. MetFORMIN (Glucophage) 500 mg PO BID Restart ___ in the evening 11. Midodrine 10 mg PO BID 12. QUEtiapine Fumarate 200 mg PO QHS 13. Simvastatin 40 mg PO QPM 14. Tiotropium Bromide 1 CAP IH DAILY 15. Venlafaxine XR 75 mg PO DAILY 16. Warfarin 2 mg PO 3X/WEEK (___) Restart ___ at normal dose 17. Warfarin 4 mg PO 4X/WEEK (___) Restart ___ at normal dose Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Symptomatic AAA Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: MEDICATIONS: • Take Aspirin 81 mg (enteric coated) once daily and your home Coumadin starting ___ • Do not stop Aspirin unless your Vascular Surgeon instructs you to do so. •Continue all other medications you were taking before surgery, unless otherwise directed •You make take Tylenol or prescribed pain medications for any post procedure pain or discomfort WHAT TO EXPECT AT HOME: It is normal to have slight swelling of the legs: •Elevate your leg above the level of your heart (use ___ pillows or a recliner) every ___ hours throughout the day and at night •Avoid prolonged periods of standing or sitting without your legs elevated It is normal to feel tired and have a decreased appetite, your appetite will return with time •Drink plenty of fluids and eat small frequent meals •It is important to eat nutritious food options (high fiber, lean meats, vegetables/fruits, low fat, low cholesterol) to maintain your strength and assist in wound healing •To avoid constipation: eat a high fiber diet and use stool softener while taking pain medication ACTIVITIES: •When you go home, you may walk and go up and down stairs •You may shower (let the soapy water run over groin incision, rinse and pat dry) •Your incision may be left uncovered, unless you have small amounts of drainage from the wound, then place a dry dressing or band aid over the area that is draining, as needed •No heavy lifting, pushing or pulling (greater than 5 lbs) for 1 week (to allow groin puncture to heal) •After 1 week, you may resume sexual activity •After 1 week, gradually increase your activities and distance walked as you can tolerate •No driving until you are no longer taking pain medications CALL THE OFFICE FOR: ___ •Numbness, coldness or pain in lower extremities •Temperature greater than 101.5F for 24 hours •New or increased drainage from incision or white, yellow or green drainage from incisions •Bleeding from groin puncture site FOR SUDDEN, SEVERE BLEEDING OR SWELLING (Groin puncture site or incision) •Lie down, keep leg straight and have someone apply firm pressure to area for 10 minutes. If bleeding stops, call vascular office. If bleeding does not stop, call ___ for transfer to closest Emergency Room. Followup Instructions: ___
10386866-DS-3
10,386,866
28,641,140
DS
3
2113-11-14 00:00:00
2113-11-14 10:53:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: ___: Laparoscopic appendectomy History of Present Illness: The patient is a ___ female who presented to the emergency department with signs and symptoms of acute appendicitis. Her complete workup, including history, physical examination, laboratory studies, and CT scan, led to a high clinical and radiographic suspicion for acute appendicitis. After extensive discussion with the patient and her family regarding the risks, benefits, alternatives, and complications of such a procedure, informed consent was signed for appendectomy, and she was scheduled for the operating room. Pending OR availability, she was transferred to the operating room. Past Medical History: None Social History: ___ Family History: Non contributory Physical Exam: On Admission: VS - T 97.0, HR 70, BP 115/72, RR 15, SaO2 100% RA Gen: NAD, non-toxic CV: RRR Pulm: no respiratory distress, clear bilaterally Abd: soft, non-distended, no scars. Tender in RLQ with guarding and rebound. +Rovsing's sign. Ext: wwp, no edema, palpable distal pulses Prior to discharge: VS: 98.5, 94, 104/58, 18, 98% RA GEN: NAD, pleasant CV: RRR, no m/r/g PULM: CTAB ABD: Laparoscopic incisions with occlusive dressing and c/d/i. EXTR: Warm no c/c/e. +pp Pertinent Results: ___ 06:28AM BLOOD WBC-17.2* RBC-2.57* Hgb-7.8* Hct-23.5* MCV-91 MCH-30.4 MCHC-33.2 RDW-12.1 RDWSD-40.0 Plt ___ ___ 06:28AM BLOOD Glucose-96 UreaN-14 Creat-0.7 Na-141 K-3.7 Cl-105 HCO3-23 AnGap-17 ___ 06:28AM BLOOD ALT-22 AST-24 AlkPhos-69 TotBili-0.3 ___ 06:28AM BLOOD Albumin-4.8 ___ 05:55AM URINE Color-Yellow Appear-Hazy Sp ___ ___ 05:55AM URINE Blood-NEG Nitrite-NEG Protein-TR Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.5 Leuks-NEG ___ 05:55AM URINE RBC-3* WBC-1 Bacteri-FEW Yeast-NONE Epi-<1 ___ 05:55AM URINE Mucous-RARE ___ CT ABD: IMPRESSION: Acute appendicitis. No evidence of periappendiceal fluid collection or rupture. Brief Hospital Course: The patient was admitted to the General Surgical Service on ___ for evaluation and treatment of abdominal pain. Admission abdominal/pelvic CT revealed acute appendicitis, WBC was elevated at 17.2. The patient underwent laparoscopic appendectomy, which went well without complication (reader referred to the Operative Note for details). After a brief, uneventful stay in the PACU, the patient arrived on the floor tolerating clears, on IV fluids, and IV Morphine for pain control. The patient was hemodynamically stable. When tolerating a diet, the patient was converted to oral pain medication with continued good effect. Diet was progressively advanced as tolerated to a regular diet with good tolerability. The patient voided without problem. During this hospitalization, the patient ambulated early and frequently, was adherent with respiratory toilet and incentive spirrometry, and actively participated in the plan of care. The patient received subcutaneous heparin and venodyne boots were used during this stay. At the time of discharge on POD 1, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The patient was discharged home without services. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Medications on Admission: None Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H do not exceed more then 3000 mg/day 2. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 3. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*40 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Acute appendicitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the surgery service at ___ for evaluation of abdominal pain. You were found to have acute appendicitis and underwent laparoscopic appendectomy. You have done well in the post operative period and are now safe to return home to complete your recovery with the following instructions: . Please resume all regular home medications , unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon, who will instruct you further regarding activity restrictions. Avoid driving or operating heavy machinery while taking pain medications. Please follow-up with your surgeon and Primary Care Provider (PCP) as advised. Incision Care: *Please call your doctor or nurse practitioner if you have increased pain, swelling, redness, or drainage from the incision site. *Avoid swimming and baths until your follow-up appointment. *You may shower, and wash surgical incisions with a mild soap and warm water. Gently pat the area dry. *If you have steri-strips, they will fall off on their own. Please remove any remaining strips ___ days after surgery. Followup Instructions: ___
10386925-DS-30
10,386,925
21,189,064
DS
30
2134-06-26 00:00:00
2134-06-27 13:18:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Cipro Attending: ___. Chief Complaint: nausea and 3 episodes of bloody diarrhea Major Surgical or Invasive Procedure: endoscopy/colonoscopy ___ History of Present Illness: ___ female with history of cholangiocarcinoma s/p hepatic lobe resection, commob bile duct excision, hepaticojejunostomy with Roux-en-Y, multiple admissions for biliary sepsis w/ placement of biliary drainage tubes, and recurrent C.diff, became nauseated last evening around 8:30 pm after eating custard and had some diarrhea. She woke this morning and had 3 episodes of diarrhea with significant amount of blood (colored the water "cherry red") since 6 am. Pt has hx of chronic C.Diff and reports vanco stopped about 1.5 weeks ago per pt (last ___ per prio notes). In the ED, initial vital signs were 98.8 96 105/62 15 100% RA. Patient was noted to have periumbilical tenderness to palpation, a large reducible hernia. She was also noted to have black stools, and had an episode of dizziness. Her Hct went from 32 (on ___ to 26 (today), thus pt was transfused 1 u pRBCs in setting of symptomatic anemia and black stools. Transplant surgery was consulted who evaluated the patient and felt that she had no acute surgical issue at this time. C. diff cultures were sent, BCx were sent. On the floor, VS were 98.1 124/71 74 rr 16 100RA WT 52.2kg. She is in no acute distress. C/o intermittent RLQ pain, but is no pain currently. Review of Systems: (+) chills, nausea, diarrhea, blood in toilet, dark stools with blood (-) fever, sore throat, cough, shortness of breath, chest pain, abdominal pain, constipation, dysuria, foul smelling urine. Past Medical History: -Presumed cholangiocarcinoma (partially resected with HA encasement) -Endometrial cancer s/p XRT -HTN -HLD -Hypothyroidism -Recurrent UTIs -Right anterior portal vein thrombosis seen on CT ___ -Enterococcal bacteremia (___) -Clostridium Difficile (___) PSH: - ___ s/p removal of percutaneous biliary drains, drains were placed in ___ via Roux limb for occluded biliary stents -A common bile duct excision, left lateral segmentectomy and Roux-en-Y hepaticojejunostomy on ___, for what was presumed to be a cholangiocarcinoma (no tissue dx) -multiple biliary stents placed PTC's with R post duct drain & RBD stent -FNA right duct (___) -lap cholecystectomy -Hysterectomy -___ ERCP/stent removal x1 -___ PTC with 2 ___ PTBD's in right ant system -Pullback cholangiogram/removal of external PTBDs (___) -Exchange of internal/external ___ BD (___) Social History: ___ Family History: Mother died of ovarian cancer at age ___, Father, hx HTN and DM, died of stroke at age ___ Physical Exam: ADMIT PE: Vitals- 98.1 124/71 74 rr 16 100RA WT 52.2kg General- Alert, oriented, no acute distress HEENT- Sclera anicteric, MM dry, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- Clear to auscultation bilaterally decreased BS right side, no wheezes, rales, ronchi CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- soft, reducible epigastric hernia tender to deep palp, tender in RLQ, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- CNs2-12 intact, motor function grossly normal Rectal exam: no stool in rectal vault, guaiac negative DISCHARGE PE: Vitals- Tm 98.2 ___ ___ 18 96-97%RA General- Alert, oriented, no acute distress HEENT- Sclera anicteric, MM dry, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- Clear to auscultation bilaterally, no wheezes, rales, ronchi CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- soft, reducible epigastric hernia tender to deep palp, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- CNs2-12 intact, motor function grossly normal Pertinent Results: ADMIT LABS: ___ 12:20PM BLOOD WBC-6.9 RBC-2.85* Hgb-8.3* Hct-26.5* MCV-93 MCH-29.2 MCHC-31.4 RDW-16.0* Plt ___ ___ 12:20PM BLOOD Neuts-77.0* ___ Monos-3.9 Eos-0.3 Baso-0.3 ___ 12:48PM BLOOD ___ PTT-30.5 ___ ___ 12:20PM BLOOD Plt ___ ___ 12:20PM BLOOD Glucose-99 UreaN-27* Creat-0.8 Na-140 K-3.9 Cl-106 HCO3-26 AnGap-12 ___ 12:20PM BLOOD ALT-16 AST-26 AlkPhos-147* TotBili-0.4 ___ 12:20PM BLOOD Lipase-26 ___ 12:20PM BLOOD Albumin-3.4* ___ 12:33PM BLOOD Lactate-1.6 DISCHARGE LABS: ___ 06:10AM BLOOD WBC-4.5 RBC-3.28* Hgb-9.6* Hct-29.2* MCV-89 MCH-29.4 MCHC-33.0 RDW-16.5* Plt ___ ___ 06:10AM BLOOD Glucose-89 UreaN-17 Creat-0.7 Na-138 K-3.8 Cl-106 HCO3-27 AnGap-9 ___ 06:10AM BLOOD LD(LDH)-144 AlkPhos-192* ___ 06:10AM BLOOD Calcium-8.1* Phos-3.4 Mg-1.9 MICRO: Time Taken Not Noted Log-In Date/Time: ___ 12:57 pm STOOL CONSISTENCY: NOT APPLICABLE Source: Stool. **FINAL REPORT ___ C. difficile DNA amplification assay (Final ___: Negative for toxigenic C. difficile by the Illumigene DNA amplification assay. (Reference Range-Negative). STUDIES: Colonoscopy ___: Internal hemorrhoids, Polyp in the sigmoid colon Otherwise normal colonoscopy to cecum . Endoscopy ___: Follow up biopsies; will ultimately need EUS for submucosal mass, -Given unclear etiology of stricture and history of presumed cholangiocarcinoma, would procede with further imaging of this area including SBFT and MRCP ___ gastric biopsy: pending . MRCP ___: Pending Brief Hospital Course: ___ with ___ recent C diff having completed PO vanc ~ 1 wk prior to presentation, presumed cholangiocarcinoma s/p common bile duct excision, left lateral segmentectomy and Roux-en-Y hepaticojejunostomy (___) presents with acute nausea, bloody diarrhea, and black stools in the ED blood transfusion, symptoms now resolved. . # Anemia: Patient presented to hospital with bright red blood in the toilet and a hct decrease from ___ to from 32 to 26 on presentation. Per report, patient may have had black stools in the ED, however, pt denied any ETOH or NSAID consumption. She received a total of 2 units PRBCs during her hospital stay. She had no BRBPR while in the hospital. High dose PPI was started initially and discontinued upon dicharge. On colonoscopy, patient was found to have hemorrhoids and single polyp, likely cause of bleeding thought to be from hemorrhoids. On endoscopy, she was noted to have gastric mass which was biopsied and duodenal stricture through which the scope was unable to pass. MRCP was done to better evaluate this area, and in the setting of mild elevation of alk phos, though chronic, there is concern for recurrence of malignancy. Final read is pending upon discharge. She will follow up with GI for biopsy results and MRCP final, plans for future workup. . # Nausea/diarrhea: Patient presented with an episode of nausea and diarrhea after eating custard and recently completing course of antibiotics for C. diff. C. diff assay was negative and symptoms resolved without further intervention. . CHRONIC ISSUES: # Elevated alk phos: Patient has had elevated alkaline phosphatases since ___ when she was diagnosed with presumed cholangiocarcinoma. Alk phos levels were relatively low during this hospitalization. . # Hypothyroidism: Patient continued on home regimen. - Levothyroxine Sodium 100 mcg PO 5X/WEEK (___) - Levothyroxine Sodium 50 mcg PO 2X/WEEK (___) . # Gallstones / occlusions of bile ducts: Patient continued home regimen - cont ursodiol 300 mg PO TID per home . TRANSITION ISSUES: # Code: Full (discussed with patient) # Communication: Patient and daughter ___ (daughter) ___ cell ___ (home) # Follow up with GI, biopsies pending # Follow up with Oncology # Follow up with Transplant surgery Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Levothyroxine Sodium 100 mcg PO MTUWETHFRI 2. Levothyroxine Sodium 50 mcg PO SASUN 3. Ursodiol 300 mg PO TID 4. Acetaminophen Dose is Unknown PO Frequency is Unknown 5. OxycoDONE (Immediate Release) 2.5 mg PO Q4H:PRN pain hold for sedation adn rr<10 Discharge Medications: 1. Levothyroxine Sodium 100 mcg PO MTUWETHFRI 2. Levothyroxine Sodium 50 mcg PO SASUN 3. OxycoDONE (Immediate Release) 2.5 mg PO Q4H:PRN pain hold for sedation adn rr<10 4. Ursodiol 300 mg PO TID 5. Acetaminophen 325 mg PO Q6H:PRN pain Discharge Disposition: Home Discharge Diagnosis: duodenal stricture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms ___, It was a pleasure taking care of you at ___. You were admitted because of your nausea and bloody stools. Your hematocrit was found to be low and you were given two units of blood. You had a colonoscopy that showed hemorrhoids. You also had an endoscopy that showed a narrowing of the first part of your small intestine, and you had an MRCP done to better evaluate this finding. You were also found to have a mass in your stomach, and a biopsy was taken. It is very important for your health that you follow up with your outpatient providers. Please see the attached sheet for your updated medication list. Followup Instructions: ___
10386925-DS-32
10,386,925
28,592,400
DS
32
2134-10-10 00:00:00
2134-10-13 18:08:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Cipro / Oxycodone Attending: ___. Chief Complaint: Abdominal Pain Major Surgical or Invasive Procedure: Fluid collection I and D ___ EGD ___ Picc placement and removal History of Present Illness: ___ hx of unresectable cholangiocarcinoma s/p incisional hernia repair (___) c/b C.diff colitis on PO Vancomycin presents with abdominal pain. Patient reports intermittent pain in her upper abdomen, and right side of her back for months. It last varying lengths of duration. She developed the same pain today that resolved prior to arriving in the ER. She denies N/V, fever/chills, diarrhea, melena/hematochezia. She is passing flatus with soft stools. She is able to tolerate POs but her appetite has been decreasing the last few weeks. Reguarding her post-operative course she was seen in clinic for follow up and was noted to have some incisional erythema and was started on Zyvox for which she just completed 4 days ago. In addition there was a soft tissue mass noted in the right flank where her prior PTBD was located, concerning for tumor seeding. A CT A/P was obtained on ___ which demonstrated increased ascites as well as omental enhancement concerning for carcinomatosis. A small fluid collection was noted in the subcutaneous tissue under the incision and a mass/phlegmon was noted in the right flank. Aspiration was attempted of this area on ___ without results. ROS: + per HPI. - fever/chills, CP, SOB, N/V, diarrhea, melena, hematochezia, jaundice, night sweats. Past Medical History: -Presumed cholangiocarcinoma (partially resected with HA encasement) -Endometrial cancer s/p XRT -HTN -HLD -Hypothyroidism -Recurrent UTIs -Right anterior portal vein thrombosis seen on CT ___ -Enterococcal bacteremia (___) -Clostridium Difficile (___) PSH: - ___ s/p removal of percutaneous biliary drains, drains were placed in ___ via Roux limb for occluded biliary stents -A common bile duct excision, left lateral segmentectomy and Roux-en-Y hepaticojejunostomy on ___, for what was presumed to be a cholangiocarcinoma (no tissue dx) -multiple biliary stents placed PTC's with R post duct drain & RBD stent -FNA right duct (___) -lap cholecystectomy -Hysterectomy -___ ERCP/stent removal x1 -___ PTC with 2 ___ PTBD's in right ant system -Pullback cholangiogram/removal of external PTBDs (___) -Exchange of internal/external ___ BD (___) Social History: ___ Family History: Mother died of ovarian cancer at age ___, Father, hx HTN and DM, died of stroke at age ___ Physical Exam: On Admission: 99.2 92 ___ 96% RA Gen: A&O, NAD CV: RRR, no M/R/G Pulm: CTAB Abd: soft, mild distension. Mild TTP periumbilical. RUQ incision healed without hernia. There is minimal erythema over the medial portion. There is a non-tender mass in the right flank area where prior PTBD was with overlyng erythema. This is non-tender. Ext: w/d, 3+ lower extremity edema DRE: no stool in vault, gauaic + . On Discharge: VS: 98.1/98.1, 100/60-114/70, 88-101, 20, 93-96% RA Gen: no acute distress, lying in bed HEENT: no scleral icterus, EOMI, PERRL, MMM Pulm: crackles left mid lung field and decreased breath sounds right base Card: regular rhythm, borderline tachy, nml S1S2, no r/m/g Abd: distended, non-tender, drain in place over R flank lesion, mild erythema of epigastric region, +BS Ext: 1+ pitting edema B/L thighs and L UE Neuro: non focal Pertinent Results: On Admission: ___ WBC-4.2 RBC-2.81* Hgb-8.2* Hct-24.3* MCV-86# MCH-29.1 MCHC-33.7 RDW-16.1* Plt Ct-35*# ___ PTT-29.1 ___ Glucose-107* UreaN-27* Creat-0.9 Na-131* K-3.9 Cl-97 HCO3-27 AnGap-11 ALT-14 AST-25 AlkPhos-100 TotBili-0.4 Lipase-14 Albumin-2.3* Calcium-7.5* Phos-2.1* Mg-1.9 Lactate-1.7 . CT Scan ___ IMPRESSION: 1. No appreciable change compared to CT from ___ in burden of cholangiocarcinoma along the hepatic hilum with worsening ascites, but similar peritoneal enhancement, omental stranding, and a few nodes or nodules in the right upper quadrant. While there is concern for peritoneal involvement by tumor, this is not definitive and as the nodules have not clearly increased, this could certainly be secondary the prior infections and liver disease with portal vein compression. 2. Interval increase in size of tiny fluid and gas collection in the abdominal wall of the right flank with a more conspicuous skin sinus track suggests progression of infection. As previously mentioned, tumor infiltration would be unlikely but cannot be completely excluded. . ___ CT torso with con: 1. Slightly increasing biliary dilatation as compared to the prior studies. 2. Known cholangiocarcinoma along the hepatic hilum with worsening ascites and suggestion of erosion into the duodenum as described above. Peritoneal nodules as well as portal vein compression are stable. 3. Right lower lobe collapse. Small-to-moderate right-sided pleural effusion and trace left pleural effusion. ___ ___: IMPRESSION: No DVT in either lower extremities. ECHO ___: The left atrium is normal in size. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF >55%). Right ventricular chamber size and free wall motion are normal. The aortic root is mildly dilated at the sinus level. The ascending aorta is mildly dilated. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. Mild (1+) aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Trivial mitral regurgitation is seen. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. IMPRESSION: Normal global and regional biventricular systolic function. Mild aortic regurgitation. Mild to moderate tricuspid regurgitation. Bilateral pleural effusions and ascites, not further characterized on this cardiac study. U/S L UE Veins ___: Non-occlusive thrombus surrounding the PICC in the right axillary and subclavian veins. MICRO: ___ CULTUREBlood Culture, Routine-PENDINGINPATIENT ___ CULTUREBlood Culture, Routine-PENDINGINPATIENT ___ CULTURE-FINALINPATIENT -- no growth ___ SCREENMRSA SCREEN-FINALINPATIENT -- none isolated ___ FLUIDGRAM STAIN-FINAL; FLUID CULTURE-FINAL; ANAEROBIC CULTURE-FINALINPATIENT -- no growth ___ STAIN-FINAL; WOUND CULTURE-FINAL {PSEUDOMONAS AERUGINOSA}; WOUND CULTURE (Final ___: This culture contains mixed bacterial types (>=3) so an abbreviated workup is performed. Any growth of P.aeruginosa, S.aureus and beta hemolytic streptococci will be reported. IF THESE BACTERIA ARE NOT REPORTED BELOW, THEY ARE NOT PRESENT in this culture.. PSEUDOMONAS AERUGINOSA. SPARSE GROWTH. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ PSEUDOMONAS AERUGINOSA | CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S ANAEROBIC CULTURE-FINAL -- no growthINPATIENT ___ STAIN-FINAL; WOUND CULTURE-FINAL {PSEUDOMONAS AERUGINOSA}; ANAEROBIC CULTURE-FINALINPATIENT ___. difficile DNA amplification assay-FINAL -- no growthINPATIENT -- none isolated ___ VANCOMYCIN RESISTANT ENTEROCOCCUS-FINALINPATIENT -- no growth ___ CULTUREBlood Culture, Routine-FINALEMERGENCY WARD -- no growth ___ CULTUREBlood Culture, Routine-FINALEMERGENCY WARD -- no growth . Labs During Hospitalization and on Discharge: ___ 05:46AM BLOOD WBC-7.3 RBC-2.75* Hgb-8.3* Hct-24.8* MCV-90 MCH-30.0 MCHC-33.3 RDW-17.1* Plt ___ ___ 07:22AM BLOOD ___ ___ 07:55AM BLOOD Ret Aut-0.7* ___ 05:46AM BLOOD Glucose-94 UreaN-11 Creat-0.5 Na-133 K-3.8 Cl-106 HCO3-23 AnGap-8 ___ 03:50PM BLOOD ALT-39 AST-80* AlkPhos-203* TotBili-0.9 ___ 05:46AM BLOOD ALT-30 AST-30 LD(LDH)-263* AlkPhos-109* TotBili-0.3 ___ 07:38AM BLOOD proBNP-561* ___ 03:50PM BLOOD CK-MB-2 cTropnT-<0.01 ___ 11:41PM BLOOD CK-MB-1 cTropnT-<0.01 ___ 06:08AM BLOOD CK-MB-2 cTropnT-<0.01 ___ 11:28AM BLOOD CK-MB-2 cTropnT-<0.01 ___ 07:40PM BLOOD Albumin-2.5* ___ 06:22AM BLOOD Albumin-2.3* Calcium-7.5* Phos-2.1* Mg-1.9 Iron-31 ___ 05:46AM BLOOD Albumin-1.9* Calcium-6.5* Phos-1.8* Mg-1.9 ___ 06:22AM BLOOD calTIBC-176* VitB12-427 Folate-11.8 Ferritn-157* TRF-135* ___ 06:55AM BLOOD Hapto-202* ___ 05:46AM BLOOD 25VitD-PND ___ 07:55AM BLOOD CEA-2.8 AFP-4.8 ___ 06:34PM BLOOD Lactate-2.2* ___ 02:40PM BLOOD Lactate-1.1 ___ 07:55AM BLOOD CA ___ -Test ___ 12:18PM URINE Color-Red Appear-Clear Sp ___ ___ 12:18PM URINE Blood-NEG Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG ___ 12:18PM URINE RBC-3* WBC-1 Bacteri-NONE Yeast-NONE Epi-0 TransE-<1 ___ 12:18PM URINE CastHy-2* ___ 12:18PM URINE Mucous-OCC Brief Hospital Course: ___ y/o female with extensive medical and recent surgical history who presents with abdominal pain. On admission the patient underwent CT of the abdomen and pelvis. There are several notable findings, including a right flank wound (CT reports area of abnormal enhancement in the right flank along the oblique muscles previously described as a phlegmon; now shows interval increase in size of central fluid and gas collection measuring up to 1.6 cm of longest axis diameter with associated probable fistulous tract communicating with the skin -- more likely to be superinfected metastasis than pure phlegmon). The wound drained, and patient was treated with antibiotics. She was initially on a surgical service, but was transferred to oncology service. Hospitalization complicated by hematemesis and hypotension requiring brief MICU stay. #. Right flank purulent mass: Pt had rupture of right flank collection revealing purulence with CT scan demonstrating fistulous tract from abdominal wall communicating with the skin. Although initial culture after rupture was negative, repeat aspiration overnight revealed Pseudomonas. Based on imaging, it appears that the mass may be a tumor focus, superinfected, as opposed to an abscess/phlegmon. ID recommended cefepime and Flagyl, which will be continued until patient sees outpatient ID physician ___ in follow up. #. Cholangiocarcinoma with possible peritoneal carcinomatosis: Not a surgical candidate. Therapeutic and diagnostic paracentesis (for cytology) done on ___, but without definitive evidence of cancer in the peritoneum. Normal CEA and AFP and CA ___. Treatment in future depending on staging and resolution of acute infection. She will have medical oncology and radiation oncology outpatient follow up. # Hypotension: Patient became hypotensive in AM of ___ to SBP in ___. Transferred to MICU. Responded well to 4L of IVF. Resolved. Unclear event as precipitant but likely some form of inflammatory response evident given WBC count elevation vs. bleeding alone. Could have been related to inflammatory response from tumor invasion and bleed versus transient biliary obstruction. No clear infectious source found outside of flank mass, which was already being treated. Volume depletion or HCT drop alone could explain hypotension, but pt may have had transient biliary obstruction (alk phos elevation, relative ___ elevation) which then resolved. # GI bleed: Patient had hematemesis with hypovolemia. EGD shows esophagitis and gastritis. Unclear if this is fully responsible for the GI bleed, but given small volume hematemesis, this is most likely cause, as opposed to duodenal tumor which was not visualized and thus would be unlikely to cause hematemesis. GI did not find much on EGD that would suggest tumor eroding into dudeonum. Per GI, radiology reviewed films, and no clear evidence of tumor communicating into duodenum. If pt were to continue to have unexplained melena, then tumor into duodenum would seem more likely. High-dose PPI and Carafate were prescribed. No further GI bleeding after the EDG. # Mixed cholestatic and hepatocellular transaminitis: Transient obstruction seems likely given interval biliary dilation seen on CT, combined with elevated alk phos and ___ + hepatocellular picture. This may have played a role in the transient SIRS response requiring ICU transfer. #. C diff: PCR here was negative. Pt however gets recurrent C diff with abx. Thus, she is being prophylaxed while on cefepime with oral vanco 125 mg Q8h # Worsening ascites: Likely from peritoneal carcinomatosis. Pt was tapped ___. Then restarted on PO Lasix. # Edema: Pt with anasarca. Likely from low albumin, >4L repletion in ICU. ECHO nml. # Right lung opacification: RLL collapse on CT on ___. Not short of breath. No urgent need for bronch. Unclear etiology: ? mucous plug versus pleural effusion but effusion only small to moderate. Per ICU, nothing clear to tap. Aggressive physical and respiratory therapy. # Rising INR: Most likely from poor nutrition. PO vitamin K 5 mg x 3 days was planned, but this was stopped ___ after only 1 dose due to LUE line-associated DVT as below. # PICC-associated UE DVT: Patient had LUE swelling and, based on UE venous US, an UE DVT. We cannot anticoagulate given bleed, so removed PICC and placed another on the right side. # Prophylaxis: Boots. Would hold off on heparin given continued evidence of low grade GI bleed. # Hypothyroid: stable. Continued home levothyroxine. # Goals of care: This was readdressed. If pt were to clinically decompensate, unlikely to do well given host of comorbidities and recurrent illnesses. However, pt does want to be full code. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Furosemide 20 mg PO DAILY 2. Levothyroxine Sodium 125 mcg PO DAILY 3. Prochlorperazine 2.5-5 mg PO Q6H:PRN nausea 4. Ursodiol 300 mg PO TID 5. Acetaminophen 650 mg PO Q8H:PRN pain 6. Vancomycin Oral Liquid ___ mg PO BID 7. Famotidine 20 mg PO DAILY Discharge Medications: 1. Sucralfate 1 gm PO BID RX *sucralfate 1 gram/10 mL 1 Suspension(s) by mouth twice a day Disp #*14 Gram Refills:*0 2. CefePIME 2 g IV Q24H RX *cefepime [Maxipime] 2 gram 2 grams IV Q24H Disp #*14 Unit Refills:*0 3. Vancomycin Oral Liquid ___ mg PO Q8H RX *vancomycin 125 mg 125 mg by mouth every eight (8) hours Disp #*90 Unit Refills:*0 4. Acetaminophen 650 mg PO Q8H:PRN pain 5. Furosemide 20 mg PO DAILY 6. Levothyroxine Sodium 125 mcg PO DAILY 7. Prochlorperazine 2.5-5 mg PO Q6H:PRN nausea 8. Ursodiol 300 mg PO TID 9. Calcium Carbonate 1000 mg PO TID W/MEALS Do not take within 2 hours of taking levothyroxine RX *calcium carbonate 400 mg (1,000 mg) 2 tablet, chewable(s) by mouth three times a day Disp #*180 Tablet Refills:*0 10. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H RX *metronidazole 500 mg 1 tablet(s) by mouth every eight (8) hours Disp #*42 Tablet Refills:*0 11. Omeprazole 40 mg PO BID RX *omeprazole 40 mg 1 capsule,delayed ___ by mouth twice a day Disp #*60 Capsule Refills:*0 12. Potassium Chloride 20 mEq PO DAILY RX *potassium chloride 10 mEq 2 capsules by mouth daily Disp #*60 Capsule Refills:*0 13. Vitamin D 800 UNIT PO DAILY RX *ergocalciferol (vitamin D2) 400 unit 2 tablet(s) by mouth daily Disp #*60 Capsule Refills:*0 14. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain Hold for sedation RX *tramadol 50 mg 1 tablet(s) by mouth every six (6) hours Disp #*20 Tablet Refills:*0 15. Outpatient Lab Work Diagnosis: Skin/Soft tissue infection on cefepime - weekly BMP,ALT,AST,CBC w/diff start ___ till cefepime completion. Please fax to: Dr. ___ and ___: Fax: ___ Discharge Disposition: Home with Service Facility: ___ Discharge Diagnosis: Primary: Superinfected abdominal fluid collection, GI bleed, Left upper extremity DVT (Axillary and subclavian) Secondary: Cholangiocarcinoma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you at ___. You were admitted for abdominal pain. A fluid collection was found which tracked to your skin. This grew out a bacteria called Pseudomonas. You are being treated for this with IV and oral antibiotics. The fluid collection has improved. You had an episode of low blood pressure and GI bleeding which led to a stay in the ICU for a few days. An endoscopy showed some inflammation in your esophagus and stomach and a small tear but no active bleeding. A PICC was placed in your left arm for the antibiotics, but this caused a clot. Thus, this PICC was removed, and one was placed on the right side. You should have labs on ___ and then weekly to ensure stability of your hematocrit and your renal and liver function. Please see attached for an updated medication list. Followup Instructions: ___
10386925-DS-33
10,386,925
20,632,501
DS
33
2134-11-15 00:00:00
2134-11-15 14:09:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Cipro / Oxycodone Attending: ___. Chief Complaint: fever Major Surgical or Invasive Procedure: none History of Present Illness: Ms. ___ is a ___ year old woman with a history of metastatic cholangiocarcinoma s/p stenting who presented to the ER with a temp of 101.5 at home. 6 days ago she switched antibiotics from cefepime to doxycyline for her abdominal wall infection. She has had progressive redness over her abdomen since this time. She reports temperatures which started 2 days ago and were as high as 101. She took tylenol for this but when they persisted today she came into the ER. She has occasional chills. She denies other symptoms of cough, shortness of breath, urinary symptoms, diarrhea or abdominal pain. She has leg swelling which is improved since being on lasix. She takes 20 mg daily because she feels that 40 mg is too much. In the emergency department, initial vitals: 98.2 113 97/59 16 94%. Blood and urine cultures were obtained. She had a CXR which was showed interval resolution of previously noted small left pleural effusion, and interval decrease in size of small right pleural effusion. Bibasilar atelectasis. She was given vanc/cefepime. Transplant surgery was contacted and did not feel intervention was warrented for her fever and rising alk phos. Review of systems: (+) Per HPI (-) Denies night sweats, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denied cough, shortness of breath. Denied chest pain or tightness, palpitations. Denied nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denied arthralgias or myalgias. Past Medical History: PAST ONCOLOGIC HISTORY: - ___: initially presented with jaundice. Imaging showed a moderate intrahepatic ductal dilatation without evidence of hepatic or pancreatic mass. - ___: ERCP with stent placement. Brushings were negative twice. - ___: surgical resection showed encasement of the right hepatic artery by presumed malignancy and a full resection was not completed. Final pathology, however, demonstrated low-grade dysplasia and findings worrisome for sclerosing cholangitis, but no malignancy. She was hospitalized multiple times for biliary strictures, abscesses, and bacteremia. - ___ she underwent EUS with biopsy of a porta hepatis mass. This was positive for malignant cells and consistent with adenocarcinoma. - ___ initially for incisional hernia repair. Her hospitalization was complicated by lactobacillus bacteremia, Clostridium difficile infection, and a wound infection. - ___ hospitalized with abdominal pain, wound infection/fistula, complicated by hematemesis and hypotension. OTHER PAST MEDICAL HISTORY: Biliary obstruction, as above: cholangiocarcinoma vs. sclerosing cholangitis - Stage IC endometrial cancer dx ___ incidentally during vaginal hysterectomy for uterine prolapse (in retrospect, mild vaginal bleeding). Postoperative radiation recommended because ovaries and tubes were grossly normal at surgery but were not assessed pathologically. In addition, no LN assessment. XRT ___ to ___: 45 Gy in 5 fractions to entire pelvis using the four-field technique with ___ MV photons. Vaginal apex received an additional 9 Gy and 5 fractions via opposed fields, also with ___ MV photons. Multiple emergency room presentations after radiation for nausea and vomiting consistent with partial SBO. All these treated conservatively - Hypertension. - Hyperlipidemia. - Hypothyroidism. - Hx recurrent UTIs - remote D&C, apparently benign - Breast biopsy in ___ for atypical lobular hyperplasia. Social History: ___ Family History: Mother: Died of ovarian cancer at age ___. Father: History of hypertension and diabetes. Died of stroke at age ___. Physical Exam: VS: T98.6 BP 120/64 HR 106 RR 20 94% RA GENERAL: alert and oriented, NAD HEENT: No scleral icterus. PERRLA/EOMI. MMM. OP clear. Neck Supple, No LAD. CARDIAC: RR. Normal S1, S2. No m/r/g. LUNGS: CTA B, good air movement bilaterally. ABDOMEN: NABS. Soft, mildly distended. Incision is clean and well-healed. There is a 5 cm area of surrounding erythema around surgical site. No induration or evidence of deep infection. EXTREMITIES: 2+ peripheral edema to the knees bilaterally. 2+ dorsalis pedis/ posterior tibial pulses. NEURO: A&Ox3. Appropriate. CN ___ grossly intact. Preserved sensation throughout. ___ strength throughout. . DISCHARGE EXAM: PHYSICAL EXAM VS: Tm 100.6 Tc97.9 bp 127/59 HR 82 RR 18 SaO2 96 RA GENERAL: alert and oriented, slightly anxious HEENT: No scleral icterus. Neck Supple, No LAD. CARDIAC: RR. Normal S1, S2. No m/r/g. LUNGS: CTAB, good air movement bilaterally. ABDOMEN: NABS. Soft, distended. Incision is clean and well-healed. There is a 5 cm area of surrounding erythema around surgical site. No significant change EXTREMITIES: peripheral edema to the knees bilaterally. normal perfusion NEURO: A&Ox3. Appropriate. CN ___ grossly intact. Preserved sensation throughout. ___ strength throughout. . Pertinent Results: ___ 07:45PM BLOOD WBC-11.0# RBC-2.88* Hgb-9.0* Hct-26.8* MCV-93 MCH-31.3 MCHC-33.8 RDW-18.8* Plt ___ ___ 07:45PM BLOOD Neuts-88.4* Lymphs-6.1* Monos-4.2 Eos-1.1 Baso-0.2 ___ 07:45PM BLOOD Glucose-115* UreaN-18 Creat-0.8 Na-129* K-5.0 Cl-94* HCO3-25 AnGap-15 ___ 07:45PM BLOOD ___ PTT-33.4 ___ ___ 07:45PM BLOOD ALT-25 AST-76* AlkPhos-278* TotBili-0.7 ___ 07:45PM BLOOD Albumin-2.4* Calcium-7.7* Phos-3.3 Mg-1.7 . CXR: IMPRESSION: Interval resolution of previously noted small left pleural effusion, and interval decrease in size of small right pleural effusion. Bibasilar atelectasis. . ___ 06:20AM BLOOD Neuts-87.4* Lymphs-6.4* Monos-5.6 Eos-0.4 Baso-0.2 ___ 12:10AM BLOOD Neuts-87.2* Lymphs-6.1* Monos-6.1 Eos-0.5 Baso-0.1 ___ 06:25AM BLOOD WBC-12.4* RBC-2.56* Hgb-8.2* Hct-23.9* MCV-93 MCH-31.9 MCHC-34.2 RDW-18.5* Plt ___ ___ 06:20AM BLOOD WBC-10.2 RBC-2.52* Hgb-8.1* Hct-23.5* MCV-93 MCH-32.3* MCHC-34.7 RDW-18.4* Plt ___ ___ 12:10AM BLOOD WBC-9.0 RBC-2.36* Hgb-7.6* Hct-21.7* MCV-92 MCH-32.1* MCHC-34.8 RDW-18.3* Plt ___ ___ 06:25AM BLOOD Glucose-94 UreaN-20 Creat-0.8 Na-131* K-4.1 Cl-97 HCO3-28 AnGap-10 ___ 12:10AM BLOOD Glucose-112* UreaN-20 Creat-0.7 Na-130* K-4.0 Cl-98 HCO3-25 AnGap-11 ___ 06:25AM BLOOD ALT-24 AST-47* LD(LDH)-195 AlkPhos-247* TotBili-0.9 ___ 12:10AM BLOOD ALT-16 AST-25 AlkPhos-201* Amylase-29 TotBili-0.6 ___ 06:25AM BLOOD Albumin-2.3* Calcium-7.9* Phos-3.4 Mg-1.8 ___ 01:36AM BLOOD Lactate-1.4 . CT ABD & PELVIS WITH CONTRAST Study Date of ___ 5:37 ___ 1. Tubular fluid-filled structure in the right flank (300b:26, 2aA:35) without definite sinus tract to the skin surface but extension at least to the intra-abdominal cavity is improved from ___ at which time there was a sinus tract to the skin and significantly improved from the prior CT of ___ at which time there was a focal subcutaneous collection of air and fluid with a sinus tract to the skin. Subcutaneous fluid and stranding in the right lateral and anterior abdominal wall with shallow but slightly rim enhancing fluid collection measuring 3.6 x 0.8 cm (2aA:35). 2. Interval development of peripheral ill-defined hypodense lesion segment 6 measuring 17 x 15 mm (2aA:21) from ___ may represent early abscess formation, infarct or biloma given its linear extension centrally (2aA:18). Stable biliary dilatation compared to the most recent prior CT of ___. 3. Known cholangiocarcinoma with ascites and worsening generalized anasarca from ___. Decreased distention of small bowel with persistent bowel wall edema from ___. Brief Hospital Course: ASSESSMENT AND PLAN: Ms. ___ is a ___ year old woman with a history of locally advanced cholangiocarcinoma s/p resection which was not complete. She has had multiple admissions for biliary obstruction but more recently an abdominal infection for which she was on cefepime, changed to doxycyline 6 days ago. Gram stain of the abscess grew pseudomonas on ___. She presents with fever and increased redness of the wound. . 1. Fever: Initial sources of infection included pneumonia, UTI, bacterial infection or skin infection. She has no evidence of PNA on CXR and UA is clear. Urine culture was negative. She has no clear evidence of active malignancy to be causing fever. She does not have evidence of biliary obstruction based on laboratory data or clinical symptoms. She was evaluated by the hepatobiliary service in the ER who did not think that she had any problems that would require surgical intervention. She was initially changed from outpatient Doxycycline to Cefepime q24. ID was consulted and recommended changing the dosing from q12 to q24. They also recommended obtaining a CT scan of the abdomen to see if there was an underlying fluid collection or abscess. The CT revealed a small hypodensity in the liver that was consistent with abscess. I had a thorough discussion with the patient about the possibility of taking a biopsy of the lesion and the potential risks involved vs. a more conservative line of management such as continual IV ABX. She was clear that the less invasive approach was preferred. I discussed this decision with the ID consulting team who agreed. She should get a repeat CT in approximately 4 weeks to assess for resolution. . Of note, the patient had a temperature of 100.6 the evening of ___. KUB was obtained as well as blood cultures though without neutropenia, this is not a true fever. The ID consult team suggested to add on Flagyl for better anerobic coverage in addition to the oral Vancomycin. Her outpatient ID MD can decide whether to taper the Vancomycin or wait until Cefepime and Flagyl are complete. . 2. Cholangiocarcinoma: The patient was followed by the oncology consultant for medicine, Dr. ___. In discussions, she stated that she was not intererested in chemotherapy as the risks outweighed the benefits. She mentioned the possiblity of XRT, but I am unsure if this option is viable. She will discuss with Dr. ___ options 5 days after discharge. Considerations should also given to palliative treatments only as the patient made clear her disinterest in ___ medical procedures. . 3. Anemia secondary to inflammation and blood loss. The patient has a baseline anemia from inflammation caused by infection as well as her malignancy. In addition, she had a guiac positive brown stool. She had no episodes of bright red blood per rectum, melena, coffee ground emesis, or other evidence of active bleeding. Transplant surgery was aware of her decrease in Hct and did not feel it was a result of her surgery. I called the GI consult team who said preliminarily, she would not need a repeat endoscopy from the one she had on ___ regardless, the patient states she would not want an endscopy regardless. She was given 2 units PRBCs for comfort and may require additional transfusions as an outpatient to improve fatigue. Her PPI was increased to BID and Carafate added per the recommendations of GI after her last endoscopy. . 4. Hx of C. Diff: No evidence of worsening infection. Normal bowel movements daily. Continued Vancomycin 125 mg PO BID . 5. ___ Edema: Per patient this was from prior hospitalization and IV fluids. Lasix 20 mg PO daily was continued with the exception of the day of ___. She maintained normal renal function and had chronic, asymptomatic hyponatremia. . I spent > 90 minutes in discussion with patient, family, RNs, consultants, case management, and in discharge planning . Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Doxycycline Hyclate 100 mg PO Q12H 2. Levothyroxine Sodium 125 mcg PO DAILY 3. Omeprazole 40 mg PO DAILY 4. Furosemide 20 mg PO DAILY 5. Ursodiol 300 mg PO BID 6. Vancomycin Oral Liquid ___ mg PO BID Discharge Medications: 1. Omeprazole 40 mg PO BID RX *omeprazole 40 mg 1 capsule,delayed ___ by mouth twice a day Disp #*60 Capsule Refills:*1 2. Ursodiol 300 mg PO BID 3. Vancomycin Oral Liquid ___ mg PO BID 4. Levothyroxine Sodium 125 mcg PO DAILY 5. CefePIME 2 g IV Q12H RX *cefepime [Maxipime] 1 gram 1 gram IV twice a day Disp #*60 Vial Refills:*0 6. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H RX *metronidazole [Flagyl] 500 mg 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills:*0 7. Morphine Sulfate ___ ___ mg PO Q3H:PRN pain RX *morphine 15 mg ___ tablet(s) by mouth q3 Disp #*60 Tablet Refills:*0 8. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush 9. Sucralfate 1 gm PO BID RX *sucralfate [Carafate] 1 gram 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*1 10. Furosemide 20 mg PO DAILY 11. Docusate Sodium 100 mg PO BID:PRN constipation RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*1 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Liver Abscess Cholangiocarcinoma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted with a fever likely caused by a liver abscess and not a cellulitis Followup Instructions: ___
10387100-DS-19
10,387,100
28,065,541
DS
19
2142-09-13 00:00:00
2142-09-14 22:02:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: dark urine/light stool Major Surgical or Invasive Procedure: None History of Present Illness: ___ year old man with history of hypertension, hypercholesterolemia and diabetes who presents to the ___ with fatigue x ___s dark urine/light stools since ___. The patient notes that his health began to decline when he was switched from crestor to lipitor on ___ due to impending formulary change of his insurance. He noticed fatigue after the switch, and on ___ he noted decreased appetite and the aforementioned colour changes in his stool and urine. Other symptoms he has noted has included some generalized musculoskeletal pain in his neck, back and left thigh. He also has noted some chills since ___, but denies frank fevers. His last dose of lipitor was the night before admission on ___. Review of systems was negative for any recent abnormal food exposures. No history of hepatitis or IV drug use. No belly pain, nausea, vomiting, brbpr or melena. No dysuria or history of kidney problems. No chest pain, cough or shortness of breath. He does endorse fairly significant EtOH intake, generally ___ beers a day but as much as 6 drinks occasionally on weekends. . In the ED, initial VS: 99.4 84 127/62 18 100% ra. The patient underwent a RUQ ultrasound that showed no extra or intrahepatic duct dilation. The gallbladder was collapsed, although gallbladder wall thickening was apparent. Labs were notable for moderate elevation in aminotransferases, alkaline phosphatase and mild conjugated hyperbilirubinemia. The patient also had elevation in creatinine to 1.8, although baseline was unknown. Past Medical History: Hypertension Hypercholesterolemia Diabetes - diet controlled. Erectile dysfunction Alcohol abuse Social History: ___ Family History: FAMILY HISTORY: Father deceased ___ from colon ca. Mother deceased from complications of diabetes. No siblings. Children are healthy. No family history of inflammatory bowel disease or liver disease. Physical Exam: Admission VS - 100.4 129/75 91 18 98% on RA GENERAL - well-appearing in NAD, comfortable, appropriate HEENT - NC/AT, PERRLA, EOMI, mild scleral and oral icterus, MMM, OP clear NECK - supple, no thyromegaly, no JVD, no carotid bruits LUNGS - CTA bilat, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use HEART - PMI non-displaced, RRR, no MRG, nl S1-S2 ABDOMEN - NABS, soft/NT/ND, Palpable spleen tip and liver edge, no rebound/guarding EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs) SKIN - no rashes or lesions LYMPH - no cervical, axillary, or inguinal LAD NEURO - grossly non focal. Pertinent Results: ___ 03:28PM BLOOD WBC-6.3 RBC-4.00* Hgb-11.7* Hct-33.7* MCV-84 MCH-29.3 MCHC-34.8 RDW-14.8 Plt ___ ___ 04:45AM BLOOD WBC-5.8 RBC-3.60* Hgb-10.5* Hct-30.2* MCV-84 MCH-29.1 MCHC-34.7 RDW-14.9 Plt ___ ___ 03:28PM BLOOD Neuts-68.8 Lymphs-12.6* Monos-4.3 Eos-14.0* Baso-0.3 ___ 03:28PM BLOOD ___ PTT-28.8 ___ ___ 04:45AM BLOOD ___ PTT-28.5 ___ ___ 03:28PM BLOOD Glucose-122* UreaN-26* Creat-1.8* Na-135 K-3.9 Cl-101 HCO3-22 AnGap-16 ___ 04:45AM BLOOD Glucose-77 UreaN-21* Creat-1.4* Na-135 K-3.6 Cl-105 HCO3-20* AnGap-14 ___ 03:28PM BLOOD ALT-139* AST-98* CK(CPK)-132 AlkPhos-306* TotBili-2.7* DirBili-2.1* IndBili-0.6 ___ 04:45AM BLOOD ALT-111* AST-91* CK(CPK)-140 AlkPhos-277* TotBili-2.5* ___ 03:28PM BLOOD Lipase-38 ___ 03:28PM BLOOD Albumin-4.1 PENDING Labs ___ 04:45AM BLOOD IgM HAV-PND ___ 04:45AM BLOOD AMA-PND Smooth-PND ___ 04:45AM BLOOD ___ ___ 5:21 am URINE Source: ___. URINE CULTURE (Pending): Urine studies ___ 05:21AM URINE Color-Yellow Appear-Clear Sp ___ ___ 05:21AM URINE Blood-NEG Nitrite-NEG Protein-TR Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG ___ 05:21AM URINE RBC-0 WBC-1 Bacteri-NONE Yeast-NONE Epi-<1 ___ 05:21AM URINE Mucous-RARE ___ 05:21AM URINE Hemosid-NEGATIVE ___ 05:21AM URINE Hours-RANDOM Creat-81 Na-81 K-11 Cl-83 Imaging RUQ u/s: Contracted/collapsed gallbladder. apparent GB wall thickening/edema may in part relate to contracted state vs true edema. Neg sonographic ___. No intra-extra hepatic biliary dilatation. patent portal vein. liver nl in echotexture. Brief Hospital Course: ___ y.o man with history of HTN, HL, and DM present with myalgias, low grade fever, mild organomegaly and cholestatic liver enzymes concerning for DILI. . #Liver injury - Most likely dx given LFT pattern is cholestatic drug-induced liver injury. Would also consider autoimmune hepatitis type 1 given low grade temps and eosinophilia. Both of the above can present very similarly. Low concern for alcohol hepatitis or statin myopathy given nontypical lab patterns. Low suspicion for cholecystitis given exam and other findings. Labs for autoimmune hep was sent including ___, ama and antismooth muscle antibodies and his anti-mitochondrial antibody returned positive with a ratio of 1:160 at time of discharge. LFTs downtrending at time of discharge. Plan to continue to hold statin and cholestyramine at time of discharge with f/u with PCP in few days for repeat labs. The patient's PCP was notified of the positive AMA and will decide whether to refer the patient to hepatology to evaluate for PBC versus type I autoimmune hepatitis. . # Eosinophilia: Likely ___ hypersensitivity component of DILI vs autoimmune hepatitis. Would also consider parasitic infection given loose stool although lower likelihood given lack of travel. Ordered stool o/p which are pending at time of discharge. . # Low grade fever - Less likely to be infectious or cholecystitis esp given benign exam. Can see low grade/fever with DILI and autoimmune hepatitis. Did not spike fever during hospitalization. Urine culture was checked for low grade temp and XXX at time of discharge. . #Acute kidney injury - Admission creatinine 1.8 now improving. Fena 1% and appears to be improving w IVF. Baseline appears to be ~1.3 per Atrius records. Home ACE and diuretic were held on admission and restarted prior to discharge. INACTIVE ISSUES #Diabetes - QID fingersticks, will start insulin if these are presistently high. he did not require insulin administration. Home asa was continued. Metformin was discontinued in the setting of hepatitis (this was changed after discharge via telephone). . #Hypertension - Normotensive during hospitalization. On admission team held ace-i, diuretic given acute renal failure but these were restarted as above. TRANSITIONAL ISSUES: Liver: Work up of positive AMA, repeat LFTs, both communicated to PCP. # FEN: IVFs / replete lytes prn / heart healthy diabetic diet # PPX: heparin SQ # ACCESS: PIV # CODE: Full # CONTACT: ___, Wife ___ ___ ___ on Admission: Confirmed w ___ pharmacy lisinopril 40mg daily (hydrochlorothiazide not since ___ chlorthalidone 25mg daily cholestyramine-aspartame powder 4g/1 scoop Lipitor 80mg qhs viagra 100mg metformin 500mg ER daily, takes occasionally aspirin 81mg Discharge Medications: 1. aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO DAILY (Daily). 2. lisinopril 40 mg Tablet Sig: One (1) Tablet PO once a day. 3. chlorthalidone 25 mg Tablet Sig: One (1) Tablet PO once a day. 4. metformin 500 mg Tablet Extended Rel 24 hr Sig: One (1) Tablet Extended Rel 24 hr PO once a day: Takes sporadically. 5. Viagra 100 mg Tablet Sig: One (1) Tablet PO once a day as needed: Take 1 hour prior to sex . Discharge Disposition: Home Discharge Diagnosis: Drug induced liver injury Eosinophilia Fever Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital with elevated liver tests and change in your urine/stool consistent with a drug induced liver injury. This is likely due to the atorvastatin which has been stopped. We checked blood tests to exclude autoimmune disease as the cause of your symptoms and these were pending at time of discharge. We will communicate these results with Dr. ___ PCP. Dr. ___ recheck your liver studies when he sees you on ___. Please continue to stay off of the atorvastatin. The following changes were made to your medications: STOP atorvastatin (lipitor) and cholestyramine. Continue other home medications including chlorthalidone, lisinopril, viagra and metformin. Please follow up with your doctors as listed below. Followup Instructions: ___
10387377-DS-13
10,387,377
21,717,675
DS
13
2188-08-05 00:00:00
2188-08-06 14:25:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Codeine / Penicillins / albuterol Attending: ___ Chief Complaint: Chest Pain Major Surgical or Invasive Procedure: Cardiac Catherization ___ History of Present Illness: This is a ___ yo F with CAD s/p CABG (___) with recurrent admissions due to chest pain with DES placed to LAD and POBA to ostial ___ diagonal artery on ___ who was transfered here from an outside hospital due to chest pain. The patient noted mild, left sided chest pain 2 days prior to admission. The patient has been compliant with her medications including aspirin and plavix. Last night, the pain became worse and woke the patient up from sleep around 1AM. The patient's pain starts under her left breast and radiates above the breast and across the chest. The pain also radiates to the left elbow. The patient describes this pain as the same as her cardiac pain prior to the stent placement. When the patient awaoke, she took 1 nitro with some relief. She awoke again with the same pain and took ___ more nitros. When the pain did not resolve, the patient called the ambulance. The patient says that she had mild nausea, diaphoresis, and palpitations associated with these episodes. She denied SOB. The patient says that the pain was worse with deep breaths but was not positional. At the OSH, the patient was given nitropaste, bloodwork did not reveal any abnormalities, and the EKG was not concerning. The patient was started on a heparin gtt and transfered here for further workup. . Initial VS: 99.2 72 118/48 12 100% 2L nc. On interview, the patient was chest pain free. . REVIEW OF SYSTEMS + recent Stroke On review of systems, no bleeding at the time of surgery, myalgias, joint pains, cough, hemoptysis, black stools or red stools. She denies recent fevers, chills or rigors . Cardiac review of systems is notable for absence of dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, palpitations, syncope or presyncope. Past Medical History: Cardiac Risk Factors: Diabetes(+),Dyslipidemia(+),Hypertension(+) # CAD -- s/p MI in ___ (2v CAD on cardiac cath) # CABG -- ___ with mitral valve repair and MAZE # Chronic Diastolic Congestive Heart Failure -- LVEF 50% on ___ with mild regional systolic dysfunction # Paroxysmal atrial fibrillation -- no episodes since MAZE -- no longer on Coumadin # WPW s/p ablation # Pulmonary hypertension # Hypertension # Hyperlipidemia # Diabetes Mellitus Type 2 # Hypothyroidism s/p thyroid irradiation -- previously hyperthyroid many years ago # COPD # Carotid Stenosis # Kidney Stones # Tonsillectomy # H/o viral gastroenteritis # GERD Social History: ___ Family History: # Mother -- heart murmur # Children -- two sons with arrhythmia, one died from MI at age ___, daughter with thyroid cancer # Maternal Grandmother -- diabetes Physical ___: VS: T= 97.4 BP= 128/70 HR= 88 RR= 20 O2 sat= 98% RA GENERAL: Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthalesma. NECK: Supple with JVP not elevated. CARDIAC: Normal sinus rhythm. Nl S1, S2, ___ systolic ejection murmur at RUSB that does not obscure S2, radiation to carotids. no S3, S4 LUNGS: Distant breath sounds. No crackles, wheezes, or consolidations ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by palpation. No abdominial bruits. EXTREMITIES: trace ___ edema, left calf tenderness NEURO: CN II-XII tested and intact, strength ___ throughout, sensation grossly normal. Gait not tested. Pertinent Results: ADMISSION LABS: ___ 01:30PM BLOOD WBC-7.9 RBC-4.00* Hgb-12.2 Hct-37.8 MCV-94 MCH-30.4 MCHC-32.3 RDW-13.4 Plt ___ ___ 01:30PM BLOOD Neuts-62.3 ___ Monos-4.2 Eos-1.3 Baso-1.2 ___ 01:30PM BLOOD ___ PTT-31.4 ___ ___ 01:30PM BLOOD Glucose-123* UreaN-24* Creat-1.0 Na-140 K-3.8 Cl-103 HCO3-26 AnGap-15 ___ 01:30PM BLOOD Calcium-9.2 Phos-3.3 Mg-2.0 DISCHARGE LABS: ___ 07:20AM BLOOD WBC-9.6 RBC-3.40* Hgb-10.7* Hct-33.3* MCV-98 MCH-31.4 MCHC-32.2 RDW-13.9 Plt ___ ___ 07:20AM BLOOD ___ PTT-25.1 ___ ___ 07:20AM BLOOD Glucose-115* UreaN-22* Creat-0.9 Na-138 K-3.9 Cl-102 HCO3-30 AnGap-10 ___ 07:20AM BLOOD Calcium-9.1 Phos-3.8 Mg-1.9 Cardiac Enzymes: ___ 01:30PM BLOOD cTropnT-<0.01 ___ 10:00PM BLOOD CK-MB-2 cTropnT-<0.01 ___ 08:00AM BLOOD CK-MB-2 cTropnT-<0.01 ___ 11:48PM BLOOD CK-MB-10 ___ 07:20AM BLOOD CK-MB-20* ___ 10:00PM BLOOD CK(CPK)-48 ___ 08:00AM BLOOD CK(CPK)-33 LENIs: No clot ___ ============= Cardiac Cath: See OMR for final report. Not dictated by time of discharge. Brief Hospital Course: ___ yo F with CAD s/p CABG and recent cath with DES and POBA to LAD, multivessel disease planned for staged intervention who presents here with chest pain but negative CEs and no significant EKG changes. 1. Chest Pain: This is likely cardiac chest pain given the patient's risk factors, known CAD, and similar pain to previous. This is not likely stent thrombosis due to compliance with aspirin and plavix and negative enzymes, and quick resolution of pain. The patient underwent a cardiac cath that showed LAD with patent stent then 99% mid with distal filling from LIMA (no change from previous. RCA 40% proximal, 80% mid, 80% posterolateral. The patient underwent Rotoblator with 1.5 burr followed by DES of mid-RCA with 2 overlapping DES, Balloon PTCA of posterolateral with moderate residual stenosis but difficult to advance larger balloons. The patient also complained of bilateral leg tenderness, but LENIs were negative for any DVT. The patient will continue aspirin and plavix indefinitely. She will continue her metoprolol, lisinopril, nitro, and ranolazine as needed. CHRONIC DISEASES: 2. Chronic Diastolic Heart Failure: The patient looked euvolemic on exam. Continued lasix 40mg Daily, lisinopril 2.5mg Qday, Metoprolol 100mg Qday 3. Hyperlipidemia: On statin 4. DM2: On Glimepiride 5. COPD: on spiriva, supplemental O2 6. GERD: on protonix 7. Hypothyroidism: On levothyroxine . TRANSITIONAL ISSUES: None Medications on Admission: Plavix 75mg Qday Atorvastatin 80mg Qday Nitro SL PRN Lisinopril 2.5mg Qday Tylenol PRN Glimepiride 1mg Qday Levothyroxinw 88mcg Qday Metoprolol XL 100mg Qday Spiriva Qday Colace Ranolazine 500mg Qday Lasix 40mg Qday Protonix 40mg Qday Aspirin 325mg Qday Discharge Medications: 1. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. ranolazine 500 mg Tablet Extended Release 12 hr Sig: One (1) Tablet Extended Release 12 hr PO Qday (). 4. pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours). 5. metoprolol succinate 100 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily). 6. lisinopril 5 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily). 7. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: One (1) Cap Inhalation DAILY (Daily). 8. atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 9. nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Tablet, Sublingual Sublingual PRN (as needed) as needed for chest pain. 10. levothyroxine 88 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily). 11. glimepiride 1 mg Tablet Sig: One (1) Tablet PO once a day. 12. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6 hours) as needed for pain. 13. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 14. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day. Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary diagnosis - Coronary artery disease - Unstable Angina Secondary diagnosis - Pulmonary hypertension - Hypertension - Hyperlipidemia - Diabetes Mellitus Type 2 - Hypothyroidism s/p thyroid irradiation - COPD - GERD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You came to our hospital for scheduled catheterization of your coronary arteries. She tolerated the procedure very well. During the procedure, we opened up with a right sided coronary artery with a drug eluting stent. You also underwent an ultrasound of your legs, which did not reveal any blood clots. We continued all your home medications, and you should be able to go home today. . No changes were made to your home medication list. . It has been a pleasure taking care of you here at ___. We wish you a speedy recovery. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Followup Instructions: ___
10387770-DS-17
10,387,770
25,294,592
DS
17
2197-02-04 00:00:00
2197-02-08 20:45:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins / Lipitor Attending: ___. Chief Complaint: weakness and fatigue Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is an ___ year old gentleman with a history of chronic kidney disease (baseline creatinine 1.6), non-insulin dependent diabetes (HA1c 6.9 ___, who presented with weakness and fatigue. The patient was in his usual state of health until 3 weeks ago when he noticed progressive fatigue leading to sleeping 18 hours per day and decreased energy for daily activities. He also reports weakness in both legs and a new weakness leading to an inability to open water bottles. The patient also reports decreased appetite and PO food intake due to a new lump in his throat that was painless but provided resistance to swallowing and occasionally made him gag. The lump is intermittent and the patient reports that it went away yesterday and has not returned. He has also noted a change to the consistency of his bowel movements with more loosely formed stool. The patient denies any abdominal pain, nausea, vomitting, blood in his sputum, constipation, BRBPR, melena. He endorses chills, but denies fever or night sweats. The patient presented to his PCP ___ ___ and was found to have hypotension 78/38 sitting and 82/40 lying down. In the ED, vitals were: 97.6, 54, 76/47, 16, 92RA. A Chest Xray revealed no focal consolidation or pleural effusion. A bedside ultrasound showed no effusions; the IVC collapses easily. Labs notable for BUN/Cr rise to 84/4.3 and potassium of 5.7. EKG reported by ED: SR @ 62, no ST elevation. The patient was given Kayexalate and and calcium gluconate in the ED. On the floor at 9AM vitals were: 98.1 93/57 85 18 98RA. Orthostatic blood pressure was 110/54 supine and 112/62 standing after 3 minutes. The patient reported feeling 100% better, but endorsed some weakness. He reported that the lump in his throat was gone. His last bowel movement was the night of admission and was very loose. At 9:30 AM ___ the patient's heart rate spiked to 140-160 and a bed side EKG showed irregularly irregular rhythm indicating atrial fibrillation. The patient received IV 5 mg metoprolol and his BP decreased to 110-120 range. He denies chest pain, palpitations, headache, dizziness, blurry vision, nausea, vomitting. He received a second IV push of 5 mg metoprolol. Past Medical History: 1. Diabetes mellitus with peripheral neuropathy and chronic renal failure (cre = 1.6 on ___ with estGFR = 42). %HbA1c = 6.9 on ___. 2. Emphysema. 3. Hypertension. 4. Posterior vitreous detachment. 5. Urolithiasis. 6. History of basal cell carcinomas. 7. Hypersensitivity reaction. 8. Allergic rhinitis. 9. Vitamin B12 deficiency with vitB12 = 154 on ___. 10. Hypogammaglobulinemia. Social History: ___ Family History: FAMILY HISTORY: FH significant for mother with gastric ___ @ age ___ died age ___ Father emphysema died age ___. Siblings: no hx of cancer Maternal 3 aumts and MGM also with h/o CA in the abdomen, unknown which types. Physical Exam: PHYSICAL EXAM: VITALS: 98.7 129/66 56 18 100RA; Ins: 1230, Outs: 1375 GENERAL: Laying supine in bed, comfortable, in no acute distress. HEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, moist mucous membranes, OP clear. NECK: Supple, no thyromegaly, no thyroid bruits, JVP at 7, no carotid bruits. no palpable neck mass. HEART: RRR, no MRG, nl S1-S2. LUNGS: CTA bilat, no ronchi/rales/wheezes, good air movement, resp unlabored. ABDOMEN: Soft/NT/ND, no masses or HSM, no rebound/guarding. No CVAT. EXTREMITIES: warm and well perfused, no cyanosis, clubbing. No edema of the lower extremities, 1+ peripheral pulses. SKIN: 1+ pitting edema on lower back. Echymoses on abdomen and upper extremities and hands from telemetry stickers. LYMPH: No cervical LAD. NEURO: Awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ in right hamstrings and ___ in right hipflexors. Otherwise, muscle strength ___ throughout, sensation grossly intact throughout. 2+ reflexes bilaterally in patella, achilles, bicep and tricep. Discharge Exam: PHYSICAL EXAM: Vitals: 98.5 (tmax 98.5) 114/78 (range: 114/78 - 150/80), 72, 18 100RA ins 1710 mL; outs 1650 mL Blood Glucose ___: AM: 132; Noon: 223; ___: 182; bedtime: 211 GENERAL: The patient is sitting up in bed; comfortable looking. in no acute distress. HEENT: normocephalic atraumatic; extraoccular movements intact, moist mucus membranes, pupils equally round and reactive to light NECK: JVP at 6, no carotid bruits, no lymphadenopathy CARDIO: normal S1 S2, no murmurs rubs or gallops, regular rate and rhythm LUNGS: clear to auscultation bilaterally ABD: soft, nontender nondistended, normoactive bowel sounds, no guarding / rebound EXTREMITIES: 1+ sacral edema; no ankle edema; 1+ dorsal pedis pulses, warm and well perfused. Strength ___ in right tricep; ___ throughout. NEURO: CN II - XII intact; Awake and oriented x 3. Pertinent Results: ADMISSION LABS: ___ 08:30PM WBC-6.7 RBC-3.64* HGB-11.4* HCT-37.9* MCV-104* MCH-31.3 MCHC-30.1* RDW-13.6 PLT COUNT-222 ___ 08:30PM NEUTS-67.3 ___ MONOS-4.6 EOS-1.7 BASOS-0.3 ___ 02:55PM GLUCOSE-143* UREA N-84* CREAT-4.3*# SODIUM-137 POTASSIUM-5.7* CHLORIDE-111* TOTAL CO2-11* ANION GAP-21* ___ 11:15PM TOT PROT-5.5* CALCIUM-10.1 PHOSPHATE-4.4 MAGNESIUM-1.7 ___ 06:34PM LACTATE-2.2* ADMISSION URINALYSIS ___ 02:55PM URINE HOURS-RANDOM CREAT-174 TOT PROT-35 PROT/CREA-0.2 albumin-11.3 alb/CREA-64.9* ___ 08:00PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 08:00PM URINE BLOOD-TR NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG ___ 08:00PM URINE RBC-<1 WBC-1 BACTERIA-FEW YEAST-NONE EPI-0 ___ 08:00PM URINE HYALINE-4* ___ 08:00PM URINE MUCOUS-RARE BLOOD GASES: ___ 08:48AM BLOOD Type-VENOUS pO2-169* pCO2-29* pH-7.14* calTCO2-10* Base XS--18 Comment-GREEN TOP ___ 05:08PM BLOOD Type-ARTERIAL pO2-107* pCO2-24* pH-7.39 calTCO2-15* Base XS--8 ___ 05:20PM BLOOD Type-ARTERIAL pO2-122* pCO2-29* pH-7.38 calTCO2-18* STUDIES: EKG ___: Sinus rhythm at the lower limits of normal rate. Borderline low limb lead voltage. Peaked precordial T waves - consider hyperkalemia. Since the previous tracing of ___ T waves may be more peaked. Rate 60. CHEST XRAY ___: No acute cardiopulmonary process. ECHO ___: "Suboptimal image quality. Mild symmetric left ventricular hypertrophy with preserved global biventricular systolic function. No valvular pathology or pathologic flow identified." RENAL ULTRASOUND ___: "Renal cysts. Otherwise, normal renal ultrasound. Possible focal hypoechoic liver lesion, seen only on one image." LIVER AND GALLBLADDER ULTRASOUND ___: Multiple simple hepatic cysts. Dilated pancreatic duct with atrophic pancreatic parenchyma. The etiology is indeterminate. This should be further investigated with multiphasic CT/MRI or ERCP. CT HEAD ___ "No evidence of intracranial mass nor acute process. If there is continued clinical concern, an MRI, even without contrast, is more sensitive for the detection of intracranial mass or acute infarction. Fluid opacification of the right sphenoid sinus which should be correlated with clinical signs of sinusitis." CT TORSO ___: 1. No evidence of solid pancreatic mass. Coarse calcifications within the pancreatic duct in the head and uncinate process is associated with chronic postobstructive loss of parenchyma at the body and tail of pancreas with associated ductal dilation. 2. Vascular calcifications of the origin of the coronary arteries. Minimal vascular calcifications of the aortic arch without aneurysmal change. 3. Multiple hepatic cysts. One cyst with calcifications is seen at the liver dome, probably representing a slightly complicated cyst but unlikely to be of clinical significance. 4. Atrophic appearance of both kidneys. Probable renal pelvic cyst on the left, incompletely characterized. 5. Possible punctate stone dependently within the gallbladder. 6. Liver is borderline low-density, which may be related to mild hepatic steatosis. 7. Slight fullness of the left adrenal gland without discrete nodularity. 8. Colocolonic fistula in the rectum, which appears chronic in nature. MRI Head (___): 1. No acute intracranial abnormality. 2. Generalized cerebral volume loss with mild changes of chronic small vessel ischemic disease. TELEMETRY ___: Telemetry showed normal sinus rhytym with no events but showed 4 beats of PVCs. VIDEO OROPHARYNGEAL SWALLOW: ___: Barium passed freely through the oropharynx without evidence of ostruction. There was vallecular and pyriform sinus residue with all consistencies. Anterior osteophytes are present at C4-C5 which may also be contributing to patients symptoms. There was penetration with thin liquids and no aspiration. TELEMETRY ___: Telemetry showed normal sinus rhytym with no events but showed 7 beats of PVCs which resolved spontaneously. Brief Hospital Course: The patient is a ___ year old gentleman with a history of CKD (baseline creatinine = 1.6), DM, and HTN who presents with weakness, hypotension, fatigue, and dysphagia in the setting of weight loss found to have a severe non gap metabolic acidosis and acute on chronic kidney failure as well as new onset atrial fibrillation. # Dysphagia/decreased appetite/weight loss: Mr. ___ presented with a 3 week history of progressive dysphagia for both solids and liquids. He endorsed the feeling of an intermittent "lump in his throat," weight loss, and difficulty swallowing. Past records indicated an 11 lb weight loss since ___. Pt stated his appetite decreased markedly and he began eating and drinking much less over the past 3 weeks, with typical fluid intake of only 2 cups of water. On admission, he described improvement of the feeling and subsequent increase in appetite. Due to fatigue, weight loss, weakness, and a family history of GI cancer, concern for malignancy was high. GI was consulted. A CT torso did not reveal malignancy, but demonstrated coarse calcifications in the pancreatic duct in the head and uncinate process with chronic postobstructive loss of parenchyma at the body and tail of pancreas with associated ductal dilation. No acute intervention was necessary for this chronic process. Video swallow and speech and swallow consult revealed mild oropharyngeal dysphgia most notable for pharyngeal residue with all consistencies which is c/w pt's complaints of feeling food, liquid, and pills stuck in his throat. The pt was found to have anterior osteophytes at C4-C5 as well as reduced UES opening which do appear to be contributing to the pharyngeal residue. The patient was counseled to take smaller bites, to chew well, and to drink a lot of fluid with meals. # Dilated pancreatic duct seen on imaging - This was incidentally found on workup for his fatigue and weight loss. GI was consulted who discussed the pancreatic duct obstruction with ERCP. As he was asymptomatic with normal LFTs, no additional work-up was recommended. The patient was scheduled for follow up with Dr. ___ GI. #. Acute renal failure with metabolic acidosis/acidemia - The patient has a history of CKD with a baseline creatinine of 1.6-2.0. This was found on admission here to be 4.3. Pt had VBG showing pH of 7.14 and a non-anion gap acidosis. Renal US was unremarkable and pt's SPEP, UPEP, and free light chain k/l ratio revealed no evidence of monoclonal antibody disease. The patient's acidosis was presumed to be diarrhea versus renal tubular acidosis and was treated with sodium bicarbonate. The patient's acidosis corrected. With fluids, the patient's creatinine trended downward and stabilized at 2.6 to 2.8. He was seen by nephrology here and will follow up with them as an outpatient. He was discharged on sodium bicarbonate tabs BID. His ACE-inhibitor and spironolactone were discontinued. His medications became renally dosed including discontinuation of metformin and lowering of januvia to 50 mg. # Atrial fibrillation - The pt went into atrial fibrillation on his first admission day and was completely asympomatic. He was rate controlled with metoprolol and then converted back to NSR within 18 hours. An echo was performed and demonstrated a mildly dilated left atrium and mild LVH, but no other valvular abnormalities and no pericardial effusion. This was his first known episode of Atrial fibrillation and the patient remained on telemetry for 5 more days without any further episodes of atrial fibrillation; thus anticoagulation was not started. It was presumed that the atrial fibrillation was due to the patient's acidosis and volume depleted state. However, the patient does have substrate for the disease given his enlarged LA and recurrence of the disease would warrant anticoagulation given his CHADS score of 3. # Right sided weakness/Dysarthria: Physical exam revealed right sided hamstring weakness of ___ and right sided bicep weakness of ___. There was also question of 1 month history of dysarthria reported by his family. Labs revealed normal morning cortisol, CK and TSH levels. A CT of the head did not reveal a hemorrhagic stroke. Given initial concern for malignancy as well as atrial fibrillation, MRI was performed which showed no evidence of recent stroke or other acute abnormality. The patient's strength improved throughout his hospital stay. He was not dysarthric. # Hypotension: The patient presented to a medical appointment on ___ with BP of 78/38 sitting and 82/40 lying down. Pt's blood pressures returned to within normal limits after administration of fluids. Quinapril and spironolactone were discontinued. # Diabetes mellitus: The patient required about 8 units of sliding scale humalog daily. Because of his new ___, his sitagliptin was decreased from 100 to 50 mg. Metformin was also discontinued due to ___. The patient was started on glipizide and was told to measure his blood sugars TID and to report these values to Dr. ___ further ___ of his medications. # Macrocytic Anemia: The patient was guaiac negative here. He was seen by Dr. ___ prior to admission who performed a workup for the patient's anemia with blood smear revealing occasional macro-ovalocytes. Because b12 and folate levels were normal and patient not on any medications that cause megaloblastic maturation, it was thought that patient likely has an element of myelodysplasia. He had burr cells (due to renal failure). TRANSITIONAL ISSUES: 1. Repeat basic metabolic panel within the next week. Notable labs on last check: Hct 31.2, Cr 2.8, serum bicarbonate 23. 2. Determine whether sodium bicarbonate needs to be continued. 3. Outpatient follow-up with PCP, ___, and GI. 4. Per recommendation of Nephrology, ACE-inhibitor and metformin were stopped. 5. Glipizide was started. Continuing Januvia. Patient wsa instructed to check blood sugars frequently at home. 6. Monitor weight. Code status: Full Medications on Admission: ASPIRIN - 81 MG TABLET - ONE EVERY DAY FLUTICASONE - 50 mcg Spray, Suspension - 1 spray nasal twice a day METFORMIN - 850 mg Tablet - 1 Tablet(s) by mouth three times a day METOPROLOL TARTRATE - 25 mg Tablet - 1 Tablet(s) by mouth twice a day QUINAPRIL - 40 mg Tablet - 1 Tablet(s) by mouth once a day SITAGLIPTIN [JANUVIA] - 100 mg Tablet - 1 Tablet(s) by mouth once a day SPIRONOLACTONE - 25 mg Tablet - 1 Tablet(s) by mouth twice a day CYANOCOBALAMIN (VITAMIN B-12) [VITAMIN B-12] - 1,000 mcg Tablet - 2 Tablet(s) by mouth once a day Discharge Medications: 1. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 2. fluticasone 50 mcg/actuation Spray, Suspension Sig: One (1) Spray Nasal twice a day. 3. cyanocobalamin (vitamin B-12) 1,000 mcg Tablet Sig: Two (2) Tablet PO once a day. 4. sodium bicarbonate 650 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). Disp:*60 Tablet(s)* Refills:*0* 5. glipizide 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp:*30 Tablet(s)* Refills:*0* 6. Outpatient Lab Work Please have a chem-7 drawn on ___ and faxed to Dr ___ at ___. Diagnosis: Acute kidney injury 7. Januvia 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp:*30 Tablet(s)* Refills:*0* 8. metoprolol tartrate 25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). Discharge Disposition: Home Discharge Diagnosis: acute on chronic kidney disease atrial fibrillation with rapid ventricular reponse non-anion gap metabolic acidosis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___ ___. You came in for weakness, fatigue, difficulty swallowing, low blood pressure, and weight loss. You were found to have some functional swallowing difficulties, and some bone spurs in your neck that may be contributing to your symptoms. There is no acute intervention that needs to be done for this. It is very important that you drink fluids despite these symptoms. You were found to have injury to your kidneys and low blood pressure because you were not drinking enough. With fluids, your blood pressure and kidney function improved, but it still has not returned to normal. During your stay, you started to have an irregular and rapid heart beat. This improved with correction of your metabolic abnormalities. Lastly, because of your worsened kidney function, you should not take metformin for your diabetes. You should keep a close eye on your blood glucoses, measuring them before every meal and bedtime and record this. You can then show these numbers to your primary care doctor, who can adjust your medications and how to further proceed in managing your diabetes. If your blood sugars are above 200 or less than 100, you should call Dr. ___ let him know. His phone number is ___. Please have your blood drawn on ___, and the results faxed to Dr. ___. The following changes were made to your medications: STOP Metformin STOP Quinapril STOP Spironolactone DECREASE Januvia to 50mg START Sodium bicarbonate START GLIPIZIDE 5mg DRINK at least 2L of fluid a day. This is very important to do. Have your family help with this. Followup Instructions: ___
10387770-DS-18
10,387,770
25,124,191
DS
18
2198-03-15 00:00:00
2198-03-17 13:33:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins / Lipitor Attending: ___ Chief Complaint: Generalized weakness Major Surgical or Invasive Procedure: none History of Present Illness: ___ male w/ PMH of CKD (baseline cr 2.0-4.0 in recent months), NIDDM (HA1c 6.9 ___, emphysema, hypertension, and vitamin B12 deficiency, now presenting w/ generalized weakness x 3 months. Pt states that he has been feeling fatigued over the last ___ months. He also states that he was taking metformin 850mg po tid (2 qam and 1 qpm). Pt reports that he self-titrated down on his metformin several months ago due to improved DM control. Once he got down to one pill per day, he noticed rising sugars, so he began taking 3 pills per day approximately ___ months ago. Over the last two weeks, Pt reported severe weakness and occasional shakiness, also slowed / slightly slurred speech. Pt then came to the ED for evaluation. Denies any fevers, chills, weight loss or night sweats. He denies any chest pain, dyspnea. He denies any easy bruising, but does report easy fatigability. His right sided weakness/dysarthria appears unchanged since ___. and he continues to have ___ weakness on the right side. CT and MRI imaging have been unrevealing. In the ED, initial vitals were: 98 80 95/57 18 98% RA. His labs were significant for HCT 30.5, Cr 4.3, HCO3 13, lactate 3.9, and pH 7.21, anion gap of 17. He received 1L NS, and renal was consulted, who recommended sending urine lytes, stopping metformin, may need to start PO bicarbonate, and to admit to medicine for observation. There will be ongoing discussions regarding RRT on the floor. Repeat lactate prior to transfer to floor was 2.7. On the floor, VS: 97.4, 116/65, 73, 18, 100% RA. Pt's family reports that he has been intermittently somnolent during the day, sleeping at odd times for hours and then waking up. He also has not been eating or drinking much for the last ___ weeks. Review of systems: (+) Per HPI, reports extreme fatigue, slurred / slow speech, intermittent somnolence as above. (-) Denies fever, chills, night sweats, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Past Medical History: 1. Diabetes mellitus with peripheral neuropathy and chronic renal failure (cr = 2.1-4.0 from ___. %HbA1c = 6.7 on ___. 2. Emphysema. 3. Hypertension. 4. Posterior vitreous detachment. 5. Urolithiasis. 6. History of basal cell carcinomas. 7. Hypersensitivity reaction. 8. Allergic rhinitis. 9. Vitamin B12 deficiency 10. Hypogammaglobulinemia. Social History: ___ Family History: FAMILY HISTORY: ___ significant for mother with gastric ___ @ age ___ died age ___ Father emphysema died age ___. Siblings: no hx of cancer Maternal 3 aumts and MGM also with h/o CA in the abdomen, unknown which types. Physical Exam: ADMISSION EXAM: Vitals: 97.4, 116/65, 73, 18, 100% RA. General: well appearing elderly man in no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, moist mucosa Neck: supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: no foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, ___ strength in left upper and both lower extremities, ___ strength in right upper extremity, grossly normal sensation throughout, 2+ reflexes bilaterally, steady, normal gait w/ cane. No asterixis. DISCHARGE EXAM: Vitals: 98.1, 107-130/61-64, 75, 18, 100%RA, pain ___. General: well appearing elderly man in no acute distress CV: Irregularly irregular, normal S1 + S2, no murmurs, rubs, gallops Pertinent Results: ADMISSION LABS: ___ 01:55PM WBC-7.0 RBC-3.09* HGB-10.1* HCT-30.5* MCV-99* MCH-32.7* MCHC-33.2 RDW-13.3 ___ 01:55PM NEUTS-71.6* ___ MONOS-4.7 EOS-1.2 BASOS-0.4 ___ 01:55PM PLT COUNT-222 ___ 01:55PM ___ PTT-31.6 ___ ___ 01:55PM GLUCOSE-138* UREA N-72* CREAT-4.3* SODIUM-140 POTASSIUM-4.6 CHLORIDE-108 TOTAL CO2-15* ANION GAP-22* ___ 01:55PM ALT(SGPT)-8 AST(SGOT)-11 ALK PHOS-64 TOT BILI-0.2 ___ 01:55PM LIPASE-15 ___ 01:55PM ALBUMIN-4.3 CALCIUM-9.9 PHOSPHATE-4.6* MAGNESIUM-1.9 ___ 05:50PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG ___ 05:50PM URINE RBC-2 WBC-1 BACTERIA-FEW YEAST-NONE EPI-<1 ___ 05:50PM URINE MUCOUS-RARE ___ 05:50PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 05:50PM URINE HOURS-RANDOM CREAT-59 SODIUM-52 POTASSIUM-20 CHLORIDE-56 ___ 08:32PM ___ PO2-26* PCO2-37 PH-7.21* TOTAL CO2-16* BASE XS--13 ___ 08:32PM LACTATE-2.7* ___ 08:32PM O2 SAT-42 ___ 06:05PM ___ PO2-115* PCO2-29* PH-7.21* TOTAL CO2-12* BASE XS--15 PERTINENT LABS: ___ 06:05PM LACTATE-3.9* DISCHARGE LABS: ___ 09:02AM BLOOD Lactate-1.6 ___ 06:25AM BLOOD WBC-5.6 RBC-2.73* Hgb-9.2* Hct-25.7* MCV-94 MCH-33.6* MCHC-35.6* RDW-13.7 Plt ___ ___ 06:25AM BLOOD Glucose-145* UreaN-57* Creat-3.4* Na-142 K-3.4 Cl-109* HCO3-22 AnGap-14 ___ 06:25AM BLOOD Calcium-9.3 Phos-3.6 Mg-1.9 PERTINENT IMAGING: VENOUS MAPPING LEFT UPPER EXT (___): 1. Preserved phasicity of bilateral subclavian veins, indirect sign of central venous patency. 2. Patent left cephalic and basilic veins, with diameters as described above. 3. Patent left brachial and radial arteries, with no calcifications seen in the current study. ADMISSION EKG: Atrial fibrillation with rapid ventricular response. Consider prior inferior wall myocardial infarction. Compared to the previous tracing of ___ atrial fibrillation has appeared. Brief Hospital Course: Mr. ___ is an ___ male w/ PMH of CKD (baseline creatinine ___ in recent months), NIDDM (HA1c 6.7%), emphysema, hypertension, and vitamin B12 deficiency, now presenting w/ generalized weakness x 3 months found to be in metabolic acidosis secondary to metformin toxicity. ACTIVE DIAGNOSES: # Metabolic acidosis: His initial labs at admission with AG 17, HCO3 15, delta AG/delta HCO3 of ___ with elevated lactate are consistent with diagnosis of anion gap plus non anion gap metabolic acidosis, with appropriate respiratory compensation. There is lactic acidosis related to metformin, along with non anion gap metabolic acidosis related to inability to handle obligatory proton intake. His metformin was stopped. He was treated with IVF which helped to resolve the lactic acidosis (lactate 1.6 on ___ and greatly improved the pt's symptoms, but bicarb remained at 14 with a venous pH of 7.23 the following day. Renal was consulted. He was treated with oral bicarb 1300mg BID, without great benefit. He was given IV bicarb x1, which resulted in a normal bicarb (22) on the day of discharge. The pt was discharged with a prescription for oral bicarb 1300mg BID. His electrolytes should be re-checked at his PCP ___ and need for continued bicarb re-assessed. # Chronic kidney disease stage IV: Mr. ___ had hx of stage III-IV chronic kidney disease related to diabetes, hypertension and prior episodes of ___. His renal failure has been worsening over the past 6 months, and is now late stage IV-early stage V. Renal was consulted and started preparation for RRT. Options were discussed including HD, HHD and PD. He is leaning towards HD, but wants to read about the subject. The pt has follow up with the surgeons for arranging access. In the meantime, avoid IVs, phlebotomies and BP checks in his left arm. He will follow up with ___ (___) and Dr. ___ in the ___ clinic. # Type II Diabetes Mellitus: Pt has had good control with A1c 6.7% in ___. Pt was on ___ 50mg daily and metformin 850mg TID. Given his CRF, metformin must be discontinued indefinitely. A ___ consult was obtained to assist in med management. Januvia must be renally dosed, so the pt was discharged on ___ 25mg daily. If further BG control needed, glipizide 2.5mg daily could be added. The pt should call for a ___ at the ___ (seen by Dr. ___ as ___, and should also call for BG <80. CHRONIC DIAGNOSES: # Paroxysmal Atrial fibrillation: The pt was generally well rate-controlled but had occasional asymptomatic nocturnal bradycardia down to the ___ on his home dose of metoprolol (50mg BID). He was discharged on Toprol XL 37.5mg PO daily. In addition, anticoagulation was discussed with the patient, whose CHADS score is 3. He was resistant to the idea of starting Coumadin, despite being told the risks and benefits, and was instructed to discuss the issue with his PCP and cardiologist. # Vitamin B12 Deficiency: Most recent B12 shows pt is repleted. His home B12 was continued on discharge. # Hypertension: The pt was continued on his home dose of tamsulosin. Beta-blocker dose changed (see above). # Vitamin D deficiency: The pt was continued on his home dose of calcitriol. # Primary prevention: The pt was continued on aspirin 81 daily. TRANSITIONAL ISSUES: -The patient's DM regimen has changed to ___ 25mg daily. Metformin was discontinued indefinitely. He needs close follow up with his blood sugars and should be seen in the ___ clinic (pt to call for appt). -The patient's metoprolol was discontinued and replaced with metoprolol XL 37.5mg daily. -Anticoagulation is recommended for this pt with paroxysmal A. fib and CHADS score 3. He refused to initiate treatment with Coumadin. His PCP and cardiologist should discuss this issue further with the pt. -The pt is taking oral bicarbonate and should have his electrolytes re-tested as part of his PCP follow up. -___ arm precautions are new for this pt, who is planning for fistula placement in the coming weeks. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Calcitriol 0.25 mcg PO EVERY OTHER DAY 2. Calcitriol 0.5 mcg PO EVERY OTHER DAY 3. Fluticasone Propionate NASAL 1 SPRY NU BID 4. MetFORMIN (Glucophage) 850 mg PO 2 TABS IN AM AND 1 TAB IN ___ 5. Metoprolol Tartrate 25 mg PO BID hold for sbp < 90 or hr < 60 6. Januvia *NF* (sitaGLIPtin) 50 mg Oral daily 7. Tamsulosin 0.4 mg PO HS 8. Aspirin 81 mg PO DAILY 9. Cyanocobalamin ___ mcg PO DAILY 10. Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry eyes Discharge Medications: 1. Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry eyes 2. Aspirin 81 mg PO DAILY 3. Calcitriol 0.25 mcg PO EVERY OTHER DAY 4. Calcitriol 0.5 mcg PO EVERY OTHER DAY 5. Cyanocobalamin ___ mcg PO DAILY 6. Fluticasone Propionate NASAL 1 SPRY NU BID 7. Januvia *NF* (sitaGLIPtin) 25 mg Oral daily RX *sitagliptin [Januvia] 25 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 8. Tamsulosin 0.4 mg PO HS 9. Sodium Bicarbonate 1300 mg PO BID RX *sodium bicarbonate 650 mg 2 tablet(s) by mouth twice a day Disp #*120 Tablet Refills:*0 10. Metoprolol Succinate XL 37.5 mg PO DAILY RX *metoprolol succinate [Toprol XL] 25 mg 1.5 tablet extended release 24 hr(s) by mouth once a day Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSES: # Metformin adverse effect # metabolic acidosis # Paroxysmal Atrial fibrillation # Chronic kidney disease SECONDARY DIAGNOSES: # Type 2 diabetes mellitus with complications # Hypertension # Emphysema Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a pleasure to care for you during your hospitalization at ___. You were admitted because of a toxicity from metformin, called metabolic acidosis. It caused you to be very sleepy and weak. Your metformin was stopped permanently and you were treated with IV fluids and bicarbonate, a medicine used to decrease acid in the blood. In terms of your diabetes medications, you will be discharged home on just Januvia 25mg daily. DO NOT TAKE METFORMIN. You should call Dr. ___ office on ___ to schedule a ___ appointment within the week. You will also be sent home with a new prescription for bicarbonate pills, to help counteract the acid in your blood. You were also found to have worsening kidney function. The kidney doctors saw ___ and suspect you will need dialysis in the near future. You will need to follow up with them to plan for fistula placement soon. You have paroxysmal atrial fibrillation (originally thought to be a new diagnosis for you, but upon further investigation into the records, you have a history of it in the past). Because your heart rate was low during the night, you will be discharged on 37.5mg metoprolol XL (a slightly lower dose than what you were previously on, as well as a longer-acting medication). You will need to discuss anticoagulation with Dr. ___ it is indicated for your heart rhythm to prevent stroke, but you did not want to start the medication in the hospital. Followup Instructions: ___
10387770-DS-20
10,387,770
23,454,089
DS
20
2202-12-30 00:00:00
2202-12-31 22:45:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins / Lipitor Attending: ___. Chief Complaint: Fall Major Surgical or Invasive Procedure: None History of Present Illness: This is a an ___ y.o. male with history of chronic a. fib on coumadin, DM type II, HFpEF(EF >65% ___, and CKD stage V, with a chronic right pleural effusion presents with progressive decline in functional status (decreased appetite and mobility) with fall from standing today. He presented to the emergency department after reporting fall from standing with unknown head strike. He endorsed unclear recollection of the event (thinks he slipped on something in the bathroom), but is pretty certain he had no loss of consciousness and wife reports he was aware when she came into the room. No bowel or bladder incontinence. Past Medical History: 1. Diabetes mellitus with peripheral neuropathy and chronic renal failure (cr = 2.1-4.0 from ___. %HbA1c = 6.7 on ___. 2. Emphysema. 3. Hypertension. 4. Posterior vitreous detachment. 5. Urolithiasis. 6. History of basal cell carcinomas. 7. Hypersensitivity reaction. 8. Allergic rhinitis. 9. Vitamin B12 deficiency 10. Hypogammaglobulinemia. 11. Pleural effusion 12. CHF 13. Afib on warfarin, CHADS2Vasc 5 Social History: ___ Family History: FAMILY HISTORY: ___ significant for mother with gastric ___ @ age ___ died age ___ Father emphysema died age ___. Siblings: no hx of cancer Maternal 3 aumts and MGM also with h/o CA in the abdomen, unknown which types. Physical Exam: ADMISSION Physical Exam: ======================== VITALS: Temp 98.4 BP135/72 HR100 SpO295% RR 18 GENERAL: Comfortable, well-appearing. HEENT: Normocephalic, atraumatic. Pupils equal, round, and reactive bilaterally, extraocular muscles intact. Sclera anicteric and without injection. Moist mucous membranes, good dentition. Oropharynx is clear. NECK: No JVD visualized. Neck is supple with full range of motion. CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. ___ RUSB systolic murmur LUNGS: Clear to auscultation bilaterally w/appropriate breath sounds appreciated in all fields. No wheezes, rhonchi or rales. No increased work of breathing. ABDOMEN: Normal bowels sounds, non distended, non-tender to deep palpation in all four quadrants. No organomegaly. EXTREMITIES: No clubbing, cyanosis, or edema. Pulses DP/Radial 2+ bilaterally. There is no lower extremity edema. There is a well-appearing wound with sutures in Left hand. SKIN: Warm. Cap refill <2s. No rash. Diffuse bruising at arms and sites of insulin injections. NEUROLOGIC: CN2-12 intact. ___ strength throughout. Alert and oriented to person, place, but thought it was ___. Correctly knew ___ was yesterday. Difficulty with weeks in reverse. Left arm fistula: Bruit with palpable thrill present DISCHARGE PHYSICAL EXAM ======================= VS: ___ 1137 BP: 103/64 HR: 73 RR: 20 O2 sat: 99% O2 delivery: Ra GENERAL: Resting comfortably in bed in no acute distress. HEENT: Normocephalic, atraumatic. EOMI. Dry mucous membranes. NECK: Supple. JVP flat while lying. CARDIAC: Regular rhythm, normal rate. ___ RUSB systolic murmur LUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or rales. ABDOMEN: Soft, non-tender, non-distended. EXTREMITIES: Warm, well perfused. No edema. SKIN: Scattered ecchymosis in upper extremities. distal extremities warm and well perfused. PSYCH/NEURO: Calm, A+O x1-2 Pertinent Results: DISCHARGE LABS: ___ 06:25AM BLOOD WBC-16.4* RBC-3.19* Hgb-10.4* Hct-32.8* MCV-103* MCH-32.6* MCHC-31.7* RDW-13.0 RDWSD-48.9* Plt ___ ___ 06:25AM BLOOD Plt ___ ___ 06:25AM BLOOD ___ PTT-40.4* ___ ___ 06:25AM BLOOD Glucose-162* UreaN-81* Creat-5.0* Na-138 K-4.2 Cl-95* HCO3-20* AnGap-23* ___ 06:25AM BLOOD Calcium-9.4 Phos-5.3* Mg-2.6 ADMISSION LABS: ___ 01:00PM BLOOD Neuts-82.6* Lymphs-9.9* Monos-7.0 Eos-0.0* Baso-0.1 Im ___ AbsNeut-9.19* AbsLymp-1.10* AbsMono-0.78 AbsEos-0.00* AbsBaso-0.01 ___ 01:00PM BLOOD Plt ___ ___ 01:00PM BLOOD ___ PTT-40.1* ___ ___ 01:00PM BLOOD Glucose-274* UreaN-42* Creat-4.5* Na-140 K-3.3* Cl-85* HCO3-30 AnGap-25* ___ 01:00PM BLOOD ALT-8 AST-11 CK(CPK)-42* AlkPhos-113 TotBili-1.0 ___ 01:00PM BLOOD Lipase-38 ___:00PM BLOOD ___ ___ 07:50AM BLOOD CK-MB-3 cTropnT-0.12* ___ 08:50AM BLOOD CK-MB-2 cTropnT-0.09* ___ 09:40AM BLOOD CK-MB-1 cTropnT-0.10* ___ 03:39AM BLOOD CK-MB-2 cTropnT-0.11* ___ 01:00PM BLOOD Albumin-3.4* Calcium-9.9 Phos-4.4 Mg-1.5* ___ 01:09PM BLOOD Lactate-3.3* ___ 06:30PM BLOOD Lactate-2.3* ___ 10:52AM BLOOD Lactate-1.9 K-3.4 IMAGING/OTHER STUDIES ===================== * ___ TTE: The left atrial volume index is severely increased. Left ventricular wall thickness, cavity size, and global systolic function are normal (LVEF>55%). Due to suboptimal technical quality, a focal wall motion abnormality cannot be fully excluded. Diastolic function could not be assessed. Right ventricular chamber size and free wall motion are normal. The aortic root is mildly dilated at the sinus level. The number of aortic valve leaflets cannot be determined. The aortic valve leaflets are mildly thickened (?#). No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Mild to moderate (___) mitral regurgitation is seen. There is moderate pulmonary artery systolic hypertension. There is no pericardial effusion. Compared with the prior study (images unable to be reviewed) of ___, the degree of mitral regurgitation is greater. Estimated pulmonary artery pressures are higher. Brief Hospital Course: This patient is a an ___ y.o. male with history of chronic a. fib on Coumadin, DM type II, HFpEF(EF >65% ___, and CKD stage V, with a chronic right pleural effusion and scarring who presented with progressive decline in functional status (decreased appetite and mobility)with fall from standing and multiple falls recently. He was initially admitted for a ___ evaluation and became unresponsive in the AM of ___ and found to have sustained monomorphic VT. He was subsequently transferred to the CCU where he was started on IV Amiodarone and then transferred back to the medical ward. #Monomorphic Ventricular Tachycardia: The patient became unresponsive in the AM of ___ and found to have sustained monomorphic VT on telemetry and EKG. A CODE BLUE was called and the patient received two shocks, a 150mg IV and a 300 mg IV amiodarone bolus, and was then started on an amiodarone drip before being transferred to the CCU. The patient stabilized on the amiodarone drip in the CCU and was transferred to the medical floor. He was subsequently started on Amiodarone 400mg PO BID to complete a 10g Amiodarone load (to end on ___. The patient will be transitioned to Amiodarone 400mg PO QD on ___ (once 10g load is complete). He was continued on warfarin for anticoagulation for his atrial fibrillation (as discussed below). The source of his VT was thought to be secondary to a reentry mechanism due to myocardial scarring as the patient does have evidence of possible prior inferior MI with Q waves in II, III and aVF. #Goals of Care #Declining Functional Status #Fall #Concern for Aspiration/ Dysphagia The patient initially presented to the ED after sustaining multiple falls and having increasing difficulty with ambulation and preforming his ADLs at home. Initially his falls were thought to be mechanical vs. possible orthostasis, however, given his VT arrest (as above), it most likely arrhythmogenic syncope. Following the patient's VT arrest and ICU stay, the ___ hospital course was complicate by delirium, concerns for aspiration, and severe deconditioning. ___ saw the patient and had recommended rehab. Speech and Swallow saw the patient and determined the patient to be at high aspiration risk and had initially recommended NPO. A goals of care discussion was held with the family and patient made the patient DNR/DNI, and do not hospitalize. It was established that the patient's main goal was to be able to get home and he and the family were amenable to rehab as bridge. Per family meeting wish to go ahead and allow patient to eat and the patient was order modified aspiration diet. #UTI The patient became acutely delirious on ___ and an infectious work up was sent including a urine culture which was positive for E. coli. He was treated with CTX starting on ___ with plans for a 7 days course for a complicated UTI to end on ___. Converted to cefpodoxime on discharge. #Encephalopathy The patient acutely developed altered mental status in ___ of ___ which included vivid hallucinations and agitation. He was A&O x0 at that time. Neuro exam was non-focal. The following day his delirium had substantially improved, however, he remained more somnolent and had not returned to his baseline. Thought to be hospital delirium in the setting of recent arrest and infection. We continued to treat his infection as above and prescribed Seroquel QHS PRN. #Chronic Afib on Coumadin The patient has known A. fib with a CHADS2vasc 5: 7.5% annual risk of CVA, 15% total event risk (including TIA). He presented with an elevated INR to 6.8 and his Warfarin was initially held. For rate and rhythm control the patient was initially continued on his home Metoprolol which was discontinued after his VT arrest when he was started on amiodarone. For anticoagulation the patient's INR was initially supratherapeutic and trended down. He continued to be intermittently supratherapeutic during his hospitalization and his warfarin was dosed based on INR levels. #HFpEF The patient has known HFpEF with his last TTE prior to admission in ___ with EF 65%. BNP 26808 on arrival, though the patient appeared dried on initial presentation and his weight was down. This was thought to be secondary to over diuresis in the setting of poor PO intake. The patient's home Torsemide and Metolazone were initially held given his dry appearance on presentation. Ultimately his home Torsemide 80mg QD was resumed. We continued to hold his home metolazone 2.5mg PO QD as patient appeared euvolemic or volume down throughout his hospitalization. #CKD Stage V: The patient had known CKD-V on presentation likely secondary to HTN or DM. He has an intact left AV fistula intact with good bruit though patient, however, he opted not to pursue HD moving forward. His baseline Cr is ~3.5-4.5 since ___. #BPH: The patient was continued on Tamsulosin. #Diabetes mellitus: Complicated by peripheral neuropathy and chronic renal failure. Most recent HbA1c = 6.7. The patient was continued on his home Glargine 6U qAM and his home Lispro 3U with breakfast and 2 w/ dinner TANSITIONAL ISSUES: [] Patient will complete cefpodoxime for his UTI on ___ [] Patient's Amiodarone should be switched to from 400mg PO BID to ___ PO QD starting on ___ [] INR remains labile and will require regular checks over the next week to 2 weeks to maintain at a therapeutic level. Would check next INR on ___ and if <3.0, would start 1.0mg PO QD with a repeat INR in ___ days. [] Patient requires ongoing work with ___ to be able to safely transition home, which may include transition to acute rehab once he recovers sufficiently. If patient ultimately does not recover enough to transition home, will merit further goals of care discussion and consideration of hospice (patient family aware of this as a possible contingency but we and they are hopeful he will mount enough recovery) [] Ongoing work with swallow therapist. [] Discharge Cr: 5.0. Patient not interested in dialysis based on GOC. The patient may begin to develop symptoms from his worsening kidney function (volume overload, uremia, further AMS) and this should be a discussion with his family and him about how they would like to proceed (i.e. if hospitalization is in goals of care, if he would like to pursue hospice, etc.). [] Patient has 8cm left hand wound. Sutures removed on ___. Would re-examine hand wound intermittently and ensure that it does not look infected and is not opening up/ dehiscing. [] Patient's home metolazone is being held currently. Appears euvolemic, but if appears to be volume overloaded may consider restarting Metolazone. [] CODE STATUS: DNR/DNI/No Dialysis/ No escalation of Care. [] CONTACT: ***HCP: ___/ Relationship: Daughter/ Phone number: ___ phone: ___ ***Alternate HCP: ___ ___ ***Pt would also like wife ___ to be a contact: ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Calcitriol 0.5 mcg PO DAILY 2. Collagenase Ointment 1 Appl TP DAILY 3. Donepezil 5 mg PO QHS 4. Fluticasone Propionate NASAL 1 SPRY NU BID 5. Glargine 6 Units Breakfast Humalog 3 Units Breakfast Humalog 2 Units Dinner 6. Metolazone 2.5 mg PO PRN BEFORE TORSEMIDE WHEN THERE IS LEG SWELLING Leg swelling 7. Metoprolol Succinate XL 25 mg PO DAILY 8. Omeprazole 40 mg PO DAILY 9. Tamsulosin 0.4 mg PO QHS 10. Torsemide 80 mg PO DAILY 11. Aspirin 81 mg PO DAILY 12. Cyanocobalamin ___ mcg PO BID 13. Artificial Tears ___ DROP BOTH EYES PRN dry eyes 14. Sodium Bicarbonate 1300 mg PO BID 15. Warfarin 2.5 mg PO 5X/WEEK (___) 16. Warfarin 5 mg PO 2X/WEEK (MO,FR) Discharge Medications: 1. Amiodarone 400 mg PO BID Duration: 4 Doses 2. Amiodarone 400 mg PO DAILY PLEASE START FIRST DOSE IN AM of ___ 3. Docusate Sodium 100 mg PO BID 4. Multivitamins W/minerals 1 TAB PO DAILY 5. QUEtiapine Fumarate 25 mg PO QHS:PRN agitation, hallucinations 6. Ramelteon 8 mg PO QHS 7. Senna 17.2 mg PO BID 8. Glargine 6 Units Breakfast Humalog 3 Units Breakfast Humalog 2 Units Dinner 9. Artificial Tears ___ DROP BOTH EYES PRN dry eyes 10. Aspirin 81 mg PO DAILY 11. Calcitriol 0.5 mcg PO DAILY 12. Collagenase Ointment 1 Appl TP DAILY 13. Cyanocobalamin ___ mcg PO BID 14. Donepezil 5 mg PO QHS 15. Fluticasone Propionate NASAL 1 SPRY NU BID 16. Metoprolol Succinate XL 25 mg PO DAILY 17. Omeprazole 40 mg PO DAILY 18. Tamsulosin 0.4 mg PO QHS 19. Torsemide 80 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Ventricular Tachycardia Arrest HFpEF CKD Stage V Atrial Fibrillation Type II Diabetes Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Lethargic but arousable. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at ___. WHY WAS I IN THE HOSPITAL? - You were admitted to the hospital because you had a fall at home and had not been walking/moving as well at home. WHAT HAPPENED TO ME IN THE HOSPITAL? - While you were in the hospital you had an arrhythmia called Ventricular Tachycardia for which you were given medications and required an electrical shock. - You were sent to the ICU and started on an IV medication to help treat your arrhythmia - Your medications were adjusted to help your heart function better - We had our physical therapists work with you to help you rehabilitate. - You were found to have a urinary tract infection for which you were treated with IV antibiotics. - We had multiple meetings with you and your family to discuss what the best plan is going forward with your treatment WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. - Please see the section below for a list of all of your medications We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
10387936-DS-20
10,387,936
20,326,543
DS
20
2143-12-15 00:00:00
2143-12-16 14:46:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Fever, abdominal pain, nausea, emesis, diarrhea Major Surgical or Invasive Procedure: None History of Present Illness: ___ y/o M with no PMH who presented to the ED on ___ with fever, diffuse abdominal pain, nausea, SOB and diarrhea. He had been seen in the ED the day prior for one day of fatigue, myalgias, fevers/chills, HA's and nausea. He reports starting to feel poorly in the middle of the day after class. When his sxs persisted that afternoon, he presented to the hospital. He had normal labs and a negative flu swab in the ED, diagnosed with viral syndrome and sent home. The patient's symptoms worsened that night and he developed severe abdominal pain. He says the pain was diffuse, severe (___) and fluctuated in severity. He reports worse pain with eating. His vomiting and diarrhea persisted and he reports that both were non-bloody. He did not take his temperature at home. He was unable to eat/drink at home. He continued to experience nausea, vomiting, HA's and chills on ___ and represented to the ED. He says he has never had any prior issues with diarrhea and has never experienced this constellation of sxs in the past. He denies any chest pain or shortness of breath. No urinary symptoms. He does not report any sick contacts, recent travel or changes to eating habits. He endorses a rash on his knuckles that developed over the last month. No family history of similar presentations. In the ED, initial vital signs were: T 102.4, HR 104, BP 116/53, RR 16, 100% RA - Exam notable for: Normal cardiac and pulmonary exam. Right lower quadrant tenderness without rebound or guarding. - Labs were notable for CRP 140.4, WBC 3.7 (with 40% bands); Hct 34.0; Plt ct ___ Cr 1.0; C diff neg; Cal 7.7; Mag 1.2; lactate 2.7; stool studies, blood cx, ESR UA, lactate are pending. - Studies performed include a bedside ultrasound which did not show any definitive inflamed appendix. CT abdomen and pelvis with contrast showed diffuse thickening of the right ascending colon and terminal ileum concerning for IBD. - Patient was given cipro/flagyl, IV fluids, Zofran and morphine - Vitals on transfer: T:102.1 BP: 138/74 HR:93 RR:18 O2sat:97%RA Upon arrival to the floor, the patient was stable with diffuse abdominal pain, HA's, nausea. He was able to tolerate clear liquids without vomiting, but still complained of nausea. Review of Systems: (+) per HPI (-) vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, BRBPR, melena, hematochezia, dysuria, hematuria. Past Medical History: None Social History: ___ Family History: Reports diabetes on his father's side. No other medical conditions that he is aware of. Physical Exam: Admission exam: Vitals- T:102.1 BP: 138/74 HR:93 RR:18 O2sat:97%RA GENERAL: In some discomfort but well-appearing; AOx3, NAD HEENT: PERRL, EOMI, MMM NECK: Thyroid is normal in size and texture, no nodules. No cervical lymphadenopathy. CARDIAC: Regular rhythm, normal rate, no murmurs/rubs/gallops. No JVD. LUNGS: Clear to auscultation bilaterally w/appropriate breath sounds appreciated in all fields. No wheezes, rhonchi or rales. Resonant to percussion. BACK: Skin. no spinous process tenderness. no CVA tenderness. ABDOMEN: Guarding, tender diffusely and especially in RLQ, no rebound tenderness, negative ___ sign EXTREMITIES: No clubbing, cyanosis, or edema, no sign of atrophy/hypertrophy. Pulses DP/Radial 2+ bilaterally. SKIN:Hyperpigmentation on knuckles bilaterally. NEUROLOGIC: CN2-12 intact. ___ strength throughout. Discharge exam: Vitals- T:97.9 BP:105/63 P:52 RR:18 O2sat:98%ra GENERAL: lying in bed, comfortable, AOx3, NAD HEENT: PERRL, EOMI, MMM CARDIAC: Regular rhythm, normal rate, no murmurs/rubs/gallops. No JVD. LUNGS: Clear to auscultation bilaterally w/appropriate breath sounds appreciated in all fields. No wheezes, rhonchi or rales. ABDOMEN: bowel sounds present, non-distended, mildly tender to palpation diffusely. No peritoneal signs, neg ___ sign. EXTREMITIES: No edema. SKIN:Hyperpigmentation on knuckles bilaterally. Pertinent Results: Admission labs: ___ 04:30PM BLOOD WBC-4.7# RBC-4.99 Hgb-12.6* Hct-38.6* MCV-77* MCH-25.3* MCHC-32.6 RDW-13.2 RDWSD-37.1 Plt ___ ___ 04:30PM BLOOD Neuts-80* Bands-13* Lymphs-3* Monos-3* Eos-0 Baso-1 ___ Myelos-0 AbsNeut-4.37 AbsLymp-0.14* AbsMono-0.14* AbsEos-0.00* AbsBaso-0.05 ___ 04:30PM BLOOD Plt Smr-LOW Plt ___ ___ 04:30PM BLOOD Glucose-161* UreaN-9 Creat-0.9 Na-136 K-3.4 Cl-102 HCO3-18* AnGap-19 ___ 10:04AM BLOOD ALT-15 AST-16 AlkPhos-37* TotBili-0.3 ___ 10:04AM BLOOD Calcium-7.7* Phos-2.7 Mg-1.2* ___ 01:00AM BLOOD calTIBC-226* Ferritn-229 TRF-174* ___ 10:04AM BLOOD CRP-140.4* ___ 04:50PM BLOOD Lactate-2.7* Discharge labs: ___ 06:35AM BLOOD WBC-6.0 RBC-5.14 Hgb-12.8* Hct-39.4* MCV-77* MCH-24.9* MCHC-32.5 RDW-13.9 RDWSD-38.6 Plt ___ ___ 06:35AM BLOOD ___ PTT-32.0 ___ ___ 06:35AM BLOOD Glucose-84 UreaN-4* Creat-0.7 Na-141 K-4.5 Cl-103 HCO3-24 AnGap-19 ___ 06:35AM BLOOD ALT-209* AST-216* AlkPhos-67 TotBili-0.3 ___ 06:35AM BLOOD Calcium-8.9 Phos-4.9* Mg-2.1 ___ 02:12PM BLOOD calTIBC-235* Ferritn-581* TRF-181* ___ 06:35AM BLOOD HBsAg-Negative HBsAb-Negative HBcAb-Negative HAV Ab-Negative Imaging: CT Abdomen/Pelvis with Contrast ___ 1. Marked mural thickening involving the ascending colon and terminal ileum concerning for inflammatory bowel disease. Small volume ascites and reactive lymph nodes in the right lower quadrant. 2. Normal appendix. 3. Left renal collecting system. RUQ U/S ___ Normal abdominal ultrasound. No ultrasound findings correlating to the reported history of right upper quadrant pain. MICROBIOLOGY: ___ 10:00 am STOOL CONSISTENCY: NOT APPLICABLE Source: Stool. **FINAL REPORT ___ FECAL CULTURE (Final ___: SALMONELLA SPECIES. SALMONELLA ID CONFIRMED BY STATE LAB ON ___. Reported to and read back by ___ ___ ___ @12:35 ___. CAMPYLOBACTER CULTURE (Final ___: NO CAMPYLOBACTER FOUND. OVA + PARASITES (Final ___: CANCELLED. PATIENT CREDITED. Three separate stool specimens collected EVERY OTHER DAY are recommended for optimum sensitivity. Duplicate specimens collected on the same day will not be processed, since this does not increase diagnostic yield. Make sure to label date and time of collection on each stool specimen submitted to ensure appropriate processing. FECAL CULTURE - R/O VIBRIO (Final ___: NO VIBRIO FOUND. FECAL CULTURE - R/O YERSINIA (Final ___: NO YERSINIA FOUND. FECAL CULTURE - R/O E.COLI 0157:H7 (Final ___: NO E.COLI 0157:H7 FOUND. Brief Hospital Course: ___ y/o M with no PMH who presented to the ED with 2 days of fever/chills, vomiting, non-bloody diarrhea, and worsening abdominal pain consistent with salmonella enterocolitis and transaminitis. #Salmonella enterocolitis Patient presented with 2 days of fevers to 102.1, worsening diffuse abdominal pain, vomiting and non-bloody diarrhea. CT demonstrated thickening of ascending colon and terminal ileum, numerous reactive lymph nodes in the right lower quadrant, and normal appendix. Stool studies positive for salmonella infection, possibly acquired from lab exposure at his school. Initially treated with cipro/flagyl, now narrowed to cipro with clinical improvement. Pt w/associated odynophagia, and was thus tested for HIV and EBV, which were negative. His pain was managed with IV morphine, nausea with Zofran, and he was given IV maintenance fluids as needed. At the time of discharge, he had much improved pain, no diarrhea, and was able to tolerate PO. # Abnormal liver function tests: Patient's liver function tests were elevated, which is likely a manifestation of Salmonella enteritidis enterocolitis, which will likely ___: ___. ___, ___, et al. Abnormalities in liver enzyme levels during Salmonella enteritidis enterocolitis. Rev ___. ___. He had no RUQ pain or tenderness, RUQ ultrasound without acute process, and hepatitis serologies were negative. Monospot and CMV were negative. His LFTs will be checked ___ days after discharge, and he will follow-up with his PCP ___ ___ weeks. # Anemia: Hgb of 11.3 on admission which increased to 12.8 by discharge. Unclear of his baseline. This is likely a function of acute marrow suppression secondary to infection, which is already self-resolving. His CBC will be checked ___ days after discharge, and he will follow-up with his PCP ___ ___ weeks. Transitional issues: - LFTs on discharge: AST 216, ALT 209, Alk Phos 67, Tbili 0.3 - Hemoglobin on discharge: 12.8 - ___ meds: Ciprofloxacin 500 mg PO BID (Day 1 = ___, 7 day course, last day = ___ -***Instructed Mr. ___ he should not handle or prepare food for others for ___ weeks given asymptomatic shedding phase. This phase will be prolonged in setting of antibiotics. #Emergency Contact/HCP: Mom ___ Medications on Admission: None Discharge Medications: 1. Ciprofloxacin HCl 500 mg PO Q12H RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day Disp #*5 Tablet Refills:*0 2. Ondansetron 4 mg PO Q8H:PRN nausea RX *ondansetron 4 mg 1 tablet(s) by mouth q8H: prn Disp #*10 Tablet Refills:*0 3.Outpatient Lab Work ICD-10: R94.5 Transaminitis Labs: Hemoglobin, Liver Function Tests Please fax results to: Attn: ___, MD (___) Discharge Disposition: Home Discharge Diagnosis: Primary diagnosis: Infectious colitis (salmonella) Secondary diagnosis: Transaminitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted for severe abdominal pain, fevers, nausea, and diarrhea. You were found to have an infection of your colon caused by salmonella bacteria. This infection was likely acquired from your recent handling of salmonella in school. We treated you with broad antibiotics (ciprofloxacin and flagyl) to treat your infection, and your condition improved. Once you leave, you should continue taking the ciprofloxacin antibiotic for 2 more days (until the end of the day on ___. In the hospital, we also noticed that your Liver Function Tests (LFTs) were increasing, which could be a sign of liver inflammation. This may be related to your salmonella infection. An ultrasound of your liver was normal. Please have your labs checked at the ___ lab (___) on ___ or ___. For questions, their phone number is ___. To be clear, this is just to get labs drawn to minimize costs while you establish insurance in ___. The results will be sent to us, and we will follow-up. Please also see your PCP in ___ in the next ___ weeks. If your condition worsens for any reason, or you develop ___ or worsening pain, fever, yellowing of eyes or skin, confusion, inability to tolerate food (nausea or vomiting) proceed straight to the emergency department. It was a pleasure to take care of you. Sincerely, Your ___ team Followup Instructions: ___
10388043-DS-11
10,388,043
22,871,741
DS
11
2142-10-06 00:00:00
2142-10-06 17:41:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Keflex Attending: ___. Chief Complaint: syncope Major Surgical or Invasive Procedure: none History of Present Illness: Ms. ___ is a ___ female with metastatic triple negative breast cancer complicated by malignant urinary obstruction requiring intermittent self-catherization who presents with syncope. Patient was recently admitted ___ to ___ with fevers and urine retention found to have sepsis from pyelonephritis. She was treated with 7-day course of ciprofloxacin. She was seen in ___ clinic and started on capecitabine 2500mg daily. Patient reports 5 days ago, she developed lightheadedness and dizziness upon sitting up in bed and standing associated with room spinning. She also note associated feeling warm and sweaty. This lasted between 20 minutes to 1 hour and improved with lying on a cold surface. Then 2 days ago, she was going to the bathroom to lie down on the cold floor when she had a syncopal event, striking her head. Then on ___ night, patient had the same episode in the early morning where she got up to go to the bathroom and had a syncopal event in the bathroom where she hit her head and lost consciousness. She was found on the ground by her mother who noted that she was disoriented. She denies any seizure activity or tongue biting. She denies associated chest pain, palpitations, shortness of breath, headaches, slurred speech, and weakness/numbness. She felt dizzy all day on ___ so presented for to see her oncologist who referred her into the ED. She otherwise endorses new hoarseness for the past 1 week. She notes increased right arm lymphedema with decreased strength and intermittent numbness. She notes decreased appetite but has been drinking plenty of fluids. Also some mild diarrhea since starting capecitabine. On arrival to the ED, initial vitals were 97.1 90 131/85 20 95% RA. Exam was notable for normal neurological exam. Labs were unremarkable. Blood and urine cultures were sent. CXR and head CT were negative. CT neck showed non-specific retropharyngeal edema and persistent right neck mass. She was given morphine 2mg IV, Tylenol 1g IV, Zofran 4mg IV, and 1L NS. Prior to transfer vitals were 98.1 85 114/79 16 97% RA. On arrival to the floor, patient reports ___ right-sided neck pain. She denies fevers/chills, headache, vision changes, weakness/numbnesss, shortness of breath, cough, hemoptysis, chest pain, palpitations, abdominal pain, nausea/vomiting, hematemesis, hematochezia/melena, dysuria, hematuria, and new rashes. Past Medical History: PAST ONCOLOGIC HISTORY: -late ___: discovered to have a right upper outer quadrant breast mass. - Right partial mastectomy and sentinel node biopsy performed at ___ in ___ on ___ revealed an infiltrating ductal carcinoma with 2 of 4 positive sentinel nodes, ER positive, PR positive, and HER-2 negative. Reexcision and axillary dissection were performed in ___, with negative margins and 6 negative nodes by report - She underwent radiation therapy, and chemotherapy (Adriamycin, cyclophosphamide, Taxol, Avastin). -___: she was found to have metastatic disease involving her neck, ovaries, and bones. - Not currently getting chemotherapy, getting XRT for bony metastasis in neck. Had been enrolled in study investigating the safety and efficacy of Eribulin Mesylate in Combination With Pembrolizumab. Pembrolizumab permanently discontinued on ___, due to recurrent pneumonitis. Determined to have progression of her disease and therefore taken off study with Eribulin, effective ___. PAST MEDICAL HISTORY: - breast cancer, as above - pembrolizumab-induced cryptogenic organizing pneumonia - hypothyroidism - HLD Social History: ___ Family History: Father - multiple myeloma (___). No family history of breast or ovarian cancer. Physical Exam: ADMISSION VITALS: Afebrile and vital signs stable GENERAL: Alert and in no apparent distress EYES: Anicteric, pupils equally round ENT: Ears and nose without visible erythema, masses, or trauma. Oropharynx without visible lesion, erythema or exudate. TM normal, cone of line intact bilaterally. Right neck with thickened, course skin post-radiation, limited rotational ROM. CV: Heart regular, no murmur, no S3, no S4. No JVD. No ___ edema RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: Abdomen soft, non-distended, non-tender to palpation. Bowel sounds present. GU: No suprapubic fullness or tenderness to palpation MSK: Neck supple, moves all extremities, strength grossly full and symmetric bilaterally in all limbs SKIN: No rashes or ulcerations noted NEURO: Alert, oriented, face symmetric, gaze conjugate with EOMI, speech fluent, moves all limbs, sensation to light touch grossly intact throughout PSYCH: pleasant, appropriate affect DISCHARGE VITALS: Afebrile and vital signs stable GENERAL: Alert and in no apparent distress EYES: Anicteric, pupils equally round ENT: Ears and nose without visible erythema, masses, or trauma. Oropharynx without visible lesion, erythema or exudate. TM normal, cone of line intact bilaterally. Right neck with thickened, course skin post-radiation, limited rotational ROM. CV: Heart regular, no murmur, no S3, no S4. No JVD. No ___ edema RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: Abdomen soft, non-distended, non-tender to palpation. Bowel sounds present. GU: No suprapubic fullness or tenderness to palpation MSK: Neck supple, moves all extremities, strength grossly full and symmetric bilaterally in all limbs SKIN: No rashes or ulcerations noted NEURO: Alert, oriented, face symmetric, gaze conjugate with EOMI, speech fluent, moves all limbs, sensation to light touch grossly intact throughout PSYCH: pleasant, appropriate affect Pertinent Results: ADMISSION ___ 08:15PM BLOOD WBC-6.2 RBC-3.77* Hgb-10.5* Hct-32.1* MCV-85 MCH-27.9 MCHC-32.7 RDW-17.1* RDWSD-50.8* Plt ___ ___ 08:15PM BLOOD Neuts-69.5 Lymphs-17.7* Monos-9.7 Eos-2.3 Baso-0.5 Im ___ AbsNeut-4.28 AbsLymp-1.09* AbsMono-0.60 AbsEos-0.14 AbsBaso-0.03 ___ 08:15PM BLOOD Glucose-119* UreaN-12 Creat-0.7 Na-140 K-3.9 Cl-102 HCO3-27 AnGap-11 ___ 08:15PM BLOOD cTropnT-<0.01 ___ 09:07PM BLOOD Lactate-1.4 DISCHARGE ___ 05:35AM BLOOD WBC-6.2 RBC-3.97 Hgb-10.8* Hct-33.9* MCV-85 MCH-27.2 MCHC-31.9* RDW-17.4* RDWSD-52.3* Plt ___ ___ 05:35AM BLOOD Glucose-95 UreaN-10 Creat-0.7 Na-137 K-4.2 Cl-100 HCO3-26 AnGap-11 ___ 05:35AM BLOOD Albumin-3.7 Calcium-8.7 Phos-4.1 Mg-2.1 IMAGING ___ MRI 1. No acute intracranial abnormality. No evidence of intracranial metastatic disease at this time. 2. Solitary punctate focus of FLAIR hyperintensity, right external capsule, nonspecific. This could relate to sequelae of migraines, prior trauma, or early changes of chronic white matter microangiopathy. 3. Partially visualized enhancement and edema in the right inferior mastoid soft tissues at the posterolateral skullbase, without definitive apparent bony involvement. No focal fluid collection. This can be previously seen on examination of ___, previously described as concerning for metastatic disease. Brief Hospital Course: # Syncope: Patient with syncope in setting of dizziness. Differential includes vasovagal (with significant edema, now post-radiation changes and mass in the area, carotid sinus may be involved), cancer-related (possible brain mets or from new chemotherapy), med-related. Tele unremarkable throughout stay. No recurrence of Sx inpatient and ambualting without difficulty. Revealed that pt was taking Flexeril briefly around the time of Sx starting, which may have been contributing; this was held. Brain MRI showed no acute abnormality. Primary oncologist saw the patient on the day of discharge and agreed that she was safe for discharge with close outpatient follow up. Coached patient on slowly transitioning from lying to sit to stand; will stay out of work through the holiday week. #UTI: E coli in urine, >100k patient reports having had subtle UTI Sx in the past treated. Bactrim DS BID x3 days; last will be ___ am dose. Discharged with remaining doses. # Metastatic Triple Negative Breast Cancer: # Secondary Neoplasm of Bone: # Secondary Neoplasm of Lymph Node: # Secondary Neoplasm of Omentum: Recently started on Capecitabine. Evidence of metastatic spread to retropharyngeal area with edema probably ___ radiation, likely compression likely of laryngeal nerve. Updated Dr. ___. # Malignant Bladder Neck Obstruction: Extensive involvement by the neoplasm in floor of pelvis with mass in vesico-uterine pouch and extrinsic compression of ureters. Intermittent straight catheterization, as at home. # Mispositioned Port: CXR with port tip likely in right brachiocephalic vein. Now s/p repositioning this admission by ___ with no issues thereafter. # Anemia: At baseline. No evidence of bleeding. Likely due to chronic disease/malignancy. # Hypothyroidism: Continue home levothyroxine # Right Arm Lymphedema; chronic; continue supportive care TRANSITIONAL ISSUES: - f/u with oncologist - f/u pain regimen following DC of flexeril - consider further outpatient imaging to assess for effect of radiation/mass on carotid sinus if symptoms do not resolve Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Ferrous Sulfate 325 mg PO DAILY 2. Levothyroxine Sodium 175 mcg PO DAILY 3. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit oral DAILY 4. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 5. Capecitabine 1000 mg PO QAM 6. Capecitabine 1500 mg PO QPM 7. Cyclobenzaprine ___ mg PO HS:PRN pain 8. Ondansetron 8 mg PO Q8H:PRN nausea/vomiting Discharge Medications: 1. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 tablet(s) by mouth twice daily as needed Disp #*30 Tablet Refills:*2 2. Senna 8.6 mg PO BID:PRN Constipation - First Line RX *sennosides [senna] 8.6 mg 1 tab by mouth twice daily as needed Disp #*30 Tablet Refills:*1 3. Sulfameth/Trimethoprim DS 1 TAB PO BID Duration: 3 Days RX *sulfamethoxazole-trimethoprim 800 mg-160 mg 1 tablet(s) by mouth twice daily Disp #*2 Tablet Refills:*0 4. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 5. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit oral DAILY 6. Capecitabine 1000 mg PO QAM 7. Capecitabine 1500 mg PO QPM 8. Ferrous Sulfate 325 mg PO DAILY 9. Levothyroxine Sodium 175 mcg PO DAILY 10. Ondansetron 8 mg PO Q8H:PRN nausea/vomiting Discharge Disposition: Home Discharge Diagnosis: syncope retropharnygeal mass, edema, s/p radiation therapy UTI Discharge Condition: stable Discharge Instructions: You were admitted due to dizziness and a fall. It is not entirely clear what caused this but it may be due to your cancer or cancer treatment. Fortunately the MRI of your brain showed no acute changes. We also found that you may have a urinary tract infection and you were started on antibiotics. Please take the last two doses tonight and tomorrow morning. Please take all medications as prescribed and make sure to see your oncologist in follow up. Followup Instructions: ___
10388177-DS-10
10,388,177
22,335,321
DS
10
2136-04-17 00:00:00
2136-04-17 20:02:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Shortness of breath Major Surgical or Invasive Procedure: Endoscopic Gastroduodenoscopy, Colonoscopy History of Present Illness: ___, status post whipple procedure for groove pancreatitis complicated by wound infection, anastamotic leakage at the pancreaticojejunal anastamosis, with four days of melena, fatigue, and found at OSH ED to be in SVT up to 190 and have a HCT of 15. Per the wife, the patient had four days of increasingly melanic stools and the day of presentation to the OSH ED, had an episode of shaking, chills, and light-headedness followed by shortness of breath. It was after this that he presented to the OSH ED and had the above listed findings. He was transferred emergently to the ___ ED after receiving 2U PRBC and several rounds of adenosine which eventually broke his SVT. On initial evaluation in the ___, he was stable and responding appropriately to questions though he did appear quite pale. Past Medical History: Significant for a ___ history of diabetes, which has recently become insulin-dependent. He has a hypervascular lesion in the right kidney concerning for renal cell carcinoma. Social History: ___ Family History: He has no family history of gastrointestinal malignancy. Physical Exam: Gen: Well appearing, no acute distress CV: Regular rate and rhythm, no murmurs,rubs or gallops Pulm: Clear to auscultation bilaterally Abd: Soft, not distended, JP drain x2 in the R abdomen, nontender, no rebound or guarding, hypoactive bowel sounds, no palpable Ext: No ___ edema, ___ warm and well perfused Pertinent Results: ___ 08:36AM HCT-23.4* ___ 04:35AM WBC-23.4* RBC-2.34*# HGB-6.8*# HCT-20.9*# MCV-90 MCH-29.2 MCHC-32.6 RDW-15.1 Brief Hospital Course: On ___ the patient was admitted to the General Surgical Service for evaluation and treatment of SOB revealed to be secondary to anemia to a crit of 15 at an outside hospital, he was transferred to the ___ ED where he was transfused 2 units of blood and admitted to the ICU. Neuro: The patient received Dilaudid with good effect and adequate pain control. When tolerating oral intake, the patient was transitioned to oral pain medications. CV: Upon admission to the ICU, the patient's vitals were monitored, closely, he received serial HCT checks, (Q4 hours) and was transfused another unit of blood. After his hematocrit stabilized his vitals were consistently stable and his labs were drawn daily. Pulmonary: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. Good pulmonary toilet, early ambulation and incentive spirometry were encouraged throughout hospitalization. GI/GU/FEN: Upon admission he had a DRE with a positive GUAIAC. The patient was made NPO with IV fluids. A CT scan of his abdomen revealed no evidence of internal bleeding. He received an EGD to identify the source of his bleed. A clean based ulcer was identified at his gastro-jejunal anastomosis and was clipped. He received a colonoscopy prep, and received a colonoscopy, this revealed no source of bleeding. It was determined that the source of bleeding must be the ulcer, and he was started on IV PPI, and evaluated for H. pylori which was negative. He was restarted on tube feeds, and his PO diet was advanced when appropriate, which was well tolerated. Patient's intake and output were closely monitored, and IV fluid was adjusted when necessary. Electrolytes were routinely followed, and repleted when necessary. ID: The patient's white blood count and fever curves were closely watched for signs of infection. His EGD revealed an active esophageal candidiasis. He was started on and completed a course of fluconazole. Endocrine: The patient's blood sugar was monitored throughout his stay; insulin dosing was adjusted accordingly. A ___ consult was retained for the patients relatively new diagnosis of diabetes. Prophylaxis: The patient received subcutaneous heparin and venodyne boots were used during this stay; was encouraged to get up and ambulate as early as possible. At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Of note, the patient is declining to take pancreatic replacement enzymes at this time due to lack of insurance coverage and prohibitive cost of the medication. Medications on Admission: Amlodipine 5 mg PO daily, lantus 24- 26 in evening, metoprolol 25 mg tablet ER BID, percocet ___ mg ___ tablet(s) Q ___ hours for pain, aspirin 81 mg ___ QD, omeprazole 20mg BID Discharge Medications: 1. omeprazole 20mg PO BID -> (patient was given pantoprazole prescription but his insurance did not cover it, and he already had a standing prescription for omeprazole 20mg PO BID at home which he was instructed to continue as part of his therapy until told otherwise in ___ clinic) 2. Tamsulosin 0.4 mg PO HS RX *tamsulosin 0.4 mg 1 capsule(s) by mouth at bedtime Disp #*30 Capsule Refills:*0 3. Glargine 18 Units Bedtime Insulin SC Sliding Scale using Insulin RX *insulin glargine [Lantus] 100 unit/mL please take before bedtime. 18 Units before BED; Disp #*1 Vial Refills:*2 RX *insulin syringe-needle U-100 [Insulin Syringe] 30 gauge x ___ per insulin teaching as needed Disp #*3 Box Refills:*2 Disp #*3 Box Refills:*2 4. Amoxicillin 1000 mg PO Q12H H. pylori Duration: 7 Days RX *amoxicillin 500 mg 1 tablet(s) by mouth twice a day Disp #*14 Tablet Refills:*0 5. Clarithromycin 500 mg PO Q12H H. pylori Duration: 7 Days RX *clarithromycin [Biaxin] 500 mg 1 tablet(s) by mouth twice a day Disp #*14 Tablet Refills:*0 6. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H pain RX *oxycodone-acetaminophen [Percocet] 5 mg-325 mg 1 tablet(s) by mouth every ___ hours Disp #*30 Tablet Refills:*0 7. Insulin SC Sliding Scale Insulin SC Sliding Scale using HUM Insulin RX *insulin lispro [Humalog KwikPen] 100 unit/mL Up to 10 Units per sliding scale four times a day Disp #*2 Box Refills:*3 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: bleeding ulcer Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You may shower with your drains in place, but please keep them covered while in shower and change dressings afterwards with clean, dry dressings. Do not soak in a tub. Please call Dr. ___ or return to the emergency department if you have any bright red blood per rectum or dark tarry stools, bloody vomit, a fever greater than 100.5 degrees, significant increase in redness or drainage from around your wounds, significant increase or change in color of the drainage from your abdominal drain, or for any other medical concerns related to your recent surgery and post-operative course. Please take all prescribed medications as instructed, and call Dr. ___ office with any questions. Followup Instructions: ___
10388429-DS-22
10,388,429
25,170,552
DS
22
2172-02-07 00:00:00
2172-02-08 19:53:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Codeine / Tape ___ / Morphine / Atorvastatin / Zocor / Tobramycin Attending: ___ Chief Complaint: Dyspnea and orthopnea Major Surgical or Invasive Procedure: None History of Present Illness: ___ with systolic CHF (EF40-45% on last formal TTE), CAD s/p multiple MIs and PCI with BMSx2 to the RCA and DES x1 to the RCA, Afib on warfarin, recent basilar stroke, PAD s/p stents who presents from rehab with shortness of breath and orthopnea. The patient is a somewhat poor historian, she is accompanied by her husband who provides some history. She states that she was feeling mildly SOB at the end of her recent hospitalization and since arriving to rehab yesterday. However, she felt significantly more SOB this AM when she was trying to get dressed. She denies CP and cannot remember the last time she had CP or chest discomfort. She does not remember having heart attacks in the past or what she felt like at that time. She reports ongoing dry cough with no fevers and no dysuria. She is unable to be specific about her diet, but states that she tried to avoid foods high in salt. She has been receiving all her medications at the hospital and at rehab recently. She normally sleeps on 2 pillows but states this is for comfort and not related to her breathing, she denies any PND. She had felt short of breath recently with walking, even short distances while at rehab and in the hospital. Prior to her previous admission, she lived independently at home with her husband. She did not wear oxygen at home prior to her last admission. In the ED, initial vitals were 97.9 96 135/95 16 98% 4L NC Labs and imaging significant for BNP of 15,000 and trop of 0.04. Patient given Lasix 40mg IV at OSH ED. Also reportedly had ED echo which showed EF of 35%. She received ASA 325mg in the ED. Vitals on transfer were ___, 130/91, 91, 26, 94%RA On arrival to the floor, patient reports feeling comfortable at rest with no SOB or chest pain. She has no complaints but appears mildly confused. Her husband reports that she has been intermittently confused lately, but is unable to specify how long this has been going on for. REVIEW OF SYSTEMS On review of systems, s/he denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, cough, hemoptysis, black stools or red stools. S/he denies recent fevers, chills or rigors. S/he denies exertional buttock or calf pain. All of the other review of systems were negative. Cardiac review of systems is notable for absence of chest pain, dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, palpitations, syncope or presyncope. Past Medical History: 1. CARDIAC RISK FACTORS: +Diabetes, +Dyslipidemia, +Hypertension 2. CARDIAC HISTORY: -CABG: None -PERCUTANEOUS CORONARY INTERVENTIONS: inferior STEMI with had total occlusion of RCA s/p BMS x2 in ___. Also had DES placed in mid-RCA in ___. -PACING/ICD: None 3. OTHER PAST MEDICAL HISTORY: -Afib on warfarin -Cerebrovascular atherosclerosis -Basilar aneurysm s/p multiple coiling (some failed attempts, last ___ -H/o mesenteric ischemia s/p ex-lap -H/o ruptured AAA s/p repair in ___ -S/p right common and external iliac stent in ___ -H/o hydrocephalus s/p VP shunt placement in ___ -Sp multiple abdominal surgeries ___ Social History: ___ Family History: Father died of an MI in his ___, but no other family members with CAD. No known history of strokes in her family. Physical Exam: Admission exam: VS: T=98.3 BP 137/44 HR 100 RR 26 ___ Weight: 74kg GENERAL: NAD. Oriented x1 (name only, knows "hospital"). Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthalesma. NECK: Supple with JVP to the ear lobe CARDIAC: PMI located in ___ intercostal space, midclavicular line. regular rate with occasional premature beats, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. CTAB with no crackles, but diminished lung sounds at the bases bilat. ABDOMEN: Multiple well-healed incisions and well-healed ileostomy. Mild tenderness to palp in all quardants. Normoactive BS EXTREMITIES: No c/c/e. Significant bruising over the right groin int he area of her recent vascular access, small 1-2cm hematoma with mild TTP int he right groin. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. NEURO: CN II-XII intact, dysmetria with finger-to-nose bilaterally, but worse on left. Only mild discoordination with rapid alternating movements in ___. Strength ___ in all extremities. PULSES: Right: DP 1+ ___ 1+ Left: DP 2+ ___ 2+ Discharge exam - unchanged from above except as below: VS: O2sat >95% on RA Weight: 68.2kg Neck: JVP of approx 6cm Lungs: slightly diminished breath sounds at the bases bilat Neuro: A&Ox ___ (name and occasionally location) Pertinent Results: Admission labs: ___ 05:10AM BLOOD WBC-5.0 RBC-3.34* Hgb-10.6* Hct-33.3* MCV-100* MCH-31.8 MCHC-32.0 RDW-13.5 Plt ___ ___ 05:10AM BLOOD ___ PTT-26.2 ___ ___ 05:10AM BLOOD Glucose-182* UreaN-12 Creat-1.0 Na-142 K-4.0 Cl-110* HCO3-23 AnGap-13 ___ 05:10AM BLOOD Calcium-9.0 Phos-3.8 Mg-1.8 ___ 04:00PM URINE Color-Straw Appear-Clear Sp ___ ___ 04:00PM URINE Blood-LG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-TR ___ 04:00PM URINE RBC-31* WBC-3 Bacteri-NONE Yeast-NONE Epi-0 Discharge labs: ___ 07:15AM BLOOD WBC-6.1 RBC-3.53* Hgb-11.4* Hct-35.3* MCV-100* MCH-32.4* MCHC-32.4 RDW-12.9 Plt ___ ___ 07:15AM BLOOD ___ ___ 07:15AM BLOOD Glucose-71 UreaN-18 Creat-1.2* Na-143 K-4.3 Cl-102 HCO3-32 AnGap-13 ___ 07:15AM BLOOD Mg-2.1 Cardiac enzymes: ___ 04:15PM BLOOD cTropnT-0.04* ___ ___ 11:53PM BLOOD CK-MB-3 cTropnT-0.04* ___ 07:17AM BLOOD CK-MB-3 cTropnT-0.04* Imaging: -CXR (___): Bilateral pleural effusions with overlying atelectasis. Underlying consolidation not excluded. Brief Hospital Course: ___ with systolic CHF (EF40-45% on last formal TTE), CAD s/p multiple MIs and PCI with BMSx2 to the RCA and DES x1 to the RCA, Afib on warfarin, recent basilar stroke, PAD s/p stents who presents from rehab with shortness of breath and orthopnea. # PUMP/Acute on chronic systolic heart failure: She appeared volume overloaded on exam with JVP to the earlobe and worsening pleural effusions on CXR with mild pulm edema. This in combination with her symptoms of DOE and orthopnea suggested an exacerbation of her systolic heart failure. Etiology of her exacerbation is thought to be from fluids she received during her recent admission to neurology where she had proedures performed. She also received 2 units of PRBCs during this admission. Her troponin was stable x3 at 0.04 and CK-MB was negative. She was given IV Lasix for diuresis, she initially responded well to 20mg IV but subsequently required 40mg IV. Her symptoms improved with diuresis and her weight decreased approximately 6kg during this hospitalization. She was started on torsemide 10mg PO daily at the time of discharge. She will follow-up with Dr. ___ cardiology, who she has not seen for many years. She was already on an ACEi at admission and her beta blocker was converted to metoprolol succinate. She was educated on adhering to a low sodium diet, we also discussed these issues with her husband. # CORONARIES: She has a history of multiple MIs and her reduced ejection fraction with regional wall motion abnormalities are thought to be secondary to these infarcts. She remained chest pain free during this admission and did not report chest pain prior to the onset of her dyspnea and orthopnea. She was continued on ASA 325, metoprolol (converted to succinate at discharge), and lisinopril 10mg. # RHYTHM: She was occasionally tachycardic to the 100s during this admission. Has a h/o Afib, although rhythm appeared to be atrial tach vs Afib. Her metoprolol was increased from 50mg q8h to 50mg q6h with improvement in her heart rate. At discharge, she will continue metoprolol succinate 200mg daily. She was continued on warfarin during this admission, dose was decreased to 3mg. She will need a repeat INR checked on ___, please fax results to Dr. ___ at ___. --Chronic issues-- # T2DM: Blood sugar remained variable, she was as low as the ___ and as high as ~400. She was continued on her home dose of Lantus and a regular insulin sliding scale. # PAD s/p right CIA and CEA stents: Continued on ASA 325mg daily # HTN: BP remained relatively well controlled. She was continued on lisinopril and metoprolol as above. # Hyperlipidemia: Continued on rosuvastatin # Recent cerebellar stroke: She continued to have deficits in her neurologic exam, cerebellar signs including rapid alternating movements and finger-to-nose were diminished L>R. She was continued on warfarin and ASA as above. # Code status this admission: DNR/ *OK to intubate* # EMERGENCY CONTACT: ___ (husband): ___ # Transitional issues: -Will follow-up with Dr. ___ her systolic heart failure -Metoprolol 50mg tid changed to metoprolol succinate 200mg daily at discharge -Started on torsemide 10mg PO daily at discharge -Will need chem-10 and INR checked on ___, please fax results to Dr. ___ at ___. Medications on Admission: 1. warfarin 5 mg daily 2. albuterol sulfate 2.5 mg /3 mL (0.083 %) Q6PRN 3. aspirin 325 mg daily 4. lisinopril 10 mg daily 5. insulin glargine 15 units AM, 18 units ___ . 6. insulin regular human Insulin sliding scale (120-160 for 2U, 160-200 for 4U, etc.). 7. nicotine 14 mg/24 hr 8. rosuvastatin 20 mg daily 9. trazodone 25mg PRN insomnia 10. folic acid 1 mg daily 11. thiamine HCl 100 mg daily 12. lipase-protease-amylase 5,000-17,000 -27,000 unit Capsule TID w/ meals 13. metoprolol tartrate 50 mg TID 14. bisacodyl 10mg daily PRN 15. docusate sodium 100 mg BID Discharge Medications: 1. albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1) neb Inhalation Q6H (every 6 hours) as needed for shortness of breath or wheezing. 2. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 4. nicotine 14 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr Transdermal DAILY (Daily). 5. rosuvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 6. insulin glargine 100 unit/mL Solution Sig: Fifteen (15) units Subcutaneous Each morning. 7. insulin glargine 100 unit/mL Solution Sig: Eighteen (18) units Subcutaneous Each evening. 8. insulin regular human 100 unit/mL Solution Sig: sliding scale units Injection three times a day. 9. trazodone 50 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime) as needed for insomnia. 10. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 11. thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 12. lipase-protease-amylase 12,000-38,000 -60,000 unit Capsule, Delayed Release(E.C.) Sig: One (1) Cap PO TID W/MEALS (3 TIMES A DAY WITH MEALS). 13. metoprolol succinate 200 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO once a day. Disp:*30 Tablet Extended Release 24 hr(s)* Refills:*0* 14. bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) Tablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for constipation. 15. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 16. torsemide 10 mg Tablet Sig: One (1) Tablet PO once a day. Disp:*30 Tablet(s)* Refills:*0* 17. Outpatient Lab Work Chem-10 and ___ on ___, fax results to Dr. ___ at ___ 18. warfarin 3 mg Tablet Sig: One (1) Tablet PO once a day: At 4PM daily. Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary diagnosis: Acute on chronic systolic heart failure Secondary diagnoses: Coronary artery disease Hypertension Type 2 diabetes Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you during your admission to ___ for shortness of breath. You had extra fluid in your lungs which led to your shortness of breath, this likely happened because you got fluids during your last admission. You received IV Lasix to help get rid of the extra fluid. You will go home with a diuretic pill ("water pill") to help keep the fluid off. You will also follow-up with a cardiologist after discharge The following changes were made to your medications: START torsemide 10mg PO daily START metoprolol succinate 200mg by mouth daily CHANGE warfarin to 3mg by mouth daily STOP metoprolol tartate Followup Instructions: ___
10388546-DS-18
10,388,546
26,923,676
DS
18
2204-08-16 00:00:00
2204-08-19 22:01:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: OBSTETRICS/GYNECOLOGY Allergies: Codeine Attending: ___. Chief Complaint: CC: abdominal pain Major Surgical or Invasive Procedure: exploratory laparotomy total abdominal hysterectomy bilateral salpingo-oophorectomy omentectomy splenectomy rectosigmoid resection and reanastomosis with protective ileostomy optimal primary cytoreduction History of Present Illness: Ms. ___ is a ___ woman who was called into the emergency department by Dr. ___ concern for obstruction from what is believed to be ovarian malignancy. Ms. ___ reports that she has had several weeks of abdominal discomfort and bloating. She was seen by her primary care doctor and had an outpatient CT last ___ that demonstrated a 6cm right adnexal mass adjacent to the sigmoid, omental caking, a 1.2cm splenic lesion, and mild-moderate ascites. The liver and lung bases were unremarkable. She developed nausea/vomiting from the PO contrast, and was then seen at the ___ emergency room where she received IV hydration and antiemetics. As there was no evidence of bowel obstruction or renal failure, she was discharged home so that she could fly to ___ with plan for work-up on her return. While in ___, she had increased pain and was unable to have a bowel movement. She was admitted to a hospital there, but deferred surgery at that time. She just arrived back in ___ today. She reports that her last normal bowel movement was on ___ (over a week ago). She has been taking colace and miralax with minimal benefit. She has very little appetite, but otherwise denies nausea or emesis. She continues to feel bloated. She denies any difficulties with voiding. Denies fever/chills, SOB/CP, palpitations, or dizziness. Her CA-125 from ___ is 103.2 Past Medical History: Obstetrical History: G3P3 -SVD x 3, uncomplicated per pt Gynecologic History: -Menarche: ___ -Reports regular menses. Denies h/o menorrhagia or dysmenorrhea -Went through menopause in her early ___. -Last Pap test in ___ was negative -Denies history of abnormal Paps -Denies h/o fibroids, cysts -Last mammogram in ___ normal -Denies history of breast disease -Denies h/o pelvic infections or STIs Past Medical History: - hypothyroidism s/p thyroidectomy (Pathology was Oncocytic (Hurthle cell) neoplasm with atypical features) - colonic adenoma in ___. Last colonoscopy ___ with diverticulosis but otherwise no abnormalities - osteopenia - lumbar spondylosis Past Surgical History: - left thyroid lobectomy and isthemectomy (___) - completion thyroidectomy (___) performed because previous pathology not clear if malignancy or not Social History: ___ Family History: -Brother died of colon cancer diagnosed in his ___ -Another brother died of brain cancer -Niece diagnosed with breast cancer in her ___ -Denies a family history of ovarian, uterine, or cervical malignancy Physical Exam: On Admission: VS: 98.8 84 137/63 16 99% RA Gen: comfortable appearing Caucasian woman, presents with her husband and her sister CV: rate ___, normal rhythma, no murmur Resp: CTAB, good air movement throughout, no crackles or wheezes Abd: hypoactive bowel sounds presents, softly distended, nontender to palpation Extremities: good perfusion, no edema, calves nontender DISCHARGE EXAM: AVSS, NAD RRR, CTAB Abdomen soft, NT, ND, nl BS Ostomy site pink, putting out liquid brown stool and gas Left JP drain site dry and healing with steristrips Mild erythema on inferior third of vertical paramedian incision. no induration or TTP. Incision otherwise c/d/i and healing well with steristrips. Extremities 1+ pitting edema overally improved, NT soft bilaterally Pertinent Results: ADMISSION LABS: ___ 04:45PM BLOOD WBC-12.0*# RBC-4.74 Hgb-13.8 Hct-41.1 MCV-87 MCH-29.0 MCHC-33.5 RDW-13.9 Plt ___ ___ 04:45PM BLOOD Neuts-76.4* Lymphs-17.6* Monos-5.1 Eos-0.6 Baso-0.3 ___ 04:45PM BLOOD ___ PTT-26.3 ___ ___ 04:25PM BLOOD ___ ___ 04:45PM BLOOD Glucose-78 UreaN-11 Creat-0.6 Na-136 K-3.9 Cl-97 HCO3-24 AnGap-19 ___ 11:00AM BLOOD Albumin-4.1 Calcium-8.3* Phos-3.4 Mg-1.9 ___ 04:45PM BLOOD CEA-1.6 ___ 08:25PM BLOOD CA ___ -Test Day of discharge: ___ 05:29AM BLOOD WBC-14.1* RBC-2.66* Hgb-8.1* Hct-24.1* MCV-91 MCH-30.3 MCHC-33.5 RDW-14.6 Plt ___ ___ 05:29AM BLOOD Glucose-101* UreaN-6 Creat-0.4 Na-139 K-4.2 Cl-105 HCO3-27 AnGap-11 ___ 05:29AM BLOOD Calcium-7.5* Phos-4.6* Mg-1.9 ___ PATHOLOGY: 1. Omentum, biopsy (A-J): Metastatic adenocarcinoma, see synoptic report. 2. Uterus and cervix (K-Q): - Metastatic adenocarcinoma, present on anterior and posterior uterine serosa. - Leiomyoma, measuring up to 1.2 cm. - Unremarkable cervix and atrophic endometrium. 3. Spleen (R): No carcinoma seen. See addendum for microscopic description of the splenic nodule. 4. Omentum (S-W): Metastatic adenocarcinoma, see synoptic report. 5. Anastomotic donut (X): Unremarkable colonic segment. 6. Rectosigmoid colon, bilateral fallopian tubes and ovaries (Y-AL): Ovarian adenocarcinoma extending into the colonic serosa circumferentially with construction but not complete obstruction of the bowel. No colonic mucosal involvement. Ovary Synopsis Staging according to ___ Joint Committee on Cancer Staging Manual -- ___ Edition, ___ MACROSCOPIC Specimen Type: Right salpingo-oophorectomy, left salpingo-oophorectomy, hysterectomy, omentectomy, rectosigmoid colon. Tumor Site Dominant Side (2x larger): Bilateral. Surface Involvement: Present. Tumor Size Greatest dimension: 7 cm. Other organs/Tissues Received: Rectosigmoid colon, spleen. MICROSCOPIC Histologic Type: Serous, carcinoma. Histologic Grade: G3: poorly differentiated. Washings/cytology: Not applicable. Fallopian tube Serosal implant. Uterus Serosa: Implant. Endometrium: Negative. Omentum: Implant, macroscopic. EXTENT OF INVASION Primary Tumor TNM (FIGO): pT3c (IIIC): Peritoneal metastasis beyond pelvis more than 2 cm in greatest dimension and/or regional lymph node metastasis. Regional Lymph Nodes: pNX: Cannot be assessed. Lymph Nodes: None submitted. Distant metastasis: pMX: Cannot be assessed. Venous/lymphatic vessel invasion (V/L): Present. Comments: The degree of parenchymal ovarian involvement is limited; this may represent a primary peritoneal carcinoma. Entire tubal fimbria has been examined microscopically Brief Hospital Course: Ms. ___ was admitted to the GYN oncology service for further evaluation of her adnexal mass and symptoms of obstruction, which were attributed to likely ovarian cancer. The decision was made to continue her admission until planned surgery due to a failure to thrive. She was begun on total parenteral nutrition on hospital day #3. On (HD #7) ___ she underwent optimal cytoreduction with an exploratory laparotomy, a total abdominal hysterectomy, bilateral salpingo-oophorectomy, rectosigmoid resection with primary anastomosis, omentectomy, splenectomy, and diverting ileostomy, see operative report for details. Final pathology showed metastatic ovarian adenocarcinoma, see pathology report for details. She was admitted to the intensive care unit for close postoperative monitoring due to intraoperative hypotension and concern for fluid overload. She was extubated on postoperative day #1, remained hemodynamically stable, and was transferred to the floor on POD #2. Below is a summary of her course by system: # Postoperative care: postoperative pain was controlled with a thoracic epidural and IV medications until she was ultimately transitioned to oral medications without difficulty. She had two ___ drains that put out decreasing amounts of serosanguinous fluid and where removed on POD #7. Staples were removed POD#9, and ___ erythema was noted. Keflex was begun for presumed cellulitis. The tape from her JP drain site caused skin blistering--these were monitored and showed no signs of infection. # Heme: She received 3 units of packed red cells intraoperatively and remained hemodynamically stable throughout her recovery. Her hematocrit slowly drifted to 24.1, and on the day of discharge she received 2 units of packed red cells in anticipation of undergoing chemotherapy. In total, she received 5 units of pRBC during her hospitalization. # ID: Her WBC count was noted to peak at 17.5 during her recovery, but she remained afebrile without focal complaints. Urinalysis was negative, and culture contaminated. Her leukocytosis improved without intervention. She was ultimately treated for presumed incisional cellulitis for a planned 10 day course. #GU: Her creatinine remained normal. By POD#5 she was ambulating well enough for the foley to be discontinued, and she voided without difficulty. # GI: NGT was removed POD#3, the ostomy began to discharge bowel contents, and her diet was advanced to regular by POD#7. Her TPN was weaned accordingly, and triglycerides and LFTs were normal. The Ostomy nurse provided teaching and care. Asymptomatic oral thrush was treated with nystatin swish with noted improvement. # Health maintenance: due to her splenectomy, she received Menactra, Haemophilus B Conj, Pneumovax 23 vaccines prior to discharge. She remained on prophyiclactic lovenox, pneumatic compression boots, PPI and incentive spirometer throughout her admission. She was discharged on POD #10 ambulating with a cane, voiding, on a regular diet, and passing some rectal flatus. She felt confident in her ability to care for her ostomy, and she was set up for home ___, Ostomy care, and home ___ visits (was was prescribed a walker to use as needed). She has follow up scheduled with Dr. ___ in medical oncology and Dr. ___ ___ GYN oncology surgeon. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Levothyroxine Sodium 137 mcg PO DAILY Discharge Medications: 1. Levothyroxine Sodium 137 mcg PO DAILY 2. Ibuprofen 600 mg PO Q6H:PRN pain RX *ibuprofen 600 mg 1 tablet(s) by mouth every six (6) hours Disp #*100 Tablet Refills:*1 3. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO Q4H:PRN pain RX *oxycodone-acetaminophen 5 mg-325 mg ___ tablet(s) by mouth every four (4) hours Disp #*60 Tablet Refills:*0 4. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*100 Capsule Refills:*1 5. Cephalexin 500 mg PO Q6H RX *cephalexin 500 mg 1 tablet(s) by mouth every six (6) hours Disp #*40 Capsule Refills:*0 6. Rolling Walker Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: stage IIIC peritoneal cancer Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance Discharge Instructions: Dear ___ were admitted to the gynecologic oncology service after undergoing the procedures listed below. ___ have recovered well after your operation, and the team feels that ___ are safe to be discharged home. Please follow these instructions: . * Take your medications as prescribed. * Do not drive while taking narcotics. * Do not combine narcotic and sedative medications or alcohol * Do not take more than 4000mg acetaminophen (APAP) in 24 hrs * No strenuous activity until your post-op appointment * Nothing in the vagina (no tampons, no douching, no sex) for 12 weeks. * No heavy lifting of objects >10 lbs for 6 weeks. * ___ may eat a regular diet. * Continue to follow up with Ostomy nurses recommendations . Incision care: * ___ may shower and allow soapy water to run over incision; no scrubbing of incision. No bath tubs for 6 weeks. . To reach medical records to get the records from this hospitalization sent to your doctor at home, call ___. . Followup Instructions: ___
10388675-DS-16
10,388,675
20,325,171
DS
16
2180-05-15 00:00:00
2180-05-16 23:03:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Encephalopathy Major Surgical or Invasive Procedure: EGD on ___ with APC of bleeding GAVE History of Present Illness: ___ is a ___ male with a h/o hepatitis C and cirrhosis taken to ___ with confusion, agitation, elevated ammonia levels to 277, asterixis on OSH ED exam. Per wife (pt currently intubated), pt at baseline has no cognitive deficits, has never had hepatic encephalopathy that she knows of. He was admitted to ___ 1.5 weeks ago for a few days for SOB, and over the course of about 2 days had 9L of ascites removed. He was d/c'd home on lactulose (new Rx). Over the last 2 wks, she says he has lost about 40lbs total from the lactulose and diuretics. He was at home this past week doing well, but on ___ appeared sluggish, was slow to respond, was very shaky and confused (trying to go to bathroom in closet). EMS came and per notes the pt was AAOx2 upon exam. Per wife, pt had not been taking lactulose daily. 20mg labetalol given at ___ as he had BP's 200s/ 120s. Two 20G PIV's. OG tube placed prior to MICU admission. BID ___: Ammonia 277, K 4.7, lactate 1.1, Tn <0.01, CK-MB 1.1. Patient was intubated for agitation/confusion and combativeness/safety issue (not for medical reasons per ___ ___ notes) and sedated with propofol. Per report intubation was difficult, unclear why. He was transferred secondary to lack of intensive care unit beds. In the ___ ED, initial vitals: 36.8 104 176/95 20 97% Other Patient presented to ED intubated and sedated. ED bedside ultrasound did not reveal any tappable ascites. Hyperkalemia to 6.3 was treated with insulin, dextrose, calcium, started kayexalate per OGT. Patient was hemodynamically stable and afebrile. CT head obtained in ED; f/u CXR done b/c ETT seemed misplaced. Ammonia: 130. Lactate:0.9. Glu:162. Given CeftriaXONE 1 g IV in ED. On ___ CXR did not show RUL collapse, but 0700 CXR does. OGT and ETT secretions noted to be bloody/bilious. On arrival to the MICU, pt was intubated and sedated. Hx obtained with wife per above. Review of systems: (+) Per HPI Past Medical History: Hep C (per wife, ___ about ___, was on interferon x 8mo then stopped) Cirrhosis (per wife, ___ a few weeks ago) Bipolar dz HTN Social History: ___ Family History: ___ Physical Exam: ADMISSION EXAM: =============== Afebrile, 88 131/81 18 100% VENT GENERAL: intubated and sedated HEENT: Sclera anicteric, dry mouth, OG and ETT in place NECK: JVP not elevated, no LAD LUNGS: Clear to auscultation anteriorly, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, gallops ABD: soft, non-tender, non-distended, bowel sounds hypoactive, no organomegaly, no appreciable fluid wave or increased tympany EXT: Warm, well perfused, 2+ pulses, no edema SKIN: not jaundiced; face with several nondescript erythematous papules NEURO: sedated at moment DISCHARGE EXAM: =============== VS: Tm 98.6 Tc 97.7 F, BP 120/66, HR 82, RR 20, 99% RA I/O: 240/60 + 2 bm GEN: Alert and oriented, no distress HEENT: NCAT, MMM, EOMI, sclerae anicteric NECK: supple, no JVD or ___, no thyroid abnormality CV: RRR, ___ systolic murmur loudest at RUSB LUNGS:CTAB ABD: +BS, mildly distended but soft, non-tender RECTAL: EXTR: Warm, no edema SKIN: 4mm nevus on L middle back (family says has been there for ___ stable); no spider angiomata GU: no foley NEURO: A&O, conversing well, no asterixis, days of week backwards correct Pertinent Results: ADMISSION LABS: ================ ___ 06:50AM BLOOD WBC-5.4 RBC-3.53* Hgb-10.2* Hct-32.9* MCV-93 MCH-28.8 MCHC-30.9* RDW-16.2* Plt Ct-66* ___ 06:50AM BLOOD ___ PTT-31.9 ___ ___ 06:50AM BLOOD UreaN-27* Creat-2.2* Na-139 K-6.3* Cl-110* HCO3-24 AnGap-11 ___ 06:50AM BLOOD ALT-32 AST-49* AlkPhos-221* TotBili-1.5 ___ 06:50AM BLOOD Lipase-149* Micro: ___: blood/urine cx negative ___: no MRSA/VRE IMAGING: ========== ___ TTE The left atrial volume index is mildly increased. No atrial septal defect is seen by 2D or color Doppler. The estimated right atrial pressure is ___ mmHg. Normal left ventricular wall thickness, cavity size, and global systolic function (biplane LVEF = 59 %). Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. There is no valvular aortic stenosis. The increased transaortic and transpulmonic velocities are likely related to increased stroke volume due to high stroke volume. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Physiologic mitral regurgitation is seen. There is no pericardial effusion. IMPRESSION: Normal global and regional biventricular systolic function with increased transaortic and transpulmonic velocities due to high stroke volume. No pathologic valvular flow. ___ EGD Impression: Grade 3 varix at the lower third of the esophagus Grade 2 varices at the lower third of the esophagus Angioectasias in the antrum with active bleeding (thermal therapy) Erythema, congestion and mosaic appearance in the fundus compatible with portal gastropathy Question of a duodenal varix Otherwise normal EGD to third part of the duodenum ___ Abdominal MRI IMPRESSION: 1. Cirrhotic liver with numerous T1 hyperintense regenerative nodules. 1.9 cm arterial hyper enhancing lesion in segment IV B of the liver, without delayed washout or pseudocapsule, although highly suspicious, does not meet OPTN criteria for HCC at this time. Recommended short interval followup MRI in 3 months. The sonographic abnormality in segment II corresponds to an exophytic regenerative nodule. 2. Marked splenomegaly with extensive perisplenic collaterals, small amount of upper abdominal ascites, consistent with portal hypertension. CXR ___ FINDINGS: Compared to the prior study, there appears to been interval improvement in the previously seen subsegmental atelectasis of the right upper lobe. Density in the right peritracheal position on the current exam is thought to represent vascular structures, within the range of normal for technique. The right minor fissure is restored to normal position and thickness. There may be minimal linear atelectasis at the left base, but no consolidation or effusion is detected. There is mild upper zone redistribution, but no overt CHF. No effusion. The NG tube tip overlies the stomach. The side port may lie immediately distal to the GE junction. US ___ IMPRESSION: 1. Exophytic lmass in the left lobe of the liver measures 2.5 cm. Further characterization with multiphasic CT or MRI abdomen is recommended. 2. Coarse liver parenchyma and a nodular contour are consistent with the provided diagnosis of cirrhosis. Patent hepatic vasculature. 3. Splenomegaly, gallbladder wall edema, varices and trace ascites also consistent with the provided diagnosis of cirrhosis. 4. Atrophic right kidney. ___ CT head IMPRESSION: 1. No evidence of acute intracranial process. 2. Thickening of multiple ethmoid air cells. Correlate with patient symptoms. Brief Hospital Course: ___ male with a h/o hepatitis C and cirrhosis taken to ___ with confusion, agitation, elevated ammonia levels, asterixis on OSH ED exam. ACTIVE ISSUES: =============== # Hepatic encephalopathy: Pt presented to the ___ ICU from OSH with acute hepatic encephalopathy that required intubation secondary to agitation. The most likely etiology of this episode of hepatic encephalopathy is non-adherence to lactulose. Per report, pt had not been taking lactulose daily. Infectious workup was negative. RUQ US showed patent hepatic vasculature and a 2.5cm exophytic lesion. Head CT showed no evidence of acute intracranial process. Pt was able to be extubated less than 24 hours after arrival to ___. Pt was started on lactulose q2H and rifaxamin and his mental status improved. No clear source of infection and TEE normal. Pt was subsequently transferred to the liver service, where he was changed to lactulose TID in the setting of possible melena (discussed below). Pt's mental status continued to improve, and he was discharged on rifiaximin/lactulose. # Esophageal varices/Melena: Pt presented with a recent EGD from ___ ___ demonstrating 3 cords of grade I esophageal varices, no gastric varices, portal hypertensive gastropathy, and gastritis. On presentation to the ___ liver service from the ICU, pt had a melenic stool. Pt's hgb was noted to have dropped from 10.2 to 8.6. Pt was subsequently started on PPI IV BID and octreotide gtt. Pt's hgb subsequently stabilized without requiring transfusion. Pt subsequently underwent EGD ___ which demonstrated grade 2 and grade 3 varices. Also underwent argon coagulation of bleeding gastric varices. He completed a 5-day course of octreotide and was started on pantoprazole and sucralfate. He was discharged on ciprofloxacin to prevent infection. # Exophytic liver mass: Pt was found to have a 2.5cm exophytic mass in the left lobe of the liver on RUQ ultrasound. The MICU team discussed this finding with the patient/family. AFP was found to be elevated at 26.8. MRI liver was performed and demonstrated the same mass with recommendations for f/u in 3 months. # Neutropenia: During his hospital course, pt was noted to have developed neutropenia to 880. Most likely due to portal hypertension and splenic sequestration leading to pancytopenia. # Hepatitis C Cirrhosis: Pt presented with decompensated cirrhosis ___ class B and MELD 18 at time of transfer. Pt's cirrhosis has been complicated by grade one esophageal varices, ascites, and encephalopathy. Pt's home nadolol was held in the setting of possible GI bleed, and pt's diuretics were held in the setting of ___. Prior to discharge pt's home nadolol and diuretics were restarted. # Hypernatremia: He most likely accumulated his 3.1L free water deficit (based on admission weight 98kg) from not eating while intubated and not receiving feeds. He later became thirsty and po intake was encouraged. # New murmur: Unremarkable echo, most likely flow murmur from high output state and anemia. Discussed with patient and wife. CHRONIC ISSUES: =================== # CKD: Pt presented with a Cr of 2.2 from Cr of 2.1 ___. Cr 1.77 last year and 2.0 this year per PCP ___. Wife says this is from 10+ yrs ago lithium-induced injury. Trended down during hospital stay. # Bipolar dz: Continued on home seroquel. TRANSITIONAL ISSUES: ===================== - needs EGD in 2 weeks - needs repeat MRI liver in 3 weeks - electrolytes and CBC in 1 week (restarting diuretics, borderline neutropenia at discharge) - patient instructed not to drive Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Spironolactone 50 mg PO DAILY 2. QUEtiapine Fumarate 400 mg PO QHS 3. Lactulose 10 mL PO DAILY 4. Furosemide 20 mg PO EVERY OTHER DAY 5. Nadolol 20 mg PO DAILY 6. Methocarbamol ___ mg PO TID:PRN pain Discharge Medications: 1. Lactulose 15 mL PO TID Aim for 3 bowel movements per day. Increase to ___ stools/day if signs of confusion RX *lactulose 10 gram/15 mL 15 mL by mouth three times a day Refills:*0 2. QUEtiapine Fumarate 400 mg PO QHS 3. Pantoprazole 40 mg PO Q12H RX *pantoprazole 40 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 4. Rifaximin 550 mg PO BID RX *rifaximin [Xifaxan] 550 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 5. Sucralfate 1 gm PO QID RX *sucralfate 1 gram 1 tablet(s) by mouth Four times a day Disp #*120 Tablet Refills:*0 6. Furosemide 20 mg PO EVERY OTHER DAY 7. Spironolactone 50 mg PO DAILY 8. Nadolol 20 mg PO DAILY 9. Ciprofloxacin HCl 500 mg PO Q12H Duration: 3 Days RX *ciprofloxacin 500 mg 1 tablet(s) by mouth twice a day Disp #*6 Tablet Refills:*0 10. Outpatient Lab Work Please check Na, K, Cl, HCO3, BUN, Cr, Mag, Phos, and Hemoglobin, Hematocrit, WBC in ONE WEEK (around ___. Fax results to ___ ___, NP ICD 9: 571.5 cirrhosis Discharge Disposition: Home Discharge Diagnosis: Primary: acute hepatic encephalopathy; Bleeding GAVE (Gastric Antral Vascular Ectasia); liver mass Secondary: Hepatitis C cirrhosis; esophageal varices Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. No asterixis Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at ___ ___. You were transferred here from ___ for an episode of confusion due to build up of toxins that your liver is unable to clear because of your cirrhosis. You required sedation and a breathing tube and ICU admission to give you medicines to help you clear those toxins and your mental status improved. You will need to continue these medications (LACTULOSE and RIFAXIMIN) every day to decrease your risk of confusion, and you should NOT DRIVE. While you were here you were noted to have black stools and endoscopy revealed some slow bleeding in your stomach that is due to increased pressures created by your liver. The bleeding was stopped with cautery, but you will need another EGD in 2 weeks for possible banding (treatment) of your varices (dilated blood vessels) in your esophagus. Imaging of your liver showed a small 1.9cm mass, which should be looked at again with MRI in 3 months to make sure it is not cancerous. Please weigh yourself daily and call your doctor if your weight increases by more than 3 pounds or if your abdomen gets very distended. Followup Instructions: ___
10388675-DS-18
10,388,675
28,991,398
DS
18
2180-07-05 00:00:00
2180-07-07 16:33:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: abdominal pain Major Surgical or Invasive Procedure: None History of Present Illness: In brief, Mr. ___ is a ___ with history of decompensated HCV cirrhosis (Childs ___ Class B), complicated by encephalopathy, portal hypertension with esophageal varices and gastropathy, GAVE, being worked up for transplant who presents with abdominal pain. ___ has a recent admission ___ for lightheadedness, found to have hgb 6.5, no overt bleeding but underwent EGD, GAVE treated with APC, started on iron supplementation. ___ underwent repeat EGD on ___ which showed medium sized varices without high risk features, esophageal candidiasis, and angioectasias treated with thermal therapy. ___ has not started fluconazole because his instructions were to decrease nightly seroquel to 50 (from 400mg) while on fluconazole and ___ did not have any 50mg tablets. On ___ ___ started to have some lower abdominal discomfort rated ___ that ___ attributed to constipation, took some extra lactulose and stooled (not black or bloody) and passed a lot of gas which relieved the pain. The following day ___ developed ___ RUQ pain only noticeable when ___ presses on the RUQ, coughs, or moves around. No changes in bowel movements, no fevers, nausea, vomiting, or changes in color of stools or urine. Wife called the liver clinic and ___ was referred to the ED for admission. Of note, ___ had an abdominal MRI ___ which showed 4 lesions that meet criteria for diagnosis of HCC (the largest is 2x2cm), and one smaller lesion that does not (8mm). These findings have not yet been discussed with the patient. In the ED initial vitals were: 99.6 72 131/68 18 100% RA - Labs were significant for Hgb 10.2 (10.4 2d prior), plt 35 (below baseline, INR 1.3, Cr 2.4 (about baseline), tbil 2.4, (from 1.3 2 days ago), UA negative for infection. US showed patent vasculature, no fluid to tap. - Patient was given no medications. Vitals prior to transfer were:98.5 64 118/73 16 100% RA On the floor, patient has ___ RUQ pain only with palpation of his upper abdomen. ___ is otherwise comfortable. Review of Systems: (+) per HPI (-) fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. Past Medical History: - HCV cirrhosis diagnosed in ___, complicated by hepatic encephalopathy, portal hypertension, varices, portal hypertensive gastropathy, hypernatremia - history of melena in setting of multiple esophageal varices (grades I to 3) and possible duodenal varix, as well as portal hypertensive gastropathy and GAVE - HCV genotype 1b s/p relapse after interferon/Ribavirin x8-9 months years ago - Exophytic liver mass found during ___ admission, due for 3 month f/u ___ - Neutropenia attributed to splenic sequestration - Bipolar Disorder - Chronic Kidney Disease secondary to lithium - Hypertension Social History: ___ Family History: No family history of malignancy Physical Exam: Admission physical exam: VS - Tc 97.7 HR 67 BP 113/75 RR 20 99% 02 sat on RA GENERAL: well appearing middle aged gentleman, well-groomed, in no distress HEENT: AT/NC, EOMI, icteric sclera, pink conjunctiva, patent nares, MMM NECK: nontender supple neck, no LAD, no JVD CARDIAC: regular rate, rhythm, S1/S2, ___ systolic murmur, no gallops, or rubs LUNG: clear to auscultation bilaterally, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, tenderness to palpation in RUQ. Pain localizes to liver edge on inspiration as palpate. No rebound/guarding, +splenomegaly. EXTREMITIES: no cyanosis, clubbing or edema PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact, no asterixis SKIN: warm without rashes, has scattered spider angiomata and palmar erythema Discharge physical exam: VS - Tc 97.7 HR 67 BP 113/75 RR 20 99% 02 sat on RA GENERAL: well appearing middle aged gentleman, well-groomed, in no distress HEENT: AT/NC, EOMI, icteric sclera, pink conjunctiva, patent nares, MMM NECK: nontender supple neck, no LAD, no JVD CARDIAC: regular rate, rhythm, S1/S2, ___ systolic murmur, no gallops, or rubs LUNG: clear to auscultation bilaterally, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, tenderness to palpation in RUQ. Pain localizes to liver edge on inspiration as palpate. No rebound/guarding, +splenomegaly. EXTREMITIES: no cyanosis, clubbing or edema PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact, no asterixis SKIN: warm without rashes, has scattered spider angiomata and palmar erythema Pertinent Results: Admission labs: ___ 07:41PM BLOOD WBC-4.4# RBC-3.28* Hgb-10.2* Hct-32.5* MCV-99* MCH-31.1 MCHC-31.3 RDW-20.5* Plt Ct-35* ___ 07:41PM BLOOD Neuts-68.1 ___ Monos-9.3 Eos-2.1 Baso-0.5 ___ 08:01PM BLOOD ___ PTT-31.8 ___ ___ 07:41PM BLOOD Glucose-93 UreaN-30* Creat-2.4* Na-138 K-4.7 Cl-110* HCO3-23 AnGap-10 ___ 07:41PM BLOOD ALT-42* AST-68* AlkPhos-215* TotBili-2.4* ___ 07:41PM BLOOD Albumin-3.2* ___ 07:49PM BLOOD Lactate-2.2* Discharge labs: ___ 08:28AM BLOOD WBC-3.2* RBC-3.18* Hgb-9.4* Hct-31.2* MCV-98 MCH-29.7 MCHC-30.2* RDW-20.5* Plt Ct-36* ___ 08:28AM BLOOD Plt Ct-36* ___ 08:28AM BLOOD Glucose-146* UreaN-29* Creat-2.3* Na-138 K-4.1 Cl-109* HCO3-22 AnGap-11 ___ 08:28AM BLOOD ALT-40 AST-61* AlkPhos-185* TotBili-2.1* ___ 08:28AM BLOOD Calcium-8.6 Phos-3.7 ___ EGD Medium sized varices without high risk features at the distal esophagus Esophageal candidiasis Angioectasias in the antrum (thermal therapy) Otherwise normal EGD to third part of the duodenum ___ Liver US wet read RUQ US: nothing acute (vasculature patent, gallbladder decompressed, tumors not seen due to coarse echotexture, no fluid to tap, some gallbladder thickening explained by cirrhosis) ___ CT chest 1. Assessment of the chest demonstrated no definitive evidence of metastatic disease. Mild emphysema and centrilobular nodules are most likely consistent with respiratory bronchiolitis, please correlate clinically. 2. Several mediastinal lymph nodes, some of them borderline that should be reassessed in three months for documentation of stability. 3. Potential anemia. 4. Paracardiac lymph nodes, borderline as well and should be reassessed at the same time. 5. Stigmata of cirrhosis, partially imaged, will be assessed in details as part of the MRI of the abdomen and the corresponding report will be issued. ___ MRI abdomen IMPRESSION: 1. Three OPTN-5a lesions within segments II and VI, and one OPTN-5b lesion within segment IVb. 2. 8 mm arterially enhancing lesion within segment VII, not meeting OPTN-5 criteria. 3. Hepatic cirrhosis with multiple regenerative nodules. 4. Massive splenomegaly with perisplenic and perigastric varices reflecting chronic portal hypertension. 5. Small amount of perihepatic and perisplenic ascites. Brief Hospital Course: ___ with history of decompensated HCV cirrhosis (___ Class B), complicated by encephalopathy, portal hypertension with esophageal varices and gastropathy, GAVE, being worked up for transplant who presents with abdominal pain. His abdominal resolved quickly on the floor and ___ was anxious for same day discharge home. # Abdominal pain: Patient appears to have a tender liver edge, which may have bene related to a more inferior liver lesion. ___ had no signs or symptoms of cholecystitis, no rebound tenderness or peritoneal signs. Not constipated. US was negative for clot. Discussed with liver team, did serial abdominal exams, trended MELD labs, and followe up blood and urine cultures. # Esophageal candidiasis: Was prescribed fluconazole previously but never started course because ___ was concerned about decreasing his seroquel dosing and risk of a manic episode. ___ was switched to nystatin swish and swallow for 10 day course, with GI followup. # liver lesions: New MRI findings (liver lesions) discussed with patient. Did not yet discuss with him whether this will impact his transplant. Tumor board meets ___. After this will be discussed with patient, wife, and hepatology. # HCV cirrhosis: undergoing transplant work up, patient of Dr. ___ is Childs B, with diuretic-controlled ascites, varices, and history of encephalopathy. TrendED MELD labs daily, continueD furosemide and spironolactone for ascites. Continue lactulose and rifaxamin for h/o encephalopathy. # GAVE/Varices: No signs of active bleeding. Continued sucralfate, nadolol and PPI, and iron supplementation. # Thrombocytopenia: Worse than baseline possibly related to massive splenomegaly (sequestration) and decreased thrombopoetin production. Trended daily. Held heparin, used pneumoboots while platelets <50K . # Bipolar disorder: Continued seroquel. TRANSITIONAL ISSUES: # Will need to have discussion with patient and wife about 4 liver lesions and how will impact transplant. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Furosemide 20 mg PO EVERY OTHER DAY 2. Lactulose 30 mL PO TID 3. Nadolol 20 mg PO DAILY 4. Pantoprazole 40 mg PO Q12H 5. QUEtiapine Fumarate 400 mg PO QHS 6. Rifaximin 550 mg PO BID 7. Spironolactone 50 mg PO DAILY 8. Sucralfate 1 gm PO QID 9. Ferrous Sulfate 325 mg PO BID 10. Fluconazole 200 mg PO Q24H Discharge Medications: 1. Ferrous Sulfate 325 mg PO BID 2. Furosemide 20 mg PO EVERY OTHER DAY 3. Lactulose 30 mL PO TID 4. Nadolol 20 mg PO DAILY 5. Pantoprazole 40 mg PO Q12H 6. QUEtiapine Fumarate 400 mg PO QHS 7. Rifaximin 550 mg PO BID 8. Spironolactone 50 mg PO DAILY 9. Sucralfate 1 gm PO QID 10. Nystatin Oral Suspension 5 mL PO QID Duration: 10 Days RX *nystatin 100,000 unit/mL 5 ml by mouth four times a day Disp #*1 Bottle Refills:*0 Discharge Disposition: Home Discharge Diagnosis: HCV cirrhosis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted with abdominal pain that resolved without intervention. Your labs and workup was all reassuring. Liver team discussed your MRI and will continue to follow you as an outpatient. Followup Instructions: ___
10388675-DS-21
10,388,675
25,596,778
DS
21
2180-10-26 00:00:00
2180-11-04 15:46:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: epigastric pain Major Surgical or Invasive Procedure: EGD ___ History of Present Illness: ___ year old male with HCV cirrhosis, ___ s/p RFA ablation x2, most recently on ___, CKD and GAVE with prior GI bleed s/p EGD on ___ with ___ who presented to ___ ED on ___ for sudden onset severe epigastric pain. Of note, patient was recently admitted to ___ ___ for radiofrequency ablation of HCC without complications. Surveillance EGD on ___ showed 1 cord of grade II varices in the distal esophagus, findings consistent with GAVE, and mucosa with a mosaic pattern consistent with mild portal hypertensive gastropathy. An Argon-Plasma Coagulator was applied successfully. Admitted to ___, Liver US showed acute left portal vein thrombus, for which he was treated with a heparin drip on ___. Early morning of ___ patient found hypotensive 70/40 with a fever ___. Patient was AOx3 but felt "foggy". Stat labs showed Hct 24.6 (down from 28.5 on admit) with lactate 3.2. 300cc melanotic stool. CTX given. Transfer to MICU initiated at 2AM. Past Medical History: - HCV cirrhosis diagnosed in ___, complicated by hepatic encephalopathy, portal hypertension, varices, portal hypertensive gastropathy, hypernatremia - ___ with 4 discrete lesions s/p RFA ablation ___ with complete resolution of ___ lesions. Had RFA of final lesion ___ - history of melena in setting of multiple esophageal varices (grades I to 3) and possible duodenal varix, as well as portal hypertensive gastropathy and GAVE - HCV genotype 1b s/p relapse after interferon/Ribavirin x8-9 months years ago - Neutropenia attributed to splenic sequestration - Bipolar Disorder - Chronic Kidney Disease secondary to lithium - Hypertension Social History: ___ Family History: No family history of malignancy or liver disease Physical Exam: Admission Physical Exam: Vitals- ___ BP:100/70 P:70 R: 18 O2: 96% RA GENERAL: AOx3, NAD, mentating at baseline HEENT: OP w/o blood, no scleral icterus LUNGS: Diffuse mild wheezes CV: rrr, no murmur ABD: soft, moderately distended, epigastric ttp w/o guarding EXT: warm, peripheral pulses intact, no ___ edema SKIN: no rash or skin breakdown Discharge Physical Exam: VS:T 98.2, Tmax 98.4, HR 67 BP 128/66 RR 18 O2 96RA I/O: 50/550 (since midnight), 1140/550+ last 24 hours, 3 BM GENERAL: AOx3, NAD, mentating at baseline HEENT: clear oropharynx, scleral icterus LUNGS: CTAB, no w/r/r CV: rrr, no murmur/gallops/rups ABD: soft, distended, nontender EXT: warm, peripheral pulses intact, trace ___ edema SKIN: no rash or skin breakdown, (+) Jaundice Pertinent Results: ON ADMISSION ___ 06:59PM WBC-3.3* RBC-3.21* HGB-10.5* HCT-32.7* MCV-102* MCH-32.6* MCHC-32.0 RDW-16.1* ___ 06:59PM NEUTS-69.6 ___ MONOS-7.2 EOS-2.1 BASOS-0.7 ___ 07:05PM LACTATE-2.1* ___ 06:59PM PLT COUNT-56* ___ 06:59PM LIPASE-116* ___ 06:59PM ALT(SGPT)-59* AST(SGOT)-114* ALK PHOS-317* TOT BILI-1.8* ON DISCHARGE ___ 05:45AM BLOOD WBC-3.1* RBC-2.76* Hgb-9.0* Hct-28.0* MCV-101* MCH-32.5* MCHC-32.1 RDW-16.5* Plt Ct-44* ___ 05:45AM BLOOD ___ PTT-32.7 ___ ___ 05:45AM BLOOD Glucose-79 UreaN-32* Creat-2.1* Na-133 K-4.7 Cl-106 HCO3-17* AnGap-15 ___ 05:45AM BLOOD ALT-57* AST-120* LD(LDH)-179 AlkPhos-313* TotBili-9.7* ___ 05:45AM BLOOD Calcium-8.1* Phos-3.4 Mg-2.2 MICRO ___ 1:04 pm BLOOD CULTURE Source: Venipuncture. Blood Culture, Routine (Pending): ___ 1:41 am URINE Source: ___. **FINAL REPORT ___ URINE CULTURE (Final ___: <10,000 organisms/ml. ___ 9:30 pm BLOOD CULTURE Blood Culture, Routine (Pending): ___ 3:32 am MRSA SCREEN Source: Nasal swab. MRSA SCREEN (Pending): ___ 12:22 am BLOOD CULTURE Source: Venipuncture. Blood Culture, Routine (Preliminary): GRAM NEGATIVE ROD(S). PRELIMINARY SENSITIVITY. These preliminary susceptibility results are offered to help guide treatment; interpret with caution as final susceptibilities may change. Check for final susceptibility results in 24 hours. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ GRAM NEGATIVE ROD(S) | AMPICILLIN------------ R CEFEPIME-------------- S CEFTAZIDIME----------- S CEFTRIAXONE----------- S CIPROFLOXACIN--------- S GENTAMICIN------------ S MEROPENEM------------- S TOBRAMYCIN------------ S Anaerobic Bottle Gram Stain (Final ___: GRAM NEGATIVE ROD(S). ___ 7:51 pm URINE Source: ___. **FINAL REPORT ___ URINE CULTURE (Final ___: Culture workup discontinued. Further incubation showed contamination with mixed skin/genital flora. Clinical significance of isolate(s) uncertain. Interpret with caution. ENTEROCOCCUS SP.. >100,000 ORGANISMS/ML.. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ENTEROCOCCUS SP. | AMPICILLIN------------ <=2 S NITROFURANTOIN-------- <=16 S TETRACYCLINE---------- =>16 R VANCOMYCIN------------ 1 S ___ 7:05 pm BLOOD CULTURE Blood Culture, Routine (Pending): ___ 4:00 pm SWAB Source: Rectal swab. R/O VANCOMYCIN RESISTANT ENTEROCOCCUS (Pending): ___ 6:59 pm BLOOD CULTURE Blood Culture, Routine (Pending): IMAGING: CHEST (PORTABLE AP) ___ 9:59 ___ Normal heart, lungs, hila, mediastinum, and pleural surfaces. No evidence of intrathoracic malignancy or infection. CHEST (PA & LAT) ___ 7:08 ___ Normal heart, lungs, hila, mediastinum, and pleural surfaces. No evidence of intrathoracic malignancy or infection. MRI ABDOMEN W/O & W/CONTRAST (___): IMPRESSION: 1. Hepatic cirrhosis with trace perihepatic ascites. Multiple regenerative nodules and two arterially enhancing lesions, unchanged, which likely are perfusional but attention to these areas are recommended on subsequent exams. No lesion identified concerning for hepatocellular carcinoma. 2. Radiofrequency ablation defects in segments II, IV, VI, and VII with coagulative necrosis. Smooth hyperenhancement is identified around the segment IV ablation zone likely reflective of altered perfusion related to treatment. 3. Occlusive thrombus in the left portal vein. 4. Heterogeneous material is identified within the gallbladder. This may represent gallbladder sludge however hemorrhage cannot be entirely excluded. 5. Splenomegaly with venous varices compatible with portal hypertension. 6. Bibasilar atelectasis. ___ Liver ultrasound: 1. Acute left portal vein thrombus. Patent main and right portal veins. 2. 1.9 and 2.9 cm left and right hepatic lobe lesions most consistent with RF ablation sites. No focal fluid collection. Treatment sites better assessed on prior MR dated ___. 3. Coarse nodular hepatic parenchyma consistent with known history of cirrhosis. Splenomegaly and trace ascites noted. 4. Persistent gallbladder sludge with gallbladder wall thickening likely related to chronic cirrhosis. ___ Chest xray: No evidence of acute cardiopulmonary disease. Brief Hospital Course: ___ with HCV and HCC, recent RFA on ___ and EGD with APC ___, admitted on ___ for severe epigastric pain, found to have new L portal vein thrombus, treated with a heparin drip and 1 dose coumadin. Morning of ___ found hypotensive and febrile with 24hr Hct drop from 28 to 24, and subsequently transferred to MICU for stabilization. Heparin drip stopped, given 1 dose VitK. EGD on ___ showed slow ooze from GAVE, no active variceal bleeding, no intervention. Subsequently HD stable. Received total 2U RBC, 1U FFP, 1U Plts, last RBC transfusion on ___ at 1AM. Pt remained HD stable with no further melena/bleeding. He was found to have E coli bacteremia and enterococcus UTI. # E coli bacteremia: Grew on ___ blood cx. Was hypotensive previously, but now hemodynamically stable (SBP>100 over last 24h). No ascites to tap. Urine culture did not grow E.coli. Likely bacterial translocation during GIB. Previously on CTX and switched to cipro on ___ given sensitivities. Patient remained afebrile and HD stable. He was switched to cipro for 2 week course to end ___. Qtc was monitored and was 420 on day of discharge. - cipro x2 weeks until ___ - monitor QTc with EKG today as patient is also on high dose seroquel #Acute blood loss – in the setting of anticoagulation with heparin gtt. Heparin was stopped. EGD showed GAVE and grade 3 varices with red ___ sign. No banding performed as patient is s/p APC for GAVE. H/H has been stable. H/H stable prior to DC.- continue to trend h/h, transfuse goal Hb > 7. Continued PPI - anticoagulation has been discontinued - continue nadolol 40mg daily # UTI: Enterococcus as per ___ Urine Cx. Was on vancomycin but sensitive to ampicillin and switched to augmentin on ___. - augmentin until ___ for 10 day course #Hypotension: originally thought to be sepsis vs acute blood loss. Hct 28 to 24, source would likely be UGIB given recent EGD findings and melena. Recent UA and CXR unremarkable, but SBP was on differential. There were no ascites to tap. Patient remained HD stable on the floor. #Hepatic Vein Thrombosis - L hepatic vein thrombosis in the setting of known HCC. Initially treated with heparin gtt on ___, which was d/c'ed on ___ in setting of bleed. - Discontinued anticoagulation due to bleed # Thrombocytopenia: Likely from splenic sequestration vs consumption. # HCV cirrhosis: Patient is not a transplant candidate due to ___ not meeting ___ criteria for transplant consideration. He is ___ Score 13 (class C), with diuretic-controlled ascites, grade II-III varices and GAVE and history of encephalopathy, MELD 31. s/p recent RFA x2 most recently ___. No current e/o encephalopathy or decompensation of liver disease on exam. Tbili trending up. Diuretics were held in setting of UGIB, no accumulation of ascites, will restart at discharge. Continued with rifaximin/lactulose and nadolol for grade 3 varices. -MRI will be discussed at next tumor meeting to determine if candidate for live liver donor pending if mass at PVT is determined to be tumor vs. bland - restarted 20mg lasix and 50mg spironolactone on discharge # CKD: Patient with history of CKD from lithium with baseline creatinine 2.3. Currently stable. Trending down 3.1 (___) to 2.5 (___). # Bipolar disorder: Continued home seroquel #___ s/p RFA: Patient s/p repeat RFA of single remaining liver lesion without complications TRANSITIONAL ISSUES -will need to complete 14 days of antibiotics for E. coli bacteremia from last negative blood culture (___). Last day of ciprofloxacin is ___ -please follow up pending blood cultures -will need to complete 10 day course of antibiotics for UTI. Last day of augmentin is ___ -will have chem7, LFTs, coags drawn on ___ with results to be faxed to Dr. ___ follow up with results -nadolol uptitrated from 20mg to 40mg daily. please adjust dose as needed. # Communication: Patient; ___ (wife) ___ # Code: Full Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Furosemide 20 mg PO EVERY OTHER DAY 2. Lactulose 15 mL PO TID 3. Nadolol 20 mg PO DAILY 4. Pantoprazole 40 mg PO Q12H 5. QUEtiapine Fumarate 400 mg PO QHS 6. Rifaximin 550 mg PO BID 7. Ferrous Sulfate 325 mg PO DAILY 8. Spironolactone 50 mg PO DAILY Discharge Medications: 1. Ferrous Sulfate 325 mg PO DAILY 2. Lactulose ___ mL PO TID encephalopathy 3. Nadolol 40 mg PO DAILY RX *nadolol 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 4. QUEtiapine Fumarate 400 mg PO QHS 5. Rifaximin 550 mg PO BID 6. Amoxicillin-Clavulanic Acid ___ mg PO Q8H please take until ___. please take it at least 2 hour apart from iron RX *amoxicillin-pot clavulanate [Augmentin] 500 mg-125 mg 1 tablet(s) by mouth every 8 hours Disp #*18 Tablet Refills:*0 7. Ciprofloxacin HCl 750 mg PO Q12H please take until ___. please take it at least 2 hour apart from iron RX *ciprofloxacin 750 mg 1 tablet(s) by mouth every 12 hours Disp #*20 Tablet Refills:*0 8. Furosemide 20 mg PO EVERY OTHER DAY 9. Pantoprazole 40 mg PO Q12H 10. Spironolactone 50 mg PO DAILY 11. Aluminum-Magnesium Hydrox.-Simethicone ___ mL PO QID:PRN dyspepsia please take only as needed RX *alum-mag hydroxide-simeth 200 mg-200 mg-20 mg/5 mL ___ mL by mouth four times a day as needed Refills:*0 12. Outpatient Lab Work please check chem7, coags, AST, ALT, alk phos, tbili and fax results to Dr. ___. Phone: ___ Fax: ___ ICD-9 code: ___.5, ___.4 Discharge Disposition: Home Discharge Diagnosis: PRIMARY: portal vein thrombosis, E. coli bacteremia, urinary tract infection, GI bleed in setting of anticoagulation SECONDARY: HCV cirrhosis, HCC Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you during your stay at ___ ___. You came in to the hospital because of abdominal pain and we found a clot in the large vein that goes to your liver. As a result, we started you on a blood thinner, but this caused you to bleed. The blood thinner was therefore discontinued and you stopped bleeding. You also have an infection in your bloodstream likely due to bacteria from your gut that travelled to your bloodstream when you were bleeding. As a result you will need to take antibiotics (ciprofloxacin) for a total of 14 days (last day ___. You also have an infection in your urine and will need to take antibiotics (augmentin) for a total of 10 days. Please make sure you follow up with your appointments. Your case will be discussed at the tumor board next week. Please have your blood drawn on ___. We wish you the best, Your ___ team Followup Instructions: ___
10388767-DS-10
10,388,767
24,446,997
DS
10
2185-12-10 00:00:00
2185-12-12 07:22:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: ___, BRBPR Major Surgical or Invasive Procedure: ___ EGD/Colonoscopy History of Present Illness: ___ with multiple medical comorbidities (although no h/o liver dz or other condition requiring anticoagulation) significant for diverticulosis and hemorrhoids (last screening ___ ___, who presents from PCP ___/ c/o episodic rectal bleeding for 1 week. Patient reports that she started to notice intermittent dark-black stools or blood in toilet bowl; she has also noticed some mild epigastric and lower abdominal discomfort. In the ED, patient was initially noted to be afebrile with T97.4 HR92 BP124/79 RR18 98RA. Patient was T&S'd, received 2 pIVs, and initiated on pantoprazole IV drip. Labs were notable for lactate WNL, hgb 9.6, LFTs WNL, chemistries WNL. Exam was notable for black stools on DRE with +guaiac. GI was consulted from the ED; will take On the floor, AVSS. Over the past 2 days, patient reports the episodes have increased in severity and frequency, and have been accompanied with worsening fatigue. Also reporting some lightheadedness upon standing. Patient denies recent f/c/n/v/d. No CP/SOB. No She denies recent alcohol abuse or extensive use of NSAIDs. Past Medical History: 1. CAD s/p cardiac cath @ BWH-hx coronary endothelial dysfunction no obstructive disease ___ 2. HTN 3. Hyperlipidemia 4. Diabetes mellitus, borderline 5. Hx DVT in ___ 6. Morbid obesity 7. Asthma 8. Anxiety 9. Dementia, on donepezil 10. Lumbar spinal stenosis 11. Hx of depression 12. Panic disorder w/ agoraphobia 13. Migraines 14. Empty sella syndrome 15. Hx fatty liver 16. Esophageal reflux 17. Insomnia 18. Vitamin B12 deficiency 19. Nephrolithiasis 20. h/o thrombophlebitis (deep femoral v) 21. internal hemorrhoids 22. diverticulosis 22. b/l pseudophakia Social History: ___ Family History: No known GI malignancy Physical Exam: ADMISSION PHYSICAL EXAM: VS: 97.7 144/73 84 18 100RA GENERAL: Alert, oriented, obese woman in no acute distress, very pleasant woman HEENT: Sclera anicteric, MMM, oropharynx clear NECK: supple, JVP not elevated, no LAD LUNGS: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, gallops ABD: soft, non-distended, mildly tender over epigastric region with deeper palpation, +BS, no rebound tenderness or guarding, no organomegaly EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema SKIN: no rashes NEURO: AOx3, grossly intact DISCHARGE PHYSICAL EXAM: VS: 98.1 ___ 110s-120s/40s-80s ___ 96-100RA GENERAL: Alert, oriented, obese woman in no acute distress, very pleasant HEENT: no JVD LUNGS: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, gallops ABD: soft, non-distended, non-tender, +BS, no rebound tenderness or guarding, no organomegaly EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema SKIN: no rashes NEURO: AOx3, grossly intact Pertinent Results: ADMISSION LABS ============== ___ 03:09PM BLOOD WBC-9.8 RBC-3.27* Hgb-9.6* Hct-30.4* MCV-93 MCH-29.4 MCHC-31.6* RDW-14.5 RDWSD-49.1* Plt ___ ___ 03:09PM BLOOD Neuts-61.8 ___ Monos-9.0 Eos-2.4 Baso-0.8 Im ___ AbsNeut-6.04 AbsLymp-2.48 AbsMono-0.88* AbsEos-0.23 AbsBaso-0.08 ___ 03:09PM BLOOD ___ PTT-31.3 ___ ___ 03:09PM BLOOD Glucose-128* UreaN-19 Creat-0.7 Na-140 K-3.7 Cl-101 HCO3-25 AnGap-18 ___ 03:09PM BLOOD ALT-23 AST-19 AlkPhos-72 TotBili-0.5 ___ 03:09PM BLOOD Albumin-4.2 ___ 03:17PM BLOOD Lactate-1.7 DISCHARGE LABS =============== ___ 01:10PM BLOOD WBC-8.6 RBC-3.06* Hgb-9.0* Hct-28.3* MCV-93 MCH-29.4 MCHC-31.8* RDW-14.7 RDWSD-49.3* Plt ___ ___ 06:15AM BLOOD Glucose-101* UreaN-6 Creat-0.6 Na-142 K-3.9 Cl-106 HCO3-27 AnGap-13 ___ 06:15AM BLOOD Calcium-8.6 Phos-3.6 Mg-2.2 IMAGING/STUDIES: ================= ___ GI Bleed Embo/Angiogram FINDINGS: 1. Right common femoral arteriogram showing normal anatomy with low common femoral artery bifurcation. 2. No active extravasation identified on ___, selective sigmoid branch (adjacent to endoscopically placed clips), or SMA arteriograms. No embolization perform. IMPRESSION: No active extravasation identified. No embolization performed. EGD ___ Findings: Esophagus: Normal esophagus. Stomach: Normal stomach. Duodenum: Normal duodenum. Recommendations: No source of bleeding identified. Proceed to colonoscopy. OK to discontinue IV PPI. Additional notes: The attending was present for the entire procedure. The patient's home medication list is appended to this report. FINAL DIAGNOSIS: Normal examination. Estimated blood loss = zero. No specimens were taken for pathology. ___ Colonoscopy Impression: Fresh blood and clots were seen throughout the whole colon. Severe diverticulosis was seen throughout the whole colon. An actively bleeding diverticulum was identified at 35 cm in the sigmoid colon. 2cc of epinephrine were injected into the diverticulum in attempts at hemostasis, but unsuccessful. An endoclip was placed adjacent to the bleeding diverticulum for ___ localization. ___ was consulted for embolization. Large nonbleeding internal hemorrhoids were seen on retroflexion in the rectum. A 4mm polyp was seen in the left colon, but not removed in the setting of active bleeding. Otherwise normal colonoscopy to cecum Recommendations: ___ consult for embolization. Transfuse 1u PRBC now for active bleeding. Maintain active type and cross and large bore IV access. After the acute episode has resolved, recommend repeat colonoscopy for polypectomy. Additional notes: The procedure was performed by the fellow and the attending. The attending was present for the entire procedure. The patient's reconciled home medication list is appended to this report. FINAL DIAGNOSES are listed in the impression section above. Estimated blood loss = zero. No specimens were taken for pathology Brief Hospital Course: ___ p/w one week h/o dark-black stools c/f melena and UGIB vs R-sided colonic bleed perhaps in setting of diverticulosis. # GIB: H/o hemorrhoids and diverticulosis, both which would cause more BRBPR; however could be R-sided. Most likely UGIB given h/o GERD, report of dark stools and recent abdominal discomfort; last colonoscopy over ___ years ago. HD stable, but complaining of some lightheadedness, c/f orthostasis, symptomatic anemia. Patient received 2 pIVs on admission and IV pantoprazole, consented for blood products, made NPO at ___ for ___, and written for moviprep. Underwent ___ ___ which showed diverticular bleed which was clipped and injected with epi for attempt at hemostasis; hemostasis unsuccessful so, patient underwent ___ guided embolization procedure; however, ___ was unable to identify the bleed. Patient remained HD stable with stable hgb and so was discharged the following day. Hgb 9.0 at discharge. # CAD: s/p cardiac cath @ ___. No CP currently. Continued home ASA 81mg. # HTN: Stable. Held home ACEI and HCTZ in setting of acute GIB and while NPO. # dementia: Stable. Continued home donepezil (ARICEPT) 5 mg QHS. # HL: Stable. Continued home ATORVASTATIN 80 MG qd. # anxiety/depression: Continued home venlafaxine 100 mg QD. # Asthma/RAD: no respiratory complaints at this time. Continued home albuterol, fluticasone, loratidine. TRANSITIONAL ISSUES =================== -H/H on discharge 9.0/28.3 -EGD/Colonoscopy showed bleeding diverticula -Lisinopril restarted, but HCTZ held. Please reassess and consider restarting HCTZ. -Pt should have CBC within a week to ensure stable H/H -FULL code Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Fluticasone Propionate 110mcg 2 PUFF IH BID 2. Venlafaxine 100 mg PO BID 3. Donepezil 5 mg PO QHS 4. Loratadine 10 mg PO DAILY 5. Omeprazole 20 mg PO DAILY 6. Atorvastatin 80 mg PO QPM 7. Lisinopril 5 mg PO DAILY 8. Hydrochlorothiazide 12.5 mg PO DAILY 9. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath 10. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain 11. Aspirin 81 mg PO DAILY Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Donepezil 5 mg PO QHS 5. Fluticasone Propionate 110mcg 2 PUFF IH BID 6. Loratadine 10 mg PO DAILY 7. Venlafaxine 100 mg PO BID 8. Lisinopril 5 mg PO DAILY 9. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain 10. Omeprazole 40 mg PO DAILY RX *omeprazole 40 mg 1 capsule(s) by mouth Daily Disp #*30 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: PRIMARY: -gastrointestinal bleed SECONDARY: -diverticulosis -diabetes mellitus (type II) -CAD -HTN -HLD -anxiety/depression -asthma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted to the ___ because of bloody stools. This was concerning for bleeding in your stomach and/or your colon. Because you had not had any imaging in several years, you underwent an upper endoscopy (camera from above) and a colonoscopy (camera from below) to see your stomach and colon, respectively. We found a bleeding diverticula, or pouch of your intestine. Please continue to follow up with your primary care doctor on ___ at 11:00 am. Please do not take your hydrochlorothiazide for now. It was a pleasure taking part in your care, Your ___ Medicine Team Followup Instructions: ___
10388863-DS-19
10,388,863
25,782,468
DS
19
2112-03-28 00:00:00
2112-03-28 16:33:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: Oxycodone / Aquaphor / Lamictal XR Attending: ___. Chief Complaint: diplopia Major Surgical or Invasive Procedure: Right-sided ventriculoperitoneal shunt placement. History of Present Illness: Mr. ___ is a ___ year old man with a history of atypical carcinoid tumor of the lung and brain who presents to the ER with gait unsteadiness and diplopia in the past 2 weeks. He states he has never had trouble with his vision in the past but his right eye became blurred/double vision, now his left eye is affected. He has noticed more discoordination when walking, tripping over things. He denies falls. His headaches have been worse in the past 2 weeks. he has been taking dilaudid 2mg tablets ___ times per day. He denies changes in speech, swallowing, falls, focal weakness or numbness. He saw his PCP today who referred him to the ER. He recently started Temodar (240 mg daily) and took this for 1 week on, completing this week yesterday. In the emergency department, initial vitals: 97.7 83 129/77 16 100%. Head CT showed numerous supratentorial and infratentorial metastatic lesions which were unchanged since ___. He received 10 mg of IV dexamethasone and 2mg IV dilaudid. On the floor, he complains of a headache all over his head. The dilaudid he received in the ER lasted for a few hours. He denies cough, shortness of breath, nausea, vomiting, diarrhea. REVIEW OF SYSTEMS: (+) Per HPI + constipation (-) Denies fever, chills, night sweats, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denied cough, shortness of breath. Denied chest pain or tightness, palpitations. Denied nausea, vomiting, diarrhea, or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denied arthralgias or myalgias. Past Medical History: PAST ONCOLOGIC HISTORY (summarized from ___ clinic notes): - presented in ___ with personality changes, disinhibition and headache. Head CT at OS___ showed R frontal hemorrhage. Repeat head CTA ___ showed a 3.6 x 3.2cm hyperdense subependymal mass in R inferior frontal lobe, most c/w a subependymal astrocytoma. There was a 6mm hyperdense nodule in L lateral ventricle & several hyperdense areas in supratentorium. He started phenytoin/decadron. Brain MRI ___ showed mult. intra-parenchymal brain lesions. - ___: CT Torso showed RUL mass, 5.3 cm w/ adjacent nodules, up to 7mm. Mediastinal & R hilar lymphadenopathy present, up to 2.5cm - ___: bronchoscopy w/ FNA of 4L LN was (+) for neuroendocrine tumor. - ___: pt had stereotactic brain bx intraparenchymal lesion was non-diagnostic. - ___: repeat brain bx. Path was (+) for metastatic carcinoid, w/ proliferative index (Ki-67 or MIB) 50%, c/w atypical carcinoid. - ___: WBRT He was admitted - ___: Cisplatin Etoposide x 4 cycles with concomittent chest RT - ___: completed chest XRT - ___: brain MRI showed 2 new brain lesions w/ significant growth of L parieto-occipital lesion. - ___: Cyberknife PAST MEDICAL HISTORY: ADHD previously on Adderall Cervical disk fusion by anterior approach ___ years ago Multiple lipomas removed Social History: ___ Family History: Father died at ___ of colon CA. His mother is ___, she had surgery for benign thyroid nodules. There is otherwise no known history of cancer in his family. Physical Exam: Admission Physical Exam: VS: T97.3 BP 123/76 HR 65 RR 16 96% RA GENERAL: alert and oriented, NAD HEENT: No scleral icterus. PERRLA/EOMI. MMM. OP clear. Neck Supple, No LAD. Report blurred vision in the left on lateral gaze. CARDIAC: RR. Normal S1, S2. No m/r/g. LUNGS: CTA B, good air movement bilaterally. ABDOMEN: NABS. Soft, NT, ND. No HSM EXTREMITIES: No c/c/e, 2+ dorsalis pedis/ posterior tibial pulses. NEURO: A&Ox3. Appropriate. CN ___ grossly intact. Preserved sensation throughout. ___ strength throughout. Tandem gait slightly unsteady. . Discharge Physical Exam: VS: T98.1 BP 100s-120s/60s-80s HR ___ RR 18 98% RA GENERAL: alert and oriented, NAD, right side of head shaved from surgery HEENT: No scleral icterus. PERRLA/EOMI. MMM. OP clear. Neck Supple, No LAD. Report blurred vision in the left on lateral gaze. CARDIAC: RR. Normal S1, S2. No m/r/g. LUNGS: CTAB, good air movement bilaterally. ABDOMEN: NABS. Soft, NT, ND. No HSM EXTREMITIES: No c/c/e, 2+ dorsalis pedis/ posterior tibial pulses. NEURO: A&Ox3. Appropriate. CN ___ grossly intact. Preserved sensation throughout. ___ strength throughout. Tandem gait slightly unsteady. Pertinent Results: Admission Labs: ___ 02:50PM BLOOD WBC-13.7* RBC-4.61 Hgb-12.8* Hct-36.5* MCV-79* MCH-27.8 MCHC-35.0 RDW-14.8 Plt ___ ___ 02:50PM BLOOD Neuts-88.8* Lymphs-6.4* Monos-4.0 Eos-0.4 Baso-0.4 ___ 02:50PM BLOOD ___ PTT-23.6* ___ ___ 02:50PM BLOOD Glucose-161* UreaN-27* Creat-1.0 Na-139 K-3.8 Cl-104 HCO3-21* AnGap-18 ___ 02:50PM BLOOD Calcium-9.1 Phos-3.2 Mg-2.2 . Pertinent Labs: ___ 06:20AM BLOOD WBC-14.2* RBC-4.25* Hgb-11.9* Hct-35.9* MCV-85 MCH-28.0 MCHC-33.0 RDW-15.1 Plt ___ ___ 07:00AM BLOOD ___ PTT-23.9* ___ ___ 06:20AM BLOOD Glucose-122* UreaN-19 Creat-0.9 Na-139 K-4.4 Cl-100 HCO3-29 AnGap-14 ___ 06:20AM BLOOD Calcium-8.6 Phos-3.3 Mg-2.3 ___ 06:57AM BLOOD Valproa-31* ___ 06:25AM BLOOD Valproa-80 . CT HEAD W/O CONTRAST Study Date of ___ 3:00 ___ IMPRESSION: Numerous infratentorial and supratentorial metastatic lesions, as detailed above, appear largely stable in size and distribution since ___ MR exam but significantly progressed since ___ CT study. Hyperdense components in the bifrontal lesions may represent foci of hemorrhage. Lesion in the midbrain is in close proximity to left oculomotor nerve nucleus could explain patient's diplopia. MR HEAD W & W/O CONTRAST Study Date of ___ 12:27 ___ IMPRESSION: Numerous supra- and infra-tentorial metastatic lesions. Some lesions are stable, some are new and most have increased in size as compared to the prior study. CHEST (PRE-OP PA & LAT) Study Date of ___ 7:52 ___ IMPRESSION: No acute intrathoracic process. CT HEAD W/O CONTRAST Study Date of ___ 6:03 ___ IMPRESSION: Interval placement of right transfrontal ventriculostomy catheter, without acute intracranial hemorrhage or other short-interval change. Brief Hospital Course: ASSESSMENT AND PLAN: Mr. ___ is a ___ year old man with atypical carcinoid tumor involving the brain and lungs who is admitted with diplopia and gait unsteadiness. 1. Metastatic Carcinoid Tumor: On arrival an MRI of the head was performed which showed multiple metastatic lesions. This imaging was reviewed by neuro-oncology and neurosurgery and there was significant concern for hydrocephalus from a metastatic lesion compressing the aqueduct. The decision was made to take the pt for a shunt placement. He was given Dexamethasone 4mg QID prior to surgery. A VP shunt was placed without complication. He had received some symptom improvement following shunt placement. We also added Valproic acid to his regimen as well for headache and seizure prophylaxis. 2. Headache: Most likely from metastatic disease and multiple lesions in the pts brain. We controlled his headaches with Dilaudid prn for pain and added Valproic acid to his regimen. His Valproic acid level was therapeutic at time of discharge. 3. Transitional-The pt has follow up appointments with hematology oncology following discharge. He was instructed to make a follow up appointment with Neurosurgery in 4 wks. Medications on Admission: dexamethasone 4 mg PO BID hydromorphone 2 mg tab PO BID PRN pain lorazepam 1mg PO daily PRN anxiety, sleep ondansetron HCl 8 mg PRN nausea temozolomide [Temodar] 100 mg once daily 7 days on 7 days off temozolomide [Temodar] 140 mg Capsule once daily 7 days on 7 days off Topiramate 100 mg Tablet PO BID Discharge Medications: 1. hydromorphone 2 mg Tablet Sig: ___ Tablets PO every ___ hours as needed for pain, headache. Disp:*30 Tablet(s)* Refills:*0* 2. lorazepam 1 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed for insomnia. 3. ondansetron HCl 8 mg Tablet Sig: One (1) Tablet PO every eight (8) hours as needed for nausea. 4. divalproex ___ mg Tablet, Delayed Release (E.C.) Sig: Two (2) Tablet, Delayed Release (E.C.) PO BID (2 times a day). Disp:*120 Tablet, Delayed Release (E.C.)(s)* Refills:*2* 5. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). Disp:*60 Capsule(s)* Refills:*2* 6. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation. Disp:*60 Tablet(s)* Refills:*2* 7. dexamethasone 4 mg Tablet Sig: One (1) Tablet PO twice a day. 8. temozolomide 100 mg Capsule Sig: One (1) Capsule PO once a day: 7 days on and 7 days off. 9. temozolomide 140 mg Capsule Sig: One (1) Capsule PO once a day: 7 days on 7 days off . 10. famotidine 40 mg Tablet Sig: One (1) Tablet PO once a day. Disp:*30 Tablet(s)* Refills:*2* Discharge Disposition: Home Discharge Diagnosis: Carcinoid Tumor with Mets to the Brain occlusive hydrocephalus Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mr. ___, It was a pleasure taking care of you at ___ ___. You were admitted with blurry vision and difficulty walking. An MRI of your brain showed that there was an increased amount of fluid present. Neurosurgery placed a shunt to help drain this excess fluid. The following changes have been made to your medications: STOP: Topiramate CHANGE: Hydromorphone 2mg every ___ for pain START: Divalproex for headaches Famotidine to prevent ulcers Docusate Sodium to soften stool Senna for constipation **Your scalp sutures are dissolvable and you have steri strips at your abdominal incision. Both these areas can get wet on ___. Do not scrub the wounds, pat dry. Followup Instructions: ___
10389189-DS-17
10,389,189
25,606,796
DS
17
2119-10-25 00:00:00
2119-10-26 13:26:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: UROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Priapism Major Surgical or Invasive Procedure: Distal T shunt for treatment of priapism History of Present Illness: ___ year old who developed priapism 36hrs prior and failed aspiration and PE irrigation at an OSH. Transferred to ___, later taken to OR for T shunt. Past Medical History: None Social History: ___ Family History: None Physical Exam: NAD Perfused Nonlabored breathing Abd SND Ext WWP Priapism improved although still firm, glans soft, doppler with good flow Pertinent Results: ___ 10:20PM GLUCOSE-96 UREA N-15 CREAT-0.8 SODIUM-138 POTASSIUM-4.1 CHLORIDE-102 TOTAL CO2-22 ANION GAP-18 ___ 10:20PM estGFR-Using this Brief Hospital Course: Presented to the ED from OSH with persistent priapism s/p failed failed aspiration and PE irrigation. Transferred to ___ and taken to OR for T shunt. Postoperatively pain dramatically improved in AM. However, appearance of phallus is still quite firm. Aspiration of corporeal bodies with 19G needle did not produce any blood flow. Doppler US revealed likely clot in bilateral corporeal bodies with antegrade venous flow. There was normal flow in superficial arteries and a question of a possible AV fistula. Given risk of further intervention, good flow on doppler, improved pain, sent home without further intervention. The patient was discharged in stable condition, eating well, ambulating independently, voiding without difficulty, and with pain control on oral analgesics. On exam, incision was clean, dry, and intact, with no evidence of hematoma collection or infection. The patient was given explicit instructions to follow-up in clinic in one week. Medications on Admission: None Discharge Medications: 1. Acetaminophen 1000 mg PO Q6H 2. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*40 Capsule Refills:*0 3. Ibuprofen 600 mg PO Q6H:PRN Pain - Mild RX *ibuprofen 600 mg 1 tablet(s) by mouth every six (6) hours Disp #*30 Tablet Refills:*0 4. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Moderate RX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Priapism Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: -Resume your pre-admission/home medications except as noted. ALWAYS call to inform, review and discuss any medication changes and your post-operative course with your primary care doctor. -___ OTHERWISE NOTED; AVOID aspirin or aspirin containing products and supplements that may have “blood-thinning” effects (like Fish Oil, Vitamin E, etc.). This will be noted in your medication reconciliation. IF PRESCRIBED (see the MEDICATION RECONCILIATION): -IBUPROFEN (the ingredient of Advil, Motrin, etc.) may be taken even though you may also be taking Tylenol/Acetaminophen. You may alternate these medications for pain control. For pain control, try TYLENOL FIRST, then ibuprofen, and then take the narcotic pain medication as prescribed if additional pain relief is needed. -Ibuprofen should always be taken with food. Please discontinue taking and notify your doctor should you develop blood in your stool (dark, tarry stools) -Call your Urologist's office to schedule/confirm your follow-up appointment in 2 weeks AND if you have any questions. -Do not eat constipating foods for ___ weeks, drink plenty of fluids to keep hydrated -No vigorous physical activity or sports for 4 weeks or until otherwise advised. Light household chores/activity and leisurely walking/activity is OK and should be continued. Do NOT be a “couch potato” -Tylenol should be your first-line pain medication. A narcotic pain medication has been prescribed for breakthrough pain ___. -Max daily Tylenol (acetaminophen) dose is THREE to FOUR grams from ALL sources -Do not lift anything heavier than a phone book (10 pounds) or drive until you are seen by your Urologist in follow-up and/or as directed in the “handout” -You may shower normally but do NOT immerse your incisions or bathe -Do not drive or drink alcohol while taking narcotics and do not operate dangerous machinery -Colace has been prescribed to avoid post surgical constipation and constipation related to narcotic pain medication. Discontinue if loose stool or diarrhea develops. Colace is a stool-softener, NOT a laxative -If you have fevers > 101.5 F, vomiting, or increased redness, swelling, or discharge from your incision, call your doctor or go to the nearest emergency room. Followup Instructions: ___
10389768-DS-10
10,389,768
21,411,295
DS
10
2148-07-29 00:00:00
2148-07-30 13:39:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Chest pain Major Surgical or Invasive Procedure: Coronary cath ___ s/p 2x DES to RCA History of Present Illness: This is a ___ with no past medical history who presented to an OSH with chest pain and transferred to the ___ ___ yo male with no pmh who present from an osh as an NSTEMI. Endorsing substernal cp since 5p. Presented to OSH where found to have dynamic ECG changes in an inferior lateral distribution. Constant chest pressure with right arm pain. OSH where CTA without dissection and troponin positive to 0.3. In the ED initial vitals were: 97.9 68 106/68 19 97% NC EKG: inferioapical q-waves and TWI Labs/studies notable for: WBC=11.3 Plt 144, proBNP=167, trop 0.68, MB=138 lactate. Patient was given: full dose aspirin, loaded with clopidogrel, IV heparin, Atrovastatin, nitro ggt for chest pain. The patient continued to have chest pain despite nitro drip and was send to the CCU for further monitoring pending further eval for cath. On arrival to the CCU: 98.4 89/68 72 94% on RA. patient complains of ___ chest pain. was given 1L NS Past Medical History: no past medical history. Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ========================== ADMISSION PHYSICAL EXAM ========================== VS: 98.4 89/68 72 94% on RA general: look in pain chest: good air entry bilat with no wheeze or crackles. heart: normal S1 and S2 with no murmur. abdomen: soft and non-tender. ext: warm and well perfused. ======================== DISCHARGE PHYSICAL EXAM ======================== VS: Tc 99.3 106-118/65-74, 74-83, 98% on RA general: Adult male in NAD chest: good air entry bilat with no wheeze or crackles. heart: normal S1 and S2 with no murmur. abdomen: soft and non-tender. ext: warm and well perfused. Pertinent Results: ======================== ADMISSION LABS ======================== ___ 02:10AM BLOOD WBC-11.3* RBC-4.55* Hgb-14.4 Hct-42.9 MCV-94 MCH-31.6 MCHC-33.6 RDW-13.0 RDWSD-44.7 Plt ___ ___ 02:10AM BLOOD Neuts-75.2* Lymphs-15.5* Monos-6.3 Eos-1.6 Baso-0.4 Im ___ AbsNeut-8.53* AbsLymp-1.76 AbsMono-0.71 AbsEos-0.18 AbsBaso-0.04 ___ 02:10AM BLOOD ___ PTT-85.1* ___ ___ 02:10AM BLOOD Glucose-123* UreaN-15 Creat-0.9 Na-139 K-3.8 Cl-105 HCO3-24 AnGap-14 ___ 02:10AM BLOOD CK(CPK)-869* ___ 02:10AM BLOOD CK-MB-138* MB Indx-15.9* proBNP-167* ___ 02:10AM BLOOD cTropnT-0.68* ___ 02:10AM BLOOD Calcium-8.6 Phos-2.9 Mg-2.1 ___ 04:19PM BLOOD %HbA1c-5.0 eAG-97 ___ 08:13AM BLOOD Triglyc-175* HDL-32 CHOL/HD-4.7 LDLcalc-83 LDLmeas-109 ___ 02:10AM BLOOD ASA-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 02:23AM BLOOD Lactate-1.3 =========== MICRO =========== None ============== IMAGING ============== ___ CXR There is moderate interstitial pulmonary edema. No focal infiltrates to suggest pneumonia. Borderline enlargement of the cardiomediastinal silhouette. No pleural effusion. No pneumothorax. ___ Cardiovascular Cath Physician ___ ___ Right dominant LM: No disease. LAD: No disease. Gives collaterals to the RCA. LCx: No disease. RCA: Mid vessel diffuse 50% disease. Distal thrombotic occlusion. Impressions: Occluded RCA, successfully stented with 2 overlapping DES. Ticagrelor 180 loaded on table. TR band to right wrist. Recommendations ASA for life, Ticagrelor 90 BID x ___ year, then switch to 60 BID thereafter. ___ Cardiovascular ECHO Conclusions The left atrium is elongated. Left ventricular wall thicknesses and cavity size are normal. There is mild symmetric left ventricular hypertrophy with normal cavity size. There is mild regional left ventricular systolic dysfunction with mild focal basal inferior and inferoseptal hypokinesis (PDA distribution). The remaining segments contract normally (LVEF = 50%). Right ventricular chamber size and free wall motion are normal. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. The mitral valve appears structurally normal with trivial mitral regurgitation. There is no mitral valve prolapse. The pulmonary artery systolic pressure could not be determined. There is no pericardial effusion. IMPRESSION: Mild regional left ventricular systolic dysfunction, c/w CAD. ======================== DISCHARGE LABS ======================== ___ 06:50AM BLOOD WBC-9.0 RBC-4.41* Hgb-14.1 Hct-42.4 MCV-96 MCH-32.0 MCHC-33.3 RDW-13.0 RDWSD-46.5* Plt ___ ___ 06:50AM BLOOD Glucose-100 UreaN-11 Creat-0.9 Na-142 K-4.0 Cl-105 HCO3-23 AnGap-18 ___ 06:50AM BLOOD Calcium-9.1 Phos-2.9 Mg-2.0 ___ 04:19PM BLOOD %HbA1c-5.0 eAG-97 ___ 08:13AM BLOOD Triglyc-175* HDL-32 CHOL/HD-4.7 LDLcalc-83 LDLmeas-109 ___ 02:10AM BLOOD ASA-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 02:23AM BLOOD Lactate-1.3 Brief Hospital Course: Summary ___ with no PMH presented with new onset of central chest pain with q-waves and elevation in trops consistent with acute MI. He underwent cardiac cath ___ with 2 DES to RCA and did well post procedure without complications. # Non-ST elevation myocardial infarction: Presented with increasing trops and ST changes on the EKG. He underwent cardiac cath ___ with 2 DES to RCA and did well post procedure without complications. He was discharged on Aspirin 81mg daily, Atorvastatin 80mg Daily, Metoprolol succinate 25mg daily and ticagrelor 90mg BID. # R ear fullness and hearing loss: During admission, patient developed fullness and diminished hearing in his R ear. Was not associated with dizziness, vision changes, nasal discharge or pain. Exam was unrevealing. He was given Flonase prescription to help with any Eustachian tube dysfunction. We also set up outpatient ENT referral. Transitional Issues - Followup appointments were made with PCP, ENT and cardiology. - He was prescribed aspirin, atorvastatin, metoprolol and ticagrelor for post-MI care. He should take the aspirin and ticagrelor for at least ___ year post ___. - Given Flonase for ear fullness and hearing loss and will follow with ENT as above. # CODE: Full # Contact: ___ Relationship: OTHER Phone: ___ Medications on Admission: None Discharge Medications: 1. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 2. Atorvastatin 80 mg PO QPM RX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 3. Fluticasone Propionate NASAL 1 SPRY NU DAILY RX *fluticasone 50 mcg/actuation 1 spray daily Disp #*30 Spray Refills:*0 4. Metoprolol Succinate XL 25 mg PO DAILY RX *metoprolol succinate 25 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 5. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain take and call ___ RX *nitroglycerin 0.3 mg 1 tablet(s) sublingually prn chest pain Disp #*100 Tablet Refills:*0 6. TiCAGRELOR 90 mg PO BID RX *ticagrelor [Brilinta] 90 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*3 Discharge Disposition: Home Discharge Diagnosis: Primary diagnosis: NSTEMI Secondary diagnosis: R sided hearing loss Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You came to ___ with chest pain and were found to have a heart attack. We placed a stent to keep your artery open. Please take the medications we have prescribed and keep the appointments we have made. It was a pleasure taking care of you, best of luck. Your ___ medical team Followup Instructions: ___
10390100-DS-11
10,390,100
26,330,031
DS
11
2145-06-22 00:00:00
2145-06-24 11:49:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Norvasc / Keflex / latex / metoprolol Attending: ___. Chief Complaint: R distal femur fracture Major Surgical or Invasive Procedure: Fixation, distal femoral fracture, with retrograde intramedullary nail ___ History of Present Illness: This is a ___ with a history of afib on Coumadin, s/p right knee replacement (___) complicated by incisional wound infection s/p IV vanco and po Bactrim (___) presenting after mechanical fall at home with right distal femoral metaphyseal oblique fracture with displacement, near but not communicating with recent TK. She underwent fixation on ___ complicated by bleeding requiring 4 uPRB. She became more delirious after her surgery and transferred to the medical service. Her course has been complicated by supratherapeutic INR (3.5 despite 2 uFFP), ___ (Cr 2.6, baseline 1.6) thought ___ Bactrim and chlorthalidone and fevers to 103. Per report, she was previously A&Ox3 and appropriate. At the time, she was in severe pain and was using her dilaudid PCA. On the medical service, her Hct was 24.1 but no further blood products could be given as she was persistently febrile for > 6 hours. At 22:30, she developed new hypotension to 78, although asymptomatic (other than ongoing delirium). She was given 1L NS and 2 uPRBC without improvement in blood pressure. Given hypotension and nursing concern, she was transferred to the MICU. Past Medical History: - A fib on Coumadin - HTN - R TKR (___) c/b incisional infection s/p ___ - Sepsis ___ pyelonephritis (___) - Diastolic CHF - COPD Social History: ___ Family History: Non-contributory Physical Exam: ADMISSION PHYSICAL EXAM: Vitals: 100.8, HR 92, 95/38, 100% on 2L GENERAL: Alert, oriented, no acute distress HEENT: Sclera anicteric, dry mucous membranes, oropharynx clear NECK: supple LUNGS: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 S2, III/VI early systolic murmur, no rubs/gallops ABD: soft, non-tender, non-distended, no rebound tenderness or guarding EXT: R knee larger than left with surgical staples in place, tender to touch but no erythema/warmth/oozing w/ healing edges. Both legs Warm, well perfused, 1+ pulses b/l ___, 2+ pulses radially, no clubbing, cyanosis or edema. SKIN: R Achilles skin abrasion 2x2cm NEURO: AOX3, alert and attentive, CNII-XII intact, moving all extremities, normal strength UE DISCHARGE PHYSICAL EXAM: VS: 98.9 141/66 70 20 94%RA Gen: AAOx3 HEENT: AT/NC, eyes anicteric, PERRL, MMM CV: RRR, (+)S1, S2, SEM at RUSB Pulm: CTAB Abd: soft, ND/NT, no rebound/guarding GU: no foley in place Ext: RLE significantly larger than left, wrapped in ace-bandage from foot to upper thigh, (+) edema in ankle, (+) palpable DP. LLE edematous to calf. Skin: no evidence of ecchymosis, rash. PLE wrapped as above Neuro: AAOx3 Pertinent Results: ADMISSION LAB VALUES: ___ 01:00AM PLT COUNT-205 ___ 01:00AM NEUTS-71.5* LYMPHS-17.1* MONOS-6.0 EOS-4.8 BASOS-0.2 IM ___ AbsNeut-8.65* AbsLymp-2.07 AbsMono-0.73 AbsEos-0.58* AbsBaso-0.03 ___ 01:00AM WBC-12.1* RBC-2.69* HGB-8.6* HCT-26.5* MCV-99* MCH-32.0 MCHC-32.5 RDW-12.5 RDWSD-44.9 ___ 01:00AM estGFR-Using this ___ 01:00AM GLUCOSE-138* UREA N-35* CREAT-2.6*# SODIUM-136 POTASSIUM-4.2 CHLORIDE-101 TOTAL CO2-21* ANION GAP-18 ___ 03:38AM ___ PTT-44.9* ___ ___ 03:30PM ___ ___ 05:55PM ___ PTT-37.1* ___ ___ 05:55PM HCT-19.5*# ___ 05:55PM GLUCOSE-151* UREA N-34* CREAT-2.6* SODIUM-136 POTASSIUM-4.7 CHLORIDE-105 TOTAL CO2-23 ANION GAP-13 ___ 08:37PM URINE HOURS-RANDOM UREA N-324 CREAT-149 SODIUM-34 POTASSIUM-50 CHLORIDE-17 DISCHARGE LAB VALUES: PERTINENT IMAGING/STUDIES: CT RLE: IMPRESSION: 1. Spiral fracture through the mid and distal diaphysis of the right femur with half shaft width posteromedial displacement and 90 degree external rotation of the distal fragment. No intra-articular extension. 2. Small intramuscular hematoma. 3. Gastrocnemius muscle lipoma. CT HEAD: No acute intracranial process. CT CSPINE: IMPRESSION: 1. No fracture or prevertebral fluid. 2. Mild C3 on CT retrolisthesis is likely chronic and degenerative in nature. 3. Mild to moderate multilevel cervical spine degenerative change, with severe neural foraminal narrowing worst bilaterally at C5-6. Brief Hospital Course: Ms. ___ is a ___ lady w/ Afib on Coumadin, s/p R knee replacement (___) c/b incisional wound infection (___) presenting after mech fall w/ femur fx s/p fixation c/b ___ and supratherapeutic INR now w/ persistent fever, leukocytosis, unstable Hct concerning for infection and continued bleed transferred to MICU for hypotension. Stabilized w/fluid resuscitation and additional PRBCs. Transferred back to ___ med floor where she remained stable and was discharged to rehab. # Hypotension: Combination of possible sepsis with fever and leukocytosis and blood loss in setting of operation/supratherapeutic INR. Urine cx, blood cx, CXR negative. Started on vanc and zosyn and continued on vanc given c/f soft tissue infection in the setting of recent instrumentation. Pt also required additional 1 unit pRBC and 2 units FFP in MICU although no source of bleeding identified except for intra-operative/hematoma. Pressor requirement ended after transfusions and patient was transferred back to ___ med floor. She remained HDS, afebrile. She was evaluated by ID and given no identified source of infection in the setting of stability, her antibiotics were discontinued. #Fever/leukocytosis: Presumed sepsis with no pneumonia on CXR and no UA abnormalities. Given persistently high fever in the setting of post-operative, other possible etiologies included atelectasis possible although febrile to 103 w/o improvement w/Tylenol vs transfusion reaction although also unlikely given time separation from last transfusion vs malignant hyperthermia although time course also unlikely and no rigidity on exam vs possible allergic rxn given known allergy to tape and possibly received something in OR that was a trigger vs per ortho c/f inoculation of overlying cellulitis into wound. Patient received 2 days of Zosyn which was stopped and she was continued on Vancomycin on transfer to the floor. Her thigh and knee were monitored closely by Orthopedics and medical team with no external signs of cellulitis identified. She remained afebrile for >48hours prior to discharge and was not discharged on antibiotics. # Anemia: Initially incomplete response to transfusions after 2uFFP, 1uPRBC following surgery. Serial thigh measurements for concern for hematoma/compartment syndrome were unchanged. H&H stable when transferred to the floor and remained stable through discharge. # Altered mental status: Acute episode of AMS in the ICU in setting of history of delirium with hospitalization. Much improved on discharge to the floor. Narcotics were avoided and delirium precautions were put in place. She was AAOx3 on discharge. # Elevated INR: on Coumadin for a fib. Elevated to 3.0 on admission, increased to ___ s/p 2uFFP. Possible etiology for elevation is recent antibiotic use. Received 2 unit FFP and 5mg Iv vit K with complete correction to INR of 1.0. She was restarted on 2.5mg of Coumadin on ___ and subcut heparin. On discharge, her INR was 1.0 and she received a 2nd dose of 2.5mg Coumadin. # ___: admission Cr 2.0 with high of 2.5 in MICU (baseline 1.6). Likely pre-renal from blood loss, dehydration, sepsis. FeNa of 0.41%. Held lisinopril and chlorthalidone pending renal recovery. Following fluid resuscitation Cr improved to below baseline (1.2 on discharge) and her home medications were restarted # R femur fx: s/p fixation (___): R distal metaphyseal femoral fracture adjacent to, but not communicating with recent R TKR in the setting of a mechanical fall. S/p OR on ___ for fixation c/b bleeding. Ortho managed wound care during admission. Required PCA for pain control which was able to be downtitrated to standing Tylenol, tramadol PRN for pain. She was evaluated by physical therapy who felt she required rehab. # HTN: Home meds held in MICU in setting of c/f sepsis. Following transfer to the floor, patient's home medications were restarted. TRANSITIONAL ISSUES: [] d/c on 2.5mg Coumadin, INR at d/c 1.0 -> continue to monitor [] d/c w/o antibiotics -> if becomes febrile, consider thigh/knee as likely source [] avoiding narcotics for pain control -> standing Tylenol, tramadol 50mg PRN for breakthrough # CODE: Full # CONTACT: ___ (husband) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H:PRN pain 2. Atorvastatin 20 mg PO QPM 3. Carvedilol 12.5 mg PO BID 4. Cetirizine 10 mg PO DAILY 5. Lisinopril 40 mg PO DAILY 6. Vitamin D ___ UNIT PO DAILY 7. TraMADOL (Ultram) 25 mg PO Q6H:PRN pain 8. Docusate Sodium 100 mg PO BID 9. Senna 8.6 mg PO HS 10. Warfarin 3.75 mg PO 4X/WEEK (___) 11. Sulfameth/Trimethoprim DS 1 TAB PO BID Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN pain 2. Atorvastatin 20 mg PO QPM 3. Carvedilol 12.5 mg PO BID 4. Docusate Sodium 100 mg PO BID 5. Lisinopril 40 mg PO DAILY 6. Senna 8.6 mg PO HS 7. Warfarin 2.5 mg PO DAILY16 Duration: 1 Dose 8. Chlorthalidone 25 mg PO DAILY 9. Heparin 5000 UNIT SC BID 10. Vitamin D ___ UNIT PO DAILY 11. Cetirizine 10 mg PO DAILY 12. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain RX *tramadol 50 mg 1 tablet(s) by mouth every 6 hours Disp #*56 Tablet Refills:*0 Discharge Disposition: Extended Care Facility: ___ ___ Diagnosis: Primary Diagnoses -Distal right femur fracture -Hypotension -Fever -___ Secondary Diagnoses -HTN Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, You were admitted to the ___ for management of your right femur fracture. The repair of your femur was successful. However, after your procedure, you became very sick requiring transfer to the medical intensive care unit. You were admitted to our intensive care unit where you received fluids and blood, along with antibiotics. At this point you were stable enough for general medical care on the medicine floor where you were evaluated by the Infectious Disease team. Given your normal temperature and no signs of infection, your antibiotics were stopped. You should follow-up with your primary care doctor. You should also follow the orthopedic instructions below. Thank you for letting us be a part of your care! Your ___ Team SPECIFIC INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - Touchdown weight bearing right lower exremity MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - No dressing is needed if wound continues to be non-draining. Followup Instructions: ___
10390112-DS-13
10,390,112
20,837,301
DS
13
2148-07-29 00:00:00
2148-07-31 14:25:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Dyspnea Major Surgical or Invasive Procedure: TEE Cardioversion History of Present Illness: ___ with PMH of cardiomyopathy (unknown details), HTN, HLD, recently diagnosed atrial fibrillation not on anticoagulation presenting with dyspnea. Patient reports worsening dyspnea over the past 5 days. He was recently traveling to a wedding in ___ - denied any change in diet, continued to exercise but noted progressively worsening SOB with exertion. This is associated with 2 pillow orthopnea and cough x 2 weeks. He notes mild abdominal bloating. He denies chest pain. Denies fevers, chills, abdominal pain, nausea, vomiting constipation. The patient initially presented to outpatient NP for evaluation. There, he was found to have O2 sat 91% on RA and HR 128 on office ECG. He was suspected to have CHF exacerbation and was referred to the ___ ED for further evaluation. Of note, per NP ED referral, patient has been followed by cardiology for CAD, cardiomyopathy and AF. He was prescribed xarelto in ___ for anticoagulation, but deferred starting the medication until after his scheduled cataract surgery (scheduled for tomorrow ___. The patient otherwise reported compliance with his metoprolol. In the ED initial vitals were: T97.6, HR 166, BP 133/103, RR 22, O2 93% on RA Exam notable for: diminished breath sounds in b/l bases. Cardiac exam tachycardic. Abdomen soft, NT/ND, no ___ edema Labs/studies notable for: - Na 141, K 4.4, Cl 104, HCO3 21, BUN 19, Cr 1.0, Glucose 122 - WBC 9.1, PMNs 71.3%, Leuks 17.4%, Hgb 14.4, HCT 43.0, Plt 243 - trop < 0.01, proBNP 3252 - UA negative, TSH pending - EKG: (reportedly) afib RVR with intermittent runs of VT, ___ beats - CXR: Bibasilar opacities, right greater than left may reflect atelectasis or infection in the appropriate setting. Pulmonary vascular engorgement without overt signs of pulmonary edema. Patient was given: - metoprolol 5mg IV x1, metoprolol 12.5mg PO x1 with improvement in HR to ___ Vitals on transfer: T97.7, HR 109, BP 121/89, RR 25, O2 92% on NC On the floor, patient endorses mild ongoing dyspnea with occasional dry cough and no other symptoms. ROS: Cardiac review of systems is notable for absence of chest pain, palpitations, syncope or presyncope. Denies exertional buttock or calf pain. On further review of systems, denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, hemoptysis, black stools or red stools. Denies recent fevers, chills or rigors. All of the other review of systems were negative. Past Medical History: 1. CARDIAC RISK FACTORS: +hypertension, +dyslipidemia, no diabetes 2. CARDIAC HISTORY: - CABG: None - PERCUTANEOUS CORONARY INTERVENTIONS: None - PACING/ICD: None 3. OTHER PAST MEDICAL HISTORY: ? CAD (patient unsure on details, no prior cath) H/o cardiomyopathy in ___ H/o Duodenal ulcer Prostate cancer with biopsy in ___ showing low risk cancer BPH Pseudoexfoliation glaucoma Afib with RVR diagnosed in ___ Social History: ___ Family History: Brother with history of MIs in his ___, now deceased. Father with ? anxiety. No other known family cardiac history. Physical Exam: ADMISSION PHYSICAL EXAM: ========================= VS: 98 124/94 138 20 97%RA GENERAL: Comfortable appearing gentleman in NAD HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink. No xanthelasma. NECK: Supple with JVP of 10 cm. CARDIAC: Irregular, normal S1, S2. No murmurs/rubs/gallops. No thrills, lifts. LUNGS: No chest wall deformities, respirations unlabored, bibasilar crackles ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: 1+ pitting edema to ankles bilaterally with sock lines notable on exam SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Distal pulses palpable and symmetric DISCHARGE PHYSICAL EXAM: ========================= Vitals: T 97.5 BP 116/85 (99-118/68-85) HR 95 (73-95) RR ___ O2 95-99% RA I/O: 8h ___, 24h ___ Weight: 88.1 <- 88.2 <- 89.6 Telemetry: Afib with intermittent runs of nonsustained vtach, also with PVCs. GENERAL: Comfortable appearing gentleman in NAD HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink. No xanthelasma. NECK: Supple with no appreciable JVP. CARDIAC: Irregularly irregular, tachycardia, normal S1, S2. No murmurs/rubs/gallops. No thrills, lifts. LUNGS: No chest wall deformities, respirations unlabored, no crackles. ABDOMEN: Soft, distention improved from yesterday, nontender to palpation. No HSM. EXTREMITIES: 2+ pitting edema to ankles bilaterally with sock lines notable on exam SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Distal pulses palpable and symmetric Pertinent Results: ADMISSION LABS: ================ ___ 02:30PM NEUTS-71.3* LYMPHS-17.4* MONOS-9.4 EOS-1.1 BASOS-0.6 IM ___ AbsNeut-6.47* AbsLymp-1.58 AbsMono-0.85* AbsEos-0.10 AbsBaso-0.05 ___ 02:30PM WBC-9.1 RBC-4.98 HGB-14.4 HCT-43.0 MCV-86 MCH-28.9 MCHC-33.5 RDW-14.4 RDWSD-44.9 ___ 02:30PM TSH-3.6 ___ 02:30PM cTropnT-<0.01 ___ 02:30PM proBNP-3252* ___ 02:30PM GLUCOSE-122* UREA N-19 CREAT-1.0 SODIUM-141 POTASSIUM-4.4 CHLORIDE-104 TOTAL CO2-21* ANION GAP-20 ___ 03:00PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-NEG ___ 03:00PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 03:00PM URINE UHOLD-HOLD ___ 03:00PM URINE GR HOLD-HOLD ___ 03:00PM URINE HOURS-RANDOM ___ 03:00PM URINE HOURS-RANDOM ___ 11:35PM MAGNESIUM-1.8 ___ 11:35PM cTropnT-<0.01 ___ 11:57PM LACTATE-1.5 DISCHARGE LABS: ================ ___ 03:40AM BLOOD WBC-5.7 RBC-4.93 Hgb-14.0 Hct-42.8 MCV-87 MCH-28.4 MCHC-32.7 RDW-14.2 RDWSD-44.5 Plt ___ ___ 03:40AM BLOOD Plt ___ ___ 03:40AM BLOOD Glucose-94 UreaN-24* Creat-1.0 Na-138 K-4.4 Cl-101 HCO3-24 AnGap-17 ___ 03:40AM BLOOD ALT-28 AST-19 ___ 03:40AM BLOOD Calcium-8.9 Phos-4.5 Mg-2.0 RADIOLOGY: =========== CHEST (PORTABLE AP) ___ IMPRESSION: Bibasilar opacities, right greater than left may reflect atelectasis or infection in the appropriate setting. Pulmonary vascular engorgement without overt signs of pulmonary edema. CARDIAC STUDIES: ================= CARDIOVASCULAR ECHO ___ CONCLUSIONS The left atrial volume index is moderately increased. No left atrial mass/thrombus seen (best excluded by transesophageal echocardiography). The estimated right atrial pressure is ___ mmHg. There is mild symmetric left ventricular hypertrophy with normal cavity size. There is severe global left ventricular hypokinesis (biplane LVEF = 25 %). Systolic function of apical segments is relatively preserved. [Intrinsic left ventricular systolic function is likely more depressed given the severity of mitral regurgitation.] The estimated cardiac index is depressed (<2.0L/min/m2). No masses or thrombi are seen in the left ventricle. The right ventricular cavity is mildly dilated with moderate global free wall hypokinesis. The aortic root is mildly dilated at the sinus level. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Moderate to severe (3+) mitral regurgitation is seen. There is moderate pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Mild symmetric left ventricular hypertrophy with severe global hypokinesis in a pattern most c/w a non-ischemic cardiomyopathy. Moderate to severe mitral regurgitation. Moderate pulmonary artery systolic hypertension. Right ventricular cavity dilation with free wall hypokinesis. Mildly dilated aortic root. CLINICAL IMPLICATIONS: The left ventricular ejection fraction is <40%, a threshold for which the patient may benefit from a beta blocker and an ACE inhibitor or ___. Brief Hospital Course: Mr. ___ is a ___ year old male with history of cardiomyopathy who presented with dyspnea found to atrial fibrillation with RVR and new systolic heart failure exacerbation. # Systolic CHF exacerbation EF 25% Echocardiogram prior to cardioversion showed an ejection fraction of 25% and patient presented with dyspnea on exertion. Patient was diuresed with IV Lasix and transitioned to 40 mg PO Lasix prior to discharge. Patient continued on lisinopril 40 mg daily. Weight on discharge was: 88.1kg (194.2lbs) # Atrial Fibrillation: Patient presented with atrial fibrillation with RVR. He was stared on xarelto 20 mg daily. TSH 3.6, ALT 28, AST 19 prior to starting amiodarone. He was discharged on metoprolol succinate 75 mg BID, amiodarone 400 mg BID, and xarelto 20 mg daily. Patient was cardioverted to sinus rhythm on ___. Amiodarone dose should be down-titrated upon follow up with Dr. ___. # Cataracts: He was scheduled for upcoming cataracts surgery that was cancelled as patient would have to hold xarelto prior to this procedure. Patient instructed to take xarelto every day especially in the month after cardioversion. As such he was instructed to reschedule his cataract surgery in 1 month. This was relayed to his eye doctor Dr. ___. # Hypertension: Patient remained normotensive throughout hospitalization. Lisinopril 40 mg daily continued. Metoprolol succinate 75 mg BID continued as above. # BPH: -Continued tamsulosin # H/o duodenal ulcer: Continued omeprazole. H/H remained stable. TRANSTIONAL ISSUES: ===================== -weight on discharge: 88.1kg (194.2lbs) -Lasix 40 mg daily started -metoprolol succinate 75 mg BID started -xarelto 20 mg daily started -amiodarone 400 mg BID started, dose to be down-titrated on follow up with Dr. ___ 3.6, ALT 28, AST 19 prior to starting amiodarone Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Tamsulosin 0.8 mg PO QHS 2. Fluticasone Propionate NASAL 2 SPRY NU DAILY 3. Metoprolol Succinate XL 50 mg PO DAILY 4. Omeprazole 20 mg PO DAILY 5. Desonide 0.05% Cream 1 Appl TP BID 6. amLODIPine 5 mg PO DAILY 7. Lisinopril 40 mg PO DAILY 8. Pravastatin 40 mg PO QPM 9. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS Discharge Medications: 1. Rivaroxaban 20 mg PO DINNER Daily with the evening meal. RX *rivaroxaban [Xarelto] 20 mg 1 tablet(s) by mouth daily with dinner Disp #*30 Tablet Refills:*3 2. Fluticasone Propionate NASAL 2 SPRY NU DAILY 3. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 4. Omeprazole 20 mg PO DAILY 5. Tamsulosin 0.8 mg PO QHS 6. Desonide 0.05% Cream 1 Appl TP BID 7. Lisinopril 40 mg PO DAILY 8. Pravastatin 40 mg PO QPM 9. amLODIPine 5 mg PO DAILY 10. Furosemide 40 mg PO DAILY RX *furosemide 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*1 11. Metoprolol Succinate XL 75 mg PO BID RX *metoprolol succinate 50 mg 1.5 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 12. Amiodarone 400 mg PO BID Please do not take if lightheaded, fatigued, or if HR < 50 beats per minute RX *amiodarone 400 mg 1 tablet(s) by mouth Twice per day Disp #*60 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Atrial Fibrillation Heart Failure Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to ___ because you had difficulty breathing. You were found to have an abnormal heart rhythm called atrial fibrillation, that caused the fluid to back up to the rest of your body. This caused you to have difficulty breathing. For your abnormal heart rhythm, we started you on an anticoagulant called xarelto. This is a blood thinner that helps to prevent blood clots in your heart, and also helps to prevent these clots from traveling to the rest of your body and causing a stroke. It is very important that you take this medication every day and do not miss ___ dose. We also started you on a new medication to control your heart rate so that your heart could better work to pump blood forward to the rest of your body. You also underwent a procedure called cardioversion. This helped to shock your heart into a regular heart rate. You were then started on a new medication to help to keep your heart beating in this regular rhythm. For your difficulty breathing and fluid overload, we started you on some diuretic medications to help take some extra fluid off. This helped to control the swelling of your legs, improved the bloating sensation you experienced, and helped with your shortness of breath. We have made changes to your medication list, so please make sure to take your medications as directed. You will also need to have close follow up with your heart doctor and your primary care doctor. Please call your cardiology doctor at ___ if you feel lightheaded, fatigued, or have a slow heart rate that is less than 50 beats per minute. Please weigh yourself every day and call your doctor if your weight increases by more than 3lbs over 2 days. Your weight at time of discharge was 88.1kg (194.2lbs). It was a pleasure to take care of you. We wish you the best with your health! Your ___ Cardiac Care Team Followup Instructions: ___
10390714-DS-12
10,390,714
29,932,079
DS
12
2172-01-16 00:00:00
2172-01-16 17:27:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: ciprofloxacin / Iodinated Contrast- Oral and IV Dye / morphine / Penicillins / Quinolones Attending: ___. Chief Complaint: Shortness of breath Major Surgical or Invasive Procedure: ___ Cath with DES to LAD History of Present Illness: ___ year old female with no prior PMH and on no meds at home. One month history of shortness of breath. Thought it would go away. Progressively worsened to the point where she would get short of breath even making her bed. She states it was a fairly sudden onset of shortness of breath a month ago. No chest pain, no fainting spells. Only significant thing she mentioned was that she had a cold a couple weeks before the onset of shortness of breath. Usually lays on 2 pillows but since a month ago, gets short of breath on 2 pillows and sometimes have to sit in a chair to catch her breath. No PND. No prior heart attacks. No prior heart disease. No prior h/o arrhthymia or valvular disease. Smoked 2 packs a day for ___ years but started smoking when she was ___ years old. Quit smoking in ___ when she was ___ years old around. No alcohol use. No recreational drug use. At baseline, could walk for miles with no significant shortness of breath. Now, can barely make it to the car without feeling very short of breath. Denies: vision changes, headaches, sore throat, cough, chest pain, no palpitations aside from when she moves around a lot, abdominal pain, diarrhea, constipation, swelling in the legs, Went to ___ for worsening DOE. Was transferred to ___ for further evaluation for ACS vs PE. Was given full dose aspirin in ___ prior to transfer to ___. At, ___, labs/studies: -Na 143 K 4.1 Cl 112 HCO3 14 Glc 129 BUN 25 Cr 1.2 Ca 9.1 -Trop T <0.01 x2 D-dimer 1852 -CBC 6.9 H/H ___ Plt 244 -___ 13.3 PTT 29.1 INR 1.19 -VBG pH 7.39 PCO2 25 PO2 82 HCO3 16 -CXR: Mild cardiomegaly. No CHF. No focal infiltrates or pleural effusions. Mediastinal contour grossly unremarkable. Past Medical History: 1. CARDIAC RISK FACTORS - Hypertension - Dyslipidemia 2. CARDIAC HISTORY - CABG: None - PERCUTANEOUS CORONARY INTERVENTIONS: None - PACING/ICD: None 3. OTHER PAST MEDICAL HISTORY DVT in unknown leg in the 1990s Cholecystectomy Thumb surgery Humerus and scapular surgery for surgery Social History: ___ Family History: -Father: had a pacemaker - unclear reason why -Mother: passed away, had DM -Sister: none -1 cousin passed away from MI in the ___ Physical Exam: Admission Exam: =================== GENERAL: Well-developed, well-nourished. NAD. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva pink, no pallor or cyanosis of the oral mucosa. NECK: Supple, difficult to assess JVP given body habitus CARDIAC: RRR, normal S1, S2. No murmurs/rubs/gallops. No thrills, lifts. LUNGS: unlabored breathing, clear to auscultation bilaterally, no wheezes, no crackles ABDOMEN: Soft, NTND. No tenderness to palpation EXTREMITIES: 1+ pitting edema bilaterally SKIN: No stasis dermatitis, ulcers, scars. PULSES: Distal pulses palpable and symmetric Discharge Exam: ==================== T 98.6PO BP 144 / 81R SittingHR67RR18Sat 96%Ra GENERAL: NAD, pleasant HEENT: Sclera anicteric, AC/NT LUNGS: no crackles, normal WOB HEART: RRR, no murmurs, no JVD ABDOMEN: +BS, soft, NTND EXTREMITIES: WWP, trace bilateral ___ edema up to knees Pertinent Results: Admission Labs: ================= ___ 07:00PM BLOOD WBC-7.2 RBC-4.60 Hgb-13.7 Hct-45.3* MCV-99* MCH-29.8 MCHC-30.2* RDW-17.8* RDWSD-64.4* Plt ___ ___ 07:00PM BLOOD Neuts-73.4* Lymphs-17.5* Monos-6.9 Eos-1.1 Baso-0.7 Im ___ AbsNeut-5.29 AbsLymp-1.26 AbsMono-0.50 AbsEos-0.08 AbsBaso-0.05 ___ 07:00PM BLOOD ___ PTT-22.3* ___ ___ 07:00PM BLOOD Glucose-125* UreaN-25* Creat-1.4* Na-144 K-4.3 Cl-111* HCO3-12* AnGap-21* ___ 07:00PM BLOOD ALT-13 AST-21 AlkPhos-86 TotBili-0.8 ___ 07:00PM BLOOD ___ ___ 07:00PM BLOOD Albumin-3.7 Cholest-239* ___ 11:39AM BLOOD %HbA1c-5.8 eAG-120 ___ 07:00PM BLOOD Triglyc-152* HDL-42 CHOL/HD-5.7 LDLcalc-167* LDLmeas-178* ___ 01:45PM BLOOD TSH-1.1 ___ 01:08AM BLOOD Type-ART pO2-73* pCO2-21* pH-7.38 calTCO2-13* Base XS--10 ___ 01:08AM BLOOD Lactate-1.7 Pertinent Studies: ====================== ___ LHC Single vessel CAD with 50% pLAD and positive iFR succesfully treated with 1 DES. IVUS of stent showing good result and LMCA MLA >9 mm. Mildly elevated left-side filling pressures.(17) ___ TTE: The left atrial volume index is moderately increased. The right atrium is moderately dilated. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thicknesses are normal. The left ventricular cavity is mildly dilated. There is severe regional left ventricular systolic dysfunction with hypokinesis of the anterior and septal segments; the lateral segments contract best. No masses or thrombi are seen in the left ventricle. Right ventricular chamber size is normal with mild global free wall hypokinesis. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets are mildly thickened (?#). There is no aortic valve stenosis. Trace aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. An eccentric, posteriorly directed jet of moderate to severe (3+) mitral regurgitation is seen. Due to the eccentric nature of the regurgitant jet, its severity may be significantly underestimated (Coanda effect). Moderate [2+] tricuspid regurgitation is seen. There is severe pulmonary artery systolic hypertension. No vegetation/mass is seen on the pulmonic valve. There is no pericardial effusion. IMPRESSION: Severely depressed left ventricular systolic dysfunction consistent with proximal left anterior descending coronary artery disease. At least moderate to severe mitral regurgitation. Moderate tricuspid regurgitation. Severe pulmonary hypertension. ___ CTA Chest: 1. Moderately limited examination due to respiratory motion artifact at the lung bases. Within these limitations, no evidence of pulmonary embolism. 2. Moderate cardiomegaly. Diffuse mosaic attenuation of the lung parenchyma with mild septal thickening at the lung bases, likely reflecting a combination of air-trapping and pulmonary edema. Trace left pleural effusion. 3. Diffuse bronchial wall thickening may reflect chronic airways disease and/or fluid overload. 4. Multiple enlarged mediastinal lymph nodes measuring up to 1.7 cm in short axis, nonspecific, but may be reactive. Discharge Labs: ================== ___ 06:35AM BLOOD WBC-6.9 RBC-4.70 Hgb-13.9 Hct-44.1 MCV-94 MCH-29.6 MCHC-31.5* RDW-16.3* RDWSD-56.5* Plt ___ ___ 06:35AM BLOOD Plt ___ ___ 06:20AM BLOOD Glucose-102* UreaN-30* Creat-1.5* Na-142 K-4.1 Cl-103 HCO3-24 AnGap-15 ___ 06:20AM BLOOD Calcium-9.0 Phos-4.2 Mg-2.0 Brief Hospital Course: Patient Summary: ================== ___ with h/o DVT in the ___, who presented with subacute progressive dyspnea on exertion, as well as EKG changes at OSH. Diagnosed with acute HFrEF (EF 30%). Coronary angiogram with single vessel CAD with 50% pLAD, successfully treated with 1 DES. Started on DAPT and diuresed to dry weight of 91.5kg on discharge. Active Issues: ================== #Acute HFrEF (EF 30%) #CAD w/ DES to pLAD Patient presented with volume overload with elevated BNP and TTE with newly reduced EF of 30% and regional WMA. LHC with single vessel CAD and 50% stenosis of pLAD treated with 1 DES. LVED mildly elevated at 17. Started on DAPT. Diuresed well with IV Lasix boluses and discharged on PO Lasix 20mg ___. Medications optimized with lisinopril 10mg, Metop succinate 50mg, Atorvastatin 80mg, Plavix 75mg, and ASA 81mg. Will need a repeat TTE in 6 weeks following discharge for evaluation of EF post stent placement. Discharge weight: 91.5kg Discharge diuretic: 20mg PO Lasix MWF Discharge Cr: 1.5 #CKD Unclear baseline Cr, with admission Cr of 1.4. Spot total protein/Cr ratio of 2.8, though in the setting of UTI, concerning for CKD due to poorly controlled hypertension. Started on lisinopril 10mg daily. Will need a repeat UA and total protein/Cr ratio in follow up to assess for CKD.. #UTI Dysuria, with urine culture growing pan sensitive E.coli. No recent hospitalization, history of recurrent UTI, CVA tenderness, fever, chills or leukocytosis. Completed Nitrofurantoin 100mg x5 days while in ___. # HLD: Lipid panel this admission notable for LDL 178, TC 239, HDL 42, ___ 152. Basline CK 108. Started on Atorvastatin 80mg. # Hyperglycemia: Pre-diabetic based on an A1C of 5.8%. Educated on diet to prevent diabetes. # Non-anion gap metabolic acidosis: On presentation with anion gap acidosis likely ___ starvation ketoacidosis in the setting of being NPO for a cath for a very long period of time. Acidosis resolved spontaneously without treatment other than PO intake. Transitional Issues: ======================== [] Follow up Chem 7 in 1 week and assess volume status for adequacy of Lasix regimen [] Elevated pulmonary artery pressure, recommend outpatient sleep study for OSA [] Repeat TTE in 6 weeks following discharge for re-evaluation of EF and potential consideration of referral to electrophysiology for possible ICD evaluation if LVEF remains severely depressed [] Repeat Total protein/Cr ratio in follow up to assess for CKD [] Prescribed outpatient cardiac rehab [] Follow up with PCP ___ non-specific mediastinal lymph nodes measuring up to 1.7 cm in greatest dimension in the event follow-up imaging should be considered. Discharge weight: 91.5kg Discharge diuretic: 20mg PO Lasix MWF Discharge Cr: 1.5 #CODE STATUS: Full #CONTACT: Name of health care proxy: ___ Relationship: husband Phone number: ___ >30 minutes spent on discharge planning/coordination of care. Medications on Admission: None Discharge Medications: 1. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*2 2. Atorvastatin 80 mg PO QPM RX *atorvastatin 80 mg 1 tablet(s) by mouth nightly Disp #*30 Tablet Refills:*2 3. Clopidogrel 75 mg PO DAILY to prevent stent thrombosis RX *clopidogrel 75 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*2 4. Furosemide 20 mg PO 3X/WEEK (___) RX *furosemide 20 mg 1 tablet(s) by mouth three times per week, ___ Disp #*30 Tablet Refills:*0 5. Lisinopril 10 mg PO DAILY RX *lisinopril 10 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*2 6. Metoprolol Succinate XL 50 mg PO DAILY RX *metoprolol succinate 50 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*2 Discharge Disposition: Home Discharge Diagnosis: Primary diagnosis: Acute systolic heart failure, ischemic Coronary artery disease Secondary diagnosis: Acute kidney injury Urinary tract infection Hyperlipidemia Pre-diabetes Metabolic acidosis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted to the hospital because you were feeling short of breath. What happened while you were in the hospital? - You had ultrasound of your heart that showed you have congestive heart failure - Your shortness of breath was caused from extra fluid accumulation in your body - You were started on a medication called Lasix that helped take fluid off of your body and improve your breathing - You had coronary angiogram done that showed blockage of one of the arteries to the heart. You got a stent placed in this artery. This blockage is likely the cause of your heart failure. - You were started on new medications to help with this - You were improved significantly and were ready to leave the hospital. What should you do after leaving the hospital? -Your weight at discharge is 201.72 lbs. Please weigh yourself today at home and use this as your new baseline -Please weigh yourself every day in the morning. Call your doctor if your weight goes up by more than 3 lbs in a day, or 5 lbs in a week. -It is very important to take your aspirin and clopidogrel (also known as Plavix) every day. These two medications keep the stents in the vessels of the heart open and help reduce your risk of having a future heart attack. If you stop these medications or miss ___ dose, you risk causing a blood clot forming in your heart stents. Please do not stop taking either medication without taking to your heart doctor. -___ take your medications as listed in discharge papers and follow up at the listed appointments. We wish you the best! - Your ___ Healthcare Team Followup Instructions: ___
10390732-DS-20
10,390,732
22,177,535
DS
20
2147-07-01 00:00:00
2147-07-01 13:31:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: Iron / lisinopril / Iodinated Contrast Media - IV Dye Attending: ___. Chief Complaint: Transplant kidney hematoma Major Surgical or Invasive Procedure: ___: Evacuation of subcapsular hematoma ___: Temporary triple lumen catheter via the left internal jugular venous collateral approach ___: Placement of left portacath History of Present Illness: HPI: ___ w/ mechanical MVR/AVR, ESRD, complex dialysis access history with bilateral UE AVGs, left fem-fem AVG, s/p DDRT ___, who presents with RLQ pain and worsening kidney function (baseline Cr 2.2, up to 2.8 on check today). His K was note to be 6.2. Mr ___ underwent a transplant kidney biopsy on ___ due to proteinuria for which he had to be admitted and placed on a heparin gtt due to his mechanical valves. Post biopsy his Cr remained stable at 2.2 for several days until he was discharged on ___. He states that his pain over the allograft began suddenly today while watching the TV. He denies any trauma to the area. He thinks that he may have had some decreased urine output over the last several days but this has not been recorded. He was given insulin/dextrose/lasix in the ED for his hyperkalemia with repeat K of 5.6. ROS: (+) per HPI (-) Denies fevers, chills, night sweats, unexplained weight loss, changes in appetite, trouble with sleep, pruritis, jaundice, rashes, bleeding, easy bruising, headache, dizziness, vertigo, syncope, weakness, paresthesias, nausea, vomiting, hematemesis, bloating, cramping, melena, BRBPR, dysphagia, chest pain, shortness of breath, cough, edema, urinary frequency, urgency Past Medical History: ESRD, HTN, dCHF, multiple line infections, restless leg syndrome, asthma, VRE, Mitral valve endocarditis with aortic valve annular abscess, MRSA, edema, anemia, afib, chronic peridontitis, GERD, vitamin D deficiency, osteoporosis, pericardial effusion w/ tamponade PSH: -AVR & MVR (mitral valve endocarditis w/ aortic valve annular abscess) (___) -pericardiocentesis (pericardial effusion w/ tamponade) ___, ___ -placement of PD catheter ___, ___ -L forearm graft excision (infected graft) ___, ___ -Removal of PD cathether (infected) ___, ___ -L femoral AV graft ___, ___ -DDRT c/b DGF ___, ___ -bilateral nephrectomies -___ venogram left thigh AVG ballon angioplasty -multiple UE AVG/fistulas now non-functional -transjugular liver biopsy ___ Social History: ___ Family History: mother with HTN Physical Exam: Vitals: 98.3 66 144/91 16 96% GENERAL: Awake, mild distress from pain HEENT: MMM CARDS: RRR, mechanical S1/S2 PULM: CTAB, no w/r/r ABDOMEN: RLQ allograft is swollen, tense and tender to palpation. No bruit. No suprapubic pain. GU exam is WNL EXTREMITIES: 1+ edema. Multiple thrombosed AVG/AVF in the upper arms. NEURO: no asterixis, moving all exremities, alert and oriented Pertinent Results: Labs on Admission: ___ WBC-8.2 RBC-3.40* Hgb-9.1* Hct-31.6* MCV-93 MCH-26.7* MCHC-28.7* RDW-15.6* Plt ___ PTT-46.8* ___ Glucose-189* UreaN-43* Creat-2.9* Na-138 K-5.8* Cl-110* HCO3-19* AnGap-15 Calcium-8.6 Phos-3.7 Mg-1.7 ___ HBsAg-NEGATIVE HBsAb-NEGATIVE HBcAb-NEGATIVE ___ tacroFK-10.9 . Cardiac Perfusion Study: 1. Normal cardiac perfusion with moderate left ventricular enlargement. 2. Normal ___ motion with an ejection fraction of 54%. Brief Hospital Course: ___ y/o male well known to transplant service who was admitted with pain over the transplant kidney three weeks post transplant kidney biopsy. Ultrasound showed a large subcapsular hematoma. He underwent evacuation of the hematoma on ___. Surgeon was Dr. ___ ___ who noted a large amount of relatively fresh appearing hematoma upon opening the renal capsule. Also of note when the capsule was opened there was no evidence of high pressure within the kidney itself. Renal parenchyma was boggy, but pink and did exhibit bleeding. Approximately 100 cc of clot was removed. He was transferred to the ICU for further management. Heparin drip was started following surgery. INR was subtherapeutic on admission at 1.9 Baseline creatinine of 2.0 was increased to 2.9 that further increased to 3.4. He also had hyperkalemia with K of 5.8 which was initially treated with insulin, dextrose and calcium gluconate. A temprorary dialysis line with VIP port was placed in anticipation of need for dialysis as well as very poor access history. Potassium was 7.2 post op, and he underwent a single hemodialysis session. Urine output on admisison was less than 400 cc. Urine output improved after hematoma evacuation(~1000 - 1500cc/day). Creatinine decreased from a peak of 4.3 post operatively to 2.5 by POD 12. On POD 2, he was having complaint of chest pain. Cardiology was called and troponins were cycled and negative. A cardiac echo was done showing mildly dilated and hypokinetic right ventricle with moderate to severe tricuspid regurgitation and at least moderate pulmonary hypertension. Well seated AVR and MVR with elevated gradient across the mitral valve. Mildly dilated thoracic aorta. He then underwent a cardiac perfusion study which showed normal cardiac perfusion with moderate left ventricular enlargement and normal ___ motion with an ejection fraction of 54%. He was stable and was able to transfer to the regular transplant floor. Heparin drip and warfarin were resumed on POD 2. He required 7 days on the heparin drip before the INR was at a therapeutic level. On ___, he went to the OR for a PORT placement in a small vessel noted on chest CT. Surgeon was Dr. ___. Interventional radiology was contacted and after premed with steroid and benadryl prep (3 doses of 50mg of prednisone)he underwent removal of the OR placed port and revision of the left chest ___ Port-A-Cath, with 28 cm length of tubing terminating in the right atrium. Also noted was distally occluded or tightly stenosed Left internal jugular vein at junction with rachiocephalic vein. Small contrast injection beyond this demonstrated entral patency of the brachiocephalic vein into the superior vena cava and right atrium. At end of case he developed hives and shortness of breath and required emergent treatment for anaphylaxis. He was transferred to the ICU for management and did well eventually transferring back to the med-surg unit. Facial swelling and generalized edema was treated with IV doses of Lasix then he was transitioned back to torsemide with improved edema. He did complain of shortness of breath/cough and was evaluated by a pulmonary consult. Repeat CXR was concerning for worsened loculated right pleural effusion. TTE revealed 65-70%EF with moderate TR and severe systolic pulmonary hypertension. Pulmonary Consult recommendations were to continue diuresis as volume overload may have exacerbated severity of pulmonary hypertension. Inhalers were continued. He was also given 1 unit of PRBC for hct of 23 and epogen was increased to 3000units 3x per week in attempt to improve anemia. No intervention was planned to intervene on the loculated effusion given that he remained afebrile and wbc was wnl. Overal edema decreased with weight dropping to 74kg by ___ on torsemide 40mg daily. Baseline weight pre-hospitalization was 74kg. Overall, he was feeling well and ready for discharge back to ___ ___. RLQ incision staples were removed. Incision was inctact Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Carvedilol 12.5 mg PO BID 2. Dapsone 100 mg PO DAILY 3. FoLIC Acid 1 mg PO DAILY 4. Mycophenolate Mofetil 500 mg PO BID 5. Omeprazole 40 mg PO DAILY 6. PredniSONE 5 mg PO DAILY 7. Tiotropium Bromide 1 CAP IH DAILY 8. Torsemide 10 mg PO DAILY 9. Albuterol Inhaler 2 PUFF IH Q8H:PRN SOB 10. Alendronate Sodium 70 mg PO QSUN 11. Epoetin Alfa 3800 units SC WEEKLY 12. mometasone 220 mcg (120 doses) inhalation BID 13. Vitamin D 50,000 UNIT PO QMONTH 14. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315-250 mg-unit oral DAILY 15. Sodium Chloride Nasal ___ SPRY NU QID:PRN nasal congestion 16. Warfarin 7.5 mg PO DAILY16 17. Guaifenesin 5 mL PO Q6H:PRN congestion x 5 days 18. Tacrolimus 7.5 mg PO Q12H Discharge Medications: 1. Carvedilol 12.5 mg PO BID 2. Dapsone 100 mg PO DAILY 3. Epoetin Alfa 3000 UNIT SC QMOWEFR 4. FoLIC Acid 1 mg PO DAILY 5. Mycophenolate Mofetil 500 mg PO BID 6. Omeprazole 40 mg PO DAILY 7. PredniSONE 5 mg PO DAILY 8. Tiotropium Bromide 1 CAP IH DAILY 9. Torsemide 40 mg PO DAILY 10. Warfarin 5.5 mg PO DAILY16 11. Acetaminophen 325-650 mg PO Q6H:PRN pain 12. Albuterol Inhaler 2 PUFF IH Q8H:PRN SOB 13. Alendronate Sodium 70 mg PO QSUN 14. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315-250 mg-unit oral DAILY 15. Guaifenesin 5 mL PO Q6H:PRN congestion x 5 days 16. mometasone 220 mcg (120 doses) inhalation BID 17. Sodium Chloride Nasal ___ SPRY NU QID:PRN nasal congestion 18. Tacrolimus 11 mg PO Q12H 19. Vitamin D 50,000 UNIT PO QMONTH 20. Senna 8.6 mg PO BID constipation 21. Sarna Lotion 1 Appl TP BID 22. HYDROmorphone (Dilaudid) 2 mg PO Q3H:PRN pain 23. Fluticasone Propionate 110mcg 2 PUFF IH BID 24. Docusate Sodium 100 mg PO BID 25. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN sob/wheeze 26. Heparin Flush (100 units/ml) 5 mL IV PRN DE-ACCESSING port Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Kidney transplant subcapsular hematoma Left IJ vein stenosis Need for long term IV access, portacath placed Loculated R pleural effusion Pulmonary hypertension Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Please call the transplant clinic at ___ for fever > 101, chills, nausea, vomiting, diarrhea, constipation, inability to tolerate food, fluids or medications, increased abdominal pain, pain at the new port site, incisional redness, drainage or bleeding, dizziness or weakness, decreased urine output or dark, cloudy urine, swelling of abdomen or ankles, weight gain or loss of more than 3 pounds in a day, monitor for signs of elevated INR to include nosebleed, rectal bleeding, dark tarry stools or easy bruising or any other concerning symptoms. You will have labwork drawn twice weekly every ___ and ___ as arranged by the transplant clinic, with results to the transplant clinic (Fax ___ . CBC, ___ Chem 10, AST, T Bili, Trough Tacro level, urinalysis. Transition to Belatacept is under discussion and will be implemented in conjunction with the transplant clinic. Follow your medication card, keep it updated with any dosage changes, and always bring your card with you to any clinic or hospital visits. You may shower.Drink enough fluids to keep your urine light in color. Have your blood sugars and blood pressure checked. Report consistently elevated values to the transplant clinic Check your weight daily. If weight decreases 3 pounds in a day, hold the torsemide Do not increase, decrease, stop or start medications without consultation with the transplant clinic at ___. There are significant drug interactions with anti-rejection medications which must be considered in medication management following transplant Consult transplant binder, and there is always someone on call at the transplant clinic with any questions that may arise Followup Instructions: ___
10390810-DS-3
10,390,810
26,871,911
DS
3
2139-05-07 00:00:00
2139-05-08 21:36:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Keflex Attending: ___ Chief Complaint: Nausea/ vomiting Major Surgical or Invasive Procedure: Transjugular liver biopsy History of Present Illness: ___ F with no PMH presenting as a transfer from ___ with transaminitis and hyperbilirubinemia. Patient reports she has had vomiting 2 hours after dinner every other day for the past two weeks. Her sx started ___ when she ate 1.5lbs cherries and felt lightheaded for 10 minutes afterwards. The next day she ate fish and ___ greens and vomited. She has had vomiting around 7:30pm qOD regardless of food ingested since then. She never has nausea in the morning. There is no blood in her vomit, just the food she ate. She has also had fatigue for this amount of time and noted amber urine for about 1 week. She finally went in yesterday because she felt she was not getting better. The patient is a CNA who works outpatient. She denies known biohazardous exposures. She was once told she has had hepatitis but does not remember active disease. She most recently traveled to the ___ in ___ but otherwise no recent foreign travel. She also goes to ___ weekly. She takes no medications, vitamins, or supplements. She has no sick contacts. She denies drugs or etoh. She does smoke cigarettes and has DOE for many years. She has not been sexually active in ___ years. The patient also had a breast abscess in ___ for which she was treated x 10 days with abx. She took ibuprofen for pain, has no recent Tylenol use. She cant remember the antibiotic taken. In the Emergency Department: Initial Vitals: 97.7 78 111/62 19 100% RA. Also had an episode of hypotension to 83/60 at 1000 ___ Labs: Notable for ALT: 1855 AP: 222 Tbili: 10.8 Alb: 3.6 AST: ___ INR:1.4 Plts:123. Tox screen negative Studies: EKG QTC:___/___ Consults: None Pt was given: 2L NS Vitals on transfer: 98.2 70 115/45 24 97% RA ROS: per HPI, denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. Past Medical History: None Social History: ___ Family History: Parents died of "old age" in the ___. Sister has DM. Physical Exam: ADMISSION EXAM: VS: 98.4 126/89 71 18 99%RA GENERAL: Pleasant, well-appearing, in no apparent distress. HEENT: normocephalic, atraumatic, + scleral icterus, PERRLA, EOMI, OP clear. NECK: Supple, no LAD, no thyromegaly. CARDIAC: RRR, normal S1/S2, no murmurs rubs or gallops. PULMONARY: Clear to auscultation bilaterally, without wheezes or rhonchi. ABDOMEN: obese, soft, non-tender, non-distended, no organomegaly. EXTREMITIES: Warm, well-perfused, no cyanosis, clubbing or edema. SKIN: Without rash. Sub-cm scar on R breast at previous site of abscess, well-healed NEUROLOGIC: A&Ox3, No asterixis DISCHARGE EXAM: PHYSICAL EXAMINATION: VS:98 99-109/53-57 ___ 18 97%RA GENERAL: Pleasant, well-appearing, in no apparent distress. HEENT: normocephalic, atraumatic, + scleral icterus NECK: Supple CARDIAC: RRR, normal S1/S2, no murmurs rubs or gallops. PULMONARY: CTAB ABDOMEN: obese, soft, non-tender, non-distended, no organomegaly. EXTREMITIES: Warm, well-perfused, no cyanosis, clubbing or edema. SKIN: Without rash. NEUROLOGIC: A&Ox3, No asterixis Pertinent Results: ADMISSION LABS: ___ 09:15AM BLOOD WBC-7.6 RBC-4.49 Hgb-13.9 Hct-40.8 MCV-91 MCH-31.0 MCHC-34.1 RDW-16.7* RDWSD-54.7* Plt ___ ___ 09:15AM BLOOD WBC-7.6 RBC-4.49 Hgb-13.9 Hct-40.8 MCV-91 MCH-31.0 MCHC-34.1 RDW-16.7* RDWSD-54.7* Plt ___ ___ 09:15AM BLOOD Neuts-53.1 ___ Monos-10.1 Eos-1.6 Baso-0.7 Im ___ AbsNeut-4.07 AbsLymp-2.61 AbsMono-0.77 AbsEos-0.12 AbsBaso-0.05 ___ 09:15AM BLOOD ___ PTT-30.6 ___ ___ 09:15AM BLOOD Glucose-86 UreaN-7 Creat-0.7 Na-140 K-4.1 Cl-105 HCO3-25 AnGap-14 ___ 09:15AM BLOOD ALT-1855* ___ AlkPhos-222* TotBili-10.8* DirBili-7.3* IndBili-3.5 ___ 09:15AM BLOOD Lipase-60 ___ 05:00PM BLOOD Albumin-3.3* Calcium-8.6 Phos-1.9* Mg-2.0 ___ 09:15AM BLOOD HBsAg-Negative HBsAb-Positive HBcAb-Positive* IgM HAV-Negative ___ 05:00PM BLOOD AMA-NEGATIVE Smooth-POSITIVE * ___ 05:00PM BLOOD ___ ___ 05:00PM BLOOD IgG-1602* IgA-208 IgM-54 ___ 06:40AM BLOOD HIV Ab-Negative ___ 09:15AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 09:15AM BLOOD HCV Ab-Negative ___ 06:22 Notable Infectious: HERPES SIMPLEX VIRUS 1 AND 2 (IGG) Test Result Reference Range/Units HSV 1 IGG TYPE SPECIFIC AB >5.00 H HSV 2 IGG TYPE SPECIFIC AB >5.00 H Value Interpretation ----- -------------- <0.90 Negative 0.90-1.10 Equivocal >1.10 Positive ___ 07:20 HERPES SIMPLEX VIRUS 1 AND 2 ANTIBODY IGM Test Result Reference Range/Units HSV 1 IGM SCREEN Negative Negative HSV 2 IGM SCREEN Negative Negative ___ 17:00 LYME DISEASE ANTIBODY, IMMUNOBLOT Test Name Flag Results Unit Reference Value --------- ---- ------- ---- --------------- Lyme Disease Ab, Immunoblot, S IgG Immunoblot AB Positive kDa Negative IgG Band(s): p93, p66, p41, p39, p30, p18 IgM Immunoblot Negative kDa Negative IgM Band(s): No bands detected ___ 10:40 am TISSUE Source: Liver biopsy. **FINAL REPORT ___ GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. TISSUE (Final ___: Reported to and read back by ___ ___ ___ 11:10AM. ENTEROCOCCUS SP.. Isolated from broth media only, INDICATING VERY LOW NUMBERS OF ORGANISMS. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ENTEROCOCCUS SP. | AMPICILLIN------------ =>32 R PENICILLIN G---------- =>64 R VANCOMYCIN------------ 1 S ANAEROBIC CULTURE (Final ___: NO ANAEROBES ISOLATED. ___ 5:00 pm SEROLOGY/BLOOD CHEM S# ___ ADDED 06.02. **FINAL REPORT ___ RAPID PLASMA REAGIN TEST (Final ___: REACTIVE. Reference Range: Non-Reactive. QUANTITATIVE RPR (Final ___: REACTIVE AT A TITER OF 1:4. Reference Range: Non-Reactive. TREPONEMAL ANTIBODY TEST (Final ___: TP-PA REACTIVE. TEST PERFORMED BY ___ LAB. LFT TREND: ___ 09:15AM BLOOD ALT-1855* ___ AlkPhos-222* TotBili-10.8* DirBili-7.3* IndBili-3.5 ___ 06:40AM BLOOD ALT-1871* AST-2297* LD(LDH)-765* AlkPhos-226* TotBili-14.4* ___ 05:35AM BLOOD ALT-1735* AST-2163* AlkPhos-220* TotBili-18.5* ___ 05:40AM BLOOD ALT-1605* AST-1805* AlkPhos-217* TotBili-19.2* ___ 06:20AM BLOOD ALT-1433* AST-1696* AlkPhos-204* TotBili-20.6* ___ 01:29PM BLOOD ALT-1227* AST-1313* AlkPhos-202* TotBili-21.9* ___ 05:35AM BLOOD ALT-968* AST-772* AlkPhos-219* TotBili-23.1* ___ 06:00AM BLOOD ALT-658* AST-309* AlkPhos-226* TotBili-19.9* ___ 12:56PM BLOOD ALT-630* AST-275* AlkPhos-226* TotBili-20.0* ___ 05:25AM BLOOD ALT-501* AST-235* AlkPhos-249* TotBili-16.5* ___ 05:35AM BLOOD ALT-401* AST-243* AlkPhos-217* TotBili-14.5* DISCHARGE LABS: ___ 05:35AM BLOOD WBC-12.5* RBC-4.06 Hgb-13.1 Hct-36.0 MCV-89 MCH-32.3* MCHC-36.4 RDW-21.4* RDWSD-65.4* Plt ___ ___ 05:35AM BLOOD ___ PTT-27.9 ___ ___ 05:35AM BLOOD Glucose-64* UreaN-13 Creat-0.7 Na-135 K-3.5 Cl-100 HCO3-27 AnGap-12 ___ 05:35AM BLOOD ALT-401* AST-243* AlkPhos-217* TotBili-14.5* ___ 05:35AM BLOOD Calcium-8.1* Phos-3.0 Mg-2.1 STUDIES: Liver needle core biopsy ___: 2. Severely active hepatitis with zones of collapse amounting to 30% of the liver parenchyma. 3. Marked portal, periportal and lobular mixed inflammation comprised of lymphocytes, focally prominent plasma cells, neutrophils and rare eosinophils lobular apoptotic hepatocytes. 4. Diffuse bile duct damage and proliferation. 5. No viral cytopathic effect identified. 6. Trichrome stain shows no advanced fibrosis. 7. Reticulin stain confirms areas of collapse. 8. Iron stain demonstrates no stainable iron. 9. CMV, HSV and Treponema immunostains are negative. Note: The differential diagnosis include viral, autoimmune or drug induced injury. IMAGING: Liver US ___: IMPRESSION: 1. Contracted gallbladder, without sonographic evidence of acute cholecystitis. 2. Probable extrarenal pelvis on the right. ___ CT Abd: 1. No intrahepatic or intra-abdominal fluid collections. 2. Heterogeneous hepatic parenchymal density may reflect underlying steatosis or heterogenous enhancement relating to history of acute hepatitis. 3. Subcentimeter hypodense lesions within hepatic segments V and III are incompletely characterized on this single phase examination, and are not seen on the recent ultrasound from ___. These are statistically likely benign, such as cysts or biliary hamartomas, but if follow-up is desired, ultrasound could be repeated in 6 months. 4. Intermediate-density hypodense renal lesion arising from the upper pole of the left kidney was not included on the recent ultrasound. This could be reassessed with a focused ultrasound examination. RECOMMENDATION(S): 6 month followup US to reassess liver hypodensities. Focused ultrasound examination of the left upper pole renal lesion to exclude solid mass; this can also be performed at the same time as the assessment of the liver. ___ CT Chest: 1. No segmental lung consolidation or fluid collection. 2. Multiple pulmonary nodules, up to 4 mm, are statistically likely benign but warrant follow-up chest CT in 12 months. 3. Irregular 3.0 cm hypodense left thyroid nodule warrants dedicated thyroid ultrasound. RECOMMENDATION(S): 1. Follow-up chest CT in 12 months. 2. Dedicated thyroid ultrasound. Brief Hospital Course: Ms. ___ is a ___ with no PMHx who presents with transaminitis and hyperbilirubinemia. #Acute hepatitis: Patient presented with ALT 1855; AP 222; Tbili 10.8; Alb 3.6; AST ___. Hepatitis antibody tests from ___ show previous Hep A infection and immunity to Hep B from natural infection. Denies any recent EtOH use and ALT:AST ratio not consistent. No history of syncope or hypotension except briefly BP to 83 systolic in ED. Tylenol level negative at ___. ___ be due to Keflex use in ___, which can cause cholestatic jaudice, hepatitis, and transaminitis. No thrombosis on RUQ. ___ and Anti-mitochondrial Abs negative. HBsAg negative, Hep B Abs positive. IgG CMV positive but IgM negative. Anti-smooth positive. Pathology significant for severely active hepatitis with zones of collapse amounting to 30% of the liver parenchyma. Steroids were started ___. Found to have ENTEROCOCCUS in broth of liver bx and was prophylactically treated with vancomycin while on IV steroids. #Reactive RPR: per pt she has a hx of syphilis and got an antibiotic for it. Per patient had tx in ___. Had positive treponemal Ab. Per ___ public health department: original titer 1:2 in ___, ___ w/ 3 doses PCN. Would not repeat treatment unless plan for transplant TRANSITIONAL ISSUES: ================= - Avoid Keflex in the future - Discharged on 2 weeks of 40 PO prednisone through ___, then will need repeat LFTs to determine additional course - Weekly labs - Noted to have lung nodules on CT. Recommend repeat CT in ___ year - Noted to have hypodensity on L kidney. Recommend outpatient follow-up - Noted to have two discreet hypodensities on Liver, recommend outpatient RUQ US in 2 months. - 30 x 17 mm hypodense nodule in the left lobe of the thyroid warrants further evaluation with dedicated thyroid ultrasound non urgently #CODE: DNR, Ok to intubate #CONTACT: ___ (daughter) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. This patient is not taking any preadmission medications Discharge Medications: 1. PredniSONE 40 mg PO DAILY RX *prednisone [Deltasone] 20 mg 2 tablet(s) by mouth daily Disp #*28 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis: Acute hepatitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were seen at ___ because your liver tests were very abnormal. You were found to have acute hepatitis, which we think was caused by the Keflex you took, which may have triggered an autoimmune reaction. Please avoid Keflex (cephalexin) in the future. Once an infectious case was excluded, you were treated with steroids. You will need to continue steroids with close monitoring of your liver tests as an outpatient. It would be very dangerous to stop the steroids without consulting with your doctor, not only because you could harm your liver but also because stopping steroids abruptly can cause withdrawal (they need to be tapered off). Please continue to take your medications as prescribed and follow up at your outpatient appointments. You will need weekly labs while you are being monitored. We wish you the best in your health, Your ___ team Followup Instructions: ___
10390866-DS-21
10,390,866
26,714,008
DS
21
2191-12-06 00:00:00
2191-12-07 11:45:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Aspirin Attending: ___. Chief Complaint: shortness of breath and bleeding into right leg Major Surgical or Invasive Procedure: blood transfusion ___ History of Present Illness: ___ with history of hepatitis C, thrombocytopenia, leukopenia, hyponatremia, prior IVDU and heavy alcohol use who presents with SOB x 6 days. States he is now short of breath when walking a few feet. Prior to 6 days ago he was very active, able to run up a flight of steps. No cough, fever, chills, recent travel. Denies any bloody/black stools, not vomiting blood. The patient also has developed diffuse ecchymoses on both of his legs with painful swelling of his right thigh and ankle with bilateral lower extremity rash. He noticed this starting about 6 weeks ago. He had the same thing a year ago which resolved on its own. The patient attributes his leg swelling and bruising to sitting in his car for 14 hrs a day for months on end as part of his job as a ___. He denies any recent trauma. He saw his PCP for this issue last month without a diagnosis. At baseline, he denies easy bleeding or bruising. No family history of bleeding disorders or heme malignancies that he knows of. Of note, patient has a history of mild thrombocytopenia since ___ (120-140K), was seen by hematologist a month ago without a denfinitive diagnosis. Since ___, plt improved to low normal range. In addition, the patient has a history of mild leukocytopenia since ___. His WBC counts have been in the 2.7-3.6K range, with relatively normal differential; his eosinophil percentage is slightly elevated at 5.5-6%, however in the setting of leukocytopenia his absolute eosinophilic count remains well within normal range. Furthermore, review of his labwork in ___ is also notable for macrocytic RBC indices in recent years, however the patient has not been anemic prior to today. He has not had any manifestations of liver failure, coagulopathy or impaired hepatic synthetic function. A CT of the abdomen and pelvis from ___ showed no evidence of splenomegaly or hepatomegaly. In the ED, initial vs were: 99.0 80 168/86 16 100% RA. Labs were remarkable for Hct 45 -> 24, Na 122, elevated d-dimer. Guaiac negative. CTA negative for PE, RLE doppler negative for DVT. Vitals on Transfer: 76 142/70 16 98% RA. On the floor, patient denies SOB while at rest, but quickly becomes dyspneic when walking out of his room down the hall. He reports severe pain in his right thigh. Past Medical History: - Obsessive compulsive disorder - Hyperlipidemia - Hypertension - GERD - Glaucoma - Diverticulitis s/p partial colectomy - Hyponatremia - Thrombocytopenia - Leukopenia - Hepatitis C, reportedly with undetectable viral load - Gout - Hammertoe Social History: ___ Family History: There is no known family history of hemoglobinopathies, bleeding diathesis, thrombophilias, hematologic malignancies. Mother had an MI, father passed when patient was ___ years old. Cancer runs in his mother's side of the family, but he is unsure of what type, thinks related to brain. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals- 98.2, 144/81, 78, 16, 100% RA General- Alert, oriented, no acute distress HEENT- Sclera anicteric, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- Clear to auscultation bilaterally, no wheezes, rales, ronchi CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly. Subumbilical surgical scar GU- no foley Ext- Large hematoma circumferentially involving right thigh that is painful to light palpation. Hematoma over lateral right ankle. Large ecchymoses with palpable purpura and petechiae scattered over bilateral lower extremities. 2+ DP and ___ pulse on left foot, 1+ DP pulse on right foot. Right leg with 2+ edema extending up to knee. Extremities are both warm and well perfused. DISCHARGE PHYSICAL EXAM: Vitals- T 98 BP 132/78 HR 67 RR 67 O2 sat 100% RA General- Alert, oriented, no acute distress. HEENT- Sclera anicteric, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- Clear to auscultation bilaterally, no wheezes, rales, ronchi CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- Tender ecchymoses/hematoma circumferentially over proximal right thigh with swelling, warmth and yellowish discoloration of entire right leg. R leg flexion limited to 30 degrees. Large ecchymosis over left posterior thigh. Petechiae over bilateral distal ___. Dorsal pedal pulses 1+ bilaterally. Neuro- CNs2-12 intact, motor function grossly normal Pertinent Results: ADMISSION LABS: ___ WBC-3.3* RBC-2.51*# Hgb-8.9*# Hct-24.7*# MCV-99* MCH-35.3* MCHC-35.9* RDW-13.2 Plt ___ ___ Neuts-61.4 ___ Monos-8.7 Eos-2.2 Baso-0.3 ___ ___ PTT-27.3 ___ ___ ___ ___ Ret Aut-4.9* ___ Glucose-100 UreaN-10 Creat-0.9 Na-122* K-4.7 Cl-90* HCO3-21* AnGap-16 ___ ALT-29 AST-37 LD(LDH)-143 AlkPhos-59 TotBili-1.2 DirBili-0.4* IndBili-0.8 ___ D-Dimer-4258* ___ calTIBC-325 VitB12-448 Folate-18.2 Hapto-245* Ferritn-933* TRF-250 OTHER PERTINENT LABS: ___ Thrombn-12.8 ___ ESR-86* ___ FacVIII-248 ___ VWF AG-218 VWF ___ ___ RheuFac-10 CRP-38.0* ___ C3-132 C4-17 ___ HIV Ab-NEGATIVE HCV viral load - no RNA detected DISCHARGE LABS: ___ WBC-3.1* RBC-2.61* Hgb-9.1* Hct-25.8* MCV-99* MCH-35.0* MCHC-35.5* RDW-14.3 Plt ___ ___ Hct-27.7* ___ Cryoglb-NO CRYOGLO Brief Hospital Course: ___ with history of HTN, HLD, GERD and hepatitis C s/p treatment with ribavirin, prior IVDU who presents with SOB x 6 days. # SOB: Likely secondary to symptomatic anemia. CTA negative for PE. No clinical signs of pneumonia. No chest pain to suggest cardiac etiology. With history of hep C, pulmonary manifestation of cryoglobulinemia is possible but probably less likely. Cryoglobulins pending at time of discharge. Pt was transfused 1 unit PRBC. Had symptomatic improvement in SOB and did not require supplemental O2 at any time. # Anemia: Hct dropped from 45 -> 24 within 2 months. Likely secondary to blood loss into his leg, but unclear as to why patient would have a spontaneous bleed. His coags and plt count are normal. With concominant leukopenia and history of thrombocytopenia, production defect from myelosuppression from ethanol toxicity, nutrition deficiency, MDS, leukemia, viral process (HIV, parvovirus), drug toxicity were considered. However, elevated retic count suggests that the bone marrow is responding and his LFTs are normal. Hematology evaluated the patient and did not feel that this was a bone marrow or hematologic problem. Recent ultrasound did not show splenomegaly to support splenic sequestration. B12, folate and iron studies do no suggest deficiency. HIV is negative. CT angiogram showed no evidence of active bleeding. # Rash: Purpuric and ecchymotic with scattered petechiae on lower extremities. Not pruritic or painful. History of hep C raised concern for mixed cryoglobulinemia or other vasculitis, however dermatology did not feel the rash looked vasculitic and they thought it was simply a manifestation of bleeding. Associated ecchymoses and hematoma also is concerning for platelet dysfunction, but plt function normal as detailed above. Elevated ESR and CRP raise concern for rheumatologic process. This can be further evaluated in the outpatient setting. C3 and C4 are normal. ANCA and cryoglobulins were negative. # Hyponatremia: Chronic, Na has been in 125-130 range since ___. Prerenal v SIADH. Chronic nature more suggestive of SIADH, however urine electrolytes are more suggestive of potomania. Given chronic nature, we did not attempt to aggresively correct. # Leukopenia: WBC has been stably low since ___. Differential is normal. Prior thrombocytopenia raised concern for chronic smouldering myelosuppressive process such as MDS, leukemia, ethanol toxicity, however hematology did not feel there was a bone marrow problem. A rheumatologic problem is still a possibility. # H/O Hepatitis C: Reportedly undetectable viral load. Patient has no clinical signs of hepatic decompensation. LFTs, coags, and albumin are normal. Purpuric rash is concerning for mixed cryoglobulinemia. HCV viral load is negative. # HTN: Continued amlodipine and atenolol # GERD: Continued omeprazole - TRANSITIONAL ISSUES: Will need re-check of CBC, electrolytes at PCP ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. ALPRAZolam 0.25 mg PO BID:PRN anxiety 2. Amlodipine 5 mg PO DAILY 3. Atenolol 100 mg PO DAILY 4. Omeprazole 20 mg PO DAILY 5. travoprost 0.004 % ___ daily Discharge Medications: 1. ALPRAZolam 0.25 mg PO BID:PRN anxiety 2. Amlodipine 5 mg PO DAILY 3. Atenolol 100 mg PO DAILY 4. Omeprazole 20 mg PO DAILY 5. travoprost 0.004 % ___ daily Discharge Disposition: Home Discharge Diagnosis: Right Lower Extremity Hematoma Blood loss anemia Hyponatremia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mr. ___, You were admitted to ___ for shortness of breath, a rash and a hematoma in your right leg. A chest CT was obtained and was negative for a pulmonary embolism (blood clot in your lung). Hematology was consulted for your low white blood cell count, history of low platelet count and spontaneous bleeding into your right leg. They do not think this is a hematologic or bone marrow problem. Dermatology was consulted to evaluate the rash but they did not think a biopsy would provide additional information. Your work-up failed to reveal the underlying cause of bleeding. You were transfused to treat your blood loss. A CT angiogram of your right leg showed old evidence of bleeding but nothing active. Followup Instructions: ___
10390866-DS-22
10,390,866
21,727,001
DS
22
2195-11-16 00:00:00
2195-11-16 20:29:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: All allergies / adverse drug reactions previously recorded have been deleted Attending: ___ Chief Complaint: sudden dizziness, gait unsteadiness, nausea/vomiting Major Surgical or Invasive Procedure: none History of Present Illness: Mr. ___ is a ___ year old man with history of HTN, HLD, alcoholic hepatitis, chronic leukopenia and thrombocytopenia, hepatitis C, gout, GERD, chronic low back pain on Percocet who presents with several hour history of acute onset dizziness. History obtained from patient. Patient reports he was in his usual state of health until 9AM this morning. He had previously woken up at 0700 and felt in his usual state of health. He was laying in bed watching TV when he developed acute onset of dizziness, which came on suddenly, "like a switch." He describes the sensation as a lightheaded sensation. Since onset at 0900 it has been constant, always present at some level. It is exacerbated with head position changes and with standing. It is associated with nausea and vomiting; he had three episodes of vomiting at home. No associated hearing loss, no tinnitus, no room-spinning vertigo, no diplopia or visual changes, no focal weakness, no sensory changes, no headache until arriving in the ED when he has a low grade right frontal headache. He has never had this sensation before. After it began, he was able to walk downstairs and notes that he felt generally unsteady. He had to hold onto the walls and railing on the stairs very tightly, which is a change for him. He denies any preceding falls, denies LOC. Denies any preceding confusion, difficulty speaking or understanding speech, chest pain, and shortness of breath. Denies recent medication changes. Denies recent illness. Denies fevers/chills. Since being in the ED, vitals have been within normal limits. After receiving Zofran his nausea has been improved. Of note, the patient drinks 3 to 4 alcoholic beverages per day. He tells me that he has been consistent with his alcohol use and denies any changes in consumption. However, family pulled me aside after completing the evaluation with concern that he may be drinking more than 3 to 4 beverages per day, as he seems somewhat tremulous this morning. He does not discuss these details with them. Of note, patient has a longstanding history of leukopenia and thrombocytopenia, for which he has seen Hematology and Oncology in the past, thought to be multifactorial including liver disease and underlying HCV. Past Medical History: HTN HLD GERD Alcoholic hepatitis Hepatitis C attributed to remote IV drug use Chronic thrombocytopenia and leukopenia Chronic low back pain on Percocet History of diverticulitis Chronic hyponatremia Anxiety, OCD Social History: ___ Family History: There is no known family history of hemoglobinopathies, bleeding diathesis, thrombophilias, hematologic malignancies. Mother had an MI, father passed when patient was ___ years old. Cancer runs in his mother's side of the family, but he is unsure of what type, thinks related to brain. Denies family history of stroke. Physical Exam: ADMISSION PHYSICAL EXAMINATION =============================== Vitals: T 98.7F, BP 144/78, HR 83, RR 18, O2 100% RA Orthostatic Vital Signs Supine HR 68, BP 145/81 Seated HR 73, BP 129/84 Standing HR 84, BP 120/73 General: Awake, alert, in no acute distress HEENT: NCAT, no oropharyngeal lesions, neck supple ___: warm, well perfused; regular on telemetry Pulmonary: breathing non labored on room air Abdomen: Soft, NT, ND, no guarding Extremities: Warm, no edema ___ test negative (did not provoke nystagmus; reports constant dizziness regardless) Neurologic Examination: - Mental status: Awake, alert, oriented x 3. He is irritable. Able to relate history without difficulty. Attentive, able to name ___ backward without difficulty. Speech is fluent with full sentences, intact repetition, and intact verbal comprehension. Naming intact. No paraphasias. No dysarthria. Normal prosody. No apraxia. No evidence of hemineglect. No left-right confusion. Able to follow both midline and appendicular commands. - Cranial Nerves: PERRL 3->2 brisk. no skew. Head impulse test indeterminate. Gaze conjugate. VF full to number counting. EOMI, no nystagmus. V1-V3 without deficits to light touch bilaterally. No facial movement asymmetry. Hearing intact to finger rub bilaterally. Normal Rhinne and Weber test. Palate elevation symmetric. SCM/Trapezius strength ___ bilaterally. Tongue midline. - Motor: Normal bulk and tone. No drift. He has bilateral action tremor, L>R arm, but no intention tremor. [___] L 5 5 5 5 ___ 5 5 5 5 5 R 5 5 5 5 ___ 5 5 5 5 5 - Reflexes: [Bic] [Tri] [___] [Quad] [Gastroc] L 2+ 2+ 2+ 2+ 1 R 2+ 2+ 2+ 2+ 1 Plantar response flexor bilaterally - Sensory: No deficits to light touch, pin, or proprioception bilaterally. No extinction to DSS. - Coordination: No dysmetria with finger to nose testing bilaterally. Normal cerebellar mirroring test. No dysdiadokinesia. Normal heel to shin test. No truncal ataxia. Good speed and intact cadence with rapid alternating movements. - Gait: Able to stand without assistance though takes several minutes to do so due to ongoing dizziness. Delayed initiation. Narrow base. He is very unsteady and begins to fall when taking steps. No sway in one direction or other. Unable to talk in tandem. Romberg negative. DISCHARGE PHYSICAL EXAM: ======================== Vitals: T 98.2, BP 160s-180s/80s-90s, HR ___, RR 18, O2 97% RA General: Awake, alert, in no acute distress HEENT: NCAT, no oropharyngeal lesions, neck supple ___: warm, well perfused; regular on telemetry Pulmonary: breathing non labored on room air Abdomen: Soft, NT, ND, no guarding Extremities: Warm, no edema Neurologic Examination: - Mental status: Awake, alert, oriented x 3. Speech is fluent with full sentences, intact repetition, and intact verbal comprehension. No dysarthria. No apraxia. No evidence of hemineglect. No left-right confusion. Able to follow both midline and appendicular commands. - Cranial Nerves: PERRL 3->2 brisk. no skew. Head impulse test normal. Gaze conjugate. VF full to number counting. EOMI, several beats nystagmus on right gaze. V1-V3 without deficits to light touch bilaterally. No facial movement asymmetry. Hearing intact to finger rub bilaterally. Normal Rhinne and Weber test. Palate elevation symmetric. SCM/Trapezius strength ___ bilaterally. Tongue midline. - Motor: Normal bulk and tone. No drift. He has bilateral action tremor, R>L arm, improved from yesterday, but no intention tremor. [___] L 5 5 5 5 ___ 5 5 5 5 5 R 5 5 5 5 ___ 5 5 5 5 5 - Reflexes: [Bic] [Tri] [___] [Quad] [Gastroc] L 2+ 2+ 2+ 2+ 1 R 2+ 2+ 2+ 2+ 1 Plantar response flexor bilaterally - Sensory: No deficits to light touch, pin, or proprioception bilaterally. No extinction to DSS. - Coordination: No dysmetria with finger to nose testing bilaterally. Right action tremor>left action tremor, improved from yesterday. Normal cerebellar mirroring test. No dysdiadokinesia. Normal heel to shin test. - Gait: Able to stand and walk without assistance and without difficulty. No sway in one direction or other. Romberg negative. PHYSICAL EXAM: VS: T 98.1, BP 160s-180s/80s-90s, HR 60-70s, RR 18, O2 98-100% RA General: Awake, alert, in no acute distress HEENT: NCAT, no oropharyngeal lesions, neck supple ___: warm, well perfused; regular on telemetry Pulmonary: breathing non labored on room air Abdomen: Soft, NT, ND, no guarding Extremities: Warm, no edema Neurologic Examination: - Mental status: Awake, alert. Speech is fluent with full sentences, intact repetition, and intact verbal comprehension. No dysarthria. No apraxia. No evidence of hemineglect. No left-right confusion. Able to follow both midline and appendicular commands. - Cranial Nerves: PERRL 3->2 brisk. no skew. Gaze conjugate. VF full to finger movement. EOMI, several beats nystagmus on right gaze. V1-V3 without deficits to light touch bilaterally. No facial movement asymmetry. Hearing intact to finger rub bilaterally. Normal Rhinne and Weber test. Palate elevation symmetric. SCM/Trapezius strength ___ bilaterally. Tongue midline. - Motor: Normal bulk and tone. No drift. He has bilateral action tremor, R>L arm, improved from yesterday, but no intention tremor. [___] L ___ R ___ - Reflexes: [Bic] [Tri] [___] [Quad] [Gastroc] L 2+ 2+ 2+ 2+ 1 R 2+ 2+ 2+ 2+ 1 Plantar response flexor bilaterally - Sensory: No deficits to light touch, pin, or proprioception bilaterally. No extinction to DSS. - Coordination: No dysmetria with finger to nose testing bilaterally. Right action tremor>left action tremor, stable since yesterday. Normal cerebellar mirroring test. No dysdiadokinesia. Normal heel to shin test. - Gait: Able to stand and walk without assistance. No sway in one direction or other. Romberg negative. Pertinent Results: ADMISSION LABS: ============== ___ 08:50PM %HbA1c-5.5 eAG-111 ___ 04:17PM URINE HOURS-RANDOM ___ 04:17PM URINE bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG oxycodn-POS* mthdone-NEG ___ 04:17PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 04:17PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR* GLUCOSE-150* KETONE-NEG BILIRUBIN-NEG UROBILNGN-2* PH-7.0 LEUK-NEG ___ 04:17PM URINE RBC-3* WBC-1 BACTERIA-FEW* YEAST-NONE EPI-0 ___ 03:52PM ___ PTT-25.5 ___ ___ 03:30PM GLUCOSE-164* UREA N-13 CREAT-0.7 SODIUM-134 POTASSIUM-4.3 CHLORIDE-92* TOTAL CO2-24 ANION GAP-18* ___ 03:30PM estGFR-Using this ___ 03:30PM cTropnT-<0.01 ___ 03:30PM ALBUMIN-4.2 CALCIUM-9.0 PHOSPHATE-3.2 MAGNESIUM-1.1* CHOLEST-163 ___ 03:30PM TRIGLYCER-92 HDL CHOL-47 CHOL/HDL-3.5 LDL(CALC)-98 ___ 03:30PM WBC-3.2* RBC-3.61* HGB-12.8* HCT-34.7* MCV-96 MCH-35.5* MCHC-36.9 RDW-11.1 RDWSD-39.4 ___ 03:30PM NEUTS-77.4* LYMPHS-6.9* MONOS-14.4* EOS-0.0* BASOS-0.0 IM ___ AbsNeut-2.47 AbsLymp-0.22* AbsMono-0.46 AbsEos-0.00* AbsBaso-0.00* ___ 03:30PM PLT COUNT-129* IMAGING: ======== ___ CTA Head & Neck: Hyperdense changes in the cerebellar vermis immediately posterior to the fourth ventricle most likely represents blood products. This may represent a subacute infarct with hemorrhagic transformation or an intracranial hemorrhage. Mild to moderate atherosclerotic changes, but no significant assess stenosis by NASCET criteria. Mild to moderate atherosclerotic changes involving the intracranial vessels as described above. No aneurysm formation or complete stenosis. ___ MRI Head: 1. Subacute infarct or blood products involving the cerebellar vermis immediately posterior to the fourth ventricle. If concern for aneurysm, consider CTA head. 2. Chronic right cerebellar infarcts. 3. Probable small vessel ischemic changes, as described. 4. Paranasal sinus disease and nonspecific bilateral mastoid fluid, as described. ___ TTE: PFO. Normal biventricular systolic function. No pathologic valvular flow. ___ LENIs: No evidence of deep venous thrombosis in the right or left lower extremity veins. ___ MRI/MRA Brain: 1. T2/FLAIR hyperintensity with associated blooming artifact and mild vascularity within the cerebellar nodulus a similar to the previous examination. 2D time-of-flight MRA imaging demonstrates a probable connection between this finding and the distal left ___. An occult vascular malformation such as an AVM or cavernoma is felt most likely, and could be further evaluated by cerebral angiography. 2. Mild associated restricted diffusion within the cerebellar vermis in the vicinity of the lesion as described above, which may represent underlying subacute ischemic changes. 3. Frontal lobe predominant global cerebral atrophy and evidence of chronic microangiopathy. 4. Chronic infarctions within the right cerebellar hemisphere. INTERVAL LABS: ============== ___ 04:35AM BLOOD VitB12-709 ___ 04:35AM BLOOD TSH-0.58 ___ 05:00AM BLOOD WBC-3.3* RBC-3.61* Hgb-12.7* Hct-35.5* MCV-98 MCH-35.2* MCHC-35.8 RDW-11.3 RDWSD-40.8 Plt ___ ___ 05:00AM BLOOD Glucose-77 UreaN-9 Creat-0.7 Na-133 K-3.8 Cl-89* HCO3-27 AnGap-17* ___ 05:00AM BLOOD ALT-219* AST-216* AlkPhos-84 TotBili-1.4 ___ 05:00AM BLOOD Calcium-8.4 Phos-2.6* Mg-1.4* Brief Hospital Course: ___ year old man with history of HTN, HLD, alcoholic hepatitis, chronic leukopenia and thrombocytopenia, hepatitis C, gout, GERD, chronic low back pain on Percocet who presented with acute onset dizziness and gait unsteadiness, physical exam findings of +Romberg, bilateral action tremor and MRI findings c/w possible subacute vermis infarct d/t vertebral artery calcifications. MRA with findings concerning for cerebellar AVM vs cavernoma, radiology recommending cerebral angiography. # Subacute cerebellar infarct # TIA He developed acute onset dizziness and unsteadiness associated with nausea and vomiting. He had MRI which showed subacute infarct or blood products involving the cerebellar vermis immediately posterior to the fourth ventricle as well as right cerebellar infarcts. His acute onset of symptoms are not entirely explained by a subacute infarct, but could be related to possible TIA (artery-artery vs. cardioembolic) or component of EtOH w/d (scoring on CIWA) vs. chronic EtOH use. TTE showed PFO. LENIS were negative. His risk factors were assessed: A1c 5.5, LDL 98. TSH .58. For his HTN, we resumed home atenolol 100 mg daily and amlodipine 10 mg daily. We started Plavix 75 mg daily (he had prior history of GI distress and hematoma on ASA 81 mg), but on further discussion, he would like to re-try Aspirin 81 mg daily (and if he does not tolerate, then he will take Plavix 75 mg in place of Aspirin 81 mg). We also started Atorvastatin 10mg daily (low dose given chronic elevation in LFTs). LFTs will need to be checked w/ in one week of discharge. ___ recommended home with outpatient physical therapy services. He was counseled on smoking cessation. #Cerebellar vermis vascular malformation c/f AVM vs Cavernoma Abnormal GRE signal first seen on ___ MRI. Subsequently followed up with MRA of the brain which revealed increased vascularity at the site of the nodule, suspicious for a small AVM vs. a Cavernoma. Radiology recommended f/u with cerebral angiography. Discussed this with ___, who recommended outpatient follow up. This was discussed with the patient and his family; Neurosurgery will contact him to schedule this as an outpatient. # ETOH Use Disorder # ETOH Withdrawal No history of w/d seizures, but did have alcohol hepatitis in the past. Patient adamant he does not have a problem with EtOH. He reports he measures out how much he drinks, to the point of compulsion. His family expressed concerns that he does drink more than he says. He was monitored on CIWA and did require diazapam 10 mg x2 initially but did not score after that. He was started on thiamine and folic acid. Recommend ongoing counseling post-discharge. SW had seen patient inpatient. # Tranasminitis # Hep C AST/ALT at recent baseline (200s), no synthetic dysfx. He was scheduled to see Dr. ___ in ___, but there is no indication that he actually had that appointment. Recommend follow-up as outpatient. # Chronic back pain Continued home regimen of oxycodone. # Chronic pancytopenia Prior eval by hematology and felt to be related to chronic EtOH. His labs were within normal. Recommend EtOH cessation and continued follow-up with heme-onc. TRANSITIONAL ISSUES: ==================== # MEDICATIONS: Please see discharge medications. [] Please continue to trend blood pressure, goal normotensive. [] Please follow-up CBC (chronic pancytopenia). recommend f/u with heme. [] Recommend f/u with liver given hepatitis C. [] Please follow-up LFTs given stable transaminitis and starting atorvastatin 10 mg. [] Please refer to social work if patient desires for ongoing alcohol cessation. [] Neurosurgery will contact him to arrange for outpatient cerebral angiography. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Omeprazole 20 mg PO DAILY 2. Atenolol 100 mg PO DAILY 3. amLODIPine 10 mg PO DAILY 4. ALPRAZolam 0.25 mg PO BID:PRN Anxiety, insomnia 5. OxyCODONE--Acetaminophen (5mg-325mg) 2 TAB PO Q8H:PRN Pain - Moderate Discharge Medications: 1. Atorvastatin 10 mg PO QPM 2. Clopidogrel 75 mg PO DAILY 3. FoLIC Acid 1 mg PO DAILY 4. Multivitamins 1 TAB PO DAILY 5. Thiamine 100 mg PO DAILY 6. ALPRAZolam 0.25 mg PO BID:PRN Anxiety, insomnia 7. amLODIPine 10 mg PO DAILY 8. Atenolol 100 mg PO DAILY 9. Omeprazole 20 mg PO DAILY 10. OxyCODONE--Acetaminophen (5mg-325mg) 2 TAB PO Q8H:PRN Pain - Moderate Discharge Disposition: Home Discharge Diagnosis: Subacute cerebellar infarct Transient Ischemic Attack Cerebellar AVM Alcohol withdrawal Patent foramen ovale Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were hospitalized due to symptoms of dizziness and difficulty walking. This was likely caused by a TIA (Transient Ischemic Attack), which is considered a warning. Your brain imaging did not reveal an acute stroke, but did show that you have had prior strokes. Strokes are a condition where a blood vessel providing oxygen and nutrients to the brain is blocked by a clot. The brain is the part of your body that controls and directs all the other parts of your body, so damage to the brain from being deprived of its blood supply can result in a variety of symptoms. Stroke can have many different causes, so we assessed you for medical conditions that might raise your risk of having stroke. In order to prevent future strokes, we plan to modify those risk factors. Your risk factors are: *High blood pressure *High Cholesterol *Alcohol use *Tobacco use We imaged your brain as part of your stroke work-up and incidentally, we found that some of the blood vessels in part of your brain may have a unique shape ("vascular malformation"). We recommend that you follow up with neuroradiology. We do not think that the symptoms that you presented with were caused by this finding. Your Medications have been changed as follows: START Atorvastatin 10 mg qHS. This may affect your liver levels and you can follow up with your pcp about this START Aspirin 81 mg daily. If you are unable to tolerate aspirin, you can start Plavix 75 mg instead. Please take your other medications as prescribed. Please see discharge medication list for details. Please follow up with Neurosurgery as well as with Neurology and your primary care physician as listed below. If you experience any of the symptoms below, please seek emergency medical attention by calling Emergency Medical Services (dialing 911). In particular, since stroke can recur, please pay attention to the sudden onset and persistence of these symptoms: - Sudden partial or complete loss of vision - Sudden loss of the ability to speak words from your mouth - Sudden loss of the ability to understand others speaking to you - Sudden weakness of one side of the body - Sudden drooping of one side of the face - Sudden loss of sensation of one side of the body Sincerely, Your ___ Neurology Team Followup Instructions: ___
10390866-DS-23
10,390,866
21,475,379
DS
23
2196-09-19 00:00:00
2196-09-19 18:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Facial Droop, Syncope Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ year old man with history of CVA, HTN, HLD, alcoholic hepatitis, chronic leukopenia and thrombocytopenia, hepatitis C, gout, GERD, chronic low back pain who presents with syncopal episode and right facial droop. Patient states that he has been working non stop for the past 2 days and has essentially not been eating, only drinking "a few beers." He went home today after working and went to urinate. He began feeling light-headed, lowered himself to the ground, and lost consciousness. He thinks he came to within seconds, and he felt dizzy. He did strike his head. His wife saw him and felt he had a facial droop, so she encouraged him to come to the ED. He denies cp, sob, n/v. Denies recent illnesses. Denies history of alcohol withdrawal. He states he drinks "a few drinks per day" and says he has done this for his whole life. Of note, the patient had a recent hospitalization in ___ for dizziness and gait unsteadiness and was found to have a subacute infarct vs AVM vs cavernoma in the cerebellar vermis as well as right cerebellar infarcts. Given the severity of his symptoms, he was also thought to have TIA with potentially a component of alcohol withdrawal/chronic alcohol use. TTE showed a PFO at that time. In the ED, initial VS were: 97.2 71 117/74 18 100% RA Exam notable for: unsteady and lightheaded during gait testing. NIHSS 0. ECG: Labs showed: 122 | 84 | 9 --------------<141 4.3 | 21 | 0.8 WBC 1.5, hgb 11.3 (MCV 100), plt 59 coags WNL ALT 136, AST 255, tbili 1.0, ALP 117 trop <0.01, BNP 294 Lactate 1.8 Serum ETOH: 11 serum ASA, acetaminophen, TCA negative Utox negative Ucr 15, UNa 76, Uosm 206 UA negative Imaging showed: CT C spine without contrast: No cervical spine fracture or malalignment. CT Head without contrast: No acute intracranial process. No acute hemorrhage. CXR No acute cardiopulmonary process. Patient received: IVFNS 1000 mL IVMetoclopramide 10 mg Positive orthostatic VS Transfer VS were: 67 108/67 12 100% RA On arrival to the floor, patient reports feeling weak and light-headed. He has no other complaints. REVIEW OF SYSTEMS: 10 point ROS reviewed and negative except as per HPI Past Medical History: HTN HLD GERD Alcoholic hepatitis Hepatitis C attributed to remote IV drug use Chronic thrombocytopenia and leukopenia Chronic low back pain on Percocet History of diverticulitis Chronic hyponatremia Anxiety, OCD Social History: ___ Family History: There is no known family history of hemoglobinopathies, bleeding diathesis, thrombophilias, hematologic malignancies. Mother had an MI, father passed when patient was ___ years old. Cancer runs in his mother's side of the family, but he is unsure of what type, thinks related to brain. Denies family history of stroke. Physical Exam: ADMISSION PHYSICAL EXAM ======================== GENERAL: NAD HEENT: EOMI, PERRL, anicteric sclera, dry MM NECK: supple, no LAD, no JVD HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: Nondistended, nontender in all quadrants, no rebound/guarding. Refuses deep palpation. EXTREMITIES: no cyanosis, clubbing, or edema NEURO: A&Ox3, moving all 4 extremities with purpose, no facial droop. CN II-XII grossly intact. SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE PHYSICAL EXAM ======================= VS: 98.3 PO 162 / 86 93 18 99 Ra GENERAL: thin older gentleman, no acute distress, conversant HEENT: EOMI, PERRL, anicteric sclera, dry MM NECK: supple, no LAD, no JVD HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: Nondistended, nontender in all quadrants, no rebound/guarding. EXTREMITIES: no cyanosis, clubbing, or edema NEURO: A&Ox3, CN2-12 intact, moving all four extremitis Pertinent Results: ADMISSION LABS ============== ___ 08:25PM BLOOD WBC-1.5* RBC-3.09* Hgb-11.3* Hct-30.9* MCV-100* MCH-36.6* MCHC-36.6 RDW-12.7 RDWSD-46.5* Plt Ct-59* ___ 08:25PM BLOOD Neuts-70.0 Lymphs-15.0* Monos-12.4 Eos-1.3 Baso-0.0 Im ___ AbsNeut-1.07* AbsLymp-0.23* AbsMono-0.19* AbsEos-0.02* AbsBaso-0.00* ___ 08:25PM BLOOD ___ PTT-26.3 ___ ___ 08:25PM BLOOD Plt Smr-VERY LOW* Plt Ct-59* ___ 08:25PM BLOOD Glucose-141* UreaN-9 Creat-0.8 Na-122* K-4.3 Cl-84* HCO3-21* AnGap-17 ___ 08:25PM BLOOD ALT-136* AST-255* AlkPhos-117 TotBili-1.0 ___ 08:25PM BLOOD cTropnT-<0.01 ___ 08:25PM BLOOD proBNP-294* ___ 08:25PM BLOOD Albumin-4.0 Calcium-9.3 Phos-3.2 ___ 08:25PM BLOOD ASA-NEG Ethanol-11* Acetmnp-NEG Tricycl-NEG ___ 09:52PM BLOOD Lactate-1.8 IMAGING ======= CXR ___ IMPRESSION: No acute cardiopulmonary process. CT Head ___ FINDINGS: Hyperdensity on prior CT centered at the cerebellar vermis is not seen on the current exam. There is no acute intra-axial or extra-axial hemorrhage, mass effect, midline shift, or acute major vascular territorial infarct. Hypodensity in the right thalamus is likely from a prior lacunar infarct. Ventricles and sulci are prominent compatible with global volume loss. Dense atherosclerotic calcifications are noted within the intracranial ICAs and vertebral arteries Included paranasal sinuses and mastoids are clear. Skull and extracranial soft tissues are unremarkable. Chronic deformity of the left lamina papyracea may be from remote prior trauma. IMPRESSION: No acute intracranial process. No acute hemorrhage. CT C Spine ___ FINDINGS: Alignment is normal. No fractures are identified.Degenerative changes are most notable at C5-6 with intervertebral disc height loss and uncovertebral joint hypertrophy. There is secondary moderate right foraminal narrowing at this level. No significant canal narrowing. Apparent widening of the intervertebral disc anteriorly at C6-7 is unchanged from prior CTA neck.There is no prevertebral edema. The thyroid and included lung apices are unremarkable. Dense atherosclerotic calcifications noted at the carotid bulbs. IMPRESSION: No cervical spine fracture or malalignment. DISCHARGE LABS =============== ___ 08:35AM BLOOD WBC-4.0 RBC-3.04* Hgb-10.9* Hct-30.6* MCV-101* MCH-35.9* MCHC-35.6 RDW-12.6 RDWSD-46.5* Plt Ct-61* ___ 05:25AM BLOOD Neuts-70.8 Lymphs-14.6* Monos-12.0 Eos-0.5* Baso-0.5 Im ___ AbsNeut-1.36* AbsLymp-0.28* AbsMono-0.23 AbsEos-0.01* AbsBaso-0.01 ___ 06:15AM BLOOD ___ PTT-26.3 ___ ___ 08:35AM BLOOD Glucose-148* UreaN-9 Creat-0.8 Na-125* K-3.0* Cl-86* HCO3-23 AnGap-16 ___ 06:15AM BLOOD ALT-119* AST-207* LD(LDH)-188 AlkPhos-111 TotBili-1.4 ___ 08:35AM BLOOD Calcium-8.6 Phos-2.4* Mg-1.1* Brief Hospital Course: SUMMARY STATEMENT =================== Mr. ___ is a ___ year old man with history of CVA, alcohol use disorder, hepatitis c, chronic pancytopenia who presented with a syncopal episode at home. Problems addressed during his hospitalization are as follows: ACUTE ISSUES: =============== #Syncope: Patient presented after a fall at home. He was sitting on his couch drinking beer, got up to use restroom, began urinating, then fell and hit the left side of his head. No prodromal symptoms. There was concern for a facial droop when he was in the ED after a physician asked his wife whether he had a facial droop and she reported "maybe". He had no neurologic deficits, CT spine/head unremarkable. Orthostatics positive. Etiology most likely orthostatic/micturition syncope. Likely hypovolemic from working outdoors for long periods of time coupled with poor PO intake. Also used diazepam prior to his fall prescribed for back pain. This, in conjunction with alcohol use also contributory. His home alprazolam was held. He was evaluated by neurology who agreed this was unlikely stroke or seizure and more consistent with micturition/orthostatic syncope . He did not get additional neurologic workup. There was a low suspicion for cardiogenic etiology, as previous TTE without valvular disease, telemetry unremarkable. On discharge, he did have small degree of ongoing orthostasis but was no longer symptomatic and blood pressure ~130s upon standing, so felt it was safe to discharge with plans for outpatient follow up with PCP and consideration of further testing. #Pancytopenia: Presented with WBC to 1.5 (ANC 1.07k), previously lowest of 2.7. Thrombocytopenia to ___, previously lowest of 98. Given chronic alcohol use, as well as associated transaminitis with AST/ALT of 2:1, suspect alcohol use is primary driver of pancytopenia. No evidence of splenomegaly on ultrasound to suggest sequestration. No obvious drug contributions or liver synthetic dysfunction. Viral studies including HIV and Hep C viral load negative. Hemolysis labs negative. Needs to have outpatient follow up. #ETOH Use Disorder: No history of withdrawal seizures, but daily drinker, reporting ___ beers per day, however suspect he drinks more than he states after discussions with family. ETOH serum tox mildly elevated on admission, briefly placed on CIWA scoring up to 3, not requiring diazepam, no additional evidence of withdrawal. Seen by social work team and appeared to be in pre-contemplative stage. Refused resources to aid in alcohol cessation. Initiated thiamine, folic acid, multivitamin supplementation. #Hyponatremia: Most likely hypovolemic hyponatremia. Presented with Na 122. Of note, he is chronically hyponatremic, Na 122-130 range since approximately ___. His sodium returned to baseline after receiving IV fluids. #Cerebellar stroke/AVM: No evidence of stroke and evaluated by neurology as above in #syncope. Continued aspirin and atorvastatin. #Chronic back pain Oxycodone PRN. #Malnutrition (severity unknown): Reports approximately 20 lb weight loss over the last year secondary to poor appetite. Seen by nutrition. Refused PO supplements. Encouraged to eat 3 meals per day. #Tranasminitis #Hep C Patient was planned to follow up with Dr. ___ further management of hepatitis C but patient never went to appointment. Repeat Hep C viral load negative. Transaminase elevation likely also due to alcohol use, evidenced by 2:1 AST/ALT ratio. #Hypertension: Held amlodipine, atenolol in setting of orthostatics as above. #insomnia: Discontinued alprazolam in setting of syncope as above. #GERD: Continued omeprazole TRANSITIONAL ISSUES: =================== [] consider outpatient referral for autonomic testing. Consider initiating salt tabs or midodrine if ongoing orthostasis [] ongoing alcohol cessation counseling [] needs further outpatient workup of pancytopenia [] needs outpatient follow up for chronic back pain. Provided a short script of oxycodone [] discharge weight: 62.78 kg (138.4 lb) [] please check CBC, BMP at next PCP ___ [] consider holding aspirin if thrombocytopenia worsens [] remained normotensive off amlodipine and atenolol, consider discontinuing indefinitely [] held alprazolam, would avoid prescribing any sedative medications given daily alcohol use and syncope [] consider salt tablets for chronic hyponatremia [] continue to monitor weight loss [] continue to encourage alcohol cessation >30 minutes spent coordinating discharge home Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. amLODIPine 10 mg PO DAILY 2. Atenolol 100 mg PO DAILY 3. Omeprazole 20 mg PO DAILY 4. FoLIC Acid 1 mg PO DAILY 5. Multivitamins 1 TAB PO DAILY 6. Thiamine 100 mg PO DAILY 7. ALPRAZolam 0.25 mg PO BID:PRN Anxiety, insomnia 8. Atorvastatin 10 mg PO QPM 9. Aspirin 81 mg PO DAILY Discharge Medications: 1. OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Severe may cause sedation. Avoid driving RX *oxycodone 5 mg 1 tablet(s) by mouth Q8H:PRN Disp #*15 Tablet Refills:*0 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 10 mg PO QPM 4. FoLIC Acid 1 mg PO DAILY 5. Multivitamins 1 TAB PO DAILY 6. Omeprazole 20 mg PO DAILY 7. Thiamine 100 mg PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: #syncope #hyponatremia #pancytopenia #etoh use disorder #Cerebellar stroke/AVM #chronic back pain #malnutrition (severity unknown) #transaminitis #HTN #GERD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at the ___ ___. WHY DID I COME TO THE HOSPITAL? --You came to the hospital because you fell at home and hit your head. WHAT HAPPENED WHEN I WAS IN THE HOSPITAL? --We evaluated you and found that you did not have a stroke. You also did not have any damage to your brain or skull. --Your blood pressure became low with standing. We gave you lots of fluids and stopped some of your home medications including alprazolam, which can make you more likely to fall. We believe you likely fell because you were dehydrated and also because you used a medication that makes you very tired when used with alcohol ("diazepam" which you took for back pain). --The level of salt in your body was low. We believe this was from dehydration. Your salt levels improved with fluids. --Your blood counts were low. We believe this is related to your alcohol use. WHAT SHOULD I DO WHEN I LEAVE THE HOSPITAL? --Please continue to take your medications as prescribed and follow-up with your doctors as ___. We wish you all the ___! Your ___ care team Followup Instructions: ___
10390877-DS-2
10,390,877
28,589,927
DS
2
2143-04-19 00:00:00
2143-04-19 14:13:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: right sided weakness and difficulty speaking Major Surgical or Invasive Procedure: ___ placed, but removed prior to discharge. History of Present Illness: ___ is a ___ year old man with history of MI, HTN, HL, multiple prior CVAs thought to be cardioembolic on Coumadin, who presents with right sided weakness and aphasia. History is limited as patient is unable to answer questions. Of note, he gets most of his care including admissions for prior CVAs at ___. According to the family members, ___ was otherwise in his usual state of health until 9PM the evening prior to presentation. This morning around ___, his wife found him lying in bed, staring up and not able to speak, as well as right sided facial droop and weakness. He was emergently taken to ___, where the initial NIHSS was 15. He did not receive tPA due to being outside the window, on Coumadin with therapeutic INR. ___ showed chronic right MCA territory infarct, no hemorrhage, and no acute findings. INR was 2.82. Past Medical History: MI, GI BLEED/DUODENAL ULCER, Hyperlipidemia, Hypertension, CVAs, triple AAA repair, prior cardiac arrest Social History: ___ Family History: MVI omeprazole 20mg PO Simvastatin 40mg qHS ASA ___ Metoprolol 50mg daily HCTZ 25mg daily Coumadin 2.5mg PO daily Physical Exam: Discharge Physical Exam: Vitals: Temp: 97.5-98.5 HR: ___ BP: 117-138/70-87. RR: ___ O2 sats: 93-97% Neurologic Examination: - Mental status: Sitting up in bed, eating, in good spirits. Cracks jokes. Dysarthric, but improving. Dobhoff tube removed. - Cranial Nerves: Pupils are equal and reactive. EOMI without nystagmus. Right hemianopia on BTT. Right facial droop. - Sensorimotor: left arm/leg, right leg are full strength. Right arm able to offer some resistance to antigravity. Tricep 4-. Bicep 4+. Wrist extensor 2. Finger extensor 1. Nods to tactile stimulation. - Coordination: No dysmetria on left, unable to test on right. HTS intact. - Gait: deferred Admission Physical Exam: General: NAD HEENT: NCAT, no oropharyngeal lesions, neck supple ___: RRR, no M/R/G Pulmonary: CTAB, no crackles or wheezes Abdomen: Soft, NT, ND, +BS, no guarding Extremities: Warm, no edema Neurologic Examination: - Mental status: Eyes open, alert, tracks examiner. Effortful but able to produce name, very dysarthric. Unable to repeat or name objects. Follows commands. - Cranial Nerves: Pupils are equal and reactive. EOMI without nystagmus. Right hemianopia on BTT. Right facial droop. Tongue protrudes to left. - Sensorimotor: left arm/leg, right leg are full strength. Right arm able to offer some resistance to antigravity. Tricep 4-. Bicep 4+. Wrist extensor 2. Finger extensor 1. Nods to tactile stimulation. - Reflexes: [Bic] [Tri] [___] [Quad] [Gastroc] L 2+ 2+ 2+ 2+ 1 R 2+ 2+ 2+ 2+ 1 Plantar response mute bilaterally - Coordination: No dysmetria on left, unable to test on right. HTS intact. - Gait: deferred Pertinent Results: ___ 02:40PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 09:30PM BLOOD TSH-0.62 ___ 09:30PM BLOOD Triglyc-221* HDL-31 CHOL/HD-4.1 LDLcalc-53 ___ 09:30PM BLOOD %HbA1c-6.6* eAG-143* ___ 09:30PM BLOOD Albumin-3.7 Calcium-8.4 Mg-2.0 Cholest-128 ___ 02:40PM BLOOD cTropnT-<0.01 ___ 09:30PM BLOOD CK-MB-2 cTropnT-<0.01 ___ 02:40PM BLOOD ALT-24 AST-37 AlkPhos-60 TotBili-0.6 ___ 02:40PM BLOOD Glucose-99 UreaN-15 Creat-1.4* Na-142 K-5.1 Cl-108 HCO3-22 AnGap-17 ___ 02:40PM BLOOD WBC-8.2 RBC-5.17 Hgb-11.4* Hct-38.7* MCV-75* MCH-22.1* MCHC-29.5* RDW-20.1* RDWSD-51.4* Plt ___ ___ 02:40PM BLOOD Neuts-57.8 ___ Monos-13.1* Eos-5.5 Baso-0.7 Im ___ AbsNeut-4.76 AbsLymp-1.88 AbsMono-1.08* AbsEos-0.45 AbsBaso-0.06 MRI on ___: 1. Acute to late sub-acute infarction in the distribution of the left MCA and PCA territories. Findings may be embolic in origin. 2. No evidence of intracranial hemorrhage. Multiple chronic infarctions as described above. 3. Diminutive flow voids of the left M2 segments of the middle cerebral artery. Please refer to recently performed CTA report for additional details. Brief Hospital Course: ___ is a ___ year old man with history of MI, HTN, HLD, multiple prior CVAs thought to be cardioembolic on Coumadin, who presented with right sided weakness and difficulty speaking. Exam notable for right hemianopia, right facial droop, pseudobulbar palsy with dysarthria --- right arm > leg weakness. Taken together, likely superior division left MCA syndrome. He was out of the window for both tPA and endovascular intervention. Given that he was therapeutic on warfarin, one could suspect failure of Coumadin vs artery to artery embolism. He also was found to have heart failure and a dyskinetic cardiac apex on echo, which could be a source of clot, even while on warfarin. Another likely etiology, based on the appearance of the strokes on MRI, is watershed. He could have had an embolism in the left ICA that then broke off to other vessels, causing a combined watershed + embolic stroke syndrome. Echo: Suboptimal image quality. Mild symmetric left ventricular hypertrophy with global systolic dysfunction c/w multivessel CAD or other diffuse process. Dialted ascending aorta. No definite structural cardiac source of embolism identified. Carotid ultrasounds showed: on the left moderate plaque with a 40-59% carotid stenosis. On the right there is a less than 40% stenosis. Mr. ___ biggest issue during his hospitalization was his ability to swallow. On ___, he had a dobhoff tube placed, which he tolerated well, and received formula feeds through for several days. On ___, he had a video swallow study performed, and was allowed to begin taking a modified dysphagia diet. His dobhoff ___ tube was removed on ___, and he was able to eat his modified diet all by mouth prior to discharge. Nutrition was consulted, and agreed with plans for all oral feeds moving forward. Because Mr. ___ had a stroke even on warfarin, we discussed with hematology the possibility of hyper coagulability. It was decided to change him to apixaban 5mg BID on ___ & to follow-up with hematology as an outpatient to discuss workup for a hyper-coagulable state, since he had a stroke even though he was therapeutic on warfarin. ============================================ AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic Attack 1. Dysphagia screening before any PO intake? (x) Yes, confirmed done - () Not confirmed () No 2. DVT Prophylaxis administered? (x) Yes - () No 3. Antithrombotic therapy administered by end of hospital day 2? (x) Yes - () No 4. LDL documented? (x) Yes (LDL = 53) - () No 5. Intensive statin therapy administered? (simvastatin 80mg, simvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg, rosuvastatin 20mg or 40mg, for LDL > 100) (x) Yes - () No [if LDL >100, reason not given: ] 6. Smoking cessation counseling given? (x) Yes - () No [reason () non-smoker - () unable to participate] 7. Stroke education (personal modifiable risk factors, how to activate EMS for stroke, stroke warning signs and symptoms, prescribed medications, need for followup) given (verbally or written)? (x) Yes - () No 8. Assessment for rehabilitation or rehab services considered? () Yes - () No 9. Discharged on statin therapy? (x) Yes - () No [if LDL >100, reason not given: ] 10. Discharged on antithrombotic therapy? (x) Yes [Type: (x) Antiplatelet - (x) Anticoagulation] - () No 11. Discharged on oral anticoagulation for patients with atrial fibrillation/flutter? (x) Yes - () No - () N/A Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Warfarin 2.5 mg PO DAILY16 2. Metoprolol Succinate XL 25 mg PO DAILY 3. Simvastatin 40 mg PO QPM 4. Centrum (multivit-iron-min-folic acid;<br>multivit-mins-ferrous gluconat) 3,500-18-0.4 unit-mg-mg oral DAILY 5. Fish Oil (Omega 3) 1000 mg PO BID 6. Aspirin 81 mg PO DAILY Discharge Medications: 1. Apixaban 5 mg PO BID 2. Metoprolol Succinate XL 25 mg PO DAILY Take half of your original dose, take 12.5mg daily, and follow your blood pressures. 3. Aspirin 81 mg PO DAILY 4. Centrum (multivit-iron-min-folic acid;<br>multivit-mins-ferrous gluconat) 3,500-18-0.4 unit-mg-mg oral DAILY 5. Fish Oil (Omega 3) 1000 mg PO BID 6. Simvastatin 40 mg PO QPM Discharge Disposition: Extended Care Facility: ___ ___) Discharge Diagnosis: Acute ischemic stroke. Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, You were hospitalized due to symptoms of right-sided weakness and difficulty talking resulting from an ACUTE ISCHEMIC STROKE, a condition where a blood vessel providing oxygen and nutrients to the brain is blocked by a clot. The brain is the part of your body that controls and directs all the other parts of your body, so damage to the brain from being deprived of its blood supply can result in a variety of symptoms. Stroke can have many different causes, so we assessed you for medical conditions that might raise your risk of having stroke. In order to prevent future strokes, we plan to modify those risk factors. Your risk factors are: - Prior strokes - Heart disease - Diabetes - Hypertension We are changing your medications as follows: - Replacing warfarin with apixaban. Please take your other medications as prescribed. Please follow up with Neurology and your primary care physician as listed below. If you experience any of the symptoms below, please seek emergency medical attention by calling Emergency Medical Services (dialing 911). In particular, since stroke can recur, please pay attention to the sudden onset and persistence of these symptoms: - Sudden partial or complete loss of vision - Sudden loss of the ability to speak words from your mouth - Sudden loss of the ability to understand others speaking to you - Sudden weakness of one side of the body - Sudden drooping of one side of the face - Sudden loss of sensation of one side of the body Sincerely, Your ___ Neurology Team Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Followup Instructions: ___
10391232-DS-14
10,391,232
21,818,897
DS
14
2165-11-25 00:00:00
2165-11-25 20:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Left fistula swelling Major Surgical or Invasive Procedure: None History of Present Illness: ___ y/o male with history of Hep C, HTN, HLD, ESRD on dialysis maturing fistula in left arm, who presented from dialysis with hematoma over fistula. He currently gets dialysis through right upper chest tunneled catheter. His fistula was placed on ___. He started regular exercise on ___ and since then has had progressive swelling over the fistula with tightness and moderate pain. Stopped dialysis hour and a half early today. In the ED, initial vitals were: 97.8 70 124/75 18 99% RA Exam notable for thrill and bruit over the left arm fistula. Minimal swelling overlying on the medial side. No overlying erythema. Pulses intact distally Imaging notable for 7.9 cm complex multiloculated fluid collection adjacent to the left upper extremity fistula compatible with a hematoma. Transplant surgery was consulted and recommended: no need for surgical intervention, admission to medicine Patient was not given anything in the ED On the floor, initial vitals were 97.8 134/77 77 18 96 RA. ROS: (+) Per HPI (-) Denies fever, chills, night sweats, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Past Medical History: ESRD on TThS HD HCV, untreated - diagnosed recently HTN HLD Social History: ___ Family History: Mother passed away from cancer in her ___ but spent time HD Father alive, has diabetes Physical Exam: ADMISSION PHYSICAL EXAM ======================= Vital Signs: 97.8 134/77 77 18 96 RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema. L fistula with bruit and palpable thrill Neuro: CNII-XII grossly intact Access: tunneled HD line, peripherals DISCHARGE PHYSICAL EXAM ======================= VITALS: 97.2 | 126/74 | 67 | 18 | 95%ra GENERAL: Well-appearing, no acute distress, alert and oriented. HEENT: Sclera anicteric, MMM, oropharynx clear, no appreciable lymphadenopathy CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops. Palpable left radial and ulnar pulses. LUNGS: Clear to auscultation bilaterally without wheezes, rales, rhonchi ABDOMEN: Soft, non-tender, non-distended. +Bowel sounds present. Small (<3cm) reducible umbilical hernia with superior semicircular scar. No organomegaly appreciated. No rebound or guarding. GU: No foley, otherwise deferred EXTREMITIES: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema. L fistula with bruit and palpable thrill. Incision healed, but soft 6-8cm hematoma. Otherwise warm with brisk capillary refill, normal motor exam. Upper extremity strength exam intact ___ shoulder abduction, elbow flexion/extension, wrist flexion/extension, grip strength). Some numbness to light palpation of medial distribution. NEURO: Face grossly symmetric, moving all limbs with purpose against gravity. Pertinent Results: ADMISSION LABS ============== ___ 09:00PM BLOOD WBC-3.4* RBC-3.51* Hgb-10.7* Hct-31.8* MCV-91 MCH-30.5 MCHC-33.6 RDW-13.5 RDWSD-43.3 Plt ___ ___ 09:00PM BLOOD Glucose-84 UreaN-36* Creat-11.5* Na-139 K-4.7 Cl-97 HCO3-29 AnGap-18 DISCHARGE LABS =============== ___ 07:10AM BLOOD WBC-3.7* RBC-3.58* Hgb-10.8* Hct-32.5* MCV-91 MCH-30.2 MCHC-33.2 RDW-13.2 RDWSD-42.8 Plt ___ ___ 07:10AM BLOOD ___ PTT-31.2 ___ ___ 07:10AM BLOOD Glucose-79 UreaN-43* Creat-12.0* Na-137 K-5.1 Cl-95* HCO3-26 AnGap-21* IMAGING ======== ___ ULTRASOUND UPPER EXTREMITY FINDINGS: Targeted grayscale and color Doppler ultrasound images were obtained of the patient's symptomatic site along the left upper extremity fistula. There is a complex multiloculated fluid collection lateral to the left upper extremity fistula. This measures 7.9 x 1.7 x 5.8 cm. This is approximately 0.5 cm deep to the skin. No internal vascularity is noted within this collection on color Doppler imaging. Normal color wall to wall flow is noted in the partially imaged portions of the left upper extremity fistula. IMPRESSION: 7.9 cm complex multiloculated fluid collection adjacent to the left upper extremity fistula compatible with a hematoma. Brief Hospital Course: ___ y/o male with history of Hep C, HTN, HLD, ESRD ___ ?FSGS vs. HTN) on dialysis via tunneled right chest catheter with maturing fistula in left arm, who presented from dialysis with new swelling beneath fistula. #FISTULA HEMATOMA: Evaluated by transplant surgery in the ED. Imaging and exam consistent with hematoma. Felt to be no need for acute intervention. No flow through fluid collection. Currently dialyzed through tunneled line. Will be seen by Dr. ___ on ___ when she rotates through ___ and there is a plan in the next few months for superficialization of the fistula, which is currently too deep to use in dialysis. #UMBILICAL HERNIA: Reportedly repaired at ___ in ___ on ___. Patient reports intermittent discomfort from it, sometimes while stooling, sometimes while standing, sometimes at rest. The hernia is <3cm, reducible, and the patient tolerates POs well and is having normal bowel movements. No evidence of infection, incarceration. #ESRD on HD: Per prison nursing provider, records state this is from hypertension. TThS HD. Missed part of most recent HD session, no urgent need for HD while in-house given stable electrolytes per nephrology and he will resume usual schedule at discharge. Continued calcitriol, sevelamer. #HTN: Continued home amlodipine, atenolol. #ANEMIA: Normocytic, likely secondary to ESRD. On epogen, IV iron as an outpatient #HCV: Untreated; reportedly a recent diagnosis due to prison tattoo. No known viral load or genotype available, but these should be assessed in the outpatient setting. # CODE: Full code presumed # CONTACT: ___ ___ TRANSITIONAL ISSUES =================== - FISTULA: Patient should be seen by Dr. ___ at ___ on ___ for follow up of fistula. Dr. ___. As previously established, the fistula will likely require a revision unrelated to the current hematoma, and this should be coordinated between Dr. ___ nephrology, and Mr. ___ general practitioner team. - HERNIA: Umbilical hernia, reportedly repaired ___ at ___ ___ in ___ with other procedures, causing patient some discomfort. Reducible, and patient still eating well and passing flatus. No intervention needed at this time. Recommend intermittent monitoring. - HCV: Consider viral load and genotyping in outpatient setting. - HYPERTENSION: Consider switch to labetalol from atenolol as the latter is renally cleared. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. amLODIPine 5 mg PO DAILY 2. Atenolol 100 mg PO DAILY 3. Atorvastatin 10 mg PO QPM 4. Calcitriol 0.25 mcg PO DAILY 5. Ferric Gluconate 125 mg IV 1X/WEEK (WE) 6. sevelamer CARBONATE 1600 mg PO TID W/MEALS 7. Nephro-Vite (B complex-vitamin C-folic acid) 0.8 mg oral DAILY 8. Vitamin D ___ UNIT PO ONCE A MONTH Discharge Medications: 1. amLODIPine 5 mg PO DAILY 2. Atenolol 100 mg PO DAILY 3. Atorvastatin 10 mg PO QPM 4. Calcitriol 0.25 mcg PO DAILY 5. Ferric Gluconate 125 mg IV 1X/WEEK (WE) 6. Nephro-Vite (B complex-vitamin C-folic acid) 0.8 mg oral DAILY 7. sevelamer CARBONATE 1600 mg PO TID W/MEALS 8. Vitamin D ___ UNIT PO ONCE A MONTH Discharge Disposition: Extended Care Discharge Diagnosis: PRIMARY DIAGNOSIS ================== LEFT FISTULA HEMATOMA SMALL REDUCIBLE UMBILICAL HERNIA SECONDARY DIAGNOSES =================== HCV HYPERTENSION HYPERLIPIDEMIA Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, WHY WAS I IN THE HOSPIAL? *You were admitted because of swelling over fistula WHAT HAPPENED IN THE HOSPITAL? *An ultrasound revealed the swelling to be a hematoma (blood collection) *Transplant surgery saw you and determined that it was not safe or necessary to drain the collection at this time. WHAT SHOULD I DO WHEN I LEAVE THE HOSPITAL? *Keep your left arm elevated above the level of your heart whenever possible. This will help the swelling. *Take Tylenol for pain. *Tell your doctor if you have worsening weakness or numbness in your hand *Tell your doctor if you have vomiting or worsening abdominal pain, or if the hernia in your abdomen cannot be pushed back in anymore. We wish you the best! -Your care team at ___ Followup Instructions: ___
10391698-DS-13
10,391,698
25,190,401
DS
13
2120-10-03 00:00:00
2120-10-04 07:34:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Augmentin / Omnicef Attending: ___. Chief Complaint: hyperglycemia Major Surgical or Invasive Procedure: None History of Present Illness: ___ with T1DM on an insulin pump p/w hyperglycemia, nausea, and vomiting for 10 hours. Her insulin pump ran out of insulin overnight because she accidentally had a vial with less insulin than usual and was unable to obtain a refill from the pharmacy in the evening. She woke up this morning feeling poorly and has been nauseous and vomiting since. She has had about 5 episodes of NBNB vomiting since onset. Prior to this morning, she was feeling in her usual state of good health. No fevers or chills. No abdominal pain or diarrhea. No CP/SOB, no dysuria. She tested her ketones at home, which were positive, prompting her visit to the emergency department. Of note, patient recently moved to ___ from ___ for school and so she has not yet established a PCP or endocrinologist. She does not know her insulin pump settings at the moment. In the ED, - Initial Vitals: 98.0, 128, 114/50, 20 99%RA - Exam: Generally uncomfortable appearing, otherwise unremarkable - Labs: CBC: 21 > 13.1/42.1 < 288 BMP: 132/6.8/100/___/1.0 <449 AG 25 LA 3.7 VBG: ___ --> ___ LA 1.7 UA: +ketones, +1000 gluc - Imaging: CXR wnl - Consults: None - Interventions: 4L LR + ___ @250cc/hr, insulin gtt, Mg 4g, Zofran Past Medical History: DM1 on insulin pump Social History: ___ Family History: Reviewed and found to be not relevant to this illness/reason for hospitalization. Physical Exam: Admission exam: ================ VS: 98.9, 114, 128/66, 27, 99% Gen: NAD HEENT: NCAT, PERRL, EOMI Resp: CTA B/L CV: Regular tachycardia, +S1/S2, no m/r/g, no JVD, no pedal edema, 2+ distal upper extremity and lower extremity pulses. Capillary refill <2 sec. Abd: Soft, Nontender, Nondistended, no rigidity or guarding MSK: No cyanosis, clubbing or edema Skin: No rash, Warm and dry, No petechiae Neuro: Alert and following commands, moving all extremities spontaneously, sensation intact to light touch, speech fluent Psych: Normal mood/mentation . . Discharge exam: =============== NAD MMM, OP clear RR, no m/r/g CTAB Abd soft, NT, BS+ No joint swelling/erythema/tenderness No large rashes or skin lesions Awake, alert, conversant w/ clear speech, stable gait Calm, cooperative, pleasant Pertinent Results: Admission labs: =============== ___ 04:20PM BLOOD Glucose-454* Lactate-3.9* ___ 05:02PM BLOOD ___ pO2-74* pCO2-29* pH-7.05* calTCO2-9* Base XS--21 ___ 04:42PM BLOOD WBC-21.0* RBC-4.60 Hgb-13.1 Hct-42.1 MCV-92 MCH-28.5 MCHC-31.1* RDW-12.4 RDWSD-41.0 Plt ___ ___ 04:42PM BLOOD Neuts-89.9* Lymphs-5.5* Monos-2.9* Eos-0.1* Baso-0.4 Im ___ AbsNeut-18.90* AbsLymp-1.16* AbsMono-0.62 AbsEos-0.02* AbsBaso-0.08 ___ 04:42PM BLOOD Glucose-449* UreaN-22* Creat-1.0 Na-132* K-6.8* Cl-100 HCO3-6* AnGap-25* ___ 04:42PM BLOOD Albumin-4.6 Calcium-9.8 Phos-5.6* Mg-2.1 ___ 04:42PM BLOOD ALT-16 AST-23 AlkPhos-156* TotBili-1.0 ___ 04:42PM BLOOD Lipase-6 ___ 07:18PM BLOOD Beta-OH-5.3* ___ 07:18PM BLOOD HCG-<5 . . Notable labs: ============= ___ 01:25AM BLOOD %HbA1c-8.7* eAG-203* ___ 05:15AM BLOOD calTIBC-272 Ferritn-72 TRF-209 ___ 01:25AM BLOOD Triglyc-62 HDL-44 CHOL/HD-2.8 LDLcalc-65 . . Micro: ====== -___ UCx: NGTD ***Interpret any positive result w/ caution given associated UA was negative for inflammation/infection. -___ BCx: NGTD -___ BCx: NGTD . . Imaging: ======== -___ CXR: FINDINGS: Heart size is normal. The mediastinal and hilar contours are normal. The pulmonary vasculature is normal. Lungs are clear. No pleural effusion or pneumothorax is seen. There are no acute osseous abnormalities. IMPRESSION: No acute cardiopulmonary abnormality. . . Discharge labs: ================ ___ 05:15AM BLOOD WBC-10.3* RBC-3.54* Hgb-10.1* Hct-30.6* MCV-86 MCH-28.5 MCHC-33.0 RDW-13.0 RDWSD-40.5 Plt ___ ___ 05:15AM BLOOD ___ PTT-29.1 ___ ___ 09:00AM BLOOD Glucose-97 UreaN-5* Creat-0.6 Na-143 K-4.0 Cl-109* HCO3-18* AnGap-16 ___ 05:15AM BLOOD Calcium-8.2* Phos-1.9* Mg-2.1 . . Brief Hospital Course: # DKA: presented w/ DKA due to running out of insulin and having issues with insurance refilling. Treated in ICU w/ insulin gtt & IVF resuscitation with resolution of anion gap. Feeling well without any localizing signs/symptoms of infection, pan-negative ROS, and she was tolerating a regular diet on the day of discharge. . # Type I DM: Evaluated by ___ Diabetes team. Insulin pump education performed by the diabetes educator. Filled Rx for insulin and delivered to bedside prior to discharge. Patient to follow up in ___ clinic in next 1 week to establish care with ___ diabetologist (is student living in ___, is originally from ___. . . . . . Time in care: >45 minutes in discharge-related activities today. . . Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Sertraline 50 mg PO DAILY 2. Insulin Pump SC (Self Administering Medication)Insulin Lispro (Humalog) Target glucose: 80-180 3. Tri-Sprintec (28) (norgestimate-ethinyl estradiol) 0.18/0.215/0.25 mg-35 mcg (28) oral DAILY Discharge Medications: 1. Insulin Pump SC (Self Administering Medication)Insulin Lispro (Humalog) Basal Rates: Midnight - 23:59: 1.25 Units/Hr Meal Bolus Rates: Breakfast = 1:4.8 Lunch = 1:4.8 Dinner = 1:4.8 Snacks = 1:4.8 High Bolus: Correction Factor = 1:24 Correct To ___ mg/dL MD has ordered ___ consult Use of ___ medical equipment: Insulin pump Reason for use: medically necessary and justified as ___ cannot provide this type of equipment or suitable alternative not appropriate. Provider acknowledges patient competent RX *insulin lispro [Humalog U-100 Insulin] 100 unit/mL 100 units SC ASDIR Disp #*4 Vial Refills:*12 2. Sertraline 50 mg PO DAILY 3. Tri-Sprintec (28) (norgestimate-ethinyl estradiol) 0.18/0.215/0.25 mg-35 mcg (28) oral DAILY Discharge Disposition: Home Discharge Diagnosis: # DKA # Type I DM Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Ms. ___, You were admitted to the hospital with diabetic ketoacidosis, a diabetic emergency, due to running out of insulin for your insulin pump. You were treated with an insulin drip in the ICU and improved rapidly. You were evaluated by our ___ Diabetes team who would like to see you in clinic within the next 1 week to establish care with a ___ primary Diabetologist. They are working on scheduling an appointment for you and will contact you. If you have not heard from them within the next 2 days, please call their clinic at ___ and let them know you were seen here at ___ and need an appointment within the next 1 week. It was a pleasure caring for you and we wish you the best! Sincerely, Your ___ Medicine Team Followup Instructions: ___
10392116-DS-20
10,392,116
25,173,613
DS
20
2190-12-09 00:00:00
2190-12-12 09:22:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Throat discomfort Major Surgical or Invasive Procedure: None History of Present Illness: ___ w/ PMHx GERD, esophageal spasm, and anxiety presenting with throat andchest burning. Patient has long history of issues with GERD and is followed by GI as an outpatient. She said that she intermittently has issues at home and yesterday had quite severe symptoms which seemed to pop up after she experienced the emotional stressor of her washer leaking just after being installed in her home. She tried nexium/zantac with incomplete relief of her symptoms. She was also being bothered by a bit of a cough and runny nose though says that these symptoms have been present for quite some time. She denied any frank chest pain, SOB, abdominal pain, n/v/d, constipation, dysuria, or frequency. In the ED, initial VS were: 101.3 80 130/54 12 98% RA Labs notable for: Na 131, trop neg x2, LFTs wnl UA: Hazy, 30 prot, 40 ket, 7 RBC, few bacteria Imaging showed: CXR: PA and lateral views of the chest provided. The lungs are hyperinflated with biapical pleuroparenchymal scarring again noted. No focal consolidation, large effusion or pneumothorax is seen. No signs of pneumothorax or pneumomediastinum. The cardiomediastinal silhouette is stable. Bony structures are intact. No free air below the right hemidiaphragm. CT Torso: 1. No evidence of pancreatitis. Please note that CT findings of pancreatitis may lack clinical findings by 48 hours. 2. No evidence of small-bowel obstruction colitis or diverticulitis. 3. Large quantity of gas and stool throughout the bowel. Patient received: ___ 19:56 PO Aluminum-Magnesium Hydrox.-Simethicone 30 mL ___ 19:56 PO Lidocaine Viscous 2% 10 mL Transfer VS were: 99.3 93 143/55 16 99% RA On arrival to the floor, patient reports that her reflux symptoms have resolved but that she is having significant dry mouth. She is otherwise well and without any acute complaint. 10 point ROS reviewed and negative except as per HPI Past Medical History: 1. Coronary vasospams - ___ the pt was admitted to ___ ___ due to CP unrelieved by NTG and was found to have TWIs ___. Her first troponin and CK were normal but the second troponin was elevated. Due to weather conditions, pt was transferred to ___ (Dr. ___ ___ rather than BI, where she underwent diagnostic cath. The angiogram revealed focal ___ LAD dx (pt has a copy of the CD) which responded to NTG. Subsequent intra- vascular US revealed no sig. plaque in quite a nl appearing segment where the angiographic stenosis had been, c/w vasospasm. 2. GERD 3. Depression. Social History: ___ Family History: M: Breast CA and silent MI F: Parkinsons Physical Exam: PHYSICAL EXAM ON ADMISSION: ========================= VS: 99.3 138/64 89 19 99% Ra GENERAL: Pleasant elderly F in NAD HEENT: NCAT, dry mucous membranes NECK: Supple, neck veins flat sitting upright HEART: RRR, no m/r/g LUNGS: CTAB anteriorly ABDOMEN: Soft, NT/ND, BS+ EXTREMITIES: WWP, no c/c/e PULSES: 2+ DP pulses bilaterally NEURO: A&Ox3, moving all 4 extremities with purpose SKIN: warm and well perfused, no excoriations or lesions, no rashes PHYSICAL EXAM ON DISCHARGE: ========================= VS: 99.6 PO 132 / 54 90 12 98 RA GENERAL: Pleasant elderly F in NAD, runny nose HEENT: NCAT, dry mucous membranes NECK: Supple, neck veins flat sitting upright HEART: RRR, no m/r/g LUNGS: CTAB anteriorly ABDOMEN: Soft, NT/ND, BS+ EXTREMITIES: WWP, no c/c/e PULSES: 2+ DP pulses bilaterally NEURO: A&Ox3, moving all 4 extremities with purpose SKIN: warm and well perfused, no excoriations or lesions, no rashes Pertinent Results: LABS ON ADMISSION: ================ ___ 06:42PM BLOOD WBC-6.0# RBC-3.77* Hgb-11.2 Hct-33.6* MCV-89 MCH-29.7 MCHC-33.3 RDW-13.1 RDWSD-42.5 Plt ___ ___ 06:42PM BLOOD Neuts-89.7* Lymphs-4.8* Monos-5.0 Eos-0.0* Baso-0.2 Im ___ AbsNeut-5.39# AbsLymp-0.29* AbsMono-0.30 AbsEos-0.00* AbsBaso-0.01 ___ 06:42PM BLOOD Glucose-150* UreaN-14 Creat-0.7 Na-131* K-4.5 Cl-92* HCO3-23 AnGap-16 ___ 09:35PM BLOOD ALT-18 AST-33 AlkPhos-64 TotBili-0.5 ___ 09:35PM BLOOD Lipase-18 ___ 06:42PM BLOOD cTropnT-<0.01 ___ 09:35PM BLOOD cTropnT-<0.01 ___ 09:35PM BLOOD Albumin-3.9 LABS ON DISCHARGE: ================ ___ 08:35AM BLOOD WBC-6.5 RBC-3.43* Hgb-10.2* Hct-30.4* MCV-89 MCH-29.7 MCHC-33.6 RDW-13.3 RDWSD-43.5 Plt ___ ___ 08:35AM BLOOD Glucose-95 UreaN-13 Creat-0.6 Na-131* K-4.0 Cl-92* HCO3-25 AnGap-14 ___ 08:35AM BLOOD Calcium-8.6 Phos-2.9 Mg-1.9 MICRO: ====== IMAGING: ======= CXR: PA and lateral views of the chest provided. The lungs are hyperinflated with biapical pleuroparenchymal scarring again noted. No focal consolidation, large effusion or pneumothorax is seen. No signs of pneumothorax or pneumomediastinum. The cardiomediastinal silhouette is stable. Bony structures are intact. No free air below the right hemidiaphragm. CT Abdomen and pelvis: 1. No evidence of pancreatitis. Please note that CT findings of pancreatitis may lack clinical findings by 48 hours. 2. No evidence of small-bowel obstruction, colitis or diverticulitis. 3. Large quantity of gas and stool throughout the bowel. Brief Hospital Course: Mrs. ___ is a ___ yo female with past medical history of chronic watery rhinorrea, esophagitis, and GERD, who presented with throat pain in the setting of fever, worsening runny nose, and cough, suggestive of viral upper respiratory infection. ACUTE ISSUES: ============= #Throat pain: Initially, the patient reported chest pain, which raised concern for cardiac pain or severe esophagitis. Trops were negative and ECG showed no ischemic changed. Upon further questioning, she clarified that she had no chest pain but rather throat pain. Her symptoms were likely due to upper respiratory viral infection. Per review of records, she saw ENT on ___ for throat chronic rhinorrhea. At that time, an endoscopy was performed and showed normal hypopharynx and larynx, mild reflux changes, and no glottic abnormality. She was able to tolerate PO intake and her throat pain has improved. She had symptomatic relief with lozenges PRN. #Fevers: She was febrile in ED to 101.3 with cough and sore throat. Exam was benign and there was no leukocytosis on labs. UA bland. CXR with biapical scarring though no definitive consolidation. CT chest without any findings which would explain fevers. Her symptoms are likely due to upper respiratory viral infection. She received conservative treatment. #GERD: Patient with long-standing and significant issues with GERD. Initially her symptoms were thought to be due to severe GERD, though patient clarified that had throat pain and not chest/epigastric pain. She was treated with BID PPI and ranitidine. #Hyponatremia: Likely in the setting of poor PO intake. Encouraged PO intake. CHRONIC ISSUES: =============== #Esophageal spasm #Atypical chest pain: Continued verapamil. #Anxiety: Continued PRN ativan. #Allergic rhinitis: Fluticasone while in house as home azelastine not on formulary. ***TRANSITIONAL ISSUES:*** - Ensure resolution of symptoms - Continue PPI BID, make sure patient takes it 30 minutes before her meals - Consider follow-up with ENT in case her symptoms persist Medications on Admission: The Preadmission Medication list is accurate and complete. 1. azelastine 0.15 % (205.5 mcg) nasal BID 2. esomeprazole magnesium 40 mg oral BID 3. LORazepam 0.5-1 mg PO Q6H:PRN Anxiety 4. Ranitidine 150 mg PO BID 5. Verapamil SR 120 mg PO Q24H 6. Vitamin D 1000 UNIT PO DAILY 7. Calcium Carbonate Suspension Dose is Unknown PO TID 8. Multivitamins 1 TAB PO DAILY Discharge Medications: 1. azelastine 0.15 % (205.5 mcg) nasal BID 2. Calcium Carbonate Suspension Dose is Unknown PO TID 5 mL (1 tsp) = 1250 mg Calcium Carbonate = 500 mg of Elemental Calcium 3. esomeprazole magnesium 40 mg oral BID 4. LORazepam 0.5-1 mg PO Q6H:PRN Anxiety 5. Multivitamins 1 TAB PO DAILY 6. Ranitidine 150 mg PO BID 7. Verapamil SR 120 mg PO Q24H 8. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: Upper respiratory tract infection SECONDARY DIAGNOSIS: Hyponatremia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, ___ was a pleasure taking care of you at ___ ___. You came to the hospital because you were experiencing severe throat pain. You also had a runny nose, fever, and a cough. These symptoms are likely due to a viral infection and will get better within a few days. There was an initial concern that you had a bad stomach reflux. Upon further clarification, you clarified that the pain is in your throat and not in the stomach. You do not need a scope to look at the esophagus and stomach at this time. Please make sure to follow-up with your doctors as ___. Also, you should continue taking your acid reflux medications 30 minutes before your meals twcice a day. You can take other the counter lozenges to relieve the throat pain. We wish you all the best in health. Your ___ team Followup Instructions: ___
10392429-DS-16
10,392,429
20,402,482
DS
16
2125-12-29 00:00:00
2126-01-26 15:06:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: abdominal pain Major Surgical or Invasive Procedure: ___: ERCP with sphincterotomy and stone extraction ___: Laparoscopic cholecystectomy History of Present Illness: ___ man with atrial fibrillation on Eliquis, coronary artery disease s/p 2 stents several years ago, diabetes, OSA, presents with 24 hours of severe epigastric pain, Rigors, vomiting transferred from OSH emergency room after found to have gallstone pancreatitis. He lives in ___ but is in ___ visiting for his birthday. His wife and him normally go to ___ and ___. He was in his normal state of health until 24 hours ago when he had sudden onset of abdominal pain after eating pizza. He tried taking Tums and Pepto-Bismol with no relief. The pain continued to get worse and he subsequently had nausea and vomiting. Later this afternoon he started to notice rigoring so he went to urgent care where he was found to have obstructive pancreatitis and a possible NSTEMI he was transferred to ___ emergency room. Per report in the emergency room there he was found to have elevated liver function tests AST 147 ALT 150 T bili of 3.7 and a lipase of 2200. Per report troponin was 0.21. A right upper quadrant ultrasound was done which showed a markedly distended gallbladder with thickened wall, nonmobile gallstone within the neck of the gallbladder suspicious for acute cholecystitis. He was given Zosyn and transferred to our emergency room. Past Medical History: Atrial fibrillation CAD Diabetes OSA Hyperlipidemia Hypertension Social History: ___ Family History: His father died of an MI, his uncle died of an MI his mom died of old age in her late ___ she lived at a nursing home. He states numerous family members have had gallstones or had their gallbladder removed Physical Exam: ADMISSION PHYSICAL EXAM: =========================== VS: 99.0 PO 156 / 75 85 20 95 2L NC General Appearance: pleasant, comfortable, no acute distress Eyes: PERLL, EOMI, no conjuctival injection, +icteric ENT: no sinus tenderness, MMM, oropharynx without exudate or lesions Respiratory: CTA b/l with good air movement throughout Cardiovascular: RR, S1 and S2 wnl, no murmurs, rubs or gallops Gastrointestinal: nd, +b/s, soft, tender to palpation in the mid epigastric and right upper quadrant area, no masses or HSM Extremities: no cyanosis, clubbing or edema Skin: warm, no rashes/no jaundice/no skin ulcerations noted Neurological: Alert, oriented to self, time, date, reason for hospitalization. fluent speech. Psychiatric: pleasant, appropriate affect GU: no catheter in place Discharge Physical Exam: Temp: 98.5, BP: 169/90, HR: 71 RR: 18, O2 sat: 95% Gen: A&O x3. In NAD. Sitting up in chair CV: HR irregular, rate controlled Pulm: LS ctab Abd: soft, appropriately TTP incisionally. Lap sites CDI, OTA. Ext: WWP no edema Pertinent Results: ADMISSION LABS -------------- ___ 08:00PM BLOOD WBC-16.0* RBC-4.33* Hgb-12.2* Hct-38.7* MCV-89 MCH-28.2 MCHC-31.5* RDW-14.6 RDWSD-47.7* Plt ___ ___ 01:46AM BLOOD ___ ___ 08:00PM BLOOD Glucose-227* UreaN-18 Creat-0.9 Na-141 K-4.0 Cl-107 HCO3-23 AnGap-11 ___ 08:00PM BLOOD ALT-142* AST-126* AlkPhos-117 TotBili-3.9* ___ 08:00PM BLOOD Lipase-1016* ___ 08:00PM BLOOD cTropnT-0.01 ___ 08:00PM BLOOD Albumin-3.3* Calcium-8.9 Phos-3.7 Mg-1.7 IMAGING ------- CXR ___ IMPRESSION: Low lung volumes with possible mild pulmonary vascular congestion and small bilateral pleural effusions. Bibasilar airspace opacities likely reflect atelectasis in the setting of low lung volumes, with aspiration or infection difficult to exclude in the correct clinical setting. CT ABD/PELVIS ___ IMPRESSION: 1. Dilated common bile duct due to choledocholithiasis in the distal common bile duct with evidence of cholangitis involving the distal common bile duct. ERCP is recommended for further evaluation and management. 2. Cholelithiasis with evidence of acute cholecystitis. 3. Gallstone-associated mild interstitial edematous pancreatitis. No peripancreatic fluid collections. 4. 5.3 x 4.0 cm minimally complex hypodense rim calcific structure in the right lateral aspect of the pericardium, likely a calcified pericardial cyst. ERCP ___ - Ampulla normal - pancreatogram: normal without evidence of filling defects - cholangiogram: CBD 8mm. left and right hepatic ducts and intrahepatic branches dilated. large filling defects suggestive of stones - sphincterotomy performed - multiple balloon sweeps with the removal of multiple stones - final cholangiogram with no evidence of filling defects RUQUS ___ IMPRESSION: 1. Mildly distended gallbladder with cholelithiasis and small amount of pericholecystic fluid, compatible with known cholecystitis. 2. No evidence of intrahepatic or extrahepatic biliary dilatation. Brief Hospital Course: ___ yo man with AFib on Eliquis, CAD s/p 2 stents several years ago, NIDDM, OSA, presenting with abdominal pain, found to have gallstone pancreatitis, cholecystitis, and cholangitis. Patient presented with lab and imaging consistent with gallstone pancreatitis, with lipase > ___ and elevated LFTs. His Eliquis was held in the setting of multiple procedures during this hospitalization. He underwent successful ERCP on ___, with sphincterotomy, stent placement and multiple stones. ACS was consulted, and the patient underwent laparoscopic cholecystectomy on ___ , which went well without complication (reader referred to the Operative Note for details). After a brief, uneventful stay in the PACU, the patient arrived on the floor tolerating clears, on IV fluids, and oral analgesia for pain control. The patient was hemodynamically stable. Pain was well controlled. Diet was progressively advanced as tolerated to a regular diet with good tolerability. The patient voided without problem. During this hospitalization, the patient ambulated early and frequently, was adherent with respiratory toilet and incentive spirometry, and actively participated in the plan of care. The patient received subcutaneous heparin and venodyne boots were used during this stay. Home Eliquis was restarted on POD2. At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The patient was discharged home without services. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. MetFORMIN (Glucophage) 1000 mg PO BID 2. Apixaban 5 mg PO BID 3. Atorvastatin 80 mg PO QPM 4. Metoprolol Succinate XL 12.5 mg PO BID 5. Januvia (SITagliptin) 100 mg oral DAILY 6. Aspirin 81 mg PO DAILY Discharge Medications: 1. Acetaminophen 500 mg PO Q6H 2. OxyCODONE (Immediate Release) 2.5-5 mg PO Q4H:PRN Pain - Moderate RX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours Disp #*5 Tablet Refills:*0 3. Polyethylene Glycol 17 g PO DAILY RX *polyethylene glycol 3350 17 gram 1 packet(s) by mouth once a day Disp #*10 Packet Refills:*0 4. Senna 8.6 mg PO BID RX *sennosides [senna] 8.6 mg 1 tablet(s) by mouth twice a day Disp #*10 Tablet Refills:*0 5. Aspirin 81 mg PO DAILY 6. Atorvastatin 80 mg PO QPM 7. Januvia (SITagliptin) 100 mg oral DAILY 8. MetFORMIN (Glucophage) 1000 mg PO BID 9. Metoprolol Succinate XL 12.5 mg PO BID 10. HELD- Apixaban 5 mg PO BID This medication was held. Do not restart Apixaban until ___ Discharge Disposition: Home Discharge Diagnosis: Gallstone pancreatitis Choledocholithiasis Chronic cholecystitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to ___ with abdominal pain and were found to have gallstone pancreatitis. You underwent an ERCP to remove stones from your common bile duct. Once your pain and liver function lab values improved, you were taken to the operating room and had your gallbladder removed laparoscopically. You tolerated this well. You are now eating and your pain is under control on oral medications. Your lab tests postoperatively look good. You can restart your eliquis tomorrow ___. You will need to call the Acute Care Surgery clinic to schedule a follow-up appointment. ACTIVITY: o Do not drive until you have stopped taking pain medicine and feel you could respond in an emergency. o You may climb stairs. o You may go outside, but avoid traveling long distances until you see your surgeon at your next visit. o Don't lift more than ___ lbs for 4 weeks. (This is about the weight of a briefcase or a bag of groceries.) This applies to lifting children, but they may sit on your lap. o You may start some light exercise when you feel comfortable. o You will need to stay out of bathtubs or swimming pools for a time while your incision is healing. Ask your doctor when you can resume tub baths or swimming. HOW YOU MAY FEEL: o You may feel weak or "washed out" for a couple of weeks. You might want to nap often. Simple tasks may exhaust you. o You may have a sore throat because of a tube that was in your throat during surgery. o You might have trouble concentrating or difficulty sleeping. You might feel somewhat depressed. o You could have a poor appetite for a while. Food may seem unappealing. o All of these feelings and reactions are normal and should go away in a short time. If they do not, tell your surgeon. YOUR INCISION: o Tomorrow you may shower and remove the gauzes over your incisions. Under these dressing you have small plastic bandages called steri-strips. Do not remove steri-strips for 2 weeks. (These are the thin paper strips that might be on your incision.) But if they fall off before that that's okay). o Your incisions may be slightly red around the stitches. This is normal. o You may gently wash away dried material around your incision. o Avoid direct sun exposure to the incision area. o Do not use any ointments on the incision unless you were told otherwise. o You may see a small amount of clear or light red fluid staining your dressing or clothes. If the staining is severe, please call your surgeon. o You may shower. As noted above, ask your doctor when you may resume tub baths or swimming. YOUR BOWELS: o Constipation is a common side effect of narcotic pain medications. If needed, you may take a stool softener (such as Colace, one capsule) or gentle laxative (such as milk of magnesia, 1 tbs) twice a day. You can get both of these medicines without a prescription. o If you go 48 hours without a bowel movement, or have pain moving the bowels, call your surgeon. PAIN MANAGEMENT: o It is normal to feel some discomfort/pain following abdominal surgery. This pain is often described as "soreness". o Your pain should get better day by day. If you find the pain is getting worse instead of better, please contact your surgeon. o You will receive a prescription for pain medicine to take by mouth. It is important to take this medicine as directed. o Do not take it more frequently than prescribed. Do not take more medicine at one time than prescribed. o Your pain medicine will work better if you take it before your pain gets too severe. o Talk with your surgeon about how long you will need to take prescription pain medicine. Please don't take any other pain medicine, including non-prescription pain medicine, unless your surgeon has said its okay. o If you are experiencing no pain, it is okay to skip a dose of pain medicine. o Remember to use your "cough pillow" for splinting when you cough or when you are doing your deep breathing exercises. If you experience any of the following, please contact your surgeon: - sharp pain or any severe pain that lasts several hours - pain that is getting worse over time - pain accompanied by fever of more than 101 - a drastic change in nature or quality of your pain MEDICATIONS: Take all the medicines you were on before the operation just as you did before, unless you have been told differently. If you have any questions about what medicine to take or not to take, please call your surgeon. Followup Instructions: ___
10392686-DS-15
10,392,686
21,527,402
DS
15
2124-11-06 00:00:00
2124-11-28 09:02:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: CARDIOTHORACIC Allergies: codeine Attending: ___. Chief Complaint: Chest pain and dyspnea on exertion Major Surgical or Invasive Procedure: ___ - 1. Coronary artery bypass grafting x3 with the left internal mammary artery to the left anterior descending artery and reverse saphenous vein graft to the posterior descending artery and obtuse marginal artery. 2. Patch repair of atrial septal defect. History of Present Illness: Ms. ___ is a ___ year old woman with a history of coronary artery disease, diabetes mellitus, hyperlipidemia, hypertension and prior non-ST elevation myocardial infarction in ___. A cardiac catheterization in ___ demonstrated two vessel coronary artery disease with 99% proximal OM1 which was successfully treated with a 3.5 x 13 mm BX Velocity stent. She was also noted to have a 60-70% mid RCA lesion. She reports being under significant emotional stress as her ___ year old son was hospitalized for Encephalitis for over a month and her mother-in-law passed away. Over the past two months she has been experiencing intermittent chest discomfort/tightness and dyspnea with climbing stairs. Symptoms improve with rest. She underwent a cardiac catheterization which revealed coronary artery disease. She was scheduled for surgery however she has developed worsening chest pain over the last few days. She states that previously she could walk up a flight of stairs without SOB but now cannot. She states that her chest pain (described as pressure radiating across her chest) has been occurring more frequently in the last few days. She also states she experienced an episode of L hand pain similar to her prior MI. She then awoke overnight with chest pain, which is the first time she has experienced this. She presented to the ED for evaluation. Her EKG was without ischemia and troponin assays were negative. She is now admitted for expedited CABG work up. Past Medical History: Coronary artery disease s/p stent in ___ Diabetes mellitus type 2 Hyperlipidemia Hypertension Non-ST Elevation Myocardial Infarction, ___ Surgical History: Cholecystectomy Partial hysterectomy Social History: ___ Family History: Mother had MI in her ___ and "enlarged" heart. Physical Exam: Admission exam 97.6, 72 NSR, 170/84, RR 10, 97% RA General: NAD, lying in bed Skin: Dry [x] intact [x] HEENT: PERRLA [x] EOMI [x] Neck: Supple [x] Full ROM [x] Chest: Lungs clear bilaterally [x] Heart: RRR [x] Irregular [] Murmur [] grade ______ Abdomen: Soft [x] non-distended [x] non-tender [x] bowel sounds +[x] Extremities: Warm [x], well-perfused [x] Edema [] no edema Varicosities: None [x] Neuro: Grossly intact [x] Pulses: Femoral Right:2+ Left:2+ DP Right:2+ Left:2+ ___ Right:2+ Left:2+ Radial Right:2+ Left: 2+ Carotid Bruit: Right: absent Left: absent Discharge Physical Exam VS: T 98.0 HR: 60-70's SR BP: 118-137/70's RR: 18 Sats: 98% RA Wt: 69.7 kg pre-op 66 kg General: NAD Cardiac: RRR Resp: clear breath sounds GI: benign Extr: warm no edema Wound: sternal & Right lower extremity clean dry intact. sternum stable Neuro: awake, alert walks independently Pertinent Results: Echo ___: PRE BYPASS The left atrium is dilated. No spontaneous echo contrast or thrombus is seen in the body of the left atrium/left atrial appendage or the body of the right atrium/right atrial appendage. The right atrium is dilated. A left-to-right shunt across the interatrial septum is seen at rest. A secundum type atrial septal defect, about 0.8 cm in width, is present. Regional left ventricular wall motion is normal. Overall left ventricular systolic function is normal (LVEF>55%). The right ventricular cavity is dilated with normal free wall contractility. There are simple atheroma in the ascending aorta. There are simple atheroma in the aortic arch. There are complex (mobile) atheroma in the descending aorta. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. Trace aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Physiologic mitral regurgitation is seen (within normal limits). The tricuspid valve leaflets are mildly thickened. There is no pericardial effusion. Dr. ___ was notified in person of the results in the operating room at the time of the study. POST BYPASS The patient is atrially paced. There is low normal right ventricular systolic function. There is normal left ventricular systolic function. Valvular function is unchanged from the prebypass study. The thoracic aorta is intact after decannulation. CXR: ___ilateral pleural effusions and bibasilar atelectasis. No pneumothorax is identified. The size and appearance of the cardiomediastinal silhouette is unchanged. Again noted is a right internal jugular central venous catheter whose tip projects over the cavoatrial junction. IMPRESSION: No significant interval change since the prior study with small bilateral pleural effusions and bibasilar atelectasis. Admission Labs: ___ WBC-9.1 RBC-3.93 Hgb-10.7* Hct-33.3* MCV-85 MCH-27.2 MCHC-32.1 RDW-12.4 RDWSD-37.9 Plt ___ ___ Glucose-110* UreaN-20 Creat-0.8 Na-144 K-4.1 Cl-107 HCO3-23 ___ ALT-41* AST-64* LD(LDH)-273* AlkPhos-50 Amylase-36 TotBili-<0.2 Discharge Labs: ___ WBC-11.7* RBC-3.20* Hgb-8.9* Hct-27.2* MCV-85 MCH-27.8 MCHC-32.7 RDW-13.1 RDWSD-40.4 Plt ___ ___ Glucose-120* UreaN-14 Creat-0.8 Na-140 K-4.1 Mg-2.0 Discharge Labs: ___ 04:53AM BLOOD WBC-11.7* RBC-3.20* Hgb-8.9* Hct-27.2* MCV-85 MCH-27.8 MCHC-32.7 RDW-13.1 RDWSD-40.4 Plt ___ ___ 04:53AM BLOOD Plt ___ ___ 03:14PM BLOOD ___ PTT-25.8 ___ ___ 05:11AM BLOOD Glucose-120* UreaN-14 Creat-0.8 Na-140 K-4.1 ___ 05:11AM BLOOD Mg-2.0 Radiology Report CHEST (PA & LAT) Study Date of ___ 4:22 ___ Final Report: There are trace bilateral pleural effusions and bibasilar atelectasis. No pneumothorax is identified. The size and appearance of the cardiomediastinal silhouette is unchanged. Again noted is a right internal jugular central venous catheter whose tip projects over the cavoatrial junction. IMPRESSION: No significant interval change since the prior study with small bilateral pleural effusions and bibasilar atelectasis. ___, MD electronically signed on SAT ___ 4:43 ___ Brief Hospital Course: ___ was admitted following presenting with unstable chest pain. Her original planned surgical date was ___ but due to her unstable chest pain, she was admitted for medical management with surgery sooner. EKG and enzymes were negative and underwent usual pre-operative work-up. On ___ she was taken to the operating where she underwent a coronary artery bypass graft x 3 and ASD closure. Please see operative report for surgical details. Following surgery she was transferred to the CVICU for invasive monitoring in stable condition. Later this day he was weaned from sedation, awoke neurologically intact and extubated. Patient remained hemodynamically stable, she was weaned from pressor therpy, required Atrial pacing for Sinus bradycardia. Patient was started on Lopressor and Lasix. She had post-op nausea that resolved with scopolamine patch, and avoiding narcotics. Patient was transferred to the floor POD1. Pacing wires and chest tubes were removed in timely fashion. She was transfused 1PRBC on POD2 for acute blood loss anemia, Hct 22 bumped to 27 appropriately. Patient was seen by the physical therapy department strengthening and mobility. She continue to progress well and was ready for discharge to home on POD 4. All follow-up appointment arranged. Medications on Admission: ATENOLOL - atenolol 50 mg tablet. tablet(s) by mouth - (Prescribed by Other Provider; one po qd) ATORVASTATIN - atorvastatin 80 mg tablet. 1 tablet(s) by mouth daily - (Prescribed by Other Provider) METFORMIN - metformin ER 500 mg tablet,extended release 24 hr. 1 tablet(s) by mouth twice a day - (Prescribed by Other Provider; bid) OMEPRAZOLE - omeprazole 20 mg capsule,delayed release. capsule(s) by mouth - (Prescribed by Other Provider; one po qd) SITAGLIPTIN [JANUVIA] - Januvia 100 mg tablet. 1 tablet(s) by mouth daily - (Prescribed by Other Provider; ) Medications - OTC ASPIRIN - aspirin 325 mg tablet,delayed release. tablet(s) by mouth - (Prescribed by Other Provider; one po qd) CHOLECALCIFEROL (VITAMIN D3) - cholecalciferol (vitamin D3) 1,000 unit capsule. capsule(s) by mouth - (Prescribed by Other Provider; one po qd) CINNAMON BARK [CINNAMON] - Cinnamon 500 mg capsule. 4 capsule(s) by mouth daily - (Prescribed by Other Provider; ) IBUPROFEN - ibuprofen 200 mg tablet. ___ tablet(s) by mouth tabets daily over course day - (Prescribed by Other Provider) OMEGA-3 FATTY ACIDS-FISH OIL [FISH OIL] - Fish Oil 360 mg-1,200 mg capsule. 1 capsule(s) by mouth twice a day - (Prescribed by Other Provider) Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 2. Aspirin EC 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Furosemide 20 mg PO DAILY Duration: 7 Days RX *furosemide 20 mg 1 tablet(s) by mouth once a day Disp #*7 Tablet Refills:*1 5. Januvia (SITagliptin) 100 mg oral DAILY 6. MetFORMIN XR (Glucophage XR) 500 mg PO BID Do Not Crush 7. Metoprolol Tartrate 50 mg PO BID RX *metoprolol tartrate 50 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*180 Tablet Refills:*1 8. Omeprazole 20 mg PO DAILY 9. Polyethylene Glycol 17 g PO DAILY 10. Senna 17.2 mg PO DAILY RX *sennosides [Senna Concentrate] 8.6 mg 1 by mouth at bedtime Disp #*30 Tablet Refills:*0 11. Vitamin D 1000 UNIT PO DAILY 12. HELD- Fish Oil (Omega 3) 1000 mg PO BID This medication was held. Do not restart Fish Oil (Omega 3) until seen by your PCP ___: Home With Service Facility: ___ Discharge Diagnosis: Coronary artery disease s/p Coronary artery bypass graft x 3 ASD s/p closure Past medical history: Hypertension Hyperlipidemia s/p stent in ___ Diabetes mellitus type 2 Cholecystectomy Partial hysterectomy Discharge Condition: Alert and oriented x3, non-focal Ambulating, gait steady Sternal pain managed with oral analgesics Sternal Incision - healing well, no erythema or drainage Edema: none Discharge Instructions: 1. Shower daily -wash incisions gently with mild soap 2. No baths or swimming, look at your incisions daily 3. NO lotion, cream, powder or ointment to incisions 4. Daily weights. keep a log. Call with weight gain of ___ pounds over several days 5. Monitor sternal incision for signs of infection: fevers > 101, redness, drainage or increased pain. Should any of these symptoms occur please call the office immediately. ___ 6. No driving for approximately one month and while taking narcotics Clearance to drive will be discussed at follow up appointment with surgeon 7. No lifting more than 10 pounds for 10 weeks 8. Encourage full shoulder range of motion, unless otherwise specified 9. Please wear bra to reduce pulling on incision, avoid rubbing on lower edge **Please call cardiac surgery office with any questions or concerns ___. Answering service will contact on call person during off hours** Followup Instructions: ___
10393281-DS-11
10,393,281
26,073,810
DS
11
2161-07-25 00:00:00
2161-07-26 23:23:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Bleeding in urostomy bag Major Surgical or Invasive Procedure: TIPs and ___ embolization ___ History of Present Illness: Ms. ___ is a ___ year-old woman with PMH of HCV cirrhosis (s/p Harvoni ___ with SVR, currently inactive on transplant list due to low MELD) c/b thrombocytopenia, portal hypertension, and varices, transitional cell carcinoma (s/p neo-adjuvant cisplatin/gemcitabine, radical cystectomy, urethrectomy, TAH/BSO, and ileal conduit diversion in ___ who presented to the ED with bleeding in her urostomy bag that began the afternoon of admission. Around 2pm day of admission she noted frank blood draining into her urostomy bag. She presented to ___ where 400 cc of blood were reportedly emptied from her ostomy and she received 2 units pRBCs. Her hemoglobin on presentation was 9.1 and she received 1 L LR. The ED physician who examined her visualized a parastomal varix at 6:00 without signs of active bleeding. She was transferred to ___ for further management. She presented to ___ ___ with blood in her ostomy bag after increasing her aspirin usage reportedly to 4 325mg pills daily for weeks to treat left shoulder pain from her humeral fracture ___. CT A&P at ___ showed engorged varices. She was transferred to ___, Dr. ___ recommended transfer to ___ for embolization or expedited TIPS workup but she ended up signing out AMA. Spironolactone and propranolol were held on discharge but resumed by Dr. ___ on ___. No bleeding in between discharge and now. Urine cytology sent during that visit to evaluate for recurrent urothelial malignancy was negative. She denies recent fevers, dyspnea, chest pain, abdominal pain, diarrhea, constipation, or worsening leg swelling. Past Medical History: - Bladder cancer s/p cystectomy with ileal loop urostomy at ___ about ___ years ago - Hepatitic C Cirrhosis - Hypertension - Type II Diabetes - GERD Social History: ___ Family History: She has a father and mother with cirrhosis thought to be due to alcohol. Her mother had breast cancer and her sister has lung cancer that is metastatic to the liver and spleen. Physical Exam: ADMISSION PHYSICAL EXAM VS: ___ 2316 Temp: 98.9 PO BP: 107/65 L Sitting HR: 65 RR: 16 O2 sat: 96% O2 delivery: Ra GENERAL: Pleasant, NAD HEENT: EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM NECK: supple, no JVD HEART: RRR, S1/S2, ___ systolic mumur at apex LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly. No fluid wave Ostomy RLQ pink, bag draining clear yellow urine EXTREMITIES: Trace edema left ankle, no cyanosis, clubbing PULSES: 2+ DP pulses bilaterally NEURO: A&Ox3, moving all 4 extremities with purpose SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE PHYSICAL EXAM Temp 98.4 BP106 / 68 HR 57 RR 18SaO2 96%Ra GENERAL: Pleasant, NAD HEENT: EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM NECK: supple, no JVD HEART: RRR, S1/S2, ___ systolic mumur at apex LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, nontender in all quadrants except around ostomy bag, no rebound/guarding, no hepatosplenomegaly. No fluid wave Ostomy RLQ pink, bag draining clear yellow urine EXTREMITIES: Trace edema left ankle, no cyanosis, clubbing NEURO: A&Ox3, moving all 4 extremities with purpose SKIN: warm and well perfused, no excoriations or lesions, no rashes Pertinent Results: ADMISSION LABS ___ 07:45PM BLOOD WBC-5.4 RBC-3.06* Hgb-9.0* Hct-26.7* MCV-87 MCH-29.4 MCHC-33.7 RDW-16.3* RDWSD-51.3* Plt Ct-86* ___ 07:45PM BLOOD Glucose-124* UreaN-11 Creat-0.8 Na-139 K-4.4 Cl-106 HCO3-22 AnGap-11 ___ 07:45PM BLOOD ALT-11 AST-33 AlkPhos-107* TotBili-0.8 ___ 03:30AM BLOOD Calcium-8.1* Phos-3.7 Mg-1.2* NOTABLE LABS ___ 07:45PM BLOOD Lipase-98* ___ 05:34AM BLOOD %HbA1c-5.7 eAG-117 ___ 08:02PM BLOOD Lactate-1.6 ___ 08:11PM URINE RBC-4* WBC-25* Bacteri-FEW* Yeast-NONE Epi-0 DISCHARGE LABS ___ 06:03AM BLOOD WBC-6.8 RBC-2.94* Hgb-8.6* Hct-26.4* MCV-90 MCH-29.3 MCHC-32.6 RDW-15.9* RDWSD-52.2* Plt Ct-57* ___ 06:03AM BLOOD Glucose-93 UreaN-9 Creat-0.8 Na-139 K-3.5 Cl-105 HCO3-22 AnGap-12 ___ 06:03AM BLOOD ALT-21 AST-44* AlkPhos-95 TotBili-1.6* ___ 06:03AM BLOOD Albumin-3.1* Calcium-7.6* Phos-2.4* Mg-1.8 MICROBIOLOGY __________________________________________________________ ___ 5:01 pm URINE Source: ___. **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. __________________________________________________________ ___ 12:50 pm BLOOD CULTURE #1. Blood Culture, Routine (Pending): No growth to date. __________________________________________________________ Time Taken Not Noted Log-In Date/Time: ___ 8:12 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. __________________________________________________________ ___ 7:55 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. __________________________________________________________ ___ 7:45 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. IMAGING & PROCEDURES KUB ___ Diffuse gaseous distension, predominantly of the colon, without evidence of obstruction. CXR ___ Lungs are low volume with bibasilar atelectasis. Cardiomediastinal silhouette is stable. There is no pleural effusion. No pneumothorax is seen. Subsegmental atelectasis in the right lower lobe has resolved TIPS 1. Pre-TIPS right atrial pressure of 18 and balloon-occluded portal pressure measurement of 36 resulting in portosystemic gradient of 18 mmHg. 2. Left hepatic venogram in the AP and ___ positions confirmed appropriate position of the TIPS cannula. 3. Initial portal venogram demonstrates a large esophageal varix. Additional venogram of the distal SMV/stomal varix demonstrate a an enlarged varix in the right lower quadrant adjacent to the patient's urostomy. 4. Post embolization venogram of the stoma varix demonstrate complete stasis of the vessel. 5. Post embolization portal venogram demonstrates absence of flow within the embolized esophageal varix as well as brisk flow through the left hepatic vein to left portal vein TIPS. 6. Post-TIPS right atrial pressure of 23 and portal pressure of 30 resulting in portosystemic gradient of 7 mmHg. IMPRESSION: Successful right internal jugular access with transjugular intrahepatic portosystemic shunt placement (left hepatic vein to left portal vein) with decrease in porto-systemic pressure gradient (18 mmHg to 7 mmHg). Successful sclerosis and embolization of a large right lower quadrant stomal varix adjacent to the patient's urostomy and successful sclerosis and embolization of an esophageal varix. CTA A/P ___ 1. Cirrhotic liver with stigmata of portal hypertension. No lesions meeting optn criteria for ___. 2. Rim enhancing segment 7 hepatic lesion is stable and remains indeterminate. 3. Enlarged right inguinal lymph nodes, probably reactive. 4. Sigmoid colonic wall thickening can be secondary to chronic fibromuscular hyperplasia due to chronic diverticulitis. However, underlying mass lesion cannot be excluded. Correlation with colonoscopy results is recommended. RECOMMENDATION(S): Recommend ultrasound-guided biopsy of the new enlarged right inguinal lymph nodes given history of bladder carcinoma. Brief Hospital Course: Ms. ___ is a ___ year-old woman with PMHx of HCV cirrhosis (s/p Harvoni ___ with SVR) c/b thrombocytopenia, portal hypertension, and varices, transitional cell carcinoma (s/p neo-adjuvant cisplatin/gemcitabine, radical cystectomy, urethrectomy, TAH/BSO, and ileal conduit diversion in ___ who presented to the ED with recurrent bleeding from her urostomy in the setting of known parastomal varices. She underwent TIPs and embolization of stomal varix on ___ without issue. #RECURRENT PARASTOMAL VARICEAL BLEEDING: #ACUTE BLOOD LOSS ANEMIA. Patient presented with blood in her ostomy bag in setting of known parastomal varices. Previously in setting of excess aspirin use, but she reported no NSAID use recently. Hgb 9.1 at ___, reportedly received 2 units prior to transfer with inappropriate bump in hemoglobin. Patient had bag exchange at OSH with no hematuria noted since exchange. No hematemesis, melena, or hematochezia. ___ consulted who agreed that Ms. ___ was a suitable candidate for TIPs and embolization. CT scan (___) showed extensive intra-abdominal varices, some of which herniated into the subcutaneous tissues through the right lower quadrant ileostomy. CT scan also noted enlarged right inguinal lymph nodes. Patient is now s/p TIPs and embolization of stomal varix (___). # Nausea. Patient was found to have significant nausea during her hospital course. Etiology was unclear; KUB did not show SBO or ileus, on Zofran. Hba1c 5.7, low concern for gastroparesis. Patient started on MiraLAX and senna given KUB with no obstruction but distension and gas. Relief of nausea by morning of ___ after several bowel movements. She ate a bagel that morning with no issue. #HCV CIRRHOSIS. MELD-Na 11, previously on transplant list but inactivated ___. Hx of varices, SBP. and hepatic encephalopathy. EGD ___ with medium sized varices in lower third of esophagus not banded. No ascites on clinical exam. -Continued lactulose titrated to ___ BMs daily at first and then replaced with senna, miralax as above. Patient reports that she is not fully compliant with lactulose at home. Lactulose changed to 15 mg QAM. -Continued home rifaximin -Continued home propranolol for known varices and then discontinued post-TIPs -Continued home lasix/spironolactone -Continued home ciprofloxacin for SBP prophylaxis. Consider discontinuing in the outpatient setting as below. # Leukocytosis. Patient with WBC spike of 10.1 on ___ from ___. Deemed likely leukemoid in setting of recent TIPs. Patiently also briefly hypoxic w/ O2 requirement of 2 L. CXR ___ with subsegmental atelectasis but no evidence of PNA. Hypoxia and WBC count resolved without intervention. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Ciprofloxacin HCl 500 mg PO Q24H 2. Furosemide 20 mg PO BID 3. Pantoprazole 20 mg PO Q24H 4. Propranolol 10 mg PO BID 5. Rifaximin 550 mg PO BID 6. Lactulose 30 mL PO QID 7. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild 8. Spironolactone 50 mg PO DAILY 9. Multivitamins 1 TAB PO DAILY 10. biotin 5 mg oral DAILY Discharge Medications: 1. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First Line RX *polyethylene glycol 3350 [Miralax] 17 gram 1 powder(s) by mouth Daily Disp #*30 Packet Refills:*0 2. Senna 17.2 mg PO QHS RX *sennosides [senna] 8.6 mg 2 tabs by mouth at bedtime Disp #*60 Tablet Refills:*0 3. Lactulose 15 mL PO QAM RX *lactulose 10 gram/15 mL 15 mL by mouth QAM Refills:*0 4. Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet Refills:*0 5. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild 6. biotin 5 mg oral DAILY 7. Ciprofloxacin HCl 500 mg PO Q24H 8. Furosemide 20 mg PO BID 9. Multivitamins 1 TAB PO DAILY 10. Rifaximin 550 mg PO BID 11. Spironolactone 50 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Primary ====== Acute blood loss anemia Recurrent parastomal variceal bleed Secondary ======== HCV cirrhosis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear, You were admitted to the hospital because of concern for bleeding. WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL? - You were admitted to the hospital and underwent a procedure called TIPS (transjugular Intrahepatic Portosystemic Shunt) to relieve pressure from a known dilated blood vessel around your ostomy. - You had nausea and abdominal bloating while here. You were found to have significant gas on x-ray and on exam. You were started on medications to help you move your bowels and your symptoms improved. WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL? - Please take all of your medications as prescribed (listed below) - Keep your follow up appointments with your doctors - Please call your doctor or present to the emergency department if you experience any of the danger signs listed below. It was a pleasure participating in your care. We wish you the best! - Your ___ Care Team Followup Instructions: ___